SF|LF|MetaMap CUI|CSI|Ratio in CSI|UMLS CUI|UMLS SOURCE|ADAM|Ratio in ADAM|Dictionary
5-FU|2,4(1H,3H)-Pyrimidinedione, 5-fluoro-;5-Fluoro-2,4(1H, 3H)-pyrimidinedione;5-Fluoro-2,4(1H,3H)-pyrimidinedione||||C0016360|MSH;NCI;NDFRT;PDQ|||
5-FU|2,4-Dioxo-5-fluoropyrimidine||||C0016360|NCI;PDQ|||
5-FU|5 Fluorouracil;5 fluorouracil;5-Fluorouracil;5-fluoro-uracil;5-fluorouracil;5fluorouracil;5 fu;5-FU;5-Fu;5-fu;5FU;5-Fluracil;5Fluracil;5FU - Fluorouracil;FLUOROURACIL;Fluoro Uracil;Fluorouracil;fluorouracil;Fluoruracil;Fluouracil|C0016360|1|1|C0016360|CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.9959|
5-FU|5-flourouracil||||||1|0.0018|
5-FU|FU|C0016360;C1424823|||C0016360|PDQ|||
5-FU|Fluorouracil (product)||||C0016360|SNOMEDCT|||
5-FU|Fluorouracil (substance)||||C0016360|SNOMEDCT|||
5-FU|Fluorouracil [Chemical/Ingredient]||||C0016360|NDFRT|||
5-FU|chemotherapy|C0013216;C0013217;C0392920|||||1|0.0024|
6-MP|1,7-Dihydro-6H-purine-6-thione;6H-Purine-6-thione, 1,7-dihydro-||||C0000618|MSH;NCI;NDFRT;PDQ|||
6-MP|1,7-Dihydro-6H-purine-6-thione Monohydrate||||C0000618|NCI;PDQ|||
6-MP|3H-Purine-6-thiol;6 MP;6-MP;6-mp;6MP;6 Mercaptopurine;6 mercaptopurine;6-Mercaptopurine;6-mercaptopurine;Mercapto-6-purine;Purine, 6-mercapto-;6 Thiohypoxanthine;6-Thiohypoxanthine;6 Thiopurine;6 thiopurine;6-Thiopurine;6-thiopurine;6-Purinethiol;6-Thioxopurine;6MP - Mercaptopurine;MERCAPTOPURINE;Mercaptopurine;mercaptopurine;Mercapurin;Mern|C0000618|1|1|C0000618|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|1|
6-MP|6-Mercaptopurine [Chemical/Ingredient]||||C0000618|NDFRT|||
6-MP|6H-Purine-6-thione, 1,7-dihydro- (9CI)||||C0000618|NCI;PDQ|||
6-MP|7-Mercapto-1,3,4,6-tetrazaindene||||C0000618|NCI;PDQ|||
6-MP|MERCAPTOPURINE A 06||||C0000618|MSH|||
6-MP|MP||||C0000618|PDQ|||
6-MP|Mercaptopurine (product)||||C0000618|SNOMEDCT|||
6-MP|Mercaptopurine (substance)||||C0000618|SNOMEDCT|||
6-MP|Purine-6-thiol (8CI)||||C0000618|NCI;PDQ|||
AAA|A4||||C1705543|NCI|||
AAA|AAA||||C0162871;C0271742;C0611285;C1364818;C1705543|MEDLINEPLUS;NCI;OMIM|||
AAA|AAA - Abdominal aortic aneurysm;abdominal aortic aneurysm (AAA);ABDOMINAL AORTIC ANEURYSM;ANEURYSM, ABDOMINAL AORTIC;Abdominal Aortic Aneurysm;Abdominal Aortic Aneurysms;Abdominal aortic aneurysm;Aneurysm, Abdominal Aortic;Aneurysms, Abdominal Aortic;Aortic Aneurysm, Abdominal;Aortic Aneurysms, Abdominal;abdominal aortic aneurysm;abdominal aortic aneurysms|C0162871;C2926614|1|0.998|C0162871;C2926614|CHV;COSTAR;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.93|1
AAA|ABETA|C1420510;C1705543|||C1705543|NCI|||
AAA|ABPP|C0054150;C0611285|||C0611285|NCI|||
AAA|ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME;ADDISONIAN-ACHALASIA SYNDROME;Achalasia-addisonian syndrome;Addisonian achalasia syndrome;ALACRIMA-ACHALASIA-ADDISONIANISM;Alacrima-Achalasia-Addisonianism;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;Alacrima-achalasia-adrenal insufficiency neurologic disorder;ALLGROVE SYNDROME;Allgrove Syndrome;Allgrove syndrome;allgrove syndrome;allgroves syndrome;Achalasia Addisonianism Alacrimia syndrome;Alacrimia-achalasia-addisonianism;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;Glucocorticoid deficiency and achalasia;Glucocorticoid deficiency with achalasia;HYPOADRENALISM WITH ACHALASIA;Hypoadrenalism with achalasia;TRIPLE-A SYNDROME;Triple A syndrome;triple a syndrome|C0271742|||C0271742|CHV;MSH;MTH;NCI;OMIM;SNOMEDCT|||
AAA|ACTH resistant adrenal insufficiency, achalasia and alacrima;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMA||||C0271742|MSH;OMIM|||
AAA|AD1||||C1705543|NCI|||
AAA|AMYLOID BETA A4 PRECURSOR PROTEIN;Amyloid Beta (A4) Precursor Protein;Amyloid Beta A4 Protein Precursor;amyloid beta (A4) precursor protein|C0611285;C1364818|||C0611285;C1364818|HUGO;NCI;OMIM|||
AAA|AMYLOID OF AGING AND ALZHEIMER DISEASE||||C1364818|OMIM|||
AAA|ANEURYSM, AORTA, ABDOMINAL;abdominal aorta aneurysm;abdominal aneurysm;abdominal aneurysms;aneurysm abdominal|C0162871|||C0162871|CHV;DXP|||
AAA|APP||||C0611285;C1364818|HUGO;NCI;OMIM|||
AAA|APP Gene;APP gene;CEREBRAL VASCULAR AMYLOID PEPTIDE;DEMENTIA, EARLY-ONSET PROGRESSIVE, AUTOSOMAL RECESSIVE;peptidase nexin-II|C1364818|||C1364818|HUGO;MTH;NCI;OMIM|||
AAA|APP protein, human;APPI;Alzheimer Disease 1 Protein;Alzheimer's Disease Amyloid Protein;Cerebralvascular Amyloid Peptide;PN II;PN-II;PreA4;Protease Nexin-II, Alzheimer Disease;peptidase nexin-II, human;protease nexin 2, human|C0611285|||C0611285|MSH;MTH;NCI|||
AAA|APP wt Allele|C1705543|||C1705543|MTH;NCI|||
AAA|Abdominal aortic aneurysm (disorder)||||C0162871|SNOMEDCT|||
AAA|Aleuria aurantia agglutinin||||||1|0.0034|
AAA|Amyloid|C0002716;C0011560;C0611285|||C0611285|NCI|||
AAA|Amyloid Beta (A4) Precursor Protein (Protease Nexin-II, Alzheimer Disease) Gene||||C1364818|NCI|||
AAA|Amyloid Beta (A4) Precursor Protein (Protease Nexin-II, Alzheimer Disease) wt Allele||||C1705543|NCI|||
AAA|Amyloid Beta-Peptide|C0078939;C0611285|||C0611285|NCI|||
AAA|Amyloid of Aging and Alzheimer Disease Protein||||C0611285|NCI|||
AAA|Anguilla anguilla agglutinin||||||1|0.0046|
AAA|Aortic Aneurysm, Abdominal [Disease/Finding]||||C0162871|NDFRT|||
AAA|CVAP||||C0611285;C1364818;C1705543|NCI;OMIM|||
AAA|Glucocorticoid deficiency with achalasia (disorder)||||C0271742|SNOMEDCT|||
AAA|PN2|C0332398;C0611285;C1364818|||C0611285;C1364818|NCI;OMIM|||
AAA|PROTEASE NEXIN II;Protease Nexin II|C0085151;C0611285;C1364818|||C0611285;C1364818|NCI;OMIM|||
AAA|abdominal Aorta|C0003484;C1269882|||||1|0.0189|
AAA|abdominal aortic aneurysm repair|C0741152|||||1|0.004|
AAA|abdominal aortic aneurysmectomy||||||||1
AAA|achalasia-addisonism-alacrimia||||||||1
AAA|acne-associated arthritis||||||||1
AAA|acquired aplastic anemia|C0271907|1|0.002|C0271907|SNOMEDCT|||1
AAA|acute anxiety attack||||||||1
AAA|acute apical abscess|C1290646|||C1290646|SNOMEDCT|||
AAA|addiction, autoimmune diseases, aging||||||||1
AAA|alpha-aminoadipic acid|C0000257|||C0000257|MSH;NDFRT;SNOMEDCT|||
AAA|amalgam|C0440138;C0580619|||||||1
AAA|amino acid analysis||||||||1
AAA|amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) protein, human||||C0611285|MSH|||
AAA|androgenic anabolic agent||||||||1
AAA|aneurysm of ascending aorta|C0856747|||C0856747|CHV;SNOMEDCT|||1
AAA|angiography of abdominal aorta||||||||1
AAA|anti-actin antibody|C0369998|||C0369998|SNOMEDCT|||
AAA|anti-albumin antibodies||||||1|0.0029|
AAA|antigen-extracted allogenic||||||||1
AAA|aromatic amino acid;aromatic amino acids|C0301713|||C0301713|CHV;MSH;SNOMEDCT|1|0.0201|1
AAA|arrest after arrival||||||||1
AAA|arthroscopy, arthroscopy, arthrotomy||||||||1
AAA|aryl acylamidase|C0052439|||C0052439|MSH;SNOMEDCT|||
AAA|autoantibodies|C0004358|||||1|0.0052|
AAA|autolyzed antigen-extracted allogeneic||||||1|0.0029|
AAA|autolyzed, antigen-extracted, allogenic||||||||1
AAA|cellular activities||||||1|0.008|
ABG|A1B||||C1412045|OMIM|||
ABG|A1BG;A1BG gene;ALPHA-1-B-GLYCOPROTEIN;alpha-1-B glycoprotein|C1412045|||C1412045|HUGO;MTH;OMIM|||
ABG|ABG|C0150411;C1412045|||C0150411;C1412045|NCI;OMIM|||
ABG|ABG - Arterial blood gas analysis;ABGs measurement;Analysis of arterial blood gases and pH;Arterial Blood Gas Measurement;Arterial blood gas analysis;analysis arterial blood gas;arterial blood gas analysis;Arterial blood gases;arterial blood gases;Blood gases, arterial measurement;Gases, arterial measurement;Measurement of systemic arterial blood gases;arterial blood gas;blood gas arterial;arterial blood gase|C0150411|1|1|C0150411|CCS;CHV;ICD9CM;MTH;NCI;SNOMEDCT|1|0.8022|1
ABG|Analysis of arterial blood gas (oxygen saturation, pO2, pCO2, CO2, pH); rest only||||C0150411|MTH|||
ABG|Analysis of arterial blood gases and pH (procedure)||||C0150411|SNOMEDCT|||
ABG|Arterial bld gas measure||||C0150411|ICD9CM|||
ABG|Arterial blood gas analysis (procedure)||||C0150411|SNOMEDCT|||
ABG|Atrophic body gastritis||||||1|0.0604|
ABG|Blood Gas Analysis;Blood Gas Measurement|C0005800;C0150411|||C0150411|NCI|||
ABG|Blood gases, arterial measurement (procedure)||||C0150411|SNOMEDCT|||
ABG|GAB|C0016910;C1412045|||C1412045|OMIM|||
ABG|air-bone gap||||||1|0.1374|1
ABG|aortoiliac bypass graft||||||||1
ABG|axiobuccogingival||||||||1
AB|AB;Ab;NOS AB;NOS Ab;Little NOS Ab;Little not otherwise specified Antibody;Unidentified Ab;Unidentified Antibody;not otherwise specified AB;not otherwise specified Antibody|C0003241|||C0000769;C0003241;C0580927;C1705545;C2700382|LNC;MSH;NCI;SNOMEDCT|||
AB|AB - Zebrafish;AB Zebrafish|C2700382|||C2700382|MTH;NCI|||
AB|AB Term Type|C1705545|||C1705545|MTH;NCI|||
AB|AB hearing assessment list|C0580927|||C0580927|MTH;SNOMEDCT|||
AB|AB hearing assessment list (physical object)||||C0580927|SNOMEDCT|||
AB|ABNORM||||C0000769|MSH|||
AB|Ace bandage|C0336591|||||||1
AB|Alcian blue|C0001933|||||1|0.0444|1
AB|Antibodies;Antibody;Antibody, NOS;antibodies;antibody|C0003241;C0021027|||C0003241;C0021027;C1621287|AOD;CHV;CSP;FMA;GO;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.7669|1
AB|Antibodies [Chemical/Ingredient]||||C0003241|NDFRT|||
AB|Antibody (substance)||||C0003241|SNOMEDCT|||
AB|Autologous blood||||||1|0.0112|
AB|X-ray finding||1|0.002|||||
AB|abdomen|C0000726;C0230168;C1281594|||C0000726;C0230168;C1281594|AOD;CHV;CSP;CST;FMA;HL7V2.5;LCH;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT;UWDA|||
AB|abdominal|C0000726|||C0000726|CHV;LNC;NCI;SNOMEDCT|||1
AB|able-bodied||||||1|0.0264|
AB|abnormal|C0205161;C2347472;C2699333|||||||1
AB|abnormalities;abnormality|C0000768;C0000769;C1704258|||C0000769|MSH|||1
AB|abortion|C0156543;C0392535|1|0.690|C0156543;C0392535;C1548806|AOD;CHV;COSTAR;CSP;CST;HL7V2.5;LCH;MEDLINEPLUS;NCI;SNOMEDCT|||1
AB|abortus|C0000781;C1281512;C2004086|||||||1
AB|active bilaterally||||||||1
AB|acute bronchitis|C0149514|||||1|0.0045|
AB|aid to the blind|C0001844|||||||1
AB|air bleed||||||||1
AB|air-bone||||||||1
AB|amobarbital|C0002640|||||1|0.0051|
AB|amphotericin B|C0002679|||||1|0.0163|
AB|ankle-brachial||1|0.002|||||1
AB|anomalies;teratologic|C0000769|||C0000769|MSH;MTH|||
AB|anterior basal||||||||1
AB|anterior burster||||||1|0.0163|
AB|antibiotic;antibiotics|C0003232|||C0003232|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.014|1
AB|antibodi;antibodied;antibodis||||C0003241|CHV|||
AB|antibodys||||C0003241|CHV|||
AB|antigen binding|C1148575|||C1148575|GO;MTH;NCI|||1
AB|antipyrine benzocaine|C1445655|1|0.002|||||
AB|aortic banding||||||1|0.0056|
AB|apex beat|C0277909|||||||1
AB|apical-to-basolateral||||||1|0.0073|
AB|apnea and bradycardia||||||||1
AB|armboard||||||||1
AB|arsenobetaine|C0052420|||||1|0.0051|
AB|arterial blood|C0229665;C1550611;C2335890|1|0.002|||||
AB|artium baccalaureus|C1549948|||C1549948|NCI|||
AB|asbestos bodies;asbestos body|C0333598|||C0333598|NCI;SNOMEDCT|1|0.0247|1
AB|asthmatic bronchitis|C1319018|||C1319018|CHV;MTH;SNOMEDCT|||1
AB|attentional blink|C1955945|||C1955945|MSH|1|0.0298|1
AB|autoantibodies|C0004358|||||1|0.0118|
AB|autogenous bone||||||1|0.0034|
AB|autonomic blockade||||||1|0.0073|
AB|axiobuccal||||||||1
AB|azure B|C0052827|||||||1
AB|blood group in ABO system||1|0.274|||||1
AB|teratology|C0000769;C0220925|||C0000769|MSH|||
AB|type A, type B||1|0.016|||||
ABR|ABR;ABR gene;ACTIVE BCR-RELATED GENE;active BCR-related gene|C1412101|||C1412101|HUGO;MTH;OMIM|||
ABR|American Board of Radiology||||||1|0.0143|
ABR|Auditory brainstem response;auditory brain stem response;auditory brainstem response|C0079319;C0085854|1|1|C0085854|CHV;MSH|1|0.9697|1
ABR|MDB|C0025149;C0043896;C1412101|||C1412101|HUGO|||
ABR|abortus-Bang-ring||||||||1
ABR|abrasion|C0043242;C0580209;C1302752|||||||1
ABR|absolute bedrest||||||||1
ABR|agglutination test for brucellosis||||||||1
ABR|anterior band remover||||||||1
ABR|arterial baroreflex||||||||1
ABR|artery to bronchus ratio||||||||1
ABR|audiometric brainstem response||||||||1
ABR|auditory brain stem evoked response|C0079319|||C0079319|MSH|||
ABR|auditory brainstem||||||1|0.0101|
ABR|response testing||||||1|0.0059|
ACE|AC|C1879503|||C0050385|PDQ|||
ACE|AC chemotherapy protocol;AC protocol;CA protocol;Cyclophosphamide/Doxorubicin;Doxorubicin/Cyclophosphamide;cyclophosphamide/doxorubicin;doxorubicin cyclophosphamide;cyclophosphamide/doxorubicin protocol|C0050385|||C0050385|CHV;MSH;MTH;NCI;PDQ|||
ACE|ACE;ACe|C0022709;C0201888|||C0022709;C0050385;C0108844;C0201888;C0279078;C1413931|CSP;HUGO;NCI;OMIM;PDQ|||
ACE|ACE (wrap)||1|0.016|||||
ACE|ACE - Angiotensin-converting enzyme;Angiotensin Converting Enzyme;Angiotensin converting enzyme;Angiotensin-Converting Enzyme;Angiotensin-converting enzyme;angiotensin converting enzyme;angiotensin converting enzymes;angiotensin-converting enzyme;Antigens, CD143;CD143 Antigen;CD143 Antigens;Carboxycathepsin;Dipeptidyl Carboxypeptidase I;Dipeptidyl carboxypeptidase I;Dipeptidyl Peptidase A;Peptidase P;Peptidyl Dipeptidase A;Peptidyl-Dipeptidase A;Peptidyl-dipeptidase A;peptidyl dipeptidase A;dipeptidyl peptidase;kininase|C0022709|1|0.982|C0022709;C0201888;C2258685|CHV;CSP;GO;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.9545|1
ACE|ACE Gene;ACE gene|C1413931|||C1413931|HUGO;LNC;MTH;NCI|||
ACE|ACE measurement;Angiotensin Converting Enzyme Measurement;Angiotensin converting enzyme measurement;Angiotensin-I-converting enzyme measurement;Peptidyl dipeptidase A measurement|C0201888|||C0201888|MTH;NCI;SNOMEDCT|||
ACE|ACE-II;AVE;CAVP-16;CDE chemotherapy protocol;CDE protocol;CDE protocol-cyclophosphamide/doxorubicin/etoposide|C0108844|||C0108844|CHV;MSH;MTH;NCI;PDQ|||
ACE|ACE1|C1413931;C2984140|||C1413931|HUGO;OMIM|||
ACE|ANGIOTENSIN I-CONVERTING ENZYME;Angiotensin I Converting Enzyme;Angiotensin I-Converting Enzyme;angiotensin converting enzyme i;angiotensin i converting enzyme;DIPEPTIDYL CARBOXYPEPTIDASE 1;Dipeptidyl Carboxypeptidase 1;KININASE II;Kininase II|C0022709;C1413931|||C0022709;C1413931|CHV;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||
ACE|ANTIGENS CD 143;CD 143 ANTIGENS||||C0022709|MSH|||
ACE|APE|C0032636;C1675848|||C0279078|NCI;PDQ|||
ACE|APE chemotherapy protocol;cisplatin/cytarabine/etoposide protocol|C0279078|||C0279078|CHV;MTH|||
ACE|ARA-C/CDDP/VP-16||||C0279078|NCI;PDQ|||
ACE|Addenbrooke's Cognitive Examination||||||1|0.0017|
ACE|Angiotensin I Converting Enzyme (Peptidyl-Dipeptidase A) 1 Gene||||C1413931|NCI|||
ACE|Angiotensin converting enzyme inhibitors|C0003015;C2757044|||||1|0.0023|
ACE|Angiotensin converting enzyme measurement (procedure)||||C0201888|SNOMEDCT|||
ACE|Angiotensin-converting enzyme (substance)||||C0022709|SNOMEDCT|||
ACE|CA||||C0050385|NCI;PDQ|||
ACE|CAE||||C0108844|NCI;PDQ|||
ACE|CAVP|C0055598;C0108844;C0163868|||C0108844|NCI;PDQ|||
ACE|CD143|C0022709;C1413931;C2599700;C2984140|||C0022709;C1413931|HUGO;NCI|||
ACE|CDE|C0108844;C1521917|||C0108844|NCI;PDQ|||
ACE|CED||||C0108844|NCI;PDQ|||
ACE|CTX/DOX||||C0050385|NCI;PDQ|||
ACE|CTX/DOX/VP-16||||C0108844|NCI;PDQ|||
ACE|Cisplatin/Cytarabine/Etoposide;cisplatin/cytarabine/etoposide||||C0279078|NCI;PDQ|||
ACE|Cyclophosphamide/Doxorubicin/Etoposide;cyclophosphamide/doxorubicin/etoposide||||C0108844|NCI;PDQ|||
ACE|DCP1|C0752526;C1413931;C2984140|||C1413931|OMIM|||
ACE|Dipeptidyl carboxypeptidase I (substance)||||C0022709|SNOMEDCT|||
ACE|EC 3.2.1.-||||C0022709|NCI|||
ACE|EC 3.4.15.1||||C0022709|NCI|||
ACE|Kininase A||||C0022709|MSH;NDFRT|||
ACE|Peptidyl dipeptidase A measurement (procedure)||||C0201888|SNOMEDCT|||
ACE|Peptidyl-Dipeptidase A [Chemical/Ingredient]||||C0022709|NDFRT|||
ACE|accessory cholera enterotoxin|C0216868|||C0216868|MSH|||1
ACE|acentric||||||||1
ACE|acerebellar||||||1|0.0021|
ACE|acetaldehyde|C0000966|||C0000966|AOD;CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|||
ACE|acetate|C0000975|||C0000975|AOD;CHV;CSP;LNC;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
ACE|acetone|C0001002|||C0001002|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
ACE|acetonitrile|C0050456|||||||1
ACE|acetylcholine esterase;acetylcholinesterase|C0001044|||C0001044;C1412122|AOD;CHV;CSP;HUGO;LNC;MSH;MTH;NDFRT;OMIM;RXNORM;SNOMEDCT|1|0.0064|
ACE|actinium emanation||||||||1
ACE|acute care for elderly||||||||1
ACE|acute cerebral encephalopathy||||||||1
ACE|acute coronary event||||||||1
ACE|adrenocortical extract||||||||1
ACE|advanced combined encoder||||||||1
ACE|adverse clinical event||||||||1
ACE|aerobic chair exercise||||||||1
ACE|aerosol cloud enhancer||||||||1
ACE|affinity capillary electrophoresis||||||1|0.0116|
ACE|alcohol, chloroform, ether||||||||1
ACE|amygdaloid central nucleus;central amygdaloid nucleus|C0175219|||C0175219|FMA|1|0.0068|
ACE|angiotensin I converting enzyme (peptidyl-dipeptidase A) 1||||C1413931|HUGO|||
ACE|angiotensin converting enzyme (ACE) test||||C0201888|CHV|||
ACE|angiotensin converting enzyme gene||||||1|0.0015|
ACE|antegrade colonic enema||||||||1
ACE|antegrade continence enema||1|0.002|||1|0.0044|1
ACE|arm crank ergometer||||||1|0.0011|
ACE|arm crank ergometry||||||1|0.0009|
ACE|autologous-cultured epithelium||||||||1
ACE|central nucleus of the amygdala||||||1|0.0061|
ACE|cisplatin, cytarabine, and etoposide chemotherapy protocol||||C0279078|CHV|||
ACE|cyclophosphamide and etoposide||||||1|0.0006|
ACE|cyclophosphamide doxorubicin (AC protocol);cyclophosphamide doxorubicin (AC) protocol||||C0050385|CHV|||
ACE|cyclophosphamide, doxorubicin and etoposide chemotherapy protocol||||C0108844|CHV|||
ACL|ACL|C0683459;C1412125|||C0683459;C1412125|AOD;HUGO;OMIM|||
ACL|ACLY;ACLY gene;ATPCL;CLATP|C1412125|||C1412125|HUGO;MTH;OMIM|||
ACL|ATP CITRATE LYASE;ATP citrate lyase;ATP-citrate lyase;ATP citrate synthase|C0004199;C1412125|||C1412125|HUGO;OMIM|1|0.009|
ACL|Achievement Checklist||||||||1
ACL|Adjective Check List;Adjective CheckList;adjective check list|C0683459|||C0683459|AOD;CHV;MTH|1|0.0082|1
ACL|Allen Cognitive Level||||||||1
ACL|American cutaneous leishmaniasis|C1328252|||||1|0.0301|
ACL|accessory collateral ligament||||||||1
ACL|acetyl-L-carnitine|C0524474|1|0.008|||||
ACL|acromegaloid features, cutis verticis gyrata, corneal leukoma||||||||1
ACL|adenocarcinoma of the lung|C0152013|||||1|0.0043|
ACL|anal canal length||||||||1
ACL|anterior|C0205094|||||1|0.0043|
ACL|anterior cruciate||||||1|0.0047|
ACL|anterior cruciate ligament|C0078960;C1748452|1|0.984|C0078960;C1748452|CHV;FMA;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.6521|1
ACL|anti-cardiolipin;anticardiolipin||1|0.002|||1|0.0886|1
ACL|anti-cardiolipin antibody;anticardiolipin antibodies|C0162596|||||1|0.1897|
ACL|antibodies to cardiolipin||||||1|0.009|
AC|(drug) AC||1|0.322|||||
AC|A||||C0560271|NCI|||
AC|AC;ac;AC Regimen;AC regimen;Adriamycin-Cytoxan Regimen;CA Regimen|C1879503|||C0003354;C0050385;C0560271;C1300813;C1412573;C1550738;C1879503|HL7V3.0;HUGO;LNC;MTH;NCI;OMIM;PDQ|||
AC|AC DEFICIENCY;ACDase;ACID CDase;ASAH;ASAH1;ASAH1 gene;FLJ21558;N-ACYLSPHINGOSINE AMIDOHYDROLASE 1;N-ACYLSPHINGOSINE DEACYLASE;PHP32|C1412573|||C1412573|HUGO;MTH;OMIM|||
AC|AC chemotherapy protocol;AC protocol;CA protocol;Cyclophosphamide/Doxorubicin;Doxorubicin/Cyclophosphamide;cyclophosphamide/doxorubicin;doxorubicin and cyclophosphamide;doxorubicin cyclophosphamide;cyclophosphamide/doxorubicin protocol|C0050385|||C0050385|CHV;MSH;MTH;NCI;PDQ|1|0.0077|
AC|ACE;ACe|C0022709;C0201888|||C0050385|CSP;NCI;PDQ|||
AC|ACID CERAMIDASE;acid ceramidase|C1412573;C2350443|||C1412573|OMIM|1|0.0033|
AC|ACID CERAMIDASE DEFICIENCY;FARBER LIPOGRANULOMATOSIS|C0268255;C1412573|||C1412573|OMIM|||
AC|AG||||C0003354|NCI|||
AC|ANTIGUA AND BARBUDA;Antigua and Barbuda;Barbuda and Antigua||||C0003354|AOD;MSH;MTH;NCI;SNOMEDCT|||
AC|ATG||||C0003354|NCI|||
AC|Abdominal Circumference;Abdominal circumference;abdominal circumference|C1300813|1|0.004|C1300813|CHV;LNC;MTH;SNOMEDCT|||1
AC|Abdominal circumference (observable entity)||||C1300813|SNOMEDCT|||
AC|Acebutolol|C0000946|||||1|0.0037|
AC|Acinetobacter calcoaceticus|C0085467|||||||1
AC|Acre;acre;acres|C0560271;C2347175|||C0560271|CHV;HL7V3.0;MTH;NCI;SNOMEDCT|||
AC|Acre British;[ACR_BR]|C0560271|||C0560271|NCI|||
AC|Acre International||||C0560271|NCI|||
AC|Adriamycin and cyclophosphamide;adriamycin cyclophosphamide||1|0.236|||1|0.003|
AC|Air Conduction;air conduction|C0234744|||C0234744|SNOMEDCT|1|0.0055|1
AC|Antigua and Barbuda (geographic location)||||C0003354|SNOMEDCT|||
AC|Ar|C2986463|||C0560271|NCI|||
AC|Arachnoid cysts|C0078981|||||1|0.003|
AC|Autographa californica|C2767814|||||1|0.0033|
AC|Before Meal;Before Meals;Before meal;before meals;meal before;Before food;before food;food before;Preprandial;preprandial;ac - ante cibum;ante cibum;ante cibus|C1550738|1|0.084|C1550738|CHV;MTH;NCI;SNOMEDCT|||1
AC|Before food (qualifier value)||||C1550738|SNOMEDCT|||
AC|Before meal (qualifier value)||||C1550738|SNOMEDCT|||
AC|CA||||C0050385|NCI;PDQ|||
AC|CERAMIDASE DEFICIENCY|C0268255;C2936785|||C1412573|OMIM|||
AC|CTX/DOX||||C0050385|NCI;PDQ|||
AC|FARBER DISEASE|C0268255;C1412573;C2936785|||C1412573|OMIM|||
AC|N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY|C1412573;C2936785|||C1412573|OMIM|||
AC|N-acylsphingosine amidohydrolase (acid ceramidase) 1||||C1412573|HUGO|||
AC|NATO code for HCN||||||||1
AC|abcoulomb||||||||1
AC|abdominal compression||||||||1
AC|aberrant crypts||||||1|0.0055|
AC|ablation catheter|C0162563|||||||1
AC|abrupt closure||||||||1
AC|absorption coefficient||||||||1
AC|absorptive cell||||||||1
AC|abuse case||||||||1
AC|accessory cell;accessory cells|C0003315|||C0003315|CSP;NCI|1|0.0373|
AC|accommodative convergence||||||||1
AC|acetate|C0000975|1|0.008|||1|0.0096|1
AC|acetone|C0001002|||||1|0.0055|
AC|acetyl||||||||1
AC|acetylcholine|C0001041;C0523441|||C0001041;C0523441|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;UWDA;VANDF|1|0.0052|
AC|achaete||||||1|0.0074|
AC|acid|C0001128|||||||1
AC|acidified complement||||||||1
AC|acidity|C0001128;C0847097;C0920750|||||||1
AC|aconitine|C0001159|||||||1
AC|acre (qualifier value)||||C0560271|SNOMEDCT|||
AC|acromioclavicular|C0695640|1|0.316|C0695640|CHV|1|0.0251|1
AC|acrylamide|C0050587|||||1|0.0037|
AC|actinium|C0001246|||||||1
AC|activated carbon;activated charcoal|C0001275|||C0001275|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT|1|0.0354|1
AC|activation coefficient||||||1|0.003|
AC|activity coefficient||||||1|0.0033|
AC|acupuncture clinic||||||||1
AC|acute|C0205178|||C0205178;C1547229;C1547295|CHV;DXP;HL7V2.5;MTH;NCI;SNOMEDCT|||1
AC|acute acalculous cholecystitis|C0267842|||||1|0.0018|
AC|acute cholecystitis|C0149520|||C0149520|AOD;CHV;COSTAR;ICD9CM;MSH;NCI;NDFRT;SNOMEDCT|1|0.0144|1
AC|adenocarcinoma|C0001418|||C0001418|AOD;CHV;CSP;CST;LCH;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0568|1
AC|adenylate cyclase|C0001492;C1382029|||C0001492;C1382029|AOD;CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.2107|1
AC|adenylate cyclase activity|C1151015|||||1|0.0044|
AC|adenylyl cyclase|C0001492|||||1|0.1985|1
AC|adherent cell;adherent cells||||||1|0.0081|1
AC|adrenal cortex|C0001613|||C0001613|AOD;CHV;FMA;LCH;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|||1
AC|adrenocorticoid||||||||1
AC|aesthetic component||||||1|0.0103|
AC|affinity chromatography|C0008551|||||1|0.0048|
AC|aftercoming||||||||1
AC|air chamber||||||||1
AC|air changes||||||||1
AC|air conditioning|C0001864|||C0001864|CHV;LCH;MSH|||
AC|alcoholic cirrhosis|C0023891|||C0023891|AOD;CHV;COSTAR;MSH;NCI;NDFRT;SNOMEDCT|||1
AC|alcoholic coma|C0394017|||||||1
AC|all culture||||||||1
AC|allergic conjunctivitis|C0009766|||||1|0.0055|
AC|allyl chloride|C0051228|||||1|0.0026|
AC|alternating|C0332270|||||1|0.0033|
AC|alternating current|C0442830|1|0.002|C0442830|CHV;SNOMEDCT|1|0.0428|1
AC|alveolar crest||||||||1
AC|ambulatory care|C0002423;C1555966|||C0002423;C1555966|AOD;CHV;CSP;HL7V3.0;MSH|||1
AC|ambulatory controls||||||||1
AC|ammonium chloride|C0002615|||||1|0.0018|
AC|amniocentesis|C0002627|||C0002627|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;NCI;SNOMEDCT|1|0.0077|
AC|amygdaloid complex|C0002708|||||1|0.0048|
AC|anchor cell||||||1|0.0044|
AC|anchored catheter||||||||1
AC|anesthesia circuit||||||||1
AC|angiocellular||||||||1
AC|antecubital|C1549091|1|0.002|C1549091|HL7V2.5|||1
AC|anterior|C0205094|||||1|0.0044|
AC|anterior chamber|C0003151|||C0003151|CHV;CSP;LNC;MSH;NCI|1|0.0579|1
AC|anterior cingulate||||||1|0.0059|
AC|anterior circulation||||||||1
AC|anterior colporrhaphy|C0195224|||C0195224|CHV;MTHICD9;SNOMEDCT|||1
AC|anterior column||||||||1
AC|anterior commissure|C0152335;C1289546|||C0152335;C1289546|FMA;NCI;SNOMEDCT|1|0.024|1
AC|anterior cruciate||||||||1
AC|antibiotic concentrate||||||||1
AC|anticholinergic|C0242896|||||||1
AC|anticoagulant|C0003280;C0848112|||C0003280|CHV;CSP;LNC;NCI;NDFRT;SNOMEDCT|1|0.0063|1
AC|anticoagulation|C0003281;C2917212;C2919015|1|0.002|||1|0.007|
AC|anticomplement|C0052026|||||||1
AC|anticomplementary||||||||1
AC|anticonvulsant|C0003286|||||||1
AC|antiinflammatory corticoid||||||||1
AC|antiphlogistic corticoid||||||||1
AC|aortic closure||||||||1
AC|aortic coarctation|C0003492|||||1|0.0033|
AC|aortic compliance||||||||1
AC|aortic constriction||||||1|0.0085|
AC|aortocoronary|C0450107|||C0450107|CHV;SNOMEDCT|||1
AC|apatite cement||||||1|0.0022|
AC|arm circumference||||||1|0.0081|1
AC|arterial capillary||||||||1
AC|arterial compliance||||||1|0.0066|
AC|articular cartilage|C0007303;C1281692|||||1|0.0111|
AC|artificial circulation|C0868932|||||1|0.003|
AC|asbestos cement||||||1|0.0022|
AC|ascending colon|C0227375|||C0227375|AOD;CHV;CSP;FMA;MSH;MTH;MTHMST;NCI;SNOMEDCT;UWDA|||1
AC|assist control||1|0.018|||||1
AC|asymptomatic carriers||||||1|0.0033|
AC|atrial contraction||||||||1
AC|atriocarotid||||||||1
AC|attenuation correction|C2986723|||||1|0.014|
AC|attenuation-corrected||||||1|0.0044|
AC|atypical carcinoid||||||1|0.0077|
AC|auditory cortex|C0004302|||C0004302|AOD;CHV;CSP;FMA;MSH;MTH;NCI;SNOMEDCT|1|0.024|
AC|autoclave|C0179177|||||||1
AC|autologous cell||||||||1
AC|axillary clearance||||||1|0.003|
AC|axiocervical||||||||1
AC|azure C|C0052828|||||||1
AC|capacity|C1516240|||||1|0.0059|
AC|carcinoma|C0007097|||||1|0.0052|
AC|concentration|C0086045;C1446561|||||1|0.0033|
AC|control|C0009932;C0243148;C1550141;C1882979;C2587213|||||1|0.0092|
AC|cyclophosphamide doxorubicin (AC protocol);cyclophosphamide doxorubicin (AC) protocol||||C0050385|CHV|||
AC|maize Activator||||||1|0.0063|
AC|maize transposable element Activator||||||1|0.0055|
AC|nucleus accumbens|C0028633|||||1|0.0037|
AC|patients had alcoholic cirrhosis||||||1|0.0004|
ACTH|1-39 ACTH;ACTH (1-39);ACTH preparation;Adrenocorticotropic hormone preparation;CCTROP;Corticotrophic hormone;Corticotropic hormone;Corticotropin preparation;acth hormone;adrenocorticotropic peptide;adrenotrophin;adrenotropin;adrenotropic hormone|C0001655|||C0001655|AOD;CHV;MSH;NDFRT;PDQ;SNOMEDCT|||
ACTH|ACTH||||C0001655;C0201835;C1337111;C1523997;C1704793|AOD;CHV;CSP;FMA;HUGO;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT;UWDA|||
ACTH|ACTH - Adrenocorticotrophic hormone;adrenocorticotropic hormone (ACTH);Adrenocorticotrophic Hormone;Adrenocorticotrophic hormone;Adrenocorticotropic Hormone;Adrenocorticotropic hormone;Hormone, Adrenocorticotrophic;Hormone, Adrenocorticotropic;adrenocorticotrophic hormone;adrenocorticotropic hormone|C0001655;C1523997;C2825093|1|1|C0001655;C0201835;C1337111;C1523997;C2825093|AOD;CHV;CSP;HUGO;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.543|1
ACTH|ACTH measurement;Adrenocorticotrophic hormone level;Adrenocorticotropic Hormone Measurement;Adrenocorticotropic hormone measurement;Corticotropin measurement;acth test;acth testing|C0201835|||C0201835|CHV;MTH;NCI;SNOMEDCT|||
ACTH|Adrenocorticotropic;adrenocorticotrophic||||||1|0.007|
ACTH|Adrenocorticotropic Hormone [Chemical/Ingredient]||||C0001655|NDFRT|||
ACTH|Adrenocorticotropic hormone (substance)||||C0001655|SNOMEDCT|||
ACTH|Adrenocorticotropic hormone measurement (procedure)||||C0201835|SNOMEDCT|||
ACTH|Adrenocorticotropin;adrenocorticotropin;CORTICOTROPIN;Corticotrophin;Corticotrophins;Corticotropin;Corticotropins;corticotrophin;corticotrophins;corticotropin;corticotropins|C0001655;C1523997|||C0001655;C0201835;C1337111;C1523997|AOD;CHV;CSP;FMA;GO;HUGO;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;UWDA;VANDF|1|0.4441|
ACTH|CLIP|C0175722;C1705205|||C1337111;C1704793|HUGO;NCI|||
ACTH|Corticotrophin (1-39);Corticotropin (1-39)||||C0001655|MSH;NDFRT|||
ACTH|Corticotrophins (product)||||C0001655|SNOMEDCT|||
ACTH|Corticotrophins (substance);Corticotropin (substance)||||C0001655;C1523997|SNOMEDCT|||
ACTH|Corticotropin preparation (product)||||C0001655|SNOMEDCT|||
ACTH|Corticotropin preparation (substance)||||C0001655|SNOMEDCT|||
ACTH|LPH|C0023832;C1337111;C1416808|||C1337111|HUGO|||
ACTH|MSH||||C1337111;C1704793|HUGO;NCI|||
ACTH|NPP;POMC Gene;POMC gene|C1337111|||C1337111|HUGO;MTH;NCI|||
ACTH|POC|C1337111;C1704793|||C1337111;C1704793|HUGO;LNC;NCI;OMIM|||
ACTH|POMC||||C1337111;C1704793|HUGO;NCI;OMIM|||
ACTH|POMC wt Allele|C1704793|||C1704793|MTH;NCI|||
ACTH|PRO-ACTH-ENDORPHIN;PROOPIOMELANOCORTIN;proopiomelanocortin|C0033195;C1337111|||C1337111|HUGO;OMIM|||
ACTH|Proopiomelanocortin (Adrenocorticotropin/ Beta-Lipotropin/ Alpha-Melanocyte Stimulating Hormone/ Beta-Melanocyte Stimulating Hormone/ Beta-Endorphin) Gene||||C1337111|NCI|||
ACTH|Proopiomelanocortin (Adrenocorticotropin/ Beta-Lipotropin/ Alpha-Melanocyte Stimulating Hormone/ Beta-Melanocyte Stimulating Hormone/ Beta-Endorphin) wt Allele||||C1704793|NCI|||
ACTH|Recombinant Corticotropin;Therapeutic ACTH|C1523997|||C1523997|MTH;NCI|||
ACTH|adrenocorticotropic hormone (ACTH) level test||||C0201835|CHV|||
ACTH|alpha-melanocyte stimulating hormone|C0002302;C1337111|||C1337111|HUGO|||
ACTH|beta-endorphin|C0005210;C1337111|||C1337111|HUGO|||
ACTH|beta-lipotropin|C0023832;C1337111|||C1337111|HUGO|||
ACTH|beta-melanocyte stimulating hormone|C0005261;C1337111|||C1337111|HUGO|||
ACTH|plasma adrenocorticotrophin||||||1|0.0059|
ADA|ADA;Ada;Ada Lindl.;Genus Ada|C1060325|||C0001457;C0002456;C1060325;C1151644;C1412179;C1705019|GO;HUGO;MSH;MTH;NCBI;NCI;OMIM|||
ADA|ADA - Adenosine deaminase|C0001457|||C0001457|SNOMEDCT|||
ADA|ADA Gene;ADA gene;Adenosine Deaminase Gene;adenosine deaminase gene|C1412179|||C1412179|HUGO;MTH;NCI|1|0.0038|
ADA|ADENOSINE AMINOHYDROLASE;Adenosine Aminohydrolase;Adenosine aminohydrolase;Aminohydrolase, Adenosine;adenosine aminohydrolase;ADENOSINE DEAMINASE;Adenosine Deaminase;Adenosine deaminase;Deaminase, Adenosine;adenosine deaminase|C0001457;C1412179|1|0.002|C0001457;C1412179|CHV;CSP;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.6517|1
ADA|Adenine Deaminase|C0001457;C0050739|||C0001457|NCI|||
ADA|Adenosine Deaminase [Chemical/Ingredient]||||C0001457|NDFRT|||
ADA|Adenosine deaminase (substance)||||C0001457|SNOMEDCT|||
ADA|Adenosine deaminase activity|C1149733|||||1|0.0159|
ADA|American Dental Association;American association dental;Association, American Dental;Dental Association, American|C0002456|||C0002456|CHV;MSH;MTH;NCI|1|0.0257|
ADA|American Diabetes Association|C1705019|1|0.992|C1705019|MTH;NCI|1|0.1002|
ADA|Americans with Disabilities Act||||||1|0.1846|1
ADA|Americans with Disabilities Act of 1990||||||1|0.0093|
ADA|Azodicarbonamide|C0043716|||||1|0.0055|
ADA|DmpF;acetaldehyde dehydrogenase (acetylating) activity|C1151644|||C1151644|GO;MTH|||
ADA|EC 3.5.4.4||||C0001457|NCI|||
ADA|alcohol dependence and abuse||||||1|0.0033|
ADA|alternated delay acquisition||||||||1
ADA|anterior descending artery||||||||1
ADA|antideoxyribonucleic acid antibody||||||||1
ADA|approved dietary allowance||||||||1
ADD|4 Androstene 3,17 dione;4-Androstene-3,17-dione||||C0002860|MSH;NCI;NDFRT|||
ADD|ADD;Add;Added|C1524062;C1883712|||C0002860;C0004269;C1524062;C1548443;C1720086;C1883712|HL7V2.5;LNC;MEDLINEPLUS;NCI;SNOMEDCT|||
ADD|ADD action code||||C1548443|MTH|||
ADD|ADIONE - Delta 4-androstenedione;Androstanedione;Delta 4-androstenedione;Delta-4-Androstenedione;delta 4 Androstenedione;delta-4-Androstenedione;Therapeutic Androstenedione;Therapeutic_Androstenedione|C0002860|||C0002860|MSH;NCI;NDFRT;SNOMEDCT|||
ADD|ANDROSTENEDIONE;Androstenedione;androstenedione;androstenedione (ADD)|C0002860;C0337432|||C0002860|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
ADD|Add - dosing instruction fragment||||C1720086|MTH;SNOMEDCT|||
ADD|Add - dosing instruction fragment (qualifier value)||||C1720086|SNOMEDCT|||
ADD|Add - instruction imperative;Addition;addition|C1883712|||C1883712|MTH;NCI|||1
ADD|Additional|C1524062|||C1524062|LNC;MTH;NCI|||
ADD|Androst-4-ene-3,17-dione||||C0002860|MSH;NCI;NDFRT|||
ADD|Androstanedione (substance)||||C0002860|SNOMEDCT|||
ADD|Androstenedione (substance)||||C0002860|SNOMEDCT|||
ADD|Androstenedione [Chemical/Ingredient]||||C0002860|NDFRT|||
ADD|Attention Deficit Disorder;attention deficit disorder|C0041671;C0339002|1|0.99|||1|0.7991|1
ADD|Attention deficit disorder of childhood;Child attention deficit disorder;Child attention deficit disorder NOS;child attention deficit disorder (child ADD)|C0004269|||C0004269|CHV;ICD9CM;MTH;MTHICD9;SNOMEDCT|||
ADD|Child attention deficit disorder (disorder);Child attention deficit disorder NOS (disorder)||||C0004269|SNOMEDCT|||
ADD|acceptable daily dose||||||||1
ADD|acute diarrheal disease||||||1|0.0268|
ADD|adduction|C0231457|||||||1
ADD|adenosine deaminase|C0001457;C1412179|||||||1
ADD|afterdischarge duration||||||1|0.0625|
ADD|alcohol and drug dependency||||||||1
ADD|androsta-1,4-diene-3,17-dione||||||1|0.0402|
ADD|angled delivery device||||||||1
ADD|anterior disc displacement||||||1|0.0491|
ADD|auditory discrimination|C0234747|||||||1
ADD|average daily dose||||||||1
ADD|delta4-Androstene-3,17-dione||||C0002860|NCI|||
ADD|let there be added||||||||1
ADD|surgical induction of anterior disk displacement||||||1|0.0223|
ADHD|ADD - Attention deficit disorder with hyperactivity||||C1263846|SNOMEDCT|||
ADHD|ADDH;addh|C1263846;C2676242|||C1263846|CHV;CSP;MSH|||
ADHD|ADHD;ADHD (attention deficit hyperactivity disorder);ADHD - Attention deficit disorder with hyperactivity;Attention deficit hyperactivity disorder (ADHD);attention deficit hyperactivity disorder (ADHD);ATTENTION DEFICIT-HYPERACTIVITY DISORDER;Attention Deficit Disorder with Hyperactivity;Attention Deficit Disorders with Hyperactivity;Attention Deficit Hyperactivity Disorder;Attention Deficit Hyperactivity Disorders;Attention deficit hyperactivity disorder;attention deficit disorder with hyperactivity;attention deficit hyperactivity disorder;Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type;Attention deficit hyperkinetic disorder;Attention-Deficit Disorder, Predominantly Hyperactive-Impulsive Type;Childhood hyperkinetic syndrome;Hyperkinetic syndrome of childhood;childhood hyperkinetic syndrome;HYPERACTIVITY OF CHILDHOOD;HYPERKINETIC SYNDROME;Hyperkinetic Syndrome;Hyperkinetic syndrome;Hyperkinetic syndrome NOS;SYNDROME HYPERKINETIC;Syndromes, Hyperkinetic;hyperkinetic syndrome;Hyperactive child syndrome;hyperactive child syndrome;Hyperactivity Disorder NOS;disorder hyperactivity;hyperactivity disorder;Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type;Hyperkinetic disorder;hyperkinetic disorder;Overactive child syndrome;Unspecified hyperkinetic syndrome of childhood;attention deficit hyper disorder;attention deficit(hyper) disorder;attention deficits disorder hyper|C1263846|1|0.998|C1263846|AOD;CHV;CSP;CST;ICD9CM;MEDLINEPLUS;MSH;MTH;MTHICD9;NDFRT;OMIM;SNOMEDCT|1|1|1
ADHD|ATTENTION DEFICIT DIS WITH HYPERACTIVITY;ATTENTION DEFICIT HYPERACTIVITY DIS||||C1263846|MSH|||
ADHD|Attention Deficit Disorder with Hyperactivity [Disease/Finding]||||C1263846|NDFRT|||
ADHD|Attention deficit disorder|C0041671;C0339002|||C1263846|SNOMEDCT|||
ADHD|Attention deficit disorder (disorder)||||C1263846|SNOMEDCT|||
ADHD|Attention deficit disorder of childhood with hyperactivity||||C1263846|ICD9CM|||
ADHD|Attention deficit hyperactivity disorder (disorder)||||C1263846|SNOMEDCT|||
ADHD|Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type (disorder)||||C1263846|SNOMEDCT|||
ADHD|Attn deficit w hyperact||||C1263846|ICD9CM|||
ADHD|Childhood hyperkinetic syndrome (disorder)||||C1263846|SNOMEDCT|||
ADHD|Hyperkinetic synd NOS||||C1263846|ICD9CM|||
ADHD|Hyperkinetic syndrome NOS (disorder)||||C1263846|SNOMEDCT|||
ADHD|[X]Hyperkinetic disorder, unspecified||||C1263846|SNOMEDCT|||
ADHD|[X]Hyperkinetic disorder, unspecified (disorder)||||C1263846|SNOMEDCT|||
ADHD|minimal brain dysfunction|C1263846;C1321905|||C1263846|CHV|||
ADL|50-DAG;50kD DAG;DAG2;DYSTROGLYCAN 2;SCARMD1;SGCA;SGCA gene|C1420005|||C1420005|HUGO;LNC;MTH;OMIM|||
ADL|A2||||C1420005|HUGO|||
ADL|ADHALIN;adhalin;SARCOGLYCAN, ALPHA|C0248537;C1420005|||C1420005|HUGO;OMIM|||
ADL|ADL;adl;adls|C0001288;C1420005|||C0001288;C1420005|CHV;CSP;LNC;MSH;NCI;OMIM;SNOMEDCT|||
ADL|Activities of Daily Living;Activities, Daily Living;Activity of Daily Living;Activity of daily living;Activity, Daily Living;Daily Living Activities;Daily Living Activity;Living Activities, Daily;Living Activity, Daily;activities of daily living;activity of daily living;daily living activities;Activities of Daily Living (activity);Activities of everyday life;Household Activity;activities of daily living (ADL);functional ability|C0001288|1|0.988|C0001288|CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.935|1
ADL|Activities of Daily Living Scale||||||1|0.0084|
ADL|Activity of daily living (function)||||C0001288|SNOMEDCT|||
ADL|Activity of daily living (observable entity)||||C0001288|SNOMEDCT|||
ADL|Activity of daily living, function (observable entity)||||C0001288|SNOMEDCT|||
ADL|Amsterdam Depression List||||||||1
ADL|DMDA2;LGMD2D|C1420005;C1842550|||C1420005|HUGO|||
ADL|DYSTROPHIN-ASSOCIATED GLYCOPROTEIN, 50-KD||||C1420005|OMIM|||
ADL|Daily Activity;daily activities|C0001288;C0871707|||C0001288|NCI|1|0.0038|
ADL|Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)||||C1420005|HUGO|||
ADL|acid detergent lignin||||||1|0.0122|
ADL|activities of daily life||||||1|0.0298|
ADL|acute adenolymphangitis||||||1|0.0046|
ADL|adhalin (limb girdle muscular dystrophy 2D)||||C1420005|HUGO|||
ADL|adolescent medicine|C0001581|||||||1
ADL|adrenoleukodystrophy|C0162309;C1412084|||||||1
ADL|aerobic dive limit||||||1|0.0061|
ADL|sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)||||C1420005|HUGO|||
AFB|AFB - Acid fast bacillus;Acid-fast bacillus;acid fast bacillus;acid-fast bacilli;acid-fast bacillus;afb|C0483226|1|0.99|C0483226|CHV;MTH;SNOMEDCT|1|0.7925|1
AFB|Acid-fast bacillus (organism)||||C0483226|SNOMEDCT|||
AFB|acetate-free biofiltration|C0282467|||||1|0.0608|
AFB|aflatoxin B|C0085754|||||||1
AFB|aflatoxin B1|C0085180|||||1|0.1279|
AFB|aflatoxin biomarker||||||||1
AFB|air-fluidized bed|C0179267|||||||1
AFB|aortofemoral bypass|C0149619|||||1|0.0189|1
AFB|aspirated foreign body|C0686705|||||||1
AFB|scid-fast bacilli (AFB)||||C0483226|CHV|||
AFI|acute febrile illness||||||||1
AFI|amaurotic familial idiocy|C0282220|||||||1
AFI|amniotic fluid index|C0552315|1|1.000|||1|0.9098|1
AFI|atrial flutter|C0004239;C1963068|||||1|0.0902|
AFO|ankle-foot orthosis||1|1.000|||1|1|1
AFP|ACID FINGER PROTEIN;RNF95;TRIM26;TRIM26 gene;TRIPARTITE MOTIF-CONTAINING PROTEIN 26;ZINC FINGER PROTEIN 173, FORMERLY;ZNF173, FORMERLY|C1421661|||C1421661|HUGO;MTH;OMIM|||
AFP|AFP||||C0002210;C0201539;C1367597;C1421661|AOD;DXP;HUGO;NCI;NDFRT;OMIM|||
AFP|AFP - Alpha-fetoprotein;alpha-fetoprotein (AFP);ALPHA-FETOPROTEIN;Alpha Fetoprotein;Alpha fetoproteins;Alpha-Fetoprotein;Alpha-fetoprotein;Alpha-fetoprotein NOS;alfa-fetoprotein;alpha Fetoprotein;alpha Fetoproteins;alpha Foetoprotein;alpha fetoprotein;alpha fetoproteins;alpha foetoprotein;alpha-Fetoprotein;alpha-Fetoproteins;alpha-feto-protein;alpha-fetoprotein|C0002210;C0201539;C1367597|1|0.996|C0002210;C0201539;C1367597|AOD;CHV;CSP;HUGO;LCH;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8558|1
AFP|AFP Gene;AFP gene;Alpha-Fetoprotein Gene|C1367597|||C1367597|HUGO;MTH;NCI|||
AFP|AFP measurement;Alpha Fetoprotein measurement;Alpha Foetoprotein measurement;Alpha-fetoprotein Measurement;Alpha one fetoprotein measurement;Alpha-1-Fetoprotein measurement;Alpha-1-Foetoprotein measurement;alpha fetoprotein test;alpha fetoprotein testing|C0201539|||C0201539|CHV;MTH;NCI;SNOMEDCT|||
AFP|Alpha one fetoprotein (AFP) test||||C0201539|CHV|||
AFP|Alpha-1-Fetoprotein;alpha 1-fetoprotein;Alpha-Fetoglobulin;alpha1-fetoprotein|C0002210|||C0002210|LNC;NCI|1|0.0263|
AFP|Alpha-1-Fetoprotein measurement (procedure)||||C0201539|SNOMEDCT|||
AFP|Alpha-fetoprotein NOS (procedure)||||C0201539|SNOMEDCT|||
AFP|FETA|C1367597;C1706654;C2828822|||C1367597|HUGO|||
AFP|Fetuin;Fetuins;fetuin|C0002210;C3178998|||C0002210|AOD;CHV;CSP;NDFRT;SNOMEDCT|||
AFP|Fetuin (substance)||||C0002210|SNOMEDCT|||
AFP|Serum alphafoetoprotein;serum alphafetoprotein||||||1|0.0134|
AFP|a-fetoprotein||||||1|0.0036|
AFP|acute flaccid paralysis||||||1|0.0496|1
AFP|adiabatic fast passage||||||||1
AFP|alpha Fetoprotein (substance)||||C0002210|SNOMEDCT|||
AFP|alpha-Fetoproteins [Chemical/Ingredient]||||C0002210|NDFRT|||
AFP|anterior faucial pillar||||||||1
AFP|anterior fontanel pressure;anterior fontanelle pressure||||||1|0.0039|
AFP|anterior forebrain pathway||||||1|0.0051|
AFP|anti-alpha-fetoprotein||||||1|0.0042|
AFP|antifreeze polypeptide||||||1|0.0036|
AFP|antifreeze protein||||||1|0.0218|
AFP|antifungal protein||||||1|0.0051|
AFP|ascending frontal parietal||||||||1
AFP|atrial filling pressure||||||||1
AFP|atypical facial pain|C0154729|||C0154729|CHV;SNOMEDCT|1|0.0048|1
AFP|serum alpha-foetoprotein|C0373538;C0546833;C1287375|||||1|0.003|
AFP|tripartite motif containing 26||||C1421661|HUGO|||
AGA|18-alpha-glycyrrhetinic acid||||||1|0.0092|
AGA|AGA||||C0071561;C0162311;C1412276|HUGO;OMIM;PDQ|||
AGA|AGA gene;ASRG|C1412276|||C1412276|HUGO;MTH|||
AGA|AGA1;ALOPECIA, ANDROGENETIC, 1;ANDROGENETIC ALOPECIA;Alopecia, Androgenetic;Androgenetic Alopecia;Androgenetic alopecia;alopecia androgenetic;androgenetic alopecia;Alopecia hereditaria;Alopecia, Male Pattern;Male Pattern Alopecia;Male pattern alopecia;male pattern alopecia;Androgenic alopecia;alopecia androgenic;androgenic alopecia;BALDNESS, MALE PATTERN;Baldness, Male Pattern;Male Pattern Baldness;Male pattern baldness;baldness male pattern;male pattern baldness;Common baldness;Hereditary alopecia;MPB;Pattern baldness;pattern baldness|C0162311|||C0162311|CHV;MSH;MTH;OMIM;SNOMEDCT|1|0.1048|1
AGA|ALOPECIA ANDROGENET;ANDROGENET ALOPECIA||||C0162311|MSH|||
AGA|ASPARTYLGLUCOSAMINIDASE;aspartylglucosaminidase;GLYCOSYLASPARAGINASE;glycosylasparaginase|C0004025;C1412276|||C1412276|HUGO;OMIM|1|0.0601|
AGA|Alopecia hereditaria (disorder)||||C0162311|SNOMEDCT|||
AGA|Androgenic alopecia (disorder)||||C0162311|SNOMEDCT|||
AGA|Glutaminase-Asparaginase;Glutaminase-asparaginase;glutaminase-asparaginase;PEG-Glutaminase-Asparaginase;PEG-L-glutaminase-L-asparaginase;Polyethylene Glycol-Glutaminase-Asparaginase;polyethylene glycol-glutaminase-asparaginase;polyethyleneglycol-L-glutaminase-L-asparaginase|C0071561|||C0071561|MSH;MTH;NCI;PDQ|||
AGA|Male pattern alopecia (disorder)||||C0162311|SNOMEDCT|||
AGA|accelerated growth area||||||||1
AGA|acetylglutamate||||||||1
AGA|acute gonococcal arthritis|C2062407|||||||1
AGA|allergic granulomatosis and angiitis||||||1|0.0077|1
AGA|allergic granulomatous angiitis|C0008728|||||1|0.0169|
AGA|anti-gliadin;antigliadin||||||1|0.0601|
AGA|anti-gliadin antibodies|C0312639|||||1|0.0354|
AGA|anti-immunoglobulin A autoantibody||||||||1
AGA|antibodies to gliadin||||||1|0.0139|
AGA|antigliadin antibodies;antigliadin antibody||||||1|0.114|1
AGA|antiglomerular antibody||||||||1
AGA|appropriate|C1548787|||||1|0.0231|
AGA|appropriate for gestational age|C2985271|1|1.000|C2985271|NCI|1|0.5378|1
AGA|average gestational age||||||||1
AGA|presents the official recommendations of the American Gastroenterological Association||||||1|0.0169|
AICD|AICD;aicd;aicds|C0972395;C2611803|||C0972395;C2611803|CHV;GO|||
AICD|APP intracellular domain||||||1|0.0388|
AICD|Activation-induced cell death of T cells;activation-induced cell death of T cells;activation-induced cell death of T-cells|C2611803|||C2611803|GO;MTH|||
AICD|Automatic Implantable Cardioverter-Defibrillators;DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER;automatic implantable cardioverter defibrillator;automatic implantable cardioverter-defibrillator|C0972395|1|1|C0972395|MTH;SPN|1|0.3134|1
AICD|activation-induced B cell apoptosis;activation-induced B-cell apoptosis||||C2611803|GO|||
AICD|activation-induced cell death||||||1|0.6478|1
AICD|activation-induced cell death of B cells;activation-induced cell death of B-cells||||C2611803|GO|||
AICD|activation-induced cell death of B lymphocytes;activation-induced cell death of B-lymphocytes||||C2611803|GO|||
AICD|activation-induced cell death of T lymphocytes;activation-induced cell death of T-lymphocytes||||C2611803|GO|||
AICD|automatic implanted cardioverter-defibrillator||||||||1
AIDS|ACQUIRED IMMUNE DEFIC SYNDROME||||C0001175|MSH|||
AIDS|ACQUIRED IMMUNE DEFICIENCY SYNDROME;Acquired Immune Deficiency Syndrome;Acquired immune deficiency syndrome;Acquired immune deficiency syndrome, NOS;acquired immune deficiency syndrome;ACQUIRED IMMUNODEFICIENCY SYNDROME, AIDS;AIDS - Acquired immunodeficiency syndrome;AIDS, ACQUIRED IMMUNODEFICIENCY SYNDROME;acquired immunodeficiency syndrome (AIDS);AIDS;AIDS, NOS;AIDS (disorder);AIDS disorders;AUTOIMMUNE DEFICIENCY SYNDROME;autoimmune deficiency syndrome;Acquired Immune Deficiency;acquired immune deficiency;Acquired Immuno Deficiency Syndrome;Acquired Immuno-Deficiency Syndrome;Acquired Immuno-Deficiency Syndromes;Immuno-Deficiency Syndrome, Acquired;Immuno-Deficiency Syndromes, Acquired;Syndrome, Acquired Immuno-Deficiency;Syndromes, Acquired Immuno-Deficiency;acquired immuno-deficiency syndrome;Acquired Immunodeficiency Syndrome;Acquired Immunodeficiency Syndromes;Acquired immunodeficiency syndrome;Acquired immunodeficiency syndrome, NOS;Immunodeficiency Syndrome, Acquired;Immunodeficiency Syndromes, Acquired;Syndrome, Acquired Immunodeficiency;Syndromes, Acquired Immunodeficiency;acquired immunodeficiency syndrome;Acquired immune deficiency syndrome (AIDS);IMMUNE DEFICIENCY SYNDROME ACQUIRED <AIDS>;IMMUNE DEFICIENCY SYNDROME ACQUIRED AIDS;Immunodeficiency due to human immunodeficiency virus infection;Immunologic Deficiency Syndrome, Acquired|C0001175|1|0.992|C0001175|AOD;CHV;COSTAR;CSP;CST;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;QMR;RAM;SNOMEDCT|1|0.9954|1
AIDS|ACQUIRED IMMUNO DEFIC SYNDROME||||C0001175|MSH|||
AIDS|ACQUIRED IMMUNODEFIC SYNDROME;IMMUNODEFIC SYNDROME ACQUIRED||||C0001175|MSH|||
AIDS|Acquired Immunodeficiency Syndrome [Disease/Finding]||||C0001175|NDFRT|||
AIDS|Acquired human immunodeficiency virus infection syndrome NOS||||C0001175|SNOMEDCT|||
AIDS|Acquired human immunodeficiency virus infection syndrome NOS (disorder)||||C0001175|SNOMEDCT|||
AIDS|Acquired immune defic. synd.||||C0001175|SNOMEDCT|||
AIDS|Acquired immune defic. syndr.||||C0001175|SNOMEDCT|||
AIDS|Acquired immune deficiency syndrome (AIDS) (disorder)||||C0001175|SNOMEDCT|||
AIDS|Acquired immune deficiency syndrome (disorder)||||C0001175|SNOMEDCT|||
AIDS|Assessment of Intelligibility of Dysarthric Speech||||||||1
AIDS|IMMUNOL DEFIC SYNDROME ACQUIRED||||C0001175|MSH|||
AIDS|acquired immunodeficiency|C0596032|||||1|0.0014|
AIDS|acquired immunodeficiency disease||||||1|0.0021|
AIDS|acquired immunodeficiency virus||||||1|0.0013|
AIDS|hearing aids|C0018768|1|0.008|||||
AI|(class) AI||1|0.002|||||
AI|(stage) AI||1|0.002|||||
AI|AI;ai|C0003353;C0003504|||C0003139;C0003353;C0003504|CHV;MSH;NCI|||
AI|AI - Aortic incompetence;AORTIC INSUFFICIENCY;Aortic Insufficiency;Aortic insufficiency;aortic insufficiency;AORTIC REGURGITATION;Aortic Regurgitation;Aortic regurgitation;Aortic regurgitation, NOS;Regurgitation, Aortic;aortic regurgitation;AORTIC VALVE INSUFFICIENCY;AORTIC VALVE, INSUFFICIENCY;Aortic Valve Insufficiency;Aortic valve insufficiency;Aortic valve insufficiency, NOS;Insufficiency, Aortic Valve;aortic valve insufficiency;AORTIC VALVE REGURGITATION;AORTIC VALVE, REGURGITATION;Aortic valve regurgitation;Aortic valve regurgitation, NOS;Regurgitation, Aortic Valve;aortic valve regurgitation;AORTIC VALVE, INCOMPETENCE;Aortic Valve Incompetence;Aortic valve incompetence;Aortic valve incompetence, NOS;Incompetence, Aortic Valve;aortic valve incompetence;AR - Aortic regurgitation;Aortic Incompetence;Aortic incompetence;Incompetence, Aortic;aortic incompetence|C0003504|1|0.972|C0003504|CHV;COSTAR;CSP;DXP;LCH;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0547|1
AI|AIA;Anguilla island;Antigua|C0003353|||C0003353|MSH;MTH;NCI;SNOMEDCT|||
AI|ANGUILLA;Anguilla|C0003025;C0003353|||C0003353|AOD;NCI|||
AI|ANTAG||||C0003139|MSH|||
AI|AR|C2986463|||C0003504|NCI|||
AI|Adequate Intake||||||1|0.0091|
AI|Amelogenesis imperfecta|C0002452|||||1|0.0397|
AI|American Indian|C0002460|||||1|0.0129|
AI|Anguilla island (geographic location)||||C0003353|SNOMEDCT|||
AI|Aortic Valve Insufficiency [Disease/Finding]||||C0003504|NDFRT|||
AI|Aortic valve regurgitation (disorder)||||C0003504|SNOMEDCT|||
AI|Apoptosis|C0162638|||||1|0.0054|
AI|Apoptotic|C1516044|||||1|0.0059|
AI|Artificial intelligence;artificial intelligence|C0003916|||||1|0.0338|1
AI|Astragalus Injection||||||1|0.0038|
AI|Axonal injury||||||1|0.007|
AI|acceleration index||||||||1
AI|acceptable intake||||||||1
AI|accidental injury|C0151736|||C0151736|AOD;CHV;CST;NCI;SNOMEDCT|||1
AI|accidentally incurred||||||||1
AI|accommodative insufficiency|C0339687|||||||1
AI|acetabular index||||||||1
AI|active ingredient|C1292749;C1372955|||||1|0.0204|
AI|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0048|
AI|acute ileus||||||1|0.0064|
AI|acute inflammation|C0333361|||||||1
AI|adiposity index||||||||1
AI|adrenal incidentalomas||||||1|0.0043|
AI|adrenal insufficiency|C0001623;C0405580|||||1|0.0091|
AI|after infection||||||1|0.0027|
AI|aggregation index||||||||1
AI|airway inflammation||||||1|0.0032|
AI|allelic imbalance|C0887935|||||1|0.0676|
AI|allergy and immunology|C0002112|||C0002112|MSH|||1
AI|allergy index||||||||1
AI|aluminum|C0002367;C2348254|||||1|0.0064|
AI|amylogenesis imperfecta||||||||1
AI|anal index||||||||1
AI|anaphylatoxin inactivator|C0003766;C1413673|||C0003766;C1413673|MSH;NDFRT;OMIM;SNOMEDCT|||1
AI|anaphylatoxin inhibitor||||||||1
AI|anchorage-independent||||||1|0.0097|
AI|androgen-independent||||||1|0.0263|
AI|angiogenesis inhibitor|C0596087|||C0596087|CHV;CSP;NCI;SNOMEDCT|||1
AI|angiotensin I|C0003006|||||1|0.1025|
AI|angiotensin inhibitor||||||||1
AI|antagonists & inhibitors;inhibitor/antagonist|C0003139|||C0003139|CSP;MSH;MTH|||
AI|anti-inflammatory|C0003209;C1515999|||||1|0.0054|
AI|anxiety index||||||||1
AI|apical impulse|C0277909|||||||1
AI|apnea index||||||||1
AI|apoptotic index;apoptotic indices||||||1|0.1728|1
AI|aromatase inhibitor|C0593802;C2757060|||||1|0.0225|1
AI|articulation index||||||||1
AI|artificial insemination|C0021587|1|0.004|C0021587;C0699895|AOD;CHV;CSP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.1797|1
AI|artificially inseminated||||||1|0.0139|
AI|association-induction||||||1|0.0048|
AI|atherogenic index||||||||1
AI|atrial insufficiency||||||||1
AI|autoimmune|C0443146|||C0443146|CHV;NCI;SNOMEDCT|||1
AI|autoimmunity|C0004368|||C0004368|CHV;CSP;MSH;NCI;SNOMEDCT|||1
AI|avian influenza|C0016627|||||1|0.0327|
AI|avidity index||||||||1
AI|axioincisal||||||||1
AI|intensity|C0522510|||||1|0.0064|
AI|primary|C0205225;C0439631|||||1|0.0107|
AI|primary auditory area||||||1|0.0043|
AI|primary auditory cortex|C2954070|||||1|0.1041|
AI|primary auditory field||||||1|0.007|
AKA|AKA;Aka;aka;Aka <sponge>|C1204024|||C1199284;C1204024;C1417685|HUGO;MTH;NCBI|||
AKA|Aka (de Laubenfels, 1949)||||C1204024|NCBI|||
AKA|Broussonetia papyrifera;broussonetia papyrifera;gou shu;paper mulberry tree;paper-mulberry|C1199284|||C1199284|CHV;MTH;NCBI|||
AKA|Broussonetia papyrifera L'Her. ex Vent.||||C1199284|NCBI|||
AKA|Math4C;NEUROD3;NEUROG1;NEUROG1 gene;NEUROGENIC DIFFERENTIATION 3;neurogenic differentiation 3;NEUROGENIN 1;neurogenin 1;NGN1;ngn1;bHLHa6|C1417685|||C1417685|HUGO;MTH;OMIM|||
AKA|above-knee amputation|C0002691|1|0.968|C0002691|CHV;NCI|1|0.1481|1
AKA|alcoholic ketoacidosis|C0268039|||C0268039|AOD;SNOMEDCT|1|0.1667|1
AKA|all known allergies||||||||1
AKA|alpha-allokainic acid|C2350922|||||||1
AKA|also known as||1|0.030|||||1
AKA|antikeratin antibodies;antikeratin antibody||||||1|0.6852|1
ALD|ADRENOLEUKODYSTROPHY;Adrenoleucodystrophy;Adrenoleukodystrophies;Adrenoleukodystrophy;adreno-leukodystrophy;adrenoleucodystrophy;adrenoleukodystrophy;ALD (Adrenoleukodystrophy);ALDs (Adrenoleukodystrophy);adrenoleukodystrophy (ALD)|C0162309;C1412084|1|0.176|C0162309;C1412084|CHV;CSP;HUGO;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0338|1
ALD|ALD;ald;Addison-Schilder disease;Adrenoleukodystrophies, X-Linked;Adrenoleukodystrophy, X-Linked;X Linked Adrenoleukodystrophy;X-Linked Adrenoleukodystrophies;X-Linked Adrenoleukodystrophy;X-linked adrenoleucodystrophy;X-linked adrenoleukodystrophy;Schilder Addison Complex;Schilder-Addison Complex;Schilder-Addison complex|C0162309|||C0162309|CHV;CSP;MSH;MTHICD9;NDFRT;OMIM;SNOMEDCT|1|0.1352|
ALD|Adrenoleukodystrophy (disorder)||||C0162309|SNOMEDCT|||
ALD|Adrenoleukodystrophy [Disease/Finding]||||C0162309|NDFRT|||
ALD|acetyl lysergic acid diethylamide||1|0.002|||||
ALD|ad lib on demand||1|0.814|||||
ALD|adrenomyeloneuropathy|C0162309;C1527231|||C0162309|CHV|||
ALD|alcoholic liver disease|C0023896|||C0023896|CHV;COSTAR;MSH;NCI;SNOMEDCT|1|0.4253|1
ALD|aldolase|C0016762|||C0016762;C0201839|AOD;CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|1|0.1032|1
ALD|aldosine|C0295644|||C0295644|MSH|||
ALD|aldosterone|C0002006|||||||1
ALD|anterior|C0205094|||||1|0.0267|
ALD|anterior latissimus dorsi||||||1|0.194|1
ALD|anterior latissimus dorsi muscle||||||1|0.016|
ALD|appraisal of language disturbances||||||||1
ALD|approximate lethal dose||||||||1
ALD|assistive listening device|C0493583|||||||1
ALD|atomic layer deposition||||||1|0.0196|
ALD|average lens density||||||||1
ALD|melanodermic leukodystrophy|C0162309;C2931920|||C0162309|CHV|||
ALD|plasma aldosterone||||||1|0.0463|
ALS|ACID-LABILE SUBUNIT;acid labile subunit;acid-labile subunit;ACID-LABILE SUBUNIT DEFICIENCY;IGFALS;IGFALS gene;IGFBP, SOLUBLE|C1456383|||C1456383|HUGO;MTH;OMIM|1|0.0073|1
ALS|ALG;Antilymphocyte Serum;Antilymphocyte Serums;Antilymphocyte serum;Serum, Antilymphocyte;Serums, Antilymphocyte;anti-lymphocyte serum;antilymphocyte sera;antilymphocyte serum|C0003372|||C0003372|CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.063|1
ALS|ALS||||C0002736;C0003372;C1456383;C1704945|CHV;CSP;DXP;HUGO;MEDLINEPLUS;MSH;NCI;OMIM|||
ALS|ALS (Amyotrophic Lateral Sclerosis);ALS - Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS;Amyotrophic Lateral Sclerosis;Amyotrophic lateral sclerosis;Sclerosis, Amyotrophic Lateral;amyotrophic lateral sclerosis;amyotrophic laterals sclerosis;Bulbar motor neuron disease;Motor neuron disease, bulbar;Disease, Lou-Gehrigs;LOU GEHRIG DISEASE;Lou Gehrig Disease;Lou Gehrig's Disease;Lou Gehrig's disease;Lou-Gehrigs Disease;lou gehrig disease;lou gehrig's disease;lou gehrigs disease;Gehrig Disease;Gehrig's Disease;Gehrigs Disease;Lateral Scleroses, Amyotrophic;Motor Neuron Disease, Amyotrophic Lateral Sclerosis|C0002736|1|0.994|C0002736|AOD;CHV;COSTAR;CSP;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.836|1
ALS|ALS1|C1704945;C1862939|||C1704945|NCI|||
ALS|Amyotrophic Lateral Sclerosis [Disease/Finding]||||C0002736|NDFRT|||
ALS|Amyotrophic Lateral Sclerosis/Progressive Muscular Atrophy||||C0002736|QMR|||
ALS|Amyotrophic lateral sclerosis (disorder)||||C0002736|SNOMEDCT|||
ALS|Amyotrophic sclerosis||||C0002736|ICD9CM|||
ALS|Antilymphocyte Globulin|C0003370;C0003372|||C0003372|NCI|||
ALS|Antilymphocyte Serum [Chemical/Ingredient]||||C0003372|NDFRT|||
ALS|GEHRIGS DIS||||C0002736|MSH|||
ALS|INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT;insulin-like growth factor binding protein, acid labile subunit|C0170857;C1456383|||C1456383|HUGO;OMIM|||
ALS|IPOA|C1420306;C1704945|||C1704945|NCI|||
ALS|LOU GEHRIG DIS;LOU GEHRIGS DIS||||C0002736|MSH|||
ALS|Lou Gehrig's disease (ALS)||||C0002736|CHV|||
ALS|MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS||||C0002736|MSH|||
ALS|SOD||||C1704945|NCI|||
ALS|SOD1 wt Allele|C1704945|||C1704945|MTH;NCI|||
ALS|Superoxide Dismutase 1, Soluble (Amyotrophic Lateral Sclerosis 1 (Adult)) wt Allele||||C1704945|NCI|||
ALS|acetolactate synthase|C0000999|||||1|0.0156|
ALS|acute lateral sclerosis||||||||1
ALS|advanced life support|C0419055|1|0.006|C0419055|CHV;SNOMEDCT|1|0.0726|1
ALS|afferent loop syndrome|C0001727|||C0001727|CHV;DXP;MSH;NDFRT;SNOMEDCT|||1
ALS|alternating least squares||||||1|0.0032|
ALS|angiotensin-like substance||||||||1
ALS|antennal lobes||||||1|0.0022|
ALS|anterolateral sclerosis||||||||1
ALS|anticipated lifespan||||||||1
ALS|antiviral lymphocyte serum||||||||1
ALS|atypical lichenoid stomatitis||||||||1
ALT|AAT1||||C0001899|NCI|||
ALT|ALAT - Alanine aminotransferase;ALT;alt;alts;ALT - Alanine aminotransferase;alt alanine aminotransferase;Alanine 2 Oxoglutarate Aminotransferase;Alanine-2-Oxoglutarate Aminotransferase;Aminotransferase, Alanine-2-Oxoglutarate;Alanine Transaminase;Alanine transaminase;Transaminase, Alanine;alanine transaminase;GPT;gpt;gpts;Glutamic Alanine Transaminase;Glutamic-Alanine Transaminase;Glutamic-alanine transaminase;Transaminase, Glutamic-Alanine;glutamic alanine transaminase;Glutamic Pyruvic Transaminase;Glutamic-Pyruvic Transaminase;Glutamic-pyruvic transaminase;Transaminase, Glutamic-Pyruvic;glutamic pyruvic transaminase;glutamic-pyruvic transaminase;transaminase glutamic-pyruvic;Glutamic-Pyruvate Transaminase;S-ALAT;s-alat;alanine transaminase (ALT)|C0001899|||C0001899;C0201836;C0376147;C2257651|AOD;CHV;CSP;GO;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
ALT|ALT measurement;alt measurement;Alanine Aminotransferase Measurement;Alanine aminotransferase measurement;GPT measurement;Glutamic pyruvate transaminase measurement;SGPT measurement|C0201836|||C0201836|CHV;MTH;NCI;SNOMEDCT|||
ALT|ALT1;Glutamate pyruvate transaminase;glutamate pyruvate transaminase|C0001899;C1415274|||C0001899|AOD;CHV;NCI;SNOMEDCT|||
ALT|Alanine Aminotransferase;Alanine aminotransferase;Aminotransferase, Alanine;alanine amino transferase;alanine aminotransferase;alanine-aminotransferase|C0001899;C0057041|1|1|C0001899;C0201836|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.1184|1
ALT|Alanine Transaminase [Chemical/Ingredient]||||C0001899|NDFRT|||
ALT|Alanine aminotransferase (substance)||||C0001899|SNOMEDCT|||
ALT|Alanine aminotransferase measurement (procedure)||||C0201836|SNOMEDCT|||
ALT|GPT1||||C0001899|NCI|||
ALT|L-Alanine:2-oxoglutarate aminotransferase;L-alanine:2-oxoglutarate aminotransferase||||C0001899|MSH;NDFRT;SNOMEDCT|||
ALT|L-alanine:2-oxoglutarate aminotransferase activity;alanine aminotransferase activity;alanine transaminase activity;alanine-alpha-ketoglutarate aminotransferase activity;alanine-pyruvate aminotransferase activity;pyruvate-alanine aminotransferase activity|C2257651|||C2257651|GO;MTH|1|0.0171|
ALT|SGPT||||C0001899;C0201836;C0376147|CHV;MSH;MTH;NCI;SNOMEDCT|||
ALT|SGPT (ALT)||||C0376147|NCI|||
ALT|SGPT - Glutamate pyruvate transaminase;alanine transferase;serum glutamate pyruvate transaminase;serum glutamate pyruvate transaminase (SGPT)|C0376147|||C0376147|CHV;MTH;NCI;SNOMEDCT|||
ALT|Serum alanine aminotransferase||||||1|0.5431|
ALT|Serum alanine transaminase||||||1|0.1109|
ALT|alanine aminotransaminase||||||1|0.0133|
ALT|alanine aminotransferase (ALT) level test||||C0201836|CHV|||
ALT|alternate|C0332270;C1523987|||||||1
ALT|alternative lengthening of telomeres||||||1|0.0341|
ALT|altitude|C0002349;C1649428|||||1|0.0085|1
ALT|anterolateral thigh||||||1|0.0123|
ALT|anterolateral tract||||||||1
ALT|antibiotic lock technique||||||||1
ALT|argon laser trabeculopexy||||||||1
ALT|argon laser trabeculoplasty|C1319234|||||1|0.1062|1
ALT|autolymphocyte therapy||||||1|0.0152|1
ALT|auxiliary liver transplantation||||||1|0.0076|
ALT|avian laryngotracheitis||||||||1
ALT|serum alanine transferase||||||1|0.0133|
AMA|AMA|C0002461;C0279755;C2825862|||C0002461;C0279755;C2825862|MSH;NCI;PDQ|||
AMA|ARA-C/L-PAM||||C0279755|NCI;PDQ|||
AMA|American Medical Association;American association medical;Association, American Medical;Medical Association, American|C0002461|||C0002461|CHV;MSH;MTH;NCI|1|0.286|
AMA|Antimitochondrial Antibodies;antimitochondrial antibodies;antimitochondrial antibody;Mitochondrial Antibody|C0312621;C2825862|1|0.05|C2825862|NCI|1|0.2882|1
AMA|Antimitochondrial Antibody Measurement|C2825862|||C2825862|MTH;NCI|||
AMA|Antimitochondrial autoantibodies||||||1|0.0409|
AMA|Cytarabine/Melphalan;cytarabine/melphalan|C0279755|||C0279755|MTH;NCI;PDQ|||
AMA|actual mechanical advantage||||||||1
AMA|advanced maternal age||1|0.062|||1|0.0301|1
AMA|against medical advice||1|0.888|||1|0.0989|1
AMA|alkaline membrane assay||||||||1
AMA|amantadine|C0002403|||||1|0.0366|
AMA|anti-mitochondrial;antimitochondrial||||||1|0.0409|
AMA|anti-mitochondrial antibodies||||||1|0.114|
AMA|antimyosin antibody||||||||1
AMA|antithyroid microsomal antibody||||||||1
AMA|apocrine membrane antigen||||||||1
AMA|arm muscle area||||||1|0.0645|1
AMA|augmentation of mandibular angle||||||||1
AMA|autoregressive moving average||||||||1
AML|ACUTE MYELOBLASTIC LEUKEMIA;Acute Myeloblastic Leukemia;Acute Myeloblastic Leukemias;Acute myeloblastic leukaemia;Acute myeloblastic leukemia;LEUKEMIA ACUTE MYELOBLASTIC;LEUKEMIA MYELOBLASTIC ACUTE;LEUKEMIA, MYELOBLASTIC, ACUTE;Leukemia, Acute Myeloblastic;Leukemia, Myeloblastic, Acute;Leukemias, Acute Myeloblastic;Myeloblastic Leukemia, Acute;Myeloblastic Leukemias, Acute;acute myeloblastic leukemia;ACUTE MYELOGENOUS LEUKEMIA;Acute Myelogenous Leukemia;Acute Myelogenous Leukemias;Acute myelogenous leukaemia;Acute myelogenous leukemia;LEUKEMIA, ACUTE MYELOGENOUS;LEUKEMIA, MYELOGENOUS, ACUTE;Leukemia, Acute Myelogenous;Leukemia, Myelogenous, Acute;Leukemias, Acute Myelogenous;Myelogenous Leukemia, Acute;Myelogenous Leukemias, Acute;acute myelogenous leukaemia;acute myelogenous leukemia;AML;AML, NOS;aml;AML - Acute Myeloid Leukemia;AML - Acute myeloid leukaemia;AML - Acute myeloid leukemia;AML - Acute myeloblastic leukaemia;AML - Acute myeloblastic leukemia;ANLL;anll;Acute Myelocytic Leukemia;Acute Myelocytic Leukemias;Acute myelocytic leukaemia;Acute myelocytic leukemia;LEUKEMIA, MYELOCYTIC, ACUTE;Leukemia, Acute Myelocytic;Leukemia, Myelocytic, Acute;Leukemias, Acute Myelocytic;Myelocytic Leukemia, Acute;Myelocytic Leukemias, Acute;acute myelocytic leukaemia;acute myelocytic leukemia;Acute Nonlymphoblastic Leukemia;Acute Nonlymphoblastic Leukemias;Leukemia, Acute Nonlymphoblastic;Leukemia, Nonlymphoblastic, Acute;Leukemias, Acute Nonlymphoblastic;Nonlymphoblastic Leukemia, Acute;Nonlymphoblastic Leukemias, Acute;acute nonlymphoblastic leukemia;Acute Nonlymphocytic Leukemia;Acute Nonlymphocytic Leukemias;Acute non-lymphocytic leukaemia;Acute non-lymphocytic leukemia;Leukemia, Acute Nonlymphocytic;Leukemia, Nonlymphocytic, Acute;Leukemias, Acute Nonlymphocytic;Nonlymphocytic Leukemia, Acute;Nonlymphocytic Leukemias, Acute;acute non-lymphocytic leukemia;acute nonlymphocytic leukemia;leukemia, acute nonlymphocytic;Acute granulocytic leukaemia;Acute granulocytic leukemia;LEUKEMIA, GRANULOCYTIC, ACUTE;acute granulocytic leukemia;Acute myeloid leukaemia - category;Acute myeloid leukemia - category;Acute myeloid leukaemia, disease;Acute myeloid leukemia, disease;Acute myeloid leukaemia, no ICD-O subtype;Acute myeloid leukemia, no ICD-O subtype;acute leukemias non lymphoblastic;acute non-lymphoblastic leukemia;non-lymphoblastic leukemia acute;acute myelogenous leukemia (AML);acute nonlymphocytic leukemia (ANLL)|C0023467|1|1|C0023467|CHV;COSTAR;CSP;CST;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;QMR;SNOMEDCT|1|0.2615|1
AML|Acute Myeloid Leukemia;Acute Myeloid Leukemia NOS;Acute Myeloid Leukemia, NOS;Acute Myeloid Leukemias;Acute myeloid leukaemia;Acute myeloid leukemia;LEUKEMIA, ACUTE MYELOID;LEUKEMIA, MYELOID, ACUTE;Leukemia, Acute Myeloid;Leukemia, Myeloid, Acute;Leukemias, Acute Myeloid;Myeloid Leukemia, Acute;Myeloid Leukemias, Acute;Myeloid leukemia, acute;acute myeloid leukaemia;acute myeloid leukemia;acute myeloid leukemias;leukemia, acute myeloid;Acute Myeloid Leukemia Not Otherwise Specified|C0023467;C2984331|||C0023467;C2984331|CHV;CSP;DXP;ICD9CM;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.7104|
AML|Acute Myeloid Leukemia Not Otherwise Categorized||||C0023467|NCI|||
AML|Acute myeloblastic leukemia (disorder)||||C0023467|SNOMEDCT|||
AML|Acute myeloid leukemia - category (morphologic abnormality)||||C0023467|SNOMEDCT|||
AML|Acute myeloid leukemia, disease (disorder)||||C0023467|SNOMEDCT|||
AML|Acute myeloid leukemia, no ICD-O subtype (morphologic abnormality)||||C0023467|SNOMEDCT|||
AML|Amlodipine;amlodipine|C0051696|||C0051696|CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0022|
AML|Hematopoeitic - Acute Myleogenous Leukemia (AML)||||C0023467|NCI|||
AML|Leukemia, Myeloid, Acute [Disease/Finding]||||C0023467|NDFRT|||
AML|[M]Acute myeloid leukaemia;[M]Acute myeloid leukemia||||C0023467|SNOMEDCT|||
AML|[M]Acute myeloid leukaemia (disorder)||||C0023467|SNOMEDCT|||
AML|acute monoblastic leukemia|C0023465;C0457334|||||||1
AML|acute monocytic leukemia|C0023465;C1318544|||||||1
AML|acute mucosal lesion||||||||1
AML|acute myeloblastic||||||1|0.0024|
AML|acute myelogenous||||||1|0.0014|
AML|acute myeloid||||||1|0.0046|
AML|acute myeloid leukemic||||||1|0.0033|
AML|anatomic medullary locking||||||1|0.0019|1
AML|angiomyolipoma|C0206633|||C0206633|CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||1
AML|anterior mitral leaflet|C0225950;C1305164|||C0225950;C1305164|FMA;SNOMEDCT;UWDA|1|0.0045|1
AML|automated multitest laboratory||||||||1
AML|renal angiomyolipoma|C0241961|||||1|0.0079|
AM|ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN;activating transcription factor 7 interacting protein;ATF7-INTERACTING PROTEIN;ATF7IP;ATF7IP gene;FLJ10688;MCAF1;p621|C1426677|||C1426677|HUGO;MTH;OMIM|||
AM|ADM||||C1412244|HUGO;OMIM|||
AM|ADM gene|C1412244|||C1412244|HUGO;MTH|||
AM|ADRENOMEDULLIN;adrenomedullin|C0215825;C1412244|||C1412244|HUGO;OMIM|1|0.1924|1
AM|AM;Am;am||||C0002467;C0003798;C0332170;C0487769;C1412244;C1426677;C2346872|HL7V3.0;HUGO;LNC;NCI;OMIM|||
AM|AM AG;Am Ag||||C0487769|LNC|||
AM|AM antigen;Am Antigen||||C0487769|LNC;MTH|||
AM|ARM|C0446516;C1140618;C1269078;C1269612|||C0003798|NCI|||
AM|ARMENIA;Armenia;armenia;Armenian S.S.R.;Armenian SSR|C0003798|||C0003798|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
AM|ATFA MODULATOR, MOUSE, HOMOLOG OF||||C1426677|OMIM|||
AM|Am element||||C0002467|CSP|||
AM|Americium;Americium, NOS;americium|C0002467|||C0002467|AOD;CSP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
AM|Americium (substance)||||C0002467|SNOMEDCT|||
AM|Americium [Chemical/Ingredient]||||C0002467|NDFRT|||
AM|Americum, NOS||||C0002467|SNOMEDCT|||
AM|Armenia (geographic location)||||C0003798|SNOMEDCT|||
AM|Astragalus membranaceus|C0949831|||||1|0.0097|
AM|Attometer|C2346872|||C2346872|MTH;NCI|||
AM|Austin Moore||||||||1
AM|Autobiographical Memory|C0561843|||||1|0.0023|
AM|During morning;In the morning;Morning;in the morning;morning;ante meridiem;om - omni mane|C0332170|||C0332170|AOD;CHV;MTH;NCI;SNOMEDCT|1|0.0184|
AM|MBD1-CONTAINING CHROMATIN-ASSOCIATED FACTOR||||C1426677|OMIM|||
AM|MCAF|C1337092;C1426677;C1522558;C1705079|||C1426677|OMIM|||
AM|Morning (qualifier value)||||C0332170|SNOMEDCT|||
AM|Sinusoidally amplitude-modulated||||||1|0.0037|
AM|acetoxymethyl||||||1|0.0074|
AM|acetoxymethyl ester||||||1|0.0094|
AM|acrylamide|C0050587|||||1|0.0047|1
AM|actomyosin|C0001291;C1325607|||||1|0.0043|1
AM|acute myelofibrosis|C0334674|||||||1
AM|adhesion molecules||||||1|0.007|
AM|adrenal medulla|C0001629|||||1|0.0084|
AM|adriamycin|C0085752|||||1|0.0097|
AM|adult male||||||||1
AM|adult monocyte||||||||1
AM|aerosol mask||||||||1
AM|aerospace medicine|C0001713;C1555853|||||||1
AM|akinetic mutism|C0001889|||||||1
AM|alternative medicine|C0002346|||||1|0.0037|1
AM|alveolar|C1440080|||||1|0.0033|
AM|alveolar macrophage;alveolar macrophages|C0085236|||C0085236|CHV;CSP;FMA;MSH;NCI;SNOMEDCT|1|0.4788|1
AM|alveolar mucosa||||||||1
AM|am - ante meridiem||||C0332170|SNOMEDCT|||
AM|amacrine cell|C0229216|||||||1
AM|amalgam|C0440138;C0580619|||||||1
AM|ambulatory monitoring|C0242882|||||1|0.0027|
AM|ametropia|C1527310|||||||1
AM|aminopyrine|C0002586|||||1|0.0033|
AM|amiodarone|C0002598|||||1|0.018|
AM|ammeter||||||||1
AM|amnion|C0002630|||||||1
AM|amniotic membrane|C0002630;C1305379|||||1|0.0214|
AM|amphetamine|C0002658;C0002667|||||1|0.0104|
AM|ampicillin|C0002680|||||1|0.005|
AM|amplitude|C2346753|||||||1
AM|amplitude modulated||||||1|0.0097|
AM|amplitude modulation||||||1|0.0277|1
AM|amygdala|C0002708|||||1|0.0321|
AM|amygdaloid||||||1|0.0057|
AM|amyl||||||||1
AM|amylase|C0002712|||||1|0.004|
AM|anovular menstruation|C0404557|||||||1
AM|anterior midpapillary||||||||1
AM|anteromeatal||||||||1
AM|anteromedial|C1179847|||||1|0.007|
AM|anteromedial nucleus|C0228319|||||1|0.0023|
AM|antimycotic||||||||1
AM|apparent motion||||||1|0.007|
AM|arabinomannan|C0052278|||||||1
AM|arbuscular mycorrhiza||||||1|0.004|
AM|arbuscular mycorrhizal||||||1|0.0551|
AM|arithmetic mean||||||1|0.0033|1
AM|arousal mechanism||||||||1
AM|artemether|C0052429|||||1|0.003|
AM|arterial malformation|C0151489|||||||1
AM|arterial mean||||||||1
AM|articulation manipulation||||||||1
AM|aseptic meningitis|C0025290|||||1|0.0084|
AM|aseptic meningo-encephalitis||||||1|0.0027|
AM|aseptic meningoencephalitis||||||1|0.004|
AM|atrial myxoma|C0151241|||||||1
AM|attitude to medication||||||||1
AM|aviation medicine|C0004431|||||||1
AM|axiomesial||||||||1
AM|before noon||1|0.980|||||1
AM|mane|C0222048;C0332170|||C0332170|SNOMEDCT|||
AM|meter angle||||||||1
AM|mixed astigmatism||||||||1
AM|myopic astigmatism||||||||1
ANA|ABUNDANT IN NEUROEPITHELIUM AREA;B-CELL TRANSLOCATION GENE 3;BTG family, member 3;BTG3;BTG3 gene;TOB5|C1412840|||C1412840|HUGO;MTH;OMIM|||
ANA|ANA;Ana;ana||||C0002463;C0003243;C0702121;C1412840;C1882141|CHV;CST;HUGO;MSH;NCI;OMIM;SNOMEDCT|||
ANA|ANA - Anti-nuclear antibody;ANF - Anti-nuclear factor;Anti-nuclear antibodies;Anti-nuclear antibody;anti-nuclear antibody;Antinuclear Autoantibody;antinuclear autoantibodies;antinuclear autoantibody;Antinuclear Factor;Antinuclear Factors;Antinuclear factor;Factor, Antinuclear;Factors, Antinuclear;antinuclear factor;antinuclear factors;antiDNA autoantibody;antinuclear antibody (ANA);antinuclear antibody ana|C0003243|||C0003243|CHV;CSP;MSH;NCI;NDFRT;SNOMEDCT|1|0.0952|
ANA|ANF||||C0003243|SNOMEDCT|||
ANA|American Nurses Association;American Nurses' Association;American Nurses' Associations;American association nurse;American association nurses;American nurse association;American nurses' association;Association, American Nurses';Associations, American Nurses';Nurses' Association, American;Nurses' Associations, American|C0002463|||C0002463|CHV;MSH;MTH|1|0.0558|
ANA|Anti nuclear factor;Anti-nuclear factor||||C0003243|SNOMEDCT|||
ANA|Antibodies, Antinuclear;Antibody, Antinuclear;Antinuclear Antibodies;Antinuclear Antibody;Antinuclear antibodies;Antinuclear antibody;antinuclear antibodies;antinuclear antibody|C0003243;C0702121|1|1|C0003243;C0702121|CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.7644|1
ANA|Antibodies, Antinuclear [Chemical/Ingredient]||||C0003243|NDFRT|||
ANA|Antinuclear Antibody Assay;Antinuclear Antibody Measurement|C0702121|||C0702121|MTH;NCI|||
ANA|Antinuclear antibody (substance)||||C0003243|SNOMEDCT|||
ANA|Of Each|C1882141|||C1882141|MTH;NCI|||
ANA|aa|C1235746|||C1882141|NCI|||
ANA|acetylneuraminic acid||||||||1
ANA|anandamide|C0211726|||||1|0.0156|
ANA|anesthesia|C0002903;C0002930;C0278134|||||||1
ANA|anesthetic|C0002932|||||||1
ANA|anti-nuclear;antinuclear||||||1|0.0525|
ANA|antinuclear antibody (ANA) test||||C0702121|CHV|||
ANA|aortic nerve activity||||||1|0.0057|
ANA|articular/nonarticular||||||||1
ANA|aspartyl naphthylamide||||||||1
ANA|nuclear antigens|C0069115|||||1|0.0107|
ANA|tob55|C1412840;C1826973|||C1412840|HUGO|||
ANCA|ANCA;anca;ANCA - Anti-neutrophil cytoplasmic antibody;Anti Neutrophil Cytoplasmic Antibodies;Anti Neutrophil Cytoplasmic Antibody;Anti-Neutrophil Cytoplasmic Antibodies;Anti-Neutrophil Cytoplasmic Antibody;Anti-neutrophil cytoplasmic antibody;Antibodies, Anti-Neutrophil Cytoplasmic;Antibody, Anti-Neutrophil Cytoplasmic;Cytoplasmic Antibodies, Anti-Neutrophil;Cytoplasmic Antibody, Anti-Neutrophil;Anti neutrophilic cytoplasm antibody;Antibodies, Antineutrophil Cytoplasmic;Antibody, Antineutrophil Cytoplasmic;Antineutrophil Cytoplasmic Antibodies;Antineutrophil Cytoplasmic Antibody;Cytoplasmic Antibodies, Antineutrophil;Cytoplasmic Antibody, Antineutrophil;antineutrophil cytoplasmic antibodies;antineutrophil cytoplasmic antibody;Neutrophil cytoplasmic Ab;Neutrophil cytoplasmic Antibody;Neutrophil cytoplasmic antibody;antineutrophil cytoplasmic antibody (ANCA)|C0103647|1|1|C0103647|CHV;LNC;MSH;MTH;NDFRT;SNOMEDCT|1|0.7358|1
ANCA|Anti neutrophilic cytoplasm antibody (substance)||||C0103647|SNOMEDCT|||
ANCA|Antibodies, Antineutrophil Cytoplasmic [Chemical/Ingredient]||||C0103647|NDFRT|||
ANCA|Antineutrophil cytoplasmic autoantibodies||||||1|0.1509|
ANCA|anti-neutrophil cytoplasm autoantibodies||||||1|0.0257|
ANCA|antineutrophil cytoplasm autoantibodies||||||1|0.0154|
ANCA|cytoplasmic auto-antibodies||||||1|0.0103|
ANCA|neutrophil cytoplasmic antigens||||||1|0.0463|
ANCA|neutrophils|C0027950;C0948762|||||1|0.0154|
ANC|ANC;Absolute Neutrophil Count;Absolute neutrophil count;absolute count neutrophils;absolute neutrophil count|C0948762|1|1|C0948762|CHV;MTH;NCI|1|0.7669|1
ANC|Active noise control||||||1|0.0199|
ANC|NEUT|C0027944;C0948762|||C0948762|NCI|||
ANC|Neutrophils|C0027950;C0948762|||C0948762|NCI|||
ANC|acid neutralization capacity||||||||1
ANC|acid neutralizing capacity||||||1|0.0359|
ANC|adult neuronal ceroid||||||||1
ANC|antenatal care|C0033052|||C0033052|CHV;SNOMEDCT|1|0.0916|
ANC|antenatal clinic|C1274027|||||1|0.0857|
AP|2-aminopurine;aminopurine|C0000263|||C0000263|CHV;CSP|1|0.0033|
AP|ABSOLUTE PITCH;Absolute pitch;MUSICAL PERFECT PITCH|C1834650|||C1834650|MTH;OMIM|1|0.003|
AP|ALKALINE PHOSPHATASE;Alkaline Phosphatase;Alkaline phosphatase;alkaline phosphatase;alkaline phosphatases;ALP - Alkaline phosphatase;alkaline phosphatase (ALP)|C0002059;C1318717|||C0002059;C0201850;C1318717;C1561546|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT;SPN|1|0.1961|1
AP|AP||||C0002059;C0179108;C0279212;C0332142;C1834650;C1879722;C1999039|LNC;NCI;OMIM;PDQ;SNOMEDCT|||
AP|AP - Alkaline phosphatase;Alkaline phosphomonoesterase;alkaline phosphomonoesterase;Glycerophosphatase;glycerophosphatase|C0002059|||C0002059|CSP;SNOMEDCT|||
AP|AP diagnosis;aps diagnosis;Pathology diagnosis;pathology diagnosis|C0332142|||C0332142|CHV;MTH;SNOMEDCT|||
AP|APPLICATOR;APPLICATORS;Applicator;applicator;applicators|C0179108;C1705092|||C0179108;C1879722|CHV;HL7V2.5;NCI;NDFRT;SNOMEDCT;VANDF|||
AP|Abasic||||||1|0.0102|
AP|Actinic prurigo|C0406217|||||1|0.0029|
AP|Actinobacillus pleuropneumoniae|C0085489|||||1|0.0015|
AP|Alkaline Phosphatase [Chemical/Ingredient]||||C0002059|NDFRT|||
AP|Alkaline phosphatase (substance)||||C0002059|SNOMEDCT|||
AP|Allopregnanolone|C0376202|||||1|0.0018|
AP|Allopurinol|C0002144|||||1|0.0027|
AP|Annular pancreas|C0149955|||||1|0.0008|
AP|Anterior Pagoda||||||1|0.0032|
AP|Anterior-Posterior;anterior and posterior;anterior posterior;anterior to posterior;anterior-posterior;anterior/posterior;posterior anterior|C1999039|1|0.968|C1999039|CHV;MTH|1|0.0023|1
AP|Antiplasmin;antiplasmin|C0003410|||||1|0.0014|1
AP|Applicator (physical object)||||C0179108|SNOMEDCT|||
AP|Applicator - device|C0179108|||C0179108|MTH|||
AP|Applicator Dosing Unit|C1879722|||C1879722|MTH;NCI|||
AP|CDDP/DOX||||C0279212|NCI;PDQ|||
AP|Cisplatin/Doxorubicin;cisplatin/doxorubicin||||C0279212|NCI;PDQ|||
AP|Orthophosphoric-monoester phosphohydrolase (alkaline optimum)||||C0002059|MSH;NDFRT|||
AP|Pathology diagnosis (contextual qualifier)||||C0332142|SNOMEDCT|||
AP|Pathology diagnosis (contextual qualifier) (qualifier value)||||C0332142|SNOMEDCT|||
AP|Phosphomonoesterase;phosphomonoesterase|C0002059;C0031678|||C0002059|CHV;SNOMEDCT|||
AP|Pseudomonas aeruginosa alkaline protease||||||1|0.0009|
AP|[14C]aminopyrine||||||1|0.0047|
AP|abdominal pain|C0000737|||C0000737|AOD;CCS;CHV;COSTAR;CST;DXP;ICD9CM;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
AP|abdominal pressure|C0429218|||||||1
AP|abdominoperineal|C0442411|1|0.008|||||1
AP|absolute power||||||1|0.0011|
AP|accelerated phase|C0457345|||||1|0.0092|1
AP|accessory pathway|C0006383;C0264897|||C0006383;C0264897|CHV;SNOMEDCT|1|0.0177|1
AP|accessory processes||||||1|0.0009|
AP|accounts payable|C0000939|||C0000939|MSH|||
AP|accumulation of 14C-aminopyrine||||||1|0.0008|
AP|acellular pertussis|C0982332|||||1|0.0027|
AP|acetaminophen|C0000970;C2917659|||||1|0.0015|
AP|acid phosphatase|C0001109|||C0001109;C0201834|CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0312|1
AP|acinar parenchyma||||||||1
AP|action potential|C0001272|||C0001272|AOD;CHV;CSP;MSH|1|0.1356|1
AP|activation peptide||||||1|0.0014|
AP|activator protein||||||||1
AP|active pepsin||||||||1
AP|active pressure||||||||1
AP|acupuncture|C0001299;C0394664|||||1|0.0029|
AP|acute pancreatitis|C0001339|||C0001339|AOD;CCS;CHV;COSTAR;ICD9CM;MTHMST;NCI;SNOMEDCT|1|0.0637|1
AP|acute phase|C0439557|||C0439557|CHV;SNOMEDCT|1|0.005|1
AP|acute pneumonia|C0740766|||C0740766|CHV;NCI|1|0.0033|1
AP|acute proliferative||||||||1
AP|adaptor protein|C1135629|||||1|0.0047|
AP|adductor pollicis|C0224288;C1305009|1|0.002|||1|0.0045|1
AP|adenomatous polyp|C0206677|||||||1
AP|adenomatous polyposis|C0032580|||C0032580|CHV;SNOMEDCT|||1
AP|adolescent psychiatry|C0001583|||||||1
AP|adult periodontitis|C0266929|||||1|0.0219|
AP|advance placement||1|0.002|||||
AP|aerosolized pentamidine||||||1|0.0044|
AP|after parturition||||||||1
AP|after polarization||||||||1
AP|alkaline phosphatase activity|C1149888|||||1|0.0039|
AP|alkaline phosphate||||||1|0.0009|
AP|alpha 2-antiplasmin|C0003410;C1418648|||||1|0.0021|
AP|alternative pathway||||||1|0.0092|
AP|alum-precipitated||||||||1
AP|alveolar permeability||||||1|0.0011|1
AP|aminopeptidase|C0002570|||C0002570|CSP;LNC;MTH;SNOMEDCT|1|0.0068|1
AP|aminopyrine|C0002586|||||1|0.0063|
AP|ammonium perchlorate|C0103081|||||1|0.0018|
AP|ampicillin|C0002680|||||1|0.0066|
AP|amyloid P|C0002721;C2825878|||||1|0.0017|
AP|amyloid P component;amyloid P-component|C0002721|||||1|0.0081|1
AP|amyloid peptide||||||||1
AP|amyloid plaques|C0333463;C2936349|||||1|0.0008|
AP|anaphylactoid purpura|C0034152|||||1|0.0018|
AP|anatomic profile||||||||1
AP|angina pectoris|C0002962|||C0002962|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;ICPC;LCH;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.023|1
AP|antepartum|C0456336|||C0456336|CHV;NCI;SNOMEDCT|||1
AP|anterior pituitary|C0032016|||C0032016|CHV;NDFRT;VANDF|1|0.0478|1
AP|anterior pituitary gland|C0032008|||||1|0.0044|
AP|antero-posterior;anteroposterior||||||1|0.0916|1
AP|antidromic potential||||||||1
AP|antigen presentation|C0206431|||||1|0.0015|
AP|antiparkinsonian|C0003405|||||||1
AP|antipsychotic|C0040615|||||1|0.0015|
AP|antipyrine|C0003420|||C0003420|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0117|
AP|antiviral protein||||||||1
AP|antral peristalsis||||||||1
AP|aortic pressure|C0456180|||C0456180|CHV;SNOMEDCT|||1
AP|aortic pulmonary||1|0.020|||||1
AP|aortopulmonary||||||||1
AP|apatite|C0003522|||||1|0.0017|
AP|apex|C1522410|||||||1
AP|apical pulse||||||||1
AP|apomorphine|C0003596|||||1|0.0027|
AP|apothecary||||||||1
AP|appendectomy|C0003611|||C0003611|AOD;CCS;CHV;COSTAR;ICD9CM;LCH;MSH;MTH;NCI;SNOMEDCT|||1
AP|appendiceal perforation||||||||1
AP|appendicitis|C0003615;C0085693|||C0003615;C0085693|AOD;CHV;COSTAR;ICD9CM;ICPC;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
AP|appendix|C0003617;C1269000|||C0003617;C1269000;C1552860|AOD;CHV;CSP;FMA;HL7V2.5;HL7V3.0;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|||1
AP|aprotinin|C0003641|||||1|0.0023|
AP|apterous||||||1|0.0044|
AP|apurinic||||||1|0.0051|
AP|apurinic acid|C0003651|||C0003651|MSH;NDFRT|||
AP|apurinic/apyrimidinic||||||1|0.0387|
AP|area postrema|C0228530;C1289468|||C0228530;C1289468|CSP;FMA;MSH;SNOMEDCT|1|0.0478|1
AP|arithmetic progression||||||||1
AP|arterial|C0003842;C0221464|||||1|0.0014|
AP|arterial blood pressure|C1272641|||||1|0.0108|
AP|arterial pressure|C0232108;C1272641|||C0232108;C1272641|CHV;SNOMEDCT|1|0.0838|1
AP|arteriosclerotic plaque||||||||1
AP|artificial perilymph||||||1|0.002|
AP|artificial pneumothorax|C0032328|||C0032328|AOD;MSH;SNOMEDCT|||1
AP|ascorbyl palmitate|C0049690|||||1|0.0014|
AP|aspiration pneumonia|C0032290|||C0032290|CHV;COSTAR;CST;LCH;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|||
AP|aspiration pneumonitis|C0032290;C1761609|||||||1
AP|assessment and plan||||||||1
AP|association period||||||||1
AP|asthmatic patients||||||1|0.0012|
AP|atherosclerotic plaque|C2936350|||C2936350|CHV;CSP;MSH;NCI;NDFRT|||1
AP|atrial pacing||||||1|0.0042|1
AP|atriopeptin|C0027481;C0201900|||||1|0.0045|
AP|atrioventricular pathway||||||||1
AP|atrium pace||||||||1
AP|attending physician|C1320929|||||||1
AP|autologous plasma||||||1|0.0009|
AP|available P||||||1|0.003|
AP|available phosphorus||||||1|0.0023|
AP|average power||||||1|0.0017|
AP|axiopulpal||||||||1
AP|cisplatin/doxorubicin protocol||||C0279212|MTH|||
AP|proteinase|C0030946;C1622131;C1947941|||||1|0.0014|
AQ|AMERICAN SAMOA;American Samoa;Eastern Samoa|C0242536|||C0242536|AOD;MSH;MTH;NCI|||
AQ|ANTARCTICA;Antarctica;antarctica;Antarctic Regions;Antarctic region;Antarctic regions|C0454691|||C0454691|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
AQ|AQ||||C0242536;C0454691;C1705414|NCI|||
AQ|AQ Term Type|C1705414|||C1705414|MTH;NCI|||
AQ|AS||||C0242536|NCI|||
AQ|ASM||||C0242536|NCI|||
AQ|ATA||||C0454691|NCI|||
AQ|AY||||C0454691|NCI|||
AQ|Acoustic quantification;acoustic quantification||||||1|0.1837|1
AQ|Aggression Questionnaire||||||1|0.0476|
AQ|Antarctica (geographic location)||||C0454691|SNOMEDCT|||
AQ|Quotient|C2347741|||||1|0.1361|
AQ|accomplishment quotient||||||||1
AQ|achievement quotient||||||||1
AQ|amodiaquine|C0002641|||||1|0.3605|
AQ|anthraquinone|C0003174;C0050133;C0303858|||||1|0.1156|
AQ|anxiety quotient||||||||1
AQ|any quantity||||||||1
AQ|aphasia quotient||||||||1
AQ|aqueous|C0599956|1|0.998|||1|0.0612|1
AQ|areca quid||||||1|0.0952|
ARB|*Arbitrary;Arbitrary;arbitrary;Arbitrary (property) (qualifier value)|C1264693|||C1264693|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|||1
ARB|ARB;Arb||||C0521942;C1264693;C2678493|LNC;NCI;OMIM;SNOMEDCT|||
ARB|Angiotensin 2 Receptor Blocker;Angiotensin 2 Receptor Blocker [EPC]|C0521942|||C0521942|NDFRT|||
ARB|Angiotensin II Receptor Antagonist;Angiotensin II Receptor Antagonists;Angiotensin II receptor antagonist;Angiotensin II receptor antagonist, NOS;Angiotensin II Receptor Blocker;Angiotensin II Receptor Blockers;angiotensin II receptor blocker|C0521942;C2757003|||C0521942|MSH;MTH;NCI;NDFRT;SNOMEDCT;USPMG|1|0.6667|
ARB|Angiotensin II receptor antagonist (product)||||C0521942|SNOMEDCT|||
ARB|Angiotensin II receptor antagonist (substance)||||C0521942|SNOMEDCT|||
ARB|Angiotensin Receptor Blockers;angiotensin receptor blocker|C0521942;C0815017|1|1|C0521942|NCI|||1
ARB|Arbitrary (property)||||C1264693|SNOMEDCT|||
ARB|BESTROPHINOPATHY|C2678493|||C2678493|MTH;OMIM|||
ARB|adrenergic receptor binder||||||||1
ARB|angiotensin II type 1 receptor blocker||||||1|0.2444|
ARB|antibiotic-resistant bacteria||||||||1
ARB|any reliable brand||||||||1
ARB|receptor blockade||||||1|0.0889|
ARDS|ADULT RESPIRATORY DISTRESS SYNDROME;Adult Respiratory Distress Syndrome;Adult respiratory distress syndrome;Adult respiratory distress syndrome, NOS;DISTRESS RESPIRATORY SYNDROME ADULTS;RESPIRATORY DISTRESS SYNDROME ADULT;RESPIRATORY DISTRESS SYNDROME, ADULT;Respiratory Distress Syndrome, Adult;Respiratory distress syndrome, Adult;SYNDROME ADULT RESPIRATORY DISTRESS;SYNDROME RESPIRATORY DISTRESS ADULT;adult respiratory distress syndrome;ADULT RESPIRATORY DISTRESS SYNDROME, ARDS;ARDS - Adult respiratory distress syndrome;adult respiratory distress syndrome (ARDS);ARDS;ards;ARDS, Human;Human ARDS;ARDSs, Human;Acquired respiratory distress syndrome;Acute Respiratory Distress Syndrome;Respiratory Distress Syndrome, Acute;acute respiratory distress syndrome;Adult RDS;adult rds;Adult hyaline membrane disease;adult hyaline membrane disease;DaNang lung;danang lung;Lung, Shock;SHOCK LUNG;Shock Lung;Shock lung;shock lung;Non-cardiogenic pulmonary edema;Non-cardiogenic pulmonary oedema;non-cardiogenic pulmonary edema;Pulmonary capillary leak syndrome;SYNDROME ADULT RESPIRATORY;adult respiratory syndrome;Vietnam lung;a r d s;a.r.d.s.|C0035222|1|1|C0035222|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.9883|1
ARDS|Adult respiratory distress syndrome (disorder)||||C0035222|SNOMEDCT|||
ARDS|Congestive atelectasis|C0035222;C0205938|||C0035222|SNOMEDCT|||
ARDS|Non-cardiogenic pulmonary edema (disorder)||||C0035222|SNOMEDCT|||
ARDS|Resp. distress synd. - adult|C0001675;C1706450|||C0035222|SNOMEDCT|||
ARDS|Respirat distress synd-adult||||C0035222|SNOMEDCT|||
ARDS|Respiratory Distress Syndrome, Adult [Disease/Finding]||||C0035222|NDFRT|||
ARDS|WET LUNG SYNDROME;wet lung syndrome|C0035222;C0158940|||C0035222|CHV;DXP|||
ARDS|acute respiratory failure|C0264490|||||1|0.0073|
ARDS|lung failure||||||1|0.0044|
ARDS|wet lung|C0034063;C0035222|||C0035222|CHV;CSP|||
ASA|2-(Acetyloxy)benzoic Acid;Benzoic acid, 2-(acetyloxy)-||||C0004057|MSH;NCI;NDFRT;PDQ|||
ASA|ASA;ASPIRIN;Aspirin;aspirin;aspirins;Acetylsalicylic Acid;Acetylsalicylic acid;Acid, Acetylsalicylic;acetylsalicylic acid;Antiplatelet aspirin;Aspirin [antiplatelet];antiplatelet aspirin;aspirin antiplatelet;Aspirin (product);Aspirin product;aspirin products;Aspirin - chemical;aspirin chemicals;acetylsalicyclic acid|C0004057|1|0.808|C0004057|AOD;CHV;CSP;LCH;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.637|1
ASA|Acetylsalicylic acid - chemical||||C0004057|SNOMEDCT|||
ASA|Adams-Stokes attack||||||||1
ASA|Adaptive Speech Alignment||||||||1
ASA|American Society of Anaesthesiologists;American Society of Anesthesiologists|C2346733|1|0.186|||1|0.153|1
ASA|American Society of Anesthesiology||||||1|0.0297|
ASA|Antiplatelet aspirin (product)||||C0004057|SNOMEDCT|||
ASA|Antiplatelet aspirin (substance)||||C0004057|SNOMEDCT|||
ASA|Aspirin (substance)||||C0004057|SNOMEDCT|||
ASA|Aspirin - chemical (substance)||||C0004057|SNOMEDCT|||
ASA|Aspirin [Chemical/Ingredient]||||C0004057|NDFRT|||
ASA|Aspirin [central nervous system use]||||C0004057|SNOMEDCT|||
ASA|Aspirin [central nervous system use] (product)||||C0004057|SNOMEDCT|||
ASA|Aspirin [central nervous system use] (substance)||||C0004057|SNOMEDCT|||
ASA|Aspirin [musculoskeletal use]||||C0004057|SNOMEDCT|||
ASA|Aspirin [musculoskeletal use] (product)||||C0004057|SNOMEDCT|||
ASA|Aspirin [musculoskeletal use] (substance)||||C0004057|SNOMEDCT|||
ASA|Aspirin product (substance)||||C0004057|SNOMEDCT|||
ASA|Atrial septal aneurysm;atrial septal aneurysm|C0521533|||||1|0.0332|1
ASA|accessible surface area||||||1|0.0148|
ASA|acetylsalicylate|C0304348|||||1|0.0071|
ASA|active systemic anaphylaxis||||||1|0.013|1
ASA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0059|
ASA|acute severe asthma|C0038218|||||1|0.0047|1
ASA|allele-specific amplification||||||1|0.0148|
ASA|aminosalicylic acid|C0030125|1|0.006|||||
ASA|anterior spinal artery|C0149603;C1278946|||||1|0.0095|1
ASA|anti-sperm antibodies|C0432662|||||1|0.0119|
ASA|antibody to surface antigen ratio||||||||1
ASA|anticoagulation regimen of aspirin||||||||1
ASA|antisperm antibodies||||||1|0.0451|
ASA|argininosuccinate|C0368700|||||||1
ASA|argininosuccinic acid|C0003777|||C0003777|CHV;MSH;NDFRT;SNOMEDCT|||1
ASA|arsenate|C0104238|||||||1
ASA|ascorbate|C0178487|||||1|0.0148|
ASA|aspirin-sensitive asthma||||||1|0.0053|1
ASA|asthma, nasal polyps, aspirin intolerance||||||||1
ASCUS|ASCUS;Asci;Ascus;asci;ascus|C0521060;C1510965|||C0521060;C0521184|CHV;GO;NCI;PDQ;SNOMEDCT|||
ASCUS|Ascus (fungus);ascus fungus|C0521060|||C0521060|CHV;MTH;SNOMEDCT|||
ASCUS|Ascus (fungus) (organism)||||C0521060|SNOMEDCT|||
ASCUS|Atypical Squamous Cell of Uncertain Significance;Atypical squamous cells of uncertain significance;atypical squamous cells of uncertain significance;Atypical Squamous Cell of Undetermined Significance;Atypical squamous cells of undetermined significance;atypical squamous cells of undetermined significance|C0521184|1|1|C0521184|CHV;MTH;NCI;PDQ;SNOMEDCT|1|1|1
ASCUS|Atypical squamous cells of undetermined significance (morphologic abnormality)||||C0521184|SNOMEDCT|||
ASCUS|ascis||||C0521060|CHV|||
ASCUS|ascu||||C0521060;C0521184|CHV|||
ASCVD|ASCVD;Ascvd;ascvd;Arteriosclerotic Cardiovascular Disease;Arteriosclerotic cardiovascular disease;Arteriosclerotic cardiovascular disease, NOS;arteriosclerotic cardiovascular disease;Atherosclerotic Cardiovascular Disease;Atherosclerotic cardiovascular disease;atherosclerotic cardiovascular disease;Cardiovascular arteriosclerosis;arteriosclerosis cardiovascular;Cardiovascular degeneration with arteriosclerosis;Cardiovascular disease with arteriosclerosis;Cardiovascular sclerosis with arteriosclerosis|C0003972|1|1|C0003972;C0007222|CHV;ICD9CM;MTH;MTHICD9;NCI;SNOMEDCT|1|1|1
ASCVD|Arteriosclerotic cardiovascular disease (disorder)||||C0003972|SNOMEDCT|||
ASCVD|CARDIOVASC DIS||||C0007222|MSH|||
ASCVD|CARDIOVASCULAR DISORDER;CARDIOVASCULAR DISORDER (NOS);CARDIOVASCULAR DISORDERS;Cardiovascular Disorder;Cardiovascular Disorders;Cardiovascular disorder;Cardiovascular disorder, NOS;DISORDER CARDIOVASCULAR (NOS);cardiovascular disorder;cardiovascular disorders;CVD;CVD, NOS;CVS disease;Cardiovascular disease, unspecified;Cardiovascular system disease;Cardiovascular system diseases;Disease of cardiovascular system;Disease of cardiovascular system, NOS;cardiovascular system disease;cardiovascular system diseases;Disorder of cardiovascular system|C0007222|||C0007222|AOD;CHV;CSP;CST;ICD9CM;NCI;SNOMEDCT|||
ASCVD|CVS - Cardiovascular system diseases||||C0007222|SNOMEDCT|||
ASCVD|CVS disorders NOS||||C0007222|SNOMEDCT|||
ASCVD|Cardiovascular Disease;Cardiovascular Diseases;Cardiovascular disease;Cardiovascular disease, NOS;Disease, Cardiovascular;Diseases, Cardiovascular;cardiovascular disease;cardiovascular diseases;Cardiovascular Disease (CVD)|C0007222;C1555754|||C0007222|CHV;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|||
ASCVD|Cardiovascular Diseases [Disease/Finding]||||C0007222|NDFRT|||
ASCVD|Cardiovascular arteriosclerosis unspecified||||C0003972|SNOMEDCT|||
ASCVD|Cardiovascular arteriosclerosis unspecified (disorder)||||C0003972|SNOMEDCT|||
ASCVD|Disease of cardiovascular system (disorder)||||C0007222|SNOMEDCT|||
ASCVD|Disorder of cardiovascular system (disorder)||||C0007222|SNOMEDCT|||
ASCVD|[X]Cardiovascular disease, unspecified||||C0007222|SNOMEDCT|||
ASCVD|[X]Cardiovascular disease, unspecified (disorder)||||C0007222|SNOMEDCT|||
ASD|ASD;asd|C0018817;C1510586|||C0018817;C1510586|CHV;DXP;OMIM;RAM|||
ASD|ASD - Atrial septal defect;Atrial septal defect (ASD);atrial septal defect (ASD);ATRIAL SEPTAL DEFECT;Atrial Septal Defect;Atrial Septal Defects;Atrial septal defect;Atrial septal defect NOS;Atrial septal defects;Defect, Atrial Septal;Defects, Atrial Septal;Septal Defect, Atrial;Septal Defects, Atrial;atrial septal defect;atrial septal defects;Congenital atrial septal defect;DEFECT ARTRIAL SEPTUM;HEART SEPTAL DEFECT ATRIAL;Heart Septal Defects, Atrial;atrial septal heart defect;atrial septal heart defects;IA SEPTAL DEFECT;Interatrial septal defect;SEPTAL DEFECT INTERATRIAL;interatrial septal defect;Interauricular septal defect;atrioseptal defect|C0018817|1|0.956|C0018817|CCS;CHV;COSTAR;CSP;CST;DXP;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.6981|1
ASD|AUTISM SPECTRUM DISORDER;Autism Spectrum Disorder;Autism Spectrum Disorders;Disorder, Autism Spectrum;Disorders, Autism Spectrum;Spectrum Disorder, Autism;Spectrum Disorders, Autism;autism spectrum disorder|C1510586|1|0.034|C1510586|MSH;MTH;NCI;OMIM|1|0.1028|1
ASD|Acute Stress Disorder;acute stress disorder|C0236816|||||1|0.066|1
ASD|Alzheimer senile dementia||||||||1
ASD|Atria septal defect (ASD)||||C0018817|OMIM|||
ASD|Atrial septal defect (disorder);Atrial septal defect NOS (disorder)||||C0018817|SNOMEDCT|||
ASD|Auricular septal defect NOS||||C0018817|SNOMEDCT|||
ASD|Auricular septal defect NOS (disorder)||||C0018817|SNOMEDCT|||
ASD|Congenital atrial septal defect (disorder)||||C0018817|SNOMEDCT|||
ASD|Heart Septal Defects, Atrial [Disease/Finding]||||C0018817|NDFRT|||
ASD|Interauricular septal defect (disorder)||||C0018817|SNOMEDCT|||
ASD|adaptive seating device||||||||1
ASD|adult Still's disease|C0085253|||||1|0.0227|
ASD|adult/adolescent spectrum of disease||||||||1
ASD|air-space disease||||||||1
ASD|aldosterone secretion defect||||||||1
ASD|androstenedione|C0002860;C0337432|||||1|0.0152|
ASD|anterior sagittal diameter||||||||1
ASD|anti-siphon device||||||1|0.0065|
ASD|antisiphon device||||||1|0.0065|1
ASD|argininosuccinic acid synthetase deficiency|C0175683|||||||1
ASD|arthritis syphilitica deformans||||||||1
ASD|arthroscopic subacromial decompression||||C0408088|SNOMEDCT|1|0.0195|
ASD|aspartate semialdehyde dehydrogenase|C0004012|||||1|0.0054|
ASD|autistic spectrum disorder|C0524528|||||1|0.0574|
AST|ASAT - Aspartate aminotransferase;Aminotransferase, Aspartate;Aminotransferases, Aspartate;Aspartate Aminotransferase;Aspartate Aminotransferases;Aspartate aminotransferase;aspartate aminotransferase;aspartate-aminotransferase;Aminotransferase, L-Aspartate-2-Oxoglutarate;L Aspartate 2 Oxoglutarate Aminotransferase;L-Aspartate-2-Oxoglutarate Aminotransferase;L-aspartate:2-oxoglutarate aminotransferase;Apoaminotransferase, Aspartate;Aspartate Apoaminotransferase;Glutamate Aspartate Transaminase;Glutamate-Aspartate Transaminase;Transaminase, Glutamate-Aspartate;Glutamate oxaloacetate transaminase;glutamate oxaloacetate transaminase;Glutamic Oxaloacetic Transaminase;Glutamic-Oxaloacetic Transaminase;Glutamic-oxaloacetic transaminase;Transaminase, Glutamic-Oxaloacetic;glutamic oxaloacetic transaminase;Glutamic-aspartic transaminase;glutamic aspartic transaminase;S-ASAT;s-asat|C0004002|1|1|C0004002;C0201899|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.109|1
AST|AST||||C0004002;C0201899;C0242192;C1420113|AOD;CHV;HUGO;NCI|||
AST|AST - Aspartate transaminase;aspartate transaminase (AST);Aspartate Transaminase;Aspartate transaminase;Transaminase, Aspartate;aspartate transaminase|C0004002;C0242192|||C0004002;C0242192|CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
AST|AST measurement;Aspartate Aminotransferase Measurement;Aspartate aminotransferase measurement;Aspartate aminotransferase assay;GOT measurement;Glutamic oxaloacetic transaminase measurement;SGOT;sgot;SGOT measurement;serum AST;serum SGOT|C0201899|||C0201899;C0242192|CHV;MSH;MTH;NCI;SNOMEDCT|||
AST|Antimicrobial susceptibility testing||||||1|0.0962|
AST|Aphasia Screening Test|C0450996|||||||1
AST|Aryl sulfotransferase|C0003942;C1152487|||||1|0.0705|
AST|Aspartate Aminotransferases [Chemical/Ingredient]||||C0004002|NDFRT|||
AST|Aspartate aminotransferase (substance)||||C0004002|SNOMEDCT|||
AST|Aspartate aminotransferase measurement (procedure)||||C0201899|SNOMEDCT|||
AST|GLUTAMIC OXALOACETIC TRANS 000||||C0004002|MSH|||
AST|GOT;got||||C0004002|AOD;CHV;SNOMEDCT|||
AST|Glutamic-Oxaloacetic Transaminase, Serum;Serum Glutamic Oxaloacetic Transaminase;Serum Glutamic-Oxaloacetic Transaminase;Transaminase, Serum Glutamic-Oxaloacetic;serum glutamic-oxaloacetic transaminase;SGOT - Glutamate oxaloacetate transaminase|C0242192|||C0242192|MSH;MTH;NCI;SNOMEDCT|||
AST|ISSD|C1096902;C1420113|||C1420113|HUGO|||
AST|L-Aspartate:2-oxoglutarate aminotransaminase||||C0004002|MSH;NDFRT|||
AST|NSD|C1420113;C2930923|||C1420113|HUGO|||
AST|SD||||C1420113|HUGO|||
AST|SGOT (AST)||||C0242192|NCI|||
AST|SIALIN;SLC17A5;SLC17A5 gene;SLD|C1420113|||C1420113|HUGO;MTH;OMIM|||
AST|SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5||||C1420113|OMIM|||
AST|Transaminase A;transaminase A||||C0004002|CSP;SNOMEDCT|||
AST|above selected threshold||||||||1
AST|acid suppression therapy||||||||1
AST|acoustic stimulation test|C0521310|||||||1
AST|acute suppurative thyroiditis|C0040150|||||1|0.0705|
AST|alcohol sniff test||||||||1
AST|androgen suppression therapy||||||1|0.0256|1
AST|angiotensin sensitivity test||||||||1
AST|anterior spinothalamic tract|C0228591;C1289706|||C0228591;C1289706|FMA;SNOMEDCT|||1
AST|antistreptolysin titer|C1318462|||||||1
AST|antistreptozyme||||||||1
AST|arginine stimulation test|C0430097|||||1|0.0385|
AST|aspartate|C0085845|||||1|0.2051|
AST|aspartate aminotransferase (AST) assay test||||C0201899|CHV|||
AST|aspartate transferase||||||1|0.0962|
AST|astigmatism|C0004106|||C0004106|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;NDFRT;OMIM;SNOMEDCT|||1
AST|atrial overdrive stimulation rate||||||||1
AST|audiometry sweep test||||||||1
AST|serum aspartate transaminase||||||1|0.2885|
AST|serum glutamate oxaloacetate transaminase (SGOT)||||C0242192|CHV|||
AST|solute carrier family 17 (anion/sugar transporter), member 5||||C1420113|HUGO|||
ATG|AC|C1879503|||C0003354|NCI|||
ATG|AG||||C0003354|NCI|||
ATG|ANTI-THYMOCYTE GLOBULIN;Anti Thymocyte Globulin;Anti-Thymocyte Globulin;Anti-Thymocyte Globulins;Antithymocyte Globulin;Antithymocyte Globulins;Antithymocyte globulin;GLOBULIN,ANTI-THYMOCYTE;Globulin, Anti-Thymocyte;Globulin, Antithymocyte;Globulins, Anti-Thymocyte;Globulins, Antithymocyte;anti thymocyte globulin;anti-thymocyte globulin;antithymocyte globulin;antithymocyte globulins;Antithymocyte Serum;Antithymocyte gamma globulin;Antithymocyte immunoglobulin;antithymocyte immunoglobulin;Antithymoglobulin;Antithymoglobulins;antithymoglobulin;Lymphocyte Immune Globulin, Anti Thymocyte Globulin;Lymphocyte Immune Globulin, Anti-Thymocyte Globulin|C0003442|1|1|C0003442|CHV;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.949|1
ATG|ANTIGUA AND BARBUDA;Antigua and Barbuda;Barbuda and Antigua||||C0003354|AOD;MSH;MTH;NCI;SNOMEDCT|||
ATG|ATG;atg||||C0003354;C0003442|CHV;NCI;PDQ;SNOMEDCT|||
ATG|ATS||||C0003442|NCI|||
ATG|Antigua and Barbuda (geographic location)||||C0003354|SNOMEDCT|||
ATG|Aurothioglucose;aurothioglucose|C0018033|||C0018033|CHV;CSP;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0216|
ATG|adenine-thymine-guanine||||||||1
ATG|angiotensinogen|C0003017|||C0003017;C0523500;C1366631|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0294|
ATG|antihuman thymocyte globulin||||||||1
ATG|antithyroglobulin|C0443883|||||||1
ATN|ALBINISM I;ALBINISM, OCULOCUTANEOUS, TYPE IA;ATN;Albinism 1;OCA1;OCA1 - Tyrosinase-negative oculocutaneous albinism;OCA1A;OCULOCUTANEOUS ALBINISM, TYPE I;OCULOCUTANEOUS ALBINISM, TYROSINASE-NEGATIVE;Oculocutaneous albinism, tyrosinase negative;Tyrosinase-negative oculocutaneous albinism;tyrosinase-negative oculocutaneous albinism;Oculocutaneous albinism type 1;Oculocutaneous albinism type 1A|C0268494|||C0268494|MSH;OMIM;SNOMEDCT|||1
ATN|Tyrosinase-negative oculocutaneous albinism (disorder)||||C0268494|SNOMEDCT|||
ATN|Tyrosinase-related oculocutaneous albinism||||C0268494|SNOMEDCT|||
ATN|acute tubular necrosis|C0022672|1|1.000|C0022672|CHV;COSTAR;CSP;DXP;MTHICD9;SNOMEDCT|1|0.9693|1
ATN|anterior thalamic nuclei|C0228316|||||1|0.0307|
ATN|augmented transition network||||||||1
ATN|autonomous thyroid nodule||||||||1
AVF|Arteriovenous fistula;Arteriovenous fistulae;arteriovenous fistula|C0003855|1|0.024|||1|0.9445|1
AVF|Lead AVF;lead aVF;aVF;avf|C0449215|||C0449215|CHV;LNC;SNOMEDCT|||
AVF|aVF (body structure)||||C0449215|SNOMEDCT|||
AVF|abdominal visceral fat|C1563740|||||1|0.0556|
AVF|antiviral factor||||||||1
AVF|augmented vector foot|C2983584|1|0.976|||||
AVF|augmented voltage left leg||||||||1
AVM|AV - Congenital arteriovenous malformation;Arteriovenous Malformation, Unspecified;CONGENITAL ARTERIOVENOUS MALFORMATION;Congenital arteriovenous malformation;a v malformation;a v malformations;a-v malformation;anomalies arteriovenous;arteriovenous anomaly;av malformation;av malformations|C0003857|||C0003857|CHV;COSTAR;MTH;SNOMEDCT|||
AVM|AVM|C0003857;C0279476|||C0003857;C0279476|MEDLINEPLUS;NCI;PDQ|||
AVM|AVM - Congenital arteriovenous malformation||||C0003857|SNOMEDCT|||
AVM|Arteriovenous Malformation;Arteriovenous Malformations;Arteriovenous malformation;Arteriovenous malformation, NOS;Malformation, Arteriovenous;Malformations, Arteriovenous;arteriovenous malformation;arteriovenous malformations|C0003857;C0334533|1|0.974|C0003857;C0334533|CHV;CSP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9807|1
AVM|Arteriovenous Malformations [Disease/Finding]||||C0003857|NDFRT|||
AVM|Arteriovenous malformation (morphologic abnormality)||||C0003857|SNOMEDCT|||
AVM|Avermectin B1a|C0052701|||||1|0.0097|
AVM|Congenital arteriovenous malformation (disorder)||||C0003857|SNOMEDCT|||
AVM|DOX/MTX/VBL||||C0279476|NCI;PDQ|||
AVM|Doxorubicin/Methotrexate/Vinblastine;doxorubicin/methotrexate/vinblastine|C0279476|||C0279476|MTH;NCI;PDQ|||
AVM|atrioventricular malformation||||||||1
AVM|avian vacuolar myelinopathy||||||1|0.0097|
AVM|aviation medicine|C0004431|||C0004431|CHV;MSH|||1
AV|AO||||C0280598|NCI;PDQ|||
AV|AV||||C0280598;C0752050;C1706433|FMA;NCI;PDQ|||
AV|Adriamycin and vincristine||||||1|0.0015|
AV|Anterior ventral nucleus of thalamus;Anteroprincipal thalamic nucleus;Anteroventral Nucleus;Anteroventral nucleus;Nucleus, Anteroventral;anteroventral nucleus;Anteroventral Thalamic Nucleus;Anteroventral thalamic nucleus;Nucleus, Anteroventral Thalamic;Thalamic Nucleus, Anteroventral;Nucleus anterior thalami ventralis;Nucleus anterior ventralis;Nucleus anteroventralis of thalamus;Nucleus anteroventralis thalami;Nucleus thalamicus anteroprincipalis;Structure of anteroventral nucleus of thalamus|C0752050|||C0752050|FMA;MSH;MTH;SNOMEDCT|1|0.0015|
AV|Anteroventral nucleus of thalamus;Nucleus anteroventralis|C0752050;C1761582|||C0752050|FMA;SNOMEDCT|||
AV|Anteroventral nucleus of thalamus (body structure)||||C0752050|SNOMEDCT|||
AV|Artificial vagina||||||1|0.0027|
AV|Atrioventricular;atrio-ventricular;atrioventricular||1|0.748|||1|0.7883|1
AV|Audiovisual;audiovisual||||||1|0.0042|1
AV|CAP;Cap;cap|C0179586;C1657858;C1706092;C2985259|||C1706433|NCI|||
AV|CAPSULE;Capsule;capsule;{Capsule}|C0006935;C1325531;C1704652;C1706433;C2825041|||C1706433|NCI;SNOMEDCT|||
AV|Capsule - unit of product usage;Capsule Dosing Unit|C1706433|||C1706433|MTH;NCI;SNOMEDCT|||
AV|Capsule - unit of product usage (qualifier value)||||C1706433|SNOMEDCT|||
AV|DOX/VCR||||C0280598|NCI;PDQ|||
AV|DOX/VCR chemotherapy protocol||||C0280598|CHV|||
AV|Doxorubicin/Vincristine;doxorubicin/vincristine||||C0280598|NCI;PDQ|||
AV|Nucleus anterior principalis (Hassler)||||C0752050|FMA|||
AV|Nucleus anteroinferior||||C0752050|FMA|||
AV|Nucleus anteroventralis (body structure)||||C0752050|SNOMEDCT|||
AV|Structure of anteroventral nucleus of thalamus (body structure)||||C0752050|SNOMEDCT|||
AV|abomasal volvulus||||||1|0.0036|
AV|abvolt||||||||1
AV|adenoassociated virus|C0001417;C1564874|||||||1
AV|adriamycin plus vincristine||||||1|0.0015|
AV|allergic vasculitis|C0151436|||||||1
AV|alveolar duct|C0391892|||C0391892|CHV;FMA;NCI;UWDA|||1
AV|annexin V|C0059249;C1332095|||||1|0.0018|
AV|anterior ventral||||||1|0.0042|
AV|anteroventral||||||||1
AV|anteversion|C0333053|||||||1
AV|anteverted||||||||1
AV|anticipatory vomiting|C0042964|||||||1
AV|aortic valve|C0003501;C1269005|1|0.016|C0003501;C1269005|AOD;CHV;CSP;FMA;HL7V2.5;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.0097|1
AV|arteriovenous|C0302193;C0450109|1|0.232|||1|0.1574|1
AV|artificial ventilation|C0035205|||||1|0.0024|1
AV|assisted ventilation|C0554804|||C0554804|CHV|1|0.0021|1
AV|auditory-visual||||||1|0.0042|1
AV|augmented vector||||||||1
AV|autophagic vacuoles|C0544966|||||1|0.0054|
AV|aviation medicine|C0004431|||||||1
AV|avoirdupois||||||||1
AV|doxorubicin and vincristine chemotherapy protocol||||C0280598|CHV|||
AV|doxorubicin/vincristine protocol||||C0280598|MTH|||
AV|femoral anteversion||||||1|0.0021|
AV|human adenovirus|C0001490|||||1|0.0027|
AV|velocity|C0439830;C1547053|||||1|0.0045|
AVR|Lead AVR;lead avr;aVR|C0449217|||C0449217|CHV;LNC;SNOMEDCT|||
AVR|aVR (body structure)||||C0449217|SNOMEDCT|||
AVR|accelerated ventricular rhythm||||||||1
AVR|acute vascular rejection||||||1|0.0634|
AVR|antiviral regulator||||||||1
AVR|aortic valve regurgitation|C0003504|1|0.010|||||
AVR|aortic valve replacement|C0003506|1|0.762|C0003506|CHV;COSTAR;NCI;SNOMEDCT|1|0.8687|1
AVR|aortic valve resistance||1|0.008|||||
AVR|arteriole-to-venule ratio||||||1|0.0133|
AVR|ascending vasa recta|C2952018|||C2952018|FMA|1|0.0398|
AVR|augmented voltage right arm||1|0.206|||||1
AVR|pathogen avirulence||||||1|0.0147|
BAI|Baying;bay;baying;bays|C0234880;C3203003|||C0234880|CHV;SNOMEDCT|||
BAI|Baying (function)||||C0234880|SNOMEDCT|||
BAI|Baying (observable entity)||||C0234880|SNOMEDCT|||
BAI|Baying, function (observable entity)||||C0234880|SNOMEDCT|||
BAI|Brain Atrophy Index;brain atrophy index||||||1|0.1395|1
BAI|bai;baies|C0234880|||C0234880|CHV|||
BAI|basilar artery insufficiency|C0004812|||||||1
BAI|basion-axial interval||||||||1
BAI|beck anxiety inventory|C0582613|1|1.000|||||
BAI|blunt abdominal injury||||||||1
BAI|blunt aortic injury||||||1|0.2791|1
BAI|breath-actuated inhaler||||||||1
BAI|bronchial arterial infusion||||||1|0.3488|1
BAI|bronchial artery infusion||||||1|0.2326|
BAL|1,2-Dithioglycerol||||C0012383|NCI|||
BAL|1-Propanol, 2,3-dimercapto-;2,3-Dimercapto-1-propanol;2,3-dimercapto-1-propanol||||C0012383|MSH;NCI;NDFRT|1|0.004|
BAL|2,3 Dimercaptopropanol;2,3-Dimercaptopropanol;2,3-dimercaptopropanol||||C0012383|MSH;NDFRT|1|0.0107|
BAL|2,3 Dithiopropan 1 o1;2,3-Dithiopropan-1-o1||||C0012383|MSH;NDFRT|||
BAL|Anti-Lewisite Agent, British;British Anti Lewisite Agent;British Anti-Lewisite Agent;Anti-Lewisite, British;British Anti Lewisite;British Anti-Lewisite;British anti-Lewisite;British anti-lewisite;british anti lewisite;british anti-lewisite;BAL - British Anti-Lewisite;British anti-Lewisite (BAL);BAL-Dimercaprol;DIMERCAPROL;Dimercaprol;dimercaprol;Dimercaptopropanol;dimercaptopropanol;Dithioglycerol|C0012383|||C0012383|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0066|1
BAL|B-AGGRESSIVE LYMPHOMA 1;BAL1;PARP9;PARP9 gene;POLY(ADP-RIBOSE) POLYMERASE 9;poly (ADP-ribose) polymerase family, member 9|C1538586|||C1538586|HUGO;MTH;OMIM|||
BAL|BAC||||C0684262|AOD|||
BAL|BAL;bal||||C0012383;C0684262;C1538586|AOD;CHV;HUGO;LNC;OMIM;SNOMEDCT|||
BAL|Blood alcohol concentration;blood alcohol concentration;blood alcohol concentration (BAC)|C0684262|||C0684262|AOD;CHV;MTH|||
BAL|Dimercaprol (product)||||C0012383|SNOMEDCT|||
BAL|Dimercaprol (substance)||||C0012383|SNOMEDCT|||
BAL|Dimercaprol [Chemical/Ingredient]||||C0012383|NDFRT|||
BAL|balance;balanced|C0014653;C0205415;C0560184|||C0205415|CHV;SNOMEDCT|||1
BAL|balsam|C0004714|||||||1
BAL|bioartificial liver|C0336562|||C0336562|CHV;CSP;MSH|1|0.021|1
BAL|biphenotypic acute leukemia|C0023464|||C0023464|MSH;NDFRT|1|0.0017|
BAL|blood alcohol level|C0428249;C0542492;C0684262|1|0.086|C0428249;C0542492;C0684262|AOD;CHV;CSP;SNOMEDCT|1|0.0158|1
BAL|bronchoalveolar||||||1|0.0078|
BAL|bronchoalveolar lavage|C0189381;C0396473;C1535502|1|0.914|C0189381;C1535502|CHV;CSP;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.9023|1
BAL|bronchoalveolar lavage fluid|C0006279|||C0006279|MSH;MTH;NCI;SNOMEDCT|1|0.0302|
BIPAP|bilevel positive airway pressure||1|1.000|||||1
BIPAP|positive airway pressure||||||1|0.9541|
BIPAP|positive airway pressure ventilation||||||1|0.0459|
BKA|Bka;CGI-35;FCF1;FCF1 gene|C1426785|||C1426785|HUGO;MTH|||
BKA|FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)||||C1426785|HUGO|||
BKA|below-knee amputation|C0002692|1|1.000|C0002692|NCI|1|0.5714|1
BKA|bongkrekic acid|C0005982|||C0005982|MSH;NDFRT|1|0.4286|
BK|Arg Pro Pro Gly Phe Ser Pro Phe Arg;Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg||||C0006100|MSH;NDFRT|||
BK|BA||||C0006036|NCI|||
BK|BIH;BOSNIA-HERZEGOVINA;Bosnia and Hercegovina;Bosnia and Herzegovina;Bosnia-Hercegovina;Bosnia-Herzegovina;Bosnia;bosnia;Bosnia - Herzegovnia;Herzegovina|C0006036|||C0006036|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|||
BK|BK;Kallidin I;kallidin I;kallidin 9|C0006100|||C0006036;C0006100|CSP;NCI;OMIM;SNOMEDCT|||
BK|BK (virus)|C0005670|1|0.686|||||
BK|BRADYKININ;Bradykinin;bradykinin;bradykinins|C0006100;C0006101;C1537501|||C0006100;C0006101;C1537501|AOD;CHV;CSP;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9115|1
BK|Bosnia - Herzegovnia (geographic location)||||C0006036|SNOMEDCT|||
BK|Bradykinin [Chemical/Ingredient]||||C0006100|NDFRT|||
BK|Ca(2+)-activated K(+)||||||1|0.0189|
BK|K+ channel||||||1|0.0072|
BK|Kallidin I (substance)||||C0006100|SNOMEDCT|||
BK|back|C0004600;C0205095;C0460009;C1281593;C1995000|||||||1
BK|below knee;below the knee;below-knee||1|0.314|||1|0.0267|1
BK|berkelium|C0005124|||||||1
BK|bovine kidney||||||||1
BK|bullous keratopathy|C0155111|||||||1
BK|calcium-activated potassium channels||||||1|0.0028|
BK|large conductance||||||1|0.0117|
BK|large-conductance Ca2+-activated K+||||||1|0.0122|
BK|large-conductance calcium-activated potassium||||||1|0.005|
BK|potassium channel|C0032824|||||1|0.0039|
BMI|BMI||||C0005893;C1305855;C1542867|AOD;CHV;CSP;LNC;NCI;OMIM|||
BMI|BMI - Body mass index;body mass index (BMI);BODY MASS INDEX;Body Mass Index;Body Mass Indices;Body mass index;Body mass index, NOS;Index, Body Mass;body mass index;Index, Quetelet;Quetelet Index;Quetelet index;Quetelet's Index;Quetelets Index;quetelet index|C0005893;C1305855|1|0.994|C0005893;C1305855;C2240399|AOD;CHV;CSP;ICD9CM;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.9842|1
BMI|Body mass index (BMI) [Ratio]||||C1542867|LNC|||
BMI|Body mass index (observable entity)||||C1305855|SNOMEDCT|||
BMI|Body mass index - observation||||C1305855|SNOMEDCT|||
BMI|Body mass index [dup] (observable entity)||||C1305855|SNOMEDCT|||
BMI|Body mass index procedure|C0005893|||C0005893|MTH|||
BMI|Body mass index:Ratio:Pt:^Patient:Qn||||C1542867|LNC|||
BMI|Body mass index:Relative Density:Point in time:^Patient:Quantitative||||C1542867|LNC;MTH|||
BMI|Bone marrow involvement|C1517677|||||1|0.0009|
BMI|Quetelet index (observable entity)||||C1305855|SNOMEDCT|||
BMI|bicuculline methiodide|C0053558|||||1|0.0133|1
BMI|biomedical informatics||||||||1
BMI|body weight|C0005910;C1305866|||||1|0.0006|
BMI|brain-machine interface||||||1|0.0009|
BMP|BCNU/MTX/PCB||||C0279266|NCI;PDQ|||
BMP|BMP;bmp|C0053932;C0279266|||C0053932;C0279266|CHV;CSP;NCI;PDQ|||
BMP|Bone Morphogenetic Protein;Bone Morphogenetic Proteins;Morphogenetic Protein, Bone;Morphogenetic Proteins, Bone;bone morphogenetic protein;bone morphogenetic proteins|C0053932|1|0.014|C0053932|CHV;CSP;MSH;MTH;NCI;NDFRT|1|1|1
BMP|Bone Morphogenetic Proteins [Chemical/Ingredient]||||C0053932|NDFRT|||
BMP|Carmustine/Methotrexate/Procarbazine;carmustine/methotrexate/procarbazine||||C0279266|NCI;PDQ|||
BMP|basic metabolic profile||1|0.912|||||1
BMP|behavior management plan||||||||1
BMP|bone marrow pressure||||||||1
BMP|carmustine/methotrexate/procarbazine protocol|C0279266|||C0279266|MTH|||
BM|BD||||C0005126|NCI|||
BM|BERMUDA;Bermuda;bermuda;BMU;Bermuda Islands;Bermudas|C0005126|||C0005126|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
BM|BM||||C0005126;C0006416;C0011135;C1704651|MEDLINEPLUS;NCI|||
BM|Barrett's metaplasia|C1862318|||||1|0.0037|
BM|Bergersen medium||||||||1
BM|Bermuda (geographic location)||||C0005126|SNOMEDCT|||
BM|Birma;Burma;burma;MYANMAR;Myanma;Myanmar;myanmar;Union of Myanmar|C0006416|||C0006416|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
BM|Bohr magneton||||||||1
BM|Bombyx mori|C0323309|||||1|0.0018|
BM|Bone Measurements;Bone Measurements Domain;Bone Mineral Density Data Domain|C1704651|||C1704651|MTH;NCI|||
BM|Bone marrow;bone marrow|C0005953|1|0.028|||1|0.7803|1
BM|Bowel Function;Bowel function;bowel function;bowel functioning;Bowel Movement;Bowel movements;bowel movement;bowel movements;bowels movement;bowels movements;Bowel action;bowel action;Bowel habit;Bowel habits;Bowel habits, NOS;bowel habit;bowel habits;Bowel motion - function;Defaecation;Defecation;Defecation, NOS;Defecations;defaecation;defecation;Normal defecation;stool passing|C0011135|1|0.918|C0011135|AOD;CHV;CSP;GO;LCH;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|||1
BM|Bowel action (observable entity)||||C0011135|SNOMEDCT|||
BM|Burma (geographic location)||||C0006416|SNOMEDCT|||
BM|Defecation (function)||||C0011135|SNOMEDCT|||
BM|Defecation (observable entity)||||C0011135|SNOMEDCT|||
BM|Defecation, function (observable entity)||||C0011135|SNOMEDCT|||
BM|MM|C0439190|||C0006416|NCI|||
BM|MMR||||C0006416|NCI|||
BM|Passes stool completely||||C0011135|SNOMEDCT|||
BM|Passes stool completely (finding)||||C0011135|SNOMEDCT|||
BM|bacterial meningitis|C0085437|||||1|0.0094|1
BM|basal medium||||||1|0.0018|1
BM|basal membrane||||||||1
BM|basal metabolism|C0678121|||||||1
BM|basement membrane|C0004799|||||1|0.1198|1
BM|basilar membrane|C0004816|||||1|0.024|1
BM|betamethasone|C0005308|||||1|0.0039|
BM|bicuculline methiodide|C0053558|||||1|0.0018|
BM|biological monitoring|C0005517|||||1|0.0022|
BM|biomedical|C1879848|||||||1
BM|bleomycin|C0005740|||||1|0.0057|
BM|blind matching||||||||1
BM|blood meal||||||1|0.0049|
BM|blood monitoring||||||||1
BM|blood monocyte|C0026473|||||||1
BM|body mass|C0518010|||||1|0.0199|1
BM|bone marrow cells|C0005955|||||1|0.0026|
BM|bone metastases;bone metastasis|C0153690|||||1|0.0053|1
BM|brain metastases|C0220650|||||1|0.0061|
BM|breast milk|C0026131;C0026140|1|0.050|||1|0.0018|1
BM|bronchial mucosa|C0225600|||||1|0.0012|
BM|buccal mass||||||||1
BM|buccal mucosa|C0026639;C1280540;C1578559|||||1|0.0016|
BM|buccomesial||||||||1
BM|bullous myringitis|C0155461|||||||1
BM|butadiene monoxide|C0047001|||||1|0.002|
BMT|BMT;bmt;BMT - Bone marrow transplant;bone marrow transplant (BMT);bone marrow transplant bmt;BONE MARROW TRANSPLANT;Bone Marrow Transplant;Bone marrow transplant;Bone marrow transplanted;bone marrow transplant;bone marrow transplants;Bone Marrow Grafting;Bone marrow graft;Graft of bone marrow NOS;Grafting of bone marrow NOS;Grafting, Bone Marrow;bone marrow graft;bone marrow grafting;Bone Marrow Transplantation;Transplantation of bone marrow;Transplantation of bone marrow, NOS;Transplantation, Bone Marrow;bone marrow transplantation;bone marrow transplantations;transplantation, bone marrow;Bone marrow transplant, not otherwise specified;Marrow Transplantation|C0005961|1|1|C0005961|CCS;CHV;COSTAR;CSP;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.9862|1
BMT|BONE MARROW TRANSPL;TRANSPL BONE MARROW||||C0005961|MSH|||
BMT|Basic Military Training||||||1|0.0031|
BMT|Bone marrow transplant (procedure)||||C0005961|SNOMEDCT|||
BMT|Bone marrow trnsplnt NOS||||C0005961|ICD9CM|||
BMT|Buschke Memory Test||||||||1
BMT|Graft of bone marrow NOS (procedure);Grafting of bone marrow NOS (procedure)||||C0005961|SNOMEDCT|||
BMT|Transplantation of bone marrow (procedure)||||C0005961|SNOMEDCT|||
BMT|basement membrane thickening|C0544995|||||||1
BMT|basement membrane thickness||||||1|0.0023|1
BMT|behavioral marital therapy||||||1|0.0038|1
BMT|benign mesenchymal tumor||||||||1
BMT|bilateral myringotomy tubes||||||||1
BMT|bone marrow|C0005953|||||1|0.0046|
BNP|B-Type Natriuretic Peptide;B-type natriuretic peptide|C0054015;C1095989|||C1095989|NCI|1|0.954|
BNP|BNP|C1095989;C1417808;C2982014|||C1095989;C1417808;C2982014|NCI;OMIM|||
BNP|Brain Natriuretic Peptide;brain natriuretic peptide;brain natriuretic peptides|C0054015|||C0054015;C1095989|CHV;MSH;NCI;NDFRT;SNOMEDCT|1|0.046|
BNP|Brain Natriuretic Peptide Measurement;Brain natriuretic peptide measurement;Brain natriuretic peptide level|C1095989|||C1095989|MTH;NCI;SNOMEDCT|||
BNP|Brain natriuretic peptide level (procedure)||||C1095989|SNOMEDCT|||
BNP|Brain natriuretic peptide measurement (procedure)||||C1095989|SNOMEDCT|||
BNP|NATRIURETIC PEPTIDE PRECURSOR B;NATRIURETIC PEPTIDE, BRAIN TYPE;NPPB Gene;NPPB gene;Natriuretic Peptide Precursor B Gene|C1417808|||C1417808|HUGO;MTH;NCI;OMIM|||
BNP|NPPB|C0049330;C1417808|||C1417808|HUGO;NCI;OMIM|||
BNP|NPPB wt Allele;Natriuretic Peptide Precursor B wt Allele|C2982014|||C2982014|MTH;NCI|||
BNP|beta-natriuretic peptide||1|0.964|||||1
BNP|brain natriuretic peptide (BNP) level test||||C1095989|CHV|||
BNP|natriuretic peptide B|C1317554;C1417808|||C1417808|HUGO|||
BOOP|BOOP;boop;Bronchiolitis Obliterans Organizing Pneumonia;Bronchiolitis obliterans organising pneumonia;Bronchiolitis obliterans organizing pneumonia;Bronchiolitis obliterans with organising pneumonia;Bronchiolitis obliterans with organizing pneumonia;bronchiolitis obliterans-organizing pneumonia;Cryptogenic Organizing Pneumonia;Cryptogenic Organizing Pneumonias;Cryptogenic organising pneumonia;Cryptogenic organizing pneumonia;Organizing Pneumonia, Cryptogenic;Organizing Pneumonias, Cryptogenic;Pneumonia, Cryptogenic Organizing;Pneumonias, Cryptogenic Organizing;cryptogenic organizing pneumonia;Cryptogenic organising pneumonitis;Cryptogenic organizing pneumonitis;bronchiolitis obliterans organizing pneumonia (BOOP)|C0242770|1|1|C0242770|CHV;ICD9CM;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|1|1
BOOP|BOOP - Bronchiolitis obliterans and organising pneumonitis;BOOP - Bronchiolitis obliterans and organizing pneumonitis||||C0242770|SNOMEDCT|||
BOOP|Bronchiolitis obliterans and organising pneumonitis;Bronchiolitis obliterans and organizing pneumonitis||||C0242770|SNOMEDCT|||
BOOP|Bronchiolitis obliterans organizing pneumonia (disorder)||||C0242770|SNOMEDCT|||
BOOP|COP|C0086825|||C0242770|NCI|||
BOOP|COP - Cryptogenic organising pneumonitis;COP - Cryptogenic organizing pneumonitis||||C0242770|SNOMEDCT|||
BOOP|Cryptogenic Organizing Pneumonia [Disease/Finding]||||C0242770|NDFRT|||
BOOP|Cryptogenic organiz pneu||||C0242770|ICD9CM|||
BPH|BEP - Benign enlargement of prostate;BPH - Benign prostatic hypertrophy;BPH - benign prostatic hypertrophy;Benign Prostatic Hypertrophy;Benign prostatic hypertrophy;Hypertrophy, Benign Prostatic;Prostatic Hypertrophy, Benign;benign prostatic hypertrophy;Benign enlargement of prostate;Benign enlargement of prostate, NOS;benign prostate enlargement;Benign hypertrophy of prostate NOS;Hypertrophy (benign) of prostate;PROSTATE, HYPERTROPHY, BENIGN;benign prostate hypertrophy;Enlarged prostate - benign;benign enlarged prostate|C0005001|||C0005001|CHV;COSTAR;DXP;ICD9CM;ICPC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.1329|
BPH|BPH;Benign Hyperplasia of Prostate;Benign Hyperplasia of the Prostate;Benign Prostate Hyperplasia;benign hyperplasia of the prostate;benign prostate hyperplasia|C0005001;C1704272|||C0005001;C1704272|CHV;CSP;DXP;MEDLINEPLUS;NCI;OMIM;PDQ;SNOMEDCT|1|0.0061|
BPH|Benign Prostatic Hyperplasia;Benign prostatic hyperplasia;Benign prostatic hyperplasia, NOS;PROSTATIC HYPERPLASIA, BENIGN;Prostatic Hyperplasia, Benign;benign prostatic hyperplasia;Benign Prostatic Hyperplasia - BPH;benign prostatic hyperplasia (BPH)|C0005001;C1704272;C2937421|1|1|C0005001;C1704272|CHV;CSP;LNC;MSH;MTH;NCI;OMIM;PDQ;SNOMEDCT|1|0.8443|1
BPH|Benign prostatic hyper.;Prostatic hyper -benign||||C0005001|SNOMEDCT|||
BPH|Benign prostatic hyperplasia (disorder)||||C1704272|SNOMEDCT|||
BPH|Brown Planthopper||||||1|0.0034|
BPH|Hypertrophy-prost.ben.||||C0005001|SNOMEDCT|||
BPH|Nodular hyperplasia of prostate gland|C1704272;C2937421|||C1704272|SNOMEDCT|||
BPH|PROSTATIC HYPERPLASIA BENIGN <PROSTATISM>||||C1704272|QMR|||
BPH|bacteriopheophytin|C0052909|||||1|0.0038|1
BPH|benign hyperplastic||||||1|0.0041|
BPH|benzo[a]pyrene hydroxylase|C0005080|||||1|0.0034|
BPH|buccopharyngeal||||||||1
BPH|hyperplastic prostate tissue||||||1|0.002|
BPH|prostate hyperplasia;prostatic hyperplasia|C0005001;C2937421|||C0005001|CHV|||
BPH|prostate hypertrophy|C0005001;C1739363|||C0005001|CHV|||
BPH|prostatic hypertrophy|C0005001;C1739363;C2937421|||C0005001|CHV|||
BPP|BPP;CBPS;Congenital bilateral perisylvian syndrome;PERISYLVIAN SYNDROME, CONGENITAL BILATERAL;Perisylvian syndrome, congenital bilateral;PMGX;POLYMICROGYRIA, BILATERAL PERISYLVIAN;Polymicrogyria, bilateral perisylvian;Perisylvian syndrome|C1845668|||C1845668|MSH;OMIM;SNOMEDCT|||
BPP|Bloembergen, Purcell, Pound||||||||1
BPP|Congenital bilateral perisylvian syndrome (disorder)||||C1845668|SNOMEDCT|||
BPP|binding protein protease||||||||1
BPP|biophysical profile||1|1.000|||1|0.2754|1
BPP|bovine PP||||||1|0.1014|
BPP|bovine pancreatic polypeptide||||||1|0.6232|1
BPP|brachial plexus paralysis|C0541435|||||||1
BPP|bradykinin potentiating peptide||||||||1
BPP|breast parenchymal pattern||||||||1
BP|72-base-pair||||||1|0.0007|
BP|BLEO/CDDP||||C0057191|NCI;PDQ|||
BP|BLOOD PRESSURE;Blood Pressure;Blood pressure;Blood pressure, NOS;Pressure, Blood;blood pressure|C0005823;C1271104;C1272641|1|0.992|C0005823;C0005824|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.7029|1
BP|BP;Bp;Binding Potential;binding potential|C2986841|||C0005823;C0005824;C0037623;C0057191;C1841672;C2986841|CHV;MTH;NCI;OMIM;PDQ|1|0.0092|
BP|BP - Blood pressure|C0005823|||C0005823|SNOMEDCT|||
BP|Back-Propagation;backpropagation||||||1|0.0026|
BP|Bell palsy;Bell's palsy|C0015469;C0376175|||||1|0.0008|1
BP|Bereitschaftspotential;bereitschaftspotential|C1704305|||C1704305|MSH|1|0.0057|
BP|Bisphosphonates|C0012544|||||1|0.0019|
BP|Bleomycin/Cisplatin;bleomycin/cisplatin||||C0057191|NCI;PDQ|||
BP|Blood Pressure Determination;Blood Pressure Determinations;Blood pressure determination;Determination, Blood Pressure;Determinations, Blood Pressure;blood pressure determination;Blood pressure taking;Blood pressure taking, NOS;take blood pressure;taking blood pressure|C0005824|||C0005824|AOD;CHV;MSH;MTH;SNOMEDCT|||
BP|Blood pressure (observable entity)||||C0005823|SNOMEDCT|||
BP|Blood pressure taking (procedure)||||C0005824|SNOMEDCT|||
BP|Bolton point||||||||1
BP|Bordetella pertussis|C0006017|||||1|0.0022|
BP|Bp (binding peptide) haptoglobin beta polypeptide chain locus||||C1841672|MTH|||
BP|British Pharmacopoeia||||||1|0.0011|
BP|DDP-BLM protocol;bleomycin/cisplatin protocol|C0057191|||C0057191|MSH;MTH|||
BP|Pharmacopoeia Britannica||||||||1
BP|SB||||C0037623|NCI|||
BP|SLB|C0037623;C1825575|||C0037623|NCI|||
BP|SOLOMON ISLANDS;Solomon Islands;Solomon islands|C0037623|||C0037623|AOD;MSH;MTH;NCI;SNOMEDCT|||
BP|Solomon islands (geographic location)||||C0037623|SNOMEDCT|||
BP|Systolic and diastolic blood pressures||||||1|0.0014|
BP|[3H]benzo[a]pyrene||||||1|0.0011|
BP|bacillary peliosis|C0343770|||||||1
BP|back pressure||||||||1
BP|bacterial pneumonia|C0004626|||||1|0.0007|
BP|barometric pressure|C0237510|||||||1
BP|base pair;base pairs;basepairs|C0600436|||||1|0.1581|1
BP|basic protein||||||||1
BP|basilar papilla|C1136024|||||1|0.0013|
BP|bathroom privileges||||||||1
BP|bed pan|C0179263|||||||1
BP|beet pulp||||||1|0.0008|
BP|before polarization||||||||1
BP|before present||||||||1
BP|behavior pattern|C0018464|||||||1
BP|bench press|C0454326|||||1|0.0013|
BP|benz(a)pyrene||||||1|0.0027|
BP|benzo(a)pyrene|C0005052|||||1|0.0207|
BP|benzo[alpha]pyrene|C1507317|||||1|0.0028|
BP|benzophenone|C0053233|||||1|0.0014|
BP|benzoyl peroxide|C0005088|||||1|0.0023|1
BP|benzpyrene|C0005097|||||||1
BP|benzylpenicillin|C0030827|||||1|0.0021|
BP|beta-protein|C1750295;C2362547|||||||1
BP|biliopancreatic||1|0.006|||||
BP|binding protein|C0242210|||||1|0.0066|1
BP|bioequivalence problem||||||||1
BP|biotic potential||||||||1
BP|biparietal||||||||1
BP|biphenyl|C0058372|||||1|0.0014|1
BP|bipolar|C0443156|||||1|0.0043|1
BP|bipolar affective disorder;bipolar disorder|C0005586|||||1|0.0051|
BP|birthplace|C0805310;C3202966|||||||1
BP|bladder pressure||||||||1
BP|blastic phase||||||1|0.0022|
BP|blood plasma|C0032105|||||1|0.0012|
BP|bodily pain||||||1|0.0015|1
BP|body part|C0229962|||||||1
BP|body plethysmography|C0032224|||||||1
BP|boiling point|C1257887|||C1257887|AOD;CHV|||1
BP|borderline personality|C0006012|||||||1
BP|bovine pericardium||||||1|0.0015|
BP|bowenoid papulosis|C0334106|||||1|0.0016|1
BP|brachial plexus|C0006090;C1278841|||||1|0.0008|
BP|breech presentation|C0006157|||||||1
BP|brevipedicellus||||||1|0.0008|
BP|bronchopleural|C0450194;C0545668|||||||1
BP|bronchopulmonary|C0545675|||||||1
BP|buccopulpal||||||||1
BP|bullous pemphigoid|C0030805|||||1|0.0335|
BP|bullous pemphigus|C0262398|||||||1
BP|bypass|C0741847|||||||1
BP|metabolism of benzo[a]pyrene||||||1|0.0029|
BP|myelin basic protein|C0014063;C1417057|||||1|0.0113|
BP|point|C1552961;C2347617|||||1|0.0014|
BP|total biopterin||||||1|0.0004|
BSO|2-Amino-4-(S-butylsulfonimidoyl) Butanoic Acid;Butanoic Acid, 2-Amino-4-(S-butylsulfonimidoyl)-;Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-||||C0054252|MSH;NCI;NDFRT;PDQ|||
BSO|BSO;Buthionine Sulfoximine;Buthionine Sulphoximine;Sulfoximine, Buthionine;buthionine sulfoximine;buthionine sulphoximine;L-Buthionine Sulfoximine;L-Buthionine sulfoximine|C0054252|||C0054252|CSP;MSH;NCI;NDFRT;PDQ|1|0.7259|
BSO|Buthionine Sulfoximine [Chemical/Ingredient]||||C0054252|NDFRT|||
BSO|D,L-buthionine-S,R-sulfoximine;DL-buthionine-S,R-sulfoximine;d,l-Buthionine-s,r-sulfoximine||||C0054252|NCI;PDQ|1|0.066|
BSO|L-buthionine-(S,R)-sulfoximine||||||1|0.1624|
BSO|L-buthionine-SR-sulfoximine||||||1|0.0165|
BSO|R-sulfoximine||||||1|0.0178|
BSO|S-(3-Amino-3-carboxypropyl)-S-butylsulfoximine||||C0054252|NCI;PDQ|||
BSO|S-(n-Butyl)homocysteine Sulfoximine||||C0054252|NCI;PDQ|||
BSO|behavior, speech, other syndromes||||||||1
BSO|bilateral sagittal osteotomy||||||||1
BSO|bilateral salpingo-oophorectomy|C0195495|1|1.000|C0195495|CHV;ICD9CM;NCI;SNOMEDCT|||1
BSO|bilateral serous otitis||||||||1
BSO|bile salt output||||||||1
BSO|buthionine sulfoximide||||||1|0.0114|
BUN|BUN||||C0005845;C0600137|AOD;MSH;MTH;NCI;SNOMEDCT|||
BUN|BUN measurement;bun measurement;Blood Urea Nitrogen Measurement;Blood urea nitrogen measurement;Blood urea measurement|C0005845|||C0005845|CHV;MTH;NCI;SNOMEDCT|||
BUN|Blood Urea;Blood urea;Urea - blood;blood urea;urea blood;Blood Urea Nitrogen;Blood urea nitrogen;Nitrogen, Blood Urea;Urea Nitrogen, Blood;blood urea nitrogen;blood urea nitrogen (BUN)|C0005845;C0600137|1|1|C0005845;C0600137|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.9937|1
BUN|Blood urea (procedure)||||C0005845|SNOMEDCT|||
BUN|Blood urea measurement (procedure)||||C0005845|SNOMEDCT|||
BUN|Blood urea nitrogen (substance)||||C0600137|SNOMEDCT|||
BUN|Blood urea nitrogen concentration||||||1|0.0063|
BUN|Blood urea nitrogen measurement (procedure)||||C0005845|SNOMEDCT|||
BUN|blood urea nitrogen (BUN) level test||||C0005845|CHV|||
BUN|bunion|C0006386|||||||1
BUN|urea nitrogen|C0600137;C1291218|||C0600137|NCI|||
BUS|1, 4-Bis[methanesulfonoxy]butane;1,4-Bis(methanesulfonoxy)butane;BSF;bsf;BU;BUSULFAN;Busulfan;Busulphan;busulfan;busulphan;Bussulfam;Busulfanum;Methanesulfonic Acid Tetramethylene Ester;Methanesulfonic acid, tetramethylene ester;Myeleukon;Sulfabutin;Tetramethylene Bis(methanesulfonate);Tetramethylene bis[methanesulfonate]|C0006463|||C0006463|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
BUS|1,4-Bitanediol Dimethanesulfonate Esters||||C0006463|NCI;PDQ|||
BUS|1,4-Butanediol Dimethylsulfonate||||C0006463|NCI;PDQ|||
BUS|1,4-Butanediol, dimethanesulfonate||||C0006463|MSH;NDFRT|||
BUS|1,4-Di(methanesulfonyloxy)butane||||C0006463|NCI;PDQ|||
BUS|1,4-Di(methylsulfonyloxy)butane||||C0006463|NCI;PDQ|||
BUS|BUS;Bus;Buses;bus;buses|C0336815;C1704736|||C0006463;C0336815;C1552509;C1704736|CHV;HL7V3.0;MSH;NCI;PDQ;SNOMEDCT|||
BUS|Bartholin, urethral, and Skene||1|1.000|||||1
BUS|Bus - Transportation Service|C1552509|||C1552509|MTH|||
BUS|Bus Device Component|C1704736|||C1704736|MTH;NCI|||
BUS|Busulfan (product)||||C0006463|SNOMEDCT|||
BUS|Busulfan (substance)||||C0006463|SNOMEDCT|||
BUS|Busulfan [Chemical/Ingredient]||||C0006463|NDFRT|||
BUS|Motor bus;Motor bus, device|C0336815|||C0336815|MTH;SNOMEDCT|||
BUS|Motor bus, device (physical object)||||C0336815|SNOMEDCT|||
BUS|bladder ultrasound|C0855956|||||||1
BUS|bulbourethral sling||||||||1
BUS|buspirone|C0006462|||||1|1|
C&S|conjunctiva and sclera;conjunctivae and sclerae||1|0.868|||||1
C&S|cough and sneeze||||||||1
C&S|culture and sensitivity||1|0.094|||||1
C&S|culture and susceptibility|C0430388|||||||1
C&S|protein C and protein S||1|0.032|||||
C3|(complement) component 3;COMPLEMENT COMPONENT 3;Complement Component 3;Complement component 3;Component 3, Complement;complement component 3|C0009506;C1332656|1|0.486|C0009506;C1332656|HUGO;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.1041|
C3|(stage) C3|C0441788|1|0.004|||||
C3|C3;Complement C3 Measurement|C2699419|||C0009506;C0456881;C1305853;C1332656;C2699419|FMA;HUGO;MTH;NCI;OMIM;SNOMEDCT;UWDA|||
C3|C3 - Complement component 3;Complement 3;complement 3;Complement component C3;Complement component C3, NOS;c3 complement component;complement component c3|C0009506|||C0009506|CHV;MSH;MTH;NDFRT;SNOMEDCT|1|0.0571|
C3|C3 - TNM certainty factor;TNM certainty factor C3;C3 certainty|C0456881|||C0456881|MTH;SNOMEDCT|||
C3|C3 - TNM certainty factor (tumor staging)||||C0456881|SNOMEDCT|||
C3|C3 Complement;C3, Complement;Complement C3;Complement, C3;c3 complement;complement C3;complement c3|C0009506;C2699419|||C0009506;C2699419|CHV;LNC;MSH;NCI;NDFRT|1|0.0143|
C3|C3 Gene;C3 gene;C3c;CPAMD1;Complement Component 3 Gene|C1332656|||C1332656|HUGO;MTH;NCI;OMIM|||
C3|C3 and PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 1||||C0009506|NCI|||
C3|C3 certainty (qualifier value)||||C0456881|SNOMEDCT|||
C3|C3 certainty (tumor staging)||||C0456881|SNOMEDCT|||
C3|C3 innervation|C1305853|||C1305853|MTH|||
C3|C3(H20)||||C0009506|SNOMEDCT|||
C3|C3(H20) (substance)||||C0009506|SNOMEDCT|||
C3|C3H/HeJ||||||1|0.0429|
C3|C3d|C1332656;C2826008;C3151071|||C1332656|OMIM|||
C3|COMPLEMENT C 03||||C0009506|MSH|||
C3|Clostridium botulinum C3 exoenzyme||||||1|0.0102|
C3|Collins solution|C0056123|||||||1
C3|Complement -third component-C3||||C0009506|SNOMEDCT|||
C3|Complement C3 [Chemical/Ingredient]||||C0009506|NDFRT|||
C3|Complement component 3 (procedure)||||C0009506|SNOMEDCT|||
C3|Complement component C3 (substance)||||C0009506|SNOMEDCT|||
C3|Flaveria pringlei|C0996999|||||1|0.0143|
C3|cervical (level) 3||1|0.498|||||
C3|complement factor 3||||||1|0.0531|
C3|propionylcarnitine|C0072196|1|0.012|||||
C3|third|C0205437|||||1|0.0571|
C3|third carpal bone|C0223733|||||1|0.0245|
C3|third cervical (c3) nerve||||C1305853|CHV|||
C3|third cervical vertebra|C0459939|||C0459939|FMA;SNOMEDCT;UWDA|||
C3|third complement component;third component of complement||||||1|0.5755|
C3|third component||||||1|0.0469|
C4|(PO Box) C4||1|0.002|||||
C4|(complement) component 4;Complement Component 4;Complement Component-4;Complement component 4;Component 4, Complement;complement component 4;C4 - Complement component 4;C4 Complement Component;Complement Component, C4;Complement component C4;Complement component C4, NOS;Component, C4 Complement;complement component c4;Complement 4;complement 4|C0009516|1|0.462|C0009516|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.1149|
C4|ACIDIC C4;C4A gene;C4A2;C4A3;C4A4;C4A6;COMPLEMENT COMPONENT 4S;CPAMD2;RG|C1412999|||C1412999|HUGO;MTH;OMIM|||
C4|C4;C4S|C0577608;C1412999|||C0009516;C0456882;C0577608;C1305858;C1412999|FMA;HUGO;NCI;OMIM;SNOMEDCT;UWDA|||
C4|C4 - TNM certainty factor;TNM certainty factor C4;C4 certainty|C0456882|||C0456882|MTH;SNOMEDCT|||
C4|C4 - TNM certainty factor (tumor staging)||||C0456882|SNOMEDCT|||
C4|C4 Complement;C4, Complement;Complement C4;Complement, C4;complement c4|C0009516;C0577608|||C0009516;C0577608|CHV;LNC;MSH;NCI;NDFRT|||
C4|C4 certainty (qualifier value)||||C0456882|SNOMEDCT|||
C4|C4 certainty (tumor staging)||||C0456882|SNOMEDCT|||
C4|C4 complement assay;C4 complement assay (procedure);Complement C4 Measurement;Complement C4 measurement;Complement component 4 test|C0577608|||C0577608|MTH;NCI;SNOMEDCT|||
C4|C4 innervation|C1305858|||C1305858|MTH|||
C4|C4A|C0523345;C1412999|||C1412999|HUGO;OMIM|||
C4|C4B||||C1412999|HUGO|||
C4|C<sub>4</sub> complement assay||||C0577608|SNOMEDCT|||
C4|C<sub>4</sub> complement assay (procedure)||||C0577608|SNOMEDCT|||
C4|C>4< complement assay||||C0577608|SNOMEDCT|||
C4|C>4< complement assay (procedure)||||C0577608|SNOMEDCT|||
C4|CO4|C1412999;C1413000|||C1412999|HUGO|||
C4|COMPLEMENT C 04||||C0009516|MSH|||
C4|COMPLEMENT COMPONENT 4A|C0009517;C1412999|||C1412999|OMIM|||
C4|Complement C4 [Chemical/Ingredient]||||C0009516|NDFRT|||
C4|Complement component 4 (procedure)||||C0009516|SNOMEDCT|||
C4|Complement component 4 (substance)||||C0009516|SNOMEDCT|||
C4|Complement component C4 (substance)||||C0009516|SNOMEDCT|||
C4|Complement component C4 (substance) [Ambiguous]||||C0009516|SNOMEDCT|||
C4|Complement-fourth component-C4||||C0009516|SNOMEDCT|||
C4|F trinervia||||||1|0.0068|
C4|Flaveria trinervia|C0997000|||||1|0.0743|
C4|RODGERS BLOOD GROUP||||C1412999|OMIM|||
C4|RODGERS FORM OF C4||||C1412999|OMIM|||
C4|cervical (level) 4||1|0.522|||||
C4|complement component 4A (Rodgers blood group)||||C1412999|HUGO|||
C4|fourth cervical (c4) nerve||||C1305858|CHV|||
C4|fourth cervical vertebra|C0459941|||C0459941|FMA;SNOMEDCT;UWDA|||
C4|fourth complement component;fourth component of complement||||||1|0.804|
C5|(complement) component 5;COMPLEMENT COMPONENT 5;Complement Component 5;Complement component 5;Component 5, Complement;complement component 5|C0009519;C1367710|1|0.008|C0009519;C1367710|HUGO;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0513|
C5|C3 and PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4||||C0009519|NCI|||
C5|C5||||C0009519;C0456883;C1305859;C1367710|FMA;HUGO;NCI;OMIM;SNOMEDCT;UWDA|||
C5|C5 - Complement component 5;C5 Complement;C5, Complement;Complement C5;Complement, C5;c5 complement;complement c5;Complement 5;complement 5;Complement component C5;Complement component C5, NOS;complement component c5|C0009519|||C0009519|CHV;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
C5|C5 - TNM certainty factor;TNM certainty factor C5;C5 certainty|C0456883|||C0456883|MTH;SNOMEDCT|||
C5|C5 - TNM certainty factor (tumor staging)||||C0456883|SNOMEDCT|||
C5|C5 Gene;C5 gene;CPAMD4;Complement Component 5 Gene|C1367710|||C1367710|HUGO;MTH;NCI|||
C5|C5 certainty (qualifier value)||||C0456883|SNOMEDCT|||
C5|C5 certainty (tumor staging)||||C0456883|SNOMEDCT|||
C5|C5 innervation|C1305859|||C1305859|MTH|||
C5|C5(-OH acylcarnitine)||1|0.010|||||
C5|COMPLEMENT C 05||||C0009519|MSH|||
C5|Complement C5 [Chemical/Ingredient]||||C0009519|NDFRT|||
C5|Complement component C5 (substance)||||C0009519|SNOMEDCT|||
C5|cervical (level) 5||1|0.982|||||
C5|fifth cervical (c5) nerve||||C1305859|CHV|||
C5|fifth cervical vertebra|C0459943|||C0459943|FMA;SNOMEDCT;UWDA|||
C5|fifth complement component;fifth component of complement||||||1|0.7692|
C5|fifth component||||||1|0.1026|
C5|five or more coughs||||||1|0.0769|
C6|C6||||C1305860;C1413014;C1419009|FMA;HUGO;OMIM;UWDA|||
C6|C6 (acylcarnitine)||1|0.004|||||
C6|C6 gene|C1413014|||C1413014|HUGO;MTH|||
C6|C6 innervation|C1305860|||C1305860|MTH|||
C6|COMPLEMENT COMPONENT 6;complement component 6|C0009523;C1413014|||C0009523;C1413014|HUGO;MSH;NDFRT;OMIM;SNOMEDCT|||
C6|HSPC;PROTEASOME SUBUNIT ALPHA-4;PROTEASOME SUBUNIT, ALPHA-TYPE, 7;PSMA7;PSMA7 gene;RC6-1;XAPC7;proteasome subunit RC6-1;proteasome subunit XAPC7|C1419009|||C1419009|HUGO;MTH;OMIM|||
C6|cervical (level) 6||1|0.992|||||
C6|complement 6|C0009523|||C0009523|MSH;NDFRT|||
C6|hexamethonium|C0062637|||||1|0.339|1
C6|proteasome (prosome, macropain) subunit, alpha type, 7||||C1419009|HUGO|||
C6|rat glioma||||||1|0.2458|
C6|sixth|C0205440|||||1|0.0847|
C6|sixth cervical||||||1|0.0424|
C6|sixth cervical (c6) nerve||||C1305860|CHV|||
C6|sixth cervical vertebra|C0459944|||C0459944|FMA;SNOMEDCT;UWDA|||
C6|sixth complement component;sixth component of complement||||||1|0.2458|
C6|sixth component||||||1|0.0424|
C7|C7||||C1305861;C1367714;C1413019;C1706327|FMA;HUGO;NCI;OMIM;UWDA|||
C7|C7 gene|C1413019|||C1413019|HUGO;MTH|||
C7|C7 innervation|C1305861|||C1305861|MTH|||
C7|CHEMOKINE, CXC MOTIF, LIGAND 10;CXCL10 Gene;CXCL10 gene;SMALL INDUCIBLE CYTOKINE SUBFAMILY B, MEMBER 10|C1367714|||C1367714|HUGO;MTH;NCI;OMIM|||
C7|COMPLEMENT COMPONENT 7;complement component 7|C0009524;C1413019|||C0009524;C1413019|HUGO;MSH;NDFRT;OMIM;SNOMEDCT|||
C7|CRG-2;crg-2;IFI10;INP10;MOB-1;mob-1;SCYB10;gIP-10|C1367714;C1706327|||C1367714;C1706327|HUGO;NCI;OMIM|||
C7|CXCL10||||C1367714|HUGO;NCI;OMIM|||
C7|CXCL10 wt Allele|C1706327|||C1706327|MTH;NCI|||
C7|Chemokine (C-X-C Motif) Ligand 10 Gene||||C1367714|NCI|||
C7|Chemokine (C-X-C Motif) Ligand 10 wt Allele||||C1706327|NCI|||
C7|INTERFERON-GAMMA-INDUCED FACTOR||||C1367714|OMIM|||
C7|INTERFERON-GAMMA-INDUCIBLE PROTEIN 10|C1367714;C1522712|||C1367714|OMIM|||
C7|IP-10|C1522712|||C1367714;C1706327|HUGO;NCI|||
C7|IP10||||C1367714|OMIM|||
C7|MOB1, MOUSE, HOMOLOG OF||||C1367714|OMIM|||
C7|cervical (level) 7||1|1.000|||||
C7|chemokine (C-X-C motif) ligand 10||||C1367714|HUGO|||
C7|complement 7|C0009524|||C0009524|MSH;NDFRT|||
C7|seventh cervical||||||1|0.2941|
C7|seventh cervical (c7) nerve||||C1305861|CHV|||
C7|seventh cervical vertebra|C0223176|||C0223176|FMA;MTH;SNOMEDCT;UWDA|||
C7|seventh component of complement||||||1|0.7059|
CABG|ACB graft||||C0010055|SNOMEDCT|||
CABG|Aortocoronary Bypass;Aortocoronary Bypasses;Aortocoronary bypass NOS;Bypass, Aortocoronary;Bypasses, Aortocoronary;aortocoronary bypass;Aortocoronary artery bypass graft;Aortocoronary bypass for heart revascularisation;Aortocoronary bypass for heart revascularization;Aortocoronary bypass for heart revascularization, NOS;Aortocoronary bypass for heart revascularization, not otherwise specified;Artery Bypass, Coronary;Artery Bypasses, Coronary;Bypass, Coronary Artery;Bypasses, Coronary Artery;CORONARY ARTERY BYPASS;Coronary Artery Bypass;Coronary Artery Bypasses;coronary artery bypass;Bypass Surgery, Coronary Artery;Coronary Artery Bypass Surgery;coronary artery bypass surgery;Bypass anastomosis for heart revascularization;CABG;CAG - Coronary artery graft;CBG - Coronary bypass graft;CORONARY BYPASS;Coronary bypass;coronary bypass;Cardiac revascularisation with aortocoronary bypass anastomosis;Cardiac revascularization with aortocoronary bypass anastomosis;Cardiac revascularisation with bypass anastomosis;Cardiac revascularization with bypass anastomosis;Cardiac revascularization with bypass anastomosis, NOS;Coronary artery bypass graft operations;Vascular aortocoronary bypass;coronary bypass surgery|C0010055|||C0010055|AOD;CHV;COSTAR;CSP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.0693|
CABG|Aortocoronary artery bypass graft (procedure)||||C0010055|SNOMEDCT|||
CABG|BYPASS SURG CORONARY ARTERY;CORONARY ARTERY BYPASS SURG||||C0010055|MSH|||
CABG|CAB|C0010055;C1417778;C2986493|||C0010055|NCI|||
CABG|CAB graft||||C0010055|SNOMEDCT|||
CABG|CABG - Coronary artery bypass graft;Coronary artery bypass graft (CABG);Coronary Artery Bypass Graft;Coronary Artery Bypass Grafting;Coronary artery bypass graft;Coronary artery bypass grafting;coronary artery bypass graft;coronary artery bypass grafting|C0010055;C1260596|1|1|C0010055;C1260596|CCS;CHV;MEDLINEPLUS;MSH;NCI;SNOMEDCT|1|0.8542|1
CABG|Cardiac revascularization with bypass anastomosis (procedure)||||C0010055|SNOMEDCT|||
CABG|Coronary A. operations||||C0010055|SNOMEDCT|||
CABG|Coronary artery bypass graft (procedure);Coronary artery bypass grafting (procedure)||||C0010055|SNOMEDCT|||
CABG|Coronary artery bypass graft (procedure) [Ambiguous]||||C0010055|SNOMEDCT|||
CABG|Coronary artery operations|C0190188|||C0010055|SNOMEDCT|||
CABG|Coronary artery operations (& bypass)||||C0010055|SNOMEDCT|||
CABG|Coronary artery operations (& bypass) (procedure)||||C0010055|SNOMEDCT|||
CABG|Heart Bypass|C0007202;C0010055|||C0010055|NCI|||
CABG|bypass graft operation||||||1|0.0017|
CABG|coronary artery bypass graft (GABG)||||C0010055|CHV|||
CABG|coronary artery bypass graft surgery||||||1|0.0724|
CABG|coronary revascularization|C0877341|||||1|0.0024|
CAD|AD||||C0280573|PDQ|||
CAD|ARA-C/DNR||||C0280573|NCI;PDQ|||
CAD|ARTERIOSCLEROSIS CORONARY ARTERY;Coronary artery arteriosclerosis;ARTERIOSCLEROTIC HEART DISEASE;Arteriosclerotic heart disease;arteriosclerotic heart disease;ASHD;ATHEROSCLEROTIC CORONARY VASCULAR DISEASE;ATHEROSCLEROTIC HEART DISEASE;Atherosclerotic heart disease;atherosclerotic heart disease;Arterioscleroses, Coronary;Arteriosclerosis, Coronary;CORONARY ARTERIOSCLEROSIS;Coronary Arterioscleroses;Coronary Arteriosclerosis;Coronary arteriosclerosis;coronary arteriosclerosis;CORONARY SCLEROSIS;Coronary sclerosis;coronary sclerosis;Coronary artery sclerosis;coronary artery atherosclerosis|C0010054|||C0010054|CHV;COSTAR;CST;DXP;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;QMR;SNOMEDCT|||
CAD|ASHD - Atherosclerotic heart disease||||C0010054|SNOMEDCT|||
CAD|Artery Disease, Coronary;Artery Diseases, Coronary;CORONARY ARTERY DISEASE;Coronary Artery Disease;Coronary Artery Diseases;Coronary artery disease;Coronary artery disease, NOS;DISEASE CORONARY ARTERY;Disease of the coronary arteries;Disease, Coronary Artery;Diseases, Coronary Artery;coronary artery disease;coronary artery diseases|C0010054;C0010068;C1956346|1|1|C0010054;C0010068;C1956346|CHV;COSTAR;CSP;CST;DXP;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9018|1
CAD|Atheroscleroses, Coronary;Atherosclerosis, Coronary;CORONARY ATHEROSCLEROSIS;Coronary Atheroscleroses;Coronary Atherosclerosis;Coronary atherosclerosis;coronary atherosclerosis|C0010054;C2733225|||C0010054|CCS;CHV;DXP;ICD9CM;MEDLINEPLUS;MSH;NCI;OMIM;SNOMEDCT|1|0.0018|
CAD|B4GALNT2;B4GALNT2 gene;GALGT2|C1428349|||C1428349|HUGO;MTH;OMIM|||
CAD|BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2||||C1428349|OMIM|||
CAD|BLOOD GROUP--Cad SYSTEM|C1862195|||C1862195|MTH;OMIM|||
CAD|CAD;Cad||||C0010054;C0010068;C0011905;C0170509;C0280573;C1413078;C1413983;C1428349;C1862195;C1956346|DXP;HUGO;MEDLINEPLUS;NCI;OMIM;PDQ|||
CAD|CAD (coronary artery disease);CAD - Coronary artery disease;CORONARY ARTERY DISORDER;CORONARY ARTERY DISORDER (NOS);DISORDER CORONARY ARTERY;Disorder of coronary artery;coronary artery disorder|C1956346|||C1956346|AOD;CSP;CST;SNOMEDCT|||
CAD|CAD Gene;CAD gene;CAD TRIFUNCTIONAL PROTEIN|C1413078|||C1413078|HUGO;MTH;NCI;OMIM|||
CAD|CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE||||C1413078|OMIM|||
CAD|CASPASE-ACTIVATED DNase;Caspase-activated DNase|C0669174;C1413983|||C1413983|OMIM|1|0.0065|
CAD|CHD (coronary heart disease);CHD - Coronary heart disease;CORONARY DISEASE;Coronary Disease;Coronary Diseases;Disease, Coronary;Diseases, Coronary;coronary disease;coronary diseases;coronary disorder|C0010068|||C0010068|CHV;CSP;CST;DXP;MSH;NCI;NDFRT;SNOMEDCT|||
CAD|CIA||||C0170509|NCI;PDQ|||
CAD|COMPUTER ASSISTED DIAG;DIAG COMPUTER ASSISTED||||C0011905|MSH|||
CAD|CORONARY ARTERY DIS||||C1956346|MSH|||
CAD|CORONARY DIS||||C0010068|MSH|||
CAD|CORONARY HEART DIS||||C0010068|MSH|||
CAD|CPAN;DEOXYRIBONUCLEASE III, CASPASE-ACTIVATED;DFF-40;DFF2;DFF40;DFFB;DFFB gene;DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT|C1413983|||C1413983|HUGO;MTH;OMIM|||
CAD|CPSase/ATCase/DHOase||||C1413078|OMIM|||
CAD|CTX/DOX/DTIC||||C0170509|NCI;PDQ|||
CAD|Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, and Dihydroorotase Gene||||C1413078|NCI|||
CAD|Cervical artery dissection||||||1|0.0034|
CAD|Cinnamyl alcohol dehydrogenase;cinnamyl alcohol dehydrogenase|C0055763|||C0055763|MSH|1|0.0031|
CAD|Computer Assisted Diagnosis;Computer-Assisted Diagnosis;Diagnosis, Computer Assisted;Diagnosis, Computer-Assisted;computer assisted diagnosis;computer-assisted diagnosis;Computer-Aided Diagnosis;computer-aided diagnosis;Computer-Assisted Diagnoses;Diagnoses, Computer-Assisted|C0011905|||C0011905|AOD;CHV;CSP;MSH;MTH;NCI|1|0.0193|1
CAD|Coronary Artery Disease [Disease/Finding]||||C1956346|NDFRT|||
CAD|Coronary Disease [Disease/Finding]||||C0010068|NDFRT|||
CAD|Coronary Heart Disease;Coronary Heart Diseases;Coronary heart disease;Disease, Coronary Heart;Diseases, Coronary Heart;Heart Disease, Coronary;Heart Diseases, Coronary;coronary heart disease;coronary heart diseases|C0010054;C0010068|||C0010054;C0010068|AOD;CHV;CSP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
CAD|Coronary arteriosclerosis (disorder)||||C0010054|SNOMEDCT|||
CAD|Coronary artery disease (disorder)||||C1956346|SNOMEDCT|||
CAD|Coronary atherosclerosis (disorder)||||C0010054|SNOMEDCT|||
CAD|CyADIC chemotherapy protocol;CyADIC protocol;CyADIC regimen;cyclophosphamide/dacarbazine/doxorubicin protocol|C0170509|||C0170509|CHV;MSH;MTH|||
CAD|Cyclophosphamide/Dacarbazine/Doxorubicin;cyclophosphamide/dacarbazine/doxorubicin||||C0170509|NCI;PDQ|||
CAD|Cytarabine/Daunorubicin;cytarabine/daunorubicin||||C0280573|NCI;PDQ|||
CAD|DA|C1602374|||C0280573|NCI;PDQ|||
CAD|DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)||||C1413983|HUGO|||
CAD|Disorder of coronary artery (disorder)||||C1956346|SNOMEDCT|||
CAD|HEART: CORONARY ARTERY||||C1956346|CST|||
CAD|Sda|C0276477;C1428349;C1553165|||C1428349|HUGO|||
CAD|beta-1,4-N-acetyl-galactosaminyl transferase 2|C0648330|||C1428349|HUGO|||
CAD|cadaver|C0006629|||C0006629|CHV;CSP;MSH;NDFRT;SNOMEDCT|||1
CAD|cadaver donor|C0524354;C1548660|||||||1
CAD|cadaveric||||||1|0.0031|1
CAD|cadaveric donor||||||1|0.0013|
CAD|calcium alginate dressing||||||||1
CAD|caldesmon|C0006746|||||||1
CAD|carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase||||C1413078|HUGO|||
CAD|cardiac ischaemia;cardiac ischemia;ischaemic heart disease;myocardial ischaemia;myocardial ischemia|C0010054;C0151744|||C0010054|CHV|||
CAD|caspase-activated deoxyribonuclease|C0669174|||C0669174|MSH;MTH|1|0.0016|
CAD|chronic actinic dermatitis|C1510437|||C1510437|CHV;MSH;SNOMEDCT|1|0.005|1
CAD|chronic airways disease|C0024117|||||||1
CAD|chronic allograft dysfunction||||||1|0.0015|
CAD|coenzyme A dehydrogenase||||||||1
CAD|cold agglutinin disease|C0175816|||C0175816|CHV;MSH;SNOMEDCT|||1
CAD|collision-activated dissociation||||||1|0.0029|
CAD|collisionally activated decomposition||||||1|0.0023|
CAD|collisionally activated dissociation||||||1|0.0101|1
CAD|compound absorption device||||||||1
CAD|compressed-air disease|C0011119|||||||1
CAD|computer-aided design|C0162517|||C0162517|MSH|1|0.0146|
CAD|computer-aided detection||||||1|0.0159|1
CAD|computer-aided diagnostic||||||1|0.0024|
CAD|computer-assisted dialogue||||||||1
CAD|congenital abduction deficiency||||||||1
CAD|constitutive activation domain||||||1|0.001|
CAD|coronary artery diameter||||||1|0.0008|
CAD|coronary atheroma|C0010054;C0264683|||C0010054|CHV|||
CAD|coronoradiographic documentation||||||||1
CAD|cyclophosphamide, dacarbazine, and doxorubicin chemotherapy protocol||||C0170509|CHV|||
CAD|cytarabine/daunorubicin (CAD)||||C0280573|CHV|||
CAD|cytarabine/daunorubicin protocol||||C0280573|MTH|||
CAD|smooth muscle caldesmon||||||1|0.0015|
CA|(7R)-7-(4-carboxybutanamido)cephalosporanate amidohydrolase activity||||C2314861|GO|||
CA|(Neoplasms) or (cancers)||||C0006826|SNOMEDCT|||
CA|(Neoplasms) or (cancers) (disorder)||||C0006826|SNOMEDCT|||
CA|7beta-(4-carboxybutanamido)cephalosporanic acid acylase activity||||C2314861|GO|||
CA|AC|C1879503|||C0050385|PDQ|||
CA|AC chemotherapy protocol;AC protocol;CA protocol;Cyclophosphamide/Doxorubicin;Doxorubicin/Cyclophosphamide;cyclophosphamide/doxorubicin;doxorubicin cyclophosphamide;cyclophosphamide/doxorubicin protocol|C0050385|||C0050385|CHV;MSH;MTH;NCI;PDQ|||
CA|ACE;ACe|C0022709;C0201888|||C0050385|CSP;NCI;PDQ|||
CA|Ammon Horn;Ammon's Horn;Ammon's horn;Ammons Horn;Horn, Ammon;Horn, Ammon's;ammon's horn;Cornu Ammonis;Cornu ammonis;cornu ammonis;Hippocampal;Hippocampal structure;Hippocampus (Brain);Hippocampus major;Hippocampus proprius|C0019564|||C0019564|AOD;CHV;CSP;FMA;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0066|
CA|Assay|C0005507;C0243073;C1510438|||||1|0.0021|
CA|BLOOD COAG FACTOR IV||||C0006675|MSH|||
CA|Blood Coagulation Factor IV;Ca - Calcium;Ca element;Ca++ element;Calcium coagulation factor;Coagulation Factor IV;Coagulation factor IV;Factor IV, Coagulation;Factor IV;factor iv;[TN420] CALCIUM|C0006675|||C0006675|CHV;CSP;LNC;MSH;NDFRT;SNOMEDCT|||
CA|CA;Ca||||C0006675;C0006754;C0006823;C0006826;C0019564;C0050385;C0201925;C2314861|AOD;CHV;GO;NCI;PDQ|||
CA|CA - Cancer;Cancer, unspecified site;Malignancy, unspecified site;Malignant neoplasm without specification of site;Malignant neoplastic disease;malignant tumoral disease|C0006826|||C0006826|AOD;CCS;ICD9CM;MTHICD9;SNOMEDCT|||
CA|CALCIUM;Calcium;Calcium (NOS);Calcium, NOS;calcium;calciums|C0006675;C0006726;C2936886|||C0006675;C0201925|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.286|1
CA|CAN||||C0006823|NCI|||
CA|CANADA;Canada|C0006823|||C0006823|AOD;CHV;CSP;HL7V3.0;LCH;MSH;MTH;NCI;SNOMEDCT|||
CA|CANCER;CANCER (NOS);Cancer;Cancers;cancer;cancers|C0006826;C0998265;C1306459|1|0.782|C0006826;C0998265;C1306459;C1547140|AOD;CHV;CSP;CST;DXP;HL7V2.5;LCH;LNC;MEDLINEPLUS;MSH;NCBI;NCI;PDQ;SNOMEDCT|1|0.0059|1
CA|COAG FACTOR IV||||C0006675|MSH|||
CA|CTX/DOX||||C0050385|NCI;PDQ|||
CA|Ca - unspecified site;Ca - unspecified site NOS||||C0006826|SNOMEDCT|||
CA|Ca - unspecified site NOS (disorder)||||C0006826|SNOMEDCT|||
CA|Calcium (substance)||||C0006675|SNOMEDCT|||
CA|Calcium Measurement;Calcium measurement;Calcium measurement, NOS;calcium measurement;calcium measurements;Calcium.total;calcium level test;total calcium test|C0201925|||C0201925|CHV;LNC;MTH;NCI;SNOMEDCT|||
CA|Calcium [Chemical/Ingredient]||||C0006675|NDFRT|||
CA|Calcium analyte||||C0006675|SNOMEDCT|||
CA|Calcium analyte (substance)||||C0006675|SNOMEDCT|||
CA|Calcium level;calcium level;calcium levels|C0201925;C0428302|||C0201925|CHV;SNOMEDCT|||
CA|Calcium measurement (procedure)||||C0201925|SNOMEDCT|||
CA|California|C0006754;C0324542;C3146274|1|0.004|C0006754|AOD;CHV;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0024|1
CA|California (geographic location)||||C0006754|SNOMEDCT|||
CA|Canada (geographic location)||||C0006823|SNOMEDCT|||
CA|Candida albicans|C0006837;C0717551|||||1|0.0108|1
CA|Caucasian American|C0221786|||||1|0.001|
CA|Cholic||||||1|0.0031|
CA|Chromosome aberrations;chromosome aberration;chromosomal aberration;chromosomal aberrations|C0008625;C0008626|||C0008625|CHV;CSP;MSH;NCI|1|0.0624|1
CA|Coagulation factor IV (substance)||||C0006675|SNOMEDCT|||
CA|Coagulation factor IV -RETIRED-||||C0006675|SNOMEDCT|||
CA|Cocaine Anonymous||||||||1
CA|Cold agglutinins;cold agglutinin|C0056097|||C0056097|CHV;LNC;NCI;SNOMEDCT|1|0.0099|1
CA|GA||||C2314861|GO|||
CA|GCA|C0039483;C1423891;C2314861|||C2314861|GO|||
CA|GL-7-ACA acylase activity;cephalosporin C acylase activity;cephalosporin acylase activity;glutaryl-7-ACA acylase activity;glutaryl-7-aminocephalosporanic acid acylase activity;glutaryl-7-aminocephalosporanic-acid acylase activity|C2314861|||C2314861|GO;MTH|||
CA|Hippocampal structure (body structure)||||C0019564|SNOMEDCT|||
CA|Hippocampus;hippocampus|C0019564;C0949582;C1029104;C1284077|||C0019564|AOD;CHV;CSP;FMA;MSH;NCI;SNOMEDCT|||
CA|Hippocampus proper||||C0019564|FMA|||
CA|MALIGNANCIES;MALIGNANCY;Malignancy;malignancies;malignancy;MALIGNANT NEOPLASM;Malignant Neoplasm;Malignant Neoplasms;Malignant neoplasm;Malignant neoplasm NOS;Malignant neoplasms;NEOPLASM MALIGNANT;Neoplasms - malignant;malignant neoplasm;malignant neoplasms;MALIGNANT TUMOR;Malignant Tumor;Malignant tumor;Malignant tumour;malignant tumor;malignant tumors;malignant tumour;malignant tumours|C0006826;C1306459|||C0006826|AIR;AOD;CHV;COSTAR;CST;LNC;MEDLINEPLUS;MTH;NCI;SNOMEDCT|||
CA|Malignant neoplasm of unspecified site;Malignant neoplasm of unspecified site NOS||||C0006826|SNOMEDCT|||
CA|Malignant neoplasm of unspecified site (disorder);Malignant neoplasm of unspecified site NOS (disorder)||||C0006826|SNOMEDCT|||
CA|Malignant neoplastic disease (disorder)||||C0006826|SNOMEDCT|||
CA|Malignant tumor (disorder);Malignant tumour (disorder)||||C0006826|SNOMEDCT|||
CA|NATO code for riot control agent bromobenzylcyanide||||||||1
CA|[X]Malignant neoplasm without specification of site||||C0006826|SNOMEDCT|||
CA|[X]Malignant neoplasm without specification of site (disorder)||||C0006826|SNOMEDCT|||
CA|abnormalities|C0000768;C0000769|||||1|0.0019|
CA|about||||||||1
CA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0049|
CA|adenocarcinoma|C0001418|||||1|0.0019|
CA|alcohol|C0001962;C0001975;C0202304|||||1|0.0021|
CA|anterior commissure|C0152335;C1289546|||||||1
CA|antigens|C0003320|||||1|0.0016|
CA|arterial|C0003842;C0221464|||||1|0.0016|
CA|caffeic acid|C0054433|||C0054433|CHV;MSH;NCI|1|0.0083|
CA|caffeine|C0006644|||C0006644;C0202348|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.0057|
CA|calcium antagonist;calcium antagonists|C0006684|||C0006684|CHV;CSP|1|0.0047|1
CA|cancer antigen||||||1|0.0056|1
CA|candle||||||||1
CA|caproic acid|C0062655|||C0062655|AOD;CHV;FMA;NCI;SNOMEDCT|||1
CA|capsid|C0006933;C1136102|||C0006933;C1136102|CHV;CSP;LNC;MSH;MTH;NCI|1|0.0168|1
CA|capsid protein|C1136102|||||1|0.0057|
CA|carbohydrate antigen|C0443758|1|0.210|C0443758|CHV;SNOMEDCT|||1
CA|carbonate apatite;carbonated apatite|C0054675|||||1|0.0018|
CA|carbonic anhydrase|C0007028|||C0007028|CHV;CSP;LCH;MSH;NDFRT;SNOMEDCT|1|0.1301|1
CA|carbonic anhydrase II|C0007034;C1413043|||||1|0.001|
CA|carcinoma|C0007097|||C0007097|AOD;CHV;COSTAR;CSP;CST;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0114|1
CA|cardiac angiography|C0002971|||||||1
CA|cardiac arrest|C0018790|||C0018790|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0201|1
CA|cardiac arrhythmia|C0003811;C1560249|||C0003811;C1560249|AOD;CHV;COSTAR;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
CA|cardiac-apnea||||||||1
CA|carotid artery|C0007272;C0162859|||C0007272;C0162859|AOD;CHV;CSP;FMA;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.0137|1
CA|cast|C0179686;C0302143|||C0179686;C0302143;C0687709;C1366482;C1413137;C1539080;C1705948;C1825060|AOD;CHV;HUGO;NCI;OMIM;SNOMEDCT|||1
CA|catalase|C0007367;C1413138|||||1|0.0021|
CA|catecholamine|C0007412|||||1|0.0975|1
CA|catecholaminergic||||||1|0.0144|1
CA|catheter ablation|C0162563|||||1|0.0017|
CA|cathode|C0007441|||C0007441|CSP;MSH|||1
CA|celiac artery;celiac axis|C0007569;C1268965|||C0007569;C1268965|CHV;FMA;LCH;LNC;MSH;MTH;SNOMEDCT;UWDA|||1
CA|cellular automata;cellular automaton||||||1|0.0051|
CA|cellulose acetate|C0050505|||C0050505|CHV;MSH;NDFRT;SNOMEDCT;VANDF|1|0.0168|1
CA|central apnea|C0520680|||||||1
CA|central nucleus of the amygdala||||||1|0.0012|
CA|cerebellar atrophy|C0740279|||||1|0.0023|
CA|cerebral aqueduct|C0007769;C1284576|||C0007769;C1284576|AOD;CHV;CSP;FMA;MSH;MTH;NCI;SNOMEDCT|||1
CA|cerebral atrophy|C0235946|||C0235946|AOD;CHV;COSTAR;CST;MTH;OMIM;SNOMEDCT|1|0.0024|1
CA|cerebral autoregulation||||||1|0.0052|
CA|chemotactic activity||||||||1
CA|child abuse|C0008060;C1541830|||||||1
CA|chloroamphetamine|C2599027|||C2599027|LNC|||
CA|choanal atresia|C0008297|||||1|0.0016|
CA|cholate|C0109497|||||1|0.0024|
CA|cholic acid|C0055568|||C0055568|AOD;CHV;LCH;MSH;NCI;NDFRT;SNOMEDCT|1|0.0205|1
CA|chorioamnionitis|C0008495|||||||1
CA|chronic anovulation||||||||1
CA|chronologic age||||||||1
CA|chronological age||||||1|0.026|
CA|circulatory arrest|C0444720|||C0444720|CHV;SNOMEDCT|||
CA|citric acid|C0055819;C1171556|||C0055819;C1171556|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0087|1
CA|clavulanic acid|C0055860|||C0055860|CHV;LCH;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT|||
CA|clotting assay||||||||1
CA|cluster analysis|C0009085|||||1|0.0036|
CA|coagglutination|C0441689|||C0441689|CHV;SNOMEDCT|||1
CA|coarctation of aorta;coarctation of the aorta|C0003492;C2930803|||C0003492;C2930803|CHV;COSTAR;MSH;OMIM|1|0.0017|1
CA|cobblestone areas||||||1|0.0009|
CA|cochlear aqueduct|C0009196|||||1|0.0026|
CA|coefficient of absorption||||||||1
CA|cold adapted||||||1|0.0012|
CA|cold-acclimated||||||1|0.0068|
CA|cold-acclimated rats||||||1|0.0017|
CA|collagen antigen||||||||1
CA|collagenolytic activity||||||||1
CA|colloid antigen||||||||1
CA|commissura anterior|C0152335|||C0152335|FMA|||
CA|common antigen||||||||1
CA|community acquired;community-acquired|C0456394|||||1|0.0026|1
CA|complement activation|C0009528;C2984768|||||1|0.001|
CA|compressed air|C0337081|||C0337081|CHV;MSH;SNOMEDCT|||1
CA|concentration|C0086045;C1446561|||||1|0.004|
CA|conception age||||||||1
CA|conditioned abstinence|C0683359|||||||1
CA|conditioned air||||||||1
CA|condyloma acuminata;condylomata acuminata;condyloma acuminatum|C0009663|||||1|0.0068|1
CA|congenital anomaly|C0000768|||||||1
CA|congruence angle||||||1|0.001|
CA|conjoint analysis||||||1|0.0024|
CA|constitutively activated||||||1|0.001|
CA|constitutively active||||||1|0.0054|
CA|contact angle||||||1|0.0012|
CA|continuous aerosol||||||||1
CA|contrast agent|C0009924|||C0009924|CHV;NCI|1|0.0064|
CA|contrast arteriography||||||1|0.0026|
CA|controlled atmosphere||||||1|0.0014|
CA|conventional angiography|C0442842|||C0442842|SNOMEDCT|1|0.0029|
CA|conventional arteriography||||||1|0.0014|
CA|conversation analysis||||||1|0.0024|
CA|coracoacromial||||||||1
CA|corneal abrasion|C0010032|||||||1
CA|coronary angiography|C0085532;C1548829|||C0085532;C1548829|AOD;CHV;HL7V2.5;MSH;MTH;SNOMEDCT|1|0.0121|
CA|coronary angioplasty|C0002997;C0190211|||||||1
CA|coronary arrest||||||||1
CA|coronary arteriography|C0085532|||||1|0.0017|
CA|coronary artery|C0205042;C1269008|||C0205042;C1269008|CHV;CSP;FMA;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0161|1
CA|coronary atherosclerosis|C0010054;C2733225|||||1|0.0012|
CA|corpora allata;corpus allatum|C0010085|||C0010085|CSP;MSH|1|0.0221|1
CA|corpora amylacea|C0333564;C1235668|||C0333564;C1235668|MTH;NCI;SNOMEDCT;UWDA|1|0.0043|
CA|corpus albicans|C0227895|||C0227895|FMA;UWDA|||1
CA|corpus amylaceum||||||||1
CA|corrected area||||||||1
CA|correspondence analysis||||||1|0.0029|
CA|cortical area||||||1|0.0033|
CA|cortisone acetate|C0056391|||C0056391|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0057|
CA|cricoarytenoid||||||||1
CA|cricoid arch||||||||1
CA|croup-associated||||||||1
CA|croup-associated virus|C0030391|||C0030391|MSH|||
CA|cyclophosphamide doxorubicin (AC protocol);cyclophosphamide doxorubicin (AC) protocol||||C0050385|CHV|||
CA|cyproterone acetate|C0056855|||C0056855|CHV;MSH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT|1|0.0186|
CA|cytosine arabinoside|C0010711|||C0010711|CHV;CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0038|1
CA|cytotoxic antibody|C0024284|||C0024284|SNOMEDCT|||1
CA|highly polymorphic||||||1|0.0009|
CA|hippocampu||||C0019564|CHV|||
CA|isolated a polymorphic dinucleotide||||||1|0.0012|
CA|live attenuated cold-adapted||||||1|0.0007|
CA|measurement of compressed air||||||1|0.0007|
CA|neoplasm/cancer||||C0006826|CSP|||
CA|plasma catecholamines||||||1|0.0057|
CA|weeks of conceptional age||||||1|0.0007|
CBC|Blood Cell Count;blood cell count|C0005771;C0009555|||C0009555|NCI|||
CBC|Blood Count, Complete;Blood Counts, Complete;Complete Blood Count;Complete Blood Counts;Complete blood count;Complete blood count, NOS;Count, Complete Blood;Counts, Complete Blood;complete blood count;complete blood counts;FBC;FBC - Full blood count;Full Blood Count;Full blood count;Full blood count NOS;full blood count;blood test full count;full blood count test|C0009555|1|1|C0009555|CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.6597|1
CBC|CBC;CBC, NOS|C0009555;C2263086|||C0009555;C2263086|CHV;CSP;GO;LNC;MTH;NCI;SNOMEDCT|||
CBC|CBC (complete blood count)||||C0009555|CSP|||
CBC|Camelot Behavioral Checklist||||||||1
CBC|Chlorambucil|C0008163|||||1|0.0471|
CBC|Complete blood count (procedure)||||C0009555|SNOMEDCT|||
CBC|Full blood count (procedure);Full blood count NOS (procedure)||||C0009555|SNOMEDCT|||
CBC|Nuclear cap binding complex location;nuclear cap binding complex location;nuclear cap binding complex;nuclear cap-binding complex|C2263086|||C2263086|GO;MTH|1|0.0576|
CBC|binding capacity|C0439155|||||1|0.0576|
CBC|cannabichromene|C0054589|||||1|0.0628|
CBC|cerebral-buccal connective||||||1|0.0314|
CBC|cerebrobuccal connective||||||||1
CBC|child behavior characteristics||||||||1
CBC|complete blood count test (CBC)||||C0009555|CHV|||
CBC|contralateral breast cancer|C1096616|||||1|0.0838|
CD4|ANTIGENS CD 004;CD 004 ANTIGENS||||C0003323|MSH|||
CD4|Antigen, CD4;Antigens, CD4;CD4 ANTIGEN;CD4 Antigen;CD4 Antigens;CD4 antigen;CD4 Molecule;CD4 molecule|C0003323;C1332714|||C0003323;C1332714|CHV;CSP;HUGO;LNC;MSH;MTH;NCI;NDFRT;OMIM|||
CD4|Antigens, CD4 [Chemical/Ingredient]||||C0003323|NDFRT|||
CD4|Antigens, T-Cell T4;T-Cell T4 Antigens;T4 Antigens, T Cell;T4 Antigens, T-Cell;CD4 - Cluster of differentiation antigen 4;CD4 Ag;CD4 Protein;CD4 Receptor, Surface;CD4 Receptors, Surface;Receptors, Surface CD4;Surface CD4 Receptor;Surface CD4 Receptors;CD4 Receptors;Receptors, CD4;cd4 receptor;cd4 receptors;Cluster of differentiation antigen 4;Leucocyte 3a;Leukocyte 3a;Lymphocyte antigen CD4;OKT4 - Ortho Kung T4;OKT4 Antigen;OKT4 antigen;Ortho Kung T4;T-cell lineage 4;T-helper cell marker;T4 - T-cell lineage 4;T4 molecule;helper T lymphocyte marker|C0003323|||C0003323|CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|||
CD4|CD 004 MOLECULE||||C0003323|MSH|||
CD4|CD 004 RECEPTORS;RECEPTORS CD 004||||C0003323|MSH|||
CD4|CD4;cd4||||C0003323;C1332714;C2698595|CHV;HUGO;LNC;NCI;OMIM|||
CD4|CD4 Antigen (P55)||||C0003323|NCI|||
CD4|CD4 Antigen (P55) Gene||||C1332714|NCI|||
CD4|CD4 Expressing T Cell Count|C2698595|||C2698595|MTH;NCI|||
CD4|CD4 Gene;CD4 gene|C1332714|||C1332714|HUGO;MTH;NCI|||
CD4|CD4 RECEPT;RECEPT CD4||||C0003323|MSH|||
CD4|Lymphocyte antigen CD4 (substance)||||C0003323|SNOMEDCT|||
CD4|RECEPT SURFACE CD4;SURFACE CD4 RECEPT||||C0003323|MSH|||
CD4|T AAB ANTIGENS T CELL 04||||C0003323|MSH|||
CD4|T helper cells|C0018894|||||1|0.2143|
CD4|T helper/inducer||||||1|0.0893|
CD4|T-CELL ANTIGEN T4/LEU3;T-Cell Antigen T4/Leu3||||C0003323;C1332714|NCI;OMIM|||
CD4|T-Cell Surface Antigen T4/Leu-3||||C0003323|NCI|||
CD4|anti-L3T4||||||1|0.4107|
CD4|cluster of differentiation 4||1|1.000|||||1
CD4|receptor|C0597357|||||1|0.2857|
CDI|1,1'-carbonyldiimidazole||||||1|0.0505|
CDI|CD-I;CDI|C0282601;C1151574|||C0282601|MSH;NCI|||
CDI|CDI (Compact Disc-Interactive)||||C0282601|NCI|||
CDI|Ca(2+)-dependent inactivation||||||1|0.0189|
CDI|Children's Depression Inventory||1|0.540|||1|0.3249|1
CDI|Color Doppler imaging;color Doppler imaging||||||1|0.3565|1
CDI|Compact Disc-Interactive;Compact Disk Interactive;Compact Disk, Interactive;Compact Disks, Interactive;Disk, Interactive Compact;Disks, Interactive Compact;Interactive Compact Disk;Interactive Compact Disks;Interactive CD|C0282601|||C0282601|MSH;MTH;NCI|||
CDI|Cotrel-Dubousset instrumentation||||||1|0.0946|1
CDI|cell-directed inhibitor||||||||1
CDI|center for diagnostic imaging||1|0.450|||||
CDI|central diabetes insipidus;cranial diabetes insipidus|C0687720|||||1|0.142|1
CDI|chronic diabetes insipidus||||||||1
CDI|clam digger's itch|C0546996|||||||1
CDI|clean, dry, intact||1|0.006|||||
CDI|communicative development inventory||||||||1
CDI|controlled diabetes insipidus||||||||1
CDI|cyclin-dependent kinase inhibitor|C0919418;C1152568;C1511576|||||1|0.0126|
CEA|ANTIGENS CD 066E||||C0007082|MSH|||
CEA|Antigen, CD66e;Antigens, CD66e;CD66e Antigen;CD66e Antigens;Antigen, Carcinoembryonic;CARCINOEMBRYONIC ANTIGEN;Carcinoembryonic Antigen;Carcinoembryonic antigen;Carcinoembryonic antigens;carcinoembryonic antigen;CD66e Ag;CEA - Carcinoembryonic antigen;CEA Family Protein;Carcinoembryonic Ag;carcinoembryonic Ag;Carcinoembryonic Antigen Family Protein;Lymphocyte antigen CD66E;Meconium Antigen 100;carcinoembryonal antigen|C0007082|1|0.888|C0007082;C0201933;C1332744|CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.7948|1
CEA|CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5;Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;carcinoembryonic antigen-related cell adhesion molecule 5|C0007082;C1332744|||C0007082;C1332744|HUGO;NCI;OMIM|||
CEA|CD 066 E ANTIGEN||||C0007082|MSH|||
CEA|CD66e||||C0007082;C1332744;C1706545|HUGO;LNC;NCI|||
CEA|CEA;CEA measurement;Carcinoembryonic Antigen Measurement;Carcinoembryonic antigen measurement;carcinoembryonic antigen test|C0201933|||C0007082;C0201933;C1332744;C1332745;C1418994;C1706545|CHV;CSP;HUGO;MSH;MTH;NCI;OMIM;SNOMEDCT|||
CEA|CEACAM5||||C0007082;C1332744;C1706545|HUGO;NCI;OMIM|||
CEA|CEACAM5 Gene;CEACAM5 gene;Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Gene|C1332744|||C1332744|HUGO;MTH;NCI|||
CEA|CEACAM5 wt Allele;Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 wt Allele|C1706545|||C1706545|MTH;NCI|||
CEA|CEACAM7;carcinoembryonic antigen-related cell adhesion molecule 7|C1332745;C1332746|||C1332745|HUGO;NCI|||
CEA|CEACAM7 Gene;CEACAM7 gene;Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 Gene|C1332745|||C1332745|HUGO;MTH;NCI|||
CEA|Carcinoembryonic Antigen CGM2|C0007082;C1332746|||C0007082|NCI|||
CEA|Carcinoembryonic Antigen [Chemical/Ingredient]||||C0007082|NDFRT|||
CEA|Carcinoembryonic antigen (substance)||||C0007082|SNOMEDCT|||
CEA|Carcinoembryonic antigen level;Carcinoembryonic antigen: (& level)||||C0201933|SNOMEDCT|||
CEA|Carcinoembryonic antigen measurement (procedure)||||C0201933|SNOMEDCT|||
CEA|Carcinoembryonic antigen: (& level) (procedure)||||C0201933|SNOMEDCT|||
CEA|Cost-effectiveness analysis;cost-effectiveness analysis|C1511536|||||1|0.0184|1
CEA|Lymphocyte antigen CD66E (substance)||||C0007082|SNOMEDCT|||
CEA|PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2;pregnancy specific beta-1-glycoprotein 2;PSBG2;PSG2;PSG2 gene;PSGGB;carcinoembryonic antigen SG8|C1418994|||C1418994|HUGO;MTH;OMIM|||
CEA|PSG1|C1418991;C1418994|||C1418994|HUGO|||
CEA|carcinoembryonic|C1440204|||||1|0.0018|
CEA|carcinoembryonic antigen gene family member 2|C1332745;C1332746;C1706153|||C1332745|HUGO|||
CEA|carotid endarterectomy|C0014099|1|0.106|C0014099|CHV;COSTAR;MEDLINEPLUS;MSH;MTH;SNOMEDCT|1|0.1416|1
CEA|central amygdala||||||1|0.0064|
CEA|central amygdaloid nucleus|C0175219|||||1|0.0031|
CEA|central nucleus of the amygdala||||||1|0.0261|
CEA|cervical epidural abscess|C1997613|||C1997613|SNOMEDCT|||
CEA|cholesterol-esterifying activity||||||||1
CEA|continuous epidural analgesia||||||1|0.0015|
CEA|cost-effectiveness analyses||||||1|0.0013|
CEA|cranial epidural abscess|C0238075|||||||1
CEA|crystalline egg albumin||||||||1
CEA|cultured epidermal autograft||||||1|0.0015|
CEA|cultured epithelial autograft;cultured epithelial autografts||||||1|0.0024|1
CEA|enzyme activity|C0243102|||||1|0.0011|
CEA|pregnancy-specific beta-1 glycoprotein|C0033002;C1418994;C1418997|||C1418994|HUGO|||
CEA|pregnancy-specific beta-1-glycoprotein 7|C0640646;C1418994;C1418999|||C1418994|HUGO|||
CF|5(6)-carboxyfluorescein||||||1|0.003|
CF|6-carboxyfluorescein|C0049522|||||1|0.0016|
CF|CAF||||C0007673|NCI|||
CF|CDDP/5-FU||||C0280055|NCI;PDQ|||
CF|CENTRAL AFRICAN REPUBLIC;Central African Republic;Ubangi-Shari|C0007673|||C0007673|AOD;LCH;MSH;MTH;NCI;SNOMEDCT|||
CF|CF;cf||||C0007673;C0007807;C0009738;C0010674;C0055160;C0280055;C0731033;C1883561|CHV;MEDLINEPLUS;MSH;NCI;OMIM;PDQ;SNOMEDCT|||
CF|CF - Cystic fibrosis;cystic fibrosis (CF);CYSTIC FIBROSIS;Cystic Fibrosis;Cystic fibrosis;Cystic fibrosis NOS;Fibrosis, Cystic;cystic fibrosis;Cystic fibrosis (disorder);Cystic fibrosis NOS (disorder);cystic disorder fibrosis;MUCOVISCIDOSIS;Mucoviscidosis;mucoviscidosis|C0010674|1|0.998|C0010674|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.727|1
CF|CF protocol;cf protocol;Cyclophosphamide/Fluorouracil;cyclophosphamide/fluorouracil;fluorouracil cyclophosphamide|C0055160|||C0055160|CHV;MSH;MTH;NCI;PDQ|||
CF|CFR|C0731033;C1305363;C1515366|||C0731033|PDQ|||
CF|CG||||C0009738|NCI|||
CF|COG||||C0009738|NCI|||
CF|CONGO;Congo;congo;Republic of the Congo|C0009738|||C0009738|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
CF|CSF||||C0007807|MSH|||
CF|CT||||C0007673|NCI|||
CF|CTX/5-FU||||C0055160|NCI;PDQ|||
CF|Calcium (6S)-Folinate||||C0731033|NCI;PDQ|||
CF|Calcium Folinate;Calcium folinate;Folinate Calcium;Folinate, Calcium;calcium folinate;folinate calcium;Calcium Leucovorin;Calcium leucovorin;LEUCOVORIN CALCIUM;Leucovorin Calcium;Leucovorin calcium;Leucovorin, Calcium;calcium leucovorin;leucovorin calcium;Calcium leucovorin preparation;Leucovorin calcium preparation;Citrovorum factor preparation;Folinic Acid Calcium Salt Pentahydrate;L-CF;Levofolinate calcium|C0731033|||C0731033|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
CF|Calcium leucovorin (substance)||||C0731033|SNOMEDCT|||
CF|Calcium leucovorin preparation (product)||||C0731033|SNOMEDCT|||
CF|Calcium leucovorin preparation (substance)||||C0731033|SNOMEDCT|||
CF|Canadian Forces||||||1|0.002|
CF|Cascade filtration;cascade filtration||||||1|0.0014|1
CF|Central African Republic (geographic location)||||C0007673|SNOMEDCT|||
CF|Christmas factor|C0015491|||||||1
CF|Cisplatin/Fluorouracil;cisplatin/fluorouracil||||C0280055|NCI;PDQ|||
CF|Citrovorum Factor;Citrovorum factor;Factor, Citrovorum;citrovorum factor|C0023413;C0731033|||C0023413;C0731033|CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||1
CF|Citrovorum Factor [Chemical/Ingredient]||||C0731033|NDFRT|||
CF|Clastogenic factors||||||1|0.0011|
CF|Concentration factors||||||1|0.0011|
CF|Congo (Brazzaville)||||C0009738|MSH|||
CF|Congo (geographic location)||||C0009738|SNOMEDCT|||
CF|Crevicular fluid||||||1|0.0026|
CF|Crude fiber;crude fibre|C2348013|||||1|0.0036|
CF|Cystic Fibrosis [Disease/Finding]||||C0010674|NDFRT|||
CF|Cystic fibrosis (disorder) [Ambiguous]||||C0010674|SNOMEDCT|||
CF|Fibrocystic disease;disease fibrocystic;diseases fibrocystic;fibrocystic disease|C0010674;C0016033;C0016034|||C0010674|CHV;SNOMEDCT|||
CF|In Cerebrospinal Fluid;cerebrospinal fluid|C0007806;C0007807|||C0007807|MSH;MTH|||
CF|LV|C0023128;C0731033;C1881413|||C0731033|PDQ|||
CF|P-FU;cisplatin/fluorouracil protocol|C0280055|||C0280055|MTH;NCI;PDQ|||
CF|With Food|C1883561|||C1883561|MTH;NCI|||
CF|caffeine|C0006644|||||1|0.003|
CF|calcaneal fibular||||||||1
CF|calf blood flow||||||||1
CF|calibration factor|C2347552|||C2347552|NCI|||1
CF|californium|C0006758|||||||1
CF|cancer free||||||||1
CF|carbol-fuchsin;carbolfuchsin|C0054697|||C0054697|MSH;SNOMEDCT|||1
CF|carboxyfluorescein|C0108453|||||1|0.0171|
CF|cardiac failure|C0018801;C0018802|||C0018801;C0018802|CHV;CST;MEDLINEPLUS;MSH;NDFRT;OMIM;SNOMEDCT|1|0.0028|1
CF|carotid foramen||||||||1
CF|carrier-free||||||||1
CF|case fatality||||||1|0.0013|
CF|case file||||||||1
CF|cationic ferritin||||||1|0.0038|
CF|cationized ferritin|C0071525|||||1|0.0171|
CF|cell-free|C1183428|||||1|0.0012|
CF|central field||||||||1
CF|central fossa||||||||1
CF|centrifugal force|C0563531|||C0563531|SNOMEDCT|||1
CF|characteristic frequency||||||1|0.0364|1
CF|charcoal-filtered air||||||1|0.0017|
CF|chemotactic factor|C0008013|||C0008013|CSP|||1
CF|chest and left leg||||||||1
CF|chick fibroblast||||||||1
CF|chicken fat||||||1|0.0009|
CF|chloroform|C0008238|||||1|0.0043|
CF|choroid fissure|C0262212|||||||1
CF|chronic fatigue|C0518656|||||1|0.0026|
CF|chronicity factor||||||||1
CF|ciprofloxacin|C0008809|||||1|0.0018|
CF|circumflex|C1880089|||||||1
CF|clavicular fracture|C0159658|||||||1
CF|climbing fiber;climbing fibre|C2752551|||||1|0.0092|1
CF|clofibrate|C0009002|||||1|0.0024|
CF|clotting factor|C0005789|||C0005789|CHV;CSP;NCI|||1
CF|clubfoot|C0009081;C0158489|||||||1
CF|coelomic fluid||||||1|0.0014|
CF|colicin factor|C1257900|||C1257900|MSH;SNOMEDCT|||1
CF|collected fluid||||||||1
CF|colonization factor||||||||1
CF|colony formation||||||1|0.0008|
CF|colony-forming||||||||1
CF|color and form||||||||1
CF|colostrum-fed||||||1|0.0013|
CF|common femoral||||||||1
CF|compare|C1707455|||||||1
CF|complement factor|C0920104;C1305959|||||||1
CF|complement fixation|C0301911;C1551400|||C0301911;C1551400|CHV;HL7V3.0;SNOMEDCT|1|0.068|1
CF|complement fixation test|C0009541|||||1|0.0034|
CF|complement fixing;complement-fixing||||||1|0.0181|1
CF|complementary feeding|C0038847|||||||1
CF|completely follicular||||||||1
CF|complex fixation||||||||1
CF|computed fluoroscopy||||||||1
CF|constant frequency;constant-frequency||||||1|0.0017|1
CF|continuous-flow||||||1|0.0022|
CF|contractile force||||||1|0.0053|1
CF|conventional fractionation||||||1|0.0029|
CF|coronary flow||||||1|0.0273|1
CF|correction factor||||||||1
CF|cortical fibroblasts||||||1|0.0013|
CF|cough fracture|C0567413|||||||1
CF|cough frequency||||||||1
CF|count fingers;counting fingers||||||1|0.0007|1
CF|coupling factor||||||||1
CF|culture filtrate||||||1|0.0062|
CF|cycling fibroblast||||||||1
CF|cystic fibrosi||||C0010674|CHV|||
CF|cystic fibrosis pancreas;pancreas cystic fibrosis;disease fibrocystic pancreas;fibrocystic disease of pancreas|C0010674;C1527396|||C0010674|CHV|||
CF|cystic fibrosys||||C0010674|CHV|||
CF|cystics fibrosis||||C0010674|CHV|||
CF|cytosolic fraction||||||1|0.0008|
CF|cytotoxic factor||||||1|0.0055|
CF|folinic acid;leucovorin|C0023413|||||1|0.0025|
CF|function|C0031843;C0542341;C0700205;C1705273|||||1|0.0018|
CF|mucoviscidose||||C0010674|CHV|||
CF|mucoviscidosi||||C0010674|CHV|||
CF|mucoviscidosys||||C0010674|CHV|||
CHF|CARDIAC FAILURE CONGESTIVE;Cardiac Failure Congestive;Congestive cardiac failure;cardiac congestive failure;cardiac failure congestive;congestive cardiac failure;CCF - Congestive cardiac failure;CHF;CHF NOS;CHF - Congestive heart failure;congestive heart failure (CHF);congestive heart failure chf;CONGESTIVE HEART FAILURE;Congestive Heart Failure;Congestive heart failure;FAILURE HEART CONGESTIVE;FAILURE, CONGESTIVE HEART;HEART FAILURE, CONGESTIVE;Heart Failure, Congestive;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart failure;failure congestive heart;heart congestive failure;heart failure congestive;Congestive heart disease;congestive disease heart;congestive diseases heart;congestive heart disease;disease congestive heart;Congestive heart failure, unspecified|C0018802|1|1|C0018802|AIR;AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;OMIM;PDQ;SNOMEDCT|1|0.891|1
CHF|Cardiac Failure;Heart Failure|C0018801;C0018802|||C0018802|NDFRT|||
CHF|Congenital hepatic fibrosis;congenital hepatic fibrosis|C0009714|||||1|0.0071|1
CHF|Congestive cardiac fail||||C0018802|SNOMEDCT|||
CHF|Congestive heart failure (disorder)||||C0018802|SNOMEDCT|||
CHF|Congetive cardiac failure||||C0018802|SNOMEDCT|||
CHF|Crimean Haemorrhagic Fever;Crimean hemorrhagic fever|C0019099|||||1|0.0035|1
CHF|Heart Failure [Disease/Finding]||||C0018802|NDFRT|||
CHF|ccf|C0009081;C0018802|||C0018802|CHV|||
CHF|chick embryo fibroblast||||||||1
CHF|chronic heart failure|C0264716|||||||1
CHF|continuous hemofiltration|C0472683|||||1|0.006|
CHF|patients with chronic heart failure||||||1|0.0925|
CHOP|ACOP;VCAP|C0055598;C0163868|||C0055598;C0163868|NCI;PDQ|||
CHOP|C EBP Homologous Protein;C-EBP Homologous Protein;C/EBP homologous protein;C/EBP-HOMOLOGOUS PROTEIN;C/EBP-Homologous Protein;Homologous Protein, C-EBP|C0287750;C1413947|||C0287750;C1413947|MSH;NCI;NDFRT;OMIM|1|0.3673|
CHOP|C/EBP Zeta Gene;DDIT3 wt Allele;DNA-Damage-Inducible Transcript 3 wt Allele;MGC4154|C2985165|||C2985165|MTH;NCI|||
CHOP|C/EBP zeta;DDIT3;DDIT3 Gene;DDIT3 gene;DNA DAMAGE-INDUCIBLE TRANSCRIPT 3;DNA-damage-inducible transcript 3;DNA-Damage-Inducible Transcript 3 Gene|C1413947|||C1413947|HUGO;LNC;MTH;NCI;OMIM|||
CHOP|C/EBP-Homologous Protein 10;CHOP, Transcription Factor;Transcription Factor CHOP;DDIT-3;DDIT3 Protein;DNA Damage Inducible Transcript 3 Protein;DNA Damage-Inducible Transcript 3 Protein;GADD153 Protein|C0287750|||C0287750|MSH;MTH;NCI;NDFRT|||
CHOP|CAVP|C0055598;C0108844;C0163868|||C0055598;C0163868|NCI;PDQ|||
CHOP|CEBPZ|C1428360;C2985165|||C2985165|NCI|||
CHOP|CHOP;chop;chopping;chops|C0163868;C0287750;C2945739;C2985165|||C0055598;C0163868;C0287750;C1413947;C2945739;C2985165|CHV;HUGO;NCI;OMIM;PDQ|||
CHOP|CHOP Regimen;CHOP regimen;Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen;VACP|C0163868|||C0055598;C0163868|MSH;MTH;NCI;PDQ|||
CHOP|CHOP chemotherapy protocol;CHOP protocol;CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine|C0055598|||C0055598|CHV;MSH;MTH|||
CHOP|CHOP-10|C0287750;C2985165|||C0287750;C2985165|NCI|||
CHOP|CHOP10;GADD153|C1413947;C2985165|||C1413947;C2985165|HUGO;NCI;OMIM|||
CHOP|COPA|C0055598;C0163868;C1413605|||C0055598;C0163868|NCI;PDQ|||
CHOP|CTX/DOX/PRED/VCR||||C0055598;C0163868|NCI;PDQ|||
CHOP|Chop (action)|C2945739|||C2945739|MTH|||
CHOP|Cyclophosphamide/Doxorubicin/Prednisone/Vincristine;cyclophosphamide/doxorubicin/prednisone/vincristine;cyclophosphamide/doxorubicin/vincristine/prednisone||||C0055598;C0163868|NCI;PDQ|1|0.2245|
CHOP|GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD153||||C1413947|OMIM|||
CHOP|Growth Arrest And DNA Damage Inducible Protein 153;Growth Arrest And DNA Damage-Inducible Protein 153||||C0287750|MSH;NDFRT|||
CHOP|Growth Arrest and DNA Damage-Inducible Protein GADD153||||C0287750|NCI|||
CHOP|Growth Arrest- and DNA Damage-Inducible Gene||||C2985165|NCI|||
CHOP|Transcription Factor CHOP [Chemical/Ingredient]||||C0287750|NDFRT|||
CHOP|cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (oncovin), prednisone||1|1.000|||||
CHOP|cyclophosphamide, doxorubicin, prednisone, and vincristine protocol||||C0055598|CHV|||
CHOP|phosphorylcholine|C0031716|||||1|0.4082|
CIC|CAPICUA, DROSOPHILA, HOMOLOG OF;capicua homolog (Drosophila)||||C1422489|HUGO;OMIM|||
CIC|CHVP;CHVP protocol;cyclophosphamide/doxorubicin/prednisone/teniposide protocol|C0055670|||C0055670|MSH;MTH;NCI;PDQ|||
CIC|CIC;CICS;cic;cics|C0055670;C1422489;C1621392|||C0055670;C1422489|CHV;HUGO;OMIM;PDQ|||
CIC|CIC gene;KIAA0306|C1422489|||C1422489|HUGO;MTH;OMIM|||
CIC|CTX/DOX/PRED/VM-26||||C0055670|NCI;PDQ|||
CIC|Cyclophosphamide/Doxorubicin/Prednisone/Teniposide;cyclophosphamide/doxorubicin/prednisone/teniposide||||C0055670|NCI;PDQ|||
CIC|carbachol inhalation challenge||||||||1
CIC|cardiac intensive care unit/CICU||1|1.000|||||
CIC|cardioinhibitor center||||||||1
CIC|central nucleus of the inferior colliculus||||||1|0.0072|
CIC|chronic inactive cirrhosis||||||||1
CIC|cicletanine|C0056686|||||1|0.0134|
CIC|circulating immune complex;circulating immune complexes|C0003313|||C0003313|OMIM|1|0.816|1
CIC|clean intermittent catheterisation;clean intermittent catheterization||||||1|0.1193|1
CIC|clean intermittent self-catheterization||||||1|0.0072|
CIC|completely in the canal||||||||1
CIC|complex instability of carpus||||||||1
CIC|conjunctival impression cytology||||||1|0.037|
CIC|constant initial concentration||||||||1
CIC|crisis intervention center||||||||1
CK|ATP Choline Transphosphatase;Choline Transphosphatase, ATP;Transphosphatase, ATP Choline;CHETK-Alpha;CHK Protein;Choline Kinase;Choline kinase;Kinase, Choline;choline kinase;Choline Phosphokinase;Phosphokinase, Choline|C0008415|||C0008415|MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
CK|ATP:choline phosphotransferase||||C0008415|MSH;NDFRT|||
CK|BB-CK;CK-BB|C0010289;C1150462|||C1150462|GO|||
CK|CC||||C0009212|NCI|||
CK|CCK||||C0009212|NCI|||
CK|CHETK-Alpha Gene;CHKA wt Allele;Choline Kinase Alpha wt Allele;Choline Kinase Gene|C1706600|||C1706600|MTH;NCI|||
CK|CHK||||C0008415;C1706600|NCI|||
CK|CHOK|C0008415;C1706600|||C0008415;C1706600|NCI|||
CK|CK;Centesimal Korsakovian Series of Attenuation;HOMEOPATHIC POTENCY OF CENTESIMAL KORSAKOVIAN SERIES;{kp_C}|C2985360|||C0008415;C0009212;C0009956;C0201973;C1150462;C1706600;C2985360|GO;MTH;NCI|||
CK|CK - Creatine kinase level;Creatine kinase level|C0750863|||C0201973|SNOMEDCT|||
CK|CK measurement;CPK measurement;Creatine Kinase Measurement;Creatine kinase measurement;Creatine phosphokinase measurement|C0201973|||C0201973|MTH;NCI;SNOMEDCT|||
CK|CK-MB;MB-CK|C0010290;C1150462|||C1150462|GO|||
CK|CK-MM;MM-CK|C0010291;C1150462|||C1150462|GO|||
CK|CKI||||C0008415;C1706600|NCI|||
CK|CKI, Yeast, Human Complement of||||C0008415|NCI|||
CK|CKMiMi;Mi-CK;creatine kinase activity|C1150462|||C1150462|GO;MTH|1|0.0105|
CK|COCOS (KEELING) ISLANDS;Cocos (Keeling) Islands||||C0009212|MSH;MTH;NCI|||
CK|COK;COOK ISLANDS;Cook Islands;cook island;cook islands|C0009956|||C0009956|CHV;MSH;MTH;NCI|||
CK|CW||||C0009956|NCI|||
CK|Choline Kinase [Chemical/Ingredient]||||C0008415|NDFRT|||
CK|Choline kinase (substance)||||C0008415|SNOMEDCT|||
CK|Conductive keratoplasty;conductive keratoplasty|C1301494|||||1|0.0054|1
CK|Creatine (phospho)kinase (& level)||||C0201973|SNOMEDCT|||
CK|Creatine (phospho)kinase (& level) (procedure)||||C0201973|SNOMEDCT|||
CK|Creatine Kinase;creatine kinase;creatinkinase;creatine phosphokinase|C0010287|1|0.998|C0010287;C0201973|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.808|1
CK|Creatine kinase measurement (procedure)||||C0201973|SNOMEDCT|||
CK|EC 2.7.1.32||||C0008415|NCI|||
CK|NATO code for cyanogen chloride||||||||1
CK|Serum creatine-kinase||||||1|0.003|
CK|anti-cytokeratin||||||1|0.0033|
CK|calf kidney||||||||1
CK|casein kinases|C0054846|||||1|0.0018|
CK|check;checked|C1283174;C1555524|||||||1
CK|chick kidney||||||1|0.0033|
CK|chicken kidney||||||1|0.0033|1
CK|cholecystokinin|C0008328;C0523565;C1413167|||C0008328;C0523565;C1413167|AOD;CHV;CSP;FMA;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;RXNORM;SNOMEDCT|||1
CK|color kinesis||||||1|0.0042|1
CK|compound K|C0675992|||||1|0.0015|
CK|contralateral knee||||||||1
CK|creatine kinase (CK) level test||||C0201973|CHV|||
CK|cyanogen chloride|C0056659|||||||1
CK|cytokeratin|C0010803;C0022564|||||1|0.1517|1
CK|cytokinin|C0010815|||C0010815|CHV;CSP|||
CK|expression of cytokeratins||||||1|0.0042|
CLL|B Cell CLL;B-Cell CLL;B-cell CLL;CLL, B-cell;b-cell cll;B Cell Leukemia, Chronic;B-Cell Leukemia, Chronic;B-Cell Leukemias, Chronic;Chronic B-Cell Leukemia;Chronic B-Cell Leukemias;Leukemia, B Cell, Chronic;Leukemia, B-Cell, Chronic;Leukemia, Chronic B-Cell;Leukemias, Chronic B-Cell;B Lymphocytic Leukemia, Chronic;B-Lymphocytic Leukemia, Chronic;B-Lymphocytic Leukemias, Chronic;Chronic B-Lymphocytic Leukemia;Chronic B-Lymphocytic Leukemias;LYMPHOCYTIC LEUKEMIA CHRONIC B;Leukemia, Chronic B-Lymphocytic;Leukemias, Chronic B-Lymphocytic;b chronic lymphocytic leukemia;B-CLL - B-cell chronic lymphocytic leukaemia;B-CLL - B-cell chronic lymphocytic leukemia;B-Cell Chronic Lymphogenous Leukemia;B-Cell Chronic Lymphoid Leukemia;CHRONIC LYMPHOCYTIC LEUKEMIA;Chronic Lymphocytic Leukemia;Chronic Lymphocytic Leukemias;Chronic lymphocytic leukaemia;Chronic lymphocytic leukemia;LEUKEMIA CHRONIC LYMPHOCYTIC;LEUKEMIA LYMPHOCYTIC CHRONIC;LEUKEMIA, CHRONIC LYMPHOCYTIC;LEUKEMIA, LYMPHOCYTIC, CHRONIC;Leukemia, Chronic Lymphocytic;Leukemia, Lymphocytic, Chronic;Leukemias, Chronic Lymphocytic;Lymphocytic Leukemia, Chronic;Lymphocytic Leukemias, Chronic;chronic leukemia lymphocytic;chronic lymphocytic leukaemia;chronic lymphocytic leukemia;leukemia chronic lymphocytic;leukemia, chronic lymphocytic;lymphocytic leukemia chronic;lymphocytic leukemia, chronic;CLL;cll;clls;CLL - Chronic lymphocytic leukaemia;CLL - Chronic lymphocytic leukemia;Leukemia, chronic lymphocytic (CLL);chronic lymphocytic leukemia (cll);cll chronic lymphocytic leukemia;CLL Lymphoplasmacytoid Lymphoma;CLL Lymphoplasmacytoid Lymphomas;Lymphoma, CLL Lymphoplasmacytoid;Lymphoma, Lymphoplasmacytoid, CLL;Lymphomas, CLL Lymphoplasmacytoid;Lymphoplasmacytoid Lymphoma, CLL;Lymphoplasmacytoid Lymphomas, CLL;Chronic Lymphatic Leukemia;Chronic lymphatic leukaemia;Chronic lymphatic leukemia;LEUKEMIA, CHRONIC LYMPHATIC;chronic lymphatic leukaemia;chronic lymphatic leukemia;Chronic Lymphoblastic Leukemia;Chronic Lymphoblastic Leukemias;Leukemia, Chronic Lymphoblastic;Leukemia, Lymphoblastic, Chronic;Leukemias, Chronic Lymphoblastic;Lymphoblastic Leukemia, Chronic;Lymphoblastic Leukemias, Chronic;chronic lymphoblastic leukemia;Chronic Lymphogenous Leukemia;chronic lymphogenous leukemia;Chronic lymphocytic leukaemia, B-cell type;Chronic lymphocytic leukemia, B-cell type;Chronic lymphoid leukaemia;Chronic lymphoid leukemia;Lymphoid leukemia, chronic;chronic lymphoid leukemia;Chronic lymphoid leukaemia, disease;Chronic lymphoid leukemia, disease;Lymphoma, Small Lymphocytic, Plasmacytoid|C0023434|1|1|C0023434|CHV;COSTAR;CSP;CST;DXP;ICD9CM;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;QMR;SNOMEDCT|1|0.9896|1
CLL|B Cell Chronic Lymphocytic Leukemia;B cell chronic lymphocytic leukemia;B-Cell Chronic Lymphocytic Leukemia;B-cell chronic lymphocytic leukaemia;B-cell chronic lymphocytic leukemia;Chronic B-Cell Lymphocytic Leukemia;Leukemia, Lymphocytic, Chronic, B Cell;Leukemia, Lymphocytic, Chronic, B-Cell;Lymphocytic Leukemia, Chronic, B Cell;Lymphocytic Leukemia, Chronic, B-Cell;chronic lymphocytic leukemia, B-cell;leukemia, B-cell chronic lymphocytic;lymphocytic leukemia, B-cell chronic;BCLL|C0023434;C1868683|||C0023434|MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
CLL|B Cell Lymphocytic Leukemia;B-Cell Lymphocytic Leukemia;b cell lymphocytic leukemia;B-Cell Leukemia;b cell leukemia;b-cell leukemia;leukemia b cell|C0023434;C2004493|||C0023434|CHV;NCI|||
CLL|B-Lymphocytic Leukemia|C2004493|||C0023434|NCI|||
CLL|B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma;B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma||||C0023434|SNOMEDCT|||
CLL|B-cell chronic lymphocytic leukemia (disorder)||||C0023434|SNOMEDCT|||
CLL|B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (morphologic abnormality)||||C0023434|SNOMEDCT|||
CLL|Chronic lymphocytic leukemia, morphology (morphologic abnormality)||||C0023434|SNOMEDCT|||
CLL|Chronic lymphoid leukemia, disease (disorder)||||C0023434|SNOMEDCT|||
CLL|DIFFUSE WELL DIFFER LYMPHOCYTIC LYMPHOMA;LYMPHOCYTIC LYMPHOMA DIFFUSE WELL DIFFER;LYMPHOMA LYMPHOCYTIC DIFFUSE WELL DIFFER||||C0023434|MSH|||
CLL|Diffuse Well Differentiated Lymphocytic Lymphoma;Diffuse Well-Differentiated Lymphocytic Lymphoma;Lymphocytic Lymphoma, Diffuse, Well Differentiated;Lymphocytic Lymphoma, Diffuse, Well-Differentiated;Lymphoma, Lymphocytic, Diffuse, Well Differentiated;Lymphoma, Lymphocytic, Diffuse, Well-Differentiated||||C0023434|MSH;NDFRT|||
CLL|Hematopoeitic - Chronic Lymphocytic Leukemia (CLL)||||C0023434|NCI|||
CLL|LYMPHOCYTIC LYMPHOMA WELL DIFFER;LYMPHOMA LYMPHOCYTIC WELL DIFFER||||C0023434|MSH|||
CLL|LYMPHOMA SMALL;SMALL LYMPHOMA||||C0023434|MSH|||
CLL|Leukemia, Lymphocytic, Chronic, B-Cell [Disease/Finding]||||C0023434|NDFRT|||
CLL|Lymphocytic Lymphoma;Lymphocytic Lymphomas;Lymphocytic lymphoma;Lymphoma, Lymphocytic;Lymphomas, Lymphocytic|C0023434;C0024303;C0855095|||C0023434|MSH;NDFRT;OMIM|||
CLL|Lymphocytic Lymphoma, Small;Lymphocytic Lymphomas, Small;Lymphoma, Small Lymphocytic;Lymphomas, Small Lymphocytic;Small Lymphocytic Lymphoma;Small Lymphocytic Lymphomas;Lymphocytic Lymphoma, Well Differentiated;Lymphocytic Lymphoma, Well-Differentiated;Lymphocytic Lymphomas, Well-Differentiated;Lymphoma, Lymphocytic, Well Differentiated;Lymphoma, Lymphocytic, Well-Differentiated;Lymphoma, Well-Differentiated Lymphocytic;Lymphomas, Well-Differentiated Lymphocytic;Well-Differentiated Lymphocytic Lymphoma;Well-Differentiated Lymphocytic Lymphomas|C0023434;C0855095|||C0023434|MSH;NDFRT|||
CLL|Lymphoma, Small Cell;Lymphoma, Small-Cell;Lymphomas, Small-Cell;Small Cell Lymphoma;Small-Cell Lymphoma;Small-Cell Lymphomas|C0023434;C0024303|||C0023434|MSH;NDFRT|||
CLL|[M]Chronic lymphoid leukaemia;[M]Chronic lymphoid leukemia||||C0023434|SNOMEDCT|||
CLL|[M]Chronic lymphoid leukaemia (disorder)||||C0023434|SNOMEDCT|||
CLL|centrocytelike cell|C1516393|||||||1
CLL|cholesterol-lowering lipid||||||||1
CLL|chronic lymphocytic||||||1|0.0033|
CLL|chronic lymphocytic leukemia cells||||||1|0.0019|
CLL|chronic lymphocytic leukemic||||||1|0.0052|
CLL|cow lung lavage||||||||1
CML|ALL|C0444868|||C0105421;C0812385;C1704799|HUGO;NCI|||
CML|BCR||||C0105421;C0812385|HUGO;LNC;NCI;OMIM|||
CML|BCR Gene;BCR gene;bcr gene;BREAKPOINT CLUSTER REGION;breakpoint cluster region;Breakpoint Cluster Region Gene|C0812385|||C0812385|CHV;HUGO;MTH;NCI;OMIM|||
CML|BCR Protein;BCR protein, human;breakpoint cluster region protein, human;c-bcr protein, human|C0105421|||C0105421|MSH;MTH;NCI|||
CML|BCR wt Allele;Breakpoint Cluster Region wt Allele|C1704799|||C1704799|MTH;NCI|||
CML|BCR-ABL Positive Chronic Myelogenous Leukemia;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;CGL;CGL - Chronic granulocytic leukaemia;CGL - Chronic granulocytic leukemia;CHRONIC GRANULOCYTIC LEUKEMIA;Chronic Granulocytic Leukemia;Chronic Granulocytic Leukemias;Chronic granulocytic leukaemia;Chronic granulocytic leukemia;Granulocytic Leukemia, Chronic;Granulocytic Leukemias, Chronic;LEUKEMIA, GRANULOCYTIC, CHRONIC;Leukemia, Chronic Granulocytic;Leukemia, Granulocytic, Chronic;Leukemias, Chronic Granulocytic;chronic granulocytic leukaemia;chronic granulocytic leukemia;granulocytic leukemia, chronic;CHRONIC MYELOCYTIC LEUKEMIA;Chronic Myelocytic Leukemia;Chronic Myelocytic Leukemias;Chronic myelocytic leukaemia;Chronic myelocytic leukemia;LEUKEMIA CHRONIC MYELOCYTIC;LEUKEMIA MYELOCYTIC CHRONIC;LEUKEMIA, MYELOCYTIC, CHRONIC;Leukemia, Chronic Myelocytic;Leukemia, Myelocytic, Chronic;Leukemias, Chronic Myelocytic;Myelocytic Leukemia, Chronic;Myelocytic Leukemias, Chronic;chronic myelocytic leukemia;myelocytic leukemia, chronic;CML - Chronic Myelogenous Leukemia;Chronic myelogenous leukemia (CML);chronic myelogenous leukemia (CML);CML - Chronic myeloid leukaemia;CML - Chronic myeloid leukemia;Chronic Myelogenous Leukemia;Chronic Myelogenous Leukemias;Chronic myelogenous leukaemia;Chronic myelogenous leukemia;LEUKEMIA, CHRONIC MYELOGENOUS;LEUKEMIA, MYELOGENOUS, CHRONIC;Leukemia, Chronic Myelogenous;Leukemia, Myelogenous, Chronic;Leukemias, Chronic Myelogenous;Myelogenous Leukemia, Chronic;Myelogenous Leukemias, Chronic;chronic myelogenous leukaemia;chronic myelogenous leukemia;leukemia, chronic myelogenous;myelogenous leukemia, chronic;Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Chronic myelogenous leukemia, no ICD-O subtype;Chronic myeloid leukaemia, disease;Chronic myeloid leukemia, disease|C0023473|||C0023473|CHV;COSTAR;CSP;CST;DXP;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;PDQ;QMR;SNOMEDCT|1|0.4572|
CML|BCR1||||C0105421;C0812385;C1704799|NCI;OMIM|||
CML|Breakpoint Cluster Region Protein|C0072449;C0105421|||C0105421|NCI|||
CML|CML;cml||||C0023473;C0105421;C0812385;C1552913;C1704799|CHV;CSP;DXP;HUGO;MEDLINEPLUS;NCI;OMIM;PDQ|||
CML|Chronic Myeloid Leukemia;Chronic Myeloid Leukemias;Chronic myeloid leukaemia;Chronic myeloid leukaemia NOS;Chronic myeloid leukemia;Chronic myeloid leukemia NOS;LEUKEMIA, CHRONIC MYELOID;LEUKEMIA, MYELOID, CHRONIC;Leukemia, Chronic Myeloid;Leukemia, Myeloid, Chronic;Leukemias, Chronic Myeloid;Myeloid Leukemia, Chronic;Myeloid Leukemias, Chronic;Myeloid leukemia, chronic;chronic myeloid leukaemia;chronic myeloid leukemia;chronic myeloid leukemias|C0023473;C2984277|||C0023473|CHV;CSP;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.4601|
CML|Chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality)||||C0023473|SNOMEDCT|||
CML|Chronic myeloid leukaemia (disorder);Chronic myeloid leukemia NOS (disorder)||||C0023473|SNOMEDCT|||
CML|Chronic myeloid leukemia, disease (disorder)||||C0023473|SNOMEDCT|||
CML|Circular Mil;circular mil;[cml_i]|C1552913|||C1552913|HL7V3.0;MTH;NCI|||
CML|D22S11|C0105421;C1704799|||C0105421;C1704799|NCI|||
CML|D22S662|C0105421;C0812385;C1704799|||C0105421;C0812385;C1704799|HUGO;NCI|||
CML|Hematopoeitic - Chronic Myelocytic Leukemia (CML)||||C0023473|NCI|||
CML|LEUKEMIA PHILA POS||||C0023473|MSH|||
CML|Leukemia, Myelogenous, Chronic, BCR-ABL Positive [Disease/Finding]||||C0023473|NDFRT|||
CML|Leukemia, Myelogenous, Ph1 Positive;Leukemia, Myelogenous, Ph1-Positive;Leukemia, Ph1-Positive Myelogenous;Leukemias, Ph1-Positive Myelogenous;Myelogenous Leukemia, Ph1 Positive;Myelogenous Leukemia, Ph1-Positive;Myelogenous Leukemias, Ph1-Positive;Ph1-Positive Myelogenous Leukemia;Ph1-Positive Myelogenous Leukemias;Leukemia, Myeloid, Ph1 Positive;Leukemia, Myeloid, Ph1-Positive;Leukemia, Ph1-Positive Myeloid;Leukemias, Ph1-Positive Myeloid;Myeloid Leukemia, Ph1 Positive;Myeloid Leukemia, Ph1-Positive;Myeloid Leukemias, Ph1-Positive;Ph1-Positive Myeloid Leukemia;Ph1-Positive Myeloid Leukemias;Leukemia, Myeloid, Philadelphia Positive;Leukemia, Myeloid, Philadelphia-Positive;Leukemia, Philadelphia-Positive Myeloid;Leukemias, Philadelphia-Positive Myeloid;Myeloid Leukemia, Philadelphia Positive;Myeloid Leukemia, Philadelphia-Positive;Myeloid Leukemias, Philadelphia-Positive;Philadelphia-Positive Myeloid Leukemia;Philadelphia-Positive Myeloid Leukemias|C0023473;C0023476|||C0023473|MSH;NDFRT|||
CML|N epsilon-carboxymethyllysine||||||1|0.0024|
CML|N(epsilon)-(carboxymethyl)lysine||||||1|0.0171|
CML|Nepsilon-(Carboxymethyl)lysine||||||1|0.0058|
CML|PHL||||C0105421;C0812385;C1704799|HUGO;NCI|||
CML|[M]Chronic myeloid leukaemia;[M]Chronic myeloid leukemia||||C0023473|SNOMEDCT|||
CML|carboxymethyllysine|C0083528|||C0083528|MSH|1|0.0081|
CML|cell-mediated lymphocytotoxicity||||||1|0.0036|1
CML|cell-mediated lympholysis|C0301896|||C0301896|NCI;SNOMEDCT|1|0.039|1
CML|cell-mediated lysis||||||1|0.0026|1
CML|central motor latency||||||||1
CML|chronic myeloblastic leukemia||1|1.000|||||1
CML|chronic myeloid leukemic||||||1|0.0024|
CML|count median length||||||||1
CML|cross midline||||||||1
CML|mediated lysis||||||1|0.0017|
CMP|5'-Cytidylic acid;Acid, Cytidylic;Acids, Cytidylic;Cytidylic Acid;Cytidylic Acids;Cytidylic acid;cytidylic acid;CMP (cytidine monophosphate);cytidine monophosphate (CMP);Cytidine Monophosphate;Cytidine monophosphate;Monophosphate, Cytidine;cytidine monophosphate|C0010729|||C0010729|CHV;CSP;MSH;MTH;NDFRT;SNOMEDCT|1|0.0921|1
CMP|C'MP protocol;lomustine/methotrexate/procarbazine protocol|C0054385|||C0054385|MSH;MTH|||
CMP|CARTILAGE MATRIX PROTEIN;Cartilage matrix protein;MATRILIN 1|C0054832;C1417041|||C1417041|OMIM|1|0.1513|
CMP|CCNU/MTX/PCB||||C0054385|NCI;PDQ|||
CMP|CMP||||C0010729;C0054385;C1417041|MSH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|||
CMP|CRTM;MATN1;MATN1 gene;matrilin 1, cartilage matrix protein|C1417041|||C1417041|HUGO;MTH;OMIM|||
CMP|Cytidine Monophosphate [Chemical/Ingredient]||||C0010729|NDFRT|||
CMP|Cytidylic acid (substance)||||C0010729|SNOMEDCT|||
CMP|Lomustine/Methotrexate/Procarbazine;lomustine/methotrexate/procarbazine||||C0054385|NCI;PDQ|||
CMP|calorie-protein malnutrition||||||||1
CMP|captioned media program||||||||1
CMP|cardiomyopathy|C0878544|1|0.006|C0878544|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MEDLINEPLUS;MSH;NCI;OMIM;SNOMEDCT|1|0.3553|1
CMP|caseinomacropeptide|C0286762|||||1|0.0789|
CMP|cervical mucus penetration||||||||1
CMP|chemical mechanical polishing||||||1|0.0461|
CMP|chondromalacia patella;chondromalacia patellae|C0008475|||C0008475|CHV|||1
CMP|colorimetric microtiter plate||||||||1
CMP|competitive medical plans|C0085130|||||||1
CMP|complementary medical practice||||||||1
CMP|complexity of mental processes||||||||1
CMP|comprehensive medical plan||||||||1
CMP|comprehensive metabolic panel|C0519825|1|0.990|||||1
CMP|control measurement point||||||||1
CMP|cow's milk protein|C0440448|||||1|0.1645|1
CMP|crossmodal priming||||||||1
CMP|cushion mouthpiece||||||||1
CMP|cyclophosphamide|C0010583|1|0.002|||||
CMP|cytidine 5'-monophosphate||||||1|0.0658|
CMP|dynamic cardiomyoplasty|C0242637|||||1|0.0461|
CMS|CAS LIGAND WITH MULTIPLE SH3 DOMAINS;CD2AP;CD2AP gene|C1422519|||C1422519|HUGO;MTH;OMIM|||
CMS|CD2-ASSOCIATED PROTEIN;CD2-associated protein||||C1422519|HUGO;OMIM|||
CMS|CENTERS FOR MEDICARE MEDICAID SERV||||C0041718|MSH|||
CMS|CMS;Centers for Medicare and Medicaid Services;Centers for Medicare&Medicaid Services;center medicaid medicare services;centers medicaid medicare services;HCFA;Health Care Financing Administration;United States Health Care Financing Administration|C0041718|1|0.008|C0041718;C1422519;C1880120|CHV;HUGO;LNC;MSH;MTH;NCI;OMIM|1|0.1692|1
CMS|Cardiovascular Measurement system||||||||1
CMS|Centers for Medicare and Medicaid Services (U.S.)||||C0041718|MSH|||
CMS|Clyde Mood Scale||||||||1
CMS|Colony Management System|C1880120|||C1880120|MTH;NCI|||
CMS|Conditioned media|C0162518|||||1|0.0227|
CMS|Conflict Management Survey||||||||1
CMS|Congenital Myasthenic Syndromes|C0751882|||||1|0.1111|
CMS|HEALTH CARE FINANCING ADMIN||||C0041718|MSH|||
CMS|Health Care Financing Administration (U.S.)||||C0041718|MSH|||
CMS|UNITED STATES CENTERS FOR MEDICARE MEDICAID SERV||||C0041718|MSH|||
CMS|UNITED STATES HEALTH CARE FINANCING ADMIN||||C0041718|MSH|||
CMS|United States Centers for Medicare and Medicaid Services;united states centers for medicare and medicaid services||||C0041718|CHV;MSH|||
CMS|cardiomediastinal silhouette||||||||1
CMS|cavernous malformations||||||1|0.0505|
CMS|central margin syndrome||||||||1
CMS|central material section||||||||1
CMS|central material supply||||||||1
CMS|cervical magnetic stimulation||||||1|0.048|
CMS|cervical mucous solution||||||||1
CMS|cholesterol monitoring system||||||||1
CMS|chromosome modification site||||||||1
CMS|chronic mild stress||||||1|0.1338|
CMS|chronic mountain sickness|C0274294|||||1|0.0732|
CMS|chronic mycelial stomatitis||||||||1
CMS|chronic myelodysplastic syndrome||||||||1
CMS|chylomicrons|C0008731|||||1|0.0303|
CMS|circulation, motion, sensation||1|0.982|||||1
CMS|clean, midstream||||||||1
CMS|click-murmur syndrome|C0026267|||||||1
CMS|clofibrate-induced muscular syndrome||||||||1
CMS|cochlear microphonics||||||1|0.0379|
CMS|compliance matching stent||||||||1
CMS|continuous motion syndrome||||||||1
CMS|cortical magnetic stimulation||||||||1
CMS|cystadenoma with mesenchymal stroma||||||1|0.0177|
CMS|cytoplasmic male sterile||||||1|0.0859|
CMS|cytoplasmic male sterility||||||1|0.197|1
CMS|solubilization||||||1|0.0227|
CMV|CDDP/MTX/VBL||||C0285131|NCI;PDQ|||
CMV|CMV||||C0010825;C0278819;C0285131|CHV;CSP;MEDLINEPLUS;NCI;PDQ|||
CMV|CMV - Cytomegalovirus;CMV, CYTOMEGALOVIRUS;cmv cytomegalovirus;cytomegalovirus (CMV);Cytomegalovirus;Cytomegalovirus, NOS;Cytomegaloviruses;cytomegalovirus;Cytomegalovirus group;Cytomegalovirus group, NOS;cytomegalovirus group;Genus Cytomegalovirus;Salivary Gland Virus;Salivary Gland Viruses;Salivary gland virus;Salivary gland virus, NOS;Virus, Salivary Gland;Viruses, Salivary Gland;salivary gland virus;salivary gland viruses|C0010825|1|0.972|C0010823;C0010825|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCBI;NCI;SNOMEDCT|1|0.9302|1
CMV|CMV chemotherapy protocol;MEC Protocol 1;MEC protocol 1;cisplatin/methotrexate/vinblastine protocol|C0285131|||C0285131|CHV;MSH;MTH;NCI|||
CMV|CTX/MTX/VP-16||||C0278819|NCI;PDQ|||
CMV|Cisplatin/Methotrexate/Vinblastine;cisplatin, methotrexate, vinblastine;cisplatin/methotrexate/vinblastine||1|0.002|C0285131|NCI;PDQ|||
CMV|Clo Mor virus|C0319042|||||||1
CMV|Cyclophosphamide/Etoposide/Methotrexate;cyclophosphamide/etoposide/methotrexate||||C0278819|NCI;PDQ|||
CMV|Cytomegalovirus (living organism) (organism)||||C0010825|SNOMEDCT|||
CMV|Cytomegalovirus (living organism) [Ambiguous]||||C0010825|SNOMEDCT|||
CMV|Cytomegalovirus group virus||||C0010825|SNOMEDCT|||
CMV|Cytomegalovirus group virus (organism)||||C0010825|SNOMEDCT|||
CMV|Genus Cytomegalovirus (organism)||||C0010825|SNOMEDCT|||
CMV|MCV|C0524587|||C0285131|PDQ|||
CMV|anti-cytomegalovirus||||||1|0.0062|
CMV|canalicular membrane vesicles||||||1|0.0023|
CMV|cancer family syndrome|C2931592|||||||1
CMV|cerebrospinal fluid|C0007806;C0007807|||||||1
CMV|circumferential shortening fraction||||||||1
CMV|colony-stimulating factor|C0009392;C0079460|||||||1
CMV|continuous mandatory ventilation||1|0.026|||||1
CMV|continuous mechanical ventilation||||||||1
CMV|contoured femoral stem||||||||1
CMV|controlled mechanical ventilation|C0419012|||C0419012|CHV;SNOMEDCT|||1
CMV|conventional mechanical ventilation||||||1|0.0205|1
CMV|cool mist vaporizer||||||||1
CMV|coronary sinus flow||||||||1
CMV|cucumber mosaic cucumovirus||||||1|0.0028|
CMV|cucumber mosaic virus|C0520499|||||1|0.0306|1
CMV|cyclophosphamide/etoposide/methotrexate protocol||||C0278819|MTH|||
CMV|cytomegaloviral||||||1|0.003|
CMV|cytomegalovirus infection|C0010823|||||1|0.0028|
CMV|promoter|C0086860|||||1|0.0015|
CNS|CLIN NURSE SPECIALIST;CLIN NURSE SPECIALISTS;NURSE SPECIALIST CLIN;NURSE SPECIALISTS CLIN;SPECIALIST CLIN NURSE;SPECIALISTS CLIN NURSE||||C0028654|MSH|||
CNS|CNS||||C0028654;C0445625;C0927232;C2347597|AOD;CSP;FMA;NCI|||
CNS|CNS - Clinical nurse specialist;Clin Spec;Clinician, Nurse;Clinicians, Nurse;Nurse Clinician;Nurse Clinicians;nurse clinician;nurse clinicians|C0028654|||C0028654|CHV;MSH;NCI;SNOMEDCT|||
CNS|CNS - Coagulase-negative staphylococcus;COAGULASE NEGATIVE STAPHYLOCOCCUS;Coagulase-Negative Staphylococcus;Coagulase-negative staphylococcus;Staphylococcus, coagulase negative;coagulase negative staphylococcus;coagulase-negative staphylococci;coagulase-negative staphylococcus;Staphylococcus, coagulase negative (organism)|C0445625|||C0445625|CHV;MTH;NCI;SNOMEDCT|1|0.0283|1
CNS|Canadian Neurological Scale||||||1|0.0013|
CNS|Central Nervous System;Central Nervous Systems;Central nervous system;Nervous System, Central;Nervous Systems, Central;System, Central Nervous;Systems, Central Nervous;central nervous system|C0927232;C1269563|1|0.998|C0927232;C1269563|AOD;CSP;CST;FMA;LCH;MSH;NCI;OMIM;SNOMEDCT;UWDA|1|0.9558|1
CNS|Central nervous system structure;Structure of central nervous system;Cerebrospinal axis;Nervous System, CNS;Neuraxis;neuraxis;Pars centralis;Systema nervosum centrale|C0927232|||C0927232|AOD;CHV;FMA;MTH;NCI;SNOMEDCT;UWDA|||
CNS|Central nervous system structure (body structure);Structure of central nervous system (body structure)||||C0927232|SNOMEDCT|||
CNS|Certified Nurse Specialist|C1549961;C2347597|||C2347597|MTH;NCI|||
CNS|Clinical Nurse Specialist;Clinical Nurse Specialists;Clinical nurse specialist;Nurse Specialist, Clinical;Nurse Specialists, Clinical;Specialist, Clinical Nurse;Specialists, Clinical Nurse;clinical nurse specialist;clinical nurse specialists|C0028654;C1610180|1|0.002|C0028654;C1610180|CHV;HL7V3.0;MSH;MTH;NCI;SNOMEDCT|1|0.0113|
CNS|Clinical nurse specialist (occupation)||||C0028654|SNOMEDCT|||
CNS|Congenital nephrotic syndrome;congenital nephrotic syndrome|C0268713;C0403399|||C0268713|CHV;NCI;SNOMEDCT|1|0.0019|1
CNS|central nervous||||||1|0.0009|
CNS|coagulase-negative staphylococcal||||||1|0.0005|
CNS|computerized notation system||||||||1
COPD|CAFL - Chronic airflow limitation;CAL - Chronic airflow limitation;CHRONIC OBSTRUCTIVE LUNG DISEASE;Chronic Obstructive Lung Disease;Chronic obstructive lung disease;Chronic obstructive lung disease, NOS;chronic obstructive lung disease;COAD;coad;COAD - Chronic obstructive airways disease;COLD (chronic obstructive lung disease);COLD - Chronic obstructive lung disease;COPD;COPD NOS;Chronic Obstructive Airway Disease;Chronic Obstructive Airways Disease;Chronic obstructive airway disease;Chronic obstructive airways disease NOS;Chronic airflow limitation;chronic airflow limitation;Chronic airway disease;chronic airway disease;chronic airways disease;Chronic airway obstruction;Chronic irreversible airway obstruction;Chronic obstructive pulmonary disease finding|C0024117|||C0024117;C1847014|AOD;CHV;COSTAR;CSP;DXP;LNC;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|||
COPD|CHRONIC OBSTRUCTIVE AIRWAY DIS||||C0024117|MSH|||
COPD|CHRONIC OBSTRUCTIVE LUNG DIS||||C0024117|MSH|||
COPD|CHRONIC OBSTRUCTIVE PULM DIS;PULM DIS CHRONIC OBSTRUCTIVE||||C0024117|MSH|||
COPD|CHRONIC OBSTRUCTIVE PULMONARY DISEASE;Chronic Obstructive Pulmonary Disease;Chronic obstructive pulmonary disease;Chronic obstructive pulmonary disease NOS;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;Pulmonary Disease, Chronic Obstructive;chronic obstructive pulmonary disease;CHRONIC OBSTRUCTIVE PULMONARY DISEASE, (COPD);COPD (Chronic Obstructive Pulmonary Disease);COPD - Chronic obstructive pulmonary disease;COPD, CHRONIC OBSTRUCTIVE PULMONARY DISEASE;Chronic Obstructive Pulmonary Disease (COPD);OBSTRUCTIVE PULMONARY DISEASE (COPD), CHRONIC;PULMONARY DISEASE (COPD), CHRONIC OBSTRUCTIVE;chronic obstructive pulmonary disease (COPD)|C0024117;C1847014|1|1|C0024117;C1847014|CHV;CSP;DXP;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|1|1
COPD|COLD|C0009264;C0009443;C0234192|||C0024117|NCI;SNOMEDCT|||
COPD|Chronic airway obstruction; not otherwise specified|C0024117;C1518425|||C0024117|CCS|||
COPD|Chronic obstructive airways disease NOS (disorder)||||C0024117|SNOMEDCT|||
COPD|Chronic obstructive lung disease (disorder)||||C0024117|SNOMEDCT|||
COPD|Chronic obstructive lung disease [Ambiguous]||||C0024117|SNOMEDCT|||
COPD|Chronic obstructive pulmonary disease finding (finding)||||C0024117|SNOMEDCT|||
COPD|DISEASE (COPD), CHRONIC OBSTRUCTIVE||||C0024117|NCI|||
COPD|PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET|C1847014|||C1847014|MTH;OMIM|||
COPD|Pulmonary Disease, Chronic Obstructive [Disease/Finding]||||C0024117|NDFRT|||
COR|3' deoxyadenosine;3'-Deoxyadenosine;3'-deoxyadenosine;3'-dA-CE Phosphoramidite;3-dAdenosine;9-Cordyceposidoadenine;CORDYCEPIN;Cordycepin;cordycepin;Cordycepine;Kordicepin|C0056331|||C0056331|CHV;CSP;MSH;MTH;NCI;PDQ;SNOMEDCT|||
COR|3'-Deoxyadenosine (product)||||C0056331|SNOMEDCT|||
COR|3'-Deoxyadenosine (substance)||||C0056331|SNOMEDCT|||
COR|COR;Cor|C0018787;C0056331|||C0018787;C0056331|FMA;NCI;PDQ|||
COR|Cardiac;cardiac|C0018787;C1522601|||C0018787|AOD;CHV;CSP;NCI|||
COR|Cardiac structure;cardiac structure;Heart structure;heart structure;coronary|C0018787|||C0018787|CHV;CSP;SNOMEDCT|||1
COR|Cardiac structure (body structure)||||C0018787|SNOMEDCT|||
COR|Congo red|C0009742|||||||1
COR|HEART;Heart;Heart, NOS;Hearts;heart|C0018787;C1281570|||C0018787|AIR;AOD;CHV;CSP;FMA;HL7V2.5;LCH;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT;UWDA|||
COR|Heart structure (body structure)||||C0018787|SNOMEDCT|||
COR|body|C0242821;C0460148;C1268086|||||||1
COR|cardi(o)-||||C0018787|AOD|||
COR|cardiac output recorder||||||||1
COR|cardiovascular|C0007226|1|0.980|||||
COR|center of rotation|C2986818|||||1|0.0885|
COR|cervico-ocular reflex;cervicoocular reflex||||||1|0.2478|1
COR|coefficient of repeatability||||||1|0.0796|
COR|coefficient of reproducibility||||||||1
COR|cold-regulated||||||1|0.0796|
COR|conditioned orientation reflex||||||||1
COR|corepressor||||||||1
COR|coroner|C0010082|||||||1
COR|corrosion|C0010106;C1880183;C2919087|||C0010106;C1880183|CHV;CSP;MSH;MTH;NCI|||1
COR|corrosive|C0524525|||C0524525;C1548763;C1551398|CHV;HL7V2.5;HL7V3.0|||1
COR|cortex|C0007776;C1176472;C2700441|||C0001614;C0007776;C0595905;C1176472;C2700441|CHV;CST;FMA;NCI;UWDA|||
COR|corticosterone|C0010124|||||1|0.1858|
COR|cortisol|C0020268|||||1|0.1858|
COR|cortisone|C0010137|||C0010137|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||1
COR|phytotoxin coronatine||||||1|0.1327|
CPAP|BM032;CENPJ;CENPJ gene;CENTROMERIC PROTEIN J;CENTROSOMAL P4.1-ASSOCIATED PROTEIN;SASS4;Sas-4;centromere protein J|C1424863|||C1424863|HUGO;MTH;OMIM|||
CPAP|CPAP|C0199451;C1424863|||C0199451;C1424863|CHV;CSP;HUGO;MTHICD9;OMIM|||
CPAP|CPAP (continuous positive airway pressure);CPAP - Continuous positive airways pressure;continuous positive airway pressure (CPAP);CPAP Ventilation;Ventilation, CPAP;cpap ventilation;CPAP treatment;cpap treatment;Continuous CPAP;Continuous Positive Airway Pressure;Continuous positive airways pressure;Pressure.continuous positive airway;continuous positive airway pressure;Continuous positive airway pressure ventilation treatment|C0199451|||C0199451|CHV;CSP;LNC;MSH;MTH;SNOMEDCT|1|0.996|
CPAP|CPAP - Continuous positive airways pressure therapy||||C0199451|SNOMEDCT|||
CPAP|Continuous CPAP (procedure)||||C0199451|SNOMEDCT|||
CPAP|Continuous CPAP (regime/therapy)||||C0199451|SNOMEDCT|||
CPAP|Continuous positive airway pressure breathing||||||1|0.004|
CPAP|Continuous positive airway pressure ventilation treatment (procedure)||||C0199451|SNOMEDCT|||
CPAP|Continuous positive airway pressure ventilation treatment (regime/therapy)||||C0199451|SNOMEDCT|||
CPAP|Continuous positive airways pressure (observable entity)||||C0199451|SNOMEDCT|||
CPAP|Continuous positive airways pressure therapy||||C0199451|SNOMEDCT|||
CPAP|LAP||||C1424863|HUGO|||
CPAP|LIP1|C1418785;C1424863;C1426073|||C1424863|HUGO|||
CPAP|constant positive airway pressure||1|1.000|||||1
CPK|ADP Phosphocreatine Phosphotransferase;Phosphocreatine Phosphotransferase, ADP;Phosphotransferase, ADP Phosphocreatine;ATP Creatine Phosphotransferase;Creatine Phosphotransferase, ATP;Phosphotransferase, ATP Creatine;CK - Creatine kinase;creatine kinase (CK);CPK - Creatine phosphokinase;creatine phosphokinase (CPK);Creatine Kinase;Creatine kinase;Kinase, Creatine;creatine kinase;Creatine Kinase-B;Creatine Kinase-B Chain;Creatine Phosphokinase;Creatine phosphokinase;Phosphokinase, Creatine;creatine phosphokinase;creatinephosphokinase|C0010287|1|1|C0010287;C0750863|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.9624|1
CPK|ATP:creatine N-phosphotransferase||||C0010287|MSH;NDFRT|||
CPK|C2-CONTAINING PHOSPHATIDYLINOSITOL KINASE;PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA;PI3K-C2alpha;PIK3C2A;PIK3C2A gene|C1418571|||C1418571|HUGO;MTH;OMIM|||
CPK|CKB||||C0010287|NCI|||
CPK|CPK||||C0010287;C1418571|CHV;OMIM|||
CPK|Cell proliferation kinetics||||||1|0.0106|
CPK|Creatine Kinase [Chemical/Ingredient]||||C0010287|NDFRT|||
CPK|Creatine kinase (substance)||||C0010287|SNOMEDCT|||
CPK|EC 2.7.3.2||||C0010287|NCI|||
CPK|calcium-dependent protein kinase|C0054490|||C0054490|MSH|||
CPK|creatine phosphate kinase||||||1|0.0106|
CPK|phosphoinositide-3-kinase, class 2, alpha polypeptide|C1310696;C1418571|||C1418571|HUGO|||
CPK|phosphokinase activity|C2266365|||||1|0.0164|
CPM|(-)-Cyclophosphamide;CYCLOPHOSPHAMIDE;Cyclophosphamide;cyclophosphamide;CYT;cyt;cyts;Ciclofosfamida;Ciclofosfamide;Claphene;Cyclophospham;Cyclophosphamidum;Cyclophosphan;Cyclophosphane;cyclophosphane;Cyclophosphanum;Cytophosphan;Cytophosphane;Mitoxan;Syklofosfamid;Zytoxan|C0010583|||C0010583|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.2597|
CPM|2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide;N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-Oxide||||C0010583|MSH;NDFRT;PDQ|||
CPM|2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide||||C0010583|PDQ|||
CPM|CARBOXYPEPTIDASE M;Carboxypeptidase M;carboxypeptidase M|C0054762;C1413672|||C1413672|HUGO;OMIM|1|0.0276|
CPM|CPM;cpm||||C0010583;C0392412;C1413672;C1705768;C2348028|HUGO;NCI;OMIM;PDQ;SNOMEDCT|||
CPM|CPM gene|C1413672|||C1413672|HUGO;MTH|||
CPM|CTX|C0293227|||C0010583|NCI;PDQ;SNOMEDCT|||
CPM|Cefpiramide|C0055010|||||1|0.0763|
CPM|Clinical Practice Model||||||||1
CPM|Colored Progressive Matrices||||||||1
CPM|Continuous Passive Motion;continuous passive motion||1|1|||1|0.1656|1
CPM|Contralateral Prophylactic Mastectomy|C1705768|||C1705768|MTH;NCI|||
CPM|Count per Minute;Counts per minute;count per minute;counts per minute;Counts per minute (cpm)|C0392412|||C0392412|CHV;MTH;NCI;SNOMEDCT|1|0.1396|1
CPM|Count/Minute||||C0392412|NCI|||
CPM|Cycle per Minute;cycle per minute|C2348028|||C2348028|MTH;NCI|||1
CPM|Cycle/min;cycle/min||||C2348028|NCI|||
CPM|Cyclophosphamide (product)||||C0010583|SNOMEDCT|||
CPM|Cyclophosphamide (substance)||||C0010583|SNOMEDCT|||
CPM|Cyclophosphamide [Chemical/Ingredient]||||C0010583|NDFRT|||
CPM|cancer pain management|C0392921|||||||1
CPM|central pontine myelinolysis|C0206083|||||1|0.1867|1
CPM|chlorpheniramine maleate|C0546857|||||1|0.0487|
CPM|chronic progressive myelopathy||||||||1
CPM|cognitive-perceptual-motor||||||||1
CPM|confined placental mosaicism||||||1|0.0763|1
CPM|continue present management||||||||1
CPM|cpm (qualifier value)||||C0392412|SNOMEDCT|||
CPM|critical path method||||||1|0.013|
CPM|percentage of normal 2-4 cycles/min||||||1|0.0065|
CPR|C-peptide immunoreactivity||||||1|0.0289|
CPR|C-peptide reactivity||||||1|0.0054|
CPR|CARDIO PULM RESUSCITATION;CARDIOPULM RESUSCITATION||||C0007203|MSH|||
CPR|CPR;CPR (cardiopulmonary resuscitation);CPR - Cardiopulmonary resuscitation;cardiopulmonary resuscitation (CPR);Cardio Pulmonary Resuscitation;Cardio-Pulmonary Resuscitation;Cardiopulmonary Resuscitation;Cardiopulmonary resuscitation;Cardiopulmonary resuscitation, NOS;Resuscitation, Cardio-Pulmonary;Resuscitation, Cardiopulmonary;cardio-pulmonary resuscitation;cardiopulmonary resuscitation;Cardiopulmonary resuscitation, not otherwise specified;heart resuscitation|C0007203|1|0.994|C0007203|AOD;CHV;CSP;ICD9CM;MEDLINEPLUS;MSH;SNOMEDCT|1|0.8239|1
CPR|Cardiopulm resuscita NOS||||C0007203|ICD9CM|||
CPR|Cardiopulmonary resuscitation (& closed cardiac massage & ventilation)||||C0007203|SNOMEDCT|||
CPR|Cardiopulmonary resuscitation (& closed cardiac massage & ventilation) (procedure)||||C0007203|SNOMEDCT|||
CPR|Cardiopulmonary resuscitation (procedure)||||C0007203|SNOMEDCT|||
CPR|Closed cardiac massage+ventil.||||C0007203|SNOMEDCT|||
CPR|Computerized Patient Record|C0600372|||||1|0.0102|
CPR|P450 reductase||||||1|0.0278|
CPR|carboxypeptidase R|C0255161|||||1|0.0043|
CPR|cardiac and pulmonary rehabilitation||||||||1
CPR|cardiopulmonary reserve||||||||1
CPR|cefpirome|C0062986|||||1|0.0214|
CPR|cefpirome sulfate|C0771341|||||1|0.0054|
CPR|centripetal rub||||||||1
CPR|cerebral cortex perfusion rate||||||||1
CPR|chicken progesterone receptor||||||1|0.0075|
CPR|chlorophenyl red||||||||1
CPR|clinical partial response||||||||1
CPR|clinical pregnancy rate||||||1|0.0037|
CPR|cochleopalpebral reflex|C0450273|||||||1
CPR|computer-based patient record||||||1|0.0273|1
CPR|contraceptive prevalence rate||||||1|0.0139|
CPR|cortisol production rate||||||1|0.0043|1
CPR|cumulative potency rate||||||||1
CPR|cumulative pregnancy rate||||||1|0.0048|
CPR|curved multiplanar reformation||||||||1
CPR|customary, prevailing, and reasonable||||||||1
CPR|cytochrome P450 oxidoreductase|C1335232|||||1|0.0032|
CPR|response|C0871261;C1704632;C1706817;C2911692|||||1|0.008|
CRP|C Reactive Protein;C reactive protein;C-Reactive Protein;C-reactive protein;Protein, C-Reactive;c reactive protein;c reactive proteins;CRP - C-reactive protein;c-reactive protein (CRP)|C0006560;C0201657;C1879974|1|1|C0006560;C0201657;C1879974|CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.9835|1
CRP|C reactive protein (substance)||||C0006560|SNOMEDCT|||
CRP|C-REACTIVE PROTEIN, PENTRAXIN-RELATED;C-reactive protein, pentraxin-related;C-Reactive Protein, Pentraxin-Related Gene;CRP Gene;CRP gene;PENTRAXIN 1, SHORT;pentraxin 1|C1413716|||C1413716|HUGO;MTH;NCI;OMIM|||
CRP|C-Reactive Protein Gene;C-Reactive Protein, Pentraxin-Related wt Allele;CRP wt Allele;MGC88244|C1879974|||C1879974|MTH;NCI|||
CRP|C-Reactive Protein Measurement;C-reactive protein measurement;CRP - C-reactive protein level|C0201657|||C0201657|MTH;NCI;SNOMEDCT|||
CRP|C-Reactive Protein [Chemical/Ingredient]||||C0006560|NDFRT|||
CRP|C-Reactive Protein [Precursor]|C0006560|||C0006560|NCI|||
CRP|C-reactive protein level|C0201657;C0428528|||C0201657|SNOMEDCT|||
CRP|C-reactive protein measurement (procedure)||||C0201657|SNOMEDCT|||
CRP|CRP||||C0006560;C0201657;C1413716;C1413766;C1826658;C1879974|CHV;HUGO;NCI;OMIM;SNOMEDCT|||
CRP|CRP1||||C1413766|OMIM|||
CRP|CSRP||||C1413766|HUGO;OMIM|||
CRP|CSRP1;CSRP1 gene;CYSTEINE-RICH PROTEIN 1;D1S181E|C1413766|||C1413766|HUGO;MTH;OMIM|||
CRP|CYSTEINE- AND GLYCINE-RICH PROTEIN 1;cysteine and glycine-rich protein 1||||C1413766|HUGO;OMIM|||
CRP|CYSTEINE-RICH PROTEIN|C0599731;C1413766;C1420342|||C1413766|OMIM|||
CRP|Canalith Repositioning Procedure;canalith repositioning procedure||||||1|0.0025|1
CRP|PPIAP10;PPIAP10 gene|C1826658|||C1826658|HUGO;MTH|||
CRP|PTX1||||C1413716;C1879974|HUGO;NCI;OMIM|||
CRP|Proteins, specific or class, C-reactive||||C0006560|MSH;NDFRT|||
CRP|c-reactive protein (CRP) test|C0850970|||C0201657|CHV|||
CRP|cardiac rehabilitation program||||||1|0.0021|
CRP|chronic recurrent parotitis||||||||1
CRP|chronic relapsing pancreatitis||||||||1
CRP|collagen-related peptide||||||1|0.0075|
CRP|colorectal polyps|C0949059|||||||1
CRP|confluent and reticulate papillomatosis;confluent and reticulated papillomatosis;confluent reticulated papillomatosis|C0263385|||C0263385|MTHICD9;SNOMEDCT|1|0.0025|1
CRP|corneal reflection pupillometer||||||||1
CRP|corneal-retinal potential||||||||1
CRP|coronary rehabilitation program||||||||1
CRP|creatine phosphate|C0031634|||||||1
CRP|cross-reacting protein||||||||1
CRP|cyclic adenosine monophosphate receptor protein||||||||1
CRP|cyclophillin related pseudogene||||C1826658|HUGO|||
CRP|peptidylprolyl isomerase A (cyclophilin A) pseudogene 10||||C1826658|HUGO|||
CRP|platelet recovery||||||1|0.0019|
CR|C-reactive||1|0.002|||||
CR|CD55||||C1824670|HUGO;OMIM|||
CR|CD55 ANTIGEN;DAF|C0108793;C1824670|||C1824670|OMIM|||
CR|CD55 gene;DECAY-ACCELERATING FACTOR FOR COMPLEMENT|C1824670|||C1824670|HUGO;MTH;OMIM|||
CR|CD55 molecule, decay accelerating factor for complement (Cromer blood group)||||C1824670|HUGO|||
CR|CHROMIUM;Chromium;Chromium, NOS;chromium|C0008574;C1445745;C2348261|||C0008574;C1445745;C2348261|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||1
CR|COSTA RICA;Costa Rica;costa rica|C0010182|||C0010182|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
CR|CR;Cr||||C0008574;C0010182;C0677874;C1420667;C1707506;C1824670;C2348261|HUGO;LNC;NCI|||
CR|CRGF;CRIPTO GROWTH FACTOR;Cripto-1;TDGF1;TDGF1 gene|C1420667|||C1420667|HUGO;MTH;OMIM|||
CR|CRI|C0010182;C1704519|||C0010182|NCI|||
CR|CRIPTO|C1332788;C1420667;C1705780|||C1420667|HUGO|||
CR|CROM|C1292305;C1824670|||C1824670|HUGO|||
CR|CS|C2987276|||C0010182|NCI|||
CR|Cajal-Retzius||||||1|0.0065|
CR|Caloric restriction|C1135809|||||1|0.0289|
CR|Calreticulin|C0054543;C1413096|||||1|0.0021|
CR|Cardiac Rehabilitation;cardiac rehabilitation|C0700431|||||1|0.0128|1
CR|Charles River||||||1|0.0015|
CR|Chromium (substance)||||C0008574|SNOMEDCT|||
CR|Chromium [Chemical/Ingredient]||||C0008574|NDFRT|||
CR|Complete Remission;In complete remission;complete remission;Complete response;complete response;Pathological Complete Remission;full remission|C0677874|1|0.032|C0677874|AOD;CHV;MTH;NCI;SNOMEDCT|1|0.7071|1
CR|Congo red|C0009742|||||1|0.0059|1
CR|Controlled Release;controlled release;controlled-release|C0868939;C1707506|1|0.906|C1707506|NCI|1|0.0252|1
CR|Controlled Release Dosage Form;Controlled Release Dose Form|C1707506|||C1707506|MTH;NCI|||
CR|Costa Rica (geographic location)||||C0010182|SNOMEDCT|||
CR|Cr - Chromium;Cr element|C0008574|||C0008574|CSP;SNOMEDCT|||
CR|Cryptococcus|C0010415|||||||1
CR|Czech Republic|C0206578|||||1|0.003|
CR|Dietary Chromium|C2348261|||C2348261|MTH;NCI|||
CR|In complete remission (qualifier value)||||C0677874|SNOMEDCT|||
CR|NATO code for dibenz(b,f)-1:4-oxazepine||||||||1
CR|TC|C0041405;C1824670|||C1824670|HUGO;LNC|||
CR|TERATOCARCINOMA-DERIVED GROWTH FACTOR 1;teratocarcinoma-derived growth factor 1||||C1420667|HUGO;OMIM|||
CR|achieved complete remission||||||1|0.001|
CR|calcification rate||||||||1
CR|calcium-binding protein calretinin||||||1|0.0023|
CR|calorie restricted;calorie-restricted||||||1|0.0017|1
CR|calorie restriction||||||1|0.0107|
CR|capillary refill|C0425716|||||||1
CR|capture-recapture||||||1|0.0014|
CR|carbonyl reductase|C1413154|||||1|0.0031|
CR|cardiac resuscitation|C2981152|||C2981152|CHV;LCH;SNOMEDCT|||1
CR|cardiac rhythm|C0232187|||C0232187|CHV;NCI;SNOMEDCT|||1
CR|cardiac rupture|C0018813|||||1|0.001|
CR|cardiorespiratory||1|0.056|||1|0.0014|1
CR|cardiorrhexis||||||||1
CR|caries resistant;caries-resistant||||||1|0.0017|1
CR|cartilage residue||||||||1
CR|case report|C0007320;C0085973|||||||1
CR|cathode ray|C0007443|||C0007443|CHV;MSH|||1
CR|center of rotation|C2986818|||||||1
CR|central ray||||||||1
CR|centric relation|C0007702|||C0007702|CHV;MSH|1|0.0039|1
CR|charge recombination||||||1|0.0013|
CR|chemoradiation|C0436307;C1559154|||C0436307;C1559154|NCI|||1
CR|chest and right arm||||||||1
CR|chest roentgenogram||||||||1
CR|chest roentgenograph||||||||1
CR|chest roentgenography||||||||1
CR|child-resistant||||||||1
CR|choice reaction||||||||1
CR|chorioretinal||||||||1
CR|chronic rejection||||||1|0.0135|1
CR|circadian rhythm|C0008810;C1522723|||||1|0.0041|
CR|clinical record||||||||1
CR|clinical research|C0008972|||C0008972|AOD;CHV;CSP;MSH;MTH;NCI|||1
CR|closed reduction||1|0.002|||||1
CR|clot retraction|C0009069;C0368983|||C0009069;C0368983|AOD;CHV;CSP;MSH;MTH|||1
CR|cockroach|C0009208;C0600185|||||1|0.0018|
CR|coefficient of repeatability||||||1|0.0014|
CR|coefficient retention||||||||1
CR|cognitive reserve|C2936352|||||1|0.001|
CR|colon resection||||||||1
CR|colonization resistance||||||1|0.0028|
CR|colony-reared||||||||1
CR|colorectal|C0555952|||C0555952|CHV;NCI;SNOMEDCT|||1
CR|complement receptor|C0034793|||C0034793|CSP;MSH;MTH;NDFRT;SNOMEDCT|1|0.0094|1
CR|complete|C0205197;C0725685|||||1|0.0182|
CR|complete regression||||||1|0.0037|
CR|complete remission rate||||||1|0.002|
CR|complete responder;complete responders||||||1|0.0063|1
CR|complete response rate||||||1|0.0027|
CR|completely||||||1|0.0013|
CR|composite resin|C0009570|||||1|0.0011|
CR|compression ratio||||||1|0.0018|
CR|computed radiographic||||||1|0.0014|
CR|computed radiography|C1547104|||C1547104|HL7V2.5|1|0.0311|1
CR|concentration ratios||||||1|0.0032|
CR|concentration-response||||||1|0.002|
CR|conditioned reflex|C0034936|||C0034936|AOD;CHV;MSH;MTH;SNOMEDCT|1|0.0048|1
CR|conditioned reinforcement||||||1|0.001|
CR|conditioned response|C0009647;C0034936|||C0009647;C0034936|AOD;CHV;NCI;SNOMEDCT|||1
CR|conditioned reward||||||1|0.0014|
CR|congenital rubella|C0035921|||||||1
CR|conserved region||||||1|0.0028|
CR|constant routine||||||1|0.0011|
CR|contact record||||||||1
CR|continuous reinforcement||||||||1
CR|contractile reserve||||||1|0.0015|
CR|control rats||||||1|0.0015|
CR|control region||||||1|0.0058|
CR|controlled respiration||||||||1
CR|controlled response||||||||1
CR|conventional radiology||||||1|0.0011|
CR|conversion rate||||||||1
CR|conversion reaction|C0009946|||||||1
CR|cooling rate||||||||1
CR|corneal reflex|C0520451|||||||1
CR|coronary resistance||||||1|0.0013|
CR|coronary revascularization|C0877341|||||1|0.0007|
CR|coronary risk||||||1|0.0011|
CR|correct response||||||||1
CR|correlation|C1707520|||||||1
CR|cortical reaction||||||1|0.0008|
CR|corticoresistant||||||||1
CR|corticosteroid-resistant||||||1|0.0013|
CR|cranial|C0037303;C3163632|||||||1
CR|cranium|C0037303;C1279062|||||||1
CR|creamed|C0700385|||||||1
CR|creatine and phosphocreatine||||||1|0.0031|
CR|creatinine|C0010294;C1561535|1|0.002|C0010294;C0201975;C1561535|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|||1
CR|cremaster ratio||||||||1
CR|cremasteric reflex|C0234176|||C0234176|SNOMEDCT|||
CR|cresyl red||||||||1
CR|critical ratio||||||||1
CR|cross-reactive||||||1|0.0013|
CR|crown|C0010384;C0226993;C1185616;C2700388|||||||1
CR|crown-rump||||||1|0.0035|1
CR|crutches|C0010397|||||||1
CR|cycloplegic refraction|C0855713|||||||1
CR|cysteine-rich||||||1|0.0014|
CR|energy cost of running||||||1|0.0014|
CR|pCR|C0032520;C0677874|||C0677874|NCI|||
CR|rates||||||1|0.0027|
CR|reactivity||||||1|0.0021|
CR|remodeling||||||1|0.0013|
CR|resistant|C0332325;C2827757|||||1|0.0023|
CR|rotation|C0035868;C0677597|||||1|0.0018|
CR|serum creatinine|C0201976;C0600061|||||1|0.0206|
CR|serum creatinine concentration||||||1|0.0011|
CSA|4-chloro-5-sulfamoylanthranilic acid|C0048170|||C0048170|MSH|||
CSA|CHORIONIC SOMATOMAMMOTROPIN A;chorionic somatomammotropin A||||C1413752|HUGO;OMIM|||
CSA|CHORIONIC SOMATOMAMMOTROPIN HORMONE 1;CSH1;CSH1 gene;CSMT;FLJ75407|C1413752|||C1413752|HUGO;MTH;OMIM|||
CSA|CKN1;COCKAYNE SYNDROME, TYPE A;Cockayne Syndrome, Type A;Type A Cockayne Syndrome;Cockayne Syndrome, Group A;Group A Cockayne Syndrome;Cockayne Syndrome, Type I;Type I Cockayne Syndrome|C0751039|||C0751039|MSH;MTH;OMIM|||
CSA|CKN1 GENE;CSA GENE;ERCC8;ERCC8 gene;EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8;excision repair cross-complementing rodent repair deficiency, complementation group 8|C1414440|||C1414440|HUGO;MTH;OMIM|||
CSA|CSA;CsA||||C0010592;C0751039;C1413752;C1414440|HUGO;NCI;OMIM;PDQ|||
CSA|CSA - Cyclosporin A;CYA - Cyclosporin;CYA - Cyclosporin A;CYSP;Ciclosporin product;Cyclosporin product;Cyclosporine (product);Cyclosporin A;Cyclosporine A;cyclosporin A;cyclosporin a;cyclosporin-A;cyclosporine a;cyclosporine-A|C0010592|1|0.996|C0010592|CHV;CSP;LCH;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0458|
CSA|CYCLOSPORINE;Ciclosporin;Cyclosporin;Cyclosporine;ciclosporin;ciclosporins;cycloSPORINE;cyclosporin;cyclosporine|C0010592;C0010594|||C0010592|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;SPN;USPMG;VANDF|1|0.507|
CSA|Canadian Standards Association||||||1|0.0028|
CSA|Central sleep apnoea;central sleep apnea|C0520680|||C0520680|CHV;MSH;NDFRT;SNOMEDCT|1|0.0123|1
CSA|Ciclosporin - chemical;Cyclosporin - chemical||||C0010592|SNOMEDCT|||
CSA|Cognitive Skills Assessment||||||||1
CSA|Controlled Substances Act||||||1|0.004|1
CSA|Cyclosporin - chemical (substance)||||C0010592|SNOMEDCT|||
CSA|Cyclosporine (substance)||||C0010592|SNOMEDCT|||
CSA|Cyclosporine [Chemical/Ingredient]||||C0010592|NDFRT|||
CSA|LACTOGEN, PLACENTAL;placental lactogen|C1314785;C1413752;C1413753|||C1413752|HUGO;OMIM|||
CSA|PL||||C1413752|HUGO;OMIM|||
CSA|analysis|C0002778;C0936012;C1524024|||||1|0.0068|
CSA|canavaninosuccinic acid|C0054576|||C0054576|MSH|||1
CSA|catalyzed signal amplification||||||1|0.0052|
CSA|cell surface antigen;cell surface antigens|C0003339|||C0003339;C1325289|CHV;GO;MSH;NCI;NDFRT|1|0.0012|
CSA|certified surgical assistant||1|0.002|||||
CSA|chemical shift anisotropy||||||1|0.016|
CSA|chicken serum albumin||||||1|0.0046|
CSA|childhood sexual abuse||||||1|0.0387|
CSA|chondroitin sulfate A;chondroitin-4-sulfate|C0086008|||||1|0.0034|1
CSA|choriomammotropin|C1314785;C1413752|||C1413752|HUGO|||
CSA|chorionic somatomammotropin hormone 1 (placental lactogen)||||C1413752|HUGO|||
CSA|chronic stable angina|C0699826|||C0699826|CHV;MSH;MTH|1|0.0037|
CSA|clinical skills assessment||||||1|0.004|
CSA|clinically significant arrhythmia||||||||1
CSA|colon-specific antigen|C0056132|||C0056132|MSH|1|0.0021|1
CSA|colony-stimulating activity||||||1|0.105|1
CSA|compressed spectral array|C0443187|||C0443187|SNOMEDCT|1|0.0068|
CSA|compressed spectral assay||||||||1
CSA|computer science and applications||||||1|0.0018|
CSA|conformational space annealing||||||1|0.0034|
CSA|continuous spinal anaesthesia;continuous spinal anesthesia||||||1|0.0086|
CSA|controlled substance analog||||||||1
CSA|coronary spastic angina||||||1|0.0061|
CSA|corticosteroid sensitive asthma||||||||1
CSA|cross-sectional area||||||1|0.2061|1
CSA|cysteine sulfinic acid|C0056878|||||1|0.0046|
CSA|hCS-A||||C1413752|HUGO|||
CSF|CEREBROSPINAL FLUID;Cerebrospinal Fluid;Cerebrospinal Fluids;Cerebrospinal fluid;Cerebrospinal fluid, NOS;Fluid, Cerebrospinal;Fluids, Cerebrospinal;In Cerebrospinal Fluid;cerebrospinal fluid;CSF - Cerebrospinal fluid;cerebrospinal fluid (CSF)|C0007806;C0007807|1|1|C0007806;C0007807|AOD;CHV;CSP;FMA;LCH;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.9145|1
CSF|CF||||C0007807|MSH|||
CSF|CSF||||C0007806;C0007807;C0009392;C0079460;C0376561|CHV;CSP;FMA;LNC;MSH;NCI;UWDA|||
CSF|CSF Recombinant||||C0376561|NDFRT|||
CSF|CSF-2|C0079460;C1150621|||C0079460|MSH;NDFRT|||
CSF|CSF-GM;GM CSF;GM-CSF;GMCSF;gm csf;gm-csf;gmcsf|C0079460;C0376563;C2825896|||C0079460|CHV;CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
CSF|CSF2;Colony Stimulating Factor 2;Colony-stimulating factor 2|C0079460;C1332791|||C0079460|MSH;NCI;NDFRT|||
CSF|Cell-Growth Inducer, Myeloid;Inducer, Myeloid Cell-Growth;Myeloid Cell Growth Inducer;Myeloid Cell-Growth Inducer;Colony stimulating factor preparation;MGI 1 Protein;MGI-1 Protein;MGI-1|C0009392|||C0009392|MSH;NCI;NDFRT;SNOMEDCT|||
CSF|Cell-Stimulating Factor, Histamine-Producing;Histamine Producing Cell Stimulating Factor;Histamine-Producing Cell-Stimulating Factor;histamine producing cell stimulating factor;TC-GM-CSF;Tumor Cell Human GM Colony Stimulating Factor;Tumor-Cell Human GM Colony-Stimulating Factor;gm-cfs|C0079460|||C0079460|CHV;CSP;MSH;NDFRT|||
CSF|Cerebral Spinal Fluid;Cerebral spinal fluid;Liquor cerebrospinalis;Spinal Fluid;Spinal fluid;spinal fluid|C0007806|||C0007806|CSP;CST;FMA;HL7V2.5;LNC;NCI;SNOMEDCT|||
CSF|Cerebrospinal fluid (substance)||||C0007806|SNOMEDCT|||
CSF|Colony Stimulating Factor;Colony Stimulating Factors;Colony stimulating factor;Colony stimulating factors;Colony-Stimulating Factor;Colony-Stimulating Factors;Colony-stimulating factor;Colony-stimulating factor, NOS;colony stimulating factor;colony stimulating factors;colony-stimulating factor;colony-stimulating factor(s);colony-stimulating factors;colony stimulating factor (CSF)|C0009392;C0079460|||C0009392;C0079460|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.057|1
CSF|Colony Stimulating Factor, Granulocyte Macrophage;Colony Stimulating Factor, Granulocyte-Macrophage;Colony-Stimulating Factor, Granulocyte-Macrophage;Colony-stimulating factor, granulocyte-macrophage;Granulocyte Macrophage Colony Stimulating Factor;Granulocyte Macrophage Colony-Stimulating Factor;Granulocyte macrophage colony stimulating factor;Granulocyte-Macrophage Colony Stimulating Factor;Granulocyte-Macrophage Colony-Stimulating Factor;granulocyte macrophage colony stimulating factor;granulocyte macrophage colony-stimulating factor;granulocyte-macrophage colony stimulating factor;granulocyte-macrophage colony-stimulating factor|C0079460;C0376563;C1149401;C1332791|||C0079460|CSP;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|||
CSF|Colony stimulating factor (substance);Colony-stimulating factor (substance)||||C0009392|SNOMEDCT|||
CSF|Colony stimulating factor preparation (product)||||C0009392|SNOMEDCT|||
CSF|Colony stimulating factor preparation (substance)||||C0009392|SNOMEDCT|||
CSF|Colony-Stimulating Factors [Chemical/Ingredient]||||C0009392|NDFRT|||
CSF|Colony-Stimulating Factors, Recombinant;Recombinant Colony Stimulating Factor;Recombinant Colony-Stimulating Factors;Recombinant Hematopoietic Colony-stimulating Factor|C0376561|||C0376561|MTH;NCI;NDFRT|||
CSF|Colony-Stimulating Factors, Recombinant [Chemical/Ingredient]||||C0376561|NDFRT|||
CSF|Colony-stimulating factor, granulocyte-macrophage (substance)||||C0079460|SNOMEDCT|||
CSF|GMCSF (granulocyte macrophage colony stimulating factor)||||C0079460|CSP|||
CSF|GRANULOCYTE MACROPHAGE COLONY A STIMULATING FACTOR||||C0079460|MSH|||
CSF|Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient]||||C0079460|NDFRT|||
CSF|Spinal fluid (substance)||||C0007806|SNOMEDCT|||
CSF|cancer family syndrome|C2931592|||C2931592|MSH|||1
CSF|cerebrospinal||||||1|0.0027|
CSF|cerebrospinal fluid samples||||||1|0.0007|
CSF|circumferential shortening fraction||||||||1
CSF|classical swine fever|C0019841|||||1|0.0109|
CSF|contoured femoral stem||||||||1
CSF|contrast sensitivity function||||||1|0.0073|
CSF|coronary sinus blood flow||||||1|0.001|
CSF|coronary sinus flow||||||1|0.0013|1
CSF|cytostatic factor|C0072454|||||1|0.0045|
CTA|CT angiography;computed tomography angiography|C1536105|||C1536105|SNOMEDCT|1|0.2805|
CTA|CT during arteriography||||||1|0.0012|
CTA|CT hepatic arteriography||||||1|0.007|
CTA|Cell Transit Analyzer||||||1|0.0117|
CTA|Computed tomographic arteriography||||||1|0.0153|
CTA|Computed tomographic arthrography||||||1|0.0059|
CTA|antigens|C0003320|||||1|0.0129|
CTA|cellulose triacetate|C0055048|||||1|0.0317|
CTA|chemotactic activity||||||||1
CTA|chemotherapeutic agent|C0003392;C0729502|||C0003392;C0729502|CHV;MTH;NCI;SNOMEDCT|||
CTA|chromotropic acid|C0055644|||||||1
CTA|clear to auscultation||1|0.792|||||1
CTA|composite tissue allograft||||||1|0.0106|
CTA|computed tomographic angiographic||||||1|0.007|
CTA|computed tomographic angiography||1|0.200|||1|0.1315|1
CTA|computed tomography of abdomen|C0412620|||||||1
CTA|conditioned taste aversion|C0815105|||C0815105|AOD;CHV;GO|1|0.4472|
CTA|conditioned taste avoidance||||||1|0.0094|
CTA|congenital trigeminal anesthesia||||||||1
CTA|cortical taste area||||||1|0.0129|
CTA|cuff tear arthropathy||||||||1
CTA|cystine trypticase agar||||||||1
CTA|cytoplasmic tubular aggregate||||||||1
CTA|cytotoxic activity||||||1|0.0094|
CTA|cytotoxic assay||||||||1
CTA|menses|C0025344;C0559892|||||||1
CTA|task analysis|C0556033|||||1|0.0059|
CT|BEHAVIOR THER COGNITIVE;COGNITIVE BEHAVIOR THER;THER COGNITIVE BEHAVIOR||||C0009244|MSH|||
CT|Behavior Therapies, Cognitive;Behavior Therapy, Cognitive;Cognitive - behavior therapy;Cognitive - behaviour therapy;Cognitive Behavior Therapies;Cognitive Behavior Therapy;Cognitive-behaviour therapy;Therapies, Cognitive Behavior;Therapy, Cognitive Behavior;behaviour cognitive therapy;cognitive behavior therapy;cognitive behaviour therapy;therapy behavior cognitive;CBT - Cognitive - behavior therapy;CBT - Cognitive - behaviour therapy;Cognition Therapies;Cognition Therapy;Therapies, Cognition;Therapy, Cognition;Cognitive Psychotherapies;Cognitive Psychotherapy;Psychotherapies, Cognitive;Psychotherapy - cognitive;Psychotherapy, Cognitive;cognitive psychotherapy;Cognitive Therapies;Cognitive Therapy;Cognitive therapy;Therapies, Cognitive;Therapy, Cognitive;cognitive therapies;cognitive therapy;therapy cognitive;Cognitive and behavioral therapy;Cognitive and behavioural therapy;behavioral cognitive therapy;cognitive and behavioral therapy;cognitive behavioral therapy;cognitive behavioural therapy;Cognitive approach;Cognitive therapy approach;Cognitive-behavioral therapy approach;Cognitive-behavioural therapy approach;cognitive behavior modification|C0009244|||C0009244|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.0027|1
CT|C-terminal|C1707271|||||1|0.0004|
CT|C.A.T. scan NOS;c a t scan;c.a.t. scan;CAT - Computerised axial tomography;CAT - Computerized axial tomography;CAT Scan, X Ray;CAT Scan, X-Ray;CAT Scans, X-Ray;Scan, X-Ray CAT;Scans, X-Ray CAT;X-Ray CAT Scan;X-Ray CAT Scans;CAT scan - NOS (procedure);cat procedure scan;cat scan procedure;CT - Computerised tomography;CT - Computerized tomography;CT Scan, X Ray;CT Scan, X-Ray;CT Scans, X-Ray;Scan, X-Ray CT;Scans, X-Ray CT;X-Ray CT Scan;X-Ray CT Scans;CT X Ray;CT X Rays;CT XRAY;X Ray, CT;X Rays, CT;CT scan without IV contrast;Computed Tomography, Transmission;Tomography, Transmission Computed;Transmission Computed Tomography;Computed Tomography, X Ray;Computed Tomography, X-Ray;Computed Tomography, Xray;Computed X Ray Tomography;Computed X-Ray Tomography;Tomographies, Computed X-Ray;Tomography, Computed X-Ray;Tomography, X Ray Computed;Tomography, X-Ray Computed;Tomography, Xray Computed;X Ray Tomography, Computed;X-Ray Computed Tomography;X-Ray Tomography, Computed;Xray Computed Tomography;computed tomography x rays;computed x-ray tomography;x-ray computed tomography;Computed axial tomography;computed axial tomography;Computerised axial tomography;Computerized Axial Tomography;Computerized axial tomography;Computerized axial tomography, NOS;computerized axial tomography;Computerised tomograph scan;Computerized tomograph scan;Computerised tomography;Computerized Tomography;Computerized tomography;computerised tomography;computerized tomography;Computerised transaxial tomography;Computerized transaxial tomography;Computerized transaxial tomography, NOS;Computerized Tomography, X Ray;Computerized Tomography, X-Ray;Tomography, X Ray Computerized;Tomography, X-Ray Computerized;X Ray Computerized Tomography;X-Ray Computerized Tomography;Computerized tomography without IV contrast;Computerized transaxial tomography without IV contrast;Tomodensitometry;tomodensitometry;Tomography, X Ray Computer Assisted;Tomography, X-Ray Computer Assisted;X Ray Computer Assisted Tomography;X-Ray Computer Assisted Tomography;assisted computer tomography;computer assisted tomography;ctt|C0040405|||C0040405|AOD;CHV;CSP;HL7V3.0;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.0935|1
CT|CAF||||C0007673|NCI|||
CT|CALC1;CALCA|C1367551;C1705783|||C1367551;C1705783|HUGO;NCI;OMIM|||
CT|CALCA Gene;CALCA gene|C1367551|||C1367551|HUGO;MTH;NCI|||
CT|CALCA wt Allele;CGRP-I;CGRP1|C1705783|||C1705783|MTH;NCI|||
CT|CALCITONIN;calcitonin|C0006668;C0770558;C1704385;C2825090|||C0006668;C0201924;C0770558;C1367551;C1704385;C2825090|AOD;CHV;CSP;FMA;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT;VANDF|||1
CT|CALCITONIN GENE-RELATED PEPTIDE|C0006669;C1367551|||C1367551|OMIM|||
CT|CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA||||C1367551|OMIM|||
CT|CAT;catting|C0007450;C0040405;C0325089;C0325090;C0524517|||C0040405|AOD;CHV;NCI|||
CT|CAT Scan;CAT Scans;CAT scan;CAT scan - NOS;CAT scan, NOS;cat scanning;cat scans;cats scan;scan cat;CT SCAN;CT Scans;CT scan;CT scans;ct scanning;scan ct|C0040405;C1547980|||C0040405|AOD;CHV;CSP;MEDLINEPLUS;NCI;SNOMEDCT|||
CT|CBT|C0009244;C1412770|||C0009244|CSP;NCI|||
CT|CENTRAL AFRICAN REPUBLIC;Central African Republic;Ubangi-Shari|C0007673|||C0007673|AOD;LCH;MSH;MTH;NCI;SNOMEDCT|||
CT|CF||||C0007673|NCI|||
CT|CGRP||||C1367551;C1705783|NCI;OMIM|||
CT|CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE;CYTIDYLYLTRANSFERASE, CTP-PHOSPHOCHOLINE|C0311989;C1418396|||C1418396|OMIM|||
CT|COGNITION THER;THER COGNITION||||C0009244|MSH|||
CT|COGNITIVE PSYCHOTHER;PSYCHOTHER COGNITIVE||||C0009244|MSH|||
CT|COGNITIVE THER;THER COGNITIVE||||C0009244|MSH|||
CT|CONTRA||||C0079164|MSH|||
CT|CT||||C0007673;C0009244;C0009778;C0010377;C0040405;C0079164;C1367551;C1418396;C1705783|HUGO;LNC;MSH;NCI;OMIM;PDQ|||
CT|CTPCT;PCYT1;PCYT1A;PCYT1A gene;PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE;PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM;phosphate cytidylyltransferase 1, choline, alpha isoform;phosphate cytidylyltransferase 1, choline, alpha|C1418396|||C1418396|HUGO;MTH;OMIM|||
CT|Calcitonin/Calcitonin-Related Polypeptide, Alpha Gene||||C1367551|NCI|||
CT|Calcitonin/Calcitonin-Related Polypeptide, Alpha wt Allele||||C1705783|NCI|||
CT|Cardiac transplantation;cardiac transplantation|C0018823|||C0018823|CHV;MSH;NCI|1|0.0004|
CT|Catalase;catalase|C0007367;C1413138|||C0007367;C1413138|AOD;CHV;CSP;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;RXNORM;SNOMEDCT;VANDF|1|0.0004|
CT|Category Test|C0589061|||||||1
CT|Central African Republic (geographic location)||||C0007673|SNOMEDCT|||
CT|Cerebral toxoplasmosis;cerebral toxoplasmosis|C0085315|||C0085315|CHV;MSH;NDFRT;SNOMEDCT|1|0.0003|
CT|Chlamydia trachomatis|C0008151|||||1|0.0075|1
CT|Cholera enterotoxin|C0116227|||||1|0.0013|
CT|Cognitive - behavior therapy (procedure)||||C0009244|SNOMEDCT|||
CT|Cognitive - behavior therapy (regime/therapy);Cognitive - behaviour therapy (regime/therapy)||||C0009244|SNOMEDCT|||
CT|Cognitive and behavioral therapy (procedure)||||C0009244|SNOMEDCT|||
CT|Cognitive and behavioral therapy (regime/therapy)||||C0009244|SNOMEDCT|||
CT|Cognitive therapy (procedure)||||C0009244|SNOMEDCT|||
CT|Cognitive therapy (regime/therapy)||||C0009244|SNOMEDCT|||
CT|Computed Tomography;Computed tomography;computed tomography;computing tomography;tomography, computed|C0040405;C1552357|1|0.998|C0040405;C1552357|CHV;HL7V2.5;HL7V3.0;NCI;PDQ;SNOMEDCT|1|0.6452|1
CT|Computed tomographic scan;Computed tomographic scanning||||||1|0.0013|
CT|Computed tomography (procedure)||||C0040405|SNOMEDCT|||
CT|Computed tomography scan - NOS;computed tomography scan;computed tomography scanning||||C0040405|SNOMEDCT|1|0.0013|
CT|Computed tomography scan - NOS (procedure)||||C0040405|SNOMEDCT|||
CT|Computer-Tomography;computertomography||||||1|0.0007|
CT|Computerised axial tomography scan - NOS;Computerized axial tomography scan - NOS||||C0040405|SNOMEDCT|||
CT|Computerized axial tomography (procedure)||||C0040405|SNOMEDCT|||
CT|Computerized axial tomography scan - NOS (procedure)||||C0040405|SNOMEDCT|||
CT|Connecticut;connecticut|C0009778|||C0009778|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0004|
CT|Connecticut (geographic location)||||C0009778|SNOMEDCT|||
CT|Coombs test|C0009961|||||||1
CT|Crotoxin;crotoxin|C0010377|||C0010377|MSH;MTH;NCI;NDFRT;PDQ|||
CT|Crotoxin [Chemical/Ingredient]||||C0010377|NDFRT|||
CT|EMI scan;emi scan||||C0040405|CHV;CSP|||
CT|KC|C0022575;C1705783|||C1705783|NCI|||
CT|Psychotherapy - cognitive (procedure)||||C0009244|SNOMEDCT|||
CT|Psychotherapy - cognitive (regime/therapy)||||C0009244|SNOMEDCT|||
CT|TOMOGRAPHY TRANSM COMPUTED||||C0040405|MSH|||
CT|alone|C0205171;C0439044;C0679994|||||1|0.0003|
CT|alpha-chymotrypsin|C0764105|||||1|0.0005|
CT|calcitonin-related polypeptide alpha||||C1367551|HUGO|||
CT|calf tenderness|C0238883|||||||1
CT|calf testis||||||||1
CT|calf thymus||||||1|0.0017|
CT|cancer/testis|C0153594|||||1|0.0028|
CT|carbon tetrachloride|C0007022|||C0007022|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0017|
CT|carboxyl terminal;carboxyl-terminal||||||1|0.0007|1
CT|carboxyl terminus||||||1|0.0003|
CT|carcinoid tumor|C0007095|||C0007095|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
CT|cardiac tamponade|C0007177|||C0007177|AOD;CHV;COSTAR;CST;ICD9CM;LCH;MSH;NCI;NDFRT;QMR;SNOMEDCT|1|0.0004|1
CT|cardiothoracic||1|0.002|||||1
CT|carotid tracing||||||||1
CT|carpal tunnel|C0007286;C0225091;C1269543|||||||1
CT|cationic trypsinogen|C1418965|||||||1
CT|celiac trunk|C0007569|||C0007569|CHV;FMA;SNOMEDCT;UWDA|1|0.0003|
CT|cell therapy|C0302189|||||||1
CT|cellulose triacetate|C0055048|||C0055048|MSH|1|0.0003|1
CT|census tract|C1317843;C1547690|||||||1
CT|center thickness||||||||1
CT|central tendon|C0230162|||||1|0.0002|
CT|cerebral thrombosis|C0079102;C0795687|||||||1
CT|cerebral tumor|C1263885|||||||1
CT|cervical traction|C0556664|||||||1
CT|cervicothoracic|C0450195|||||||1
CT|charge transport||||||1|0.0003|
CT|charge-transfer||||||1|0.0044|
CT|chemotaxis|C0008018|||||||1
CT|chemotherapy|C0013216;C0013217;C0392920|||C0013216;C0013217;C0392920|AOD;CCS;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;NCI;PDQ;SNOMEDCT|||1
CT|chest tube|C0008034|||C0008034;C1549530;C1550230|CHV;HL7V2.5;LNC;MSH|1|0.0003|1
CT|chlamydia|C0008148|||||1|0.0003|
CT|chloramine-T|C0055332|||||1|0.0011|
CT|cholera toxin|C0008356|||C0008356|CHV;CSP;MSH;NCI;NDFRT;SNOMEDCT|1|0.0346|1
CT|cholesterol, total|C0543421;C1445957|||||||1
CT|chorda tympani|C0008483;C1269597|||C0008483;C1269597|CSP;FMA;SNOMEDCT;UWDA|1|0.0035|
CT|chorda tympani nerve|C0008483|||||1|0.0009|
CT|chordae tendineae|C0008484;C1305731|||||||1
CT|chronic thyroiditis|C0242520;C0677607;C2936918|||C0242520;C0677607|CHV;COSTAR;MTH;SNOMEDCT|||1
CT|chronic tonsillitis|C0149517|||C0149517|CHV;ICD9CM;SNOMEDCT|1|0.0004|
CT|chymotrypsin|C0008742|||C0008742|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0005|1
CT|circadian time||||||1|0.0037|
CT|circulation time||||||||1
CT|classic technique||||||||1
CT|clinical trial|C0008976;C1096775|||C0008976;C1096775;C1552009|AOD;CHV;CSP;HL7V2.5;HL7V3.0;MSH;NCI|1|0.0004|
CT|closed thoracotomy||||||||1
CT|closure time||||||1|0.001|
CT|clotting time;coagulation time|C0368930|||C0368930|CHV;LNC|||1
CT|coal tar|C0009137|||C0009137|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
CT|coated tablet|C1273642|||||||1
CT|cobra toxin||||||||1
CT|coil test||||||||1
CT|collecting tubule|C0022675;C1280366|||C0022675;C1280366|CHV;SNOMEDCT;UWDA|1|0.0005|1
CT|combined tumor||||||||1
CT|compliance|C0009563;C1321605|||||1|0.0008|
CT|compressed tablet||||||||1
CT|computed tomogram||||||1|0.0036|
CT|computed tomograph||||||1|0.0008|
CT|computed tomographic||||||1|0.1414|
CT|computed tomograpy||||||1|0.0003|
CT|computerized tomogram||||||1|0.0009|
CT|computerized tomograph||||||1|0.0003|
CT|computerized tomographic||||||1|0.0128|
CT|concentration|C0086045;C1446561|||||1|0.0006|
CT|concentration-time product||||||||1
CT|condensed tannin;condensed tannins|C0072018;C0919289|||C0072018;C0919289|MSH;NCI;NDFRT|1|0.0007|
CT|conduction time||||||1|0.0011|
CT|congenital Toxoplasmosis;congenital toxoplasmosis|C0040560|||C0040560|CHV;MSH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.0003|
CT|connective tissue|C0009780|||C0009780|AOD;CHV;CSP;FMA;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0013|1
CT|conservative treatment||||||1|0.0006|
CT|continue treatment||||||||1
CT|continuous-flow tub||||||||1
CT|contraction time||||||||1
CT|contraindications;contraindications aspect;counterindications|C0079164|||C0079164|MSH;MTH|||
CT|control|C0009932;C0243148;C1550141;C1882979;C2587213|||C0009932;C0243148;C0308718;C1547100;C1550141;C1882979;C2587213|CHV;HL7V2.5;LCH;LNC;MSH;NCI;SNOMEDCT|1|0.001|
CT|control diet||||||1|0.0004|
CT|control group|C0009932|||||1|0.0002|
CT|controlled temperature|C0449862|||||||1
CT|conventional therapy|C0087111|||C0087111|NCI|||
CT|conventional treatment|C0087111;C2945704|||C0087111;C2945704|CHV;NCI|1|0.0003|
CT|core temperature||||||1|0.0005|
CT|corneal thickness|C0429493|||C0429493|CHV;SNOMEDCT|1|0.0007|1
CT|corneal transplant|C0010042|||||||1
CT|coronary thrombosis|C0010072|||||||1
CT|corrected transposition|C0332941|||||||1
CT|correctional transfer||||||||1
CT|corrective therapy||||||||1
CT|cortical thickness||||||1|0.0003|1
CT|corticosterone|C0010124|||C0010124;C0373588|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0005|
CT|corticothalamic||||||1|0.0006|
CT|cough threshold||||||||1
CT|counseling and testing||||||1|0.0004|
CT|count|C0750480;C1705566|||||||1
CT|countertransference|C0010219|||C0010219|AOD;CHV;MSH;SNOMEDCT|||
CT|countertransport||||||1|0.0005|
CT|cover test|C0278241;C0444883|||||||1
CT|crest time||||||||1
CT|cricothyroid|C0224178|||C0224178|CHV;FMA;UWDA|1|0.002|
CT|cricothyroid muscle|C0224178;C1280271|||C0224178;C1280271|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0005|
CT|crista terminalis|C0225852;C1305795|||C0225852;C1305795|FMA;SNOMEDCT;UWDA|1|0.0014|
CT|critical thinking||||||1|0.0004|
CT|crutch training||||||||1
CT|ctt scan||||C0040405|CHV|||
CT|curly tail||||||1|0.0007|
CT|cycle threshold;threshold cycle||||||1|0.0011|
CT|cystine-tellurite||||||||1
CT|cytidylyltransferase|C1333192|||C1333192|NCI|||
CT|cytoplasmic domain;cytoplasmic tail|C1511625|||C1511625|NCI|1|0.0017|
CT|cytotechnology|C1552390|||||||1
CT|cytotoxic|C0677881;C1511636|||C0677881;C1511636|MTH;NCI|||
CT|cytotoxic therapy|C0677881|||||||1
CT|cytotrophoblast|C0230960;C1281788|||C0230960;C1281788|CHV;FMA;MSH;NCI;SNOMEDCT|1|0.0007|
CT|tomography|C0040395;C0040405|||C0040405|NCI|1|0.001|
CT|training|C0040607;C0220931;C2673163|||||1|0.0008|
CT|twitch contraction time||||||1|0.0004|
CVA|ACCIDENT CEREBROVASCULAR;Accident - cerebrovascular;CEREBROVASCULAR ACCIDENT;Cerebrovascular Accident;Cerebrovascular Accidents;Cerebrovascular accident;Cerebrovascular accident, NOS;cerebrovascular accident;cerebrovascular accidents;APOPLEXY;Apoplexy;Apoplexy, NOS;apoplexy;APOPLEXY, CEREBRAL;Cerebral apoplexy;Cerebral apoplexy, NOS;Apoplexy, Cerebrovascular;Cerebrovascular Apoplexy;Brain Attack;Brain attack;Brain Vascular Accident;Brain Vascular Accidents;Vascular Accident, Brain;Vascular Accidents, Brain;vascular brain accident;CEREBRAL VASCULAR ACCIDENT;cerebral vascular accident;cerebral vascular accidents;vascular cerebral accident;CEREBROVASCULAR ACCIDENT, (CVA);CVA (Cerebrovascular Accident);CVA - Cerebrovascular accident;CVA, CEREBROVASCULAR ACCIDENT;CVAs (Cerebrovascular Accident);Cerebral Stroke;Cerebral Strokes;Stroke, Cerebral;Strokes, Cerebral;cerebral stroke;stroke cerebral;Cerebrovascular Stroke;Cerebrovascular Strokes;Stroke, Cerebrovascular;Strokes, Cerebrovascular;cerebrovascular stroke;STROKE;Stroke;Stroke NOS;Stroke, NOS;Strokes;stroke;strokes|C0038454|1|0.556|C0038454|AOD;CHV;COSTAR;CSP;CST;DXP;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8487|1
CVA|ACO||||C0054889|NCI;PDQ|||
CVA|Acute ill-defined cerebrovascular disease;Acute ill-defined cerebrovascular disease, NOS|C0001365|||C0001365|MTH;SNOMEDCT|||
CVA|Acute ill-defined cerebrovascular disease (disorder)||||C0001365|SNOMEDCT|||
CVA|Acute, but ill-defined cerebrovascular disease||||C0001365|ICD9CM|||
CVA|CAV||||C0054889|PDQ|||
CVA|CAV chemotherapy protocol;CAV protocol;VADRC;cyclophosphamide/doxorubicin/vincristine protocol|C0054889|||C0054889|CHV;MSH;MTH;NCI;PDQ|||
CVA|CDV||||C0054889|NCI;PDQ|||
CVA|CEREBRAL INFARCTION|C0007785;C0038454|||C0038454|OMIM|||
CVA|CHO||||C0054889|NCI;PDQ|||
CVA|CTX/DOX/VCR||||C0054889|NCI;PDQ|||
CVA|CVA;CVA, NOS;Cva;VA-C|C0038454;C0054889|||C0001365;C0038454;C0054889|CHV;CST;DXP;ICD9CM;NCI;PDQ;SNOMEDCT|||
CVA|CVA (cerebral vascular accident)||||C0038454|CSP|||
CVA|CVA - Cerebrovascular accident unspecified||||C0038454|SNOMEDCT|||
CVA|CVA - cerebrovascular accident (& unspecified [& stroke])||||C0038454|SNOMEDCT|||
CVA|CVA - cerebrovascular accident (& unspecified [& stroke]) (disorder)||||C0038454|SNOMEDCT|||
CVA|CVA unspecified||||C0038454|SNOMEDCT|||
CVA|Cerebrovascular accident (disorder)||||C0038454|SNOMEDCT|||
CVA|Cerebrovascular accident (disorder) [Ambiguous]||||C0038454|SNOMEDCT|||
CVA|Clavulanic acid|C0055860|||||1|0.0364|
CVA|Cough variant asthma;cough variant asthma|C0694548|||C0694548|CHV;ICD9CM;SNOMEDCT|1|0.0616|1
CVA|Cyclophosphamide/Doxorubicin/Vincristine;cyclophosphamide/doxorubicin/vincristine||||C0054889|NCI;PDQ|||
CVA|OCA|C1015366|||C0054889|NCI;PDQ|||
CVA|STROKE SYNDROME;SYNDROME, STROKE;Stroke Syndrome|C0038454;C1263853|||C0038454|NCI|||
CVA|Stroke NOS (disorder)||||C0038454|SNOMEDCT|||
CVA|Stroke [Disease/Finding]||||C0038454|NDFRT|||
CVA|Stroke and cerebrovascular accident unspecified||||C0038454|SNOMEDCT|||
CVA|Stroke and cerebrovascular accident unspecified (disorder)||||C0038454|SNOMEDCT|||
CVA|Stroke unspecified||||C0038454|SNOMEDCT|||
CVA|Stroke/CVA - undefined||||C0038454|SNOMEDCT|||
CVA|Stroke/cerebrovasc accident||||C0038454|ICPC|||
CVA|Stroke/cerebrovascular accident||||C0038454|ICPC|||
CVA|VAC||||C0054889|NCI;PDQ|||
CVA|canonical variate analysis||||||1|0.0224|
CVA|cardiovascular accident||||||||1
CVA|cerebrovascular disease|C0007820|||||1|0.0308|
CVA|cerivastatin|C0528023|||C0528023|CHV;MSH;NCI;NDFRT;SNOMEDCT;VANDF|||
CVA|cervicovaginal antibody||||||||1
CVA|chronic villous arthritis||||||||1
CVA|corrected visual acuity|C1275680|||C1275680|CHV;SNOMEDCT|||
CVA|costovertebral angle||1|0.444|||||1
CVA|cresyl violet acetate|C0056485|||||||1
CVI|Cape Verde Islands|C0006893|||||1|0.0146|
CVI|Children's Vaccine Initiative||||||1|0.0521|1
CVI|Chronic Venous Insufficiency;chronic venous insufficiency|C1306557|||||1|0.5521|1
CVI|cardiovascular incident||||||||1
CVI|cardiovascular insufficiency||||||||1
CVI|cerebrovascular incident||||||||1
CVI|cerebrovascular infarct||1|1.000|||||1
CVI|cerebrovascular infarction||||||||1
CVI|cerebrovascular insufficiency|C0241832|||||||1
CVI|common variable immunodeficiency|C0009447|||||1|0.2604|1
CVI|content validity index||||||1|0.0313|
CVI|continuous intravenous infusion|C1511497|||||1|0.0125|
CVI|continuous venous infusion||||||1|0.0104|1
CVI|cortical visual impairment|C1531862|||||||1
CVI|cyclic variation index||||||1|0.0208|
CVI|visual impairment|C0042798|||||1|0.0458|
CVP|CDDP/CTX/VP-16||||C0280556|NCI;PDQ|||
CVP|CEP||||C0280556|PDQ|||
CVP|COP|C0086825|||C0056633|PDQ|||
CVP|COP chemotherapy protocol 2;COP protocol 2;CVP Regimen;CVP regimen;Cyclophosphamide-Vincristine-Prednisone Regimen;cyclophosphamide/prednisone/vincristine protocol|C0056633|||C0056633|CHV;MSH;MTH;NCI|||
CVP|CTX/PRED/VCR||||C0056633|NCI;PDQ|||
CVP|CVP|C0056633;C0280556|||C0056633;C0280556|NCI;PDQ|||
CVP|Cisplatin/Cyclophosphamide/Etoposide;cisplatin/cyclophosphamide/etoposide||||C0280556|NCI;PDQ|||
CVP|Cyclophosphamide/Prednisone/Vincristine;cyclophosphamide, vincristine, prednisone;cyclophosphamide/prednisone/vincristine||1|0.124|C0056633|NCI;PDQ|||
CVP|PCE|C0246101;C0280556;C1588205|||C0280556|NCI;PDQ|||
CVP|PVC|C0151636|||C0280556|NCI;PDQ|||
CVP|VCP|C0056633;C1421437|||C0056633|NCI;PDQ|||
CVP|VCP-1;cisplatin/cyclophosphamide/etoposide protocol|C0280556|||C0280556|MTH;NCI;PDQ|||
CVP|cardiac valve procedure||||||||1
CVP|cardiovascular pulmonary||1|0.004|||||
CVP|cardioventricular pacing||||||||1
CVP|cell volume profile||||||||1
CVP|central venous|C0444466|||||1|0.0305|
CVP|central venous pressure|C0428640;C1321771|1|0.872|C0428640;C1321771|CHV;LCH;MSH;MTH;SNOMEDCT|1|0.9523|1
CVP|cerebrovascular profile||||||||1
CVP|chlorphenvinphos|C0008195|||||1|0.0172|
CVP|cyclophosphamide, prednisone, and vincristine chemotherapy protocol||||C0056633|CHV|||
CV|C-V;CV|C1547550;C2699739|||C0006893;C0280551;C0681921;C1547550;C1880201;C2699739|NCI;PDQ|||
CV|CAPE VERDE;Cape Verde;cape verde;Cape Verde islands;Republic of Cape Verde|C0006893|||C0006893|CHV;MSH;MTH;NCI;SNOMEDCT|||
CV|CPV|C0006893;C0056285|||C0006893|NCI|||
CV|CTX/VP-16||||C0280551|NCI;PDQ|||
CV|CTX/VP-16 chemotherapy protocol||||C0280551|CHV|||
CV|Cape Verde islands (geographic location)||||C0006893|SNOMEDCT|||
CV|Chiba norovirus||1|0.002|||||
CV|Cibus Vespertinus (dinner)||||C2699739|HL7V2.5|||
CV|Circularvection||||||1|0.0029|
CV|Coefficient of Variance;coefficient of variance;Coefficient of Variation;coefficient of variation|C0681921|||C0681921|AOD;CHV;MTH;NCI|1|0.6133|1
CV|Cross-validation|C0681935|||||1|0.0042|
CV|Crystal Violet;crystal violet|C0017440|||||1|0.0086|1
CV|Curriculum Vitae;curriculum vitae|C1880201|||C1880201|MTH;NCI|1|0.0035|1
CV|Cyclophosphamide/Etoposide;cyclophosphamide/etoposide||||C0280551|NCI;PDQ|||
CV|Dinner;Supper;cibus vespertinus|C2699739|||C2699739|MTH;NCI|||
CV|Resume|C1550028;C1880201|||C1880201|NCI|||
CV|SPL DEA Schedule V;Schedule V;Schedule V Controlled Substance;Schedule V Substance|C1547550|||C1547550|HL7V2.5;MTH;NCI|||
CV|VC||||C0280551|PDQ|||
CV|cardiac volume|C0007179|||||||1
CV|cardiovascular|C0007226|1|0.958|C0007226|LNC;NCI;OMIM|1|0.1388|1
CV|care vigilance||||||||1
CV|carotenoid vesicle|C2248600|||||||1
CV|cell volume|C0596292|||||||1
CV|central venous|C0444466|1|0.006|||1|0.007|1
CV|cerebrovascular|C1880018|||||||1
CV|cervical vertebra|C0728985;C1269049|||||||1
CV|chorionic villi;chorionic villus|C0008508|||||1|0.0154|
CV|closed vitrectomy||||||||1
CV|closing volume|C0009050|||||1|0.0227|1
CV|coated vesicles|C0242915|||||1|0.0029|
CV|coefficient of variability||||||1|0.0038|
CV|collateralizing vessel||||||||1
CV|collecting vein||||||||1
CV|color vision|C0086032|||||||1
CV|coma vigil|C0001889|||||||1
CV|common ventricle|C0152424|||||||1
CV|concentrated volume||||||||1
CV|conceptional vessel||||||||1
CV|conducting vein||||||||1
CV|conduction velocity|C0234084|||||1|0.0685|1
CV|consonant vowel||||||||1
CV|contingent valuation||||||1|0.0096|
CV|contrast venography||||||1|0.0035|
CV|contrast ventriculography||||||1|0.0035|1
CV|conventional ventilation||||||1|0.0195|1
CV|conversational voice||||||||1
CV|corpuscular volume||1|0.006|||||1
CV|costovertebral||1|0.018|||||1
CV|cowpox virus|C0010233|||||1|0.0016|
CV|craniosacral vault||||||||1
CV|cresyl violet|C0056484|||||||1
CV|critical value||||||||1
CV|cutaneous vasculitis|C0262988|||||||1
CV|cyclic voltammetry||||||1|0.0528|
CV|cyclophosphamide and etoposide chemotherapy protocol||||C0280551|CHV|||
CV|cyclophosphamide/etoposide protocol||||C0280551|MTH|||
CV|dichotic consonant-vowel||||||1|0.0051|
CV|electrical cardioversion|C0013778;C0542380|||||1|0.0022|
CV|true conjugate|C0923003|||||||1
CV|vaccine|C0042210;C1552558|||||1|0.0032|
CV|value|C1522609|||||1|0.0029|
CV|vasculitis|C0042384;C1963274|||||1|0.0029|
CV|venous compliance||||||1|0.0016|
CVS|Biopsies, Chorionic Villi;Biopsy, Chorionic Villi;Chorionic Villi Biopsies;Chorionic Villi Biopsy;chorionic villi biopsy;CVB - Chorionic villus biopsy;CVS - Chorionic villus sampling;chorionic villus sampling (CVS);Chorionic Villi Sampling;Chorionic Villus Sampling;Chorionic villus sampling;Sampling of chorionic villus;Sampling, Chorionic Villi;Sampling, Chorionic Villus;chorionic villi sampling;chorionic villus samples;chorionic villus sampling;Chorionic Villi Samplings;Chorionic Villus Samplings;Samplings, Chorionic Villi;Samplings, Chorionic Villus|C0008509|1|0.914|C0008509|AOD;CHV;CSP;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.4606|1
CVS|CORONAVIRUS 229E SUSCEPTIBILITY|C1852539|||C1852539|MTH;OMIM|||
CVS|CVS||||C0008509;C0152164;C1852539|CSP;LNC;OMIM|||
CVS|CYCLIC VOMITING SYNDROME;Cyclic vomiting syndrome;cyclic vomiting syndrome|C0152164;C2700509|||C0152164|MSH;OMIM|1|0.0343|1
CVS|Challenge virus standard||||||1|0.0263|
CVS|Coated vesicles|C0242915|||||1|0.0183|
CVS|Cyclical vomiting;Cyclical vomiting NOS;cyclical vomiting;Cyclical vomiting NOS (disorder);cyclical vomiting disorder;Cyclical vomiting syndrome;cyclical vomiting syndrome;vomiting syndrome cyclical;Cyclical vomiting syndrome (disorder);Familial cyclic vomiting syndrome;Periodic vomiting;periodic vomiting|C0152164|||C0152164|CHV;MSH;MTH;MTHICD9;SNOMEDCT|||
CVS|HCVS;HUMAN CORONAVIRUS SENSITIVITY|C1415503;C1852539|||C1852539|OMIM|||
CVS|Sampling of chorionic villus (procedure)||||C0008509|SNOMEDCT|||
CVS|cardiovascular surgery|C0038897|||||||1
CVS|cardiovascular system|C0007226;C1269562|1|0.082|||1|0.0366|1
CVS|centrifugal visual system||||||1|0.0103|
CVS|cerebral vasospasm|C0265110|||||1|0.0137|1
CVS|cervicovaginal secretions||||||1|0.0137|
CVS|challenge virus strain||||||||1
CVS|chronic variable stress||||||1|0.0137|
CVS|clathrin-coated vesicles|C0887885|||||1|0.0091|
CVS|clean-voided specimen||||||||1
CVS|coefficients of variation||||||1|0.3326|
CVS|collagen vascular sealing||||||||1
CVS|computer vision syndrome||||||||1
CVS|conduction velocities|C0234084|||||1|0.0309|
CVS|continuing vegetative state||||||||1
CVS|coronavirus susceptibility||||||||1
CVS|current vital signs||||||||1
CVS|customer, value, service||1|0.004|||||
CVS|cyclical syndrome vomitting||||C0152164|CHV|||
CVS|cyclical vomitting||||C0152164|CHV|||
CXR|CHRISTMAS ISLAND;Christmas Island;Canton and Enderbury Islands|C0006888|||C0006888|MSH;MTH;NCI|||
CXR|CX||||C0006888|NCI|||
CXR|CXR;cxr|C0006888;C0039985|||C0006888;C0039985|CHV;NCI|||
CXR|CXR - Chest X-ray;Chest Radiography;Radiography of chest;Radiography of chest, NOS;chest radiography;Chest exclusion X-ray;Plain chest X-ray;Radiographies, Thoracic;Radiography, Thoracic;Thoracic Radiographies;Thoracic Radiography;thoracic radiography;Radiologic examination of chest;Radiologic examination of chest, NOS;Thoracic cage X-ray;X-ray thoracic cage NOS;thoracic x rays;thoracic x-ray;thorax x-ray|C0039985|||C0039985|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.1794|
CXR|Chest X-ray;Chest x-ray;Chest x-ray, NOS;X-ray of chest NOS;chest X ray;chest X-ray;chest x ray;chest x rays;chest x-ray|C0039985;C1114557|1|1|C0039985|CHV;CSP;MTH;MTHICD9;NCI;SNOMEDCT|1|0.4466|1
CXR|Christmas Island (Australia)||||C0006888|MSH|||
CXR|KT|C1690540|||C0006888|NCI|||
CXR|Plain chest X-ray (procedure)||||C0039985|SNOMEDCT|||
CXR|RADIOGR THORACIC;THORACIC RADIOGR||||C0039985|MSH|||
CXR|Radiographic procedure on chest||||C0039985|SNOMEDCT|||
CXR|Radiographic procedure on chest (procedure)||||C0039985|SNOMEDCT|||
CXR|Radiography of chest (procedure)||||C0039985|SNOMEDCT|||
CXR|Thoracic cage X-ray (procedure);X-ray thoracic cage NOS (procedure)||||C0039985|SNOMEDCT|||
CXR|chest radiograph||||||1|0.3206|
CXR|chest roentgenogram||||||1|0.0534|
D&C|CURETTAGE DILATATION;Curettage and Dilatation;DILATATION CURETTAGE;Dilatation & Curettage;Dilatation and Curettage;Dilatation and curettage;Dilatation and curettage NOS;curettage dilatation;dilatation and curettage;dilatation curettage;D&C - Dilatation and curettage;DILATION AND CURETTAGE;Dilation and Curettage;Dilation and curettage;Dilation and curettage, NOS;curettage dilation;dilation and curettage;dilation curettage;Uterine endometrectomy;curettage dilatation uterus;uterus d c|C0012358|1|0.982|C0012358|AOD;CHV;COSTAR;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|1|1
D&C|D & C;D and C;D&C;c d|C0012358;C0012764;C1444662;C1512015|||C0012358|CHV;MSH;NCI|||
D&C|Dilatation and curettage NOS (procedure)||||C0012358|SNOMEDCT|||
D&C|Dilatation of cervix and curettage of uterus||||C0012358|SNOMEDCT|||
D&C|Dilatation of cervix and curettage of uterus (procedure)||||C0012358|SNOMEDCT|||
D&C|Dilation and Curettage of the Uterus;Dilation and curettage of uterus;Dilation and curettage of uterus, NOS||||C0012358|ICD9CM;NCI;SNOMEDCT|||
D&C|Dilation and curettage (procedure)||||C0012358|SNOMEDCT|||
D&C|Dilation and curettage - action||||C0012358|SNOMEDCT|||
D&C|Dilation and curettage - action (qualifier value)||||C0012358|SNOMEDCT|||
D&C|Dilation and curettage of uterus (procedure)||||C0012358|SNOMEDCT|||
D&C|deep and clear||||||||1
D&C|direct and consensual||1|0.018|||||1
D&C|drugs and cosmetics||||||||1
D1|(cyclin) D1|C0174680|1|0.014|||||
D1|(vitamin) D1||1|0.028|||||
D1|1D|C1416886;C1442449|||C1416886|HUGO;OMIM|||
D1|64kD;D1;HASHIMOTO THYROIDITIS AUTOANTIGEN, 64-KD;LEIOMODIN 1;LEIOMODIN, SMOOTH MUSCLE;LMOD1;LMOD1 gene;SMLMOD|C1416886|||C1416886|HUGO;MTH;OMIM|||
D1|THYROID AND EYE MUSCLE AUTOANTIGEN, 64-KD||||C1416886|OMIM|||
D1|THYROID-ASSOCIATED OPHTHALMOPATHY AUTOANTIGEN, 64-KD||||C1416886|OMIM|||
D1|Type 1 iodothyronine deiodinase||||||1|0.0432|
D1|day one||||||||1
D1|deiodinase type 1;type 1 deiodinase|C0669524|||||1|0.0791|1
D1|depression 1||1|0.002|||||
D1|domain|C1880389;C1883221|||||1|0.2662|
D1|domain 1||||||1|0.1151|
D1|first|C0205435;C1279901|||||1|0.1079|
D1|first day||||||1|0.0432|
D1|first diagonal branch||1|0.952|||1|0.0432|1
D1|leiomodin 1 (smooth muscle)||||C1416886|HUGO|||
D1|limited|C0439801|||||1|0.0863|
D1|type I|C0441729|||||1|0.0647|
D1|type I deiodinase||||||1|0.1007|
D1|type I iodothyronine deiodinase|C1414051|||||1|0.0504|
DCIS|Carcinoma, Intraductal;Carcinomas, Intraductal;Intraductal Carcinoma;Intraductal Carcinomas;Intraductal carcinoma;Intraductal carcinoma, NOS;carcinoma intraductal;intraductal carcinoma;Carcinoma, Intraductal, Noninfiltrating;Carcinoma, Noninfiltrating Intraductal;Carcinomas, Noninfiltrating Intraductal;Intraductal Carcinoma, Noninfiltrating;Intraductal Carcinomas, Noninfiltrating;Intraductal carcinoma, noninfiltrating;Intraductal carcinoma, noninfiltrating, NOS;Noninfiltrating Intraductal Carcinoma;Noninfiltrating Intraductal Carcinomas;DCIS of the breast;Ductal Breast Carcinoma In Situ;Ductal Breast Carcinoma in Situ;Ductal Carcinoma in situ of Breast;Ductal Carcinoma in situ of the Breast;breast carcinoma ductal situ;breast ductal carcinoma in situ;ductal carcinoma in situ of the breast;in situ ductal breast carcinoma;Ductal Carcinoma In Situ;Ductal Carcinoma in situ;Ductal carcinoma in situ;carcinoma ductal in situ;carcinoma ductal situ;ductal carcinoma in situ;ductal carcinoma situ;ductal in situ carcinoma;in situ ductal carcinoma;Intraductal Breast Carcinoma;Intraductal Carcinoma of Breast;Intraductal Carcinoma of the Breast;Intraductal carcinoma of breast;intraductal breast carcinoma;intraductal carcinoma breast;Intraductal adenocarcinoma, noninfiltrating;Intraductal adenocarcinoma, noninfiltrating, NOS;Intraductal carcinoma in situ of breast;Non-Infiltrating Ductal Adenocarcinoma of Breast;Non-Infiltrating Ductal Adenocarcinoma of the Breast;Non-Infiltrating Ductal Breast Adenocarcinoma;Non-Infiltrating Ductal Breast Carcinoma;Non-Infiltrating Ductal Carcinoma of Breast;Non-Infiltrating Ductal Carcinoma of the Breast;Non-Infiltrating Intraductal Adenocarcinoma;Non-infiltrating intraductal adenocarcinoma;Non-Infiltrating Intraductal Adenocarcinoma of Breast;Non-Infiltrating Intraductal Adenocarcinoma of the Breast;Non-Infiltrating Intraductal Breast Adenocarcinoma;Non-Infiltrating Intraductal Carcinoma;Non-infiltrating intraductal carcinoma;Non-Invasive Ductal Adenocarcinoma of Breast;Non-Invasive Ductal Adenocarcinoma of the Breast;Non-Invasive Ductal Breast Adenocarcinoma;Non-Invasive Ductal Breast Carcinoma;Non-Invasive Ductal Carcinoma of Breast;Non-Invasive Ductal Carcinoma of the Breast;Non-Invasive Intraductal Adenocarcinoma of Breast;Non-Invasive Intraductal Adenocarcinoma of the Breast;Non-Invasive Intraductal Breast Adenocarcinoma;breast cancer intraductal;intraductal breast cancer;ductal cancer in situ of the breast|C0007124|1|1|C0007124|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.9875|1
DCIS|Carcinoma, Intraductal, Noninfiltrating [Disease/Finding]||||C0007124|NDFRT|||
DCIS|DCIS;dci;dcis|C0007124;C1413929;C2348081|||C0007124|CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|||
DCIS|Intraduct carcinoma of breast||||C0007124|SNOMEDCT|||
DCIS|Intraduct carcinoma of breast (disorder)||||C0007124|SNOMEDCT|||
DCIS|Intraductal carcinoma in situ of breast (disorder)||||C0007124|SNOMEDCT|||
DCIS|Intraductal carcinoma of breast (disorder)||||C0007124|SNOMEDCT|||
DCIS|Intraductal carcinoma, noninfiltrating (morphologic abnormality)||||C0007124|SNOMEDCT|||
DCIS|Intraductal carcinoma, noninfiltrating, no ICD-O subtype||||C0007124|SNOMEDCT|||
DCIS|Intraductal carcinoma, noninfiltrating, no ICD-O subtype (morphologic abnormality)||||C0007124|SNOMEDCT|||
DCIS|[M]Intraductal carcinoma, non-infiltrating NOS||||C0007124|SNOMEDCT|||
DCIS|[M]Intraductal carcinoma, non-infiltrating NOS (morphologic abnormality)||||C0007124|SNOMEDCT|||
DCIS|carcinomas|C0007097|||||1|0.0115|
DCIS|ductal carcinoma of breast|C1527349|||||1|0.001|
DC|(diltiazem) DC||1|0.002|||||
DC|(drug) DC||1|0.002|||||
DC|2'-deoxycytidine||||||1|0.0025|
DC|CDR||||C0011485|MSH;NDFRT|||
DC|Chiropractic Physician;D.C.M.;Doctor of Chiropractic|C1512015|||C1512015|MTH;NCI|||
DC|Cytidine, 2'-deoxy-;Cytosine Deoxyribonucleoside;Deoxyribonucleoside, Cytosine;Cytosine Deoxyriboside;Deoxyriboside, Cytosine;Deoxycytidine;deoxycytidine|C0011485|||C0011485|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ|1|0.0076|1
DC|D.C.;D/C;d.c.|C0012358;C0012764;C1444662;C1512015|||C0012764;C1444662;C1512015|AOD;CHV;NCI|||
DC|DBCN;LISX|C1413938;C2699546|||C1413938;C2699546|HUGO;NCI;OMIM|||
DC|DC;dC;dc||||C0011485;C0012764;C1413938;C1444662;C1512015;C1705348;C2699546|HUGO;NCI;PDQ|||
DC|DCM||||C1512015|NCI|||
DC|DCX;DCX Gene;DCX gene|C1413938|||C1413938|HUGO;LNC;MTH;NCI;OMIM|||
DC|DCX wt Allele|C2699546|||C2699546|MTH;NCI|||
DC|DIS|C0451119;C1444662|||C1444662|NCI|||
DC|DOUBLECORTIN;doublecortin;Doublecortex; Lissencephaly, X-Linked (Doublecortin) Gene;Doublecortex; Lissencephaly, X-Linked (Doublecortin) wt Allele;doublecortex|C1413938;C2698456|||C1413938;C2699546|HUGO;NCI;OMIM|||
DC|Deoxycytidine [Chemical/Ingredient]||||C0011485|NDFRT|||
DC|Direct compression||||||1|0.0018|
DC|Discontinuation|C0457454;C1444662|||C1444662|NCI|||
DC|Discontinue;Discontinued;discontinue;discontinued|C1444662;C1706472|1|0.564|C1444662|MTH;NCI;SNOMEDCT|||1
DC|Discontinued (qualifier value)||||C1444662|SNOMEDCT|||
DC|Discontinuous|C0439599;C1444662|||C1444662|NCI|||
DC|Disease Characteristics;Disease Characteristics Domain|C1705348|||C1705348|MTH;NCI|||
DC|District of Columbia;columbia district;district of columbia;Washington, D.C.;Washington, DC|C0012764|1|0.062|C0012764|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
DC|District of Columbia (geographic location)||||C0012764|SNOMEDCT|||
DC|Dupuytren contracture;Dupuytren's contracture|C0013312|||||1|0.0038|1
DC|NATO code for diphenylarsine chloride||||||||1
DC|NATO code for diphenylcyanoarsine||||||||1
DC|SCLH||||C1413938;C2699546|HUGO;NCI|||
DC|XLIS|C1413938;C1848199;C2699546|||C1413938;C2699546|HUGO;NCI|||
DC|control|C0009932;C0243148;C1550141;C1882979;C2587213|||||1|0.0043|
DC|daily census||||||||1
DC|data communication||||||||1
DC|data conversion|C2827657|||C2827657|NCI|||
DC|daycare|C0011017;C2827363|||||||1
DC|decarboxylase|C0007054|||||||1
DC|decrease|C0392756;C0547047|||||||1
DC|deep compartment||||||||1
DC|degenerating cell||||||||1
DC|degree of conversion||||||1|0.009|
DC|dendritic cell;dendritic cells|C0003315;C0011306;C1511762|||||1|0.7836|1
DC|deoxycholate|C0086123|||C0086123|CHV;CSP;LNC;MSH;RXNORM;SNOMEDCT|1|0.0058|
DC|deoxycholic acid|C0011479|||||1|0.0022|
DC|dermatochalasis|C0010495;C0423124|||||||1
DC|descending colon|C0227389|||C0227389|AOD;CHV;CSP;FMA;MSH;MTH;MTHMST;NCI;SNOMEDCT;UWDA|||1
DC|dextran charcoal||||||||1
DC|dextrocardia|C0011813|||||||1
DC|diabetic coma|C1263960|||||||1
DC|diagnostic center||||||||1
DC|diagnostic code||||||||1
DC|diagonal conjugate|C0923004|||C0923004|FMA;UWDA|||1
DC|dichorionic||||||1|0.004|
DC|diene conjugates||||||1|0.0085|
DC|differentiated carcinoma||||||||1
DC|differentiated cell||||||||1
DC|diffuse cortical||||||||1
DC|diffusing capacity|C1280474|||||||1
DC|diffusion chambers||||||1|0.0157|
DC|digit copying||||||||1
DC|digital computer|C0086044|||C0086044|MSH|||
DC|dilated cardiomyopathy|C0007193;C2984282|||||1|0.0101|
DC|dilation and curettage||||||||1
DC|dilation catheter||||||||1
DC|diphenylarsine cyanide||||||||1
DC|diphenylcyanoarsine|C0301230|||C0301230|SNOMEDCT|||
DC|direct Coombs||||||||1
DC|direct and consensual||1|0.002|||||1
DC|direct current|C0442831|1|0.304|||1|0.0922|1
DC|disc|C0180459;C1556138;C1705229;C2348299|||C1444662|NCI|||
DC|discharge;discharged|C0012621;C0030685;C2926602|1|0.062|||||1
DC|discomfort|C0231218;C0234215|||||||1
DC|distal colon||||||||1
DC|distal cusp|C0447396|||||||1
DC|distensibility||||||1|0.002|
DC|distensibility coefficient||||||1|0.0067|
DC|distocervical||||||||1
DC|donor cells||||||||1
DC|dorsal column|C0458459|||||1|0.0139|1
DC|dorsal cortex||||||1|0.0031|
DC|doxycycline|C0013090|||||1|0.0076|
DC|dressing change|C0085671|||C0085671|CHV;MTH;SNOMEDCT|||1
DC|dual chamber|C0725893|||||||1
DC|duodenal cap|C0227300;C1284424|||C0227300;C1284424|CHV;FMA;SNOMEDCT;UWDA|||1
DC|dynamic compression||||||1|0.0013|1
DC|dyskeratosis congenita|C0265965|||C0265965|CHV;MSH;MTH;NDFRT;PDQ;SNOMEDCT|1|0.0137|1
DDAVP|1-deamino-8-D-arginine vasopressin;desmopressin|C0011701|||C0011701|CHV;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.3715|
DDAVP|1-desamino-8-D-arginine vasopressin||1|1.000|||1|0.3883|
DDAVP|DDAVP;ddavp;Desmopressine Ferring;Ferring, Desmopressine;Desmospray;Desmotabs;Ferring Brand 1 of Desmopressin Acetate;Octim;Octostim|C0701195|||C0701195|CHV;MSH;MTH;NCI;RXNORM|||
DDAVP|desmopressin acetate|C0086135|||||1|0.2095|
DDAVP|vasopressin analogue|C2917446|||||1|0.0307|
DDDR|dual, dual, dual, rate||1|1.000|||||1
DEXA|Absorptiometries, DPX;Absorptiometry, DPX;DPX Absorptiometry;Absorptiometry, Dual Energy X Ray;Absorptiometry, Dual-Energy X-Ray;Dual Energy X Ray Absorptiometry;Dual Energy X-ray Absorptiometry;Dual-Energy X-Ray Absorptiometry;X Ray Absorptiometry, Dual Energy;X-Ray Absorptiometry, Dual-Energy;dual energy x-ray absorptiometry;dual-energy X-ray absorptiometry;dual-energy x-ray absorptiometry;Absorptiometry, Dual X Ray;Absorptiometry, Dual X-Ray;Dual X Ray Absorptiometry;Dual X-Ray Absorptiometry;Dual X-ray Absorptiometry;X-Ray Absorptiometry, Dual;dual x-ray absorptiometry;BMD scan;DEXA;DXA;dxa;bone mineral density scan;dual energy x-ray absorptiometric scan|C1510486|1|0.998|C1510486|CHV;CSP;MSH;MTH;NCI;PDQ|1|0.8313|1
DEXA|DEXA scan|C1510486;C1959592|||C1510486|NCI;PDQ|||
DEXA|dexamethasone|C0011777|1|0.002|||1|0.1563|
DEXA|dual energy X-ray absorptiometer||||||1|0.0125|
DEXA|dual-energy x-ray absorptiometry (DXA) scan||||C1510486|CHV|||
DIC|1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-;1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-;5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide||||C0010927|MSH;NCI;NDFRT;PDQ|||
DIC|4-(Dimethyltriazeno)imidazole-5-carboxamide;5-(Dimethyltriazeno)imidazole-4-carboxamide;5-(dimethyltriazeno)imidazole-4-carboxamide||||C0010927|NCI;PDQ|||
DIC|5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide||||C0010927|NCI;PDQ|||
DIC|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide||||C0010927|MSH;NDFRT|||
DIC|COAG DISSEM INTRAVASC;DISSEM COAG INTRAVASC;DISSEM INTRAVASC COAG;INTRAVASC COAG DISSEM;INTRAVASC DISSEM COAG||||C0012739|MSH|||
DIC|COAGULATION (DIC), DISSEMINATED INTRAVASCULAR;DIC - Disseminated intravascular coagulation;DIC, DISSEMINATED INTRAVASCULAR COAGULATION;DISSEMINATED INTRAVASCULAR COAGULATION (DIC);INTRAVASCULAR COAGULATION (DIC), DISSEMINATED;disseminated intravascular coagulation (DIC);CONSUMPTION COAGULOPATHY;Coagulopathies, Consumption;Coagulopathy, Consumption;Consumption Coagulopathies;Consumption Coagulopathy;Consumption coagulopathy;consumption coagulopathy;Coagulation, Disseminated Intravascular;Coagulation, Intravascular Disseminated;Coagulations, Disseminated Intravascular;Coagulations, Intravascular Disseminated;DISSEMINATED INTRAVASCULAR COAGULATION;Disseminated Coagulation, Intravascular;Disseminated Coagulations, Intravascular;Disseminated Intravascular Coagulation;Disseminated Intravascular Coagulations;Disseminated intravascular coagulation;Intravascular Coagulation, Disseminated;Intravascular Coagulations, Disseminated;Intravascular Disseminated Coagulation;Intravascular Disseminated Coagulations;disseminated intravascular coagulation;Consumptive Coagulopathy;Consumptive coagulopathy;consumptive coagulopathy;Consumptive thrombohaemorrhagic disorder;Consumptive thrombohemorrhagic disorder;Consumptive thrombohemorrhagic disorder, NOS;D.I.C.;DEFIBRINATION SYNDROME;Defibrination syndrome;defibrination syndrome;DIC SYNDROME;DIC syndrome;Haemorrhagic fibrinogenolysis;Hemorrhagic fibrinogenolysis|C0012739|1|1|C0012739|CHV;CSP;CST;DXP;ICD9CM;LCH;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.8473|1
DIC|Carboxamide, Dimethyl Imidazole;Dimethyl Imidazole Carboxamide;Imidazole Carboxamide, Dimethyl;DACARBAZINE;Dacarbazine;Decarbazine;dacarbazine;DIC - Dacarbazine;DTIC;dtic;DTIC - Dacarbazine;Dacarbazine (DTIC);Dacarbazine - DTIC;Dacarbazina;Dakarbazin;Dimethyl Triazeno Imidazol Carboxamide;Dimethyl Triazeno Imidazole Carboxamide;Dimethyl-triazeno-imidazole carboxamide;Dimethyl-triazeno-imidazole-carboximide;dimethyl-triazeno-imidazole carboxamide;ICDT;Imidazole Carboxamide Dimethyltriazeno;dimethyltriazenoimidazole carboxamide|C0010927|||C0010927|CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
DIC|DIC;dic||||C0010927;C0012739;C0333710;C1420151|CST;DXP;MSH;NCI;NDFRT;OMIM;PDQ|||
DIC|DICARBOXYLATE ION CARRIER;SLC25A10;SLC25A10 gene|C1420151|||C1420151|HUGO;MTH;OMIM|||
DIC|DISSEM. INTRAVASC. COAGULATION|C0005778;C0441509;C1328723|||C0012739|CST|||
DIC|Dacarbazine (product)||||C0010927|SNOMEDCT|||
DIC|Dacarbazine (substance)||||C0010927|SNOMEDCT|||
DIC|Dacarbazine [Chemical/Ingredient]||||C0010927|NDFRT|||
DIC|Dicentric;dicentric;Dicentric Chromosome;Dicentric chromosome|C0333710|||C0333710|MTH;NCI;SNOMEDCT|||1
DIC|Dicentric chromosome (morphologic abnormality)||||C0333710|SNOMEDCT|||
DIC|Diffuse or disseminated intravascular coagulation||||C0012739|MTHICD9|||
DIC|Dimethyl (triazeno) imidazolecarboxamide||||C0010927|NCI;PDQ|||
DIC|Dissemin. intravascular coag.||||C0012739|SNOMEDCT|||
DIC|Disseminated Intravascular Coagulation [Disease/Finding]||||C0012739|NDFRT|||
DIC|Disseminated intravascular coagulation (disorder)||||C0012739|SNOMEDCT|||
DIC|SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10||||C1420151|OMIM|||
DIC|days in culture||||||1|0.0057|
DIC|deviance information criterion||||||1|0.0057|
DIC|diagnostic imaging center||||||||1
DIC|dicumarol|C0005640|||C0005640|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|||
DIC|differential interference contrast||||||1|0.0557|1
DIC|diffuse intravascular coagulation||||||||1
DIC|diisopropylcarbodiimide||||||1|0.0052|
DIC|direct isotope cystography||||||||1
DIC|disposable inner cannula||||||||1
DIC|disseminated intravascular clotting||||||1|0.0057|
DIC|disseminated intravascular coagulation syndrome||||||1|0.0098|
DIC|disseminated intravascular coagulopathy||||||1|0.0449|
DIC|dissolved inorganic carbon||||||1|0.0103|
DIC|drip infusion cholangiogram||||||||1
DIC|drip infusion cholangiograph||||||||1
DIC|drip infusion cholangiography||||||1|0.0036|1
DIC|drug information center||||||1|0.0062|1
DIC|solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10||||C1420151|HUGO|||
DIP|Biomedical Imaging Program;Diagnostic Imaging Program|C1511878|||C1511878|MTH;NCI|||
DIP|DEATH-INDUCING PROTEIN;death-inducing-protein;GRAM DOMAIN-CONTAINING PROTEIN 4;GRAMD4;GRAMD4 gene;KIAA0767|C2266648|||C2266648|HUGO;MTH;OMIM|||
DIP|DELTA SLEEP-INDUCING PEPTIDE, IMMUNOREACTOR;DSIPI;GILZ;TSC-22R;TSC22 DOMAIN FAMILY, MEMBER 3;TSC22 domain family, member 3;TSC22D3;TSC22D3 gene;hDIP|C1540075|||C1540075|HUGO;MTH;OMIM|||
DIP|DIP;Dip||||C0037390;C0040338;C0057737;C0238378;C1511878;C1540075;C2266648;C2826223|DXP;HUGO;MEDLINEPLUS;MSH;NCI;OMIM|||
DIP|DIP - Desquamative interstitial pneumonitis;Desquamative Interstitial Pneumonia;Desquamative interstitial pneumonia;PNEUMONIA, DESQUAMATIVE INTERSTITIAL;desquamative interstitial pneumonia;Desquamative interstitial pneumonitis;desquamative interstitial pneumonitis;ILD, DESQUAMATIVE;INTERSTITIAL LUNG DISEASE, DESQUAMATIVE;INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL;PNEUMONITIS, DESQUAMATIVE INTERSTITIAL, FAMILIAL;PNEUMONIA, DESQUAMATIVE INTERSTITIAL, FAMILIAL;RBILD;Respiratory Bronchiolitis Interstitial Lung Disease;Respiratory bronchiolitis interstitial lung disease;desquamative interstitial pneumonia (DIP)|C0238378|1|0.072|C0238378|CHV;DXP;ICD9CM;MTH;NCI;OMIM;SNOMEDCT|1|0.1463|1
DIP|Desquamative interstitial pneumonia (disorder)||||C0238378|SNOMEDCT|||
DIP|Desquamatv interst pneu||||C0238378|ICD9CM|||
DIP|Dip Dosing Unit|C2826223|||C2826223|MTH;NCI|||
DIP|GLUCOCORTICOID-INDUCED LEUCINE ZIPPER;glucocorticoid-induced leucine zipper||||C1540075|HUGO;OMIM|||
DIP|GRAM domain containing 4||||C2266648|HUGO|||
DIP|Resp brncio interst lung||||C0238378|ICD9CM|||
DIP|Smokeless Tobacco;Smokeless Tobaccos;TOBACCO, SMOKELESS;Tobacco, Smokeless;Tobaccos, Smokeless;smokeless tobacco|C0040338|||C0040338|AOD;CHV;CSP;MEDLINEPLUS;MSH;MTH;NCI;SPN|||
DIP|Smoking, Tobacco and Cancer - Smokeless Tobacco||||C0040338|NCI|||
DIP|Snuff;Snuffs;snuff;Snuff Tobacco;Snuff tobacco|C0037390|||C0037390|AOD;CHV;CSP;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|||
DIP|Snuff tobacco (substance)||||C0037390|SNOMEDCT|||
DIP|Spit Tobacco;Spit tobacco|C0008038;C0040338|||C0040338|MEDLINEPLUS|||
DIP|defective interfering particles|C0011139|||||1|0.0213|
DIP|degradable intake protein||||||1|0.0457|
DIP|diazenedicarboxylic acid bis(N'-methylpiperazide)||||C0057737|MSH;MTH|||
DIP|dichlorophenolindophenol|C0000232|||||||1
DIP|diffuse interstitial pneumonia||||||||1
DIP|diffuse interstitial pneumonitis||||||||1
DIP|digital image processing;digital imaging processing||||||1|0.0305|1
DIP|diisopropyl phosphate||||||||1
DIP|diphtheria toxoid vaccine|C0012551|||||||1
DIP|diploid|C0012568|||||||1
DIP|diplopia|C0012569|||||||1
DIP|dipropionate||1|0.004|||||
DIP|dipyridamole|C0012582|||C0012582|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.1768|
DIP|distal interphalangeal||1|0.924|||1|0.3628|1
DIP|distal interphalangeal joint|C0932510|||C0932510|CHV;FMA;UWDA|1|0.0549|
DIP|drip infusion pyelography||||||1|0.0945|
DIP|drip-infusion pyelogram||||||||1
DIP|drug-induced parkinsonism|C0270729|||C0270729|SNOMEDCT|1|0.0671|1
DJD|ARTHRITIS, HYPERTROPHIC;Hypertrophic arthritis;Hypertrophic arthritis, NOS;hypertrophic arthritis;ARTHRITIS, SENESCENT;ARTHROPATHY, DEGENERATIVE;Degenerative arthropathy;Degenerative arthropathy, NOS;degenerative arthropathy;Arthritides, Degenerative;Arthritis, Degenerative;Degenerative Arthritides;Degenerative Arthritis;Degenerative arthritis;Degenerative arthritis, NOS;arthritis degenerative;degenerative arthritis;DEGENERATIVE JOINT DISEASE;Degenerative Joint Disease;Degenerative joint disease;Degenerative joint disease, NOS;JOINT DISEASE, DEGENERATIVE;degenerative disease joint;degenerative disease joints;degenerative diseases joint;degenerative joint disease;DJD;Degenerative polyarthritis;Degenerative polyarthritis, NOS;Hypertrophic polyarthritis;Hypertrophic polyarthritis, NOS;OA - Osteoarthritis;oa osteoarthritis;OA - Osteoarthrosis;OS1;OSTEOARTHRITIS;Osteoarthritides;Osteoarthritis;Osteoarthritis NOS;Osteoarthritis, NOS;osteoarthritis;OSTEOARTHRITIS SUSCEPTIBILITY 1;Osteoarthritis NOS, of unspecified site;a o;o a;arthritis osteoarthritis;osteoarthritis arthritis;degenerative osteoarthritis;osteoarthritis degenerative;primary OA|C0029408|1|1|C0029408|AIR;AOD;CCS;CHV;COSTAR;CSP;DXP;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|1|1
DJD|Degenerative arthropathy (disorder)||||C0029408|SNOMEDCT|||
DJD|Degenerative joint disease (disorder)||||C0029408|SNOMEDCT|||
DJD|Degenerative polyarthritis (disorder)||||C0029408|SNOMEDCT|||
DJD|Joint degeneration||||C0029408|SNOMEDCT|||
DJD|OA;oas|C0029408;C0599973;C2985270|||C0029408|CHV;CSP;MEDLINEPLUS;OMIM|||
DJD|OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO||||C0029408|OMIM|||
DJD|OSTEOARTHROSIS;Osteoarthroses;Osteoarthrosis;osteoarthrosis;arthrosis|C0022408;C0029408|||C0029408|AOD;CHV;DXP;MEDLINEPLUS;MSH;NDFRT;OMIM;SNOMEDCT|||
DJD|Osteoarthritis (& [allied disorders]);Osteoarthritis and allied disorders||||C0029408|SNOMEDCT|||
DJD|Osteoarthritis (disorder);Osteoarthritis NOS (disorder)||||C0029408|SNOMEDCT|||
DJD|Osteoarthritis NOS, of unspecified site (disorder)||||C0029408|SNOMEDCT|||
DJD|Osteoarthritis [Disease/Finding]||||C0029408|NDFRT|||
DJD|Osteoarthrosis, unspecified whether generalized or localized||||C0029408|ICD9CM|||
DJD|[Joint degeneration] or [osteoarthritis NOS]||||C0029408|SNOMEDCT|||
DJD|[Joint degeneration] or [osteoarthritis NOS] (disorder)||||C0029408|SNOMEDCT|||
DJD|arthrosys||||C0029408|CHV|||
DJD|osteoarthriti||||C0029408|CHV|||
DJD|osteoarthrities||||C0029408|CHV|||
DJD|osteoarthrosys||||C0029408|CHV|||
DKA|ACIDOSIS DIABETIC;ACIDOSIS, DIABETIC;Acidoses, Diabetic;Acidosis, Diabetic;DIABETIC ACIDOSIS;Diabetic Acidoses;Diabetic Acidosis;Diabetic acidosis;Diabetic acidosis, NOS;diabetic acidosis;DIABETIC KETOACIDOSIS;Diabetic Ketoacidoses;Diabetic Ketoacidosis;Diabetic ketoacidosis;KETOACIDOSIS, DIABETIC;Ketoacidoses, Diabetic;Ketoacidosis - diabetic;Ketoacidosis, Diabetic;diabetic ketoacidoses;diabetic ketoacidosis;DKA;Diabetes Mellitus with Ketoacidosis;Diabetes mellitus (& [ketoacidosis]);Diabetes mellitus NOS with ketoacidosis;Diabetes mellitus with ketoacidosis;Ketoacidosis in diabetes mellitus;Diabetes with ketoacidosis;Diabetic Ketoses;Ketoses, Diabetic;diabetic ketoses;Diabetic Ketosis;Ketosis, Diabetic;diabetic ketosis;Diabetic acidosis without coma;Diabetic ketosis without coma|C0011880|1|0.998|C0011880|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|1|1
DKA|DKA - Diabetic ketoacidosis||||C0011880|SNOMEDCT|||
DKA|Diabetes mellitus (& [ketoacidosis]) (disorder);Diabetes mellitus NOS with ketoacidosis (disorder);Ketoacidosis in diabetes mellitus (disorder)||||C0011880|SNOMEDCT|||
DKA|Diabetes with ketoacidosis (disorder)||||C0011880|SNOMEDCT|||
DKA|Diabetic Ketoacidosis [Disease/Finding]||||C0011880|NDFRT|||
DKA|did keep appointment||||||||1
DLCO|Carbon Monoxide Diffusing Capability Test;DLCO|C1516251|||C1516251|NCI|||
DLCO|Diffusion Capacity of the Lung for Carbon Monoxide;diffusion capacity of the lung for carbon monoxide||||C1516251|NCI|1|0.0502|
DLCO|PFT/DLCO||||C1516251|NCI|||
DLCO|Pulmonary Function Test/Carbon Monoxide Diffusing Capability||||C1516251|NCI|||
DLCO|carbon monoxide diffusing capacity;diffusing capacity for carbon monoxide|C0199525|||||1|0.4983|
DLCO|carbon monoxide diffusion capacity;diffusion capacity for carbon monoxide||||||1|0.1605|
DLCO|diffusing capacity for CO||||||1|0.0569|
DLCO|diffusing capacity of the lung||||||1|0.0334|
DLCO|diffusing capacity of the lung for carbon monoxide||1|1.000|||1|0.1672|
DLCO|transfer factor|C0040673;C1280474|||||1|0.0334|
DM|(11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)-||||C0011777|MSH;NCI;NDFRT;PDQ|||
DM|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone;16Alpha-methyl-9alpha-fluoro-delta1-hydrocortisone;9Alpha-fluoro-16alpha-methylprednisolone;9alpha-Fluoro-16alpha- methylprednisolone;Fluoro-9alpha Methyl-16alpha Prednisolone;DEXAMETHASONE;Dexamethasone;dexamethasone;Desamethasone;Dexamethasone preparation;Dexamethasonum;Hexadecadrol;Methylfluorprednisolone|C0011777|||C0011777|AOD;CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0369|
DM|16Alpha-methyl-9alpha-fluoro-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione||||C0011777|NCI;PDQ|||
DM|16Alpha-methyl-9alpha-fluoroprednisolone||||C0011777|NCI;PDQ|||
DM|9Alpha-fluoro-11beta,17alpha,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione||||C0011777|NCI;PDQ|||
DM|CURSCHMANN-BATTEN-STEINERT SYNDROME;DM - Dystrophia myotonica;DYSTROPHIA MYOTONICA;Dystrophia Myotonica;Dystrophia myotonica;dystrophia myotonica;DYSTROPHY, MYOTONIC;Dystrophies, Myotonic;Dystrophy, Myotonic;Myotonic Dystrophies;Myotonic Dystrophy;Myotonic dystrophy;dystrophy myotonic;myotonic dystrophy;MYOTONIA ATROPHICA;Myotonia Atrophica;Myotonia atrophica;myotonia atrophica;Myotonia Dystrophica;Myotonia dystrophica;myotonia dystrophica;STEINERT DISEASE;Steinert Disease;Steinert disease;Steinert's Disease;Steinert's disease;disease steinerts;steinert disease;steinert's disease;Steinert myotonic dystrophy syndrome;Steinert syndrome;steinert syndrome;syndrome steinert|C0027126|||C0027126|CHV;COSTAR;CSP;DXP;LCH;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.1881|1
DM|Commonwealth of Dominica;DOMINICA;Dominica|C0013013|||C0013013|MSH;MTH;NCI;SNOMEDCT|||
DM|Commonwealth of Dominica (geographic location)||||C0013013|SNOMEDCT|||
DM|DM;dm||||C0011777;C0013013;C0027126;C0439199;C1414085;C1512047;C1704791|HUGO;NCI;OMIM;PDQ;SNOMEDCT|||
DM|DM KINASE;DM PROTEIN KINASE;DM protein kinase;MYOTONIN-PROTEIN KINASE|C0216045;C1414085|||C1414085|HUGO;OMIM|||
DM|DM1||||C1414085|HUGO|||
DM|DM1PK;DMK;DMPK;DMPK gene;DYSTROPHIA MYOTONICA PROTEIN KINASE;dystrophia myotonica-protein kinase;MDPK;MT-PK;thymopoietin homolog|C1414085|||C1414085|HUGO;LNC;MTH;OMIM|||
DM|DMA|C0013013;C0058243;C0301360|||C0013013|NCI|||
DM|DO||||C0013013|NCI|||
DM|DXM|C0011777;C0011816;C0350422|||C0011777|PDQ|||
DM|Decimeter;decimeter;decimetre|C0439199|||C0439199|MTH;NCI;SNOMEDCT|||1
DM|Defined Medium||||||1|0.0092|
DM|Demographics|C0011292;C0011298;C1704791|||C1704791|NCI|||
DM|Demographics Domain|C1704791|||C1704791|MTH;NCI|||
DM|Descemet membrane;Descemet's membrane|C0011665|||||1|0.0107|1
DM|Desmoplastic Melanoma|C1333280|||||1|0.0063|
DM|Deutschmarks||||||1|0.0049|
DM|Dexamethasone (product)||||C0011777|SNOMEDCT|||
DM|Dexamethasone (substance)||||C0011777|SNOMEDCT|||
DM|Dexamethasone [Chemical/Ingredient]||||C0011777|NDFRT|||
DM|Dexamethasone [endocrine use]||||C0011777|SNOMEDCT|||
DM|Dexamethasone [endocrine use] (product)||||C0011777|SNOMEDCT|||
DM|Dexamethasone [endocrine use] (substance)||||C0011777|SNOMEDCT|||
DM|Dexamethasone preparation (product)||||C0011777|SNOMEDCT|||
DM|Dexamethasone preparation (substance)||||C0011777|SNOMEDCT|||
DM|Diabetic|C0241863|||||1|0.0292|
DM|Disease management;disease management|C0039798;C0376636|||C0039798;C0376636|CHV;MSH;MTH|1|0.0185|1
DM|Distant metastasis;distant metastases;distant metastasis|C1269798|||C1269798|NCI;SNOMEDCT|1|0.0384|1
DM|Dominica (geographic location)||||C0013013|SNOMEDCT|||
DM|Double Minutes;double minute;double minutes|C1512047|||C1512047|MTH;NCI|1|0.0146|1
DM|Drosophila melanogaster|C0013139|||||1|0.018|
DM|HLA-DM||||||1|0.0088|
DM|Myotonic Dystrophy [Disease/Finding]||||C0027126|NDFRT|||
DM|NATO code for diphenylaminearsine||||||||1
DM|STEINERT DIS;STEINERTS DIS||||C0027126|MSH|||
DM|Steinert myotonic dystrophy syndrome (disorder)||||C0027126|SNOMEDCT|||
DM|Type 2 diabetes|C0011860|||||1|0.0097|
DM|adamsite|C0070542|||||||1
DM|daunomycin;daunorubicin|C0011015|||C0011015|CHV;MSH;NCI;NDFRT;PDQ|1|0.0268|
DM|decimeter (qualifier value)||||C0439199|SNOMEDCT|||
DM|decimorgan||||||||1
DM|dehydrated and malnourished||||||||1
DM|deltamethrin|C0057233|||||1|0.0044|
DM|dermatology|C0011627;C1555731|||||||1
DM|dermatomyositis|C0011633;C0221056|||C0011633;C0221056|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
DM|dermorphin|C0057492|||||1|0.0049|
DM|dexamethasone (DMX)||||C0011777|CHV|||
DM|dextromaltose||||||||1
DM|dextromethorphan|C0011816|1|0.572|C0011816|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0739|
DM|diabetes mellitus|C0011849|1|0.418|C0011849|AIR;AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;ICPC;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|||1
DM|diabetic group||||||1|0.0029|
DM|diabetic mother||||||||1
DM|diabetic patients||||||1|0.0044|
DM|diabetic rats||||||1|0.0024|
DM|diastolic murmur|C0232262|||C0232262|CHV;MSH;SNOMEDCT|||1
DM|differentiation medium||||||1|0.0039|
DM|diffuse mixed||||||||1
DM|diffusing capacity of alveolar membrane||||||||1
DM|distal metastasis||||||||1
DM|dm (qualifier value)||||C0439199|SNOMEDCT|||
DM|dopamine|C0013030;C0201989|||C0013030;C0201989|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;UWDA;VANDF|||1
DM|dorsal medulla||||||1|0.0044|
DM|dorsomedial||||||1|0.0267|1
DM|dorsomedial medulla||||||1|0.0068|
DM|dorsomedial nucleus|C0228329|||||1|0.0063|
DM|dorsomedial nucleus of the intercollicular complex||||||1|0.0024|
DM|dorsomedial visual area||||||1|0.0058|
DM|dose modification|C1707811|||||||1
DM|double membrane||||||||1
DM|double minute chromosomes||||||1|0.0058|
DM|double-muscled||||||1|0.0053|
DM|dry mass||||||1|0.0053|
DM|dry matter||||||1|0.2528|1
DM|dry muscle||||||1|0.0034|
DM|duodenal mucosa|C0227284|||C0227284|FMA;MTH;SNOMEDCT;UWDA|||1
DM|dura mater|C0013313|||||1|0.0044|
DM|dystrophia myotonica 1|C1414085;C2931688|||C1414085|HUGO|||
DM|membrane diffusing capacity||||||1|0.0131|1
DM|method|C0025663;C0449851;C0871511|||||1|0.0044|
DM|myotonic dystrophi||||C0027126|CHV|||
DM|myotonic dystrophy associated protein kinase||||C1414085|HUGO|||
DM|myotonin protein kinase A||||C1414085|HUGO|||
DM|patients with dermatomyositis||||||1|0.0146|
DM|patients with diabetes mellitus||||||1|0.1215|
DNA|DNA;DNA - Deoxyribonucleic acid;deoxyribonucleic acid (DNA);DNA molecule;dna molecule;dna molecules;Deoxyribonucleic Acid;Deoxyribonucleic acid;Deoxyribonucleic acid, NOS;Deoxyribonucleic acids;deoxyribonucleic acid;deoxyribonucleic acids|C0012854|1|1|C0012854;C1325786|AOD;CHV;CSP;FMA;GO;LCH;LNC;MSH;MTH;MTHFDA;NCI;NDFRT;SNOMEDCT;UWDA|1|1|1
DNA|DNA [Chemical/Ingredient]||||C0012854|NDFRT|||
DNA|DNA location|C1325786|||C1325786|GO;MTH|||
DNA|Deoxyribonucleic acid (substance)||||C0012854|SNOMEDCT|||
DNA|did not answer||||||||1
DNA|did not attend||||||||1
DNA|do not administer||||||||1
DNA|does not apply||||||||1
DNI|do not intubate||1|1.000|||||1
DNR|(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione;5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-;5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-||||C0011015|MSH;NCI;NDFRT;PDQ|||
DNR|DAUNOMYCIN;Daunomycin;daunomycin;DAUNORUBICIN;DAUNOrubicin;Daunorubicin;daunorubicin;DNM;dnm;Dauno Rubidomycine;Dauno-Rubidomycine;Daunorrubicina;Leukaemomycin C;RUBOMYCIN C;Rubomycin C;Rubidomycin;rubidomycin;Rubomycin;rubomycin|C0011015|||C0011015|CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.6149|
DNR|DNAR - Do not attempt resuscitation||||C0582114|SNOMEDCT|||
DNR|DNR|C0011015;C0582114|||C0011015;C0582114|NCI;PDQ;SNOMEDCT|||
DNR|DNR - Do not resuscitate;Do not resuscitate;do not resuscitate;do-not-resuscitate;Not for attempted cardiopulmonary resuscitation;Not for resuscitation|C0582114|1|0.994|C0582114;C1547313|HL7V2.5;MTH;SNOMEDCT|1|0.2764|1
DNR|DRB;drb||||C0011015|CHV;PDQ|||
DNR|Daunorubicin (product)||||C0011015|SNOMEDCT|||
DNR|Daunorubicin (substance)||||C0011015|SNOMEDCT|||
DNR|Daunorubicin [Chemical/Ingredient]||||C0011015|NDFRT|||
DNR|Department of Natural Resources||1|0.006|||||
DNR|L-lyxo-Hexopyranoside, 3.beta.-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,.alpha.-||||C0011015|NCI|||
DNR|Not for resuscitation (finding)||||C0582114|SNOMEDCT|||
DNR|did not respond||||||||1
DNR|do not report||||||||1
DNR|do-not-resuscitate order|C0079252|||C0079252|MSH|||
DNR|dorsal nerve root||||||||1
DNR|dose nonuniformity ratio||||||||1
DNR|not resuscitate||||||1|0.1086|
DOB|BD||||C0421451|NCI|||
DOB|BRTHDAT;DOB - Date of birth;Date of birth of recipient of care;Patient date of birth|C0421451|||C0421451|MTH;NCI;SNOMEDCT|||
DOB|Birth Date;Birth date;Date of Birth;Date of birth;birth date;birth date of;birthDate;births date;date of birth|C0421451;C0803906|1|0.998|C0421451|CHV;LNC;NCI;SNOMEDCT|||1
DOB|Bromdimethoxyamphetamine|C0301362|||C0301362|MTH;SNOMEDCT|||
DOB|Bromdimethoxyamphetamine (substance)||||C0301362|SNOMEDCT|||
DOB|DOB|C0301362;C0421451|||C0301362;C0421451|NCI;SNOMEDCT|||
DOB|Date of birth (finding)||||C0421451|SNOMEDCT|||
DOB|Date of birth (observable entity)||||C0421451|SNOMEDCT|||
DOB|Date of birth of person cared for||||C0421451|SNOMEDCT|||
DOB|Date of birth of recipient of care (observable entity)||||C0421451|SNOMEDCT|||
DOB|Dobrava hantavirus||||||||1
DOB|Dobutamine|C0012963|||||1|1|
DOB|dangle out of bed||||||||1
DOB|delta over baseline||||||||1
DOB|distal occlusal buccal|C0447334|||||||1
DOB|doctor's order book||||||||1
DOL|day of life||1|1.000|||||1
DOL|dolorimetric unit||||||||1
DP|2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol||||C0012582|NCI;PDQ|||
DP|CD4+CD8+|C0483191|||||1|0.0176|
DP|CD4+CD8+ double-positive||||||1|0.0451|
DP|D-penicillamine|C0030817|||||1|0.0588|
DP|D.P.;DP;dP;D.P.M.;Doctor of Podiatric Medicine;Pod.D.;PodD|C1512024|||C0012582;C1419059;C1420414;C1512024;C2599755|HUGO;LNC;MTH;NCI;OMIM;PDQ|||
DP|DIPYRIDAMOLE;Dipyridamole;dipyridamole;Dipyramidole;dipyramidole|C0012582|||C0012582|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.093|
DP|DOCKING PROTEIN|C1420414;C1760028|||C1420414|OMIM|||
DP|DP1|C1327771;C1384538;C1419059|||C1419059|OMIM|||
DP|DPM|C1512024;C1634619|||C1512024|NCI|||
DP|Dermatophagoides Pteronyssinus;Dermatophagoides pteronyssinus|C0446330;C1122992|||||1|0.1018|1
DP|Dipyridamole (product)||||C0012582|SNOMEDCT|||
DP|Dipyridamole (substance)||||C0012582|SNOMEDCT|||
DP|Dipyridamole [Chemical/Ingredient]||||C0012582|NDFRT|||
DP|Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-||||C0012582|MSH;NDFRT|||
DP|PROSTAGLANDIN D2 RECEPTOR|C0072269;C1419059|||C1419059|OMIM|||
DP|PROSTANOID DP RECEPTOR;PTGDR;PTGDR gene|C1419059|||C1419059|HUGO;MTH;OMIM|||
DP|SIGNAL RECOGNITION PARTICLE RECEPTOR|C0074511;C1420414;C1760029|||C1420414|OMIM|||
DP|SRP-alpha;SRPR;SRPR gene;Sralpha|C1420414|||C1420414|HUGO;MTH;OMIM|||
DP|data processing|C0868941|||C0868941|LCH;MTH;NCI|||1
DP|debonding pliers||||||||1
DP|deep pulse||||||||1
DP|definitive procedure||||||||1
DP|degradation product||||||||1
DP|degree of polymerisation;degree of polymerization||||||1|0.1274|1
DP|delayed puberty|C0034012|||||1|0.0059|
DP|deltopectoral|C0450110|||||||1
DP|delusional parasitosis||||||1|0.0069|
DP|dementia praecox|C0036341|||||||1
DP|dementia pugilistica|C0149843|||||||1
DP|dense plate||||||||1
DP|dental prosthesis|C0162686;C1316489|||||||1
DP|dental prosthodontics||||||||1
DP|dermal papilla|C0221931;C1282636|||||1|0.0264|
DP|dermatofibrosarcoma protuberans|C0392784|||||1|0.0118|
DP|desmoplakin|C0057555;C1414172|||||1|0.0264|
DP|desquamative pneumonia||||||||1
DP|developed pressure||||||||1
DP|dexamethasone pretreatment||||||||1
DP|diabetes-prone||||||1|0.0754|
DP|diabetic polyneuropathy|C0271680|||||1|0.0108|
DP|diaphragmatic plaque||||||||1
DP|diastolic pressure|C0428883|||||||1
DP|differential pressure||1|0.002|||||
DP|diffuse precipitation||||||||1
DP|diffuse pressure||||||||1
DP|diffusion pressure||||||||1
DP|digestible protein||||||||1
DP|diminutive polyp||||||||1
DP|diphosgene|C0601846|||C0601846|MSH|||1
DP|diphosphate|C0034320|||C0034320|CHV;CSP|||1
DP|dipropionate||||||||1
DP|direct puncture||||||||1
DP|directed percolation||||||1|0.0157|
DP|directional preponderance||||||1|0.0235|1
DP|disability pension||||||||1
DP|discharge planning|C0012622|||||||1
DP|discriminating power||||||||1
DP|disopyramide|C0012702|||||1|0.0411|
DP|disopyramide phosphate|C0700534|||||1|0.0049|
DP|displaced person||||||||1
DP|distal pancreatectomy|C0176940|||C0176940|ICD9CM;NCI;SNOMEDCT|1|0.0118|1
DP|distal phalanx|C0576464|||C0576464|SNOMEDCT|||1
DP|distal pit||||||||1
DP|distopulpal||||||||1
DP|distortion product||||||1|0.0147|
DP|donor's plasma|C0860067|||||||1
DP|dopamine|C0013030;C0201989|||||1|0.0088|
DP|dorsal|C0205095|||||1|0.0088|
DP|dorsal prostate||||||1|0.0137|
DP|dorsalis pedis||1|0.996|||||1
DP|double pneumonia||||||||1
DP|double positive||||||1|0.1126|
DP|double potential||||||1|0.0059|
DP|double product||||||1|0.0362|
DP|driving pressure||||||||1
DP|dry pint|C2348351|||C2348351|HL7V3.0;NCI|||
DP|dynamic programming||||||1|0.0088|
DP|dyspnea|C0013404|||||||1
DP|left ventricular developed pressure||||||1|0.0137|
DP|patients|C0030705|||||1|0.0147|
DP|pattern|C0449774|||||1|0.0147|
DP|phase|C0205390|||||1|0.0088|
DP|pressures|C0033095;C0460139|||||1|0.0108|
DP|prostaglandin D2 receptor (DP)||||C1419059|HUGO|||
DP|protein|C0033684|||||1|0.0118|
DP|receptor|C0597357|||||1|0.0118|
DP|signal recognition particle receptor (docking protein)||||C1420414|HUGO|||
DT|(drug) DT||1|0.006|||||
DT|2' Deoxythymidine;2'-Deoxythymidine;2'-deoxythymidine;2'-deoxythymidine (dT);DThyd;Deoxythymidine;deoxythymidine;Thymidine Deoxyriboside;thymidine deoxyriboside|C0086126|||C0086126|CHV;MSH;MTH;NCI;PDQ|1|0.0234|1
DT|3,4-dihydroxyphenylalaninechrome tautomerase||||C0114832|MSH|||
DT|BP240;BPA;BPAG1;BULLOUS PEMPHIGOID ANTIGEN 1;CATX-15;DST gene;DYSTONIN;dystonin;FLJ13425;FLJ21489;FLJ30627;FLJ32235;KIAA0728;MACF2|C1539312|||C1539312|HUGO;MTH;OMIM|||
DT|CHEMOTHER||||C0013216|MSH|||
DT|CT - Chemotherapy;DT;dT;dt;Pharmacological Treatment;Pharmacological Treatments;Treatment With Medication;chemotherapy procedures;drug therapy treatment;medication therapy;medications therapy;therapy medication;pharmacotherapeutics|C0013216|||C0013216;C0013217;C0040077;C0086126;C0114832;C0305059;C0678226;C1539312;C2926610|AOD;CHV;LNC;MSH;NCI;OMIM;PDQ;SNOMEDCT|||
DT|Chemotherapies;Chemotherapy;chemotherapies;chemotherapy|C0013216;C0013217;C0392920|||C0013216;C0013217|AOD;CHV;CSP;LCH;LNC;MEDLINEPLUS;MSH;SNOMEDCT|||
DT|DCT;Tyrosinase-Related Protein 2;Tyrosinase-Related Protein-2;tyrosinase-related protein-2;dopachrome tautomerase|C0114832;C1413933|||C0114832|MSH;NCI;PDQ|||
DT|DMH||||C1539312|OMIM|||
DT|DRUG THER;THER DRUG||||C0013216;C0013217|MSH|||
DT|DST|C0430115;C1539312|||C1539312|HUGO;OMIM|||
DT|DT - Drug therapy||||C0013216|SNOMEDCT|||
DT|DT toxoid;Diphtheria and tetanus toxoid adsorbed|C0305059|||C0305059|MTH;SNOMEDCT|||
DT|DYSTONIA MUSCULORUM, MOUSE, HOMOLOG OF||||C1539312|OMIM|||
DT|Delirium Tremens;delirium tremens|C0001957|1|0.258|C0001957|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MSH;MTHICD9;NDFRT;SNOMEDCT|1|0.0292|1
DT|Diphtheria and tetanus toxoid adsorbed (product)||||C0305059|SNOMEDCT|||
DT|Diphtheria and tetanus toxoid adsorbed (substance)||||C0305059|SNOMEDCT|||
DT|Dopachrome D-isomerase;Dopachrome delta-isomerase;Dopachrome isomerase;dopachrome isomerase;EC5.3.3.12;L-Dopachrome Delta-Isomerase;L-Dopachrome Tautomerase;dopachrome conversion factor;dopachrome oxidoreductase|C0114832|||C0114832|MSH;MTH;NCI;SNOMEDCT|||
DT|Dopachrome isomerase (substance)||||C0114832|SNOMEDCT|||
DT|Drug Therapies;Drug Therapy;Drug therapy;Drug therapy NOS;Therapies, Drug;Therapy, Drug;drug therapies;drug therapy;drugs therapies;Pharmacotherapies;Pharmacotherapy;pharmacotherapies;pharmacotherapy|C0013216;C0013217|||C0013216;C0013217|AOD;CHV;CSP;HL7V3.0;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|||
DT|Drug therapy (procedure);Drug therapy NOS (procedure)||||C0013216|SNOMEDCT|||
DT|Due To;Due to;due;due to|C0678226;C3146286|||C0678226|CHV;MTH;NCI;SNOMEDCT|||
DT|Due to (attribute)||||C0678226|SNOMEDCT|||
DT|PHARMACOTHER||||C0013216|MSH|||
DT|Resulting from;resulting from||||C0678226|CHV;SNOMEDCT|||
DT|Sabin-Feldman dye test||||||1|0.0187|
DT|Salmonella typhimurium definitive type||||||1|0.0047|
DT|TDR;TdR|C0040077;C0086126|||C0040077;C0086126|NCI;PDQ|||
DT|THYMIDINE;Thymidin;Thymidine;thymidin;thymidine|C0040077|||C0040077|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0398|
DT|TRP-2;TRP2|C0114832;C1150342;C1421166|||C0114832|NCI;PDQ|||
DT|TRP-2 protein, tyrosinase-related||||C0114832|MSH|||
DT|TYRP2|C0114832;C1413933;C2826556|||C0114832|NCI|||
DT|Thymidine (substance)||||C0040077|SNOMEDCT|||
DT|Thymidine [Chemical/Ingredient]||||C0040077|NDFRT|||
DT|decayed teeth|C0011334|||||1|0.0117|
DT|deceleration time||||||1|0.1146|
DT|decidual tissue||||||1|0.007|
DT|defibrillation threshold||||||||1
DT|definitive phage type||||||1|0.0164|
DT|depression of transmission||||||||1
DT|desmoid tumor|C0079218|||C0079218|CHV;NCI;OMIM;PDQ|1|0.0082|
DT|developed tension||||||1|0.0819|
DT|dietary thermogenesis||||||||1
DT|differently tested||||||||1
DT|diffraction tomography||||||1|0.0105|
DT|diffusion tension||||||||1
DT|diffusion tensor||||||1|0.0491|1
DT|diltiazem|C0012373|||C0012373|AOD;CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
DT|diphtheria and tetanus toxoids||||||1|0.0187|
DT|diphtheria toxin|C0012550|||C0012550|CSP;LCH;MSH;NCI;NDFRT;SNOMEDCT|1|0.2632|1
DT|diphtheria toxoid|C0012551|||C0012551|CHV;CSP;MSH;NDFRT;SNOMEDCT;VANDF|||
DT|diphtheria-tetanus||1|0.672|||1|0.0257|1
DT|diplo thickness||||||||1
DT|dipole tracing||||||1|0.0105|1
DT|discharge tomorrow||||||||1
DT|dispensing tablet||||||||1
DT|distal tubule;distal tubules||||||1|0.0374|1
DT|distance test||||||||1
DT|dorsalis tibialis||||||||1
DT|double tachycardia||||||||1
DT|doubling time|C2986483|||C2986483|NCI|1|0.1205|1
DT|drive for thinness||||||1|0.0129|
DT|drug treatment (drug therapy)||||C0013216|AOD|||
DT|dt - divisor|C2926610|||C2926610|MTH|||
DT|duration of tetany||||||||1
DT|dye test|C0441697|||C0441697|CHV;LNC;SNOMEDCT|||1
DT|dystonia musculorum||||||1|0.0292|
DT|genetically dystonic||||||1|0.0152|
DT|impedance detection times||||||1|0.0058|
DT|pharmacologic therapy;pharmacotherapeutic|C0013217|||C0013217|MSH;MTH|||
DT|resulting|C0678226|||C0678226|CHV|||
DT|threshold|C0449864|||||1|0.0199|
DT|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0152|
DT|vaccine|C0042210;C1552558|||||1|0.0105|
DTR|(drug) DTR||1|0.002|||||
DTR|DIPHTHERIA TOXIN RECEPTOR;Diphtheria Toxin Receptor;Diphtheria toxin receptor;diphtheria toxin receptor;diphtheria toxin receptors;receptor, diphtheria toxin;HB-EGF;HBEGF|C0058402;C1539630|||C0058402;C1539630;C1704816|HUGO;MSH;MTH;NCI;OMIM|1|1|
DTR|DT-R;DTR;dtr|C0058402;C1704816|||C0058402;C0489815;C1148175;C1539630;C1704816;C2681647|HUGO;LNC;NCI;OMIM|||
DTR|DTR Gene;Diphtheria Toxin Receptor Gene;Diphtheria Toxin Sensitivity Gene;HBEGF wt Allele;Heparin-Binding EGF-Like Growth Factor wt Allele|C1704816|||C1704816|MTH;NCI|||
DTR|DTR Protein;Diphtheria Toxin Sensitivity;HB-EGF precursor;heparin-binding epidermal growth factor-like growth factor precursor|C0058402|||C0058402|MSH;NCI|||
DTR|DTS||||C0058402;C1704816|NCI|||
DTR|Deep Tendon Reflex;Deep tendon reflex;Deep tendon reflexes;deep reflex tendon;deep reflexes tendon;deep tendon reflex;deep tendon reflexes;reflexes deep tendon;Myostatic Reflex|C0489815|1|0.998|C0489815|CHV;LNC;MTH;NCI|||1
DTR|Deep tendon reflex of {Reflex location};Deep tendon reflex:Finding:Point in time:{Reflex location}:Ordinal:Observed|C1148175|||C1148175|LNC;MTH|||
DTR|Deep tendon reflex:Find:Pt:{Reflex location}:Ord:Observed||||C1148175|LNC|||
DTR|Diphtheria Toxin Receptor (Heparin-Binding EGF-Like Growth Factor) Gene||||C1704816|NCI|||
DTR|Diphtheria toxin receptor (heparin-binding EGF-like growth factor)||||C1539630|HUGO|||
DTR|HBEGF Gene;HBEGF gene;HEPARIN-BINDING EGF;Heparin-Binding EGF-Like Growth Factor Gene;heparin-binding epidermal growth factor|C1539630|||C1539630|HUGO;MTH;NCI;OMIM|||
DTR|HEGFL|C0058402;C1539630;C1704816|||C0058402;C1539630;C1704816|NCI;OMIM|||
DTR|HEPARIN-BINDING EGF-LIKE GROWTH FACTOR;Heparin-Binding EGF-Like Growth Factor;heparin-binding EGF-like growth factor|C0058402;C0166825;C1539630|||C0058402;C1539630|HUGO;NCI;OMIM|||
DTR|LRRC67;LRRC67 gene|C2681647|||C2681647|HUGO;MTH|||
DTR|detorubicin|C0057578|||C0057578|MSH;NCI;PDQ|||
DTR|leucine rich repeat containing 67||||C2681647|HUGO|||
DUI|DUI;DWI law;DWI laws;driving under the influence laws;impaired driving laws|C0683692|||C0683692|AOD;CHV|||
DUI|doubly uniparental inheritance||||||1|0.1358|
DUI|driving under influence;driving under the influence|C0870447|1|1|||1|0.5802|1
DUI|driving under the influence of alcohol||||||1|0.284|
DUI|driving while intoxicated (DWI) law||||C0683692|CHV|||
DUI|driving while intoxicated laws||||C0683692|AOD|||
DVT|DEEP THROMBOPHLEBITIS;Deep thrombophlebitis;Deep thrombophlebitis, NOS;THROMBOPHLEBITIS DEEP;deep thrombophlebitis|C0149871;C0151950|||C0149871|CHV;CST;SNOMEDCT|||
DVT|DEEP VEIN THROMBOPHLEBITIS;deep vein thrombophlebitis;Deep Vein Thromboses;Deep-Vein Thromboses;Thromboses, Deep Vein;Thromboses, Deep-Vein;Vein Thromboses, Deep;deep vein thromboses;Deep Venous Thromboses;Deep-Venous Thromboses;Thromboses, Deep Venous;Thromboses, Deep-Venous;Venous Thromboses, Deep;deep venous thromboses;Deep Venous Thrombosis;Deep venous thrombosis;Deep-Venous Thrombosis;THROMBOSIS VENOUS DEEP;Thrombosis, Deep Venous;Thrombosis, Deep-Venous;Venous Thrombosis, Deep;Venous thrombosis -deep;deep venous thrombosis;deep vein thrombophlebitis (DVT)|C0149871|||C0149871|CHV;COSTAR;CST;MSH;OMIM;SNOMEDCT|1|0.9951|
DVT|DEEP VEIN THROMBOSIS;Deep Vein Thrombosis;Deep vein thrombosis;Deep vein thrombosis NOS;Deep-Vein Thrombosis;Thrombosis, Deep Vein;Thrombosis, Deep-Vein;Vein Thrombosis, Deep;deep vein thrombosis;deep-vein thrombosis;DVT - Deep vein thrombosis;deep vein thrombosis (DVT)|C0149871;C0340708|1|1|C0149871;C0340708|AOD;CHV;COSTAR;CSP;DXP;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;OMIM;SNOMEDCT|||1
DVT|DVT;DVT NOS;dvts|C0149871;C2926618|||C0149871;C2926618|CHV;DXP;LNC;MEDLINEPLUS;MTHICD9;NCI;SNOMEDCT|||
DVT|Deep thrombophlebitis (disorder)||||C0149871|SNOMEDCT|||
DVT|Deep venous thrombosis (disorder)||||C0149871|SNOMEDCT|||
DVT|Ever told by doctor that you had deep venous thrombosis||||C2926618|LNC|||
DVT|Ever told by doctor that you had deep venous thrombosis:Find:Pt:^Patient:Ord||||C2926618|LNC|||
DVT|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|||C2926618|LNC;MTH|||
DVT|deep venous thrombophlebitis||||||1|0.0051|
DWI|DWI;dwi|C0598801;C1171335|||C0598801;C1171335|CHV;CSP|||
DWI|DWI (diffusion weighted imaging);diffusion weighted imaging (DWI);Diffusion weighted imaging;diffusion weighted imaging;diffusion-weighted images;diffusion-weighted imaging|C0598801|1|0.016|C0598801|CHV;CSP;MTH|1|0.5864|1
DWI|Diffusion-weighted||||||1|0.0349|
DWI|Diffusion-weighted magnetic resonance imaging;diffusion weighted magnetic resonance imaging (DWMRI)|C2584984|||C0598801|CHV|1|0.0864|
DWI|Driving While Intoxicated;driving while intoxicated;driving while intoxicated (DWI)|C1171335|||C1171335|CHV;MTH|1|0.0947|1
DWI|diffusion-|C0012222;C1696141|||||1|0.0216|
DWI|diffusion-weighted MRI|C1136216|||||1|0.1445|
DWI|driving under influence of alcohol or drugs||||C1171335|CHV|||
DWI|driving while impaired||1|0.984|||1|0.0316|1
EBL|Endemic Burkitt's lymphoma;endemic Burkitt lymphoma|C0343640|||||1|0.0642|1
EBL|Estimated blood loss;estimated blood loss|C1443559;C2926617|1|0.998|||1|0.4404|1
EBL|endoscopic band ligation||||||1|0.1101|1
EBL|enzootic bovine leukosis|C0085165|||||1|0.3853|
EBL|erythroblastic leukemia|C0023440|||||||1
EBV|Burkitt Herpesvirus;Herpesvirus, Burkitt;Burkitt Lymphoma Virus;Burkitt's Lymphoma Virus;Burkitt's lymphoma virus;Burkitts Lymphoma Virus;Lymphoma Virus, Burkitt;E B Virus;E-B Virus;E-B Viruses;e b virus;e-b virus;EB virus;eb virus;EBV;EBV - Epstein-Barr virus;Epstein-Barr virus EBV;epstein barr virus (EBV);Epstein Barr Virus;Epstein Barr virus;Epstein-Barr Virus;Epstein-Barr virus;Virus-Epstein-Barr;epstein barr virus;epstein-barr virus;HERPESVIRUS 4 GAMMA HUMAN;Herpesvirus 4 (gamma), Human;HHV 4;HHV-4;HUMAN HERPESVIRUS 4;Herpesvirus 4, Human;Human Herpesvirus 4;Human herpesvirus 4;herpesvirus 4, human;Human herpesvirus type 4;Infectious Mononucleosis Virus;Infectious Mononucleosis Viruses;Mononucleosis Virus, Infectious;Mononucleosis Viruses, Infectious;mononucleosis infectious virus;human herpesvirus 4 group|C0014644|1|1|C0014644|AOD;CHV;CSP;LCH;LNC;MSH;NCBI;NCI;SNOMEDCT|1|0.982|1
EBV|Epstein-Barr||||||1|0.0058|
EBV|Epstein-Barr viral||||||1|0.0054|
EBV|HERPESVIRUS HUMAN 04;HUMAN HERPESVIRUS 04||||C0014644|MSH|||
EBV|Human (gamma) herpes virus 4|C0598396|||C0014644|SNOMEDCT|||
EBV|Human herpesvirus 4 (organism)||||C0014644|SNOMEDCT|||
EBV|INFECT MONONUCLEOSIS VIRUS||||C0014644|MSH|||
EBV|effective blood volume||||||||1
EBV|electron boost volume||||||||1
EBV|estimated blood volume||||||1|0.0028|1
EBV|estimated breeding values||||||1|0.0041|
ECG|2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate||||C0059422|NCI|||
ECG|ECG;ECG NOS;eCG;ecgs;EKG;ekgs;Electrocardiography;Electrocardiography NOS;electrocardiography|C0013798;C1623258|||C0013798;C0018064;C0059422;C1623258|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHICD9;NCI;SNOMEDCT|||1
ECG|ELECTROCARDIOGR||||C1623258|MSH|||
ECG|Electrocardiogram;Electrocardiogram, NOS;Electrocardiograms;electrocardiogram;electrocardiograms|C0013798;C1547122;C1623258;C1705651|||C0013798;C1623258;C1705651|CCS;CHV;CSP;ICD9CM;MSH;MTH;MTHHH;NCI;SNOMEDCT|1|0.6407|1
ECG|Electrocardiograph;electrocardiograph|C0013798;C0180600;C1623258|1|1|C0013798;C1623258|CHV;LCH;LNC|1|0.0216|1
ECG|Electrocardiographic procedure;Electrocardiographic procedure, NOS|C1623258|||C1623258|SNOMEDCT|||
ECG|Electrocardiographic procedure (procedure)||||C1623258|SNOMEDCT|||
ECG|Electrocardiographically||||||1|0.0043|
ECG|Electrocardiography (procedure);Electrocardiography NOS (procedure)||||C1623258|SNOMEDCT|||
ECG|Electrocardiography NOS (regime/therapy)||||C1623258|SNOMEDCT|||
ECG|Epicatechin-3-Gallate;epicatechin-3-gallate;epicatechin gallate;epicatechin-3-galloyl ester|C0059422|||C0059422|MSH;MTH;NCI|1|0.0084|
ECG|Equine Chorionic Gonadotropin;equine chorionic gonadotrophin;equine chorionic gonadotropin;Equine Gonadotropins;Equine gonadotropin;Gonadotropins, Equine|C0018064|||C0018064|MSH;MTH;NCI;NDFRT|1|0.0321|
ECG|Gonadotropins, Equine [Chemical/Ingredient]||||C0018064|NDFRT|||
ECG|cis-3,3?,4?,5,7-pentahydroxyflavane 3-gallate||||C0059422|NCI|||
ECG|electrocardiogram (EKG, ECG)||||C0013798|CHV|||
ECG|electrocardiographic||||||1|0.2793|
ECG|equine CG||||||1|0.0034|
ECG|exercise electrocardiography||||||1|0.0103|
ECMO|ECMO;ecmo;ECMO (extracorporeal membrane oxygenation);ECMO - Extracorporeal membrane oxygenation;Extracorporeal membrane oxygenation [ECMO];extracorporeal membrane oxygenation (ECMO);Extracorporeal Membrane Oxygenation;Extracorporeal Membrane Oxygenations;Extracorporeal membrane oxygenation;Membrane Oxygenation, Extracorporeal;Membrane Oxygenations, Extracorporeal;Oxygenation, Extracorporeal Membrane;Oxygenations, Extracorporeal Membrane;extracorporeal membrane oxygenation;extracorporeal bypass|C0015357|1|1|C0015357|AOD;CHV;CSP;ICD9CM;MSH;MTH;MTHICD9;SNOMEDCT|1|0.9852|1
ECMO|Extracorporeal memb oxy||||C0015357|ICD9CM|||
ECMO|Extracorporeal membrane oxygenation (procedure)||||C0015357|SNOMEDCT|||
ECMO|Extracorporeal membrane oxygenator;extracorporeal membrane oxygenator||||||1|0.0148|1
ECMO|enterocytopathogenic monkey orphan||||||||1
EC|(-)-Epicatechin;Epicatechin;epicatechin|C0014485;C1881340|||C1881340|NCI|1|0.0067|
EC|(-)-Epicatechol||||C1881340|NCI|||
EC|(2R-cis)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol||||C1881340|NCI|||
EC|E-CERVIC;Endocervical Route of Administration;Endocervical Route of Drug Administration;Intracervical Route of Administration|C1524042|||C1524042|MTH;NCI|||
EC|E-cadherin|C0042172;C0694872|||||1|0.0018|
EC|EC||||C0013557;C0013593;C1524042;C1881340|MSH;NCI|||
EC|ECON||||C0013557|MSH|||
EC|ECU;ECUADOR;Ecuador;ecuador|C0013593|||C0013593|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
EC|ENDOCERVICAL;Endocervical;endocervical|C0227837;C1550252|||C1524042|NCI|||1
EC|Economic;economics|C0013556;C0013557|||C0013557|MSH;MTH|||
EC|Ecuador (geographic location)||||C0013593|SNOMEDCT|||
EC|Energy charge||||||1|0.0168|
EC|Enzyme Commission|C1709239|||||1|0.0028|1
EC|Escherichia coli|C0014834|||||1|0.0282|1
EC|Euro-Collins||||||||1
EC|Euro-Collins solution|C0059905|||||1|0.0049|
EC|Eurocollins||||||1|0.0061|
EC|European Commission||||||1|0.0091|
EC|European Community|C0015179|||||1|0.0219|
EC|L-Epicatechin|C1881340|||C1881340|MTH;NCI|||
EC|adenocarcinoma|C0001418|||||1|0.002|
EC|committee|C2699414|||||1|0.0018|
EC|complex environment||||||1|0.0024|
EC|concentration|C0086045;C1446561|||||1|0.0037|
EC|contraction|C1140999|||||1|0.0026|
EC|control|C0009932;C0243148;C1550141;C1882979;C2587213|||||1|0.0073|
EC|effect of closing||||||||1
EC|effective concentration||||||||1
EC|ejection click|C0277911|||C0277911|CHV;SNOMEDCT|||1
EC|electrical cardioversion|C0013778;C0542380|||||1|0.002|1
EC|electrical conductivity|C0013777|||||1|0.0124|
EC|electrocautery|C0013804|||||||1
EC|electrochemical||||||1|0.0112|1
EC|electron capture||||||1|0.0028|1
EC|elimination capacity||||||1|0.002|
EC|elongation complex||||||1|0.0018|
EC|embryonal carcinoma|C0206659|||C0206659|CHV;CSP;MSH;NCI;OMIM;SNOMEDCT|1|0.1141|1
EC|emergency contraception|C0558252|||C0558252|CHV;MSH;SNOMEDCT|1|0.0246|1
EC|emetic center||||||||1
EC|emulsifiable concentrate||||||1|0.0043|
EC|endemic cretinism|C0342200|||C0342200|CHV;MSH;MTH;MTHICD9;OMIM;SNOMEDCT|||
EC|endochondral||||||1|0.002|
EC|endocrine cell|C0229525|||C0229525|CHV;FMA;MSH;NCI;SNOMEDCT|||
EC|endometrial cancer|C0007103;C0476089;C1883486;C2984333|||||1|0.0108|
EC|endometrial carcinoma|C0476089|||||1|0.0146|1
EC|endothelial;endothelium|C0014257|||||1|0.0091|
EC|endothelial cell;endothelial cells|C0225336|||C0225336|AOD;CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.5197|1
EC|energy cost||||||1|0.0014|
EC|enkephalin-containing||||||1|0.0018|
EC|enriched|C0359583|||||1|0.0016|
EC|enriched condition||||||1|0.0022|
EC|enteric-coated||1|0.878|||1|0.0018|1
EC|entering complaint||||||||1
EC|enterochromaffin||||||1|0.0197|
EC|enterochromaffin cell|C0014355;C0524979|||||||1
EC|enterocutaneous||1|0.090|||||
EC|entorhinal cortex|C0175196;C1289526|||C0175196;C1289526|CHV;CSP;FMA;MSH;SNOMEDCT|1|0.0499|1
EC|entrance complaint||||||||1
EC|environmental complexity||||||||1
EC|enzyme-treated cell||||||||1
EC|eosinophilic cystitis|C0742965|||||1|0.002|
EC|epidermal cell|C1179149|||C1179149|CHV;FMA;UWDA|||1
EC|epirubicin|C0014582|1|0.004|||||
EC|epithelial cell|C0014597|||C0014597|AOD;CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|||1
EC|equalization-cancellation||||||||1
EC|esophageal cancer|C0014859;C0152018;C0546837|||||1|0.0138|
EC|esophageal candidiasis|C0239295|||||1|0.0012|1
EC|esophageal carcinoma|C0152018|||C0152018|CHV;COSTAR;CST;MTH;NCI;OMIM|||1
EC|esterified cholesterol|C0008387|||||1|0.0077|
EC|ether-chloroform||||||||1
EC|ethyl carbamate|C0041964|||||1|0.0051|
EC|ethyl cellulose;ethylcellulose|C0059756|||||1|0.0181|
EC|ethyl chloride|C0015058|||C0015058|CHV;LCH;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
EC|excitation-contraction||||||||1
EC|excitatory center||||||||1
EC|experimental control||||||||1
EC|experimental immune-mediated blepharoconjunctivitis||||||1|0.0028|
EC|extensor carpi||1|0.004|||||
EC|external carotid||||||||1
EC|external conjugate|C0923007|||||||1
EC|extracapsular|C1517049|||||||1
EC|extracellular|C0521119|||||1|0.0168|1
EC|extracellular compartment||||||||1
EC|extracellular concentration||||||||1
EC|extracorporeal|C0442087;C1522201|||||||1
EC|extracorporeal circulation|C0015354|||||1|0.0041|
EC|extracranial|C0580586|||C0580586|CHV;NCI;SNOMEDCT|||1
EC|extruded cell||||||||1
EC|eye care|C0885957|||||||1
EC|eyes closed||||||||1
ECT|BCECTS;BECTS;Benign Childhood Epilepsy With Centro Temporal Spikes;Benign Childhood Epilepsy With Centro-Temporal Spikes;Benign Epilepsy With Centrotemporal Spikes;Benign Rolandic Epilepsy of Childhood;CENTRALOPATHIC EPILEPSY;Centralopathic Epilepsies;Centralopathic Epilepsy;Centralopathic epilepsy;Epilepsies, Centralopathic;Epilepsy, Centralopathic;CENTROTEMPORAL EPILEPSY;Centrotemporal Epilepsies;Centrotemporal Epilepsy;Centrotemporal epilepsy;Epilepsies, Centrotemporal;Epilepsy, Centrotemporal;TEMPORAL-CENTRAL FOCAL EPILEPSY;Temporal-central focal epilepsy|C2363129|||C2363129|MSH;OMIM;SNOMEDCT|||
ECT|BENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES||||C2363129|OMIM|||
ECT|BENIGN ROLANDIC EPILEPSY;Benign Rolandic Epilepsy;Benign Rolandic epilepsy;Epilepsy, Benign Rolandic;Rolandic Epilepsy, Benign|C0376532;C2363129|||C2363129|MSH;MTH;OMIM;SNOMEDCT|||
ECT|Benign Rolandic epilepsy (disorder)||||C2363129|SNOMEDCT|||
ECT|CONVULSIVE THER ELECTRIC||||C0013806|MSH|||
ECT|Convulsive Therapies, Electric;Convulsive Therapy, Electric;Electric Convulsive Therapies;Electric Convulsive Therapy;Therapies, Electric Convulsive;Therapy, Electric Convulsive;electric convulsive therapy;ECS;ecs;ECT - Electroconvulsive therapy;electroconvulsive therapy (ECT);ECT therapy;ect therapy;EST - Electroshock treatment;EST therapy;Electric Shock Therapies;Electric Shock Therapy;Electric shock therapy;Shock Therapies, Electric;Shock Therapy, Electric;Therapies, Electric Shock;Therapy, Electric Shock;electric shock therapy;Electroconvulsive Therapies;Electroconvulsive Therapy;Electroconvulsive therapy;Electroconvulsive therapy NOS;Electroconvulsive therapy, NOS;Therapies, Electroconvulsive;Therapy, Electroconvulsive;electroconvulsive therapy;Electroconvulsive treatment;electroconvulsive treatment;electroconvulsive treatments;Electroplexy;Electroshock Therapies;Electroshock Therapy;Electroshock therapy;Electroshock therapy, NOS;Therapies, Electroshock;Therapy, Electroshock;electroshock therapy;Electroshock treatment;electroshock treatment;electric shock treatment;electric shock treatments;electroconvulsive shock therapy;electroplexy shock therapy;shock treatment;shock treatments;shocking treatment|C0013806|1|1|C0013806|AOD;CCS;CHV;CSP;LCH;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.8923|1
ECT|ECT;ect|C0013806;C2363129|||C0013806;C2363129|AOD;CHV;CSP;MTH;MTHICD9;NCI;OMIM|||
ECT|ECT (Psychotherapy)||||C0013806|MSH|||
ECT|ECT PSYCHOTHER||||C0013806|MSH|||
ECT|ELECTROCONVULSIVE THER;Electroconvulsive ther.||||C0013806|MSH;SNOMEDCT|||
ECT|ELECTROSHOCK THER||||C0013806|MSH|||
ECT|EST;est||||C0013806|CHV;MTHICD9|||
ECT|Electroconvulsive therapy (procedure);Electroconvulsive therapy NOS (procedure)||||C0013806|SNOMEDCT|||
ECT|Electroconvulsive therapy (regime/therapy)||||C0013806|SNOMEDCT|||
ECT|Emission computed tomography;emission computed tomography|C0040398|||||1|0.0462|1
ECT|European compression technique||||||||1
ECT|SHOCK THER ELECTRIC||||C0013806|MSH|||
ECT|ecarin clotting time||||||1|0.0276|1
ECT|ectomesenchymal chondromyxoid tumor||||||||1
ECT|ectopic|C0574895|||||||1
ECT|eel calcitonin|C0013668|||||1|0.0076|
ECT|electrochemotherapy|C0678054|||||1|0.0179|1
ECT|endocurietherapy||||||1|0.0083|
ECT|enhanced computed tomography||||||||1
ECT|enteric-coated tablet|C0039226|||||||1
ECT|euglobulin clot test||||||||1
ECT|extended code therapy||||||||1
ECT|extracellular tissue||||||||1
EDC|1,2-Dichloroethane;1,2-dichloroethane;ethane, 1,2-dichloro-||||C0015081|LNC;MSH;NCI;SNOMEDCT|1|0.031|
EDC|1,2-Dichloroethane (substance)||||C0015081|SNOMEDCT|||
EDC|1,2-Ethylene Dichloride||||C0015081|NCI|||
EDC|1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride||||||1|0.0172|
EDC|1-ethyl-3-(3-dimethylaminopropyl)carbodiimide||||||1|0.2379|
EDC|1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide||||||1|0.0862|
EDC|1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride||||||1|0.0276|
EDC|Dichloroethylene|C0012074;C0015081|||C0015081|NCI|||
EDC|Due Date;Due date;due date|C2825543;C3146290|||C2825543|CHV;NCI;SNOMEDCT|||
EDC|EDC|C0015081;C1832097;C2825543|||C0015081;C1832097;C2825543|NCI;OMIM|||
EDC|EDC - Expected date of confinement||||C2825543|SNOMEDCT|||
EDC|EDD|C1825027;C2825543|||C2825543|LNC|||
EDC|EDD - Expected date of delivery;Estimated date of birth;Estimated date of confinement;estimated date of confinement;Expected Date of Confinement;expected date of confinement;baby's due date|C2825543|||C2825543|CHV;MTH;NCI;SNOMEDCT|||1
EDC|EPIDERMAL DIFFERENTIATION COMPLEX;epidermal differentiation complex|C1832097|||C1832097|MTH;OMIM|1|0.0448|
EDC|ETHYLENE DICHLORIDE;Ethylene Dichloride;Ethylene dichloride;ethylene dichloride;Ethane Dichloride;Ethylene Chloride;Glycol Dichloride|C0015081|||C0015081|LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0448|
EDC|Endocrine disrupting chemicals;endocrine disrupting chemical|C1568245|||||1|0.0483|1
EDC|Estimated date of delivery;estimated date of delivery;estimated delivery date|C2741670;C2825543|||C2825543|CHV;LNC;SNOMEDCT|||
EDC|Estimated date of delivery (observable entity)||||C2825543|SNOMEDCT|||
EDC|Ethylene dichloride (substance)||||C0015081|SNOMEDCT|||
EDC|N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide||||||1|0.031|
EDC|compounds||||||1|0.031|
EDC|date of confinement||||||1|0.0448|
EDC|delivery date|C2053594;C2825543|||C2825543|CHV|||
EDC|effective dynamic compliance||||||||1
EDC|electrodesiccation and curettage||||||||1
EDC|emergency decontamination center||||||||1
EDC|end-diastolic count||||||||1
EDC|estimated date of conception|C0425966|1|1.000|C0425966|SNOMEDCT|||1
EDC|ethanol-derived calories||||||1|0.1172|
EDC|ethyl cysteinate dimer|C2716486|||||||1
EDC|expected delivery, cesarean||||||||1
EDC|extensor digitorum communis|C1707982|||C1707982|NCI|1|0.2379|1
EDD|DD5;E3 UBIQUITIN PROTEIN LIGASE, HECT DOMAIN-CONTAINING, 1;EDD1;KIAA0896;UBR5;UBR5 gene;ubiquitin protein ligase E3 component n-recognin 5|C1825027|||C1825027|HUGO;MTH;OMIM|||
EDD|Due Date;Due date;due date|C2825543;C3146290|||C2825543|CHV;NCI;SNOMEDCT|||
EDD|EDC|C0015081;C1832097;C2825543|||C2825543|NCI|||
EDD|EDC - Expected date of confinement||||C2825543|SNOMEDCT|||
EDD|EDD|C1825027;C2825543|||C1825027;C2825543|HUGO;LNC;OMIM|||
EDD|EDD - Expected date of delivery;Estimated date of birth;Estimated date of confinement;estimated date of confinement;Expected Date of Confinement;baby's due date|C2825543|||C2825543|CHV;MTH;NCI;SNOMEDCT|||
EDD|End-diastolic diameter;end-diastolic diameter||||||1|0.2871|1
EDD|Estimated date of delivery;estimated date of delivery;estimated delivery date|C2741670;C2825543|||C2825543|CHV;LNC;SNOMEDCT|||
EDD|Estimated date of delivery (observable entity)||||C2825543|SNOMEDCT|||
EDD|HYD|C0020402;C1825027|||C1825027|HUGO;OMIM|||
EDD|HYPERPLASTIC DISCS, DROSOPHILA, HOMOLOG OF||||C1825027|OMIM|||
EDD|PROGESTIN-INDUCED PROTEIN||||C1825027|OMIM|||
EDD|date of delivery;delivery date|C2053594;C2825543|||C2825543|CHV|1|0.1188|
EDD|effective drug duration||||||||1
EDD|electron-dense deposits||||||1|0.1089|
EDD|end-diastolic dimension||||||1|0.2475|1
EDD|endothelium-dependent dilation||||||1|0.1287|1
EDD|enzyme-digested delta||||||||1
EDD|esophageal detection device||||||||1
EDD|esophageal detector device||||||1|0.1089|
EDD|estimated discharge date||||||||1
EDD|estimated due date||||||||1
EDD|expected date of delivery||1|1.000|||||1
EDD|extended daily dialysis||||||||1
ED|(drug) ED||1|0.002|||||
ED|A & E - Accident and Emergency Department||||C0562508|SNOMEDCT|||
ED|AED - Accident and Emergency department||||C0562508|SNOMEDCT|||
ED|Accident and Emergency department;accident emergency department;Casualty department;EMERGENCY ROOM;Emergency Room;Emergency room;emergencies room;emergency room;emergency rooms;Emergency Department;Emergency department;emergency department|C0562508|1|0.992|C0562508|AOD;CHV;HL7V3.0;LNC;MTH;NCI;SNOMEDCT|1|0.5907|1
ED|Accident and Emergency department (environment)||||C0562508|SNOMEDCT|||
ED|Dysfunction, Erectile;Erectile Dysfunction;Erectile dysfunction;dysfunction erectile;erectile dysfunction;erectile dysfunctions|C0242350;C1961100|1|0.002|C0242350;C1961100|CHV;CSP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.2244|1
ED|ED|C0242350;C0562508;C1547353|||C0013622;C0242350;C0562508;C1547353|LNC;MEDLINEPLUS;MSH;NCI|||
ED|EDUC||||C0013622|MSH|||
ED|Education;education|C0013621;C0013622;C0013658;C0039401|||C0013622|MSH;NCI|||1
ED|Educational aspects|C0013622|||C0013622|MTH|||
ED|Emergency department (DEEDS)||||C0562508|LNC|||
ED|Encapsulated Data Data Type;Encapsulated data - Data types|C1547353|||C1547353|MTH;NCI|||
ED|Encapsulated data|C1547353;C1548310|||C1547353|HL7V2.5|||
ED|Entner-Doudoroff||||||1|0.0041|1
ED|Erectile Dysfunction [Disease/Finding]||||C0242350|NDFRT|||
ED|Failure of erection;IMPOTENCE;Impotence;Impotence, NOS;impotence;Impotence, Male;Male Impotence;Impotence, Male Sexual;Male Sexual Impotence;Sexual Impotence, Male;Impotent;impotent;Male Erectile Disorder;Male erectile disorder;male erectile disorder;PENILE ERECTION IMPAIRMENT;Sexual impotence;Sexual impotence, NOS;sexual impotence;dysfunction erection;erection dysfunction|C0242350|||C0242350|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTHICD9;NCI;NDFRT;OMIM;QMR;SNOMEDCT|||
ED|Impotence (disorder)||||C0242350|SNOMEDCT|||
ED|Male erectile disorder (disorder)||||C0242350|SNOMEDCT|||
ED|Sexual impotence (finding)||||C0242350|SNOMEDCT|||
ED|[X] Male erectile disorder;[X]Male erectile disorder||||C0242350|SNOMEDCT|||
ED|deprivation|C0871712|||||1|0.0021|
ED|duration|C0449238;C2926735|||||1|0.0023|
ED|dysfunctioning erectile||||C0242350|CHV|||
ED|early differentiation||||||||1
ED|early distal||||||1|0.0023|
ED|eating disorder;eating disorders|C0013473|||||1|0.0301|1
ED|ectodermal dysplasia|C0013575|||C0013575|CHV;LCH;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0044|1
ED|ectopic depolarization||||||||1
ED|edema|C0013604;C1717255|||||||1
ED|edge detection||||||||1
ED|effective diameter||||||||1
ED|effective dose||||||1|0.0048|1
ED|effector domain|C0682970|||||1|0.0011|
ED|elbow disarticulation|C0408839|||C0408839|CHV|||1
ED|electrodiagnosis|C0013816|||||||1
ED|electrodialysis|C0683122|||C0683122|AOD|1|0.003|1
ED|electron diffraction||||||1|0.0037|1
ED|elemental diet|C0012163|||||1|0.0087|1
ED|embryonic day||||||1|0.0333|
ED|embryonic death||||||||1
ED|emotional defensiveness||||||||1
ED|emotional disorder|C0233459|||C0233459|CHV;CSP;MTH;SNOMEDCT|||1
ED|emotional disturbance|C0013985|||||||1
ED|emotionally disturbed|C0677660;C0677661|||C0677660;C0677661|CHV;SNOMEDCT|||1
ED|end diastole;end-diastole|C1562146|||||1|0.0119|1
ED|end-diastolic|C0442709|||||1|0.0177|
ED|endogenous depression|C0011573|||||1|0.0021|
ED|endolymphatic duct|C0014167|||||1|0.0023|
ED|energy density||||||1|0.0069|
ED|enteric drainage||||||1|0.0034|
ED|entering diagnosis||||||||1
ED|enumeration district||||||1|0.0023|
ED|enzyme deficiency|C0149676|||C0149676|CHV;COSTAR;CSP;NCI|||1
ED|epidural|C0812144|||C0592511;C0812144;C1283259;C1550254|CHV;HL7V2.5;NCI;SNOMEDCT|||1
ED|epileptiform discharge||||||||1
ED|epithelial defect||||||||1
ED|epithelial dysplasia|C0878500|||||1|0.0037|
ED|equilibrium dialysis|C1553177|||||1|0.0041|1
ED|equine dermis||||||||1
ED|equivalent dose||||||||1
ED|erythema dose||||||||1
ED|erythrocyte deformability|C0014774|||||1|0.0016|
ED|essential dynamics||||||1|0.0021|
ED|ethyldichloroarsine||||||||1
ED|ethylenediamine|C0015091|||||||1
ED|evidence of disease||||||||1
ED|exertional dyspnea|C0231807|||C0231807|CHV;OMIM;SNOMEDCT|||1
ED|exit dose||||||||1
ED|exponential distribution|C1711243|||C1711243|NCI|||
ED|extensive disease|C0849867|||C0849867|NCI|1|0.0245|1
ED|extensor digitorum|C0224268;C1304999|1|0.002|C0224268;C1304999|CHV;FMA;SNOMEDCT;UWDA|||1
ED|external diameter|C2314971|||C2314971|SNOMEDCT|1|0.0025|1
ED|extra-low dispersion||||||||1
ED|impotents||||C0242350|CHV|||
EEG|Brain electrical activity;electrical activity of the brain|C0234388|||||1|0.0044|
EEG|EEG;EEG, NOS;EEG - Electroencephalography;eeg electroencephalography;electroencephalography (EEG);Electroencephalography;electroencephalography|C0013819|||C0013819;C1552380;C1611834;C1851758|AOD;CHV;CSP;HL7V3.0;LCH;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.1623|1
EEG|EEG - Technician, Other - NUCCProviderCodes||||C1611834|MTH|||
EEG|ELECTROENCEPHALOGR||||C0013819|MSH|||
EEG|ELECTROENCEPHALOGRAPHIC PATTERNS|C1851758|||C1851758|MTH;OMIM|||
EEG|Electroencephalogram;Electroencephalogram, NOS;electro-encephalogram;electroencephalogram;electroencephalograms;Electroencephalogram (EEG)|C0013819;C1527380;C1547121;C1704279|||C0013819;C1527380;C1704279|CCS;CHV;ICD9CM;MSH;MTH;NCI;SNOMEDCT|1|0.4853|1
EEG|Electroencephalogram (procedure)||||C0013819|SNOMEDCT|||
EEG|Electroencephalographic activity||||||1|0.0035|
EEG|Electroencephalography (procedure)||||C0013819|SNOMEDCT|||
EEG|Specialist / Technologist - EEG||||C1552380|MTH|||
EEG|electro-encephalographic;electroencephalographic||||||1|0.3136|
EEG|electroencephalograph|C0443310|1|1.000|||1|0.0238|1
EEG|electroencephalographically||||||1|0.002|
EEG|video-electroencephalographic||||||1|0.0026|
EEG|video-electroencephalography||||||1|0.0024|
EF|early follicular||||||1|0.0472|
EF|eccentric fixation|C0262461|||||||1
EF|ectopic focus||||||||1
EF|edema factor|C0105042;C0962274|||C0105042;C0962274|MSH;MTH;SNOMEDCT|||1
EF|ejection fraction;ejection fractions|C0489482;C2700378|1|0.998|C0489482;C2700378|CHV;LNC|1|0.1639|1
EF|elastic fiber|C0230899|||||||1
EF|elastic fibril||||||||1
EF|elbow flexor||1|0.002|||||
EF|electric field|C0337037|||C0337037|CHV;CSP;SNOMEDCT|1|0.0861|1
EF|elongation factor|C0086206|||C0086206|CHV;CSP;MSH|1|0.1722|1
EF|embryo fibroblast||||||||1
EF|embryofetal||||||||1
EF|emergency facility||||||||1
EF|emotional factor||||||||1
EF|encephalitogenic factor||||||||1
EF|endothoracic fascia|C0225799|||C0225799|FMA;MTH;SNOMEDCT;UWDA|||1
EF|endurance factor||||||||1
EF|enrichment factors||||||1|0.0361|
EF|enteral feeding|C0086225|||||1|0.0167|
EF|eosinophilic fasciitis|C0264005|||C0264005|CHV;MTHICD9;OMIM;QMR;SNOMEDCT|1|0.1417|1
EF|eosinophilic folliculitis|C0744066|||||1|0.025|
EF|epithelial focus||||||||1
EF|equivalent focus||||||||1
EF|erectile function||||||1|0.0667|
EF|erythroblastosis fetalis|C0014761|||C0014761|CHV;CSP;CST;MSH;NDFRT;SNOMEDCT|||1
EF|erythrocytic fragmentation||||||||1
EF|escape focus||||||||1
EF|essential findings||||||||1
EF|executive function;executive functioning|C0935584|||||1|0.1611|
EF|exophthalmic factor||||||||1
EF|exoplasmic face||||||1|0.0194|
EF|exposure factor||||||||1
EF|extended field||||||||1
EF|external fixation|C0407333|||||1|0.0306|
EF|extra food||||||||1
EF|extrafine||||||||1
EF|extrinsic factor||||||||1
EF|fluid|C0005889;C0302908;C0444611;C1704353|||||1|0.0333|
EGD|Combined upper GI endoscopy||||C0079304|SNOMEDCT|||
EGD|EGD;egd;egds;Esophagogastroduodenoscopies;Esophagogastroduodenoscopy;Oesophagogastroduodenoscopy;esophagogastroduodenoscopy;oesophagogastroduodenoscopy;Fiberoptic esophagogastroduodenoscopy;Fibreoptic oesophagogastroduodenoscopy;Upper GI endoscopy;endoscopy gi upper;endoscopy upper gi;upper gi endoscopy;Upper Gastrointestinal endoscopy;Upper gastrointestinal endoscopy;upper gastrointestinal endoscopy;Upper gastrointestinal tract examination;upper digestive system endoscopy|C0079304|1|1|C0079304|AOD;CHV;CSP;LNC;MSH;MTH;MTHICD9;MTHMST;NCI;SNOMEDCT|1|0.9324|1
EGD|Endoscopic examination of esophagus, stomach and duodenum;Endoscopic examination of oesophagus, stomach and duodenum||||C0079304|SNOMEDCT|||
EGD|Endoscopic examination of esophagus, stomach and duodenum (procedure)||||C0079304|SNOMEDCT|||
EGD|Endoscopic examination of upper GI tract||||C0079304|SNOMEDCT|||
EGD|Esophagogastroduodenoscopy (procedure);Oesophagogastroduodenoscopy (procedure)||||C0079304|SNOMEDCT|||
EGD|Fiberoptic esophagogastroduodenoscopy (procedure);Fibreoptic oesophagogastroduodenoscopy (procedure)||||C0079304|SNOMEDCT|||
EGD|OGD - Esophagogastroduodenoscopy;OGD - Oesophagogastroduodenoscopy||||C0079304|SNOMEDCT|||
EGD|endocervical glandular dysplasia||||||||1
EGD|upper endoscopy|C0017195|||||1|0.0676|
EHL|Environmental Health Laboratory||||||||1
EHL|Evaporative heat loss||||||1|0.1111|
EHL|effective half-life|C2986842|||||||1
EHL|electrohydraulic lithotripsy|C2960072|||C2960072|SNOMEDCT|1|0.5802|1
EHL|endogenous hyperlipidemia|C0020480|||||||1
EHL|endoscopic hemorrhoid ligation||||||||1
EHL|essential hyperlipidemia||||||||1
EHL|extensor hallucis longus|C0224466;C1305069|1|1.000|C0224466;C1305069|CHV;FMA;SNOMEDCT;UWDA|1|0.3086|1
EKG|ECG;ECG NOS;ecgs;EKG;ekgs;Electrocardiography;Electrocardiography NOS;electrocardiography|C0013798;C1623258|||C0013798;C1623258|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.0595|1
EKG|ELECTROCARDIOGR||||C1623258|MSH|||
EKG|Electrocardiogram;Electrocardiogram, NOS;Electrocardiograms;electrocardiogram;electrocardiograms|C0013798;C1547122;C1623258;C1705651|||C0013798;C1623258|CCS;CHV;CSP;ICD9CM;MSH;MTH;MTHHH;NCI;SNOMEDCT|1|0.7135|1
EKG|Electrocardiograph;electrocardiograph|C0013798;C0180600;C1623258|1|1|C0013798;C1623258|CHV;LCH;LNC|||1
EKG|Electrocardiographic procedure;Electrocardiographic procedure, NOS|C1623258|||C1623258|SNOMEDCT|||
EKG|Electrocardiographic procedure (procedure)||||C1623258|SNOMEDCT|||
EKG|Electrocardiography (procedure);Electrocardiography NOS (procedure)||||C1623258|SNOMEDCT|||
EKG|Electrocardiography NOS (regime/therapy)||||C1623258|SNOMEDCT|||
EKG|electrocardiogram (EKG, ECG)||||C0013798|CHV|||
EKG|electrocardiographic||||||1|0.227|
EMG|ELECTROMYOGR||||C0013839|MSH|||
EMG|ELECTROMYOGRAPH, DIAGNOSTIC||||C0180677|SPN|||
EMG|EM-Electromyography;EMG;EMG - Electromyography;electromyography emg;Electromyographies;Electromyography;Electromyography, NOS;electromyography|C0013839|||C0013839;C0180677;C0200204|AOD;CHV;CSP;ICD9CM;LCH;LNC;MSH;MTH;MTHCH;MTHICD9;NCI;SNOMEDCT|||1
EMG|Electromyogram examination of eye;Electromyogram of eye;Electromyogram of eye [EMG];Ocular electromyography;Oculoelectromyography with medical evaluation|C0200204|||C0200204|ICD9CM;MTH;SNOMEDCT|||
EMG|Electromyogram examination of eye (procedure)||||C0200204|SNOMEDCT|||
EMG|Electromyogram examination of eye (regime/therapy)||||C0200204|SNOMEDCT|||
EMG|Electromyographic;electromyographic||||||1|0.7856|1
EMG|Electromyographs;electromyograph;electromyographs;electromyograph (EMG)|C0180677|||C0180677|CHV;MTH|1|0.0227|1
EMG|Electromyography (procedure)||||C0013839|SNOMEDCT|||
EMG|Electromyography (regime/therapy)||||C0013839|SNOMEDCT|||
EMG|electromyelograph||1|1.000|||||
EMG|electromyogram|C2945634|||C2945634|CHV;LNC;SNOMEDCT|1|0.0073|1
EMG|electromyographi||||C0013839|CHV|||
EMG|electromyographic activity||||||1|0.0491|
EMG|electromyographical||||||1|0.0091|
EMG|electromyographically||||||1|0.0039|
EMG|emergency|C0013956;C0175673;C2745965|||||||1
EMG|essential monoclonal gammopathy||||||||1
EMG|exomphalos, macroglossia, gigantism||||||||1
EMG|experimental myasthenia gravis|C0752087|||||1|0.0033|
EMG|eye movement gauge||||||||1
EMG|surface electromyogram||||||1|0.0555|
EMG|surface electromyography|C0430815|||||1|0.0634|
EMLA|EMLA;EMLA [brand name];Eutectic Mixture of Local Anaesthetics;Eutectic Mixture of Local Anesthetics;eutectic mixture of local anesthetics|C0059079|1|1|C0059079|CHV;MSH;MTH;NCI;PDQ;RXNORM|1|0.9067|1
EMLA|eutectic mixture of lidocaine and prilocaine||||||1|0.0933|
EMLA|eutectic mixture of lidocaine and prilocaine (EMLA)||||C0059079|CHV|||
EMS|EMERGENCY MED SERV;EMERGENCY SERV MED;MED SERV EMERGENCY;SERV EMERGENCY MED||||C0013961|MSH|||
EMS|EMERGENCY SERVICES;Emergency Services;Emergency service;emergency service|C0013961|||C0013961|CHV;HCPCS;LCH|||
EMS|EMS|C0013961;C0015063|||C0013961;C0015063|LNC;NCI|||
EMS|Electromyostimulation||||||1|0.0146|
EMS|Emergency Medical Service;Emergency Medical Services;Emergency Service, Medical;Emergency Services, Medical;Emergency medical service;Emergency medical services;Medical Emergency Service;Medical Emergency Services;Medical Service, Emergency;Medical Services, Emergency;Service, Emergency Medical;Service, Medical Emergency;Services, Emergency Medical;Services, Medical Emergency;emergency medical service;emergency medical services|C0013961;C1555738|1|1|C0013961|CHV;LCH;MEDLINEPLUS;MSH;MTH;SNOMEDCT|1|0.4595|1
EMS|Emergency medical services (qualifier value)||||C0013961|SNOMEDCT|||
EMS|Ethyl Mesilate;Ethyl Mesylate;Ethylmesilate;Ethylmesylate;Mesilate, Ethyl;Mesylate, Ethyl;Ethyl Methanesulfonate;Ethylmethane Sulfonate;Methanesulfonate, Ethyl;Sulfonate, Ethylmethane;ethyl methane sulfonate;ethyl methane sulphonate;ethyl methanesulfonate;ethyl methanesulphonate;ethylmethane sulfonate;ethylmethane sulphonate;ethylmethanesulfonate;ethylmethanesulphonate;Methanesulfonic acid, ethyl ester|C0015063|||C0015063|MSH;MTH;NCI;NDFRT|1|0.3043|1
EMS|Ethyl Methanesulfonate [Chemical/Ingredient]||||C0015063|NDFRT|||
EMS|care emergency;emergency care|C0013961;C0013969;C1527398|||C0013961|CHV|||
EMS|early morning specimen||||||||1
EMS|early morning stiffness||||||||1
EMS|electrical muscle stimulation||||||1|0.0061|1
EMS|electrical muscle stimulator||||||||1
EMS|electrophoretic mobility shift||||||1|0.0085|
EMS|emergency medical system||||||1|0.0195|1
EMS|empty spiracles||||||1|0.0103|
EMS|encephalo-myo-synangiosis;encephalomyosynangiosis||||||1|0.0152|1
EMS|endometriosis|C0014175|||C0014175|CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|||1
EMS|eosinophilia-myalgia syndrome|C0085179|||C0085179|CHV;DXP;MSH;MTH;NDFRT|1|0.0822|1
EMS|esophageal manometric sequence||||||||1
EMS|expandable metallic stent||||||1|0.0116|
EMS|extensive|C0205231|||||1|0.0073|
EMS|extensive metabolisers;extensive metabolizers||||||1|0.0609|
EMS|extramedullary site||||||||1
EMT|3-Oct|C0083838|||C1420138|HUGO;OMIM|||
EMT|EMERGENCY MED TECHNICIAN;EMERGENCY MED TECHNICIANS;MED TECHNICIAN EMERGENCY;MED TECHNICIANS EMERGENCY;TECHNICIAN EMERGENCY MED;TECHNICIANS EMERGENCY MED||||C0013963|MSH|||
EMT|EMERGENCY MEDICAL TECHNICIAN;Emergency Medical Technician;Emergency Medical Technicians;Emergency medical technician;Emergency medical technicians;Medical Technician, Emergency;Medical Technicians, Emergency;Technician, Emergency Medical;Technicians, Emergency Medical;emergency medical technician;emergency medical technicians;EMT (emergency medical technician);emergency medical technician (EMT)|C0013963;C1549968|1|1|C0013963;C1549968|AOD;CHV;CSP;HL7V2.5;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.1744|
EMT|EMT;emt||||C0013963;C0215474;C1367389;C1420138;C1523298;C1706224|AOD;CHV;GO;HUGO;NCI;OMIM;SNOMEDCT|||
EMT|EMT ORGANIC CATION TRANSPORTER 3;EXTRANEURONAL MONOAMINE TRANSPORTER;extraneuronal monoamine transporter;SLC22A3;SLC22A3 gene|C1420138|||C1420138|HUGO;MTH;OMIM|1|0.0923|
EMT|Emergency Medicine Technician;Emergency Medicine Technicians;Technician, Emergency Medicine;Technicians, Emergency Medicine;Emergency Paramedic;Emergency Paramedics;Paramedic, Emergency;Paramedics, Emergency|C0013963|||C0013963|MSH|||
EMT|Epithelial Mesenchymal Transformation;Epithelial-Mesenchymal Transformation;Epithelial-Mesenchymal Transformations;Transformation, Epithelial-Mesenchymal;Transformations, Epithelial-Mesenchymal;epithelial-mesenchymal transformation;Epithelial Mesenchymal Transition;Epithelial-Mesenchymal Transition;Epithelial-Mesenchymal Transitions;Transition, Epithelial-Mesenchymal;Transitions, Epithelial-Mesenchymal;epithelial to mesenchymal transition;epithelial-mesenchymal transition;mesenchymal to epithelial transition;mesenchymal-epithelial transition|C1523298|||C1523298|GO;MSH;MTH|1|0.6564|
EMT|IL-2-inducible T-cell kinase;IL2-INDUCIBLE T-CELL KINASE;IL2-Inducible T-Cell Kinase;IL2-inducible T-cell kinase|C0215474;C1367389|||C0215474;C1367389|HUGO;MSH;MTH;NCI;OMIM|||
EMT|IL2-Inducible T-Cell Kinase Gene;ITK;ITK Gene;ITK gene|C1367389|||C1367389|HUGO;MTH;NCI;OMIM|||
EMT|IL2-Inducible T-Cell Kinase wt Allele;ITK wt Allele|C1706224|||C1706224|MTH;NCI|||
EMT|Kinase EMT;T-Cell-Specific Kinase;T-cell-specific kinase;Tyrosine-Protein Kinase LYK;emt protein-tyrosine kinase;inducible T cell kinase;interleukin-2 tyrosine kinase|C0215474|||C0215474|MSH;NCI|||
EMT|LYK|C0215474;C1367389;C1706224|||C0215474;C1367389;C1706224|HUGO;NCI|||
EMT|PSCTK2||||C0215474;C1367389;C1706224|HUGO;NCI|||
EMT|Paramedic|C0013963;C0030450|||C0013963|SNOMEDCT|||
EMT|Paramedic (occupation)||||C0013963|SNOMEDCT|||
EMT|SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3;solute carrier family 22 (extraneuronal monoamine transporter), member 3||||C1420138|HUGO;OMIM|||
EMT|T-CELL ITK/TSK TYROSINE KINASE, MOUSE, HOMOLOG OF||||C1367389|OMIM|||
EMT|T-Cell ITK/TSK Homolog||||C0215474|NCI|||
EMT|TYROSINE KINASE EXPRESSED MAINLY IN T CELLS||||C1367389|OMIM|||
EMT|Tyrosine-Protein Kinase ITK/TSK||||C0215474|NCI|||
EMT|electronic medical textbook||||||||1
EMT|emergency medical tag|C0013962|||||||1
EMT|emergency medical treatment||||||||1
EMT|endocardial mapping technique||||||||1
EMT|epithelial-mesenchymal transdifferentiation||||||1|0.0308|
EMT|transitions||||||1|0.0462|
ENT|*Entitic;Entitic|C1304535|||C1304535|HL7V2.5;MTH;SNOMEDCT|||
ENT|5'-nucleotidase, ecto (CD73)||||C1417861|HUGO|||
ENT|CD73;E5NT;ECTO-5-PRIME NUCLEOTIDASE;NUCLEOTIDASE, ECTO-5-PRIME;NT5E;NT5E gene|C1417861|||C1417861|HUGO;MTH;OMIM|||
ENT|ENT;eNT||||C0150934;C1274038;C1304535;C1417861|CHV;HUGO;LNC;OMIM;SNOMEDCT|||
ENT|Ear, Nose and Throat;Ear, nose and throat;ear nose and throat;ear nose throat;ear throat nose;ear-nose-throat;ears nose throat;ears, nose, throat;nose ear throat;throat nose ear;ear, nose and throat (ENT)|C0150934|1|1|C0150934|AIR;CHV;MEDLINEPLUS;MTH;SNOMEDCT|1|0.4285|1
ENT|Ear, nose and throat structure||||C0150934|SNOMEDCT|||
ENT|Ear, nose and throat structure (body structure)||||C0150934|SNOMEDCT|||
ENT|Ear, nose and throat surgery;ear nose throat surgery;ear throat nose surgery;ear nose and throat (ENT) surgery|C1274038|||C1274038|CHV;CSP;MTH;SNOMEDCT|||
ENT|Ear, nose and throat surgery (qualifier value)||||C1274038|SNOMEDCT|||
ENT|Entitic (property)||||C1304535|SNOMEDCT|||
ENT|Entitic (property) (qualifier value)||||C1304535|SNOMEDCT|||
ENT|NT5|C1417861;C1417863|||C1417861|OMIM|||
ENT|NTE|C1417861;C1826637|||C1417861|OMIM|||
ENT|eN|C1417861;C2987294|||C1417861|HUGO|||
ENT|embryonic nervous tissue||||||1|0.1224|
ENT|entorhinal cortex|C0175196;C1289526|||||1|0.1837|
ENT|enzootic nasal tumor||||||||1
ENT|equilibrative nucleoside transporter||||||1|0.2653|
ENT|extranodular tissue||||||||1
EOMI|extraocular movements intact||1|1.000|||||1
EOMI|extraocular muscles intact||||||||1
EOM|EOM;eom;eoms;EXTRAOCULAR;Extraocular;extraocular|C0241886|||C0241886|CHV;DXP;NCI|||
EOM|end of message||||||||1
EOM|equal ocular movement||||||||1
EOM|error of measurement||||||||1
EOM|external otitis media||||||||1
EOM|extraocular motion||1|1.000|||||1
EOM|extraocular muscle|C0028863;C1268995|||C0028863;C1268995|CHV;CSP;FMA;NCI;SNOMEDCT;UWDA|1|0.8803|1
EOM|organic matter||||||1|0.1197|
EPO|1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha||||C0357126|MSH|||
EPO|CLGI;TIMP1 wt Allele|C1705819|||C1705819|MTH;NCI|||
EPO|COLLAGENASE INHIBITOR, HUMAN;TIMP metallopeptidase inhibitor 1;TIMP1 Gene;TIMP1 gene|C1367459|||C1367459|HUGO;MTH;NCI;OMIM|||
EPO|ECSF;EPO;Epo;epo;epos;EPO - Erythropoietin;ESA - Erythropoietin stimulating agent;Epoetin;Erythropoietin preparation;Erythropoietin stimulating agent|C0014822|||C0014822;C0202001;C0357126;C1366564;C1367459;C1414438;C1705819|CHV;CSP;HUGO;NCI;OMIM;PDQ;SNOMEDCT|||
EPO|ECSF (erythrocyte colony stimulating factor)||||C0014822|CSP|||
EPO|EOSINOPHIL PEROXIDASE;eosinophil peroxidase|C0059407;C1414438|||C0059407;C1414438|HUGO;MSH;MTH;NDFRT;OMIM|1|0.0738|
EPO|EP||||C1366564|HUGO;OMIM|||
EPO|EPA||||C1367459;C1705819|NCI;OMIM|||
EPO|EPO Gene;EPO gene;Erythropoietin Gene|C1366564|||C1366564|HUGO;MTH;NCI|||
EPO|EPO assay;Erythropoietin Measurement;Erythropoietin measurement;erythropoietin level test;erythropoietin test|C0202001|||C0202001|CHV;MTH;NCI;SNOMEDCT|||
EPO|EPOETIN ALFA,RECOMBINANT;epoetin alfa recombinant||||C0357126|CHV;NDFRT;VANDF|||
EPO|EPP|C0162568;C1414438|||C1414438|HUGO|||
EPO|EPX;EPX gene;EPX-PEN|C1414438|||C1414438|HUGO;MTH;OMIM|||
EPO|ERYTHROID POTENTIATING ACTIVITY|C1367459;C1522552|||C1367459|OMIM|||
EPO|ERYTHROPOIETIN;Erythropoietin;erythropoietin;erythropoietins|C0014822;C0202001;C0357126;C0376541;C1755594|1|1|C0014822;C0202001;C0357126;C1366564|AOD;CHV;CSP;HUGO;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.9036|1
EPO|Epidemiology Program Office||||||||1
EPO|Epoetin Alfa;Epoetin alfa;epoetin alfa;Epoetin alfa (product);Epoetin alfa product;recombinant 1-165 erythropoietin, glycoform alpha|C0357126|||C0357126|CHV;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG|||1
EPO|Epoetin Alfa [Chemical/Ingredient]||||C0357126|NDFRT|||
EPO|Epoetin alfa (substance)||||C0357126|SNOMEDCT|||
EPO|Erythrocyte Colony Stimulating Factor;erythrocyte colony stimulating factor|C0014822;C0376541|||C0014822|CSP;NCI|||
EPO|Erythropoietin (substance)||||C0014822|SNOMEDCT|||
EPO|Erythropoietin [Chemical/Ingredient]||||C0014822|NDFRT|||
EPO|Erythropoietin level;erythropoietin level;erythropoietin levels|C0202001;C0427434|||C0202001|CHV;SNOMEDCT|||
EPO|Erythropoietin measurement (procedure)||||C0202001|SNOMEDCT|||
EPO|Erythropoietin preparation (product)||||C0014822|SNOMEDCT|||
EPO|Erythropoietin preparation (substance)||||C0014822|SNOMEDCT|||
EPO|Erythropoietin product||||C0014822|SNOMEDCT|||
EPO|Erythropoietin product (product)||||C0014822|SNOMEDCT|||
EPO|Evening Primrose Oil;evening primrose oil|C0700602|||||1|0.02|1
EPO|HCI||||C1367459;C1705819|NCI;OMIM|||
EPO|Hematopoietin;hematopoietin|C0014822;C0202001;C0376541|||C0014822;C0202001|CSP;NCI|||
EPO|TIMP||||C1367459;C1705819|NCI;OMIM|||
EPO|TIMP1|C1367459;C2825911|||C1367459|HUGO;NCI;OMIM|||
EPO|TISSUE INHIBITOR OF METALLOPROTEINASE 1|C0145947;C1367459;C1522552;C2825911|||C1367459|OMIM|||
EPO|Tissue Inhibitor of Metalloproteinase 1 (Erythroid Potentiating Activity, Collagenase Inhibitor) Gene||||C1367459|NCI|||
EPO|Tissue Inhibitor of Metalloproteinase 1 (Erythroid Potentiating Activity, Collagenase Inhibitor) wt Allele||||C1705819|NCI|||
EPO|epoprostenol|C0033567|||||1|0.0026|
EPO|erythropoiesis|C0014819|||C0014819|AOD;CHV;CSP;GO;LCH;MSH;NCI;SNOMEDCT|||
EPO|exclusive provider organization|C1552477|||||||1
EP|Atypical Pneumonia, Primary;Atypical Pneumonias, Primary;PNEUMONIA, PRIMARY ATYPICAL;Pneumonia, Primary Atypical;Pneumonias, Primary Atypical;Primary Atypical Pneumonia;Primary Atypical Pneumonias;primary atypical pneumonia|C0032302;C0702135|||C0032302|CHV;DXP;MSH;NDFRT|||
EP|CDDP-e TI;cisplatin/epirubicin protocol|C0280609|||C0280609|MTH;NCI|||
EP|CDDP/EPI||||C0280609|NCI;PDQ|||
EP|CDDP/VP-16||||C0078414|NCI;PDQ|||
EP|Cisplatin-e therapeutic implant|C0280609;C0677669|||C0280609|NCI|||
EP|Cisplatin/Epirubicin;cisplatin/epirubicin||||C0280609|NCI;PDQ|||
EP|Cisplatin/Etoposide;cisplatin and etoposide;cisplatin etoposide;cisplatin/etoposide;etoposide and cisplatin;P-VP protocol;VP-P protocol;VP-P chemotherapy protocol;VP-Plat;VPP;cisplatin/etoposide protocol|C0078414|||C0078414|CHV;MSH;MTH;NCI;PDQ|1|0.0154|
EP|E-prostanoid||||||1|0.0128|
EP|EP||||C0014508;C0032302;C0078414;C0115922;C0280609;C1366564;C1706321|HUGO;MSH;NCI;OMIM;PDQ;SNOMEDCT|||
EP|EPIDEMIOL||||C0014508|MSH|||
EP|EPO||||C1366564|HUGO;NCI;OMIM|||
EP|EPO Gene;EPO gene;Erythropoietin Gene|C1366564|||C1366564|HUGO;MTH;NCI|||
EP|EPO wt Allele;Erythropoietin wt Allele|C1706321|||C1706321|MTH;NCI|||
EP|ERYTHROPOIETIN;erythropoietin|C0014822;C0202001;C0357126;C0376541;C1755594|||C0014822;C0202001;C0357126;C0376541;C1366564;C1755594|AOD;CHV;CSP;GO;HUGO;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.2156|
EP|Eaton agent pneumonia;Eaton's agent pneumonia;Eatons agent pneumonia;PNEUMONIA, EATON AGENT;Endemic pneumonia;Mycoplasma pneumoniae pneumonia;Mycoplasmal pneumonia;PNEUMONIA, MYCOPLASMAL;mycoplasmal pneumonia;PAP due to Mycoplasma pneumoniae;PNEUMONIA, COLD AGGLUTININ POSITIVE;cold agglutinin positive pneumonia;Pneumonia due to Eaton's agent;Pneumonia due to Mycoplasma pneumoniae;Primary atypical pneumonia due to Mycoplasma pneumoniae|C0032302|||C0032302|CHV;CSP;DXP;ICD9CM;MTHICD9;SNOMEDCT|||
EP|Electrophysiology;electrophysiology|C0013865;C1446476|1|0.996|||1|0.0164|1
EP|Endocrine-paracrine||||||1|0.0051|
EP|Endogenous pyrogen;endogenous pyrogen;LEM;Leucocyte endogenous mediator;Leukocyte endogenous mediator;leukocyte endogenous mediator;leukocyte pyrogen|C0115922|||C0115922|CSP;MSH;MTH;SNOMEDCT|1|0.0317|1
EP|Infection by PPLO|C0026936;C0032302|||C0032302|SNOMEDCT|||
EP|MYCOPLASMA PNEUMONIA;Mycoplasma Pneumonia;Mycoplasma Pneumonias;Mycoplasma pneumonia;Pneumonia, Mycoplasma;Pneumonias, Mycoplasma;mycoplasma pneumonia;mycoplasmas pneumonia;pneumonia mycoplasma|C0026941;C0032302|||C0032302|CHV;COSTAR;MSH;MTH;NDFRT;QMR;SNOMEDCT|||
EP|Mycoplasma pneumonia (disorder)||||C0032302|SNOMEDCT|||
EP|Mycoplasmal pneumonia (disorder)||||C0032302|SNOMEDCT|||
EP|PE||||C0078414|NCI;PDQ|||
EP|PGE(2) receptors||||||1|0.0031|
EP|PPLO;pplo||||C0032302|CHV;CSP|||
EP|PVp||||C0078414|NCI;PDQ|||
EP|Pneu mycplsm pneumoniae||||C0032302|ICD9CM|||
EP|Pneumonia due to Mycoplasma pneumoniae (disorder)||||C0032302|SNOMEDCT|||
EP|Pneumonia due to PPLO|C0032302;C0553970|||C0032302|SNOMEDCT|||
EP|Pneumonia, Mycoplasma [Disease/Finding]||||C0032302|NDFRT|||
EP|bovine encephalitogenic protein||||||1|0.0026|
EP|cisplatin and etoposide chemotherapy protocol||||C0078414|CHV|||
EP|early phase||||||1|0.0031|
EP|ectopic pregnancy|C0032987;C1315536|||C0032987|CCS;CHV;COSTAR;CSP;DXP;ICD9CM;ICPC;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;QMR;SNOMEDCT|1|0.1068|1
EP|edible portion||||||||1
EP|egg production||||||1|0.0138|
EP|electrophoresis|C0013855|||C0013855|AOD;CHV;CSP;HL7V3.0;LCH;LNC;MSH;NCI;SNOMEDCT|||1
EP|electrophoretic||||||||1
EP|electrophysiologic||||||1|0.0296|1
EP|electrophysiological||||||1|0.0143|
EP|electroprecipitin||||||||1
EP|elopement precaution||||||||1
EP|emergency physician||||||1|0.0184|
EP|emergency procedure|C1298802|||||||1
EP|encephalitogenic peptide||||||1|0.0031|
EP|end point|C2349179;C2826544|||C2349179|MTH;NCI|||1
EP|endocochlear potential|C0234738|||||1|0.1058|
EP|endoperoxide||||||||1
EP|endorphin|C0014242;C0205752|||||||1
EP|endoscopic papillotomy|C0085263|||||1|0.0066|
EP|enteropeptidase|C0014366;C1418973|||C0014366;C1418973|CHV;HUGO;LNC;MSH;MTH;NDFRT;SNOMEDCT|||1
EP|entopeduncular nucleus|C0228359|||||1|0.023|
EP|environmental protection|C0242228|||||||1
EP|enzootic pneumonia||||||1|0.0046|
EP|enzyme product||||||||1
EP|eosinophilic pneumonia|C0034068;C1527407|||C0034068;C1527407|CHV;COSTAR;CST;MSH;MTH;NCI;SNOMEDCT|1|0.0066|1
EP|ependymal|C0521405|||||||1
EP|ephedrine|C0014479|||||1|0.0051|
EP|epicardial|C0442016|||||||1
EP|epidemiologic|C0014507;C0014508|||C0014508|MTH|||
EP|epidemiology|C0014507;C0014508;C0699910|||C0014508|MSH|||
EP|epirubicin|C0014582|||C0014582|CHV;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
EP|epithelial|C0221908|||||||1
EP|epithelium|C0014609|||||||1
EP|epoxide|C0014630|||C0014630|CHV;CSP|||
EP|equilibrium point|C0678589|||||1|0.0026|
EP|erythrocyte protoporphyrin||||||1|0.023|1
EP|erythrophagocytosis|C0302486|||C0302486|CHV;MTH;NCI;SNOMEDCT|||1
EP|erythropoietic porphyria|C0162530|||C0162530|CHV;MSH;NCI;NDFRT;SNOMEDCT|||1
EP|escape protein||||||1|0.0046|
EP|esophageal pressure|C0232531|||C0232531|CHV;CSP;SNOMEDCT|||1
EP|esophoria|C0152216|||||||1
EP|estrogen-progesterone||||||1|0.0056|
EP|etoposide phosphate|C0059874|||||1|0.0056|
EP|etoposide plus cisplatin||||||1|0.0051|
EP|evoked potential;evoked potentials|C0015214;C0561862|||C0015214|AOD;CHV;CSP;MSH;SNOMEDCT|1|0.208|1
EP|excretory phase||||||||1
EP|extreme pressure||||||||1
EP|pale ear||||||1|0.0051|
EP|period|C0439531;C1948053|||||1|0.0056|
EP|phosphoenzyme||||||1|0.0271|
EP|phosphoenzyme intermediate||||||1|0.0051|
EP|phosphorylated intermediate||||||1|0.0107|
EP|pressure|C0033095;C0460139;C1306345|||||1|0.0118|
EP|pressure strain elastic modulus||||||1|0.0097|
EP|progesterone|C0033308;C2757070|||||1|0.0087|
EP|prostaglandin E|C0033559|||||1|0.0072|
EP|receptor|C0597357|||||1|0.0066|
EP|vivo electroporation||||||1|0.0046|
ERCP|CHOLANGIOPANCREATOGR ENDOSCOPIC RETROGRADE;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGR;RETROGRADE CHOLANGIOPANCREATOGR ENDOSCOPIC||||C0008310|MSH|||
ERCP|Cholangiopancreatographies, Endoscopic Retrograde;Cholangiopancreatography, Endoscopic Retrograde;Endoscopic Retrograde Cholangiopancreatographies;Endoscopic Retrograde Cholangiopancreatography;Endoscopic retrograde cholangiopancreatography;Endoscopic retrograde cholangiopancreatography, NOS;Retrograde Cholangiopancreatographies, Endoscopic;Retrograde Cholangiopancreatography, Endoscopic;endoscopic retrograde cholangiopancreatography;ERCP (endoscopic retrograde cholangiopancreatography);ERCP - Endoscopic retrograde cholangiopancreatography;Endoscopic retrograde cholangiopancreatography [ERCP];endoscopic retrograde cholangiopancreatography (ERCP);Endoscopic retrograde cholangio-pancreatography;Endoscopic retrograde choledochopancreatography;endoscopic retrograde choledochopancreatography|C0008310|||C0008310|AOD;CHV;CSP;ICD9CM;MSH;MTH;MTHICD9;MTHMST;NCI;SNOMEDCT|1|0.9215|1
ERCP|Consent Type - ERCP|C1548852|||C1548852|MTH|||
ERCP|Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct;Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct NOS||||C0008310|SNOMEDCT|||
ERCP|Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct (procedure);Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct NOS (procedure)||||C0008310|SNOMEDCT|||
ERCP|ERCP;ERCP, NOS|C0008310;C1548852|||C0008310;C1548852|HL7V2.5;LNC;MSH;MTHICD9;MTHMST;NCI;SNOMEDCT|||
ERCP|ERP||||C0008310|AOD|||
ERCP|Endosc retro cholangiopa||||C0008310|ICD9CM|||
ERCP|Endoscopic catheterisation of pancreatic duct and bile duct systems;Endoscopic catheterization of pancreatic duct and bile duct systems||||C0008310|SNOMEDCT|||
ERCP|Endoscopic catheterization of pancreatic duct and bile duct systems (procedure)||||C0008310|SNOMEDCT|||
ERCP|Endoscopic retrograde cholangiopancreatography (procedure)||||C0008310|SNOMEDCT|||
ERCP|Endoscopic retrograde cholangiopancreatography (procedure) [Ambiguous]||||C0008310|SNOMEDCT|||
ERCP|Endoscopic retrograde cholangiopancreatography -RETIRED-||||C0008310|SNOMEDCT|||
ERCP|endoscopic retrograde cholangiography|C0193504|||||1|0.0224|
ERCP|endoscopic retrograde cholangiopancreaticography||||||1|0.0318|
ERCP|endoscopic retrograde cholangiopancreatogram||||||1|0.0087|1
ERCP|endoscopic retrograde cholangiopancreatograph||1|1.000|||||1
ERCP|endoscopic retrograde cholangiopancreatographic||||||1|0.0062|
ERCP|endoscopic retrograde pancreatography|C0337380|||||1|0.0094|
ER|E2R - Estrogen receptor;E2R - Oestrogen receptor;Estrogen receptor site;Oestrogen receptor site|C0034804|||C0034804|SNOMEDCT|||
ER|EPIREGULIN;epiregulin;EREG|C0296263;C1366644|||C1366644|HUGO;NCI;OMIM|||
ER|ER;Er;ERBIUM;Erbium;erbium;Erbium Metallicum|C0014688|||C0014239;C0014688;C0014716;C0034804;C1366644;C1414461;C1521863;C1706235;C1706324;C1707968|AOD;CHV;GO;HUGO;LCH;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;SNOMEDCT|||1
ER|ER-Alpha|C0665341;C1521863|||C1521863|NCI|||
ER|ERA;Era|C0681698;C1414461;C1706235|||C1414461;C1706235|HUGO;NCI|||
ER|EREG Gene;EREG gene;Epiregulin Gene|C1366644|||C1366644|HUGO;MTH;NCI|||
ER|EREG wt Allele;Epiregulin wt Allele|C1706324|||C1706324|MTH;NCI|||
ER|ERI;ERITREA;Eritrea|C0014716|||C0014716|AOD;MSH;MTH;NCI|||
ER|ESR||||C1414461;C1706235|NCI;OMIM|||
ER|ESR1||||C1414461;C1521863;C1706235|HUGO;NCI;OMIM|||
ER|ESR1 Gene;ESR1 gene;Estrogen Receptor 1 Gene|C1414461|||C1414461|HUGO;MTH;NCI|||
ER|ESR1 protein, human;NR3A1 protein, human;estrogen receptor 1, human;estrogen receptor alpha, human|C1521863|||C1521863|MSH;MTH|||
ER|ESR1 wt Allele;Estrogen Receptor 1 wt Allele|C1706235|||C1706235|MTH;NCI|||
ER|ESRA;NR3A1|C1414461;C1706235|||C1414461;C1706235|HUGO;NCI;OMIM|||
ER|ESTROGEN RECEPT;RECEPT ESTROGEN||||C0034804|MSH|||
ER|ESTROGEN RECEPTOR;Estrogen Receptor;Estrogen Receptors;Estrogen receptor;Oestrogen receptor;Receptors of estrogens;Receptors, Estrogen;estrogen receptor;estrogen receptors;oestrogen receptor;oestrogen receptors;estrogen receptor (ER)|C0034804;C1414461;C1521863|1|0.036|C0034804;C1414461;C1521863|CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.4295|1
ER|ESTROGEN RECEPTOR 1;Estrogen Receptor 1;estrogen receptor 1|C1121711;C1414461;C1521863|||C1414461;C1521863|HUGO;NCI;OMIM|||
ER|ESTROGEN RECEPTOR, ALPHA;Estrogen Receptor Alpha;Estrogen receptor alpha|C0665341;C1414461;C1521863|||C1414461;C1521863|NCI;OMIM|1|0.008|
ER|Emergency Room;emergency room|C0562508|1|0.896|C0562508;C1546435|AOD;CHV;HL7V2.5;HL7V3.0;NCI|1|0.0299|1
ER|Endoplasmic Reticulum;Endoplasmic reticulum;Endoplasmic reticulum, NOS;Reticulum, Endoplasmic;endoplasmic reticulum;Reticulum cytoplasmaticum;Reticulum endoplasmicum;endoplasmic reticulum (ER)|C0014239|||C0014239|AOD;CHV;CSP;FMA;GO;LCH;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.4321|1
ER|Endoplasmic reticulum (body structure)||||C0014239|SNOMEDCT|||
ER|Endoplasmic reticulum (cell structure)||||C0014239|SNOMEDCT|||
ER|Erbium (substance)||||C0014688|SNOMEDCT|||
ER|Erbium [Chemical/Ingredient]||||C0014688|NDFRT|||
ER|Ergastoplasm|C0014239;C0230779|||C0014239|MSH;SNOMEDCT|||
ER|Estradiol|C0014912|||||1|0.0025|
ER|Estradiol Receptor;estradiol receptor|C0034803;C0034804;C1521863|||C0034803;C0034804;C1521863|MSH;NCI;NDFRT;SNOMEDCT|||1
ER|Estrogen receptor (substance)||||C0034804|SNOMEDCT|||
ER|Extended Release;extended release;extended-release;Extended Release Dosage Form;Extended Release Dose Form|C1707968|1|0.068|C1707968|MTH;NCI|1|0.0152|1
ER|OR - Estrogen receptor;OR - Oestrogen receptor||||C0034804|SNOMEDCT|||
ER|Receptors, Estrogen [Chemical/Ingredient]||||C0034804|NDFRT|||
ER|XR|C1707968;C1962945|||C1707968|NCI|||
ER|early|C1279919|||||1|0.0014|
ER|early repolarization|C1997354|||||||1
ER|early response||||||1|0.0008|
ER|early reticulocyte||||||||1
ER|efficacy ratio||||||||1
ER|ejection rate||||||||1
ER|electrical resistance|C0162535;C1547024|||||1|0.0007|
ER|electroresection||||C0441536|SNOMEDCT|||1
ER|electrorheological||||||1|0.0013|
ER|end range||||||||1
ER|endoplasmic reticular||||||1|0.001|
ER|endoscopic resection||||||1|0.0009|
ER|endovascular repair||||||1|0.0006|
ER|energy restriction||||||1|0.0032|
ER|energy retention||||||1|0.0009|
ER|energy-restricted||||||1|0.0009|
ER|enhanced reactivation||||||1|0.0011|1
ER|enhancement ratio||||||1|0.0053|1
ER|environmental resistance||||||||1
ER|epigastric region|C0230185|||C0230185|AOD;CHV;FMA;NCI;SNOMEDCT;UWDA|||1
ER|equine rhinopneumonia||||||||1
ER|equivalent roentgen||||||||1
ER|erythrocyte receptor|C0142009|||C0142009|MSH|||1
ER|erythromycin|C0014806|||||1|0.0022|
ER|esophageal rupture|C0281839|||C0281839|CHV;COSTAR|||1
ER|estrogen;oestrogen|C0014939;C2936882|||||1|0.0507|
ER|estrogen receptor protein|C0059672|||||1|0.0005|
ER|estrogen receptor status;oestrogen receptor status|C1516974;C2919114|||||1|0.0014|
ER|ethoxyresorufin|C0059734|||||1|0.0009|
ER|evoked response||||||1|0.0023|1
ER|expiratory reserve|C0802739;C0806093|||C0802739;C0806093|LNC;MTH|||1
ER|extended external rotation||||||||1
ER|extended resistance||||||||1
ER|external reduction||||||||1
ER|external resistance||||||||1
ER|external rotation|C0231462|||C0231462|CHV;SNOMEDCT;UWDA|1|0.0014|1
ER|extraction ratio||||||1|0.0026|1
ER|eye research||||||||1
ER|rabbit erythrocytes||||||1|0.001|
ER|reversal potential||||||1|0.0018|
ES|(drug) ES||1|0.002|||||
ES|ARSC|C1420490;C2699259|||C2699259|NCI|||
ES|ARSC1;STS wt Allele|C2699259|||C2699259|MTH;NCI|||
ES|ASC|C2985440|||C2699259|NCI|||
ES|E-SINUS;ENDOSINUSIAL;Endosinusial;Endosinusial Route of Administration;Endosinusial Route of Drug Administration|C1522661|||C1522661|MTH;NCI|||
ES|EC 3.1.6.2||||C2699259|NCI|||
ES|EFTs;EWING TUMOR;Ewing Tumor;Ewing's Tumor;Ewing's tumor;Ewing's tumour;Ewings Tumor;Tumor, Ewing's;ewing tumor;ewing's tumor;ewing's tumors;ewings tumor;ewings tumors;Ewing Family of Tumors;Ewing's Family of Tumors;Ewing's Family of Tumours;Ewing's family of tumors;Tumors of Ewing's Family;Tumors of the Ewing's Family;Ewing sarcoma family of tumors|C0553580|||C0553580|CHV;CSP;DXP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
ES|EL SALVADOR;El Salvador;el salvador|C0013754|||C0013754|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
ES|ES;Es||||C0013754;C0037747;C0553580;C1522661;C1527243;C1552150;C2699259|HL7V3.0;MSH;NCI;OMIM|||
ES|ESP|C0015373;C0037747;C1421982;C2981686|||C0037747|NCI|||
ES|ETHICS;ethics|C0015000;C1527243;C1552232|||C1527243|MSH|||
ES|EWING SARCOMA;Ewing Sarcoma;Ewing sarcoma;Ewing's Sarcoma;Ewing's sarcoma;Ewings sarcoma;SARCOMA, EWING;Sarcoma, Ewing;Sarcoma, Ewing's;Sarcoma, Ewings;ewing sarcoma;ewing's sarcoma;ewings sarcoma;ewings's sarcoma;sarcoma ewing;sarcoma ewing's;sarcoma ewings;sarcoma, Ewing's|C0553580;C0684337|||C0553580|CHV;COSTAR;CSP;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.0491|1
ES|Ego Strength;ego strength||||||1|0.0029|1
ES|El Salvador (geographic location)||||C0013754|SNOMEDCT|||
ES|Embryonic stem;embryonic stem||||||1|0.5118|1
ES|Endotoxin shock||||||1|0.002|
ES|Epilepsy Surgery||||||1|0.0017|
ES|Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor||||C0553580|NCI|||
ES|Ewing's sarcoma (morphologic abnormality)||||C0553580|SNOMEDCT|||
ES|Excretory-secretory;excretory and secretory;excretory-secretory||||||1|0.0779|1
ES|Expectation Score||||||||1
ES|SLV|C0013754;C1826764|||C0013754|NCI|||
ES|SP|C0231290;C1420701;C1705920|||C0037747|NCI|||
ES|SPAIN;Spain;spain|C0037747|||C0037747|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
ES|SSDD|C0079588;C2699259;C2717836|||C2699259|NCI|||
ES|SV|C0013754;C0560132;C1704677|||C0013754|NCI|||
ES|Sarcoma, Ewing's [Disease/Finding]||||C0553580|NDFRT|||
ES|Spain (geographic location)||||C0037747|SNOMEDCT|||
ES|Steroid Sulfatase (Microsomal), Isozyme S wt Allele||||C2699259|NCI|||
ES|Steryl-sulfatase|C0052456;C2699259|||C2699259|NCI|||
ES|Supernumerary maxillary right central primary incisor|C1552150|||C1552150|MTH|||
ES|ectoplasmic specialization||||||1|0.0037|
ES|effect size|C0814843|||||1|0.031|
ES|einsteinium|C0013741|||||||1
ES|ejection sound|C0277911|||||||1
ES|elastic stockings|C0013761|||||||1
ES|elastic suspensor||||||||1
ES|electrical stimulation|C0013786|||||1|0.0701|1
ES|electrical stimulus||||||||1
ES|electrically stimulated||||||1|0.0023|
ES|electrophilic stress||||||||1
ES|electroshock|C0013870|||||||1
ES|electrospray||||||1|0.0169|1
ES|electrostimulation||||||1|0.0069|
ES|electrotherapy system||||||||1
ES|elopement status||||||||1
ES|embolic signals||||||1|0.0034|
ES|embryonic stem cells|C0596508|||||1|0.0043|
ES|emergency service|C0013961|||||||1
ES|emission spectrometry|C0596509|||||||1
ES|emotional stress|C0086209|||||1|0.0043|
ES|end stage|C0205088|||||||1
ES|end systole||||||||1
ES|end-to-side||||||||1
ES|endolymphatic sac|C0014168;C1281159|||||1|0.0342|
ES|endometrial stromal||||||1|0.0029|
ES|endometritis-salpingitis||||||||1
ES|endoscopic sclerosis||||||||1
ES|endoscopic sclerotherapy||||||1|0.0055|1
ES|endoscopic sphincterotomy|C0085263|||||1|0.0554|1
ES|endosonography|C0376443;C0376444|||||1|0.0052|
ES|endostatin|C0534628;C1332771;C1705207|||||1|0.0049|
ES|endotoxic shock|C0036981|||||1|0.0026|
ES|engraftment syndrome|C0919746|||||1|0.0026|
ES|enhanced sensitivity||1|0.028|||||
ES|environmental stimulation||||||||1
ES|enzyme estrone sulfatase||||||1|0.0057|
ES|enzyme substrate;enzyme-substrate|C0178623|||||1|0.0046|1
ES|enzyme-substrate complex|C0596529|||||1|0.0029|
ES|epileptic seizures|C0014544|||||1|0.0072|
ES|epileptic syndrome||||||||1
ES|epithelial sarcoma||||||||1
ES|epithelioid sarcoma|C0205944|||||1|0.0066|
ES|erector spinae|C0224301;C1305743|||||1|0.0109|
ES|erythromycin stearate|C0059566|||||1|0.0032|
ES|esophageal scintigraphy||||||||1
ES|esophagus|C0014876;C0545823;C1278919|||||||1
ES|esophoria|C0152216|||||||1
ES|esterase|C0014894|||||1|0.0034|1
ES|estrogens|C0014939|||||1|0.0026|
ES|estrone sulfate|C0059668|||||1|0.004|
ES|ethics qualifier|C1527243|||C1527243|MTH|||
ES|ex-smoker|C0337671|||||||1
ES|exanthem subitum|C0015231|||||1|0.0049|
ES|excretory-secretory products||||||1|0.0089|
ES|exfoliation syndrome|C0206368|||||1|0.0026|1
ES|experimental study|C0681814|||||||1
ES|expert system|C0015324|||||1|0.0086|
ES|expression site||||||1|0.004|
ES|extent score||||||1|0.0043|
ES|exterior surface||||||||1
ES|external sensory||||||1|0.0026|
ES|extra strength||1|0.938|||||1
ES|extracapsular spread||||||||1
ES|extracellular space|C0015352|||||1|0.002|
ES|extrasystole|C0340464|||||||1
ES|nitrobenzylthioinosine (NBMPR)-sensitive||||||1|0.002|
ES|sheep erythrocytes||||||1|0.0029|
ES|surface|C0205148|||||1|0.0029|
ES|sweetened ethanol solution||||||1|0.0017|
ESR|EPR spectroscopy;ESR - Electron spin resonance;ESR Spectroscopy;Spectroscopy, ESR;Electron Paramagnetic Resonance;Paramagnetic Resonance, Electron;Resonance, Electron Paramagnetic;Electron Spin Resonance;Electron spin resonance;Resonance, Electron Spin;electron spin resonance;Electron Spin Resonance Spectroscopy;Spectroscopy, Electron Spin Resonance;electron spin resonance spectroscopy;Electron paramagnetic resonance spectroscopy;electron paramagnetic resonance spectroscopy;Electron spin resonance measurement;Electron spin resonance measurement, NOS;Paramagnetic Resonance;Resonance, Paramagnetic|C0013845|||C0013845|CSP;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.5234|1
ESR|ER;ERS|C0014688;C0403549;C1704489|||C1414461;C1704489;C1706235|AOT;NCI;OMIM|||
ESR|ERA;Era|C0681698;C1414461;C1706235|||C1414461;C1706235|HUGO;NCI|||
ESR|ESR;esrs|C0086250|||C0013845;C0086250;C1176468;C1414461;C1619634;C1704489;C1706235|AOT;CHV;CSP;MTH;NCI;OMIM|||
ESR|ESR - Erythrocyte sedimentation rate;erythrocyte sedimentation rate (ESR);Erythrocyte Sedimentation Rate;Erythrocyte Sedimentation Rates;Erythrocyte sedimentation rate;Rate, Erythrocyte Sedimentation;Rates, Erythrocyte Sedimentation;Sedimentation Rate, Erythrocyte;Sedimentation Rates, Erythrocyte;erythrocyte rate sedimentation;erythrocyte sedimentation rate;erythrocyte sedimentation rates;erythrocytes rate sedimentation|C0086250;C1176468;C1619634|1|1|C0086250;C1114891;C1176468;C1619634|AOD;CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.4697|1
ESR|ESR1||||C1414461;C1706235|HUGO;NCI;OMIM|||
ESR|ESR1 Gene;ESR1 gene;ESTROGEN RECEPTOR, ALPHA;Estrogen Receptor 1 Gene|C1414461|||C1414461|HUGO;MTH;NCI;OMIM|||
ESR|ESR1 wt Allele;Estrogen Receptor 1 wt Allele|C1706235|||C1706235|MTH;NCI|||
ESR|ESRA;NR3A1|C1414461;C1706235|||C1414461;C1706235|HUGO;NCI;OMIM|||
ESR|ESTROGEN RECEPTOR;estrogen receptor|C0034804;C1414461;C1521863|||C0034804;C1414461;C1521863|CHV;CSP;LNC;NCI;OMIM;PDQ;SNOMEDCT|1|0.007|
ESR|ESTROGEN RECEPTOR 1;estrogen receptor 1|C1121711;C1414461;C1521863|||C1414461|HUGO;OMIM|||
ESR|Electron spin resonance (procedure)||||C0013845|SNOMEDCT|||
ESR|Electron spin resonance measurement (procedure)||||C0013845|SNOMEDCT|||
ESR|Erythrocyte Sedimentation Rate Measurement;Erythrocyte sedimentation rate measurement|C1176468|||C1176468|MTH;NCI;SNOMEDCT|||
ESR|Erythrocyte sedimentation rate (observable entity)||||C0086250|SNOMEDCT|||
ESR|Erythrocyte sedimentation rate - finding;Finding of erythrocyte sedimentation rate;erythrocyte sedimentation rate result|C1619634|||C1619634|MTH;SNOMEDCT|||
ESR|Erythrocyte sedimentation rate measurement (procedure)||||C1176468|SNOMEDCT|||
ESR|Extended Rotated Sidebent;Extended Sidebent Rotated|C1704489|||C1704489|AOT;MTH|||
ESR|Finding of erythrocyte sedimentation rate (finding)||||C1619634|SNOMEDCT|||
ESR|electric skin resistance||||||||1
ESR|electric skin response||||||||1
ESR|sedimentation rate|C0200704;C1176468|||C1176468|NCI|||
ESWL|Disintegration of stones by extracorporeal induced shockwaves||||C0015359|MTHICD9|||
ESWL|ESWL;eswl;ESWL (Extracorporeal Shockwave Lithotripsy);ESWLs (Extracorporeal Shockwave Lithotripsy);Extracorporeal shockwave lithotripsy [ESWL];extracorporeal shock wave lithotripsy (ESWL);Electrohydraulic Shockwave Lithotripsies;Electrohydraulic Shockwave Lithotripsy;Lithotripsies, Electrohydraulic Shockwave;Lithotripsy, Electrohydraulic Shockwave;Shockwave Lithotripsies, Electrohydraulic;Shockwave Lithotripsy, Electrohydraulic;electrohydraulic shock wave lithotripsy;Extracorporeal Shockwave Lithotripsies;Extracorporeal Shockwave Lithotripsy;Extracorporeal shockwave lithotripsy;Extracorporeal shockwave lithotripsy, NOS;Lithotripsies, Extracorporeal Shockwave;Lithotripsy, Extracorporeal Shockwave;Shockwave Lithotripsies, Extracorporeal;Shockwave Lithotripsy, Extracorporeal;extracorporeal shock wave lithotripsy;extracorporeal shockwave lithotripsy|C0015359|1|1|C0015359|CHV;CSP;ICD9CM;MSH;MTHICD9;SNOMEDCT|1|1|1
ESWL|Extracorporeal shockwave lithotripsy (procedure)||||C0015359|SNOMEDCT|||
ESWL|Extracorporeal shockwave lithotripsy - action||||C0015359|SNOMEDCT|||
ESWL|Extracorporeal shockwave lithotripsy - action (qualifier value)||||C0015359|SNOMEDCT|||
ETOH|ALCOHOL;Alcohol;alcohol|C0001962;C0001975;C0202304|||C0001962|CHV;LNC;MEDLINEPLUS;MTHSPL;NCI;NDFRT;PDQ;VANDF|||
ETOH|ALCOHOL,ETHYL;Alcohol, Ethyl;Ethyl Alcohol;Ethyl alcohol;alcohol ethyl;ethyl alcohol|C0001962;C0885054|1|1|C0001962;C0885054|AOD;CHV;CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT;VANDF|1|1|1
ETOH|Absolute Ethanol;Absolute ethanol|C0001962;C1511761|||C0001962|NCI;PDQ|||
ETOH|Alcohol, Grain;Grain Alcohol;Grain alcohol;grain alcohol;ETHANOL;Ethanol;ethanol;ethanols;ETOH;EtOH;EtOH - Alcohol;EtOH - Ethanol;Methylcarbinol|C0001962|||C0001962;C0202304|AOD;CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT|||
ETOH|Drinking alcohol|C0001948;C0001962;C0589068|||C0001962|SNOMEDCT|||
ETOH|Ethanol [Chemical/Ingredient]||||C0001962|NDFRT|||
ETOH|Ethyl alcohol (product)||||C0001962|SNOMEDCT|||
ETOH|Ethyl alcohol (substance)||||C0001962|SNOMEDCT|||
ET|CTP:ethanolamine-phosphate cytidylyltransferase activity||||C1152393|GO|||
ET|CYTIDYLYLTRANSFERASE, CTP-PHOSPHOETHANOLAMINE;ETHANOLAMINE-PHOSPHATE CYTIDYLYLTRANSFERASE|C0311988;C1418398|||C1418398|OMIM|||
ET|E-TRACHE;Endotracheal Route of Administration;Endotracheal Route of Drug Administration;Intratracheal Route of Administration;Intratracheal route;IntratrachealRoute|C1522653|||C1522653|HL7V3.0;MTH;NCI;SNOMEDCT|||
ET|ENDOTRACHEAL;endotracheal|C0599554;C1522653|1|0.4|C0599554;C1522653|CHV;CSP;HL7V2.5;MTH;NCI|1|0.0184|1
ET|ET||||C0015024;C0015127;C1152393;C1418398;C1522653|GO;HUGO;MSH;NCI;OMIM|||
ET|ETH;ETHIOPIA;Ethiopia;ethiopia;Federal Democratic Republic of Ethiopia|C0015024|||C0015024|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
ET|ETIOL||||C0015127|MSH|||
ET|Ebbinghaus test||||||||1
ET|End-tidal;end-tidal||||||1|0.0063|1
ET|Escherichia coli endotoxin|C0059291|||||1|0.0041|
ET|Essential thrombocytosis;essential thrombocytosis;essential thrombocythaemia;essential thrombocythemia|C0040028|||C0040028|CHV;COSTAR;CSP;ICD9CM;MSH;MTHICD9;NCI;PDQ;SNOMEDCT|1|0.1475|1
ET|Essential tremor;essential tremor|C0270736|||C0270736|CHV;MEDLINEPLUS;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0691|1
ET|Estrogen therapy;estrogen therapy|C0279494|||||1|0.0055|1
ET|Ethiopia (geographic location)||||C0015024|SNOMEDCT|||
ET|Etiology aspects|C0015127|||C0015127|MTH|||
ET|Ewing tumor;Ewing tumors|C0553580|||||1|0.0052|1
ET|Exchange transfusion;exchange transfusion|C0015236|||C0015236|CHV;ICD9CM;MSH;SNOMEDCT|1|0.0091|1
ET|Intratracheal||||C1522653|NCI;SNOMEDCT|||
ET|Intratracheal route (qualifier value)||||C1522653|SNOMEDCT|||
ET|Intratracheal use||||C1522653|SNOMEDCT|||
ET|PCYT2;PCYT2 gene;PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE;phosphate cytidylyltransferase 2, ethanolamine|C1418398|||C1418398|HUGO;MTH;OMIM|||
ET|aetiology;etiologies;etiology;cause;caused by;causes|C0015127;C1314792;C1524003|||C0015127|CHV;MSH|||1
ET|causality|C0015127;C1314792|||C0015127|CHV;MSH|||
ET|edema toxin||||||||1
ET|edge thickness||||||||1
ET|educational therapy|C0204583|||||||1
ET|effective temperature||||||||1
ET|ejection time|C0812388;C2697908|||C0812388;C2697908|CHV;MTH;NCI|1|0.0237|1
ET|elective termination||1|0.002|||||
ET|electron transfer|C0013846;C2244393|||C0013846;C2244393|AOD;CHV;CSP;GO;SNOMEDCT|1|0.0586|
ET|electrophoretic type||||||1|0.0061|
ET|embryo transfer;embryo transfers|C0013938|||C0013938|CHV;CSP;MSH;NCI;SNOMEDCT|1|0.0022|1
ET|endometrial thickness||||||1|0.003|1
ET|endothelin|C0079284|||C0079284|AOD;CHV;CSP;LNC;MSH;MTH;NDFRT|1|0.4616|1
ET|endothelin-1|C0079281;C1414260;C2825886|||||1|0.0333|
ET|endotoxin;endotoxins|C0014264|||C0014264|CHV;CSP;LNC;NCI;SNOMEDCT|1|0.0025|1
ET|endotracheal intubation|C0021932|||C0021932|CCS;CHV;MSH;SNOMEDCT|||
ET|endotracheal tube|C0336630;C1546626|||C0336630|CHV;MTH;SNOMEDCT|1|0.0077|
ET|endurance time||||||||1
ET|endurance training;endurance-trained||||||1|0.0129|
ET|energy transfer|C0014274|||C0014274|AOD;CHV;LCH;MSH;SNOMEDCT|||
ET|enterostomal therapy|C1555976|1|0.578|||||1
ET|enterotoxin|C0014372|||||||1
ET|environmental temperature|C2983601|||C2983601|NCI|||
ET|epidermolytic toxin||||||||1
ET|epitestosterone|C0014594|||C0014594|CHV;LNC;MSH;NDFRT|1|0.0025|
ET|epithelial tumor|C1368683|||||||1
ET|ergotamine tartrate|C0086248|||C0086248|MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
ET|erythrogenic toxin|C0059545|||C0059545|MSH|||
ET|esotropia|C0014877|||C0014877|CHV;COSTAR;DXP;ICD9CM;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0039|1
ET|esotropic||||||||1
ET|ethanol|C0001962|||||1|0.0105|1
ET|ethanolamine phosphate cytidylyltransferase activity;ethanolamine-phosphate cytidylyltransferase activity|C1152393|||C1152393|GO;MTH|||
ET|ethyl||||||||1
ET|etiocholanolone test||||||||1
ET|etoposide|C0015133|||C0015133|CHV;CSP;LCH;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0036|
ET|eustachian tube|C0015183|||C0015183|CHV;CSP;FMA;LCH;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0404|1
ET|evapotranspiration||||||1|0.0025|
ET|evolutionary trace||||||1|0.0028|
ET|exercise test;exercise testing|C0015260|||C0015260|AOD;CHV;CSP;MSH;SNOMEDCT|1|0.0157|1
ET|exercise tolerance|C0162521;C2709256|||C0162521;C2709256|CHV;CSP;LNC;MSH;MTH;SNOMEDCT|1|0.003|
ET|exercise training;exercise-trained||||||1|0.0206|
ET|exercise treadmill||||||||1
ET|exfoliative toxin||||||1|0.0072|
ET|expiration time||||||||1
ET|exploratory thoracoscopy||||||||1
ET|extracellular tachyzoite||||||||1
ET|temperature|C0005903;C0039476|||||1|0.0055|
ET|tests|C0022885;C0392366|||||1|0.0025|
ET|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0028|
FANA|fluorescent antinuclear antibody||1|1.000|||1|1|1
FENA|Fractional excretion of sodium;fractional excretion of sodium;fractional sodium excretion|C0428601;C1318192;C1955481|1|1|||1|0.9405|1
FENA|fractional excretion of Na||||||1|0.0595|
FEN|Fenoterol|C0015840|||||1|0.1739|
FEN|d,l-fenfluramine||||||1|0.1449|
FEN|fenfluramine|C0015827|||||1|0.6812|
FEN|fluids, electrolytes, nutrition||1|1.000|||||1
FEV1|FEV1|C0802965;C0849974|||C0802965;C0849974|LNC;NCI|||
FEV1|FEV1%VC;Forced Expiratory Volume 1 Test;Pulmonary Function Test/Forced Expiratory Volume 1|C0849974|||C0849974|MTH;NCI|||
FEV1|Forced Expiratory Volume in 1 Second;forced expiratory volume in 1 second|C0429706;C0849974|||C0849974|NCI|1|0.6298|
FEV1|PFT/FEV1||||C0849974|NCI|||
FEV1|Volume^at 1.0 s post forced expiration:Vol:Pt:Respiratory system:Qn||||C0802965|LNC|||
FEV1|Volume^at 1.0 s post forced expiration:Volume:Point in time:Respiratory system:Quantitative|C0802965|||C0802965|LNC;MTH|||
FEV1|fev 1|C0429706;C0802965;C0849974|||C0849974|CHV|||
FEV1|forced expiratory volume at one second||||||1|0.0186|
FEV1|forced expiratory volume during first second of expiration||||||1|0.0012|
FEV1|forced expiratory volume in 1 sec||||||1|0.2435|
FEV1|forced expiratory volume in 1s||||||1|0.0373|
FEV1|forced expiratory volume in one second||1|1.000|||||
FEV1|lung function|C0035245|||||1|0.0385|
FEV1|pulmonary function|C0231921;C1547996;C3160731|||||1|0.0161|
FEV1|vital capacity|C0042834;C0430511|||||1|0.0099|
FEV1|volume of air expelled in the first second of forced expiration||||||1|0.005|
FFP|FFP;FFP - Fresh frozen plasma|C0016709|||C0016709|NCI;SNOMEDCT|||
FFP|Federal Financial Participation||||||1|0.0349|
FFP|Fresh Frozen Plasma;Fresh Frozen Plasmas;Fresh frozen plasma;Frozen Plasma, Fresh;Frozen Plasmas, Fresh;Plasma, Fresh Frozen;Plasmas, Fresh Frozen;fresh frozen plasma|C0016709;C1547245|1|1|C0016709;C1547245|CHV;HL7V2.5;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.8542|1
FFP|Fresh frozen plasma (product)||||C0016709|SNOMEDCT|||
FFP|Fresh frozen plasma (substance)||||C0016709|SNOMEDCT|||
FFP|Fresh frozen plasma, human||||C0016709|SNOMEDCT|||
FFP|Fresh frozen plasma, human (product)||||C0016709|SNOMEDCT|||
FFP|Fresh frozen plasma, human (substance)||||C0016709|SNOMEDCT|||
FFP|fast Fourier projection||||||||1
FFP|flexible fluoropolymer||||||||1
FFP|free of progression||||||||1
FFP|freedom from progression||||||1|0.1109|1
FISH|Actinistia;Coelacanthimorpha;lobe-finned fishes <coelacanthimorph>|C1056439|||C1056439|MTH;NCBI|||
FISH|Actinopterygii;fish <Actinopterygii>;fishes <Actinopterygii>|C0998822|||C0998822|MTH;NCBI|||
FISH|Cartilaginous fish;cartilaginous fish;cartilaginous fishes;Chondrichthyes;Class Chondrichthyes;fish <Chondrichthyes>|C0327606|||C0327606|AOD;CSP;MTH;NCBI;SNOMEDCT|||
FISH|Class Chondrichthyes (organism)||||C0327606|SNOMEDCT|||
FISH|Class chondrichthyes - cartilaginous fish||||C0327606|SNOMEDCT|||
FISH|Class chondrichthyes - cartilaginous fish (organism)||||C0327606|SNOMEDCT|||
FISH|Dipneusti;Dipnoi;dipnoans;fish <Dipnoi>;fishes <Dipnoi>|C0998806|||C0998806|MTH;NCBI|||
FISH|FISH;Fish;Fish (NOS);Fish, NOS;Fishes;fish;fishes|C0016163;C2349190;C2700184|||C0016163;C0162789;C0327606;C0949652;C0998806;C0998822;C1056205;C1056439;C1696695;C1822711;C2349190;C2700184|AOD;CHV;CSP;HL7V3.0;HUGO;LCH;LNC;MSH;MTH;NCBI;NCI;SNOMEDCT|||
FISH|FISH (fluorescent in situ hybridization);fluorescent in situ hybridization (FISH);FISH - fluorescence in situ hybridisation;FISH - fluorescence in situ hybridization;FISH Technic;FISH Technics;Technic, FISH;Technics, FISH;FISH Technique;FISH Techniques;Technique, FISH;Techniques, FISH;fish technique;fishing techniques;Fluorescence In Situ Hybridization;Fluorescence in Situ Hybridization;Fluorescence in situ Hybridization;Fluorescence in situ hybridisation;Fluorescence in situ hybridization;Hybridization in Situ, Fluorescence;In Situ Hybridization, Fluorescence;fluorescence hybridization situ;fluorescence in situ hybridisation;fluorescence in situ hybridization;Fluorescent in Situ Hybridization;Hybridization in Situ, Fluorescent;In Situ Hybridization, Fluorescent;fluorescent hybridization situ;fluorescent in situ hybridisation;fluorescent in situ hybridization|C0162789|1|0.898|C0162789|CHV;CSP;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.9968|1
FISH|Fish (food)|C2349190|||C2349190|MTH|||
FISH|Fish (organism)||||C0016163|SNOMEDCT|||
FISH|Fish Flavor|C2700184|||C2700184|MTH;NCI|||
FISH|Fluorescence in situ hybridization (procedure)||||C0162789|SNOMEDCT|||
FISH|Hyperoartia;fish <Hyperoartia>;fishes <Hyperoartia>|C1056205|||C1056205|MTH;NCBI|||
FISH|Hyperotreti;Hyperotretus;fish <Hyperotreti>;fishes <Hyperotreti>|C0949652|||C0949652|MSH;MTH;NCBI|||
FISH|KIAA0418;SH3PXD2A;SH3PXD2A gene;five SH3 domains|C1822711|||C1822711|HUGO;MTH|||
FISH|Pisces;pisces|C0016163|||C0016163|AOD;CHV|||
FISH|SH3 and PX domains 2A||||C1822711|HUGO|||
FISH|fish - EntityCode|C1696695|||C1696695|MTH|||
FISH|fish <Coelacanthimorpha>;fishes <Coelacanthimorpha>||||C1056439|NCBI|||
FISH|fishes <chondrichthyan>||||C0327606|NCBI|||
FISH|fluorescence in situ hybridization technique||||||1|0.0013|
FISH|lobe-finned fishes||||C1056439|NCBI|||
FISH|situ hybridization analysis||||||1|0.0019|
FSH|FOLLICLE STIMULATING HORMONE;Follicle Stimulating Hormone;Follicle stimulating hormone;Follicle-Stimulating Hormone;Follicle-stimulating hormone;follicle hormone stimulating;follicle hormones stimulating;follicle stimulating hormone;follicle-stimulating hormone;follicle-stimulating hormones;FOLLITROPIN;Follitropin;follitropin;FSH (Follicle Stimulating Hormone);FSH - Follicle-stimulating hormone;follicle stimulating fsh hormone;FSH preparation;Follicle stimulating hormone preparation;Follicle-stimulating horm prod;Follicle-stimulating hormone product;Follicular stimulating hormone;follicular hormones stimulating;follicular stimulating hormone;Follitropin preparation;Pituitary follicle stimulating hormone;fshs|C0733758|1|0.53|C0202022;C0733758|AOD;CHV;CSP;FMA;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;UWDA;VANDF|1|0.1429|1
FSH|FSH||||C0202022;C0733758|AOD;CHV;CSP;FMA;NCI;SNOMEDCT;UWDA|||
FSH|FSH - Follicle stimulating hormone level;FSH measurement;Follicle Stimulating Hormone Measurement;Follicle stimulating hormone measurement;Follicle stimulating hormone level|C0202022|||C0202022|MTH;NCI;SNOMEDCT|||
FSH|FSH level|C0202022;C0428406|||C0202022|SNOMEDCT|||
FSH|Fairview Southdale Hospital||1|0.462|||||
FSH|Follicle Stimulating Hormone [Chemical/Ingredient]||||C0733758|NDFRT|||
FSH|Follicle stimulating hormone measurement (procedure)||||C0202022|SNOMEDCT|||
FSH|Follicle stimulating hormone preparation (product)||||C0733758|SNOMEDCT|||
FSH|Follicle stimulating hormone preparation (substance)||||C0733758|SNOMEDCT|||
FSH|Follicle-stimulating horm prod (product)||||C0733758|SNOMEDCT|||
FSH|Follicle-stimulating horm prod (substance)||||C0733758|SNOMEDCT|||
FSH|Follicle-stimulating hormone product (product)||||C0733758|SNOMEDCT|||
FSH|Pituitary follicle stimulating hormone (substance)||||C0733758|SNOMEDCT|||
FSH|facioscapulohumeral||||||||1
FSH|facioscapulohumeral muscular dystrophy;fascioscapulohumeral muscular dystrophy|C0238288|1|0.008|||1|0.1964|
FSH|focal and segmental hyalinosis||||||||1
FSH|follicle hormone stimulateing||||C0733758|CHV|||
FSH|follicle stimulating hormone (FSH) level test||||C0202022|CHV|||
FSH|follicle-stimulating||||||1|0.5893|
FSH|patients with facioscapulohumeral||||||1|0.0714|
FUTS|fairview university transitional services||1|1.000|||||
FVC|Capacities, Forced Vital;Capacity, Forced Vital;Capacity.vital.forced;Forced Vital Capacities;Forced Vital Capacity;Forced vital capacity;Vital Capacities, Forced;Vital Capacity, Forced;Vital capacity.forced;forced vital capacity|C0042834;C0430511;C0802685|1|0.994|C0042834;C0430511;C0802685|AOD;CHV;LNC;MSH;SNOMEDCT|||1
FVC|Capacities, Vital;Capacity, Vital;Capacity.vital;Vital Capacities;Vital Capacity;Vital capacity;vital capacity|C0042834;C0430511|||C0042834|CHV;LNC;MSH;MTH;SNOMEDCT|||
FVC|Capacity.vital.forced:Vol:Pt:Respiratory system:Qn||||C0802685|LNC|||
FVC|Capacity.vital.forced:Volume:Point in time:Respiratory system:Quantitative|C0802685|||C0802685|LNC;MTH|||
FVC|FORCED VITAL CAPAC||||C0042834|MSH|||
FVC|FVC;fvc|C0042834;C0802685|||C0042834;C0802685|CHV;LNC;SNOMEDCT|||
FVC|FVC - Forced vital capacity;Forced vital cap.;Lung vital capacity;lung vital capacity;vital lung capacity;VC - Vital capacity|C0042834|||C0042834|CHV;SNOMEDCT|||
FVC|Forced vital capacity (observable entity)||||C0042834|SNOMEDCT|||
FVC|Forearm vascular conductance||||||1|1|
FVC|VC;vc||||C0042834|CHV;SNOMEDCT|||
FVC|VITAL CAPAC||||C0042834|MSH|||
FVC|Vital capacity (function)||||C0042834|SNOMEDCT|||
FVC|Vital capacity (observable entity)||||C0042834|SNOMEDCT|||
FVC|Vital capacity, function (observable entity)||||C0042834|SNOMEDCT|||
FVC|false vocal cord|C0149596|||||||1
FVC|femoral vein catheter||1|0.006|||||
FVC|filled voiding flow rate||||||||1
G-CSF|CSF-G;G CSF;G-CSF;csf g;g csf;g-csf;Colony-stimulating factor, granulocytic|C0079459|||C0079459;C0210630;C1705750|CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
G-CSF|CSF3;Colony Stimulating Factor 3;Pluripoietin|C0079459;C1332793|||C0079459|NCI|||
G-CSF|CSF3 wt Allele|C1705750|||C1705750|MTH;NCI|||
G-CSF|Colony Stimulating Factor 3 (Granulocyte) wt Allele||||C1705750|NCI|||
G-CSF|Colony-Stimulating Factor (Granulocyte);Colony-stimulating factor, granulocyte;Granulocyte Colony Stimulating Factor;Granulocyte Colony-Stimulating Factor;Granulocyte colony stimulating factor;granulocyte colony stimulating factor;granulocyte colony-stimulating factor|C0079459;C2825895|1|1|C0079459|CSP;LNC;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.9888|1
G-CSF|Colony-stimulating factor, granulocytic (substance)||||C0079459|SNOMEDCT|||
G-CSF|FILGRASTIM;Filgrastim;filgrastim|C0210630;C1332793|||C0210630|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.0112|
G-CSF|Filgrastim (product)||||C0210630|SNOMEDCT|||
G-CSF|Filgrastim (substance)||||C0210630|SNOMEDCT|||
G-CSF|Filgrastim [Chemical/Ingredient]||||C0210630|NDFRT|||
G-CSF|G-CSF - Recombinant human granulocyte-colony stimulating factor;Recombinant Methionyl Human Granulocyte Colony Stimulating Factor;Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor;Recombinant-Methionyl Human Granulocyte Colony-Stimulating Factor;filgrastrim;r-metHuG-CSF;r-methug-csf|C0210630|||C0210630|CHV;CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
G-CSF|G-CSF Recombinant, Human Methionyl||||C0210630|MSH;NDFRT|||
G-CSF|GCSF;gcsf|C0079459;C1332793;C1705750;C2825895|||C0079459;C1705750|CHV;CSP;MSH;NCI|||
G-CSF|GCSF (granulocyte colony stimulating factor)||||C0079459|CSP|||
G-CSF|GRANULOCYTE COLONY A STIMULATING FACTOR||||C0079459|MSH|||
G-CSF|Granulocyte Colony-Stimulating Factor [Chemical/Ingredient]||||C0079459|NDFRT|||
G-CSF|MGC45931|C1332793;C1705750|||C1705750|NCI|||
G1|1, Gap Phase;Gap 1 Phase;Gap Phase 1;Phase 1, Gap;First Gap Phase;First Gap Phases;Gap Phase, First;Gap Phases, First;Phase, First Gap;Phases, First Gap;first gap phase;G1 Phase;G1 Phases;G1 phase;Phase, G1;Phases, G1;G1 Phase Process;G1 period|C0079395|||C0079395|CSP;GO;MSH;MTH;NCI|1|0.0461|
G1|BASIC SALIVARY PROLINE-RICH PROTEIN, BstNI TYPE, 3;PAROTID SALIVARY GLYCOPROTEIN;PRB3;PRB3 gene;PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3;proline-rich protein BstNI subfamily 3|C1418868|||C1418868|HUGO;MTH;OMIM|||
G1|Differentiated;Differentiated, NOS;differentiate;differentiated;differentiates;differentiating|C0007589;C0205615|||C0205615|CHV;SNOMEDCT|||
G1|First generation||||||1|0.0461|
G1|Fuhrman Grade 1;Fuhrman Nuclear Grade 1|C1880858|||C1880858|MTH;NCI|||
G1|G A 01 PHASE||||C0079395|MSH|||
G1|G1||||C0079395;C0205615;C0475269;C0687695;C1418868;C1880858|NCI;OMIM;SNOMEDCT|||
G1|G1 grade;G1 stage;Tumor grade G1;Tumour grade G1|C0475269|||C0475269|MTH;SNOMEDCT|||
G1|G1 grade (finding)||||C0475269|SNOMEDCT|||
G1|G1 stage (tumor staging)||||C0475269|SNOMEDCT|||
G1|G1: well differentiated||||C0475269|SNOMEDCT|||
G1|Grade 1;grade 1|C0547053;C0687695|||C0687695|CHV;NCI;SNOMEDCT|1|0.1447|
G1|Grade 1 (qualifier value)||||C0687695|SNOMEDCT|||
G1|Grade I;grade i|C0687695;C1883546|||C0205615;C0687695|CHV;NCI;SNOMEDCT|||
G1|Grade one rank|C0687695|||C0687695|MTH|||
G1|Group 1|C0441861|||||1|0.3816|
G1|PRG|C0033308;C1418868;C1418888|||C1418868|HUGO|||
G1|Well Differentiated;Well differentiated;Well-differentiated;well differentiated;well-differentiated|C0205615|||C0205615|CHV;MTH;NCI;SNOMEDCT|1|0.1053|1
G1|Well differentiated (grade) (qualifier value)||||C0205615|SNOMEDCT|||
G1|Well differentiated (grade) [Ambiguous]||||C0205615|SNOMEDCT|||
G1|Well differentiated (qualifier value)||||C0205615|SNOMEDCT|||
G1|activated|C1879547|||||1|0.0592|
G1|control group|C0009932|||||1|0.1053|
G1|first group||||||1|0.0526|
G1|first pregnancy|C0860096|1|0.998|||||1
G1|galactose 1||1|0.002|||||
G1|gap1||||||||1
G1|grid 1||||||||1
G1|patients|C0030705|||||1|0.0592|
GAF|Activation Factor||||||1|0.0644|
GAF|FGF9;FIBROBLAST GROWTH FACTOR 9|C0386595;C1333540|||C1333540|HUGO;NCI;OMIM|||
GAF|FGF9 Gene;FGF9 gene|C1333540|||C1333540|HUGO;MTH;NCI|||
GAF|FGF9 wt Allele;HBFG-9|C1708018|||C1708018|MTH;NCI|||
GAF|Fibroblast Growth Factor 9 (Glia-Activating Factor) Gene||||C1333540|NCI|||
GAF|Fibroblast Growth Factor 9 (Glia-Activating Factor) wt Allele||||C1708018|NCI|||
GAF|GAF|C1333540;C1708018|||C1333540;C1708018|NCI;OMIM|||
GAF|GLIA-ACTIVATING FACTOR;glia-activating factor||||C1333540|OMIM|||1
GAF|Global Assessment of Function;Global Assessment of Functioning;global assessment of functioning|C0017644|1|1|||1|0.7723|1
GAF|Global Assessment of Functioning Scale||||||1|0.1634|
GAF|fibroblast growth factor 9 (glia-activating factor)||||C1333540|HUGO|||
GAF|geographic adjustment factors||||||||1
GAF|giant axon formation||||||||1
GC|2R,3S)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol||||C0061012|NCI|||
GC|CHROMATOGR GAS;GAS CHROMATOGR||||C0008555|MSH|||
GC|Chromatographies, Gas;Chromatography, Gas;Gas Chromatographies;Gas Chromatography;chromatography gas;gas chromatography;Gas chromatography (GC);Gas chromatography measurement;Gas chromatography measurement, NOS;vapor phase chromatography|C0008555|1|0.01|C0008555|AOD;CHV;CSP;HL7V3.0;MSH;MTH;NCI;SNOMEDCT|1|0.258|1
GC|DBP||||C1367452;C1704663|HUGO;NCI;OMIM|||
GC|GC||||C0008555;C0061012;C1367452;C1704663|HUGO;LNC;NCI;OMIM|||
GC|GC Gene;GC gene;VITAMIN D-BINDING ALPHA-GLOBULIN;hDBP|C1367452|||C1367452|HUGO;MTH;NCI;OMIM|||
GC|GC wt Allele|C1704663|||C1704663|MTH;NCI|||
GC|GROUP-SPECIFIC COMPONENT;Group-specific component;group-specific component;VITAMIN D-BINDING PROTEIN;vitamin D binding protein|C0042872;C1367452|||C0042872;C1367452|NCI;OMIM|1|0.0618|1
GC|Gallocatechin;gallocatechin;epigallocatechol;gallocatechol|C0061012|||C0061012|MSH;MTH;NCI|||
GC|Gas chromatography measurement (procedure)||||C0008555|SNOMEDCT|||
GC|Gliomatosis cerebri;gliomatosis cerebri|C0334576|||C0334576|MSH;MTH;NCI;SNOMEDCT|1|0.0072|1
GC|Glucocorticoid hormones;glucocorticoid|C0017710|||C0017710|CHV;CSP;NCI;PDQ;SNOMEDCT|1|0.1549|1
GC|Golgi complex|C0018042|||||1|0.0087|1
GC|Group-Specific Component (Vitamin D Binding Protein) Gene||||C1367452|NCI|||
GC|Group-Specific Component (Vitamin D Binding Protein) wt Allele||||C1704663|NCI|||
GC|Neisseria gonorrhoeae|C0027573|||||1|0.0108|
GC|VDBG;VDBP|C1367452;C1704663|||C1367452;C1704663|HUGO;NCI;OMIM|||
GC|anti-galactocerebroside||||||1|0.0028|
GC|chromatographis gas||||C0008555|CHV|||
GC|conductance||||||1|0.0028|
GC|control group|C0009932|||||1|0.0023|
GC|epigallocatechin;epigallocatechins|C0061012;C2348459|||C0061012|CHV;MSH|||
GC|galactocerebroside|C0060955|||C0060955|CHV;MSH;SNOMEDCT|1|0.0205|
GC|ganglion cell|C0228071|||C0228071|CHV;CSP;FMA;NCI;SNOMEDCT|||1
GC|gas chromatograph||||||1|0.0141|
GC|gas chromatographic||||||1|0.0675|
GC|gastric cancer|C0024623;C0699791|||C0024623;C0699791|AOD;CHV;CSP;MEDLINEPLUS;MSH;MTHICD9;NCI;OMIM;PDQ;SNOMEDCT|1|0.0449|1
GC|gastric carcinoma|C0699791|||C0699791|CHV;COSTAR;CST;MTHMST;NCI;QMR;SNOMEDCT|1|0.0172|1
GC|gel chromatography|C0008559|||||||1
GC|gemcitabine and cisplatin||||||1|0.0018|
GC|general circulation||||||||1
GC|general closure||||||||1
GC|general condition||||||||1
GC|genetic counselor|C0587719|1|0.032|||||
GC|genomic control||||||1|0.0023|
GC|geriatric care|C1552319;C1552333|||||||1
GC|geriatric chair|C0179860|||||||1
GC|germinal center;germinal centre|C0282491|||C0282491|CHV;FMA;MSH;NCI;UWDA|1|0.1087|1
GC|giant cell|C0017526|||||||1
GC|gigacycle||||||||1
GC|gingival crevice|C0447436;C1280386|||||||1
GC|gingival curettage|C0038544|||||||1
GC|glassy carbon||||||1|0.0138|
GC|glucocerebrosidase|C0017768;C1414998|||C0017768;C1414998|CSP;MSH;NDFRT;OMIM|||
GC|glucocorticosteroids||||||1|0.0041|
GC|glucose challenge||1|0.004|||||
GC|glycocalicin|C0061621|||C0061621|MSH;MTH;OMIM|1|0.0059|
GC|glycocholate|C0086356|||C0086356|CHV;MSH|||1
GC|glycocholic acid|C0017905|||||1|0.0015|
GC|glycoconjugate|C0017906|||C0017906|CHV;CSP;FMA|||
GC|glycoprotein C|C0061666;C1423085|||||1|0.0354|
GC|goblet cell|C0506994|||C0506994|CHV;CSP;FMA;MSH;NCI;UWDA|||1
GC|goniocurettage||||||||1
GC|gonococcal;gonorrhea|C0018081|||||1|0.0054|1
GC|gonococci;gonococcus|C0027571;C0027573|1|0.954|||1|0.0036|1
GC|gonorrhea culture||||||||1
GC|good condition||||||||1
GC|graham cracker||||||||1
GC|granular cast||||||||1
GC|granular component|C1167080|||C1167080|GO|||
GC|granular cyst||||||||1
GC|granule cell|C0596630|||C0596630|CSP|1|0.0036|1
GC|granulocyte cytotoxic||||||||1
GC|granulomatous colitis|C0156147|||||||1
GC|granulosa cell;granulosa cells|C0018207|||C0018207|CHV;CSP;FMA;MSH;MTH;NCI|1|0.0539|1
GC|group-specific component (vitamin D binding protein)||||C1367452|HUGO|||
GC|growth cartilage||||||1|0.0023|
GC|growth cone|C0596632|||C0596632|CSP;GO;MSH|||
GC|guanine cytosine;guanine-cytosine||||||1|0.0077|1
GC|guanine plus cytosine||||||1|0.0015|
GC|guanylate cyclase;guanylyl cyclase|C0018358|||C0018358|CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0618|
GC|guanylcyclase||||||||1
GC|gustatory cortex|C0682660|||||1|0.0026|
GC|human glucocerebrosidase||||||1|0.0044|
GC|pituitary tumor|C0032019|||||1|0.0026|
GC|rat pituitary|C1882827|||||1|0.0015|
GC|sodium glycocholate||||||1|0.0021|
GCT|Carcinoid Neoplasm of Digestive System;Carcinoid Neoplasm of the Digestive System;Digestive System Carcinoid Neoplasm;Carcinoid Neoplasm of GI System;Carcinoid Neoplasm of the GI System;Carcinoid Neoplasm of Gastrointestinal System;Carcinoid Neoplasm of the Gastrointestinal System;Gastrointestinal System Carcinoid Neoplasm;Carcinoid Tumor of Digestive System;Carcinoid Tumor of the Digestive System;Digestive System Carcinoid Tumor;Carcinoid Tumor of GI System;Carcinoid Tumor of the GI System;Carcinoid Tumor of Gastrointestinal System;Carcinoid Tumor of the Gastrointestinal System;Gastrointestinal System Carcinoid Tumor;Carcinoid tumor of gastrointestinal tract;Carcinoid tumour of gastrointestinal tract;Common Neuroendocrine Tumor;Digestive Carcinoid Neoplasm;Digestive Carcinoid Tumor;GI Carcinoid Neoplasm;GI Carcinoid Tumor;GI carcinoid tumor;Gastrointestinal Carcinoid Neoplasm;Gastrointestinal Carcinoid Tumor;Gastrointestinal carcinoid tumor;carcinoid gastrointestinal tumors;carcinoid tumor, gastrointestinal;gastrointestinal carcinoid tumor|C0220620|||C0220620|CHV;MTH;NCI;PDQ;SNOMEDCT|||
GCT|Carcinoid tumor of gastrointestinal tract (disorder)||||C0220620|SNOMEDCT|||
GCT|GCT|C0205851;C0220620;C1419183|||C0205851;C0220620;C1419183|HUGO;NCI;OMIM;PDQ|||
GCT|GERM CELL NEOPL;NEOPL GERM CELL||||C0205851|MSH|||
GCT|GERM CELL TUMOR;Germ Cell Tumor;Germ Cell Tumors;Germ cell tumor;Germ cell tumor, NOS;Germ cell tumour;Tumor of Germ Cell;Tumor of the Germ Cell;Tumor, Germ Cell;Tumors, Germ Cell;cell germ tumours;cells germ tumors;germ cell tumor;germ cell tumors;germ cell tumour;germ-cell tumor;Germ Cell Neoplasm;Germ Cell Neoplasms;Germ cell neoplasm;Neoplasm of Germ Cell;Neoplasm of the Germ Cell;Neoplasms, Germ Cell;germ cell neoplasm;germ cell neoplasms|C0205851|||C0205851|CHV;CSP;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.2235|1
GCT|GLUTAMINYL CYCLASE;glutaminyl cyclase;GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE;glutaminyl-peptide cyclotransferase|C0245636;C1419183|||C1419183|HUGO;OMIM|||
GCT|General Clerical Test|C0451181|||||||1
GCT|Germ cell neoplasm (morphologic abnormality)||||C0205851|SNOMEDCT|||
GCT|Germ cell tumor (disorder);Germ cell tumour (disorder)||||C0205851|SNOMEDCT|||
GCT|QC|C0034378;C1419183|||C1419183|HUGO;OMIM|||
GCT|QPCT;QPCT gene|C1419183|||C1419183|HUGO;MTH;OMIM|||
GCT|[M]Germ cell neoplasm NOS;[M]Germ cell neoplasms||||C0205851|SNOMEDCT|||
GCT|[M]Germ cell neoplasm NOS (morphologic abnormality);[M]Germ cell neoplasms (morphologic abnormality)||||C0205851|SNOMEDCT|||
GCT|cell tumor||||||1|0.4693|
GCT|general care and treatment||||||||1
GCT|giant cell tumor of bone|C0206638|||||1|0.0987|
GCT|giant-cell thyroiditis|C0040149|||||||1
GCT|giant-cell transformation|C1856459|||||||1
GCT|giant-cell tumor|C0017525|||||||1
GCT|glucose challenge test|C0017741|1|0.998|||1|0.0931|
GCT|granular cell tumor|C0085167|||||||1
GCT|granular convoluted tubule||||||1|0.1155|
GCT|granulosa cell tumor|C0018206|||||||1
GERD|Acid Reflux;Acid reflux;acid reflux;reflux acid;Acid Reflux, Gastric;Gastric Acid Reflux;Reflux, Gastric Acid;CARDIOESOPHAGEAL RELAXATION, GASTROESOPHAGEAL REFLUX;GASTROESOPHAGEAL REFLUX;Gastresophageal reflux;Gastroesophageal Reflux;Gastroesophageal reflux;Reflux, Gastroesophageal;gastroesophageal reflux;gastrooesophageal reflux;reflux gastroesophageal;GASTROESOPHAGEAL REFLUX DISEASE;Gastresophageal reflux disease;Gastroesophageal Reflux Disease;Gastroesophageal reflux disease;Gastrooesophageal reflux disease;gastresophageal reflux disease;gastroesophageal reflux disease;gastrooesophageal reflux disease;GASTROESOPHAGEAL REFLUX, PEDIATRIC;GE REFLUX;ge reflux;GERD;gerd;GERD - Gastro-esophageal reflux disease;GERD1;GOR - Gastro-esophageal reflux;GOR - Gastro-oesophageal reflux;GORD - Gastro-esophageal reflux disease;GORD - Gastro-oesophageal reflux disease;Gastric Acid Reflux Disease;Gastro Esophageal Reflux;Gastro oesophageal Reflux;Gastro-Esophageal Reflux;Gastro-esophageal reflux;Gastro-oesophageal Reflux;Gastro-oesophageal reflux;Reflux, Gastro-Esophageal;Reflux, Gastro-oesophageal;gastro esophageal reflux;gastro oesophageal reflux;gastro-esophageal reflux;gastro-oesophageal reflux;Gastro-esophageal reflux disease;Gastro-oesophageal reflux disease;disease gastro-esophageal reflux;gastro-esophageal reflux disease;diseases esophageal reflux;esophageal reflux disease;reflux disease esophageal;gastroesophageal reflux disease (GERD)|C0017168|1|1|C0017168|CHV;CSP;CST;DXP;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;MTHMST;NCI;NDFRT;OMIM;SNOMEDCT|1|1|1
GERD|ESOPHAGEAL REFLUX;Esophageal Reflux;Esophageal reflux;Oesophageal reflux;esophageal reflux;oesophageal reflux;reflux esophageal|C0017168;C0559234|||C0017168|CHV;COSTAR;DXP;ICD9CM;MSH;NCI;NDFRT;SNOMEDCT|||
GERD|GASTROESOPHAGEAL REFLUX DIS||||C0017168|MSH|||
GERD|GER|C0017168;C0230779|||C0017168|OMIM|||
GERD|Gastroesophageal Reflux [Disease/Finding]||||C0017168|NDFRT|||
GERD|Gastroesophageal reflux (finding)||||C0017168|SNOMEDCT|||
GERD|Gastroesophageal reflux disease (disorder)||||C0017168|SNOMEDCT|||
GERD|Gastroesophageal reflux disease [Ambiguous]||||C0017168|SNOMEDCT|||
GERD|gastric reflux|C0017168;C0558176|||C0017168|NCI|||
GERD|gerding||||C0017168|CHV|||
GERD|reflux|C0017168;C0232483;C1882919|||C0017168|NCI|||
GFR|Creatinine clearance|C0812399|||||1|0.0023|
GFR|Filtration Rate, Glomerular;Filtration Rates, Glomerular;Glomerular Filtration Rate;Glomerular Filtration Rates;Glomerular filtration rate;Glomerular filtration rate, NOS;Rate, Glomerular Filtration;Rates, Glomerular Filtration;filtration glomerular rate;glomerular filtration rate;rate filtration glomerular|C0017654;C1561549|1|1|C0017654;C1561549|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.9857|1
GFR|GFR;gfr|C0017654;C1424601|||C0017654;C1424601|AOD;CHV;HUGO;NCI;OMIM|||
GFR|GUANINE NUCLEOTIDE EXCHANGE FACTOR FOR RAP1;KIAA0277;MR-GEF;MRAS-REGULATED GUANINE NUCLEOTIDE EXCHANGE FACTOR;MRGEF;RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5;RAPGEF5;RAPGEF5 gene|C1424601|||C1424601|HUGO;MTH;OMIM|||
GFR|Glomerular filtration rate (function)||||C0017654|SNOMEDCT|||
GFR|Glomerular filtration rate (observable entity)||||C0017654|SNOMEDCT|||
GFR|Glomerular filtration rate, function (observable entity)||||C0017654|SNOMEDCT|||
GFR|Inulin clearance||||||1|0.0025|
GFR|M-Ras-regulated GEF||||C1424601|HUGO|||
GFR|Rap guanine nucleotide exchange factor (GEF) 5||||C1424601|HUGO|||
GFR|glomerular filtration|C0232809|||||1|0.0069|
GFR|growth factor receptor|C0206454|||||||1
GFR|grunting, flaring, retracting||||||||1
GFR|renal function|C0232804|||||1|0.0025|
GGT|(5-L-Glutamyl)-peptide:amino-acid 5-glutamyltransferase||||C0017040|MSH;NDFRT|||
GGT|CD224;D22S672;D22S732;GAMMA-GLUTAMYLTRANSFERASE 1;gamma-glutamyltransferase 1;GGT;GGT1;GGT1 gene|C1415053|||C0017040;C0202035;C1415053|AOD;CHV;HUGO;MTH;NCI;OMIM|||
GGT|GGT - Gamma-glutamyl transferase;Gamma-Glutamyl Transpeptidase;Gamma-glutamyl transpeptidase;Transpeptidase, gamma-Glutamyl;gamma Glutamyl Transpeptidase;gamma glutamyl transpeptidase;gamma glutamyltranspeptidase;gamma-Glutamyl Transpeptidase;gamma-glutamyl transpeptidase;gamma-glutamyltranspeptidase;Glutamyl Transpeptidase;Glutamyl transpeptidase;Transpeptidase, Glutamyl;glutamyl transpeptidase|C0017040|||C0017040|AOD;CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.5887|
GGT|GGT measurement;GGTP measurement;GTP measurement;Gamma Glutamyl Transpeptidase Measurement;Gamma glutamyl transpeptidase measurement;Gamma glutamyl transferase measurement;Gamma-glutamyl transferase level;gamma glutamyl transferase level test;ggt test;test ggt|C0202035|||C0202035|CHV;MTH;NCI;SNOMEDCT|||
GGT|GGTP;ggtp||||C0017040;C0202035|CHV;MSH;MTH;NCI;NDFRT|||
GGT|Gamma Glutamyl Transferase;Gamma glutamyl transferase;Gamma-Glutamyl transferase;Gamma-glutamyl transferase;gamma Glutamyltransferase;gamma glutamyl transferase;gamma glutamyltransferase;gamma-Glutamyltransferase;gamma-glutamyl transferase;gamma-glutamyltransferase;gammaglutamyltransferase|C0017040;C0202035|1|0.998|C0017040;C0202035|AOD;CHV;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.344|1
GGT|Gamma glutamyl transferase measurement (procedure)||||C0202035|SNOMEDCT|||
GGT|Gamma-GT;gamma GTP|C0017040;C1324645|||C0017040|NCI;SNOMEDCT|||
GGT|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0091|
GGT|galactosylhydroxylysyl glucosyltransferase|C0077685|||C0077685|MSH|||
GGT|gamma-Glutamyltransferase (substance)||||C0017040|SNOMEDCT|||
GGT|gamma-Glutamyltransferase [Chemical/Ingredient]||||C0017040|NDFRT|||
GGT|serum gamma-glutamyltransferase||||||1|0.0582|
GI|ADENYLATE CYCLASE INHIBITORY PROTEIN;GNAI1 Gene;GNAI1 gene|C1415142|||C1415142|HUGO;MTH;NCI;OMIM|||
GI|G PROTEIN, ALPHA-INHIBITING 1||||C1415142|OMIM|||
GI|GASTROINTESTINAL PROBLEM;Gastrointestinal problem;gastrointestinal problem;gastrointestinal problems;Gastrointestinal tract problem;gi problems|C0017187|||C0017187|CHV;COSTAR;MTH;SNOMEDCT|||
GI|GI;Gi||||C0017187;C0017540;C0521362;C1136206;C1415142;C1551090;C1553044;C1996906|CHV;LNC;NCI;OMIM|||
GI|GI - in LOINC|C1996906|||C1996906|MTH|||
GI|GIB;GIBRALTAR;Gibraltar|C0017540|||C0017540|LCH;MSH;MTH;NCI;SNOMEDCT|||
GI|GIGANTEA||||||1|0.0034|
GI|GNAI1;Gi1 protein alpha subunit|C1415142;C1517337|||C1415142|HUGO;NCI;OMIM|||
GI|GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1||||C1415142|OMIM|||
GI|Gastrointestinal;gastro intestinal;gastro-intestinal;gastrointestinal;gastrointestinal (GI)|C0521362;C1559265;C2707256|1|1|C0521362;C1559265|CHV;LNC;MTH;NCI;OMIM|1|0.8684|1
GI|Gastrointestinal tract problem (finding)||||C0017187|SNOMEDCT|||
GI|Gb|C0041700;C1551090|||C1551090|NCI|||
GI|General Inquiry||||||||1
GI|Gibi;gibi|C1553044|||C1553044|HL7V3.0;MTH;NCI|||
GI|Gibraltar (geographic location)||||C0017540|SNOMEDCT|||
GI|Gilbert;Units Of Measure - Gilbert|C1551090|||C1551090|HL7V3.0;MTH;NCI|||
GI|Gingival Index;gingival index;gingival indices|C0017569|||C0017569|CHV;MSH|1|0.0014|1
GI|Gingival inflammation||||||1|0.002|
GI|Glass ionomer;glass ionomer|C0061297|||C0061297|CHV;MSH|1|0.0039|
GI|Glucagon immunoreactivity||||||1|0.0031|
GI|Glycemic Index;Glycemic Indices;glycaemic indices;glycemic index;glycemic indices;Glycemic Index Number;Glycemic Index Numbers|C1136206|||C1136206|CHV;MSH;MTH;NCI|1|0.0284|1
GI|Group I|C0441843|||||1|0.0116|
GI|Guanine Nucleotide Binding Protein (G Protein), Alpha Inhibiting Activity Polypeptide 1 Gene||||C1415142|NCI|||
GI|INHIBITORY G PROTEIN;inhibitory G protein|C0086706;C1415142|||C1415142|OMIM|1|0.0135|
GI|adenylate cyclase|C0001492;C1382029|||||1|0.002|
GI|gastroenterology|C0017163;C1555759;C1555978|||||1|0.0034|
GI|gastrointestinal tract|C0017189;C1281182|||||1|0.0149|
GI|gelatin infusion||||||||1
GI|gender identity|C0017249|||||||1
GI|gigantocellular reticular nucleus|C0262242|||||1|0.0017|
GI|gill|C0017558;C1552935|||||||1
GI|glass ionomer cement|C0017597|||||1|0.002|
GI|global ischemia||||||1|0.0025|
GI|glomerular index||||||||1
GI|glucose intolerance|C0271650|||C0271650|AOD;CHV;COSTAR;DXP;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0034|1
GI|glycoprotein I||||||1|0.0124|
GI|good impression||||||||1
GI|granuloma inguinale|C0018190|||||||1
GI|growth inhibiting||||||||1
GI|growth inhibition||||||1|0.0034|1
GI|guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1||||C1415142|HUGO|||
GI|guided imagery|C0150627|||||||1
GI|inhibitory GTP-binding protein||||||1|0.0076|
GI|inhibitory guanine nucleotide binding protein||||||1|0.0076|
GI|inhibitory guanine nucleotide regulatory protein||||||1|0.0034|
GJ|GD||||C0018232|NCI|||
GJ|GJ||||C0018232|NCI|||
GJ|GRD|C0018213;C0018232|||C0018232|NCI|||
GJ|GRENADA;Grenada;grenada|C0018232|||C0018232|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
GJ|Grenada (geographic location)||||C0018232|SNOMEDCT|||
GJ|gap junction|C0206117;C2984290|||||1|0.5208|1
GJ|gastric juice|C0017133|||||||1
GJ|gastrojejunal|C0545827|1|1.000|||||
GJ|gastrojejunostomy|C0399839|||||1|0.0938|1
GJ|grapefruit juice|C0452456|||||1|0.0469|1
GJ|junctional conductance||||||1|0.3385|
GT|>||||C0439093|SNOMEDCT|||
GT|> (qualifier value)|C1285164|||C0439093|SNOMEDCT|||
GT|Deficiency of GP 2 b 3 a complex||||C0040015|NDFRT|||
GT|G protein transducin||||||1|0.0114|
GT|GLANZMANN DISEASE;Glanzmann's disease;glanzmann's disease;GLANZMANN THROMBASTHENIA;Glanzmann Thrombasthenia;Glanzmann thrombasthenia;Glanzmann's thrombasthenia;Thrombasthenia, Glanzmann;glanzmann thrombasthenia;glanzmann's thrombasthenia;glanzmanns thrombasthenia;Glanzmann thromboasthenia;Glanzmann's syndrome;Glanzmann-Naegeli disorder;Hereditary haemorrhagic thrombasthenia;Hereditary hemorrhagic thrombasthenia;Hereditary thromboasthenia;Hereditary thromboasthenia, NOS;PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY;Platelet glycoprotein 2 b-3a deficiency;THROMBASTHENIA;Thrombasthenia;Thrombasthenia, NOS;Thrombasthenias;thrombasthenia;Thrombasthenia, hemorrhagic;Thrombasthenia, hereditary;Thromboasthenia;Thromboasthenia, NOS;thromboasthenia;Thrombocytasthenia;thrombocytasthenia|C0040015|||C0040015|CHV;CSP;CST;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.2023|1
GT|GLYCOPROTEIN COMPLEX IIb-IIIa, DEFICIENCY OF||||C0040015|OMIM|||
GT|GP IIb-IIIa COMPLEX, DEFICIENCY OF||||C0040015|OMIM|||
GT|GT||||C0018367;C0040015;C0439093|NCI;OMIM|||
GT|GTM;GUATEMALA;Guatemala;guatemala|C0018367|||C0018367|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
GT|Gambling Task||||||1|0.025|
GT|Gamow-Teller||||||||1
GT|Generation time;generation time||||||1|0.0114|1
GT|Glanzmann's thrombasthenia (disorder)||||C0040015|SNOMEDCT|||
GT|Glanzsmann's disease||||C0040015|SNOMEDCT|||
GT|Gliotoxin|C0017641|||||1|0.0205|
GT|Glycoprotein IIb/IIIa defect||||C0040015|SNOMEDCT|||
GT|Glycoprotein IIb/IIIa defect (disorder)||||C0040015|SNOMEDCT|||
GT|Greater Than;Greater than;greater than|C0439093|||C0439093|CHV;HL7V2.5;HL7V3.0;MTH;NCI|||
GT|Greater-than symbol >||||C0439093|SNOMEDCT|||
GT|Greater-than symbol > (qualifier value)||||C0439093|SNOMEDCT|||
GT|Guatemala (geographic location)||||C0018367|SNOMEDCT|||
GT|L-glutamic acid50-L-tyrosine50||||||1|0.0523|
GT|PLATELET FIBRINOGEN RECEPTOR, DEFICIENCY OF;Platelet Fibrinogen Receptor, Deficiency of;Platelet fibrinogen receptor, deficiency of||||C0040015|MSH;NDFRT;OMIM|||
GT|THROMBASTHENIA OF GLANZMANN AND NAEGELI;Thrombasthenia of Glanzmann and Naegeli||||C0040015|MSH;NDFRT;OMIM|||
GT|Thrombasthenia [Disease/Finding]||||C0040015|NDFRT|||
GT|UDP-Glc||||||1|0.0205|
GT|UDP-glucuronosyltransferase;UDP-glucuronyltransferase;glucuronosyltransferase;glucuronyl transferase;glucuronyltransferase|C0041560|||C0041560|MSH;NDFRT|1|0.0772|1
GT|drop|C1321095;C1705648;C2347093;C2348338|||||||1
GT|gait|C0016928|||||||1
GT|gait training|C0085673|||C0085673|CHV;SNOMEDCT|||1
GT|galactosyl transferase;galactosyltransferase|C0016964;C0702242|||||1|0.0705|1
GT|gamma-glutamyl transferase;gamma-glutamyltransferase|C0017040;C0202035|||||1|0.0591|1
GT|gamma-glutamyl transpeptidase;glutamyl transpeptidase|C0017040|1|0.06|C0017040|AOD;CHV;CSP;MSH;NDFRT;SNOMEDCT|1|0.0159|1
GT|gastrostomy|C0017196;C0546256|||C0017196;C0546256;C0595806;C1522614|AOD;CHV;ICD9CM;LCH;MSH;MTH;MTHMST;NCI;SNOMEDCT|||
GT|gastrostomy tube|C0150595;C1549523;C2985542|1|0.892|||1|0.0136|1
GT|gene therapy|C0017296|||||1|0.0295|1
GT|genetic therapy||||||||1
GT|genital tubercle|C0231058;C1281767|||||1|0.0205|
GT|germ tube|C1819077|||||1|0.0182|
GT|giant|C0017547|||||1|0.0432|
GT|gingiva treatment||||||||1
GT|gingival tissue||||||1|0.0114|
GT|glucagon test|C0337437|||||||1
GT|glucose tolerance|C0178665|1|0.004|C0178665|CHV;CSP;LNC|1|0.0727|1
GT|glucose transport|C0178666|||C0178666|CHV;CSP;GO|1|0.0136|1
GT|glucose transporter|C0017742|||||1|0.0636|
GT|glucosyltransferase|C0119452|||C0119452|CHV;CSP;MTH|||
GT|glutathione transferase|C0017837|||C0017837|CHV;CSP;LCH;MSH;NDFRT;SNOMEDCT|1|0.0409|
GT|glycityrosine||||||||1
GT|glycosyltransferase|C0085249|||C0085249;C1152069|CHV;CSP;MTH;NCI;SNOMEDCT|||
GT|glycyltyrosine|C0061748|||C0061748|MSH|||
GT|grand total||||||||1
GT|granulation tissue|C0018180|||C0018180|AOD;CHV;LCH;MSH;NCI;SNOMEDCT|1|0.0159|1
GT|great toe|C0018534;C1281588|||C0018534;C1281588|CHV;FMA;LNC;SNOMEDCT;UWDA|||1
GT|greater trochanter|C0223865;C1279114|||C0223865;C1279114|CHV;FMA;SNOMEDCT;UWDA|||1
GT|green tea|C1384640;C1704263|||||1|0.0295|1
GT|group tension||||||||1
GT|group therapy|C0033971;C1527374|||C0033971;C1527374|AOD;CHV;CSP;LNC;MSH;MTH;NCI;SNOMEDCT|||1
GT|gutta||1|0.032|||||
GT|tissue conductance||||||1|0.0614|
GTT|DROPS;Drop;Drops;drop;drop(s);drops|C0991568;C1321095;C1705648;C2347093;C2348338|||C0991568;C1321095;C2347093|CHV;HL7V3.0;NCI;NDFRT;SNOMEDCT|||1
GTT|Drop (qualifier value)||||C1321095|SNOMEDCT|||
GTT|Drop - unit of product usage;Drop Unit;Drop measurement;Metric Drop;X4;drop as a measurement|C1321095|||C1321095|CHV;MTH;NCI;SNOMEDCT|||
GTT|Drop - unit of product usage (qualifier value)||||C1321095|SNOMEDCT|||
GTT|Drop Dosage Form;Drop Dose Form;Drops [Dose Form];Drops dose form;Drops - Drug Form|C0991568|||C0991568|MTH;NCI;NDFRT;SNOMEDCT|||
GTT|Drop Dosing Unit||||C1321095|NCI|||
GTT|Drops dose form (qualifier value)||||C0991568|SNOMEDCT|||
GTT|GESTATIONAL TROPHOBLASTIC NEOPL;TROPHOBLASTIC NEOPL GESTATIONAL||||C1135868|MSH|||
GTT|GTT;Gtt;Gtts;gtt;gtts|C0017741;C1321095|||C0017741;C0991568;C1135868;C1321095;C2347093|CHV;NCI;PDQ;SNOMEDCT|||
GTT|GTT - Glucose tolerance test;Glucose Tolerance Test;Glucose Tolerance Tests;Glucose tolerance test;Glucose tolerance test NOS;Glucose tolerance test, NOS;Glucose tolerance tests;glucose test tolerance;glucose testing tolerance;glucose tests tolerance;glucose tolerance test;glucose tolerance tests;Glucose challenge test;challenge glucose testing;glucose challenge test;Glucose tolerance test (procedure);Glucose tolerance test NOS (procedure);glucose procedure testing tolerance;OGTT - Oral glucose tolerance test|C0017741|1|0.98|C0017741|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.814|1
GTT|Gestational Trophoblastic Neoplasia;Gestational trophoblastic neoplasia;Neoplasia, Gestational Trophoblastic;Trophoblastic Neoplasia, Gestational;gestational trophoblastic neoplasia;Gestational Trophoblastic Neoplasm;Gestational Trophoblastic Neoplasms;Gestational trophoblastic neoplasm;Neoplasm, Gestational Trophoblastic;Neoplasms, Gestational Trophoblastic;Trophoblastic Neoplasm, Gestational;Trophoblastic Neoplasms, Gestational;Gestational Trophoblastic Tumor;Gestational trophoblastic tumor;Gestational trophoblastic tumour;gestational trophoblastic tumor;trophoblastic tumor, gestational;trophoblastic tumor GTT|C1135868|||C1135868|MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.186|1
GTT|Gestational Trophoblastic Neoplasms [Disease/Finding]||||C1135868|NDFRT|||
GTT|Gestational trophoblastic neoplasm (disorder)||||C1135868|SNOMEDCT|||
GTT|Gestational trophoblastic neoplasm (morphologic abnormality)||||C1135868|SNOMEDCT|||
GTT|Gestational trophoblastic tumor (disorder)||||C1135868|SNOMEDCT|||
GTT|Medical Drop|C2347093|||C2347093|MTH;NCI|||
GTT|Pharmacist's Drop||||C1321095|NCI|||
GTT|[drp]|C0675739;C1413979;C1421412;C2347093;C2985158|||C2347093|NCI|||
GTT|drip||1|0.002|||||
GTT|gamma-glutamyltransferase|C0017040;C0202035|1|0.006|||||
GTT|gelatin-tellurite-taurocholate||||||||1
GTT|gestational transient thyrotoxicosis||||||||1
GTT|gestational trophoblastic disease|C1135868;C2931618|||C1135868|NCI|||
GTT|guttae||1|0.012|||||
GU|GENITOURINARY;Genitourinary;genitourinary|C0042066;C2709259|1|1|C0042066;C2709258;C2709259|CHV;LNC;NCI;OMIM|1|0.3095|1
GU|GQ|C0014651|||C0018309|NCI|||
GU|GU||||C0018309;C0042066;C2709258|NCI;OMIM|||
GU|GUAM;Guam;guam|C0018309|||C0018309|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
GU|GUM|C0017562;C0812395|||C0018309|NCI|||
GU|Genitourinary Route of Administration;Genitourinary Route of Drug Administration;GenitourinaryRoute|C2709258|||C2709258|HL7V3.0;MTH;NCI|||
GU|Genitourinary System;Genitourinary Systems;Genitourinary system;Genitourinary system, NOS;Genitourinary systems;System, Genitourinary;Systems, Genitourinary;genitourinary system|C0042066;C1280973|||C0042066|CHV;LNC;MSH;MTH;NCI;SNOMEDCT|||
GU|Genitourinary Tract;Genitourinary tract;Genitourinary tract, NOS;genitourinary tract|C0042027;C0042066;C1283794|||C0042066|CHV;LNC;NCI;SNOMEDCT|||
GU|Glucose uptake;glucose uptake|C0599781|||C0599781|CHV;CSP;GO|1|0.0688|1
GU|Guam (geographic location)||||C0018309|SNOMEDCT|||
GU|Structure of genitourinary system;System, Urogenital;Systems, Urogenital;Urogenital System;Urogenital Systems;Urogenital system;Urogenital system, NOS;urogenital system;urogenital systems;Urogenital Tract;Urogenital structure;urogenital structure;urogenital|C0042066|||C0042066|AOD;CHV;CST;MSH;NCI;SNOMEDCT|||
GU|Structure of genitourinary system (body structure)||||C0042066|SNOMEDCT|||
GU|Systema urinaria;urinary system|C0042066;C1508753|||C0042066|CHV;UWDA|||
GU|Urogenital structure (body structure)||||C0042066|SNOMEDCT|||
GU|gastric|C0038351;C1704242|||||1|0.0529|
GU|gastric ulcer|C0038358|||C0038358|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;MTHMST;NCI;NDFRT;OMIM;SNOMEDCT|1|0.4471|1
GU|gastric upset||||||||1
GU|glucose utilization||||||1|0.0529|
GU|glycogenic unit||||||||1
GU|gonococcal urethritis|C0018078|||C0018078|CHV;COSTAR;MTH;MTHICD9;NCI;SNOMEDCT|1|0.0344|1
GU|gravitational ulcer|C0042344|||C0042344|SNOMEDCT|||1
GU|reproductive and urinary system||||C0042066|CHV|||
GU|units|C0439148;C1519795|||||1|0.0344|
GU|urogenital system (urinary part)||||C0042066|CSP|||
GVHD|Disease, Graft-Versus-Host;Diseases, Graft-Versus-Host;GRAFT VERSUS HOST DISEASE;Graft Versus Host Disease;Graft versus host disease;Graft versus host disease, NOS;Graft-Versus-Host Disease;Graft-Versus-Host Diseases;Graft-Versus-Host-Disease;Graft-versus-host disease;disease graft host versus;disease graft versus host;graft versus host disease;graft-versus-host disease;graft-versus-host diseases;host versus graft disease|C0018133;C2984293|1|1|C0018133|CHV;CSP;DXP;ICD9CM;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.9812|1
GVHD|Disease, Graft-vs-Host;Diseases, Graft-vs-Host;Graft Vs. Host Disease;Graft vs Host Disease;Graft-vs-Host Disease;Graft-vs-Host Diseases;disease graft host vs;graft vs host disease;graft-vs-host disease;host vs graft disease;Disease, Homologous Wasting;Homologous Wasting Disease;homologous wasting disease;Disease, Runt;Runt Disease;runt disease;GVH;gvh;GVHD - Graft-versus-host disease;autoimmune foreign transplant disease;gvh disease|C0018133|||C0018133|CHV;CSP;DXP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0089|
GVHD|GRAFT VERSUS HOST DIS||||C0018133|MSH|||
GVHD|GRAFT VS HOST DIS||||C0018133|MSH|||
GVHD|GVHD;gvhd||||C0018133;C0278845|CHV;CSP;DXP;NCI;PDQ|||
GVHD|GVHD prophylaxis/therapy;prophylaxis/therapy, GVHD||||C0278845|NCI;PDQ|||
GVHD|Graft Versus Host Disease Prophylaxis/Therapy;Graft versus host disease prophylaxis/therapy;graft versus host disease prophylaxis/therapy;prophylaxis/therapy, graft versus host disease||||C0278845|MTH;NCI;PDQ|||
GVHD|Graft versus host disease (disorder);Graft-versus-host disease (disorder)||||C0018133|SNOMEDCT|||
GVHD|Graft versus host disease [Ambiguous]||||C0018133|SNOMEDCT|||
GVHD|Graft vs Host Disease [Disease/Finding]||||C0018133|NDFRT|||
GVHD|Graft-versus-host NOS||||C0018133|ICD9CM|||
GVHD|Graft-versus-host disease, unspecified||||C0018133|ICD9CM|||
GVHD|HOMOL WASTING DIS||||C0018133|MSH|||
GVHD|RUNT DIS||||C0018133|MSH|||
GVHD|Runting syndrome|C0018133;C1279471|||C0018133|SNOMEDCT|||
GVHD|acute graft-versus-host-disease|C0856825|||||1|0.0056|
GVHD|chronic graft-versus-host-disease|C0867389|||||1|0.0043|
GVHD|graft versu host disease||||C0018133|CHV|||
GVHD|graft versus host disease (GVHD) prophylaxis therapy||||C0278845|CHV|||
GVH|Disease, Graft-Versus-Host;Diseases, Graft-Versus-Host;GRAFT VERSUS HOST DISEASE;Graft Versus Host Disease;Graft versus host disease;Graft versus host disease, NOS;Graft-Versus-Host Disease;Graft-Versus-Host Diseases;Graft-Versus-Host-Disease;Graft-versus-host disease;disease graft host versus;disease graft versus host;graft versus host disease;graft-versus-host disease;graft-versus-host diseases;host versus graft disease|C0018133;C2984293|||C0018133;C2984293|CHV;CSP;DXP;ICD9CM;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0167|
GVH|Disease, Graft-vs-Host;Diseases, Graft-vs-Host;Graft Vs. Host Disease;Graft vs Host Disease;Graft-vs-Host Disease;Graft-vs-Host Diseases;disease graft host vs;graft vs host disease;graft-vs-host disease;host vs graft disease;Disease, Homologous Wasting;Homologous Wasting Disease;homologous wasting disease;Disease, Runt;Runt Disease;runt disease;GVH;gvh;GVHD - Graft-versus-host disease;autoimmune foreign transplant disease;gvh disease|C0018133|||C0018133|CHV;CSP;DXP;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
GVH|GRAFT VERSUS HOST DIS||||C0018133|MSH|||
GVH|GRAFT VS HOST DIS||||C0018133|MSH|||
GVH|GVHD;gvhd||||C0018133|CHV;CSP;DXP;NCI;PDQ|||
GVH|Graft versus host disease (disorder);Graft-versus-host disease (disorder)||||C0018133|SNOMEDCT|||
GVH|Graft versus host disease [Ambiguous]||||C0018133|SNOMEDCT|||
GVH|Graft vs Host Disease [Disease/Finding]||||C0018133|NDFRT|||
GVH|Graft-Versus-Host reaction|C0018134|||||1|0.0358|
GVH|Graft-versus-host NOS;graft versus host;graft-versus-host||1|1|C0018133|ICD9CM|1|0.747|1
GVH|Graft-versus-host disease, unspecified||||C0018133|ICD9CM|||
GVH|HOMOL WASTING DIS||||C0018133|MSH|||
GVH|RUNT DIS||||C0018133|MSH|||
GVH|Runting syndrome|C0018133;C1279471|||C0018133|SNOMEDCT|||
GVH|generalized visceral hypersensitivity||||||||1
GVH|graft versu host disease||||C0018133|CHV|||
GVH|graft-vs-host||||||1|0.2005|
GYN|GYN|C0018417;C0205480|||C0018417;C0205480|NCI|||
GYN|GYNECOL||||C0018417|MSH|||
GYN|Gynaecologic;Gynecologic;gynaecologic;gynecologic|C0205480|||C0205480|CHV;MTH;NCI;SNOMEDCT|||1
GYN|Gynaecology;Gynecology;gynaecology;gynecology|C0018417;C0237419|1|1|C0018417;C0237419|CHV;CSP;HL7V3.0;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|||1
GYN|Gynaecology (qualifier value);Gynecology (qualifier value)||||C0018417|SNOMEDCT|||
GYN|Gynecologic (qualifier value)||||C0205480|SNOMEDCT|||
GYN|gynecological|C0018417|||C0018417|CHV|||
GYN|gynecologist|C0237419|||C0237419|CHV;MTH;NCI;SNOMEDCT|||
GYN|gynecology (field)||||C0018417|AOD|||
HCG|CG - Chorionic gonadotrophin;CG - Chorionic gonadotropin;CG preparation;Choriogonadotrophin;Choriogonadotropin;Chorionic gonadotrophin preparation;Chorionic gonadotropin preparation;Chorionic gonadotrophin product;Chorionic gonadotropin product;Pregnancy urine hormone|C0018062|||C0018062|LNC;MSH;NDFRT;SNOMEDCT|||
HCG|CGA||||C1413366|HUGO;OMIM|||
HCG|CGA gene;CHORIONIC GONADOTROPIN, ALPHA CHAIN;FOLLICLE-STIMULATING HORMONE, ALPHA CHAIN;FSHA;GPHA1;GPHa;LHA;LUTEINIZING HORMONE, ALPHA CHAIN;THYROID-STIMULATING HORMONE, ALPHA CHAIN;THYROTROPIN, ALPHA CHAIN;TSHA;chorionic gonadotropin, alpha polypeptide;follicle-stimulating hormone alpha subunit|C1413366|||C1413366|HUGO;MTH;OMIM|||
HCG|CGB5;CGB5 gene;CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5;chorionic gonadotropin, beta polypeptide 5|C1424291|||C1424291|HUGO;MTH;OMIM|||
HCG|CGH||||C1415796;C1855900|HUGO;OMIM|||
HCG|Choriogonadotropin (substance)||||C0018062|SNOMEDCT|||
HCG|Choriogonadotropin Beta;Choriogonadotropin Beta Measurement|C1880076|||C1880076|MTH;NCI|||
HCG|Chorionic Gonadotropin;Chorionic gonadotrophin;Chorionic gonadotrophin, NOS;Chorionic gonadotropin;Chorionic gonadotropin, NOS;GONADOTROPIN, CHORIONIC;GONADOTROPIN,CHORIONIC;Gonadotropin, Chorionic;chorionic gonadotropin|C0018062;C1527152|||C0018062;C1527152|CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
HCG|Chorionic Gonadotropin [Chemical/Ingredient]||||C0018062|NDFRT|||
HCG|Chorionic Gonadotropin, Human;Chorionic gonadotrophin human;Chorionic gonadotropin human;Gonadotropin, Human Chorionic;HUMAN CHORIONIC GONADOTROPIN;Human Chorionic Gonadotropin;Human chorionic gonadotrophin;Human chorionic gonadotrophin, NOS;Human chorionic gonadotropin;Human chorionic gonadotropin, NOS;human chorionic gonadotrophin;human chorionic gonadotropin;human chorionic gonadotropins;HCG (Human Chorionic Gonadotropin);HCG - Human chorionic gonadotrophin;HCG - Human chorionic gonadotropin;human chorionic gonadotropin (HCG)|C0018062;C1141639;C1527152|1|1|C0018062;C1141639;C1527152|AOD;CHV;MSH;MTH;NCI;RXNORM;SNOMEDCT|1|0.9648|1
HCG|Chorionic gonadotropin preparation (product)||||C0018062|SNOMEDCT|||
HCG|Chorionic gonadotropin preparation (substance)||||C0018062|SNOMEDCT|||
HCG|Congenital, generalized hypertrichosis;HYPERTRICHOSIS, CONGENITAL GENERALIZED|C1855900|||C1855900|MTH;OMIM|||
HCG|GLYCOPROTEIN HORMONES, ALPHA CHAIN;glycoprotein hormones, alpha polypeptide|C0017963;C1413366|||C1413366|HUGO;OMIM|||
HCG|HCG;hCG|C0106132|||C0018062;C1141639;C1413366;C1415796;C1424291;C1527152;C1855900;C1880076|AOD;CHV;HUGO;LNC;MSH;NCI;OMIM;PDQ;SNOMEDCT|||
HCG|HCG - Human chorionic gonadotrophin product;HCG - Human chorionic gonadotropin product;HCG preparation;hCG preparation;Human chorionic gonadotrophin product;Human chorionic gonadotropin (product);Human chorionic gonadotropin product|C1141639|||C1141639|SNOMEDCT|||
HCG|HTC2|C1415796;C1855900|||C1415796;C1855900|HUGO;OMIM|||
HCG|HTC2 gene|C1415796|||C1415796|HUGO;LNC;MTH|||
HCG|Human choriogonadotropin||||||1|0.0333|
HCG|Human chorionic gonadotropin (substance)||||C1141639|SNOMEDCT|||
HCG|Pregnancy Test;Pregnancy test|C0032976;C1880076|||C1880076|LNC;NCI|||
HCG|Recombinant Human Chorionic Gonadotropin;Recombinant human chorionic gonadotrophin;Recombinant human chorionic gonadotropin;recombinant human chorionic gonadotropin|C1527152|||C1527152|MTH;NCI;PDQ;SNOMEDCT|||
HCG|Recombinant chorionic gonadotrophin||||C1527152|SNOMEDCT|||
HCG|Recombinant chorionic gonadotrophin (product)||||C1527152|SNOMEDCT|||
HCG|Recombinant human chorionic gonadotrophin (product)||||C1527152|SNOMEDCT|||
HCG|Recombinant human chorionic gonadotrophin (substance)||||C1527152|SNOMEDCT|||
HCG|human chorionic gonadotropin hormone||||||1|0.0018|
HCG|hypertrichosis 2 (generalized, congenital)||||C1415796|HUGO|||
HCG|rhCG|C1425338;C1527152|||C1527152|NCI|||
HCT|Erythrocyte Volume, Packed;Erythrocyte Volumes, Packed;Packed Erythrocyte Volume;Packed Erythrocyte Volumes;Volume, Packed Erythrocyte;Volumes, Packed Erythrocyte;HCT;Hct;Haematocrit (procedure);Hematocrit procedure;Haematocrit - PCV;Haematocrit - PCV - NOS;Hematocrit - PCV;Hematocrit - PCV - NOS;Haematocrit determination;Hematocrit determination;Hct - Haematocrit;Hct - Hematocrit;Hematocrit Measurement;Packed Red Cell Volume;Packed Red-Cell Volume;Packed Red-Cell Volumes;Red-Cell Volume, Packed;Red-Cell Volumes, Packed;Volume, Packed Red-Cell;Volumes, Packed Red-Cell;Packed cell volume measurement;hematocrit level test|C0018935|||C0018935|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
HCT|Haematocrit;Hematocrit;Hematocrits;hematocrit|C0018935;C0518014|||C0018935;C0518014|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.6566|1
HCT|Haematocrit (observable entity)||||C0018935|SNOMEDCT|||
HCT|Haematocrit - PCV - NOS (procedure);Hematocrit - PCV - NOS (procedure)||||C0018935|SNOMEDCT|||
HCT|Halstead Category Test||||||1|0.009|
HCT|Health Check Test||||||||1
HCT|Helical Computed Tomography;helical computed tomography;helical CT|C0860888|||C0860888|CHV;MSH;NCI|1|0.0352|
HCT|Hematocrit determination (procedure)||||C0018935|SNOMEDCT|||
HCT|Hematopoietic cell transplantation||||||1|0.1033|
HCT|Packed cell volume|C0018935;C1318015|||C0018935|SNOMEDCT|||
HCT|Packed cell volume (observable entity)||||C0018935|SNOMEDCT|||
HCT|Packed cell volume measurement (procedure)||||C0018935|SNOMEDCT|||
HCT|haematocrit centrifugation technique||||||1|0.0074|
HCT|haematocrit value||||||1|0.0049|
HCT|head computerized tomography|C0202691|||||||1
HCT|heart-circulation training||||||||1
HCT|hematopoietic cell transplant||||||1|0.0107|
HCT|hematopoietic stem cell transplant||||||||1
HCT|histamine challenge test|C2697609|||||||1
HCT|historic control trial||||||||1
HCT|homocytotrophic||||||||1
HCT|human calcitonin|C0770558|||C0770558|MTH;RXNORM;SNOMEDCT|1|0.091|1
HCT|human chorionic thyrotropin|C0063010|||||||1
HCT|hundred count||||||||1
HCT|hydrochlorothiazide|C0020261|1|1.000|||1|0.082|
HCT|hydrocortisone|C0020268|||||||1
HCTZ|2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide;6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide||||C0020261|MSH;NCI;NDFRT|||
HCTZ|Dichlothiazide;Dihydrochlorothiazide;HCTZ;hctz;HYDROCHLOROTHIAZIDE;Hydrochlorothiazide;hydrochlorothiazide|C0020261|1|1|C0020261|CHV;LNC;MSH;MTHFDA;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|1|1
HCTZ|Hydrochlorothiazide (product)||||C0020261|SNOMEDCT|||
HCTZ|Hydrochlorothiazide (substance)||||C0020261|SNOMEDCT|||
HCTZ|Hydrochlorothiazide [Chemical/Ingredient]||||C0020261|NDFRT|||
HDL|Alpha-lipoprotein;Lipoprotein.alpha;alpha Lipoprotein;alpha Lipoproteins;alpha-Lipoproteins;alpha-lipoprotein;HDL;hdls;HDL - High density lipoprotein;High density lipoprotein (HDL);high density lipoproteins (HDL);HDL Lipoproteins;Lipoproteins, HDL;Heavy Lipoproteins;Lipoproteins, Heavy;High Density Lipoprotein;High Density Lipoproteins;High density lipoprotein;High-Density Lipoproteins;Lipoproteins, High-Density;high density lipoprotein;high density lipoproteins;high-density lipoprotein;High densitiy lipoprotein|C0023821|1|1|C0023821;C0428472;C1325339|AOD;CHV;CSP;FMA;GO;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.9797|1
HDL|HDL Cholesterol|C0023822;C0428472|||C0428472|NCI|||
HDL|High density lipoprotein (substance)||||C0023821|SNOMEDCT|||
HDL|Lipoproteins, HDL [Chemical/Ingredient]||||C0023821|NDFRT|||
HDL|Serum HDL Cholesterol;serum HDL cholesterol;Serum HDL Cholesterol Measurement;Serum HDL cholesterol measurement|C0428472|||C0428472|MTH;NCI;SNOMEDCT|||
HDL|Serum HDL cholesterol level|C0428472;C1318181|||C0428472|SNOMEDCT|||
HDL|Serum HDL cholesterol level (procedure)||||C0428472|SNOMEDCT|||
HDL|Serum HDL cholesterol measurement (procedure)||||C0428472|SNOMEDCT|||
HDL|high density lipoprotein fraction||||||1|0.001|
HDL|high-density lipoprotein activity|C1325339|||C1325339|MTH|||
HDL|high-density lipoprotein cholesterol|C0023822|||||1|0.0194|
HELLP|HELLP||||C0162739|MSH|||
HELLP|HELLP - Syndrome of haemolysis, elevated liver enzymes and low platelet;HELLP - Syndrome of hemolysis, elevated liver enzymes and low platelet;HELLP syndrome (hemolysis, elevated liver enzymes, low platelets)||||C0162739|OMIM;SNOMEDCT|||
HELLP|HELLP Syndrome;HELLP syndrome;Syndrome, HELLP;hellp syndrome;syndrome hellp;Haemolysis-elevated liver enzymes-low platelet count syndrome;Hemolysis-elevated liver enzymes-low platelet count syndrome|C0162739|||C0162739|CHV;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||
HELLP|HELLP Syndrome [Disease/Finding]||||C0162739|NDFRT|||
HELLP|HELLP syndrome (disorder)||||C0162739|SNOMEDCT|||
HELLP|Hemolysis, Elevated Liver Enzymes, Lowered Platelets||||C0162739|MSH;NDFRT|||
HELLP|Hemolysis-elevated liver enzymes-low platelet count syndrome (disorder)||||C0162739|SNOMEDCT|||
HELLP|Syndrome of haemolysis, elevated liver enzymes and low platelet;Syndrome of hemolysis, elevated liver enzymes and low platelet||||C0162739|SNOMEDCT|||
HELLP|Syndrome of haemolysis, elevated liver enzymes and low platelet (disorder)||||C0162739|SNOMEDCT|||
HELLP|elevated liver enzymes and low platelet||||||1|0.6667|
HELLP|hellps syndrome||||C0162739|CHV|||
HELLP|hemolysis elevated liver enzymes and low platelets;hemolysis, elevated liver enzymes, low platelets||1|1|||1|0.3333|1
HIDA|HIDA;LIDOFENIN;Lidofenin;lidofenin;hepato-iminodiacetic acid;hepatoiminodiacetic acid|C0064964|1|1|C0064964|CHV;MSH;NCI|||1
HIDA|N-(carboxymethyl)-N-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)glycine||||C0064964|MSH|||
HIDA|hepatic 2,6-dimethyliminodiacetic acid||||||||1
HIT|HIT;Hit;Hit by;hit;hit by;hitting|C0332159;C1708373|||C0332159;C1708373|CHV;MTHICD9;NCI;SNOMEDCT|||
HIT|Headache Impact Test||||||1|0.0209|
HIT|Hit - database search return|C1708373|||C1708373|MTH|||
HIT|Holtzman Inkblot Technique||||||1|0.0342|1
HIT|Hydrothermal Isometric Tension||||||1|0.0152|
HIT|Struck by|C0332159|||C0332159|MTH;SNOMEDCT|||
HIT|Struck by (contextual qualifier)||||C0332159|SNOMEDCT|||
HIT|Struck by (contextual qualifier) (qualifier value)||||C0332159|SNOMEDCT|||
HIT|cell line|C0007600|||||1|0.0114|
HIT|haemagglutination inhibition test;hemagglutination inhibition test|C0018904|||C0018904|AOD;CHV;CSP;MSH|1|0.0228|1
HIT|heparin-induced thrombocytopenia|C0272285|1|1.000|C0272285|CHV;MTHICD9;SNOMEDCT|1|0.8289|1
HIT|high-intensity interval training||||||1|0.0114|
HIT|histamine inhalation test||||||||1
HIT|histamine ion transfer||||||||1
HIT|histidine triad||||||1|0.0361|
HIT|home infusion therapy|C0242945|||||1|0.019|1
HIT|hypertrophic infiltrative tendinitis||||||||1
HIT|hypertrophied inferior turbinate||||||||1
HIV|AIDS Virus;AIDS Viruses;AIDS virus;Virus, AIDS;Viruses, AIDS|C0019682;C0019704|||C0019682|CHV;MSH;SNOMEDCT|||
HIV|Acquired Immune Deficiency Syndrome Virus;Acquired Immunodeficiency Syndrome Virus;HTLV III;HTLV-III;htlv iii;htlv-iii;Human T Cell Leukemia Virus Type III;Human T-Cell Leukemia Virus Type III;Human T Cell Lymphotropic Virus Type III;Human T-Cell Lymphotropic Virus Type III;Human T Lymphotropic Virus Type III;Human T-Lymphotropic Virus Type III;LAV;LAV-HTLV-III;Lymphadenopathy Associated Virus;Lymphadenopathy-Associated Virus;Lymphadenopathy-Associated Viruses;Virus, Lymphadenopathy-Associated;Viruses, Lymphadenopathy-Associated;lymphadenopathy associated virus;Lymphadenopathy-associated virus (LAV);Virus-HIV|C0019682|||C0019682|CHV;CSP;MSH;NCI;SNOMEDCT|||
HIV|HIV|C0019682;C0019693;C0019699|||C0019682;C0019693;C0086413|AOD;CHV;CSP;HL7V2.5;HL7V3.0;LNC;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|||
HIV|HIV - Human immunodeficiency virus;HIV, HUMAN IMMUNODEFICIENCY VIRUS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);VIRUS (HIV), HUMAN IMMUNODEFICIENCY;human immunodeficiency virus (HIV);Human Immunodeficiency Virus;Human Immunodeficiency Viruses;Human immunodeficiency virus;Human immunodeficiency virus, NOS;Immunodeficiency Virus, Human;Immunodeficiency Viruses, Human;Virus, Human Immunodeficiency;Viruses, Human Immunodeficiency;human Immunodeficiency virus;human immunodeficiency virus|C0019682;C0019693|1|1|C0019682;C0019693|AOD;CHV;CSP;MEDLINEPLUS;MSH;NCBI;NCI;SNOMEDCT|1|0.9823|1
HIV|HIV - Human immunodeficiency virus infection;HUMAN IMMUNODEFICIENCY VIRUS [HIV] INFECTION;HIV DISEASE;HIV disease;HIV Infection;HIV Infections;HIV infection;HIV infections;Infection, HIV;Infections, HIV;HTLV III Infections;HTLV-III Infection;HTLV-III Infections;Infection, HTLV-III;Infections, HTLV-III;HTLV III LAV Infections;HTLV-III-LAV Infection;HTLV-III-LAV Infections;HTLV-III/LAV infection;HTLV-III/LAV infection, NOS;Infection, HTLV-III-LAV;Infections, HTLV-III-LAV;Human immunodeficiency virus [HIV] disease;Human immunodeficiency virus disease;Human immunodeficiency virus infection;Human immunodeficiency virus infection, NOS;human immunodeficiency virus infection;LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T;T Lymphotropic Virus Type III Infections, Human;T-Lymphotropic Virus Type III Infections, Human|C0019693|||C0019693|AOD;CCS;CHV;COSTAR;CSP;CST;ICD9CM;LNC;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.0037|
HIV|HIV INFECT||||C0019693|MSH|||
HIV|HIV Infections [Disease/Finding]||||C0019693|NDFRT|||
HIV|HIV Vaccine;HIV Vaccines;HIV vaccine;HIV vaccines;vaccine HIV|C0086413|||C0086413|CHV;CSP;MSH;MTH;NCI|||
HIV|HIV seropositivity or positivity||||C0019693|AOD|||
HIV|HIV/AIDS Vaccines||||C0086413|NCI|||
HIV|HTLV III INFECT||||C0019693|MSH|||
HIV|HTLV III LAV INFECT||||C0019693|MSH|||
HIV|HTLV WIII||||C0019682|MSH|||
HIV|HTLV WIII INFECTIONS||||C0019693|MSH|||
HIV|HTLV WIII LAV INFECTIONS||||C0019693|MSH|||
HIV|HTLV-III/LAV infection (disorder)||||C0019693|SNOMEDCT|||
HIV|HTLV-III/LAV infection -RETIRED-||||C0019693|SNOMEDCT|||
HIV|HUMAN IMMUNODEFIC VIRUS;HUMAN IMMUNODEFIC VIRUSES;IMMUNODEFIC VIRUS HUMAN;IMMUNODEFIC VIRUSES HUMAN;VIRUS HUMAN IMMUNODEFIC;VIRUSES HUMAN IMMUNODEFIC||||C0019682|MSH|||
HIV|HUMAN LYMPHOTROPIC VIRUS TYPE III A T||||C0019682|MSH|||
HIV|Human Immunodeficiency Virus type 1;human immunodeficiency virus type I;human immunodeficiency virus-1|C0019704|||||1|0.0091|
HIV|Human T-lymphotropic virus, type III (HTLV-III)||||C0019682|SNOMEDCT|||
HIV|Human immuno virus dis||||C0019693|ICD9CM|||
HIV|Human immunodeficiency syndrome||||||1|0.0008|
HIV|Human immunodeficiency virus (organism)||||C0019682|SNOMEDCT|||
HIV|Human immunodeficiency virus infection (disorder)||||C0019693|SNOMEDCT|||
HIV|Lymphadenopathy-associated virus, type I (LAV-I)||||C0019682|SNOMEDCT|||
HIV|T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN||||C0019693|MSH|||
HIV|[X]Human immunodeficiency virus disease||||C0019693|SNOMEDCT|||
HIV|[X]Human immunodeficiency virus disease (disorder)||||C0019693|SNOMEDCT|||
HIV|[X]Unspecified human immunodeficiency virus [HIV] disease||||C0019693|SNOMEDCT|||
HIV|[X]Unspecified human immunodeficiency virus [HIV] disease (disorder)||||C0019693|SNOMEDCT|||
HIV|human immunodeficiency||||||1|0.0036|
HIV|human immunodeficiency viral||||||1|0.0006|
HJR|HEPATOJUGULAR REFLUX;Hepatojugular reflux;hepatojugular reflux;HJR;hjr|C0239949|1|1|C0239949|CHV;DXP;SNOMEDCT|||1
HJR|Hepatojugular reflux (finding)||||C0239949|SNOMEDCT|||
HLA|ANTIGENS IR;IR ANTIGENS||||C0019630|MSH|||
HLA|Antigen, Class II;Antigens, Class II;Class II Antigen;Class II Antigens;Antigen, I-A;I A Antigen;I-A Antigen;I-A-Antigen;Antigen, IA;Antigens, Ia;IA Antigen;Ia Antigens;Ia antigen;Antigens, Ia-Like;Ia Like Antigens;Ia-Like Antigens;Antigens, Immune Response;Immune Response Antigens;Antigens, Immune-Response-Associated;Immune Response Associated Antigens;Immune-Response-Associated Antigens;Class II Histocompatibility Antigens;Histocompatibility Antigen, Class II;Histocompatibility Antigens Class II;Class II Major Histocompatibility Antigens;MHC Class II Molecule;MHC class II antigen;Major Histocompatibility Complex Class II;human lymphocyte antigen|C0019630|||C0019630|CSP;MSH;MTH;NCI;NDFRT|||
HLA|Antigens, HL-A;Antigens, HLA;HL A Antigens;HL-A Antigens;HLA Antigens;HLA antigen;HLA antigen, NOS;HLA antigens;antigens hla;hla antigen;hla antigens;Antigens, Leukocyte;Leukocyte Antigens;antigens leukocytes;leukocyte antigen;HLA Ag;HLA factors;hl antigens;human histocompatibility complex derived antigens Antigen|C0019721|||C0019721|AOD;CHV;CSP;LNC;MSH;MTH;NDFRT;SNOMEDCT|||
HLA|Antigens, Human Leukocyte;Human Leukocyte Antigen;Human Leukocyte Antigens;Human leucocyte antigen;Human leukocyte antigen;Leukocyte Antigens, Human;antigen human leucocyte;antigen human leukocyte;antigen human leukocytes;antigens human leucocyte;antigens human leucocytes;human leucocyte antigen;human leukocyte antigen;human leukocyte antigens;HLA - Human leucocyte antigen;HLA - Human leukocyte antigen;Human leucocyte antigen (HLA)|C0019629;C0019630;C0019721|1|1|C0019630;C0019721|AOD;CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|1|0.9655|1
HLA|Class II MHC Protein;MHC Class II Protein|C0019630;C2327910|||C0019630|NCI|||
HLA|HISTOCOMPATIBILITY ANTIGENS CLASS 02||||C0019630|MSH|||
HLA|HLA;hlas|C0019630;C0019721;C1315037;C2327792|||C0019630;C0019721;C1315037;C2327792|AOD;CHV;FMA;LNC;MSH;NCI|||
HLA|HLA A 00 ANTIGENS||||C0019721|MSH|||
HLA|HLA Antigens [Chemical/Ingredient]||||C0019721|NDFRT|||
HLA|HLA antigen (substance)||||C0019721|SNOMEDCT|||
HLA|HLA tissue typing antigens|C1315037|||C1315037|MTH|||
HLA|HLA tissue typing antigens and antibodies||||C1315037|LNC|||
HLA|Histocompatibility Antigens Class II [Chemical/Ingredient]||||C0019630|NDFRT|||
HLA|Human Major Histocompatibility||||||1|0.003|
HLA|Human leucocyte antigen (HLA) antigen;Human leukocyte antigen (HLA) antigen||||C0019721|SNOMEDCT|||
HLA|Human leukocyte antigen (HLA) antigen (substance)||||C0019721|SNOMEDCT|||
HLA|Human leukocyte antigen complex|C2327792|||C2327792|FMA;MTH|||
HLA|Symposium on major histocompatibility antigens||||||1|0.0055|
HLA|blood lactate||||||1|0.0035|
HLA|heart, lungs, abdomen||||||||1
HLA|histocompatibility leukocyte antigen||||||||1
HLA|histocompatibility locus antigen||||||||1
HLA|histocompatibility system||||||1|0.003|
HLA|homologous leukocyte antibody||||||||1
HLA|horizontal long axial||||||||1
HLA|human MHC||||||1|0.0035|
HLA|human leukocyte||||||1|0.0045|
HLA|human leukocyte antibody||||||||1
HLA|human leukocyte antigen system||||||||1
HLA|human major histocompatibility complex||||||1|0.0115|
HLA|hypoplastic left atrium|C1970625|||||||1
HN|HN|C0019905;C1537997;C1853668|||C0019905;C1537997;C1853668|HUGO;NCI;OMIM|||
HN|HND|C0018609;C0019905|||C0019905|NCI|||
HN|HO|C1832110|||C0019905|NCI|||
HN|HONDURAS;Honduras;honduras|C0019905|||C0019905|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
HN|HUMANIN;Humanin;humanin|C0966511;C1537997;C1853668|||C1537997;C1853668|HUGO;OMIM|1|0.0428|
HN|HUMANIN gene|C1853668|||C1853668|MTH|||
HN|Heymann nephritis|C1704378|||||1|0.097|
HN|Honduras (geographic location)||||C0019905|SNOMEDCT|||
HN|Huckman number||||||||1
HN|MT-RNR2;MTRNR2;MT-RNR2 gene;RIBOSOMAL RNA, MITOCHONDRIAL, 16S;mitochondrially encoded 16S RNA;rRNA, 16S, MITOCHONDRIAL|C1537997|||C1537997|HUGO;MTH;OMIM|||
HN|NATO code for nitrogen mustard||||||||1
HN|glycoprotein|C0017968|||||1|0.0164|
HN|haemagglutinin-neuraminidase;hemagglutinin neuraminidase;hemagglutinin-neuraminidase|C2985502|||||1|0.6118|1
HN|head and neck||||C0460004;C1283900|CHV;LNC;NCI;OMIM;SNOMEDCT|1|0.0329|1
HN|head nurse|C0018676|||C0018676|AOD;CHV;MSH|||
HN|hemagglutinin-neuraminidase protein||||||1|0.0164|
HN|hematemesis neonatorum||||||||1
HN|hemorrhage of newborn|C0270183|||C0270183|SNOMEDCT|||1
HN|hereditary nephritis|C0027706;C1567741|||C0027706;C1567741|CHV;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.0247|1
HN|heterogeneous nuclear||||||1|0.023|
HN|heteronuclear||||||1|0.0444|
HN|high necrosis||||||||1
HN|high nitrogen||||||||1
HN|high nutrition||1|1.000|||||
HN|hilar node||||||||1
HN|histamine-containing neuron||||||||1
HN|home nursing|C0019860|||C0019860|CHV;LCH;MSH|||1
HN|hyaluronectin||||||1|0.0313|
HN|hydronephrosis|C0020295|||||1|0.0164|
HN|hyperplastic nodules|C0020510|||||1|0.028|
HN|hypertensive nephrosclerosis|C0264657|||||||1
HN|hypertrophic neuropathy|C0545036|||||||1
HN|hypoglossal nucleus|C0228802|||||1|0.0148|
HPV|HPV;hpvs;HPV - Human papillomavirus;hpv human papillomavirus;human papillomavirus (HPV);human papillomavirus HPV;HUMAN PAPILLOMAVIRUS;Human Papilloma Virus;Human Papillomavirus;Human papilloma virus;Human papillomavirus;Human papillomavirus, NOS;PAPILLOMAVIRUS HUMAN;human papilloma virus;human papilloma viruses;human papillomas virus;human papillomavirus;human papillomaviruses;Human papillomavirus group;Human papillomavirus group, NOS;Verruca vulgaris virus;Wart virus;Warts virus;virus wart;virus warts;wart virus;warts virus;human papilloma viru|C0021344|1|1|C0021344;C0375016;C1512511|AOD;CHV;CSP;HL7V2.5;HL7V3.0;ICD9CM;LNC;MEDLINEPLUS;MTH;NCBI;NCI;NDFRT;SNOMEDCT;VANDF|1|0.9371|1
HPV|HPV Vaccine;HPV Vaccines;HPV vaccine;Human Papilloma Virus Vaccine;Human Papilloma Virus Vaccines;Human Papillomavirus Vaccines;Human papillomavirus vaccine;Papillomavirus Vaccines, Human;Vaccines, Human Papillomavirus;human papillomavirus vaccine|C1512511|||C1512511|MSH;MTH;NCI;SNOMEDCT|||
HPV|Haemophilus pertussis vaccine||||||||1
HPV|Hart Park virus|C0300964|||||||1
HPV|Human papillomavirus (organism)||||C0021344|SNOMEDCT|||
HPV|Human papillomavirus group (organism)||||C0021344|SNOMEDCT|||
HPV|Human papillomavirus vaccine (product)||||C1512511|SNOMEDCT|||
HPV|Human papillomavirus vaccine (substance)||||C1512511|SNOMEDCT|||
HPV|heart period variability||||||1|0.0034|
HPV|hepatic portal vein|C0032718|||||1|0.0017|1
HPV|hepatopancreatic parvovirus|C1067160|||||1|0.003|
HPV|human papillomavirus infection|C0343641|||||1|0.0031|
HPV|human parvovirus|C1955655|||||1|0.0048|1
HPV|human parvovirus B19|C0085274|||||1|0.0017|
HPV|hypoxic pulmonary vasoconstriction||||||1|0.0451|1
HR|AU|C2348420|||C1415713|HUGO|||
HR|CROATIA;Croatia;croatia;HRV|C0010343|||C0010343|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
HR|Cardiac rate;Cardiac rate, NOS;cardiac rate;cardiac rates;Heart Rate;Heart Rates;Heart rate;Heart rate, NOS;Rate, Heart;Rates, Heart;heart rate;heart rates;Hrtrate|C0018810|1|0.96|C0018810;C0488794|AOD;CHV;CSP;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.8365|1
HR|Cardiac rate (function)||||C0018810|SNOMEDCT|||
HR|Cardiac rate (observable entity)||||C0018810|SNOMEDCT|||
HR|Cardiac rate, function (observable entity)||||C0018810|SNOMEDCT|||
HR|Croatia (geographic location)||||C0010343|SNOMEDCT|||
HR|HAIRLESS, MOUSE, HOMOLOG OF;hairless homolog (mouse)||||C1415713|HUGO;OMIM|||
HR|HOUR;HOURS;Hour;hour;hours|C0439227;C0564385|||C0439227|CHV;HL7V2.5;HL7V3.0;LNC;MTH;NCI;SNOMEDCT|1|0.001|1
HR|HR;hr;hrs||||C0010343;C0018810;C0332167;C0439227;C1415713;C2265291|CHV;GO;HUGO;NCI;OMIM;SNOMEDCT|||
HR|HR - Heart rate||||C0018810|SNOMEDCT|||
HR|HR gene|C1415713|||C1415713|HUGO;MTH|||
HR|HR-PCD;plant-type hypersensitive response|C2265291|||C2265291|GO;MTH|||
HR|Halstead-Reitan||||||||1
HR|Harrington rod|C0181119|||||||1
HR|Heart rate (observable entity)||||C0018810|SNOMEDCT|||
HR|Heart rate (observable)||||C0018810|SNOMEDCT|||
HR|Heart rate (observable) (observable entity)||||C0018810|SNOMEDCT|||
HR|High risk of;high risk;high risk of;high risks;high-risk|C0332167|||C0332167|CHV;MTH;SNOMEDCT|1|0.0149|1
HR|High risk of (contextual qualifier)||||C0332167|SNOMEDCT|||
HR|High risk of (contextual qualifier) (qualifier value)||||C0332167|SNOMEDCT|||
HR|High risk of -RETIRED-||||C0332167|SNOMEDCT|||
HR|Human recombinant||||||1|0.0037|
HR|Hybrid resistance;hybrid resistance|C1369008|||C1369008|NCI|1|0.0013|
HR|O-(beta-hydroxyethyl)-rutosides||||||1|0.0021|
HR|h|C0033727;C0369286;C0441932;C0564385;C1553030|||C0439227|NCI|||
HR|h - hour|C0439227|||C0439227|SNOMEDCT|||
HR|hairless||||||1|0.0037|
HR|hairless gene||||||1|0.0008|
HR|hallux rigidus|C0264134|||||||1
HR|halorhodopsin|C0062108|||C0062108|MSH;NDFRT|||
HR|hazard ratio|C2985465|||C2985465|NCI|1|0.0624|1
HR|health related||||||||1
HR|heart|C0018787;C1281570|||||1|0.0009|
HR|hematopoietic reconstitution||||||||1
HR|hematopoietic resistance||||||||1
HR|hemerythrin|C0018976;C1149094|||||1|0.001|
HR|hemorrhagic retinopathy||||||||1
HR|heparin-releasable||||||1|0.001|
HR|hepatic resection||||||1|0.0008|
HR|hepatorenal|C0545792|||||||1
HR|heptad repeat||||||1|0.0022|
HR|heterosexual relations||||||||1
HR|high resolution;high-resolution|C1719039|||||1|0.0056|1
HR|high responders||||||1|0.0037|
HR|high responders to novelty||||||1|0.0005|
HR|higher rate||||||||1
HR|histamine release|C0019595|||C0019595|CHV;CSP;MSH|1|0.0087|1
HR|homing receptor||||||1|0.0013|
HR|homologous recombination|C0599773;C2984295|||C0599773;C2984295|CSP;MSH;NCI|1|0.018|
HR|homologous region||||||1|0.0009|
HR|hormonal response||||||||1
HR|hormone receptor|C0019929;C0083740;C1367453|||C0019929;C0083740;C1367453|CHV;CSP;MTH;NCI;OMIM|1|0.0006|
HR|hospital record|C0019980|||||||1
HR|hospital report|C0806434|||||||1
HR|host range|C2936413|||C2936413|MSH|1|0.0016|
HR|hour (qualifier value)||||C0439227|SNOMEDCT|||
HR|human resources|C0024752;C0220852;C0700103|1|0.034|C0024752;C0220852;C0700103|AOD;CHV;MSH;MTH|||1
HR|hydroxyethylrutoside|C0020354|||C0020354|CHV;MSH;NDFRT|||
HR|hyperimmune reaction||||||||1
HR|hypersensitive reaction||||||1|0.0036|
HR|hypersensitive response||||||1|0.0208|
HR|hypertensive retinopathy|C0152132|||||||1
HR|hypophosphatemic rickets|C0733682;C1704375|||||||1
HR|hypoxic reaction||||||||1
HR|hypoxic responder||||||||1
HR|light-driven chloride pump halorhodopsin||||||1|0.0003|
HR|plant hypersensitive response||||C2265291|GO|||
HR|resistant|C0332325;C2827757|||||1|0.0008|
HR|rutosides|C0035976|||||1|0.0008|
HSM|DKFZp761A179;HSM;LRRC4B;LRRC4B gene;leucine rich repeat containing 4B|C1537594|||C1537594|HUGO;MTH|||
HSM|heparin surface-modified intraocular lens||||||||1
HSM|heparin-surface-modified||||||1|1|
HSM|hepatosplenomegaly|C0019214|1|1.000|C0019214|CHV;CST;DXP;OMIM;SNOMEDCT|||1
HSM|holosystolic murmur|C0232258|||C0232258|CHV;SNOMEDCT|||1
HS|Bedtime;bedtime;bedtimes;Bedtime (qualifier value);Hour Of Sleep;hour of sleep;hora somni|C0521112|||C0521112|CHV;MTH;NCI;SNOMEDCT|1|0.0054|1
HS|DNase I hypersensitive||||||1|0.0067|
HS|DNase I hypersensitive sites||||||1|0.0113|
HS|FTDCR1B|C1367673;C1705574|||C1367673;C1705574|HUGO;NCI|||
HS|HS;Hs;Once a day, at bedtime|C1275563|||C0521112;C1275563;C1367673;C1552153;C1705574;C2674218|HL7V3.0;HUGO;MTH;NCI;OMIM;SNOMEDCT|||
HS|HS-142-1|C0122426|||||1|0.0046|
HS|HS1||||C2674218|OMIM|||
HS|HSNIK|C1335946;C1367673;C1705574|||C1367673;C1705574|HUGO;NCI;OMIM|||
HS|Harmonic Scalpel||||||1|0.0063|
HS|Hartmann solution|C0073385|||||||1
HS|Hartmann-Shack||||||||1
HS|Haynes-Stellite||||||||1
HS|Headspace||||||1|0.0109|
HS|Heparan sulfate;heparan sulfate;heparan sulphate|C0019143|||C0019143|CHV;CSP;FMA;LNC;MSH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.3035|
HS|Hopelessness Scale|C0451217|||||1|0.0059|1
HS|Humic substances|C1449672|||||1|0.0222|
HS|Hypochondriasis;hypochondriasis|C0020604|||||1|0.0105|1
HS|MAP3K14;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14;mitogen-activated protein kinase kinase kinase 14|C1335946;C1367673|||C1367673|HUGO;NCI;OMIM|||
HS|MAP3K14 Gene;MAP3K14 gene;Mitogen-Activated Protein Kinase Kinase Kinase 14 Gene;NF-KAPPA-B-INDUCING KINASE|C1367673|||C1367673|HUGO;MTH;NCI;OMIM|||
HS|MAP3K14 wt Allele;Mitogen-Activated Protein Kinase Kinase Kinase 14 wt Allele|C1705574|||C1705574|MTH;NCI|||
HS|NIK||||C1367673;C1705574|HUGO;NCI;OMIM|||
HS|Once a day, at bedtime (qualifier value)||||C1275563|SNOMEDCT|||
HS|SERINE/THREONINE PROTEIN KINASE NIK|C1335946|||C1367673|OMIM|||
HS|SPH;SPHEROCYTOSIS, HEREDITARY, 1;SPHEROCYTOSIS, TYPE 1;SPHEROCYTOSIS, TYPE 1 (disorder)|C2674218|||C2674218|MTH;OMIM|||
HS|SPH1|C1412402;C2674218;C2827376|||C2674218|OMIM|||
HS|Supernumerary maxillary left primary canine|C1552153|||C1552153|MTH|||
HS|at bedtime||1|0.964|||||1
HS|haemorrhagic septicaemia;hemorrhagic septicemia|C0086973|||C0086973|MSH;MTH;NDFRT|1|0.0071|1
HS|half strength||1|0.024|||||1
HS|half-scan||||||||1
HS|hamstring;hamstrings|C0584895|||C0584895|NCI|||1
HS|hamstring sets||||||||1
HS|hand surgery|C0187067|||||||1
HS|head sign||||||||1
HS|head sling||||||||1
HS|health status|C0018759|||C0018759|AOD;CHV;HL7V3.0;MSH;NCI;SNOMEDCT|1|0.0042|
HS|healthy smokers||||||1|0.0029|
HS|healthy subject;healthy subjects|C1708335|||||1|0.0468|1
HS|heart size|C0744689|||||||1
HS|heart sound;heart sounds|C0018820|1|0.002|C0018820|CHV;CSP;MSH;SNOMEDCT|||1
HS|heat shock|C0282498|||C0282498|NCI|1|0.0707|
HS|heat stable;heat-stable||||||1|0.0079|1
HS|heat stress|C0282507|||C0282507|CHV|1|0.0305|
HS|heat stroke|C0018843|||||1|0.0038|
HS|heavy smoker||||||||1
HS|heel spur|C0158322|||||||1
HS|heelstick|C0419343|||||||1
HS|heme synthetase|C0015880;C1414580|||||||1
HS|hemophagocytic syndrome|C0024291|||C0024291|CHV;MSH;NCI;SNOMEDCT|1|0.0084|
HS|hemorrhagic shock|C0036982|||C0036982|AOD;CHV;CSP;LCH;MSH;NCI;NDFRT;SNOMEDCT|1|0.0497|1
HS|hemorrhagic stroke|C0553692|||C0553692|CHV;DXP;OMIM;SNOMEDCT|1|0.0054|
HS|hemosorption|C0019063|||C0019063|MSH|1|0.0109|
HS|henoch schonlein|C0034152|1|0.006|||||
HS|heparin sulfate||||||||1
HS|hepatic steatosis|C0015695;C2711227|||C0015695;C2711227|AOD;CHV;OMIM|||
HS|hepatosplenic||||||1|0.0046|
HS|hereditary spherocytosis|C0037889|||C0037889|CHV;COSTAR;CSP;DXP;ICD9CM;MSH;MTH;SNOMEDCT|1|0.0886|1
HS|herpes simplex|C0019348|||C0019348|CHV;COSTAR;CST;DXP;ICD9CM;ICPC;LCH;MEDLINEPLUS;MSH;MTH;NDFRT;SNOMEDCT|1|0.0059|1
HS|heterogeneous stock||||||1|0.0096|
HS|hidradenitis suppurativa|C0162836|||C0162836|CHV;COSTAR;MEDLINEPLUS;MSH;MTH;MTHICD9;NDFRT;SNOMEDCT|1|0.0155|1
HS|high school|C0599395;C0870649|||C0599395;C0870649|CHV;CSP;NCI|||1
HS|high-salt||||||1|0.0234|
HS|high-salt diet||||||1|0.0025|
HS|high-spin||||||1|0.005|
HS|hindlimb suspension|C0376593|||C0376593|MSH|1|0.0255|
HS|hippocampal sclerosis|C1504404|||C1504404|MTHICD9|1|0.0535|1
HS|histiocytic sarcoma|C0334663|||C0334663|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
HS|homologous serum||||||||1
HS|horizontal system||||||1|0.0021|
HS|horizontally selective||||||||1
HS|horizontally selective visual cell||||||||1
HS|hormone-sensitive|C1512498|||C1512498|NCI|||
HS|horse serum|C1518416|||||1|0.0192|1
HS|hospital ship|C0337966|||||||1
HS|hospital stay||||||||1
HS|human serum||||||1|0.0301|1
HS|hunger sensation||||||1|0.0054|
HS|hydrazine sulphate|C0063067|||C0063067|CHV;SNOMEDCT|||
HS|hypereosinophilic syndrome|C0206141;C0263662;C0346421;C1540912|||||||1
HS|hyperplastic synovium||||||||1
HS|hypersensitivity|C0020517;C0520946|||||||1
HS|hypersensitivity syndrome|C0543698|||C0543698|CHV|||
HS|hypertonic saline;hypertonic saline solution|C0036085|||C0036085|CHV;NCI;PDQ;SNOMEDCT|1|0.0569|1
HS|hypertrophic scar|C0162810|||C0162810|CHV;MSH;MTHICD9;NCI;SNOMEDCT|1|0.0029|1
HS|hypochondriasis scale||||||||1
HS|hyposensitization|C0178702|||C0178702;C0354899|CHV;CSP;SNOMEDCT|1|0.0046|
HS|hypothalamic stimulation|C0441693|||C0441693|SNOMEDCT|1|0.0029|
HS|hypothalamic syndrome|C0751230|||||||1
HS|hysterosalpingography|C0020709|||||||1
HS|hysteroscopy|C0020710|||C0020710|CHV;ICD9CM;MSH;SNOMEDCT|||
HS|qHS;qh;qhs|C0558292;C1275563|||C1275563|CHV;SNOMEDCT|||
HS|score|C0449820|||||1|0.0063|
HS|serine/threonine protein-kinase|C0072402|||C1367673|HUGO|||
HSV|Genus Simplexvirus;HHV;HS - Herpes simplex;HSV;hsv;HSV - Herpes simplex virus;Herpes Simplex Virus;Herpes Simplex Viruses;Herpes simplex virus;herpes simplex virus;herpes simplex viruses;herpes virus simplex;simplex virus herpes;Herpes labialis Virus;Herpes labialis Viruses;labialis herpes virus;Herpesvirus hominis;Simplexvirus;Simplexvirus, NOS;Simplexviruses;simplexvirus;human herpesvirus;human herpesvirus 1 group|C0206558|1|1|C0206558|AOD;CHV;CSP;LNC;MEDLINEPLUS;MSH;MTH;NCBI;NCI;SNOMEDCT|1|0.9355|1
HSV|Genus Simplexvirus (organism)||||C0206558|SNOMEDCT|||
HSV|Genus: Human herpesvirus 1 group||||C0206558|SNOMEDCT|||
HSV|Herpes simplex group virus;Herpes simplex virus group;Herpes simplex virus group, NOS|C0206557|||C0206558|SNOMEDCT|||
HSV|Herpes simplex group virus (organism)||||C0206558|SNOMEDCT|||
HSV|Herpesvirus;Herpesvirus, NOS;herpesvirus|C0019369;C0206558|||C0206558|CHV;CSP;LNC;SNOMEDCT|||
HSV|Human Herpesvirus 1|C0206558;C0206679|||C0206558|NCI|||
HSV|Human herpesvirus 1 group virus||||C0206558|SNOMEDCT|||
HSV|Human herpesvirus 1 group virus (organism)||||C0206558|SNOMEDCT|||
HSV|Simplexvirus (living organism) (organism)||||C0206558|SNOMEDCT|||
HSV|Simplexvirus (living organism) [Ambiguous]||||C0206558|SNOMEDCT|||
HSV|Simplexvirus (organism)||||C0206558|SNOMEDCT|||
HSV|herpe simplex virus||||C0206558|CHV|||
HSV|herpes simplex|C0019348|||||1|0.0149|
HSV|herpes simplex viral||||||1|0.005|
HSV|herpes simplex virus type 1;herpes simplex virus type I|C0206679|||||1|0.0164|
HSV|highly selective vagotomy|C0042273|||C0042273|ICD9CM;MSH;SNOMEDCT|1|0.0194|1
HSV|hop stunt viroid|C1000459|||C1000459|NCBI|1|0.0026|
HSV|human saphenous vein||||||1|0.0062|
HSV|hyperviscosity syndrome|C0221030|||||||1
I&D|incision and drainage|C0152277|1|1.000|||||1
I&D|irrigation and debridement||||||||1
I&D|irrigation and drainage||||||||1
IA|(class) IA||1|0.006|||||
IA|(grade) IA||1|0.022|||||
IA|(stage) IA|C0456595;C0457150|1|0.550|||||
IA|(status) IA||1|0.010|||||
IA|(type) IA||1|0.010|||||
IA|A-current||||||1|0.017|
IA|A-type K+ current||||||1|0.0116|
IA|Arterial injection||||C0021487|SNOMEDCT|||
IA|Arterial injection (procedure)||||C0021487|SNOMEDCT|||
IA|Class II major histocompatibility complex||||||1|0.0116|
IA|I region-associated||||||1|0.0178|
IA|I-ARTER;I-arter;Injection, Intra-Arterial;Injection, Intraarterial;Injection, intraarterial;Injections, Intra Arterial;Injections, Intra-Arterial;Injections, Intra-arterial;Injections, Intraarterial;Intra Arterial Injections;Intra-Arterial Injection;Intra-Arterial Injections;Intra-arterial injection;Intraarterial Injection;Intraarterial Injections;intra arterial injection;intra-arterial injection;intra-arterial injections;intraarterial injections|C0021487|||C0021487|AOD;CHV;HL7V3.0;LCH;MSH;MTH;NCI;SNOMEDCT|||
IA|IA;Ia;Ia <mammal>|C1947960|||C0021487;C0022037;C0444974;C1947960|MTH;NCBI;NCI;SNOMEDCT|||
IA|INJECT INTRA ARTERIAL;INJECT INTRAARTERIAL;INTRA ARTERIAL INJECT;INTRAARTERIAL INJECT||||C0021487|MSH|||
IA|Ia (qualifier value)||||C0444974|SNOMEDCT|||
IA|Idiopathic anaphylaxis;idiopathic anaphylaxis|C0413235|||C0413235|CHV;SNOMEDCT|1|0.0124|1
IA|Induced abortion|C0392535;C1704300|||||1|0.0062|
IA|Insulin antibodies|C0021644|||||1|0.0155|
IA|Intestinal atresia;intestinal atresia|C0021828|||C0021828|CHV;MSH;MTH;NCI;NDFRT|1|0.0077|
IA|Intra-arterial injection (procedure)||||C0021487|SNOMEDCT|||
IA|Intra-articular;intra-articular;intraarticular|C0442108|||C0205528;C0442108;C1522204|CHV;MTH;NCI;SNOMEDCT|1|0.082|1
IA|Intraarterial;intra-arterial;intraarterial|C0694634|1|0.352|||1|0.2629|1
IA|Iowa|C0022037;C1555231|1|0.038|C0022037|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
IA|Iowa (geographic location)||||C0022037|SNOMEDCT|||
IA|Serotype Ia;la serotype|C0444974|||C0444974|MTH;SNOMEDCT|||
IA|Serotype Ia (qualifier value)||||C0444974|SNOMEDCT|||
IA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.017|
IA|arterial|C0003842;C0221464|||||1|0.0077|
IA|artery|C0003842;C0226004|||||1|0.017|
IA|class II MHC|C0017349|||||1|0.0217|
IA|class II antigen|C0019630|||||1|0.017|
IA|class II molecules||||||1|0.0085|
IA|component|C0449432;C1179435;C1705248|||||1|0.0077|
IA|ibotenic acid|C0020738|||C0020738|MSH;NDFRT;SNOMEDCT|1|0.0232|1
IA|ideational apraxia|C0234526|||||||1
IA|image amplification||||||||1
IA|image analysis|C0200765|||C0200765|NCI;SNOMEDCT|1|0.0356|
IA|immune -associated antigen||||||||1
IA|immune adherence|C0301893|||C0301893|SNOMEDCT|1|0.0162|1
IA|immune-associated||||||1|0.0077|
IA|immunoadsorption||||||1|0.0433|
IA|immunoassay|C0020980;C0021060|||||1|0.007|
IA|immunobiologic activity||||||||1
IA|impedance angle||||||||1
IA|imperforate anus|C0003466|||||||1
IA|inactive alcoholic||||||||1
IA|incidental appendectomy|C0192882|||||||1
IA|incisors absent||||||1|0.0062|
IA|incurred accidentally||||||||1
IA|indocyanine green angiography|C0430879|||||1|0.017|
IA|indolaminergic-accumulating||||||||1
IA|indulin agar||||||||1
IA|infantile apnea|C0745261|||||||1
IA|infantile autism|C0004352|||C0004352|AOD;CHV;MSH;SNOMEDCT|1|0.0077|1
IA|infarct area||||||1|0.0085|
IA|infected area||||||||1
IA|inferior angle||||||||1
IA|inferior apical||||||||1
IA|inflammatory arthritis|C0003864|||||1|0.0124|
IA|infrequent asthma||||||||1
IA|inhibitory antigen||||||||1
IA|inhibitory avoidance||||||1|0.0193|
IA|injected intra-arterially||||||1|0.007|
IA|innominate artery|C0006094|||||1|0.0054|
IA|insulin|C0021641;C1533581;C1579433|||||1|0.0085|
IA|interarytenoid||||||1|0.0101|
IA|interbronchial angle||||||||1
IA|internal auditory||||||||1
IA|intestinal amebiasis|C0013370;C0860230|||C0013370|CHV;MSH;NDFRT|||
IA|intimal area||||||1|0.0116|
IA|intra-abdominal|C1512910|||||1|0.0093|
IA|intra-amniotic;intraamniotic|C1512912|||C1512912|NCI|||1
IA|intra-arterially;intraarterially||||||1|0.0333|
IA|intraalveolar||||||||1
IA|intraaortic||||||||1
IA|intraatrial||||||||1
IA|intraauricular||||||||1
IA|intracranial aneurysm|C0007766|||||1|0.0124|
IA|invasive aspergillosis|C0238013|||||1|0.0897|1
IA|iodoacetamide|C0021973|||||1|0.0155|
IA|irradiation area||||||||1
IA|isonicotinic acid|C0022210|||||||1
IA|isopropyl alcohol|C0022237|||C0022237|AOD;CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||1
IA|osteopetrotic||||||1|0.0124|
IA|transient K+ current||||||1|0.0139|
IA|transient outward current||||||1|0.0139|
IA|transient potassium current||||||1|0.0116|
IB|(cycle) IB||1|0.004|||||
IB|(grade) IB||1|0.016|||||
IB|(stage) IB|C0456597;C0457152|1|0.944|||||
IB|(status) IB||1|0.016|||||
IB|(type) IB||1|0.004|||||
IB|ATP||||C1366832;C1705556|NCI|||
IB|ATP8A2||||C1366832|NCI|||
IB|ATP8A2 wt Allele;ATPase, Aminophospholipid Transporter-Like, Class I, Type 8A, Member 2 wt Allele|C1705556|||C1705556|MTH;NCI|||
IB|ATPIB||||C1366832;C1705556|NCI|||
IB|ATPase, Aminophospholipid Transporter-Like, Class I, Type 8A, Member 2;ML-1 Protein|C1366832|||C1366832|MTH;NCI|||
IB|DKFZP434B1913|C1366832;C1705556|||C1366832;C1705556|NCI|||
IB|IB;Ib;IMMUNOBLOT;Immunoblot;Immunoblotting;immunoblot;immunoblotting;Immunoblot Analysis;Immunoblot Assay;Immunoblot assay;Immunoblot assay, NOS;assays immunoblot;immunoblot assay;Immunoblottings|C0020985|||C0020985;C0444976;C1366832;C1705556|AOD;CHV;CSP;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.1373|
IB|Ib (qualifier value)||||C0444976|SNOMEDCT|||
IB|Ib serotype;Serotype Ib;serotype Ib|C0444976|||C0444976|CHV;MTH;SNOMEDCT|||
IB|Immunoblot assay (procedure)||||C0020985|SNOMEDCT|||
IB|Immunoblotting (qualifier value)||||C0020985|SNOMEDCT|||
IB|ML-1||||C1366832;C1705556|NCI|||
IB|Serotype Ib (qualifier value)||||C0444976|SNOMEDCT|||
IB|binding|C0243122;C1145667;C1167622|||||1|0.0423|
IB|ibuprofen|C0020740|||||1|0.1373|
IB|idiopathic blepharospasm||||||||1
IB|ileal bypass|C0399975|||||||1
IB|immune balance||||||||1
IB|immune body||||||||1
IB|inclusion bodies;inclusion body|C0007637|||C0007637|CHV;CSP;GO;MSH|1|0.0563|1
IB|index of body build||||||||1
IB|infantile botulism|C0238027|||||||1
IB|infectious bronchitis||||||1|0.1549|1
IB|inferior basal||||||||1
IB|insulin receptor binding test||||||||1
IB|integrated backscatter||||||1|0.1585|
IB|interferon beta|C0015980;C0751599;C2825876|1|0.002|||||
IB|international baccalaureate||1|0.010|||||
IB|intrinsic bursting||||||1|0.0352|
IB|intrinsically bursting||||||1|0.0563|
IB|ipratropium bromide|C0700580|||C0700580|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.2218|
IB|irradiated bone|C0022098|||||||1
IB|isolation bed||||||||1
ICA|Antibody to islet cells of pancreas measurement;ICA;Islet cell antibody measurement;Islet cell cytoplasma antibody|C0201519|||C0201519|LNC;MTH;SNOMEDCT|||
ICA|Antibody to islet cells of pancreas measurement (procedure)||||C0201519|SNOMEDCT|||
ICA|Ca2+ channels||||||1|0.0027|
ICA|Ca2+ currents||||||1|0.0384|
ICA|Immunocytochemical assay;immunocytochemical assay||||||1|0.0097|1
ICA|Independent component analysis||||||1|0.0769|
ICA|L-type Ca2+ current||||||1|0.0349|
ICA|L-type calcium current||||||1|0.0198|
ICA|arthritis|C0003864|||||1|0.0047|
ICA|calcium currents||||||1|0.0326|
ICA|icariin|C0063273|||C0063273|MSH|||
ICA|ileocolic anastomosis|C0192751|||||||1
ICA|intercellular adhesion||||||1|0.0035|
ICA|intercountry adoption|C0175800|||||||1
ICA|intermediate care area||||||||1
ICA|internal carotid|C0741978|||||1|0.0113|
ICA|internal carotid artery|C0007276|1|1.000|C0007276|CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.5606|1
ICA|intracranial abscess|C0021874|||||||1
ICA|intracranial anatomy||||||||1
ICA|intracranial aneurysm|C0007766|||C0007766|CHV;CSP;CST;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||1
ICA|inward calcium current||||||1|0.0159|
ICA|ionized Ca||||||1|0.0039|
ICA|ionized calcium|C0201927;C0373561;C0596235|||||1|0.0268|1
ICA|iridocorneal angle|C0229238|||C0229238|FMA;SNOMEDCT;UWDA|||
ICA|islet cell antibodies;islet cell antibody|C0063900|||C0063900|CHV;MSH;MTH;SNOMEDCT|1|0.1378|1
ICA|islet cell antibody (ICAb) test||||C0201519|CHV|||
ICA|islet cell antigen||||||||1
ICA|islet cell autoantibodies||||||1|0.007|
ICA|islet cells|C0022131|||||1|0.0136|
ICD|Between Lunch and Dinner;between lunch and dinner|C1550747|||C1550747|MTH;NCI|||
ICD|Cardioverter Defibrillators, Implantable;Cardioverter-Defibrillator, Implantable;Cardioverter-Defibrillators, Implantable;Implantable Cardioverter Defibrillators;Implantable Cardioverter-Defibrillator;Implantable Cardioverter-Defibrillators;Implantable Cardioverter-defibrillator;implantable cardioverter defibrillator;implantable cardioverter-defibrillator;Defibrillator, Implantable;Defibrillators, Implantable;Implantable Defibrillator;Implantable Defibrillators;Implantable defibrillator;defibrillator implantable;implantable defibrillator;implantable defibrillators;Implantable defibrillator, device;automatic defibrillator;automatic defibrillators;internal defibrillator;internal defibrillators|C0162589|1|1|C0162589|CHV;CSP;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.6737|1
ICD|Cell Disease, Inclusion;Cell Diseases, Inclusion;Disease, Inclusion Cell;Diseases, Inclusion Cell;INCLUSION CELL DISEASE;Inclusion Cell Disease;Inclusion Cell Diseases;Inclusion-cell Disease;inclusion cell disease;Deficiency of N-acetylglucosamine-1-phosphotransferase;N-Acetylglucosamine-1-phosphotransferase deficiency;N-acetylglucosamine-1-phosphotransferase deficiency;Disease, I-Cell;Diseases, I-Cell;I Cell Disease;I cell disease;I-CELL DISEASE;I-Cell Disease;I-Cell Diseases;I-cell disease;cell disease i;i cell disease;i-cell disease;I-cell - Inclusion cell disease;cell disease i cell inclusion;LEROY DISEASE;MUCOLIPIDOSIS II;Mucolipidosis II;mucolipidosis II;mucolipidosis ii;Mucolipidoses, Type II;Mucolipidosis Type II;Mucolipidosis type II;Mucolipidosis, Type II;Type II Mucolipidoses;Type II Mucolipidosis;mucolipidosis type ii;Mucolipidosis IIs;Mucolipidosis Type IIs|C0020725|||C0020725|CHV;CSP;DXP;MSH;MTH;MTHICD9;NCI;OMIM;SNOMEDCT|1|0.0146|1
ICD|I CELL DIS||||C0020725|MSH|||
ICD|I-cell disease (disorder)||||C0020725|SNOMEDCT|||
ICD|ICD;icd;icds|C0020725;C0162589;C0870733;C1550747|||C0020725;C0162589;C0870733;C1550747|CHV;HL7V3.0;LNC;NCI;OMIM|||
ICD|INCLUSION CELL DIS||||C0020725|MSH|||
ICD|INTERNATIONAL CLASS DIS||||C0870733|MSH|||
ICD|INTERNATIONAL STATIS CLASS DIS RELAT HEALTH PROBLEMS||||C0870733|MSH|||
ICD|Implantable defibrillator, device (physical object)||||C0162589|SNOMEDCT|||
ICD|International Classification of Diseases;international Classification of Diseases;international classification of diseases (ICD)|C0870733|||C0870733|CHV;MSH;MTH;NCI|1|0.1383|1
ICD|International Statistical Classification of Diseases and Related Health Problems||||C0870733|MSH|||
ICD|Inventory for Counseling and Development||||||||1
ICD|ML II|C0020725;C0066972|||C0020725|OMIM|||
ICD|N-Acetylglucosamine-1-phosphotransferase deficiency (disorder)||||C0020725|SNOMEDCT|||
ICD|idiopathic cerebral dysfunction||||||||1
ICD|idiopathic cervical dystonia||||||1|0.009|
ICD|immune complex disease|C0020951|||C0020951|CHV;CSP;MSH|||1
ICD|immune complex dissociation||||||1|0.0106|1
ICD|immune complex-dissociated||||||1|0.0155|
ICD|impulse control disorder|C0021122|||C0021122|AOD;CHV;SNOMEDCT|||1
ICD|indigocarmine dye||||||||1
ICD|induced circular dichroism||||||1|0.0195|1
ICD|informed consent document|C0009797|||||||1
ICD|initial claudication distance||||||1|0.0179|
ICD|initial consonant deletion||||||||1
ICD|inner canthal distance||||||||1
ICD|instantaneous cardiac death||||||||1
ICD|intercanthal distance|C1720475|||C1720475|SNOMEDCT|||1
ICD|intercapillary distance||||||1|0.0081|
ICD|internal cardioverter-defibrillator||||||||1
ICD|internal cervical device||||||||1
ICD|intracardiac defibrillator||||||||1
ICD|intracellular domain||||||1|0.026|
ICD|intracervical device||||||||1
ICD|intrauterine contraceptive device|C0021900|||C0021900|MSH;NCI;SNOMEDCT|||1
ICD|irritant contact dermatitis|C0162823|||C0162823|CHV;NCI;SNOMEDCT|1|0.0423|1
ICD|ischemic coronary disease||||||||1
ICD|isocitrate dehydrogenase|C0022157|||C0022157|CSP;LNC;MSH;NDFRT;SNOMEDCT|1|0.0244|1
ICD|isolated conduction defect||||||||1
ID|(drug) ID||1|0.002|||||
ID|DL||||C1522475|NCI|||
ID|Descriptor|C0282354;C0600091;C0678257|||C0600091|NCI|||
ID|Designation|C0600091;C1510813|||C0600091|NCI|||
ID|Designator|C0600091|||C0600091|NCI|||
ID|East Indies;IDN;Malay Archipelago;Netherlands East Indies|C0021247|||C0021247|MSH;NCI|||
ID|I-DERMAL;I-dermal||||C1522475|NCI|||
ID|IC|C0587121|||C1522475|NCI|||
ID|ID;Id;Ids;id|C0020786;C0600091;C2986768|||C0020786;C0020787;C0021247;C0150647;C0600091;C1522475;C2349049;C2986768|AOD;CHV;LNC;MSH;NCI;SNOMEDCT|||
ID|INDONESIA;Indonesia;indonesia|C0021247;C2987743|||C0021247|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
ID|INTRADERMAL;Intradermal;intradermal|C0150647|||C0150647;C1522475|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|1|0.1495|1
ID|Id Personality Component|C0020786|||C0020786|MTH|||
ID|Idaho;idaho;Idaho (geographic location)|C0020787|||C0020787|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
ID|Identifier;identifier;identifiers|C0600091;C1554104;C1554159|||C0600091;C1554104;C1554159|CHV;HL7V3.0;LNC;MTH;NCI;SNOMEDCT|1|0.0146|
ID|Identifier (property)||||C0600091|SNOMEDCT|||
ID|Identifier (property) (qualifier value)||||C0600091|SNOMEDCT|||
ID|Indonesia (geographic location)||||C0021247|SNOMEDCT|||
ID|Injected Dose;injected dose|C2986768|||C2986768|MTH;NCI|1|0.0231|1
ID|Intracutaneous;intracutaneous;Intracutaneous use;Intradermal Route of Administration;Intradermal Route of Drug Administration;Intradermal route;IntradermalRoute;Intradermal use|C1522475|||C1522475|HL7V3.0;MTH;NCI;SNOMEDCT|||
ID|Intracutaneous route|C0205524;C1522475|||C1522475|SNOMEDCT|||
ID|Intracutaneous route (qualifier value)||||C1522475|SNOMEDCT|||
ID|Intradermal Injection|C0021489;C1522475|||C1522475|NCI|||
ID|Intradermal route (qualifier value)||||C1522475|SNOMEDCT|||
ID|Intradermal use (qualifier value)||||C1522475|SNOMEDCT|||
ID|Unit of Infective Dose|C2349049|||C2349049|MTH;NCI|||
ID|anti-idiotype||||||1|0.0207|
ID|anti-idiotypic||||||1|0.0182|
ID|given either iv or intraduodenally||||||1|0.0024|
ID|identification|C0020792;C0205396|1|0.002|C0020792;C0205396|LCH;LNC;MSH;MTH;NCI|1|0.0188|1
ID|identify||||||||1
ID|idiotopes||||||1|0.0164|
ID|idiotype|C0021013|||C0021013|CHV;NCI;SNOMEDCT|1|0.1118|1
ID|idiotypic||||||1|0.0213|1
ID|iditol dehydrogenase|C0020809|||||||1
ID|ill-defined||||||||1
ID|immune deficiency|C0850497|||C0850497|CHV|||1
ID|immunodeficiency|C0021051|||C0021051|AOD;CHV;CSP;NCI;OMIM;SNOMEDCT|||
ID|immunodiffusion|C0017231|||C0017231|CHV;CSP;MSH;SNOMEDCT|1|0.0705|1
ID|immunoglobulin deficiency|C0745242|||||||1
ID|inappropriate disability||||||||1
ID|incapacitating dose||||||||1
ID|incidence density||||||1|0.0115|
ID|incision and drainage|C0152277|1|0.002|||||
ID|inclusion disease|C0010823|||||||1
ID|index of difficulty||||||1|0.0049|
ID|index of discrimination||||||||1
ID|individual dose||||||||1
ID|indomethacin|C0021246|||||1|0.0097|
ID|induction delivery||||||||1
ID|infant death|C0549159|||||||1
ID|infant-directed||||||1|0.0073|
ID|infecting dose||||||||1
ID|infectious disease|C0009450|1|0.988|C0009450;C1555764|CHV;COSTAR;CSP;HL7V3.0;LNC;MSH;NCI;SNOMEDCT|1|0.0304|1
ID|infective dermatitis|C1260874|||C1260874|CHV;MTH;SNOMEDCT|1|0.0049|
ID|infective dose|C1881203|||||||1
ID|infradentale|C2326002|||||||1
ID|inhibitor of DNA binding||||||1|0.0043|
ID|inhibitor of differentiation||||||1|0.0055|
ID|inhibitory dose||||||||1
ID|inhomogeneous deposition||||||||1
ID|initial diagnosis||||||||1
ID|initial dose||||||||1
ID|initial dyskinesia||||||||1
ID|inner diameter||1|0.002|||||1
ID|insertion/deletion||||||1|0.0091|
ID|inside diameter||||||||1
ID|insufficient data||||||||1
ID|intellectual disability|C0025362|||C0025362|CHV;MSH;SNOMEDCT|1|0.1385|1
ID|intercalated disc|C0684215|||C0684215|CSP;FMA;GO;MTH;UWDA|||
ID|intercalated duct|C1512817|||C1512817|NCI|||
ID|interdigitating||||||||1
ID|interhemispheric disconnection||||||||1
ID|internal derangement||||||1|0.0249|1
ID|internal diameter|C2314970|||C2314970|SNOMEDCT|1|0.0578|1
ID|interscan delay||||||||1
ID|interstitial disease|C1881236|||||||1
ID|intervertebral disc|C0021815;C1280211|||C0021815;C1280211|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|||
ID|intradermally||||||1|0.0541|
ID|intraduodenal||||C1512937|NCI;SNOMEDCT|1|0.0492|1
ID|intraduodenal administration||||||1|0.0055|
ID|iodine deficiency|C0342199|||C0342199|CHV;MTHICD9;SNOMEDCT|1|0.0152|
ID|iron deficiency|C0240066|||C0240066|AOD;CHV;DXP;MTH;OMIM;SNOMEDCT|1|0.0401|
ID|iron dextran|C0022092|||C0022092|CHV;MTHSPL;NCI;NDFRT;SNOMEDCT;USPMG;VANDF|||
ID|iron-deficient||||||1|0.0213|
ID|isosorbide dinitrate|C0022252|||C0022252|AOD;CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0134|
ID|isotope dilution||||||1|0.0085|
ID|mg/kg intraduodenally||||||1|0.003|
ID|microm inner diameter||||||1|0.0049|
ID|one-dimensional||||||1|0.0061|
ID|primary immunodeficiency|C0398686;C2984310|||||1|0.003|
ID|the same||||||||1
IJ|ileojejunal||||||||1
IJ|internal jugular|C1550269|1|1.000|||||1
IJ|intrajejunal||||||||1
IJ|intrajugular||||||||1
IJ|junctional current||||||1|1|
IM|At risk for impaired home maintenance management;at risk for impaired home maintenance management;Impaired home maintenance management, potential|C0231377|||C0231377|CHV;MTH;SNOMEDCT|||
IM|At risk for impaired home maintenance management (finding)||||C0231377|SNOMEDCT|||
IM|IM;Im||||C0021492;C0022132;C0231377;C0442117;C1522005|MSH;NCI;SNOMEDCT|||
IM|IM - Intramuscular||||C0442117|SNOMEDCT|||
IM|IM - Intramuscular injection;intramuscular (IM) injections;IM injection;im injection;im injections;IMI - Intramuscular injection;Injection, Intramuscular;Injection, intramuscular;Injections, Intramuscular;Intramuscular Injection;Intramuscular Injections;Intramuscular injection;Intramuscular injection NOS;intramuscular injection;intramuscular injections;Intramuscular Route of Administration|C0021492|||C0021492|AOD;CHV;CSP;HL7V3.0;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0059|
IM|IMMUNOL|C1517844|||C1522005|MSH|||
IM|IMN;ISLE OF MAN;Isle of Man|C0022132|||C0022132|MSH;MTH;NCI;SNOMEDCT|||
IM|INJECT INTRAMUSCULAR;INTRAMUSCULAR INJECT||||C0021492|MSH|||
IM|INTRAMUSCULAR;Intramuscular;intramuscular|C0021492;C0442117|1|0.922|C0021492;C0442117;C1556154|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|1|0.2258|1
IM|Index Medicus|C0021194|||||||1
IM|Indomethacin;indomethacin|C0021246|||C0021246|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHFDA;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0646|
IM|Induced motion||||||1|0.0041|
IM|Infant mortality;infant mortality|C0021278|||C0021278|AOD;CHV;CSP;MSH;NCI|1|0.0059|
IM|Intramuscular (qualifier value)||||C0442117|SNOMEDCT|||
IM|Intramuscular drug therapy||||C0021492|SNOMEDCT|||
IM|Intramuscular injection (procedure);Intramuscular injection NOS (procedure)||||C0021492|SNOMEDCT|||
IM|Isle of Man (geographic location)||||C0022132|SNOMEDCT|||
IM|M-current||||||1|0.0164|
IM|administered intramuscularly||||||1|0.01|
IM|current|C0521116;C1705970|||||1|0.0127|
IM|ice massage|C0695940|||||||1
IM|idiopathic myelofibrosis|C0001815|||C0001815|CHV;NCI;PDQ|1|0.0164|1
IM|imatinib|C0935989|||C0935989|CHV;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
IM|imatinib mesylate|C0939537|||C0939537|CHV;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0068|
IM|imidazole|C0020923;C0020924|||C0020923;C0020924|CHV;CSP;LCH;MSH;MTH;SNOMEDCT|1|0.0164|
IM|imipramine|C0020934|||C0020934;C0020935|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
IM|immature|C0205252|||C0205252|CHV;LNC;NCI;SNOMEDCT|||
IM|immobilization|C0020944|||C0020944|CHV;LNC;MSH;SNOMEDCT|1|0.0086|
IM|immunology|C0152036;C1522005|||C1522005|MSH|||
IM|immunology aspects|C1522005|||C1522005|MTH|||
IM|immunosuppression method||||||||1
IM|impaired mentation||||||||1
IM|industrial medicine|C0028802|||||||1
IM|infantile myofibromatosis|C0432284|||C0432284|MTH;SNOMEDCT|1|0.0091|
IM|infection medium||||||||1
IM|infectious mononucleosis|C0021345|||C0021345|AIR;AOD;CHV;COSTAR;DXP;ICD9CM;ICPC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;QMR;SNOMEDCT|1|0.1966|1
IM|inflammatory myopathy|C0027121|||C0027121|CHV;MSH;NDFRT;SNOMEDCT|1|0.0041|
IM|inner medulla||||||1|0.0141|
IM|inner medullary||||||1|0.0055|
IM|inner membrane||||||1|0.0123|1
IM|innocent murmur|C0232255|||||||1
IM|inspiratory muscle||||||||1
IM|integrative medicine|C2350258|||C2350258|MEDLINEPLUS;MSH|||
IM|intermediate|C0205103;C1550465;C2827755|||||1|0.0077|
IM|intermediate megaloblast||||||||1
IM|intermediate mesoderm|C1284010|||C1284010|MSH;NCI;SNOMEDCT|||
IM|intermetatarsal||||||1|0.0064|1
IM|intermuscular||||||||1
IM|internal malleolus||||||||1
IM|internal mammary||||||1|0.0082|1
IM|internal margin||||||||1
IM|internal medicine|C0021782;C1555750|||C0021782;C1555750|CHV;HL7V3.0;LCH;MSH;NCI;SNOMEDCT|1|0.0218|1
IM|internal monitor||||||||1
IM|interstitial macrophages||||||1|0.0064|
IM|interval mapping||||||1|0.0023|
IM|intestinal malrotation|C0221210;C2749839|||||||1
IM|intestinal mesenchyme||||||||1
IM|intestinal metaplasia|C0334037|||C0334037|CHV;NCI;SNOMEDCT|1|0.122|1
IM|intima-media||||||1|0.0064|
IM|intracellular macroadenoma||||||||1
IM|intracellular membrane;intracellular membranes|C0021868|||C0021868|CSP;FMA;MSH;NCI|1|0.0023|
IM|intrahepatic metastasis||||||1|0.0096|
IM|intramedullary|C1512957;C2732619|1|0.076|C1512957;C2732619|NCI;SNOMEDCT|1|0.0296|1
IM|intramembranous||||||1|0.0046|
IM|intramuscularly||||||1|0.1224|
IM|invasive mole|C0008493|||C0008493|CHV;MSH;MTHICD9;NCI;NDFRT;PDQ;SNOMEDCT|||1
IM|ionomycin|C0022020|||C0022020|CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0041|
IM|irsogladine maleate|C0091573|||C0091573|MSH|||
IM|myocardial infarction|C0027051;C2926063|||||1|0.005|
INH|4-Pyridinecarboxylic acid, hydrazide;Hydrazide, Isonicotinic Acid;Isonicotinic Acid Hydrazide;Isonicotinic acid hydrazide;isonicotinic acid hydrazide;INA - Isoniazid;INAH - Isoniazid;ISONIAZID;Isoniazid;isoniazid;Isonicotinyl Hydrazine;isonicotinyl hydrazine;Isonicotinylhydrazide|C0022209|1|0.93|C0022209|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.9547|
INH|By inhalation;INHALATION;Inhalation;inhalation;{Inhalation}|C0004048;C0205535;C1705211|||C0205535;C1705211|HL7V2.5;HL7V3.0;NCI;SNOMEDCT|||1
INH|By inhalation (route)||||C0205535|SNOMEDCT|||
INH|By inhalation (route) (qualifier value)||||C0205535|SNOMEDCT|||
INH|INH;Inh;inh||||C0022209;C0205535;C0598322;C1705211|CHV;CSP;NCI;PDQ;SNOMEDCT|||
INH|INHALANT;Inhalant;inhalant;inhalants|C0001559;C0598322;C2362548;C2825042|||C0598322|AOD;CHV;CSP;HL7V3.0;NCI;NDFRT;RXNORM|||
INH|Inhalant Dosage Form;Inhalant Dose Form;Inhalant [Dose Form];Inhalant dose form|C0598322|||C0598322|MTH;NCI;NDFRT|||
INH|Inhalation - unit of product usage;Inhalation Dosing Unit|C1705211|||C1705211|MTH;NCI;SNOMEDCT|||
INH|Inhalation - unit of product usage (qualifier value)||||C1705211|SNOMEDCT|||
INH|Inhalation Route of Administration;Inhalation Route of Drug Administration;RESPIR|C0205535|||C0205535|MTH;NCI|||
INH|Isoniazid (product)||||C0022209|SNOMEDCT|||
INH|Isoniazid (substance)||||C0022209|SNOMEDCT|||
INH|Isoniazid [Chemical/Ingredient]||||C0022209|NDFRT|||
INH|RESPIRATORY (INHALATION)||||C0205535|NCI|||
INH|Respiratory use||||C0205535|SNOMEDCT|||
INH|immunoreactive inhibin||||||1|0.0117|
INH|inhaler|C0021461;C1881212;C2825043|1|0.070|||||1
INH|inhibitor|C1999216|||||1|0.022|
INH|isoniazide||||||1|0.0117|
INR|INR|C0525032;C1704538|||C0525032;C1704538|AOT;CHV;LNC;MSH;NCI|||
INR|INR - Internationalised ratio;INR - Internationalized ratio;International Normalized Ratio;International Normalized Ratios;International normalised ratio;International normalized ratio;Normalized Ratio, International;Normalized Ratios, International;Ratio, International Normalized;Ratios, International Normalized;international normalised ratio;international normalising ratio;international normalize ratio;international normalized ratio;international normalized ratios;international normalizing ratio;International Normalized Ratio of Prothrombin Time;Internationalised ratio;Internationalized ratio;internationalised ratio;international normalized ratio (INR)|C0525032|1|1|C0525032|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.8545|1
INR|Integrated Neuromusculoskeletal Release|C1704538|||C1704538|AOT;MTH|||
INR|International normalised ratio (procedure)||||C0525032|SNOMEDCT|||
INR|International normalized ratio (observable entity)||||C0525032|SNOMEDCT|||
INR|Prothrombin Intl. Normalized Ratio||||C0525032|NCI|||
INR|Prothrombin time|C0033707|||||1|0.0137|
INR|bcr||||C0525032|CHV|||
INR|immediate nasal response||||||||1
INR|initiator|C1444748|||||1|0.0918|
INR|initiator element||||||1|0.0332|
INR|insulin receptor|C0034818;C1334133|||||1|0.0068|
IOL|IOL;iol;Primary Intraocular Lymphoma|C0281658|||C0281658|CHV;NCI;PDQ|||
IOL|Intraocular Lymphoma;Intraocular lymphoma;intraocular lymphoma;lymphoma, intraocular;intraocular lymphoma (IOL)|C0281658;C1706527|||C0281658|CHV;MTH;NCI;PDQ|||
IOL|induction of labor|C0259787|||||||1
IOL|interosseous ligament|C0447892|||||1|0.0968|
IOL|intraocular lens;intraocular lenses|C0023311;C0023319;C0336564|1|1|C0023319;C0336564;C1706007|CHV;MSH;NCI;SNOMEDCT|1|0.7849|1
IOL|intraocular lens implantation|C0023311|||||1|0.1183|
IQ|2-Amino-3-methylimidazo[4,5-f]quinoline;2-amino-3-methylimidazo(4,5-f)- quinoline;2-amino-3-methylimidazo[4,5-f]quinoline||||C1312059|MSH;MTH;NCI|1|0.4927|
IQ|2-amino-3-methyl-3H-imidazo[4,5-f]quinoline|C2744043|||||1|0.0134|
IQ|2-amino-3-methyl-imidazo[4,5-f]quinoline||||||1|0.0334|
IQ|3-Methyl-3H-imidazo[4,5-f]quinolin-2-amine||||C1312059|NCI|||
IQ|5-f]quinoline||||||1|0.016|
IQ|IQ;iq||||C0022066;C0456149;C1312059|CHV;CSP;NCI|||
IQ|IQ - Intelligence quotient;intelligence quotient (IQ);Intelligence quotient;intelligence quotient|C0456149|1|1|C0456149|CHV;MTH;SNOMEDCT|1|0.3632|1
IQ|IRAQ;Iraq;IRQ|C0022066|||C0022066|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
IQ|IZ||||C0022066|NCI|||
IQ|Ilimaquinone;ilimaquinone|C1171731|||C1171731|MSH|1|0.0134|
IQ|Intelligence quotient (observable entity)||||C0456149|SNOMEDCT|||
IQ|Iraq (geographic location)||||C0022066|SNOMEDCT|||
IQ|intelligence|C0021704|||||1|0.0534|
IQ|interquartile||||||1|0.0147|
IQ|interquartile range|C1711350|||C1711350|NCI|||
IR|Calcitonin gene-related peptide (CGRP)-immunoreactive||||||1|0.0024|
IR|INNERV||||C1619351|MSH|||
IR|IR;Ir|C0022065;C0022071|||C0022065;C0022071;C1619351|MSH;NCI|||
IR|IRAN;Iran;iran;IRN|C0022065|||C0022065|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
IR|IRIDIUM;Iridium;Iridium, NOS;iridium|C0022071;C0885452|||C0022071|AOD;CHV;CSP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
IR|Incomplete Repair||||||1|0.0018|
IR|Infra-red;infrared|C1532326|1|0.002|C1532326|SNOMEDCT|1|0.119|1
IR|Insulin resistance;insulin resistance|C0021655;C2700570|||C0021655;C2700570|CHV;CSP;LCH;MEDLINEPLUS;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0605|1
IR|Interventional radiology;interventional radiology|C0034602;C0344093|1|0.788|C0034602;C0344093|CHV;LNC;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.0039|1
IR|Intrarectal;intrarectal||||||1|0.003|1
IR|Ir element;Iridium Metallicum|C0022071|||C0022071|CSP;NCI|||
IR|Iran (geographic location)||||C0022065|SNOMEDCT|||
IR|Iran, Islamic Republic of||||C0022065|NCI|||
IR|Iridium (substance)||||C0022071|SNOMEDCT|||
IR|Iridium [Chemical/Ingredient]||||C0022071|NDFRT|||
IR|Ischemia-reperfusion;ischaemia-reperfusion;ischemia and reperfusion||||||1|0.0679|1
IR|Ratio|C0456603;C1547037|||||1|0.0071|
IR|current|C0521116;C1705970|||||1|0.002|
IR|idiopathic rhinitis||||||||1
IR|ileal resection|C0399935|||C0399935|CHV;SNOMEDCT|||1
IR|imidazoline receptors|C0063390|||||1|0.0026|
IR|immediate-release|C1708470|1|0.204|||1|0.0333|1
IR|immune response|C0301872|||C0301872|AOD;CHV;CSP;GO;MTH;NCI;SNOMEDCT|1|0.0225|1
IR|immunization rate||||||||1
IR|immunologic response||||||||1
IR|immunoreactive||||||1|0.1679|1
IR|immunoreactivity|C0597879|||||1|0.1843|
IR|immunoreagent||||||||1
IR|impedance rheography||||||||1
IR|implantation rate||||||1|0.0035|
IR|inactive renin|C0072249|||||1|0.0039|
IR|incidence rate|C1708485|||||1|0.0136|
IR|incisal ridge||||||||1
IR|index of response||||||||1
IR|individual reaction||||||||1
IR|inferior rectus|C0224129;C0582819|||||1|0.0043|1
IR|inflow resistance||||||||1
IR|information retrieval|C0021427;C0079623|||C0021427;C0079623|AOD;CHV;CSP;MSH;MTH|1|0.0049|
IR|infrared spectroscopy|C0260249|||||1|0.0122|
IR|infrarenal||||||||1
IR|inhibition rate||||||1|0.0047|
IR|innervation|C0021516;C0026828;C1619351|||C1619351|GO;MSH|||
IR|innervation aspect|C1619351|||C1619351|MTH|||
IR|inside radius||||||||1
IR|insoluble residue||||||||1
IR|inspiratory reserve||||||||1
IR|inspiratory resistance||||||||1
IR|insulin receptor|C0034818;C1334133|||||1|0.1068|1
IR|insulin requirement||||||||1
IR|insulin response||||||||1
IR|insulin-resistant||||||1|0.0067|
IR|integer ratio||||||||1
IR|intelligence ratio||||||||1
IR|intergenic region|C0887859|||||1|0.0026|
IR|intermediate risk||||||1|0.003|
IR|internal reduction|C0745350|||||||1
IR|internal resistance||||||||1
IR|internal rotation|C0231459|1|0.004|C0231459|CHV;SNOMEDCT;UWDA|1|0.0032|1
IR|intrarenal||||||1|0.0022|1
IR|intrastent restenosis||||||||1
IR|inversion recovery||||||1|0.0311|1
IR|inverted repeat;inverted repeats||||||1|0.0258|1
IR|ionizing irradiation||||||1|0.0016|
IR|ionizing radiation|C0034538|||C0034538|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.0822|1
IR|irritant reaction||||||||1
IR|isotonic reversal||||||||1
IR|isovolumetric relaxation||||||||1
IR|isovolumic relaxation|C2924435|||C2924435|LNC|1|0.001|
IR|min of reperfusion||||||1|0.0008|
IR|near-infrared||||||1|0.0047|
IR|nerve supply|C0021516;C1619351|||C1619351|MSH|||
IR|reaction|C0443286;C1114821|||||1|0.0018|
IR|resistance index|C0807745|||||1|0.0012|
IS|DNA Insertion Element;DNA Insertion Elements;Element, DNA Insertion;Elements, DNA Insertion;Insertion Element, DNA;Insertion Elements, DNA;Insertion Sequence;insertion sequence;insertion element|C0600204|||C0600204|CSP;MSH;MTH;NCI|1|0.1256|1
IS|IC|C0587121|||C0020750|NCI|||
IS|ICELAND;Iceland;iceland;ISL|C0020750|||C0020750|AOD;CHV;CSP;DXP;LCH;MSH;MTH;NCI;SNOMEDCT|||
IS|IL|C0020898;C0021764;C0022271|||C0022271|NCI|||
IS|IMMUNE SUPPRESSION;immune suppression|C0021079;C1373218;C1840264|1|0.002|C1840264|MTH;OMIM|||1
IS|INSTRUM||||C0021632|MSH|||
IS|IS;Is;is||||C0020750;C0021632;C0022271;C0441913;C0600204;C1556119;C1840264|HL7V3.0;MSH;NCI;OMIM;SNOMEDCT|||
IS|IS Element||||C0600204|NCI|||
IS|ISCW;ISSCW|C1840264|||C1840264|OMIM|||
IS|ISR;ISRAEL;Israel;israel|C0022271|||C0022271|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
IS|Iceland (geographic location)||||C0020750|SNOMEDCT|||
IS|Infantile spasms;infantile spasm|C0037769|||C0037769|CHV;MSH;NCI;OMIM|1|0.0497|1
IS|Insertion Sequence Element|C0205742;C0600204|||C0600204|NCI|||
IS|International Standard;international standard||||||1|0.0369|1
IS|Ionescu-Shiley||||||||1
IS|Israel (geographic location)||||C0022271|SNOMEDCT|||
IS|STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO||||C1840264|OMIM|||
IS|Supernumerary maxillary left first primary|C1556119|||C1556119|MTH|||
IS|currently active tumor stage;is (tumor staging)|C0441913|||C0441913|CHV;MTH;SNOMEDCT|||
IS|idiopathic scoliosis|C0595995|||C0036440;C0595995|CHV;ICD9CM;MTH;SNOMEDCT|1|0.0235|
IS|ileal segment;ilial segment|C0440779|||C0440779|SNOMEDCT|||1
IS|iliosacral||||||||1
IS|immediate sensitivity||||||||1
IS|immobilization stress||||||1|0.0087|
IS|immune serum|C0020960|||C0020960|CHV;CSP|1|0.0047|1
IS|immune suppressor||||||||1
IS|immune system|C0020962|||C0020962|AOD;CHV;CSP;FMA;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0121|
IS|immunological synapse|C1171348|||||1|0.0168|
IS|immunoscintigraphy|C0085264|||C0085264|NCI|1|0.0349|
IS|immunostaining||||||1|0.006|
IS|immunosuppressed||||||1|0.0087|
IS|immunosuppression|C0021079;C0021080;C1373218|||C0021079;C0021080;C1373218|AOD;CHV;CSP;LCH;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0201|
IS|immunosuppressive|C0021081|||C0021081|CHV;CSP;NCI|1|0.0228|
IS|immunosuppressive substance||||||1|0.0074|
IS|immunosuppressive therapy|C0021079|||||1|0.0074|
IS|imperative stimulus||||||1|0.0047|
IS|impingement syndrome|C0263912|||C0263912|CHV;COSTAR;SNOMEDCT|||1
IS|in situ||||||||1
IS|incentive spirometer|C1961253|1|0.006|C1961253|CHV|||1
IS|incentive spirometry|C0454512|||C0454512|CHV;MTH;SNOMEDCT|1|0.0101|
IS|index of saponification||||||||1
IS|index of sexuality||||||||1
IS|indoxyl sulfate|C0021210|||C0021210|MSH;NDFRT|1|0.0074|
IS|induced sputum|C3179346|||C3179346|MSH|1|0.0369|1
IS|inescapable shock||||||1|0.0215|
IS|infant size||||||||1
IS|infarct size||||||1|0.0994|
IS|information system;information systems|C0021428|1|0.002|||1|0.0262|1
IS|infrahyoid strap||||||||1
IS|initial segment|C1523840|||C1523840|GO|1|0.0134|1
IS|inner segments||||||1|0.0067|
IS|insertion|C0021107;C0441587;C1512796;C1883719|||C0441587;C1512796;C1883719|CHV;HL7V3.0;LNC;NCI;SNOMEDCT|1|0.0067|
IS|instrumentation|C0021632;C0348000;C1704339|||C0021632|MSH|||
IS|instrumentation aspects|C0021632|||C0021632|MTH|||
IS|insufficient signal||||||||1
IS|insulin secretion|C1256369|||||||1
IS|insulin sensitivity|C0920563|||||1|0.0322|
IS|intercellular space|C0015352|||C0015352|FMA;GO;MSH;SNOMEDCT;UWDA|||1
IS|intercostal space|C0230136;C1269872|||||||1
IS|interictal spike||||||||1
IS|internal standard||||||1|0.2411|1
IS|interspace||||||||1
IS|interstitial space|C0225319|||C0225319|AOD;CHV;FMA;SNOMEDCT;UWDA|||1
IS|interventricular septum|C0225870|||||1|0.0034|1
IS|intracardial shunt||||||||1
IS|intraspinal|C1283188|||C1283188;C1522227|CHV;MTH;NCI;SNOMEDCT|||1
IS|intrasplenic||||||||1
IS|intrastriatal||||||||1
IS|invalided from service||||||||1
IS|inventory of systems||||||||1
IS|ionic strength|C0086486|||C0086486|CSP;MSH;NCI|1|0.0107|
IS|ionized serum||1|0.002|||||
IS|ipecac syrup|C0022046|||||||1
IS|ischaemic stroke;ischemic stroke|C0948008|||C0948008|CHV;MTH;OMIM;SNOMEDCT|1|0.051|
IS|ischemia|C0022116|||C0022116|AOD;CHV;COSTAR;CSP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.006|
IS|ischemic|C0475224|||C0475224|CHV;MTH;SNOMEDCT|||
IS|ischemic score||||||||1
IS|island|C0022130|||||||1
IS|islet||||||||1
IS|isolation|C0204727;C0205409;C0220862|||||||1
IS|isoproterenol|C0022245|||C0022245|AOD;CHV;CSP;LCH;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
IS|isosorbide|C0022251|||C0022251|AOD;CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
IS|isotonic saline||||||1|0.0054|
IS|score|C0449820|||||1|0.0107|
IS|slow inward current||||||1|0.0141|
IS|space|C1883067|||||1|0.0067|
ITP|AITP;Autoimmune Thrombocytopenic Purpura;Autoimmune Thrombocytopenic Purpuras;Autoimmune thrombocytopenic purpura;Purpura, Autoimmune Thrombocytopenic;Purpura, Thrombocytopenic, Autoimmune;Purpuras, Autoimmune Thrombocytopenic;THROMBOCYTOPENIC PURPURA, AUTOIMMUNE;Thrombocytopenic Purpura, Autoimmune;Thrombocytopenic Purpuras, Autoimmune;Disease, Werlhof;Disease, Werlhof's;WERLHOF DISEASE;Werlhof Disease;Werlhof's Disease;Werlhof's disease;Werlhofs Disease;werlhof's disease;IDIOPATHIC THROMBOCYTOPENIC PURPURA;Idiopathic Thrombocytopenic Purpura;Idiopathic Thrombocytopenic Purpuras;Idiopathic purpura (& thrombocytopenic);Idiopathic thrombocytopenic purpura;Idiopathic thrombocytopenic purpura, NOS;PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;Purpura, Idiopathic Thrombocytopenic;Purpura, Thrombocytopenic, Idiopathic;Purpuras, Idiopathic Thrombocytopenic;Thrombocytopenic Purpura, Idiopathic;Thrombocytopenic Purpuras, Idiopathic;idiopathic thrombocytopenic purpura;ITP - Idiopathic thrombocytopenic purpura;ITP - idiopathic thrombocytopenic purpura;Idiopathic thrombocytopenic purpura (ITP);idiopathic thrombocytopenic purpura (ITP);Idiopathic Thrombocytopenia Purpura;Idiopathic purpura;Idiopathic purpura, NOS;idiopathic purpura|C0043117|1|1|C0043117|CHV;COSTAR;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8418|1
ITP|IMMUNE THROMBOCYTOPENIC PURPURA;immune thrombocytopenic purpura|C0043117;C0398650|||C0043117;C0398650|CHV;ICD9CM;MTH;NCI;OMIM;SNOMEDCT|||1
ITP|ITP;ITP, NOS|C0021540;C0043117|||C0021540;C0043117|CHV;DXP;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||
ITP|ITP - Inosine triphosphate;inosine triphosphate (ITP);Inosine Triphosphate;Inosine triphosphate;Triphosphate, Inosine;inosine triphosphate|C0021540|||C0021540|CHV;MSH;MTH;NDFRT;SNOMEDCT|1|0.0154|1
ITP|Ideopath thrombocytopenic pur||||C0043117|SNOMEDCT|||
ITP|Idiopathic Thrombocytopenia;idiopathic thrombocytopenia|C0043117;C0920163|||C0043117;C0920163|CHV;MTH;NCI;OMIM|1|0.0224|
ITP|Idiopathic purpura (& thrombocytopenic) (disorder);Idiopathic thrombocytopenic purpura (disorder)||||C0043117|SNOMEDCT|||
ITP|Inosine 5'-(tetrahydrogen triphosphate)||||C0021540|MSH;NDFRT|||
ITP|Inosine Triphosphate [Chemical/Ingredient]||||C0021540|NDFRT|||
ITP|Inosine triphosphate (substance)||||C0021540|SNOMEDCT|||
ITP|Ion transport peptide||||||1|0.0077|
ITP|Purpura, Thrombocytopenic, Idiopathic [Disease/Finding]||||C0043117|NDFRT|||
ITP|Thrombocytopenia Due to Platelet Alloimmunization|C0043117;C0272286|||C0043117|NCI|||
ITP|WERLHOF DIS;WERLHOFS DIS||||C0043117|MSH|||
ITP|capillary isotachophoresis||||||1|0.0208|
ITP|immune thrombocytopenia|C0272286|||C0272286|CHV;NCI;OMIM;SNOMEDCT|1|0.0486|
ITP|inosine 5'-triphosphate||||||1|0.0093|
ITP|interim treatment plan;interim treatment planning||||||||1
ITP|intrathoracic pressure||||||1|0.0247|
ITP|inverse treatment plan;inverse treatment planning||||||||1
ITP|islet-cell tumor of pancreas||||||||1
ITP|isotachophoresis|C0022257|||C0022257|MSH|||
ITP|isotachophoretic||||||1|0.0093|
IT|(drug) IT||1|0.004|||||
IT|Ca2+ current||||||1|0.0058|
IT|INTRATHECAL;Intrathecal;intrathecal|C1370196|1|0.116|C0677897;C1370196|CHV;HL7V2.5;NCI;SNOMEDCT|1|0.4525|1
IT|IT||||C0022277;C0677897|NCI|||
IT|ITA;ITALY;Italy;italy|C0022277|||C0022277|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
IT|Immune Tolerance|C0020963|||||1|0.0043|
IT|Intrathecal Route of Administration;Intrathecal Route of Drug Administration;Intrathecal use;into the spinal space|C0677897|||C0677897|CHV;MTH;NCI;SNOMEDCT|||
IT|Intrathecal route;IntrathecalRoute|C0205527;C0677897|||C0677897|HL7V3.0;SNOMEDCT|||
IT|Intrathecal route (qualifier value)||||C0677897|SNOMEDCT|||
IT|Intrathymic;intrathymic||||||1|0.0274|
IT|Intratracheal;intratracheal||||C1522653|NCI;SNOMEDCT|1|0.0987|1
IT|Italy (geographic location)||||C0022277|SNOMEDCT|||
IT|administered intrathecally||||||1|0.0232|
IT|iliotibial||1|0.080|||||1
IT|immature-to-total neutrophil||1|0.002|||||
IT|immunity test||||||||1
IT|immunologic test;immunological test|C0021061|||C0021061|CHV;MSH|||1
IT|immunotherapy|C0021083|||C0021083|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||1
IT|immunotoxin|C0021084|||C0021084|CHV;CSP;MSH;NCI;NDFRT;PDQ|1|0.0616|
IT|immunotoxin therapy|C0796507|||||||1
IT|implantation test||||||||1
IT|incentive therapy||||||||1
IT|individual therapy|C0204525|||C0204525|AOD;CHV|||1
IT|inferior temporal||||||1|0.0303|1
IT|inferior temporal cortex||||||1|0.0125|
IT|inferior turbinate|C0225434|||||||1
IT|inferotemporal||||||1|0.0125|
IT|inferotemporal cortex||||||1|0.0082|
IT|information technology|C0021423;C0683867|1|0.206|C0021423;C0683867|AOD;CHV;NCI|1|0.1021|1
IT|information transfer|C0681300|||||1|0.0024|
IT|inhalation test||||||||1
IT|inhalation therapy|C0021459|||||||1
IT|injected intrathecally||||||1|0.0207|
IT|injected intratumorally||||||1|0.0029|
IT|injection|C0021485;C1272883;C1533685|||||1|0.0043|
IT|injection time||||||||1
IT|inspection time||||||1|0.0082|
IT|inspiratory time|C0428686|1|0.002|||||1
IT|insulin therapy||||||||1
IT|insulin treatment|C0745343|||||||1
IT|intact|C0205266;C1554187|||||||1
IT|intensive therapy||||||1|0.0039|1
IT|intentional tremor||||||||1
IT|intermediate trophoblast|C1512865;C2335060|||||1|0.0077|
IT|intermittent traction|C0565524|||||||1
IT|internal thoracic||||||||1
IT|interstitial tissue|C0225318|||C0225318|CHV;SNOMEDCT|||1
IT|intertrochanteric|C0745355|1|0.028|||||1
IT|intertuberous||||||||1
IT|intestinal transplantation||||||1|0.0067|
IT|intimal thickening||||||||1
IT|intimal thickness||||||1|0.0048|
IT|intolerance and toxicity||||||||1
IT|intracellular tachyzoite||||||||1
IT|intradermal test|C0021881|||C0021881|AOD;CHV;MSH|||1
IT|intratesticular||||C1517559|NCI;SNOMEDCT|||1
IT|intrathoracic|C0595836|||C0595836|NCI;SNOMEDCT|1|0.0063|1
IT|intratracheal instillation|C1555389|||||1|0.0091|
IT|intratracheally||||||1|0.0347|
IT|intratumoral|C1517564|||C1517564|NCI|1|0.0346|1
IT|ischial tuberosity|C0223656;C1279109|1|0.096|C0223656;C1279109|CHV;FMA;SNOMEDCT;UWDA|||1
IT|isomeric transition||||||||1
IT|pravastatin or atorvastatin evaluation and infection therapy||1|0.002|||||
IT|specific immunotherapy||||||1|0.0082|
IT|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0063|
IUD|Contraceptive Device, Intrauterine;Contraceptive Devices, Intrauterine;Device, Intrauterine Contraceptive;Devices, Intrauterine Contraceptive;Intrauterine Contraceptive Device;Intrauterine Contraceptive Devices;Intrauterine contraceptive device;intrauterine contraceptive device;Contraceptive IUD;Contraceptive IUDs;IUD, Contraceptive;IUDs, Contraceptive;Device, Intrauterine;Devices, Intrauterine;INTRAUTERINE DEVICE;Intra Uterine Device;Intra-uterine device;Intrauterine Device;Intrauterine Devices;Intrauterine device;device intrauterine;devices intra uterine;devices intrauterine;intra uterine device;intra-uterine device;intrauterine device;intrauterine devices;IUCD;iucd;IUD - Intrauterine device;intrauterine devices (IUD)|C0021900|1|1|C0021900;C1546682;C1548866;C1706306|CHV;DXP;HL7V2.5;MSH;MTH;NCI;SNOMEDCT|1|1|1
IUD|IUCD - Intrauterine contraceptive device||||C0021900|SNOMEDCT|||
IUD|IUD;iuds|C0021900;C1706306|||C0021900;C1706306|CHV;CSP;NCI;SNOMEDCT|||
IUD|Intrauterine Device Dosage Form;Intrauterine Device Dose Form|C1706306|||C1706306|MTH;NCI|||
IUD|Intrauterine contraceptive device (physical object)||||C0021900|SNOMEDCT|||
IUD|Intrauterine device (physical object)||||C0021900|SNOMEDCT|||
IUD|Intrauterine device (product)||||C0021900|SNOMEDCT|||
IUD|Intrauterine device (qualifier value)||||C0021900|SNOMEDCT|||
IUD|interuncal distance||||||||1
IUD|intrauterine death|C0015927;C0595939|||C0015927;C0595939|CCS;CHV;OMIM;SNOMEDCT|||1
IUGR|(Fetal growth retardation NOS) or (intrauterine growth retardation)||||C0015934|SNOMEDCT|||
IUGR|(Fetal growth retardation NOS) or (intrauterine growth retardation) (disorder)||||C0015934|SNOMEDCT|||
IUGR|FGR - Fetal growth retardation||||C0015934|SNOMEDCT|||
IUGR|Fet growth retard wtNOS||||C0015934|ICD9CM|||
IUGR|Fetal Growth Restriction;Fetal growth restriction;Fetal Growth Retardation;Fetal growth retardation;Fetal growth retardation NOS;Fetal growth retardation, NOS;Foetal growth retardation, NOS;Growth Retardation, Fetal;Retardation, Fetal Growth;fetal growth retardation;Fetal growth retardation, unspecified;Fetal growth retardation, unspecified [weight];Fetal growth retardation, unspecified weight;Growth Retardation, Intrauterine;Intrauterine Growth Retardation;Intrauterine growth retardation;Intrauterine growth retardation, NOS;Retardation, Intrauterine Growth;growth intrauterine retardation;intrauterine growth retardation;IUGR;iugr;iugrs;IUGR - Intrauterine growth retardation;Intrauterine growth retardation (IUGR);Intrauterine Growth Restriction;Intrauterine growth restriction;growth intrauterine restriction;intrauterine growth restriction;Intrauterine growth retarded;intrauterine growth retard;Microsomia;microsomia;Microsomic baby;Poor fetal growth;poor fetal growth;Poor fetal growth state;prenatal growth disorder|C0015934|1|1|C0015934|CHV;CSP;ICD9CM;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9692|1
IUGR|Fetal Growth Retardation [Disease/Finding]||||C0015934|NDFRT|||
IUGR|Fetal growth retardation (disorder);Fetal growth retardation NOS (disorder)||||C0015934|SNOMEDCT|||
IUGR|Insufficiency - placental||||C0015934|SNOMEDCT|||
IUGR|Intrauterine growth retardatn.||||C0015934|SNOMEDCT|||
IUGR|growth retarded fetuses||||||1|0.0047|
IUGR|intrauterine growth rate||||||||1
IUGR|intrauterine growth-restricted||||||1|0.026|
IUPC|IUPC;Intrauterine pressure catheter;intrauterine pressure catheter;Intrauterine pressure catheter, device|C1443347|1|1|C1443347|MTH;SNOMEDCT|||1
IUPC|Intrauterine pressure catheter, device (physical object)||||C1443347|SNOMEDCT|||
IUP|intraurethral pressure||||||1|0.15|
IUP|intrauterine pregnancy|C0149973|1|1.000|C0149973|CHV;SNOMEDCT|1|0.52|1
IUP|intrauterine pressure||||||1|0.33|1
IU|F2|C0439453;C1414504|||C0439453|NCI|||
IU|INTERNATIONAL UNITS;International Unit;International Units;Unit International;international unit;international unit(s);international units;IU;[iU];iu;ius;International Unit of Biological Activity|C0439453|1|1|C0439453|CHV;HL7V3.0;MTH;NCI;SNOMEDCT|1|0.7606|1
IU|IU (qualifier value)||||C0439453|SNOMEDCT|||
IU|Indiana University||||||1|0.0585|
IU|Intrauterine;intrauterine|C0694756|||||1|0.1117|1
IU|idiopathic uveitis||||||1|0.0319|
IU|immunizing unit||||||||1
IU|in utero|C1708480|||||||1
IU|infectious unit||||||||1
IU|intermediate uveitis|C0042166|||||1|0.0372|
IU|international units (qualifier value)||||C0439453|SNOMEDCT|||
IU|iodouracil|C0063801|||C0063801|MSH|||
IVC|individually viable cell||||||||1
IVC|indwelling venous catheter||||||||1
IVC|inferior vena cava;inferior vena cavae|C0042458;C1269024|1|0.998|C0042458;C1269024|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.9046|1
IVC|inferior vena caval|C0521360|||||1|0.0505|
IVC|inferior venacavogram||||||||1
IVC|inferior venacavograph||||||||1
IVC|inferior venacavography||||||||1
IVC|inspiratory vital capacity|C0429710|||C0429710|SNOMEDCT|1|0.0213|1
IVC|inspired vital capacity||||||||1
IVC|integrated vector control||||||||1
IVC|intravascular coagulation||||||||1
IVC|intravenous chemotherapy|C0413365|||||||1
IVC|intravenous cholangiogram|C0203082;C1548869|||C0203082;C1548869|CHV;HL7V2.5;ICD9CM;MTH;SNOMEDCT|||1
IVC|intravenous cholangiograph||||||||1
IVC|intravenous cholangiography|C0203082|||C0203082|CHV|1|0.0237|1
IVC|intraventricular catheter||||||||1
IVC|intraventricular conduction|C0489574|||||||1
IVC|isovolumic contraction|C2923410|||||||1
IVF|Artificial Fertilization;artificial fertilization;Fertilization in Vitro;Fertilization in vitro;Fertilizations in Vitro;In Vitro Fertilization;In Vitro Fertilizations;In vitro fertilisation;In vitro fertilization;In-vitro fertilisation;In-vitro fertilization;fertilisation in vitro;fertilization in vitro;in vitro Fertilization;in vitro fertilisation;in vitro fertilization;in-vitro fertilisation;vitro fertilisation;vitro fertilization;Fertilization, Test-Tube;Fertilizations, Test-Tube;Test Tube Fertilization;Test-Tube Fertilization;Test-Tube Fertilizations;test-tube fertilization;In vitro fertilisation procedure;In vitro fertilization procedure;Test tube baby technique;Test tube ovum fertilisation;Test tube ovum fertilization|C0015915|1|0.616|C0015915|CHV;CSP;ICD10PCS;LCH;MEDLINEPLUS;MSH;MTH;MTHCH;NCI;SNOMEDCT|1|0.9695|1
IVF|CDCD2|C1419864;C1832680|||C1419864|HUGO|||
IVF|CMPD2|C1413522;C1419864|||C1419864|HUGO|||
IVF|HB1|C1419864;C1825768|||C1419864|HUGO|||
IVF|HB2|C1419864;C1825769|||C1419864|HUGO|||
IVF|HBBD|C1419864;C1879286|||C1419864|HUGO|||
IVF|HH1;ICCD;NAV1.5;Nav1.5;PFHB1;SCN5A;SCN5A gene|C1419864|||C1419864|HUGO;LNC;MTH;OMIM|||
IVF|IVF|C0015915;C1419864|||C0015915;C1419864|CHV;CSP;HUGO;MEDLINEPLUS;NCI;SNOMEDCT|||
IVF|In vitro fertilisation procedure (procedure)||||C0015915|SNOMEDCT|||
IVF|LQT3;long QT syndrome 3|C1419864;C1859062|||C1419864|HUGO|||
IVF|Other Procedures @ Physiological Systems and Anatomical Regions @ Other Procedures @ None @ External @ Other Method @ In Vitro Fertilization||||C0015915|ICD10PCS|||
IVF|SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT;sodium channel, voltage-gated, type V, alpha subunit|C1121069;C1419864|||C1419864|HUGO;OMIM|||
IVF|SSS1|C1419864;C1425415;C1837845|||C1419864|HUGO|||
IVF|Test tube ovum fertilization (procedure)||||C0015915|SNOMEDCT|||
IVF|idiopathic ventricular fibrillation|C0340493|||C0340493|MSH;OMIM|1|0.0073|
IVF|in vitro fertilization (IVF)||||C0015915|CHV|||
IVF|in vivo fertilization|C0232905|||||||1
IVF|interventricular foramen|C0016520;C1281034|||C0016520;C1281034|CHV;FMA;NCI;SNOMEDCT;UWDA|||1
IVF|intervertebral foramen|C0223085;C1281347|||C0223085;C1281347|CHV;FMA;SNOMEDCT;UWDA|||1
IVF|intravascular fluid||||||||1
IVF|intravenous fluid|C1289919|1|0.376|C1289919|CHV;NCI;SNOMEDCT|1|0.0045|1
IVF|intravenous fluorescein||||||||1
IVF|intravertebral foramen||||||||1
IVF|vitro fertilization and embryo transfer||||||1|0.0032|
IVF|vitro fertilized||||||1|0.0155|
IVIG|Antibodies, Intravenous;Intravenous Antibodies;IV Immunoglobulins;IV immunoglobulin;Immunoglobulins, IV;IVIG;Immune Globulin Intravenous;Immune Globulin, Intravenous;Intravenous Immune Globulin;intravenous immune globulin;Immunoglobulins, Intravenous;Intravenous Immunoglobulins;Intravenous immunoglobulin;intravenous immunoglobulin;intravenous immunoglobulins;Intravenous IG;intravenous Ig|C0085297|1|1|C0085297|CHV;MSH;MTH;NDFRT;PDQ;RXNORM;SNOMEDCT|1|0.9057|1
IVIG|GLOBULIN,IMMUNE (IV);Immune Globulin IV;Immune globulin IV;IG IV;IGIV;IV IG|C0085297;C1527233|||C0085297|HL7V2.5;HL7V3.0;MSH;NDFRT;PDQ;SNOMEDCT;VANDF|||
IVIG|Immune globulin IV (product)||||C0085297|SNOMEDCT|||
IVIG|Immune globulin IV (substance)||||C0085297|SNOMEDCT|||
IVIG|Immunoglobulins, Intravenous [Chemical/Ingredient]||||C0085297|NDFRT|||
IVIG|Intravenous immunoglobulin (product)||||C0085297|SNOMEDCT|||
IVIG|Intravenous immunoglobulin (substance)||||C0085297|SNOMEDCT|||
IVIG|intravenous IgG||||||1|0.0082|
IVIG|intravenous gamma globulin;intravenous gammaglobulin||||||1|0.0441|
IVIG|intravenous immunoglobulin G||||||1|0.0247|
IVIG|intravenous immunoglobulin preparations||||||1|0.0075|
IVIG|intravenous immunoglobulin therapy||||||1|0.0097|
IVP|Consent Type - IVP|C1548873|||C1548873|MTH|||
IVP|IVP;ivp|C0203108;C1548873|||C0203108;C1548873|CHV;HL7V2.5;NCI|||
IVP|IVP - Intravenous pyelogram;intravenous pyelogram (IVP);IVU - Intravenous urogram;Intravenous Pyelogram;Intravenous pyelogram;Intravenous pyelogram, NOS;intravenous pyelogram;Intravenous Pyelography;intravenous pyelography;Intravenous pyelogram without KUB;Intravenous urogram;intravenous urogram;Intravenous urography;Intravenous urography, NOS;intravenous urography;Intravenous urography without KUB;excretory urography;pyelogram;pyelograms|C0203108|||C0203108|CCS;CHV;ICD9CM;MTH;NCI;SNOMEDCT|1|0.596|1
IVP|Intravenous pyelogram (procedure)||||C0203108|SNOMEDCT|||
IVP|Intravenous urogram (procedure)||||C0203108|SNOMEDCT|||
IVP|Retired procedure (procedure) [P5-60030]||||C0203108|SNOMEDCT|||
IVP|Retired procedure [P5-60030]||||C0203108|SNOMEDCT|||
IVP|excretory urogram||||||1|0.0458|
IVP|intravascular pressure||||||||1
IVP|intravenous push|C1319196|||C1319196|NCI;SNOMEDCT|||1
IVP|intravenous pyelograph||1|1.000|||||1
IVP|intraventricular pressure|C0206177|||C0206177|CHV;CSP;MSH|1|0.0974|1
IVP|intravesical pressure|C0232843|||||1|0.0315|1
IVP|vitro embryo production||||||1|0.0229|
IVP|vitro produced||||||1|0.1547|
IVP|vitro production||||||1|0.0516|
IV|CI||||C0022326|NCI|||
IV|CIV||||C0022326|NCI|||
IV|COTE D'IVOIRE;Cote d'Ivoire;cote d'ivoire;Ivory Coast;coast ivory;ivory coast;Republic of Cote diIvoire|C0022326|||C0022326|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
IV|Fourth|C0205438;C1706303|||C1706303|NCI|||
IV|Fourth (suffix)|C1706303|||C1706303|MTH|||
IV|INTRAVENOUS;Intravenous;intravenous;IV - Intravenous;intravenous (IV)|C0348016|1|0.97|C0348016;C1522726|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|1|0.9365|1
IV|IV;On IV;iv;Roman Numeral IV;Roman numeral IV|C0677510|||C0021440;C0022326;C0348016;C0677510;C1416522;C1522726;C1706303|CHV;CSP;HL7V2.5;HUGO;LNC;MTH;NCI;SNOMEDCT|||
IV|IV (qualifier value)||||C0677510|SNOMEDCT|||
IV|IV - Intravenous infusion;IV Infusion;IVI - Intravenous infusion;Intravenous infusion (procedure);Intravenous infusion procedures;Parenteral Infusion Procedure|C0021440|||C0021440|MTH;NCI;SNOMEDCT|||
IV|IV gene;inversus situs, viscerum|C1416522|||C1416522|HUGO;MTH|||
IV|IV route;iv route;Intravenous Route of Administration;Intravenous Route of Drug Administration;Intravenous use;intravenous use;intravenous uses|C1522726|||C1522726|CHV;MTH;NCI;SNOMEDCT|||
IV|IV use;iv uses||||C1522726|CHV;SNOMEDCT|||
IV|IVI - Intavenous infusion||||C0021440|SNOMEDCT|||
IV|Infusion, Intravenous;Infusions, Intravenous;Intravenous Infusion;Intravenous Infusions;Intravenous infusion;Intravenous infusion, NOS;infusion intravenous;intravenous infusion;intravenous infusions|C0021440;C1272892;C1621368|||C0021440|CHV;MSH;NCI;SNOMEDCT|1|0.0032|
IV|Intravenous (qualifier value)||||C0348016|SNOMEDCT|||
IV|Intravenous infusion procedures (procedure)||||C0021440|SNOMEDCT|||
IV|Intravenous injection;intravenous injection|C0021494|||C0021494|AOD;CHV;MSH;NCI;SNOMEDCT|1|0.0063|
IV|Intravenous route;IntravenousRoute|C0205520;C1522726|||C1522726|HL7V3.0;SNOMEDCT|||
IV|Intravenous route (qualifier value)||||C1522726|SNOMEDCT|||
IV|Ivory Coast (geographic location)||||C0022326|SNOMEDCT|||
IV|Parenteral Infusion|C0021440;C0021441|||C0021440|NCI|||
IV|Roman numeral IV (qualifier value)||||C0677510|SNOMEDCT|||
IV|SIV||||C1416522|HUGO|||
IV|administered intravenously||||||1|0.0436|
IV|administration intravenous;intravenous administration|C0013125;C0021440|||C0021440|CHV|1|0.0034|
IV|ichnovirus|C0999783|||C0999783|NCBI|||
IV|ichthyosis vulgaris|C0079584|||C0079584|CHV;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
IV|immunodeficiency virus|C0682458|||||||1
IV|in vitro|C0021135;C1533691;C2827718|||C0021135;C1533691;C2827718|CHV;MSH;MTH;NCI|||1
IV|in vivo|C1515655|||C1515655|CHV;NCI|||1
IV|injections|C0021485;C1533685|||||1|0.0029|
IV|inserted into the vein (IV)||||C0348016|CHV|||
IV|interventricular||||||||1
IV|intervertebral|C0442106|||C0442106|CHV;SNOMEDCT|||1
IV|interview|C0021822;C0935630|||||||1
IV|intravaginal|C0442122|||C0442122|CHV;NCI;SNOMEDCT|||1
IV|intravascular|C0442123|||||||1
IV|intravenous feeding|C0021910|||C0021910|CHV;CSP;MSH;MTH;SNOMEDCT|||
IV|intravenously||||||||1
IV|intraventricular|C1517569|||C1517569;C1517571|MTH;NCI;SNOMEDCT|||1
IV|intravertebral||||||||1
IV|invasive|C0205281|||C0205281|CHV;LNC;MTH;NCI;SNOMEDCT|||1
IV|inversion|C0021943;C0021945;C1705687;C2349984|||||||1
IV|iodine value||||||||1
IV|iridovirus|C0206467|||C0206467|MSH;NCBI;SNOMEDCT|||
IV|jugular vein|C0022427;C1280188|||||1|0.0019|
IV|systemically||||||1|0.0022|
IV|vein infusion|C0021440;C1621368|||C0021440|CHV|||
JP|Aggressive Periodontitis;Periodontitis, Aggressive;Circumpubertal Periodontitis;Periodontitis, Circumpubertal;JP - Juvenile periodontitis;JPD - Juvenile periodontitis;PERIODONTITIS, AGGRESSIVE, 1;PERIODONTITIS, PREPUBERTAL;Periodontitis, Prepubertal;Prepubertal Periodontitis;Prepubertal periodontitis;Paradentosis;paradentosis|C0031106|||C0031106|CHV;MSH;NDFRT;OMIM;SNOMEDCT|||
JP|Aggressive Periodontitis [Disease/Finding]||||C0031106|NDFRT|||
JP|Early-Onset Periodontitis|C0031106;C0399447|||C0031106|MSH;NDFRT|||
JP|JA||||C0022341|NCI|||
JP|JAPAN;Japan;JPN|C0022341|||C0022341|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
JP|JP|C0022341;C0031106;C1421124|||C0022341;C0031106;C1421124|HUGO;NCI;OMIM|||
JP|JPD|C0031106;C0268414;C1416530|||C0031106|OMIM|||
JP|Jackson-Pratt||1|1.000|||||1
JP|Japan (geographic location)||||C0022341|SNOMEDCT|||
JP|Jobst pump||||||||1
JP|Juvenile Periodontitis;Juvenile periodontitis;PERIODONTITIS, JUVENILE;Periodontitis, Juvenile;juvenile periodontitis|C0031106;C1416530|||C0031106;C1416530|CHV;CSP;HUGO;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.452|1
JP|Juvenile papillomatosis||||||1|0.0565|
JP|Juvenile periodontitis (disorder)||||C0031106|SNOMEDCT|||
JP|PPP|C0031106;C0370219|||C0031106|OMIM|||
JP|Periodontosis;periodontosis|C0031106;C0600298|||C0031106|CHV;SNOMEDCT|||
JP|Prepubertal periodontitis (disorder)||||C0031106|SNOMEDCT|||
JP|T cell receptor gamma joining P;TRGJP;TRGJP gene|C1421124|||C1421124|HUGO;MTH|||
JP|T-cell receptor, gamma, joining segment JP||||C1421124|HUGO|||
JP|jimpy||||||1|0.1695|
JP|joining peptide||||||1|0.0678|
JP|joint protection||||||||1
JP|juvenile parkinsonism|C0752105|||||1|0.1017|
JP|juvenile polyposis|C0345893|||C0345893|NCI|1|0.096|1
JP|psychotropic drugs in Japanese pharmacopoeia||||||1|0.0565|
JVD|JUGULAR VENOUS DISTENTION;Jugular venous distension;jugular venous distention;JVD;jvd;Jugular venous engorgement;Venous congestion of neck|C0425687|1|1|C0425687|CHV;DXP;SNOMEDCT|||1
JVD|Jugular venous engorgement (finding)||||C0425687|SNOMEDCT|||
JVP|jugular vein pulse||||||||1
JVP|jugular venous pressure|C0428897|1|1.000|C0428897|CHV;SNOMEDCT|1|1|1
JVP|jugular venous pulsation||||||||1
JVP|jugular venous pulse|C0232133|||C0232133|SNOMEDCT|||1
KBC|knowledge based charting||1|1.000|||||
KCL|high potassium|C0856882|||||1|0.022|
KCL|potassium chloride|C0032825|1|1.000|||1|0.978|1
KUB|KUB;Kidney-Ureter-Bladder;kidneys, ureters, bladder|C1979912|1|1|C1979912|LNC;MTH|||1
KUB|kidney ultrasound biopsy||||||||1
KUB|kidneys and urinary bladder||||||||1
L1|IGKV1-16;IGKV1-16 gene;IGKV116;immunoglobulin kappa variable 1-16|C1416177|||C1416177|HUGO;MTH|||
L1|L1|C0441918;C1179698;C1416177|||C0441918;C1179698;C1416177|FMA;HUGO;NCI;SNOMEDCT;UWDA|||
L1|L1 Cancer Stage Finding;L1 Lymphatic Invasion Finding;L1 Lymphatic Stage;Lymphatic Stage L1;Lymphatic stage L1;L1 Lymphatic Vessel Invasion Finding;L1 Stage;L1 stage;L1 Stage Finding;L1 stage (finding);L1 TNM Finding|C0441918|||C0441918|MTH;NCI;SNOMEDCT|||
L1|L1 innervation|C1179698|||C1179698|MTH|||
L1|L1 stage (tumor staging)||||C0441918|SNOMEDCT|||
L1|L1: lymphatic vessel invasion||||C0441918|SNOMEDCT|||
L1|LINE-1||||||1|0.2912|
L1|Lymphatic stage L1 (tumor staging)||||C0441918|SNOMEDCT|||
L1|deferiprone|C0043832|||C0043832|CHV;MSH;MTH;NCI;RXNORM;SNOMEDCT|||
L1|first|C0205435;C1279901|||||1|0.0769|
L1|first language|C0557073|||C0557073|SNOMEDCT|1|0.1209|
L1|first larval stage||||||1|0.044|
L1|first lumbar vertebra|C0223492|||C0223492|FMA;MTH;SNOMEDCT;UWDA|||
L1|first-stage larvae||||||1|0.1264|
L1|iron chelator deferiprone||||||1|0.0934|
L1|lumbar (level) 1||1|1.000|||||
L1|lymphatic invasion|C1708790|||||||1
L1|major|C0205164|||||1|0.0495|
L1|major capsid protein||||||1|0.0659|
L1|native language|C1510558|||||1|0.0549|
L1|oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one||||||1|0.0769|
L2|L2|C1179699;C1418789;C1825810|||C0332411;C1179699;C1418789;C1825810|FMA;HUGO;OMIM;SNOMEDCT;UWDA|||
L2|L2 innervation|C1179699|||C1179699|MTH|||
L2|L2 stage|C0332411|||C0332411|MTH;SNOMEDCT|||
L2|L2 stage (finding)||||C0332411|SNOMEDCT|||
L2|L2 stage (tumor staging)||||C0332411|SNOMEDCT|||
L2|LGICZ;LGICZ1;ZACN;ZACN gene|C1825810|||C1825810|HUGO;MTH;OMIM|||
L2|LIGAND-GATED ION CHANNEL, ZINC-ACTIVATED, 1||||C1825810|OMIM|||
L2|LIPRIN-BETA-1;PPFIBP1;PPFIBP1 gene;PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 1;PTPRF-INTERACTING PROTEIN-BINDING PROTEIN 1;hSGT2;hSgt2p|C1418789|||C1418789|HUGO;MTH;OMIM|||
L2|PTPRF interacting protein, binding protein 1 (liprin beta 1)||||C1418789|HUGO|||
L2|SGT2|C1418789;C1428131|||C1418789|HUGO|||
L2|ZAC;ZAC1|C1335223;C1709407;C1825810|||C1825810|HUGO;OMIM|||
L2|Zn(2+)-ACTIVATED CHANNEL||||C1825810|OMIM|||
L2|cell line|C0007600|||||1|0.1846|
L2|lumbar (level) 2||1|1.000|||||
L2|second language|C0557074|||C0557074|CHV;SNOMEDCT|1|0.5538|
L2|second lumbar||||||1|0.0769|
L2|second lumbar (l2) nerve||||C1179699|CHV|||
L2|second lumbar vertebra|C0223507|||C0223507|FMA;MTH;SNOMEDCT;UWDA|||
L2|second-stage larvae||||||1|0.1846|
L2|zinc activated ligand-gated ion channel||||C1825810|HUGO|||
L3|CerS2;FLJ10243;LAG1 homolog, ceramide synthase 2;LASS2;LASS2 gene;SP260|C1422392|||C1422392|HUGO;MTH;OMIM|||
L3|L3|C1179700;C1419655;C1422392|||C1179700;C1419655;C1422392|FMA;HUGO;UWDA|||
L3|L3 innervation|C1179700|||C1179700|MTH|||
L3|LAG1, S. CEREVISIAE, HOMOLOG OF, 2||||C1422392|OMIM|||
L3|RIBOSOMAL PROTEIN L3;ribosomal protein L3|C0073294;C1419655|||C1419655|HUGO;OMIM|||
L3|RPL3;RPL3 gene|C1419655|||C1419655|HUGO;MTH;OMIM|||
L3|infective||||||1|0.0571|
L3|infective larvae||||||1|0.4318|
L3|infective larval||||||1|0.0174|
L3|infective stage larvae||||||1|0.0323|
L3|infective third-stage||||||1|0.0099|
L3|infective third-stage larvae||||||1|0.0943|
L3|larva|C0023047|||||1|0.0397|
L3|level 3|C0456949|||C0456949|CHV;SNOMEDCT|||
L3|lumbar (level) 3||1|1.000|||||
L3|lumbar vertebra|C0024091;C1269051|||||1|0.0273|
L3|third|C0205437|||||1|0.072|
L3|third larval stage||||||1|0.0199|
L3|third lumbar (l3) nerve||||C1179700|CHV|||
L3|third lumbar vertebra|C0223522|||C0223522|FMA;MTH;SNOMEDCT;UWDA|||
L3|third stage|C0441771|||||1|0.0273|
L3|third stage larvae||||||1|0.1712|
L4|60S ribosomal protein L4;L4;RPL4;RPL4 gene|C1419676|||C1179701;C1419676|FMA;HUGO;MTH;OMIM;UWDA|||
L4|Fourth-stage larvae||||||1|0.5842|
L4|L4 Segmental Innervation|C1179701|||C1179701|MTH|||
L4|RIBOSOMAL PROTEIN L4;ribosomal protein L4|C0073302;C1419676|||C1419676|HUGO;OMIM|||
L4|fourth larval stage||||||1|0.0693|
L4|fourth lumbar||||||1|0.099|
L4|fourth lumbar vertebra|C0223537|||C0223537|CHV;FMA;MTH;SNOMEDCT;UWDA|||
L4|fourth-stage||||||1|0.1881|
L4|layer 4||||||1|0.0594|
L4|lumbar (level) 4||1|1.000|||||
L5|5th lumbar vertebra nerves;L5 Segmental Innervation|C1179702|||C1179702|CHV;MTH|||
L5|Bone structure of L5;Fifth lumbar vertebra;fifth lumbar vertebra|C0223552|||C0223552|CHV;FMA;MTH;SNOMEDCT;UWDA|||
L5|Bone structure of L5 (body structure)||||C0223552|SNOMEDCT|||
L5|FLJ32011;KINOCILIN;kinocilin;KNCN;KNCN gene|C1969618|||C1969618|HUGO;MTH;OMIM|||
L5|KINO|C1011810;C1969618|||C1969618|HUGO;OMIM|||
L5|L5;l5|C1419683;C1969618|||C0223552;C1179702;C1419683;C1969618|CHV;FMA;HUGO;OMIM;UWDA|||
L5|L5 VERTEBRA;L5 Vertebra;L5 vertebra;l5 vertebra|C0223552;C1305617|||C0223552|CHV;FMA;NCI;UWDA|||
L5|RIBOSOMAL PROTEIN L5;ribosomal protein L5|C0073304;C1419683|||C1419683|HUGO;OMIM|||
L5|RPL5;RPL5 gene|C1419683|||C1419683|HUGO;MTH;OMIM|||
L5|fifth lumbar||||||1|0.4167|
L5|lumbar (level) 5||1|0.998|||||
L5|lumbar vertebra|C0024091;C1269051|||||1|0.5833|
LAD|Anterior descending branch of left coronary artery;Anterior interventricular branch of left coronary artery;Anterior interventricular coronary artery;LEFT ANTERIOR DESCENDING CORONARY ARTERY;left anterior descending coronary artery;Left anterior descending artery;left anterior descending artery;Left anterior descending branch of left coronary artery;Structure of anterior descending branch of left coronary artery|C0226032|||C0226032|CHV;FMA;HCPCS;MTH;SNOMEDCT;UWDA|1|0.6001|
LAD|BRANCHED CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX, E3 COMPONENT;DLD gene;DLDH;GCSL;GLYCINE CLEAVAGE SYSTEM L PROTEIN;LIPOAMIDE REDUCTASE;PHE3;PYRUVATE DEHYDROGENASE COMPONENT E3|C1414063|||C1414063|HUGO;MTH;OMIM|||
LAD|CD18||||C1706333|NCI|||
LAD|DIAPHORASE;DIHYDROLIPOAMIDE DEHYDROGENASE;dihydrolipoamide dehydrogenase;DIHYDROLIPOYL DEHYDROGENASE;LIPOAMIDE DEHYDROGENASE;Lipoamide dehydrogenase;lipoamide dehydrogenase;LIPOYL DEHYDROGENASE|C0023783;C1414063|||C0023783;C1414063|HUGO;MSH;NDFRT;OMIM|1|0.0033|1
LAD|DLD|C1414063;C2826331|||C1414063|HUGO;OMIM|||
LAD|E3||||C1414063|OMIM|||
LAD|E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex||||C1414063|HUGO|||
LAD|ITGB2 wt Allele;LCAMB;MF17|C1706333|||C1706333|MTH;NCI|||
LAD|Integrin, Beta 2 (Antigen CD18 (p95), Lymphocyte Function-Associated Antigen 1; Macrophage Antigen 1 (MAC-1) Beta Subunit) wt Allele||||C1706333|NCI|||
LAD|LAD||||C0226032;C0398738;C1414063;C1706333|FMA;NCI;OMIM|||
LAD|LAD - Leucocyte adhesion deficiency type 1;LAD - Leukocyte adhesion deficiency type 1;LAD-Type I;LEUKOCYTE ADHESION DEFICIENCY, TYPE I;LFA-1 deficiency;LFA-I Deficiency;LFA1 IMMUNODEFICIENCY;LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 1 IMMUNODEFICIENCY;Lymphocyte function-associated antigen 1 immunodeficiency;Leucocyte adhesion deficiency - type 1;Leukocyte Adhesion Deficiency Type 1;Leukocyte adhesion deficiency - type 1;Leukocyte adhesion deficiency type 1;Leucocyte adhesion molecule deficiency - type 1;Leukocyte adhesion molecule deficiency - type 1;Mo-1 deficiency|C0398738|||C0398738|MSH;MTH;NCI;OMIM;SNOMEDCT|||
LAD|LAD1|C0398738;C1416770|||C0398738|OMIM|||
LAD|LDA;lda||||C0226032|CHV;UWDA|||
LAD|LFA-1|C0079717|||C1706333|NCI|||
LAD|Left ant des coronary artery||||C0226032|HCPCS|||
LAD|Leukocyte adhesion deficiency;leukocyte adhesion deficiency|C0272187|||C0272187|CHV;NCI;SNOMEDCT|1|0.0247|
LAD|Leukocyte adhesion deficiency - type 1 (disorder)||||C0398738|SNOMEDCT|||
LAD|Ramus interventricularis anterior (Arteria coronaria sinistra)||||C0226032|FMA|||
LAD|Structure of anterior descending branch of left coronary artery (body structure)||||C0226032|SNOMEDCT|||
LAD|lactate dehydrogenase;lactic acid dehydrogenase|C0022917|||C0022917|AOD;CHV;CSP;NCI;SNOMEDCT|||1
LAD|language acquisition device||||||||1
LAD|left anterior descending||1|0.992|||1|0.2986|1
LAD|left anterior descending branch||||||1|0.0075|
LAD|left anterior descending coronary||||||1|0.0081|
LAD|left atrial defect||||||||1
LAD|left atrial diameter||||||1|0.0114|1
LAD|left atrial dilation||1|0.002|||||
LAD|left atrial dimension||||||1|0.0124|1
LAD|left axis deviation|C0232297|||C0232297|CHV;SNOMEDCT|1|0.0075|1
LAD|ligament augmentation device||||||1|0.0091|1
LAD|ligamentous anterior dislocation||||||||1
LAD|linear A disease||||||||1
LAD|linear IgA bullous dermatosis;linear IgA dermatosis;linear IgA disease|C0406650|||||1|0.0173|
LAD|linoleic acid depression||||||||1
LAD|lymphadenopathy|C0497156|1|0.006|||||
LAD|lymphocyte-activating determinant|C0019754;C0302291|||||||1
LA|AUTOANTIGEN La;LARP3;La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 3;La ribonucleoprotein domain family, member 3;SJOGREN SYNDROME ANTIGEN B;SSB gene|C1420423|||C1420423|HUGO;MTH;OMIM|||
LA|Agglutination Test, Latex;Agglutination Tests, Latex;Latex Agglutination Test;Latex Agglutination Tests;Latex agglutination test;Latex agglutination test, NOS;Test, Latex Agglutination;Tests, Latex Agglutination;agglutination latex tests;latex agglutination test;latex agglutination tests;Fixation Test, Latex;Fixation Tests, Latex;Latex Fixation Test;Latex Fixation Tests;Test, Latex Fixation;Tests, Latex Fixation;latex fixation test;LA - Latex agglutination;Latex agglutination;agglutination latex;latex agglutination;latex particle agglutination test|C0023117|||C0023117|AOD;CHV;CSP;HL7V3.0;MSH;MTH;SNOMEDCT|1|0.058|1
LA|L-arginine|C0003765|||||1|0.0044|
LA|LA;La||||C0023034;C0023117;C0024024;C1420423|HUGO;LNC;NCI|||
LA|LAO;Laos;laos;LAO PEOPLE'S DEMOCRATIC REPUBLIC;Lao People's Democratic Republic|C0023034|||C0023034|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
LA|Lanthanum;lanthanum|C0023031|||||1|0.0153|1
LA|Laos (geographic location)||||C0023034|SNOMEDCT|||
LA|Laparoscopic adrenalectomy;laparoscopic adrenalectomy|C0521267|||C0521267|CHV;SNOMEDCT|1|0.0102|1
LA|Latex agglutination test (procedure)||||C0023117|SNOMEDCT|||
LA|Los Angeles|C0024015|1|0.080|||1|0.0071|1
LA|Louisiana;louisiana;Louisiana (geographic location)|C0024024|1|0.004|C0024024|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
LA|Ludwig angina|C0024081|||||||1
LA|Lyme arthritis|C0242381|||||1|0.0048|
LA|SSB|C1167121;C1420423|||C1420423|HUGO;OMIM|||
LA|Sjogren syndrome antigen B (autoantigen La)||||C1420423|HUGO|||
LA|alpha-lactalbumin|C0002287;C1442889|||||1|0.0082|
LA|alpha-lipoic acid|C0023791|||C0023791|CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT;VANDF|||
LA|anti-SS-B||||||1|0.0037|
LA|antibodies|C0003241|||||1|0.0031|
LA|blood lactate||||||1|0.0231|
LA|blood lactate concentration||||||1|0.0037|
LA|labial|C0023759|||||||1
LA|lactalbumin|C0022912|||C0022912|CHV;CSP;LNC;MSH;NDFRT;SNOMEDCT|||
LA|lactate|C0022924;C0376261|||C0022924;C0202115;C0376261|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
LA|lactate concentration||||||1|0.0153|
LA|lactic acid|C0064582|||C0064582;C0202115|AOD;CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0384|1
LA|lactic acidemia|C0347959;C1855560|||C0347959|CHV;CSP;OMIM;SNOMEDCT|||
LA|lactic acidosis|C0001125|||C0001125|AOD;CHV;CSP;CST;DXP;MSH;MTHICD9;NDFRT;OMIM;SNOMEDCT|1|0.0034|
LA|lactide|C0293984|||C0293984|MSH|||
LA|lambert|C1551092|||||||1
LA|laminin|C0022984|||C0022984|AOD;CHV;CSP;FMA;MSH;MTH;NCI;NDFRT;UWDA|1|0.0037|
LA|language age||||||||1
LA|laparoscopic|C0031150;C0393360|||||1|0.0034|
LA|laparoscopic appendectomy;laparoscopic appendicectomy|C0372525|||C0372525|CHV;ICD9CM;NCI;SNOMEDCT|1|0.0204|1
LA|lard|C0064658|||C0064658;C1420806|CHV;HUGO;MSH;MTH;OMIM;SNOMEDCT|||
LA|large aggregates||||||1|0.0024|
LA|large amount||||||||1
LA|large aspiny||||||1|0.0031|
LA|large surfactant aggregates||||||1|0.0024|
LA|laser ablation|C0348007|||C0348007|CHV;MSH;MTH;SNOMEDCT|1|0.0041|
LA|laser angioplasty|C0078950|||C0078950|CHV;CSP;MSH|||1
LA|late abortion|C0948496|||C0948496|CHV|||1
LA|late antigen||||||1|0.0048|1
LA|lateral|C0205093|||C0205093|CHV;FMA;HL7V2.5;LNC;MTH;NCI;SNOMEDCT;UWDA|1|0.0065|
LA|lateral amygdala||||||1|0.0109|
LA|lateral apical||||||||1
LA|lateral nucleus||||||1|0.0027|
LA|lateral nucleus of the amygdala||||||1|0.0099|
LA|lauric acid|C0023139|||C0023139|AOD;CHV;LCH;MSH;NCI;SNOMEDCT|||
LA|lead acetate|C0064711|||C0064711|CHV;MSH;NDFRT;SNOMEDCT;VANDF|||
LA|left angle||||||||1
LA|left angulation||||||||1
LA|left arm|C0230347;C1268256|||C0230347;C1268256|CHV;FMA;HL7V2.5;SNOMEDCT;UWDA|||1
LA|left atria;left atrium|C0225860;C1269894|||C0225860;C1269894|AOD;CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0805|1
LA|left atrial||1|0.060|||1|0.1647|1
LA|left auricle|C0225861|||C0225861|CHV;FMA;UWDA|||1
LA|leucine aminopeptidase|C0023402|||C0023402;C0202118|CHV;LCH;MSH;MTH;NDFRT;SNOMEDCT|||1
LA|leucoagglutinin;leukoagglutinin|C0312638|||C0312638|SNOMEDCT|1|0.0088|
LA|leukemia antigen||||||||1
LA|leukoagglutinating||||||||1
LA|leukoaraiosis|C0521167;C0948163|||C0948163|MSH;NDFRT|1|0.0082|1
LA|leuprolide acetate|C0700596|||C0700596|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0289|
LA|levator ani|C0224384;C1305037|||C0224384;C1305037|CHV;FMA;NCI;SNOMEDCT;UWDA|||1
LA|levulinic acid|C0023591|||C0023591|AOD;MSH;RXNORM;SNOMEDCT|||
LA|lichen amyloidosis;lichen amyloidosus|C0268397|||C0268397|CHV|||1
LA|light adaptation|C0237452|||||||1
LA|linguoaxial||||||||1
LA|linoleate|C0125894;C0220871|||C0125894;C0220871|CSP;LNC;MSH;MTH;RXNORM|||
LA|linoleic||||||1|0.0115|
LA|linoleic acid|C0023749|||C0023749|AOD;CHV;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.1345|1
LA|lipoatrophy|C0023787;C1280433|||C0023787;C1280433|CHV;CSP;DXP;MTH;SNOMEDCT|||
LA|lithocholic acid|C0023875|||C0023875|MSH;NDFRT;SNOMEDCT|||
LA|lobuloalveolar||||||||1
LA|local anaesthesia;local anesthesia|C0002921;C2930407|||C0002921;C2930407|AOD;CHV;CSP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0292|1
LA|local anaesthetic;local anesthetic|C0002921;C0002934|||C0002921;C0002934|CHV;CSP;NDFRT;SNOMEDCT|1|0.0343|1
LA|localized adherence||||||1|0.0115|
LA|locomotor activity|C0026606|||C0026606|MSH|1|0.0149|
LA|long arm|C0575519|||||||1
LA|long axis|C0522487|||C0522487|LNC;NCI;SNOMEDCT|||
LA|long-acting||1|0.852|||1|0.0034|1
LA|loss of attachment||||||1|0.0041|
LA|low affinity||||||1|0.0027|
LA|low altitude|C0238618|||C0238618|SNOMEDCT|1|0.0031|
LA|low anxiety||||||||1
LA|low-average||||||1|0.0031|
LA|lumen area||||||1|0.0092|
LA|lupus anticoagulant|C0085240;C0311370|||C0085240|CHV;LNC;MSH;NDFRT;SNOMEDCT|1|0.1692|1
LA|lymphadenectomy|C0024203|||C0024203|AOD;CHV;CSP;MSH;NCI;PDQ;SNOMEDCT|1|0.0034|
LA|lymphocyte antibody|C0003369|||||||1
LA|lymphoid aggregates||||||1|0.002|
LDH|(S)-Lactate:NAD+ oxidoreductase||||C0022917|MSH;NDFRT|||
LDH|Dehydrogenase, L-Lactate;L Lactate Dehydrogenase;L lactate dehydrogenase;L-(+)-Lactate Dehydrogenase;L-Lactate Dehydrogenase;L-Lactate dehydrogenase;LACTATE DEHYDROGENASE L;l-lactate dehydrogenase;L-Lactic Acid Dehydrogenase;LD - Lactate dehydrogenase;LDH;LDH - Lactate dehydrogenase;Lactic Acid Dehydrogenase;Lactic acid dehydrogenase;lactic acid dehydrogenase;NAD-Lactate Dehydrogenase|C0022917|||C0022917;C0202113;C0851148|AOD;CHV;CSP;MSH;NCI;NDFRT;SNOMEDCT|||
LDH|Dehydrogenase, Lactate;Lactate Dehydrogenase;Lactate dehydrogenase;dehydrogenase lactate;lactate dehydrogenase;lactate dehydrogenases|C0022917;C1260230|1|1|C0022917;C0202113|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.9584|1
LDH|EC 1.1.1.27||||C0022917|NCI|||
LDH|L-Lactate Dehydrogenase [Chemical/Ingredient]||||C0022917|NDFRT|||
LDH|L-Lactate dehydrogenase (substance)||||C0022917|SNOMEDCT|||
LDH|LD measurement;LDH measurement;ldh measurement;Lactate Dehydrogenase Measurement;Lactate dehydrogenase measurement;Lactate dehydrogenase level;Lactic acid dehydrogenase measurement;lactate dehydrogenase level test|C0202113|||C0202113|CHV;MTH;NCI;SNOMEDCT|||
LDH|Lactate dehydrogenase (substance)||||C0022917|SNOMEDCT|||
LDH|Lactate dehydrogenase measurement (procedure)||||C0202113|SNOMEDCT|||
LDH|Lactatedehydrogenase||||||1|0.0037|
LDH|Lifetime Drinking History;lifetime drinking history|C0851148|||C0851148|AOD;CHV;MTH|||
LDH|Serum lactic dehydrogenase|C1278052|||||1|0.0209|
LDH|dehydrogenase level||||||1|0.0019|
LDH|lactate dehydrogenase activity|C1151154|||||1|0.0054|
LDH|lactate dehydrogenase release||||||1|0.0029|
LDH|layered double hydroxide||||||1|0.0021|
LDH|low-dose heparin||||||1|0.0019|1
LDH|lumbar disc herniation|C0281899|||||1|0.0029|
LDL|Beta-lipoprotein;Lipoprotein.beta;beta Lipoprotein;beta Lipoproteins;beta lipoprotein;beta lipoproteins;beta-Lipoproteins;LDL - Low density lipoprotein;low density lipoprotein (LDL);LDL Lipoproteins;Lipoproteins, LDL;LOW DENSITY LIPOPROTEIN;Lipoproteins, Low-Density;Low Density Lipoprotein;Low Density Lipoproteins;Low density lipoprotein;Low-Density Lipoproteins;low density lipoprotein;low density lipoproteins;low-density lipoprotein;low-density lipoproteins|C0023823|1|1|C0023823;C1325353|AOD;CHV;CSP;CST;FMA;GO;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.9883|1
LDL|LDL;ldls|C0023823;C0428474|||C0023823;C0428474;C1325353|AOD;CHV;CSP;FMA;GO;MEDLINEPLUS;NCI;SNOMEDCT;UWDA|||
LDL|LDL Cholesterol|C0023824;C0428474|||C0428474|NCI|||
LDL|Lipoproteins, LDL [Chemical/Ingredient]||||C0023823|NDFRT|||
LDL|Low density lipoprotein (substance)||||C0023823|SNOMEDCT|||
LDL|Serum LDL Cholesterol;Serum LDL Cholesterol Measurement;Serum LDL cholesterol measurement;Serum LDL cholesterol level|C0428474|||C0428474|MTH;NCI;SNOMEDCT|||
LDL|Serum LDL cholesterol level (procedure)||||C0428474|SNOMEDCT|||
LDL|Serum LDL cholesterol measurement (procedure)||||C0428474|SNOMEDCT|||
LDL|limitation of daily life||||||||1
LDL|loudness discomfort level||||||1|0.0021|1
LDL|low-density lipoprotein activity|C1325353|||C1325353|MTH|||
LDL|low-density lipoprotein cholesterol|C0023824|||||1|0.0097|
LDL|low-density lymphocyte||||||||1
LD|DIAG LABORATORY;LABORATORY DIAG||||C0011911|MSH|||
LD|DKFZP686C2281;FLJ45135;FMN1;FMN1 gene;FORMIN;MGC125288;MGC125289|C1539521|||C1539521|HUGO;MTH;OMIM|||
LD|Diagnoses, Laboratory;Laboratory Diagnoses;Diagnosis, Laboratory;Laboratory Diagnosis;Laboratory diagnosis;laboratory diagnosis|C0011911|||C0011911|CHV;LCH;MSH;MTH;SNOMEDCT|||
LD|Disequilibrium, Linkage;Disequilibriums, Linkage;Linkage Disequilibrium;Linkage Disequilibriums;linkage disequilibrium|C0023746|||C0023746|CHV;CSP;MSH;MTH;NCI|1|0.2263|
LD|EPM2A|C0751783;C1414435|||C1414435|HUGO;OMIM|||
LD|EPM2A GENE;EPM2A gene;LAFORIN;LDE|C1414435|||C1414435|HUGO;LNC;MTH;OMIM|||
LD|FKHL14;MFH-1;MFH1|C1414669;C1705360|||C1705360|NCI|||
LD|FMN|C0016388;C1539521|||C1539521|OMIM|||
LD|FORMIN 1;formin 1;limb deformity protein|C0125393;C1539521|||C1539521|HUGO;OMIM|||
LD|FOXC2 wt Allele;Forkhead Box C2 wt Allele;Mesenchyme Forkhead Gene|C1705360|||C1705360|MTH;NCI|||
LD|L-dopa;levodopa|C0023570|||C0023570|AOD;CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0314|1
LD|LD|C0023746;C1705360|||C0011911;C0023746;C0228342;C1414435;C1539521;C1705360|FMA;HUGO;NCI;OMIM;SNOMEDCT|||
LD|LIMB DEFORMITY, MOUSE, HOMOLOG OF||||C1539521|OMIM|||
LD|Laboratory diagnosis (contextual qualifier)||||C0011911|SNOMEDCT|||
LD|Laboratory diagnosis (contextual qualifier) (qualifier value)||||C0011911|SNOMEDCT|||
LD|Lateral Dorsal Nucleus;Lateral dorsal nucleus;Nucleus, Lateral Dorsal;Lateral Dorsal Thalamic Nucleus;Lateral dorsal thalamic nucleus;Laterodorsal Thalamic Nucleus;Laterodorsal thalamic nucleus;Nucleus, Laterodorsal Thalamic;Thalamic Nucleus, Laterodorsal;Laterodorsal nucleus, superficial part;Nucleus dorsalis lateralis thalami;Nucleus lateralis dorsalis of thalamus;Nucleus lateralis dorsalis thalami;Nucleus lateralis thalami dorsalis;Structure of lateral dorsal nucleus of thalamus;lateral dorsal nucleus (LDN)|C0228342|||C0228342|CHV;FMA;MSH;MTH;SNOMEDCT|||
LD|Lateral dorsal nucleus of thalamus;Nucleus lateralis dorsalis|C0228342;C1761577|||C0228342|FMA;SNOMEDCT|||
LD|Lateral dorsal nucleus of thalamus (body structure)||||C0228342|SNOMEDCT|||
LD|Learning disabilities;learning disabilities;learning disability|C0751265;C1321592|1|0.008|C0751265;C1321592|CHV;CSP;LCH;MEDLINEPLUS;MSH;MTH;OMIM;SNOMEDCT|1|0.114|1
LD|Legionnaires' disease|C0023241|||||1|0.0284|1
LD|Leishman-Donovan||||||||1
LD|Leishmania donovani|C0023273|||||1|0.0038|
LD|Lepidoglyphus destructor|C0446326|||||1|0.0038|
LD|Lombard-Dowell||||||||1
LD|Longissimus dorsi||||||1|0.0129|
LD|Lyme disease|C0024198|||||1|0.0351|
LD|Nucleus dorsalis superficialis (Hassler)||||C0228342|FMA|||
LD|Nucleus lateralis dorsalis (body structure)||||C0228342|SNOMEDCT|||
LD|Structure of lateral dorsal nucleus of thalamus (body structure)||||C0228342|SNOMEDCT|||
LD|epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)||||C1414435|HUGO|||
LD|labor and delivery||||||||1
LD|laboratory data|C1705214|||||||1
LD|labyrinthine defect||||||||1
LD|lactate dehydrogenase|C0022917|1|0.966|C0022917;C0202113|CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.101|1
LD|lamina densa|C0085872;C1167354;C1235665|||C0085872;C1167354;C1235665|FMA;GO;MTH;NCI;UWDA|1|0.0071|
LD|laser Doppler|C0430489|||||1|0.0305|1
LD|last dose||||||||1
LD|lateral dorsal||||||1|0.0046|
LD|laterodorsal||||||1|0.0042|
LD|latissimus dorsi|C0224362;C1305028|||C0224362;C1305028|CHV;FMA;SNOMEDCT;UWDA|1|0.0388|1
LD|latissimus dorsi muscle|C0224362|||||1|0.0046|
LD|learning disabled||||||1|0.0309|1
LD|learning disorder|C0023186|||C0023186|CHV;CSP;MSH;NCI;SNOMEDCT|||1
LD|left deltoid|C0694649|||||||1
LD|lesion depth||||||1|0.0063|
LD|lethal dose|C1443964|||C1443964|SNOMEDCT|1|0.005|1
LD|leukodystrophy|C0023520|||||||1
LD|lichenoid dysplasia||||||||1
LD|lidocaine|C0023660|||C0023660|AOD;CHV;CSP;LNC;MSH;MTH;MTHFDA;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0046|
LD|light|C0023693;C1306462;C1881376|||||1|0.0559|
LD|light difference||||||||1
LD|light differentiation||||||||1
LD|light duty||||||||1
LD|light-dark||||||||1
LD|light-dark cycle|C2718082|||C2718082|MSH|1|0.0205|
LD|limb deformity|C0239337|||||1|0.0092|
LD|limit of detection|C2718050|||C2718050|MSH|1|0.0046|
LD|limited|C0439801|||C0439801|CHV;LNC;SNOMEDCT|1|0.0042|
LD|limited disease||||||||1
LD|limiting dilution||||||1|0.018|
LD|linear dichroism||||||1|0.0263|1
LD|linguodistal||||||||1
LD|lipoatrophic diabetes|C0011859;C0221032;C1720860|||C0011859;C0221032;C1720860|CHV;MSH;OMIM;SNOMEDCT|||
LD|lipodystrophy|C0023787|||C0023787|AOD;CHV;COSTAR;CSP;CST;ICD9CM;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0142|1
LD|lithium diluent||||||||1
LD|lithium discontinuation||||||||1
LD|liver disease|C0023895|||C0023895|CCS;CHV;COSTAR;DXP;MSH;NCI;SNOMEDCT|||1
LD|living donor|C0348050|1|0.002|C0348050|CHV;MSH|1|0.0146|1
LD|loading dose||1|0.002|||1|0.0084|1
LD|local deviation||||||||1
LD|long days||||||1|0.0367|
LD|long dialysis||||||||1
LD|long dwell||||||||1
LD|longissimus|C0224306;C0448358|||||1|0.0042|
LD|longissimus muscle|C0224306|||||1|0.0025|
LD|longitudinal diameter||||||||1
LD|low density||||||1|0.0125|1
LD|low dose;low-dose|C0445550;C1708745|||C0445550;C1708745|CHV;LNC;NCI;SNOMEDCT|1|0.0259|1
LD|lumen diameter||||||1|0.005|
LD|luminance-defined||||||1|0.0038|
LD|lung destruction||||||||1
LD|lymphocyte defined||||||||1
LD|lymphocyte depletion|C0024257|||C0024257|CHV;MSH;SNOMEDCT|||1
LD|lymphocytic depletion||||||1|0.0042|
LD|lymphocytically determined||||||||1
LD|nucleus|C0007610|||||1|0.0042|
LD|patients with limited disease||||||1|0.0163|
LD|photoperiod|C0162811|||||1|0.0038|
LD|under light-dark||||||1|0.0121|
LEEP|LEEP;leep;Loop Electrosurgical Excision Procedure;Loop electrosurgical excision procedure;Loop electrosurgical excision procedure, NOS;loop electrosurgical excision procedure;loop electrosurgical excision procedure (LEEP);loop excision|C0184930|1|1|C0184930|CHV;MTHICD9;NCI;SNOMEDCT|1|1|1
LEEP|Loop Electrosurgical Excision||||C0184930|NCI|||
LEEP|Loop electrosurgical excision procedure (procedure)||||C0184930|SNOMEDCT|||
LEEP|left end-expiratory pressure||||||||1
LE|<=||||C0439090|SNOMEDCT|||
LE|<= (qualifier value)|C1285164|||C0439090|SNOMEDCT|||
LE|Antigen, Le;Antigens, Le;Le Antigen;Le Antigens;BLOOD GROUP--LEWIS SYSTEM;Blood-Group System, Lewis;Lewis Blood Group System;Lewis Blood-Group System;Lewis blood group system;System, Lewis Blood-Group;ISBT system 007;ISBT system LE;L little e NOS Ag;Le NOS AG;Le not otherwise specified AG;Le not otherwise specified Antigen;Lewis System;Lewis system;System, Lewis;Lewis group|C0023595|||C0023595|LCH;LNC;MSH;MTH;NDFRT;OMIM;SNOMEDCT|||
LE|HPS4;HPS4 GENE;HPS4 gene;Hermansky-Pudlak syndrome 4;KIAA1667|C1423767|||C1423767|HUGO;MTH;OMIM|||
LE|HuIFN-alpha||||||1|0.0096|
LE|LB||||C0023190|NCI|||
LE|LBN|C0023190;C1426383|||C0023190|NCI|||
LE|LE;Le|C0439090;C1423767|||C0023190;C0023595;C0439090;C1423767|HUGO;NCI;OMIM|||
LE|LEBANON;Lebanon;lebanon|C0023190|||C0023190|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
LE|Lateral epicondylitis|C0039516|||||1|0.0096|
LE|Le(a) Blood Group System||||C0023595|MSH;NDFRT|||
LE|Lebanon (geographic location)||||C0023190|SNOMEDCT|||
LE|Leonard||||||||1
LE|Less Than or Equal To;Less Than or Equal to;Less than or equal|C0439090|||C0439090|HL7V2.5;HL7V3.0;MTH;NCI|||
LE|Less-than-or-equal symbol <=||||C0439090|SNOMEDCT|||
LE|Less-than-or-equal symbol <= (qualifier value)||||C0439090|SNOMEDCT|||
LE|Lesser Than or Equal To||||C0439090|NCI|||
LE|Leu-enkephalin|C0014294;C1418447|||||1|0.0139|
LE|Leukocyte elastase;leukocyte elastase|C0064833;C1414369|||C0064833;C1414369|CSP;HUGO;MSH;MTH;NDFRT;SNOMEDCT|1|0.0193|
LE|Lewis||||||1|0.0622|1
LE|Lewis Blood-Group System [Chemical/Ingredient]||||C0023595|NDFRT|||
LE|Lewis blood group system (qualifier value)||||C0023595|SNOMEDCT|||
LE|Long Evans;Long-Evans|C2697858|||||1|0.2283|1
LE|Long-Evans rats|C0324537|||||1|0.0193|
LE|Loteprednol etabonate|C0126177|||||1|0.0161|
LE|labelling efficiency||||||1|0.0075|
LE|labor epidural||||||||1
LE|law enforcement|C0162469|||C0162469|AOD;CHV;MSH|||
LE|left ear|C0229299;C1289055|||C0229299;C1289055|CHV;FMA;HL7V2.5;NCI;SNOMEDCT;UWDA|1|0.0064|1
LE|left eye|C0229090|||C0229090|CHV;FMA;HL7V2.5;SNOMEDCT;UWDA|1|0.0129|1
LE|leg exercise|C0454361|||||1|0.0075|
LE|leg extension||||||1|0.0075|
LE|lens epithelial||||||1|0.0064|
LE|lens extraction|C0197689;C0197717|||||||1
LE|leucine enkephalin|C0014294|||||1|0.0182|1
LE|leukocyte esterase|C0125619;C0427760|1|0.690|||1|0.03|1
LE|leukoerythrogenic||||||||1
LE|life events|C0557155|||||1|0.0107|
LE|life expectancy|C0023671|||C0023671|AOD;CHV;CSP;LCH;LNC;MSH|1|0.0332|
LE|liquid-expanded||||||1|0.0107|
LE|live embryo||||||||1
LE|liver extract|C0023899|||||1|0.0107|
LE|local excision|C0278259|||||1|0.0193|1
LE|low-energy||||||1|0.0225|
LE|lower extremity|C0023216|1|0.268|C0023216|AOD;CHV;CST;FMA;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0364|1
LE|luminal epithelial||||||1|0.0064|
LE|luminal epithelium||||||1|0.0332|
LE|lupus erythematosus|C0409974|1|0.006|C0409974|CHV;ICD9CM;LCH;LNC;MTH;NCI;SNOMEDCT|1|0.329|1
LE|lymphedema|C0024236|1|0.006|||1|0.0129|
LE|sinemet-levodopa||1|0.002|||||
LFT|Function Test, Liver;Function Tests, Liver;Liver Function Test;Liver Function Tests;Liver function test;Liver function tests;Liver function tests NOS;Test, Liver Function;Tests, Liver Function;liver function test;liver function tests;test liver function;LFT;LFT's;LFT - Liver function test;Liver Study;liver studies;liver study;Liver funct. test -gen.;liver panel;liver panels;liver test;liver testing;liver tests|C0023901|1|1|C0023901|AOD;CHV;LCH;MSH;MTH;MTHMST;NCI;SNOMEDCT|1|1|1
LFT|Hepatic function panel;function hepatic panel;hepatic function panel|C0023901;C0812554|||C0023901|CHV;SNOMEDCT|||
LFT|Hepatic function panel (procedure)||||C0023901|SNOMEDCT|||
LFT|Liver function tests (& [general]);Liver function tests (& general);Liver function tests - general||||C0023901|SNOMEDCT|||
LFT|Liver function tests (& [general]) (procedure);Liver function tests (& general) (procedure);Liver function tests - general (procedure)||||C0023901|SNOMEDCT|||
LFT|Liver function tests (procedure);Liver function tests NOS (procedure)||||C0023901|SNOMEDCT|||
LFT|lateral femoral torsion||||||||1
LFT|latex fixation test|C0023117|||||||1
LFT|latex flocculation test||||||||1
LFT|left front transverse||||||||1
LFT|localized fibrous tumor|C1266119|||||||1
LFT|low flap transverse||||||||1
LFT|low-frequency tetanic||||||||1
LFT|low-frequency transduction||||||||1
LFT|low-frequency transfer||||||||1
LFT|lung function test|C0024119|||C0024119|AIR;CHV;MSH;NCI|||1
LIMA|Lima;lima|C1047251|||C1047251|CHV;NCBI|||
LIMA|large intestinal mucin antigen||||||1|0.0263|
LIMA|left internal mammary artery|C0447054|1|1.000|||1|0.9737|1
LMP|Date last menstrual period;Date of last menstrual period;date of last menstrual period|C0425932;C0488490|||C0425932|CHV;LNC;MTH;SNOMEDCT|||
LMP|Date of last menstrual period (observable entity)||||C0425932|SNOMEDCT|||
LMP|LMP;lmp;LMP - Last menstrual period;Last Menstrual Period;Last menstrual period;last menstrual period|C0425932|1|1|C0425932|CHV;LNC;NCI;SNOMEDCT|1|0.2586|1
LMP|latent membrane protein||||||1|0.4116|1
LMP|left mentum posterior||||||||1
LMP|low malignant potential||||||1|0.3113|1
LMP|low molecular mass polypeptide||||||1|0.0185|
LMP|lumbar puncture|C0037943;C0553794;C1548878|||||||1
LP|LIVER PANCREAS ANTIGEN;O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE;SEPSECS;SEPSECS gene|C2239920|||C2239920|HUGO;MTH;OMIM|||
LP|LP|C0037943;C0228341;C2239920|||C0037943;C0228341;C2239920|FMA;NCI;OMIM|||
LP|LP - Lumbar puncture|C0037943|||C0037943|SNOMEDCT|||
LP|Lateral Posterior Nucleus;Lateral posterior nucleus;Nucleus, Lateral Posterior;lateral posterior nucleus;Lateral Posterior Thalamic Nucleus;Lateral posterior thalamic nucleus;Laterodorsal nucleus, caudal part;Nucleus lateralis posterior thalami;Nucleus lateralis thalami posterior;Structure of lateral posterior nucleus of thalamus|C0228341|||C0228341|FMA;MSH;SNOMEDCT|1|0.016|
LP|Lateral Posterior Nucleus of the Thalamus;Lateral posterior nucleus of thalamus;Posterior lateral nucleus of thalamus|C0228341;C1761578|||C0228341|FMA;MTH;NCI;SNOMEDCT|||
LP|Lateral posterior nucleus of thalamus (body structure)||||C0228341|SNOMEDCT|||
LP|Legionella pneumophila|C0023238|||||1|0.0124|1
LP|Lipiodol|C0947677|||||1|0.0062|
LP|Lumbar Puncture;Lumbar Punctures;Lumbar puncture;Lumbar puncture, NOS;Puncture, Lumbar;Punctures, Lumbar;lumbar puncture;lumbar punctures|C0037943;C0553794;C1548878|1|0.978|C0037943;C0553794;C1548878|AOD;CHV;CSP;HL7V2.5;MSH;NCI;SNOMEDCT|1|0.0741|1
LP|Lumbar puncture (procedure)||||C0037943|SNOMEDCT|||
LP|Lumboperitoneal;lumboperitoneal||||||1|0.0108|1
LP|Lymphocyte proliferation;lymphocyte proliferation|C0596873|||C0596873|CHV;CSP;GO;LNC|1|0.017|
LP|Nucleus dorsocaudalis (Hassler)||||C0228341|FMA|||
LP|Nucleus lateralis posterior;nucleus lateralis posterior||||C0228341|FMA;SNOMEDCT|1|0.0067|
LP|Nucleus lateralis posterior (body structure)||||C0228341|SNOMEDCT|||
LP|Puncture, Spinal;Punctures, Spinal;Spinal Puncture;Spinal Punctures;Spinal puncture;spinal puncture;Rachicentesis;Spinal Tap;Spinal Taps;Spinal tap;Tap, Spinal;Taps, Spinal;spinal tap;spinal tapping;spinal taps|C0037943;C0553794|||C0037943|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|||
LP|SLA|C1420083;C2239920|||C2239920|HUGO;OMIM|||
LP|SLA/LP||||C2239920|HUGO|||
LP|SOLUBLE LIVER ANTIGEN|C0142996;C2239920|||C2239920|OMIM|||
LP|Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase||||C2239920|HUGO|||
LP|Spinal puncture and aspiration||||C0037943|SNOMEDCT|||
LP|Spinal tap (procedure)||||C0037943|SNOMEDCT|||
LP|Spinal tap (procedure) [Ambiguous]||||C0037943|SNOMEDCT|||
LP|Structure of lateral posterior nucleus of thalamus (body structure)||||C0228341|SNOMEDCT|||
LP|coefficient|C1707429|||||1|0.0072|
LP|diagnostic spinal tap||||C0037943|CHV|||
LP|hydraulic conductance||||||1|0.0118|
LP|hydraulic conductivity||||||1|0.0726|
LP|hydraulic permeability||||||1|0.0149|
LP|insulin lispro;lispro|C0293359|||C0293359|CHV;MSH;NDFRT|1|0.0051|
LP|labile peptide||||||||1
LP|labile protein||||||||1
LP|laboratory procedure|C0022885|||||||1
LP|lactic peroxidase||||||||1
LP|lactoperoxidase|C0022948;C1416903|||C0022948;C1416903|CHV;CSP;HUGO;MSH;MTH;NDFRT;OMIM|1|0.0154|
LP|lamina propria|C1179187|||C1179187|CHV;FMA;MSH;NCI;UWDA|1|0.0715|1
LP|large-plaque||||||1|0.0098|
LP|laryngopharyngeal|C0020629;C0023079|||||||1
LP|late potentials||||||1|0.0592|
LP|late proximal||||||1|0.0051|
LP|latency period|C0023103|||||1|0.0036|1
LP|latent period||||||1|0.0072|1
LP|lateral plantar||||||||1
LP|lateral posterior||||||1|0.0108|
LP|lateral prostate||||||1|0.0077|
LP|lateral pyloric||||||1|0.0237|
LP|lateral pylorus||||||||1
LP|lateralis posterior||||||||1
LP|lateroposterior thalamic nucleus||||||1|0.0026|
LP|latex particle|C0524643|||||||1
LP|leading pole||||||||1
LP|leg press||||||1|0.0057|
LP|legionella pneumonia|C0023241|||||1|0.0026|
LP|leukapheresis|C0023416|||C0023416|AOD;CHV;CSP;LCH;MSH;NCI;PDQ|1|0.0046|
LP|leukapheresis products||||||1|0.0057|
LP|leukocyte poor||||||||1
LP|leukocytic pyrogen||||||1|0.0196|1
LP|levator palati|C0448313|||||||1
LP|levator palpebrae||||||||1
LP|licensed practitioner||1|0.018|||||
LP|lichen planus|C0023646|||C0023646|AOD;CHV;COSTAR;CSP;DXP;ICD9CM;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.1009|1
LP|ligamentum patellae|C0206332;C1305920|||||||1
LP|light peak||||||1|0.0046|
LP|light perception||||||1|0.0077|1
LP|lightly padded||||||||1
LP|linear prediction||||||1|0.0057|1
LP|linear programming|C0033349|||||1|0.0087|1
LP|lingua plicata|C0040412|||||||1
LP|linguopulpal||||||||1
LP|link protein|C0065011|||C0065011|CHV;CSP;MSH;MTH|1|0.0144|
LP|lipid panel|C0200382|||||||1
LP|lipid peroxidation|C0023775|||C0023775|CHV;MSH;NCI;SNOMEDCT|1|0.1338|
LP|lipid peroxide;lipid peroxides|C0023776|||C0023776|CHV;CSP|1|0.019|
LP|lipophorin|C0065050;C1153627|||||1|0.0057|
LP|lipoprotein;lipoproteins|C0023820|||C0023820|CHV;FMA;LNC;MSH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.0345|1
LP|lipoprotein particles||||||1|0.0026|
LP|liver plasma||||||||1
LP|liver-pancreas|C1442317|||||||1
LP|long photoperiod||||||1|0.0082|
LP|loop-tail||||||1|0.0154|
LP|lost privileges||||||||1
LP|low passage||||||1|0.0026|
LP|low potency||||||||1
LP|low power||||||||1
LP|low pressure;low-pressure||||||1|0.0046|1
LP|low protein;low-protein|C0242972;C0748025|||C0242972;C0748025|CHV;HL7V3.0|1|0.0412|1
LP|low protein diet;low-protein diet|C0242972|||C0242972|CHV;MSH|1|0.0036|
LP|lung parenchyma|C0819757;C1279455|||||||1
LP|lung perfusion||||||||1
LP|luteal phase|C0024153|||C0024153|CHV;CSP;GO;LCH;MSH;MTH|1|0.0108|
LP|lymphocyte predominance||||||1|0.0098|
LP|lymphocyte predominant||||||1|0.0072|1
LP|lymphocyte proliferative||||||1|0.0031|
LP|lymphocytic predominance||||||1|0.0057|
LP|lymphoid plasma||||||||1
LP|lymphoid predominance||||||||1
LP|lymphomatoid papulosis|C0206182|||C0206182|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0082|1
LP|lymphomatous polyposis||||||||1
LP|lymphoproliferation||||||1|0.0046|
LP|lymphoproliferative||||||1|0.0103|
LP|lysylpyridinoline|C0057455|||C0057455|MSH|||
LP|serum lipoprotein||||||1|0.0067|
LP|soluble liver antigen/liver pancreas antigen||||C2239920|HUGO|||
LP|water permeability||||||1|0.0108|
LVAD|left ventricular assist device|C0181598|1|1.000|C0181598|CHV;NCI;SNOMEDCT|1|1|1
LVEF|left ventricular ejection fraction|C0428772;C0488728|1|1.000|C0428772;C0488728|LNC;MTH;SNOMEDCT|1|0.9964|1
LVEF|left ventricular function|C0080310|||||1|0.0036|
LVH|Hypertrophies, Left Ventricular;Hypertrophy, Left Ventricular;LEFT VENTRICULAR HYPERTROPHY;Left Ventricular Hypertrophies;Left Ventricular Hypertrophy;Left ventricular hypertrophy;VENTRICULAR HYPERTROPHY, LEFT;Ventricular Hypertrophies, Left;Ventricular Hypertrophy, Left;Ventricular hypertrophy (& [left]);hypertrophy left ventricular;left ventricular hypertrophy|C0149721;C0232306|1|0.994|C0149721;C0232306|CHV;COSTAR;DXP;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|1|1
LVH|Hypertrophy, Left Ventricular [Disease/Finding]||||C0149721|NDFRT|||
LVH|LV hypertrophy;lv hypertrophy;LV+ - Left ventricular hypertrophy;LVH;lvh;LVH - Left ventricular hypertrophy;left ventricular enlargement|C0149721|||C0149721|CHV;DXP;SNOMEDCT|||
LVH|Left ventricular hypertrophy (disorder);Ventricular hypertrophy (& [left]) (disorder)||||C0149721|SNOMEDCT|||
LVH|large vessel hematocrit||||||||1
LV|5-fluorouracil (5-FU)/leucovorin||||||1|0.0013|
LV|CF||||C0731033|PDQ|||
LV|CFR|C0731033;C1305363;C1515366|||C0731033|PDQ|||
LV|Calcium (6S)-Folinate||||C0731033|NCI;PDQ|||
LV|Calcium Folinate;Calcium folinate;Folinate Calcium;Folinate, Calcium;calcium folinate;folinate calcium;Calcium Leucovorin;Calcium leucovorin;LEUCOVORIN CALCIUM;Leucovorin Calcium;Leucovorin calcium;Leucovorin, Calcium;calcium leucovorin;leucovorin calcium;Calcium leucovorin preparation;Leucovorin calcium preparation;Citrovorum factor preparation;Folinic Acid Calcium Salt Pentahydrate;L-CF;Levofolinate calcium|C0731033|||C0731033|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
LV|Calcium leucovorin (substance)||||C0731033|SNOMEDCT|||
LV|Calcium leucovorin preparation (product)||||C0731033|SNOMEDCT|||
LV|Calcium leucovorin preparation (substance)||||C0731033|SNOMEDCT|||
LV|Citrovorum Factor;Citrovorum factor;Factor, Citrovorum;citrovorum factor|C0023413;C0731033|||C0731033|CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
LV|Citrovorum Factor [Chemical/Ingredient]||||C0731033|NDFRT|||
LV|LATVIA;Latvia;latvia;LVA|C0023128|||C0023128|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
LV|LG||||C0023128|NCI|||
LV|LV|C0023128;C0731033;C1881413|||C0023128;C0731033;C1881413|NCI;PDQ|||
LV|Lactobacillus viridescens|C0317606|||||||1
LV|Lassa Virus|C0023093|||||1|0.0009|
LV|Latvia (geographic location)||||C0023128|SNOMEDCT|||
LV|Lelystad virus|C0376535|||||1|0.0023|
LV|Liposome Vesicle;Multilamellar Liposome Vesicles;Small Unilamellar Vesicles|C1881413|||C1881413|MTH;NCI|||
LV|Lupus vulgaris|C0024131|||||1|0.0009|
LV|MLV|C0026398;C0026626;C1881413|||C1881413|NCI|||
LV|SUV|C1881413;C2348529|||C1881413|NCI|||
LV|lactoovovegetarian||||||||1
LV|laryngeal vestibule|C0225564|||C0225564|FMA;MTH;SNOMEDCT;UWDA|||1
LV|lateral ventricle|C0152279;C1268982|||C0152279;C1268982|CHV;CSP;FMA;MSH;NCI;SNOMEDCT|||1
LV|lecithovitellin|C0604480|||C0604480|MSH|||
LV|left ventricle|C0225897;C1269892|1|1.000|C0225897;C1269892|AOD;CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.119|1
LV|left ventricular||||||1|0.8664|1
LV|left ventricular free wall||||||1|0.0005|
LV|left ventricule||||||1|0.001|
LV|length density||||||1|0.0016|
LV|leucovorin|C0023413|||C0023413|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
LV|leukemia virus|C0596828|||C0596828|AOD;CHV;CSP|||1
LV|leukocytoclastic vasculitis|C0151436;C2973529|||||1|0.0011|
LV|lipovitellin|C0065069|||||1|0.0013|
LV|liquid ventilation|C0419019|||||1|0.0013|1
LV|live vaccine|C0042211|||C0042211|CHV;CSP|||1
LV|live virus||||||||1
LV|low vertical||||||||1
LV|low volume||||||||1
LV|lumbar vertebra|C0024091;C1269051|||C0024091;C1269051|CHV;FMA;NCI;SNOMEDCT;UWDA|||1
LV|lung ventilation|C0554804|||||1|0.0007|
LV|lung volume|C0231953|||C0231953|CHV;CSP;SNOMEDCT|1|0.0017|1
M0|M0;M0 Cancer Stage Finding;M0 Distant Metastasis Finding;M0 Distant Metastasis Stage Finding;M0 Metastasis Finding;M0 Metastasis Stage;Metastasis Stage M0;Metastasis stage M0;M0 Stage;M0 stage;M0 Stage Finding;M0 stage (finding);M0 TNM Finding;M0 category|C0445034|||C0445034|NCI;SNOMEDCT|||
M0|M0 category (finding)||||C0445034|SNOMEDCT|||
M0|M0 stage (tumor staging)||||C0445034|SNOMEDCT|||
M0|Metastasis stage M0 (tumor staging)||||C0445034|SNOMEDCT|||
M0|acute myeloid leukemia with minimal differentiation|C0522631|1|0.002|||||
M0|distant metastases||||||1|1|
M0|no evidence of distant metastases||1|0.998|||||1
MAI|GLUTATHIONE S-TRANSFERASE Z1;GLUTATHIONE S-TRANSFERASE, ZETA-1;GSTZ1;GSTZ1 gene;GSTZ1-1;MAAI;glutathione transferase zeta 1|C1415341|||C1415341|HUGO;MTH;OMIM|||
MAI|MAC (Mycobacterium avium Complex);Mycobacterium avium complex (MAC);mycobacterium avium complex (MAC);MYCOBACTERIUM AVIUM COMPLEX;Mycobacterium avium Complex;Mycobacterium avium complex;mycobacterium avium complex|C0026914;C0026916|||C0026914|CHV;CSP;LNC;MSH;MTH;NCBI;NCI;SNOMEDCT|||
MAI|MAC complex;MAIC;maic;MAIS complex;Mycobacterium avium-intracellulare Complex;Mycobacterium avium-intracellulare complex;Mycobacterium, MAIS group|C0026914|||C0026914|CHV;MSH;SNOMEDCT|1|0.0352|
MAI|MAI;mai|C0026914;C1415341|||C0026914;C1415341|CHV;HUGO|||
MAI|MALEYLACETOACETATE ISOMERASE;maleylacetoacetate isomerase|C0065576;C1415341|||C1415341|HUGO;OMIM|||
MAI|MYCOBACT AVIUM COMPLEX||||C0026914|MSH|||
MAI|MYCOBACT AVIUM INTRACELLULARE||||C0026914|MSH|||
MAI|MYCOBACT AVIUM INTRACELLULARE COMPLEX||||C0026914|MSH|||
MAI|Marriage Adjustment Inventory||||||||1
MAI|Medication Appropriateness Index||||||||1
MAI|Movement Assessment of Infants||||||1|0.0603|1
MAI|Multidimensional Anger Inventory||||||1|0.0402|
MAI|Mycobacterium avium-intracellulare|C0026914;C2718284|1|1.000|C0026914|MSH|1|0.5829|1
MAI|mac||||C0026914|CHV|||
MAI|magnetic-assisted intervention||||||||1
MAI|maximal aggregation index||||||||1
MAI|microscopic aggregation index||||||||1
MAI|milliampere impulse||||||||1
MAI|minor acute illness||||||||1
MAI|mitotic activity index||||||1|0.2814|1
MAI|morbid anxiety inventory||||||||1
MAI|movement arousal index||||||||1
MAPS|MAP;MAPs;Map;Maps;map;maps|C0024779;C0026045;C1706473|||C0024779;C0026045|AOD;CHV;CSP;FMA;LCH;MSH;MTH;NCI;UWDA|||
MAPS|MICROTUBULE ASSOC PROTEINS||||C0026045|MSH|||
MAPS|Make A Picture Story||||||||1
MAPS|Making Action Plans||||||||1
MAPS|Microtubule Associated Protein;Microtubule Associated Proteins;Microtubule-Associated Proteins;Microtubule-associated protein;microtubule associated protein;microtubule-associated proteins;microtubule-associated proteins (MAP)|C0026045|||C0026045|CHV;CSP;FMA;MSH;MTH;NCI;NDFRT;UWDA|1|0.7491|
MAPS|Microtubule-Associated Proteins [Chemical/Ingredient]||||C0026045|NDFRT|||
MAPS|Multidimensional Affect and Pain Survey||||||1|0.0174|
MAPS|Multiple antigen peptides||||||1|0.0244|
MAPS|mean arterial pressures||||||1|0.0226|
MAPS|medical advanced pain specialists||1|1.000|||||
MAPS|monophasic action potentials||||||1|0.1638|
MAPS|multiple antigenic peptides||||||1|0.0226|
MCA|1,2-Dihydro-3-methyl-benz(j)aceanthrylene||||C0000325|NCI|||
MCA|20 Methylcholanthrene;20-Methylcholanthrene;20-methylcholanthrene|C0000325|||C0000325|MSH;MTH;NCI|1|0.0043|
MCA|3-methylcholanthrene|C0000431|||||1|0.0509|
MCA|Arteria cerebri media;Structure of middle cerebral artery;Sylvian artery|C0149566|||C0149566|FMA;MTH;SNOMEDCT;UWDA|||
MCA|Arteries, Middle Cerebral;Artery, Middle Cerebral;Cerebral Arteries, Middle;Cerebral Artery, Middle;Cerebral artery middle;Middle Cerebral Arteries;Middle Cerebral Artery;Middle cerebral artery;Middle cerebral artery, NOS;artery cerebral middle;middle cerebral artery|C0149566;C1269012|1|1|C0149566;C1269012|CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.7959|1
MCA|MCA|C0000325;C0149566|||C0000325;C0149566|NCI|||
MCA|Metabolic control analysis||||||1|0.0092|
MCA|Methylcholanthrene;methylcholanthrene|C0000325;C0025732|||C0000325;C0025732|CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0151|1
MCA|Multiple Correspondence Analysis||||||1|0.0049|
MCA|Structure of middle cerebral artery (body structure)||||C0149566|SNOMEDCT|||
MCA|carcinoma associated antigen||||||1|0.0043|
MCA|main coronary artery||||||||1
MCA|major coronary artery||||||||1
MCA|mammary carcinoma|C0678222|||C0678222|NCI|1|0.0033|
MCA|medical care administration||||||||1
MCA|mesial contact area||||||||1
MCA|metacarpal amputation|C1384684|||||||1
MCA|methylcyanoacrylate|C0066180|||C0066180|MSH|||
MCA|metoclopramide|C0025853|||||1|0.0049|
MCA|microcarcinoma||||||||1
MCA|microcytotoxicity assay||||||1|0.0023|
MCA|micrometastases clonogenic assay||||||||1
MCA|middle cerebral||||||1|0.0141|
MCA|middle cerebral aneurysm||||||||1
MCA|middle cerebral arterial||||||1|0.0039|
MCA|middle colic artery|C0226328;C1280137|||||||1
MCA|minimal cross-sectional area||||||1|0.0062|
MCA|monocarboxylic acid||||||||1
MCA|monochloroacetate|C2708021|||C2708021|LNC|1|0.0039|
MCA|monochloroacetic acid|C0008225|||C0008225|CHV;MSH;NDFRT;SNOMEDCT;VANDF|1|0.0069|
MCA|monoclonal antibodies;monoclonal antibody|C0003250|||C0003250|CHV;CSP;NCI;SNOMEDCT|1|0.0424|
MCA|monocyte chemotactic activity||||||1|0.0043|
MCA|motorcycle accident|C0574035|||C0574035|CHV;SNOMEDCT|||1
MCA|mucin-like carcinoma-associated antigen||||||1|0.0108|
MCA|mucinlike carcinoma-associated antigen||||||||1
MCA|multichannel analyzer||||||||1
MCA|multiple congenital abnormalities||||||||1
MCA|multiple congenital anomalies;multiple congenital anomaly|C0000772|||C0000772|CHV;CST;ICPC;MTH;SNOMEDCT|1|0.0122|1
MCH|Ery. Mean Corpuscular Hemoglobin|C2344229;C0369183;C1261502|||C0369183|NCI|||
MCH|Erythrocyte Mean Corpuscular Hemoglobin;MCH - Mean corpuscular haemoglobin;MCH - Mean corpuscular hemoglobin;Mean corpuscular haemoglobin (MCH) - NOS;Mean corpuscular hemoglobin (MCH) - NOS;Mean corpuscular haemoglobin NOS;Mean corpuscular hemoglobin NOS;mean corpuscular hemoglobin|C0369183;C1261502|1|1|C0369183;C1261502|AOD;CHV;MSH;NCI;SNOMEDCT|||1
MCH|Erythrocyte Mean Corpuscular Hemoglobin Test;MCH - Mean cell haemoglobin;MCH - Mean cell hemoglobin;MCH determination;Mean corpuscular haemoglobin determination;Mean corpuscular hemoglobin determination|C0369183|||C0369183|MTH;SNOMEDCT|||
MCH|MCH;MCH - NOS;mch|C0369183;C1418669;C2248810|||C0369183;C1418669;C2248810|GO;HUGO;NCI;OMIM;SNOMEDCT|||
MCH|MCH - NOS (procedure)||||C0369183|SNOMEDCT|||
MCH|MELANIN-CONCENTRATING HORMONE;Melanin-concentrating hormone;melanin-concentrating hormone|C0065898;C1418669|||C1418669|OMIM|1|0.3767|1
MCH|Maternal and Child Health;maternal and child health||||||1|0.1947|1
MCH|Mean cell haemoglobin;Mean cell hemoglobin;mean cell haemoglobin;mean cell hemoglobin||||C0369183|CHV;SNOMEDCT|||1
MCH|Mean cell haemoglobin (& level);Mean cell hemoglobin (& level)|C1261502|||C0369183|SNOMEDCT|||
MCH|Mean cell haemoglobin (& level) (procedure)||||C0369183|SNOMEDCT|||
MCH|Mean corpuscular haemoglobin (MCH) - NOS (procedure)||||C0369183|SNOMEDCT|||
MCH|Mean corpuscular hemoglobin NOS (procedure)||||C0369183|SNOMEDCT|||
MCH|Mean corpuscular hemoglobin determination (procedure)||||C0369183|SNOMEDCT|||
MCH|PMCH;PMCH gene|C1418669|||C1418669|HUGO;MTH;OMIM|||
MCH|PRO-MELANIN-CONCENTRATING HORMONE;pro-melanin-concentrating hormone|C0526383;C1418669|||C1418669|HUGO;OMIM|||
MCH|acetyl-beta-methylcholine|C0524770|||||1|0.0127|
MCH|beta-methylmalyl-CoA dehydratase activity;mesaconyl-CoA hydratase activity;mesaconyl-coenzyme A hydratase activity|C2248810|||C2248810|GO;MTH|||
MCH|intrafemoral artery infusions of the endothelium-dependent vasodilator methacholine chloride||||||1|0.0058|
MCH|mean corpuscular Hb||||||1|0.0104|
MCH|mean corpuscular hemoglobin (MCH) test||||C0369183|CHV|||
MCH|methacholine|C0600370|||||1|0.3894|1
MCH|microfibrillar collagen hemostat|C1289976|||||||1
MCH|mucous cell hyperplasia||||||||1
MCH|muscle contraction headache|C0393736|||||1|0.0104|1
MCP|1-methylcyclopropene|C0960343|||||1|0.0171|
MCP|4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide||||C0025853|MSH;NDFRT|||
MCP|ANTIGEN DEFINED BY MONOCLONAL ANTIBODY TRA-2-10||||C1824669|OMIM|||
MCP|ANTIGENS CD 046;CD 046 ANTIGENS||||C0285488|MSH|||
MCP|Antigen, CD46;Antigens, CD46;CD46 Antigen;CD46 Antigens;cd46 antigen;Common Antigen, Trophoblast-Leukocyte;Trophoblast Leukocyte Common Antigen;Trophoblast leucocyte common antigen;Trophoblast leukocyte common antigen;Trophoblast-Leukocyte Common Antigen;Gp45-70;Lymphocyte antigen CD46|C0285488|||C0285488|CHV;MSH;MTH;NDFRT;SNOMEDCT|||
MCP|Antigens, CD46 [Chemical/Ingredient]||||C0285488|NDFRT|||
MCP|Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-||||C0025853|MSH;NDFRT|||
MCP|CAPG|C1413108;C1826382|||C1413108|HUGO;OMIM|||
MCP|CAPG gene;CAPPING PROTEIN, GELSOLIN-LIKE;MACROPHAGE CAPPING PROTEIN;macrophage capping protein|C1413108|||C1413108|HUGO;MTH;OMIM|||
MCP|CD46||||C0285488;C1824669|CSP;HUGO;LNC;OMIM;SNOMEDCT|||
MCP|CD46 - Cluster of differentiation antigen 46||||C0285488|SNOMEDCT|||
MCP|CD46 gene;COMPLEMENT MEMBRANE COFACTOR PROTEIN;MGC26544;MIC10;TRA2.10;TROPHOBLAST-LYMPHOCYTE CROSS-REACTIVE ANTIGEN|C1824669|||C1824669|HUGO;MTH;OMIM|||
MCP|CD46 molecule complement regulatory protein;CD46 molecule, complement regulatory protein||||C0285488;C1824669|HUGO;SNOMEDCT|||
MCP|Cluster of differentiation antigen 46||||C0285488|SNOMEDCT|||
MCP|Lymphocyte antigen CD46 (substance)||||C0285488|SNOMEDCT|||
MCP|MCP||||C0025853;C0285488;C1150292;C1413108;C1824669|GO;HUGO;OMIM;PDQ;SNOMEDCT|||
MCP|MCP - Membrane cofactor protein;membrane cofactor protein (MCP);MEMBRANE COFACTOR PROTEIN;Membrane Cofactor Protein;Membrane cofactor protein;membrane cofactor protein|C0285488;C1824669|||C0285488;C1824669|CHV;MSH;NDFRT;OMIM;SNOMEDCT|||1
MCP|METOCLOPRAMIDE;Metaclopramide;Metoclopramide;metaclopramide;metoclopramide;Metaclopromide;metaclopromide|C0025853|||C0025853|AOD;CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.3251|
MCP|Membrane cofactor protein (substance)||||C0285488|SNOMEDCT|||
MCP|Metoclopramide (product)||||C0025853|SNOMEDCT|||
MCP|Metoclopramide (substance)||||C0025853|SNOMEDCT|||
MCP|Metoclopramide -RETIRED-||||C0025853|SNOMEDCT|||
MCP|Metoclopramide [Chemical/Ingredient]||||C0025853|NDFRT|||
MCP|Metoclopramide(motility) [see chapter d for preparations]||||C0025853|SNOMEDCT|||
MCP|Metoclopramide(motility) [see chapter d for preparations] (product)||||C0025853|SNOMEDCT|||
MCP|Metoclopramide(motility) [see chapter d for preparations] (substance)||||C0025853|SNOMEDCT|||
MCP|TLX|C1417831;C1824669|||C1824669|HUGO;OMIM|||
MCP|TLX - Trophoblast leucocyte common antigen;TLX - Trophoblast leukocyte common antigen||||C0285488|SNOMEDCT|||
MCP|calcium phosphate|C0006711;C0006712;C1161320|||||1|0.0114|
MCP|capping protein (actin filament), gelsolin-like||||C1413108|HUGO|||
MCP|maximum closure pressure||||||||1
MCP|maximum contraction pattern||||||||1
MCP|mean carotid pressure||||||||1
MCP|mean circulatory pressure||||||1|0.0209|
MCP|medial coronoid process||||||1|0.0114|
MCP|melanocortin receptor|C0254370|||C0254370|MSH;MTH;NDFRT|||
MCP|melanosis circumscripta precancerosa||||||||1
MCP|metacarpophalangeal||1|1.000|||1|0.4163|1
MCP|methyl-accepting chemotaxis protein||||||||1
MCP|methylclofenapate|C0008998|||||1|0.038|
MCP|methylenecyclopropane|C1699480|||C1699480|MSH|||
MCP|microchannel plate||||||1|0.0114|
MCP|mitotic control protein||||||||1
MCP|monocrotophos|C0026472|||||1|0.0247|
MCP|monocyte chemoattractant protein;monocyte chemotactic protein|C0282566|||C0282566|CHV|||1
MCP|mucin clot prevention||||||||1
MCP|mucopolysaccharidoses|C0026703|||||||1
MCP|mucosal carrier protein||||||||1
MCP|multicatalytic protease||||||1|0.0171|
MCP|multicatalytic proteinase|C0208355;C2258865|||||1|0.0665|
MCP|multifocal choroiditis and panuveitis;multifocal choroiditis with panuveitis||||||1|0.0133|1
MCP|proteins|C0033684|||||1|0.0266|
MCP|threonine endopeptidase activity;threonine-type endopeptidase activity|C1150292|||C1150292|GO;MTH|||
MCV|CDDP/MTX/VBL||||C0285131|NCI;PDQ|||
MCV|CMV||||C0285131|CHV;NCI;PDQ|||
MCV|CMV chemotherapy protocol;MEC Protocol 1;MEC protocol 1;cisplatin/methotrexate/vinblastine protocol|C0285131|||C0285131|CHV;MSH;MTH;NCI|||
MCV|Cell Volumes, Mean;Mean Cell Volume;Mean Cell Volumes;Mean cell volume;Volume, Mean Cell;Volumes, Mean Cell;mean cell volume|C0524587;C0863148|||C0524587;C0863148|CHV;MSH;SNOMEDCT|1|0.1771|1
MCV|Cisplatin/Methotrexate/Vinblastine;cisplatin/methotrexate/vinblastine||||C0285131|NCI;PDQ|||
MCV|Corpuscular Volumes, Mean;Mean Corpuscular Volume;Mean Corpuscular Volumes;Volume, Mean Corpuscular;Volumes, Mean Corpuscular;corpuscular mean volume;mean corpuscular volume;mean corpuscular volume (MCV)|C0524587;C0863148;C1948043|1|1|C0524587;C0863148;C1948043|AOD;CHV;MSH|1|0.6325|1
MCV|Ery. Mean Corpuscular Volume|C2344229;C0524587;C0863148;C1948043|||C1948043|NCI|||
MCV|Erythrocyte Mean Corpuscular Volume;Erythrocyte mean corpuscular volume|C0524587;C1948043|||C0524587;C1948043|LNC;NCI;SNOMEDCT|||
MCV|Erythrocyte Mean Corpuscular Volume Measurement|C1948043|||C1948043|MTH|||
MCV|Erythrocyte Volume, Mean Cell;Finding of mean cell volume;Mean cell volume - finding;MCV;MCV - NOS;McV;mcV;mcv;Mean Corpuscular Volume (result)|C0524587|||C0285131;C0524587;C1948043;C1961129;C2304881|AOD;CHV;MSH;MTH;NCI;PDQ;SNOMEDCT|||
MCV|Erythrocyte mean corpuscular volume (observable entity)||||C0524587|SNOMEDCT|||
MCV|Finding of mean cell volume (finding)||||C0524587|SNOMEDCT|||
MCV|MCPyV;Merkel Cell Polyomavirus;Merkel cell polyomavirus;Merkel cell polyomaviruses;polyomavirus, Merkel cell;polyomaviruses, Merkel cell|C2304881|||C2304881|MSH;MTH;NCBI;NCI|||
MCV|MCV - NOS (finding)||||C0524587|SNOMEDCT|||
MCV|Microvolt|C1961129|||C1961129|MTH;NCI;SNOMEDCT|||
MCV|Microvolt (qualifier value)||||C1961129|SNOMEDCT|||
MCV|Middle cardiac vein;middle cardiac vein|C0226660;C1280940|||C0226660;C1280940|FMA;NCI;SNOMEDCT;UWDA|1|0.0157|
MCV|conduction velocities|C0234084|||||1|0.0157|
MCV|mean clinical value||||||||1
MCV|measles-containing vaccine||||||1|0.012|1
MCV|melanoma cell vaccine||||||1|0.012|
MCV|melanoma whole-cell vaccine||||||||1
MCV|molluscum contagiosum virus|C0026394|||C0026394|CSP;MSH;MTH;NCBI;SNOMEDCT|1|0.0723|1
MCV|motor conduction velocity||||||||1
MCV|motor nerve conduction velocity|C0457379|||C0457379|CHV;SNOMEDCT|1|0.0627|
MCV|myelocytomatosis virus||||||||1
MCV|uV|C0041625;C1961129|||C1961129|NCI|||
MDI|BIPOLAR AFFECTIVE DISORDER|C0005586|||C1839839|OMIM|||
MDI|BPAD||||C1839839|OMIM|||
MDI|MAFD2;MAJOR AFFECTIVE DISORDER 2|C1416966;C1839839|||C1839839|MTH;OMIM|||
MDI|MANIC-DEPRESSIVE ILLNESS;manic-depressive illness|C0005586;C1839839|||C0005586;C1839839|CHV;MEDLINEPLUS;OMIM;SNOMEDCT|1|0.0346|1
MDI|MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED;MDX|C1839839|||C1839839|OMIM|||
MDI|MDI|C1839839;C2984065|||C1839839;C2984065|NCI;OMIM|||
MDI|Major Depression Inventory||||||1|0.0159|
MDI|Mental Development Index;mental development index|C2825548|||||1|0.0749|1
MDI|Mental Developmental Index||||||1|0.0634|
MDI|Metered Dose Inhaler Dosage Form|C2984065|||C2984065|NCI|||
MDI|Metered Dose Inhaler Dose Form|C0993596;C2984065|||C2984065|NCI|||
MDI|Michelson Doppler imager||||||||1
MDI|Multiscore Depression Inventory||||||||1
MDI|diphenylmethane diisocyanate;methylene diphenyl diisocyanate|C0047822|||||1|0.0591|1
MDI|diphenylmethane-4,4'-diisocyanate||||||1|0.0231|
MDI|isocyanate|C0162344|||||1|0.0144|
MDI|metered dose inhaler;metered-dose inhaler|C0418991;C0993596|1|1|C0418991;C0993596|CHV;HL7V3.0;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|1|0.6585|1
MDI|methylenedioxyindenes||||||||1
MDI|modulation detection interference||||||1|0.0159|
MDI|multidirectional instability||||||||1
MDI|multiple daily injection;multiple daily injections||||||1|0.0403|1
MDI|multiple dose injection||||||||1
MD|Doctor of Medicine;M.D.|C1512018|||C1512018|HL7V2.5;MTH;NCI|||
MD|Dorsal Medial Nucleus;Medial Dorsal Nucleus;Medial dorsal nucleus;Nucleus, Dorsal Medial;Nucleus, Medial Dorsal;medial dorsal nucleus;Dorsomedial Nucleus of the Thalamus;Dorsomedial nucleus of thalamus|C0228329;C1284630|||C0228329|CHV;FMA;MSH;MTH;NCI;SNOMEDCT|||
MD|Dorsal medial nucleus of thalamus;Medial dorsal nucleus of thalamus;Dorsomedial Nucleus;Dorsomedial nucleus;Nucleus, Dorsomedial;Dorsomedial Thalamic Nucleus;Nucleus, Dorsomedial Thalamic;Thalamic Nucleus, Dorsomedial;Dorsomedial nuclear group;Medial nuclear group;Medial nuclear group of thalamus;Medial nuclear group of thalamus, NOS;Medial thalamic nuclei;Medial thalamic nucleus;Mediodorsal Nucleus;Mediodorsal nucleus;Nucleus, Mediodorsal;Mediodorsal Thalamic Nucleus;Mediodorsal thalamic nucleus;Nucleus, Mediodorsal Thalamic;Thalamic Nucleus, Mediodorsal;mediodorsal thalamic nucleus;thalamic mediodorsal nucleus;Nucleus dorsomedialis thalami;Nucleus medialis dorsalis;Nucleus medialis dorsalis thalami;Nucleus mediodorsalis thalami;Structure of dorsomedial nucleus of thalamus|C0228329|||C0228329|FMA;MSH;SNOMEDCT|1|0.0248|
MD|Dystrophies, Muscular;Dystrophy, Muscular;Muscular Dystrophies;Muscular Dystrophy;Muscular dystrophy;Muscular dystrophy NOS;Muscular dystrophy, NOS;muscular dystrophies;muscular dystrophy;Hereditary progressive muscular dystrophy;Hereditary progressive muscular dystrophy NOS;Hereditary progressive muscular dystrophy, NOS;MD - Muscular dystrophy;Myodystrophica;Myodystrophicas;Myodystrophies;Myodystrophy;myodystrophy;PMD - Progressive muscular dystrophy;Progressive muscular dystrophy;progressive muscular dystrophy|C0026850|||C0026850|AOD;CHV;COSTAR;CSP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0291|1
MD|Hered prog musc dystrphy||||C0026850|ICD9CM|||
MD|Hereditary progressive muscular dystrophy (disorder);Hereditary progressive muscular dystrophy NOS (disorder)||||C0026850|SNOMEDCT|||
MD|MD||||C0024858;C0026374;C0026850;C0228329;C1512018|FMA;MEDLINEPLUS;NCI|||
MD|MDA|C0000379;C0026374|||C0026374|NCI|||
MD|MOLDOVA, REPUBLIC OF;Moldova, Republic of;Republic of Moldova;Moldavia;Moldova;moldavia;moldova;Moldavian S.S.R.;Moldavian SSR|C0026374|||C0026374|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MD|Mantoux diameter||||||||1
MD|Marek disease;Marek's disease|C0024793|||||1|0.1075|1
MD|Maryland;maryland;Maryland (geographic location)|C0024858|||C0024858|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MD|Mean deviation;mean deviation|C1828170|||C1828170|SNOMEDCT|1|0.0531|1
MD|Meckel diverticulum;Meckel's diverticulum|C0025037|||||1|0.0137|1
MD|Mixed Dementia||||||1|0.0043|
MD|Moldavia (geographic location)||||C0026374|SNOMEDCT|||
MD|Monocular deprivation;monocular deprivation||||||1|0.0231|1
MD|Movement disorders;movement disorder|C0026650|||C0026650|CHV;COSTAR;CSP;CST;MSH;SNOMEDCT|1|0.0034|1
MD|Muscular Dystrophies [Disease/Finding]||||C0026850|NDFRT|||
MD|Muscular dystrophy (disorder)||||C0026850|SNOMEDCT|||
MD|Myelin deficiency||||||1|0.0026|
MD|Nuclei mediales (thalami)|C1305699|||C0228329|FMA|||
MD|Nucleus medialis dorsalis (Hassler)||||C0228329|FMA|||
MD|Nucleus medialis dorsalis (body structure)||||C0228329|SNOMEDCT|||
MD|Structure of dorsomedial nucleus of thalamus (body structure)||||C0228329|SNOMEDCT|||
MD|Structure of medial nuclear group of thalamus||||C0228329|SNOMEDCT|||
MD|Structure of medial nuclear group of thalamus (body structure)||||C0228329|SNOMEDCT|||
MD|diabetic|C0241863|||||1|0.0043|
MD|diseases|C0012634|||||1|0.0051|
MD|distance|C0012751|||||1|0.0069|
MD|macula densa|C0227662;C1280231|||||1|0.03|1
MD|macular degeneration|C0024437;C0242383|||||||1
MD|magnesium deficiency|C0024473|||C0024473|CHV;CSP;MSH;MTH;NDFRT;SNOMEDCT|||1
MD|main duct||||||||1
MD|maintenance dialysis||||||||1
MD|maintenance dose||||||1|0.0047|1
MD|major depression;major depressive disorder|C0041696;C1269683|||C0041696;C1269683|AOD;CHV;COSTAR;CSP;NCI;SNOMEDCT|1|0.0792|1
MD|malate dehydrogenase|C0024544;C0373676|||C0024544;C0373676|CHV;CSP;LCH;LNC;MSH;MTH;NDFRT;SNOMEDCT|||1
MD|malignant disease|C0442867|||C0442867|CHV;SNOMEDCT|||
MD|malrotation of duodenum||||||||1
MD|mammary dysplasia|C0016034|||||||1
MD|mandibular|C0024687|||||||1
MD|manic depression;manic depressive;manic-depressive|C0005586|||C0005586|CHV|||1
MD|maternal deprivation|C0024920|||C0024920|CHV;LCH;MSH;SNOMEDCT|1|0.0056|1
MD|maximal dose||||||||1
MD|mean defect||||||1|0.018|
MD|mean diastolic||||||||1
MD|mean difference||||||1|0.0116|
MD|measurable disease|C1513041|||||||1
MD|medial dorsal||||||1|0.0043|
MD|medialis dorsalis||||||1|0.0043|1
MD|median|C0549183;C0876920;C2347635;C2348144;C2939193|||||||1
MD|mediastinal disease|C0025061|||C0025061|CHV;MSH;NCI;SNOMEDCT|||1
MD|medical department|C0587450|||C0587450|CHV;MTH;SNOMEDCT|||1
MD|medical doctor|C0031831|1|1.000|||||
MD|mediodorsal||||||1|0.0223|1
MD|mediodorsal nucleus of the thalamus||||||1|0.0141|
MD|mediodorsal thalamus||||||1|0.0043|
MD|medium dosage||||||||1
MD|megadaltons||||||1|0.0128|
MD|menadione|C0025270|||||1|0.0064|
MD|mendelevium|C0025275|||||||1
MD|meningococcal disease|C0025303|||||||1
MD|mental deficiency|C0917816|||C0917816|AOD;CHV;COSTAR;CST;MSH;MTH;OMIM|||1
MD|mental depression|C0011570|||C0011570|CHV;MTH|||1
MD|mentally deficient|C0079822|||||||1
MD|mesiodistal||||||||1
MD|methyldichloroarsine|C0168004|||||||1
MD|methyldopa|C0025741|||||1|0.0039|
MD|microdensitometry||||||1|0.0081|
MD|microdialysis|C0206056|||||1|0.0201|
MD|microtube dilution||||||||1
MD|microvessel density||||||1|0.0047|
MD|minimum dosage||||||||1
MD|mitral disease|C0865573|||C0865573|MTHICD9|||1
MD|mixed diet||||||||1
MD|moderate disability||||||1|0.0026|1
MD|moderately differentiated||||||1|0.0039|1
MD|molecular dynamics|C0596957|||||1|0.3448|
MD|molecular dynamics simulations|C2717775|||||1|0.0056|
MD|monocularly deprived||||||1|0.0086|
MD|motion-defined||||||1|0.0047|
MD|multiple deficiency||||||||1
MD|multiple dendritic||||||1|0.0039|
MD|multiple dose||||||||1
MD|myelin-deficient||||||1|0.0223|
MD|myelodysplasia|C0026985;C0026986;C0033027|||C0026985;C0026986;C0033027;C1963099|CHV;COSTAR;DXP;MTH;MTHICD9;NCI;OMIM;PDQ;SNOMEDCT|||
MD|myeloproliferative disease|C0027022|||||||1
MD|myocardial damage||||||||1
MD|myocardial disease|C0878544|||C0878544|CHV;CSP;MSH;MTHICD9;SNOMEDCT|||1
MD|myotonic dystrophy|C0027126|||C0027126|CHV;COSTAR;CSP;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.0638|1
MD|patients with Meniere's disease||||||1|0.0077|
MDS|CHROMOSOME 17p13.3 DELETION SYNDROME;Lissencephaly Syndrome, Miller Dieker;Lissencephaly Syndrome, Miller-Dieker;MILLER-DIEKER LISSENCEPHALY SYNDROME;Miller-Dieker Lissencephaly Syndrome;Miller-Dieker lissencephaly syndrome;Syndrome, Miller-Dieker Lissencephaly;Lissencephaly syndrome;lissencephaly syndrome;Lissencephaly, Miller Dieker;Lissencephaly, Miller-Dieker;Miller-Dieker Lissencephaly;MDLS;Miller Dieker Syndrome;Miller Dieker syndrome;Miller-Dieker Syndrome;Miller-Dieker syndrome;Syndrome, Miller-Dieker;miller dieker syndrome;miller-dieker syndrome|C0265219|||C0265219|CHV;MSH;MTH;MTHICD9;OMIM;SNOMEDCT|||
MDS|Dysmyelopoietic Syndrome;Dysmyelopoietic Syndromes;Dysmyelopoietic syndrome;Syndrome, Dysmyelopoietic;Syndromes, Dysmyelopoietic;MDS - Myelodysplastic syndrome;Myelodysplastic Neoplasm;Myelodysplastic syndrome, unspecified;Oligoblastic Leukemia;PRELEUKEMIC SYNDROME;Preleukaemic syndrome;Preleukemic syndrome;dysmyelopoiesis|C0026986|||C0026986|DXP;ICD9CM;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|||
MDS|Hematopoeitic - Myelodysplastic Syndrome (MDS)||||C0026986|NCI|||
MDS|LIS1|C1418245;C1843916;C2698684|||C2698684|NCI|||
MDS|LIS2|C0796089;C1418248;C2698684|||C2698684|NCI|||
MDS|MDCR|C1855481;C2698684|||C2698684|NCI|||
MDS|MDS||||C0026986;C0265219;C1879299;C2698684|LNC;NCI;OMIM|||
MDS|MYELODYSPLASTIC SYNDROME;Myelodysplastic Syndrome;Myelodysplastic Syndromes;Myelodysplastic syndrome;Myelodysplastic syndrome, NOS;Myelodysplastic syndromes;Syndrome, Myelodysplastic;Syndromes, Myelodysplastic;myelodysplastic syndrome;myelodysplastic syndromes;Preleukaemia;Preleukemia;preleukemia|C0026986;C0033027|1|0.998|C0026986;C0033027|CHV;COSTAR;LCH;MSH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.8756|1
MDS|Miller Dieker syndrome (disorder);Miller-Dieker syndrome (disorder)||||C0265219|SNOMEDCT|||
MDS|Miller-Dieker Syndrome Chromosome Region Gene;PAFAH1B1 wt Allele;Platelet-Activating Factor Acetylhydrolase, Isoform Ib, Alpha Subunit 45kDa wt Allele|C2698684|||C2698684|MTH;NCI|||
MDS|Miller-Dieker syndrome (disorder) [Ambiguous]||||C0265219|SNOMEDCT|||
MDS|Minimum Data Set, 2.0;Minimum data set;minimum data set|C1879299|||C1879299|LNC;MTH|1|0.0527|1
MDS|Myelodysplasia;myelodysplasia|C0026985;C0026986;C0033027|||C0026986|CHV;NCI;OMIM;PDQ;SNOMEDCT|||
MDS|Myelodysplasia (disorder)||||C0026986|SNOMEDCT|||
MDS|Myelodysplastic Syndrome/Neoplasm||||C0026986|NCI|||
MDS|Myelodysplastic Syndromes [Disease/Finding]||||C0026986|NDFRT|||
MDS|Myelodysplastic synd NOS||||C0026986|ICD9CM|||
MDS|Myelodysplastic syndrome (clinical)||||C0026986|SNOMEDCT|||
MDS|Myelodysplastic syndrome (disorder)||||C0026986|SNOMEDCT|||
MDS|Myelodysplastic syndrome (morphologic abnormality)||||C0026986|SNOMEDCT|||
MDS|Myelodysplastic syndrome (morphology)||||C0026986|SNOMEDCT|||
MDS|Myelodysplastic syndrome (morphology) -Retired-||||C0026986|SNOMEDCT|||
MDS|PAFAH|C1418245;C1418625;C2698684|||C2698684|NCI|||
MDS|Platelet-Activating Factor Acetylhydrolase, Isoform Ib, Alpha Subunit (45kD) Gene||||C2698684|NCI|||
MDS|Smoldering Leukemia;Smoldering leukemia;Smouldering leukaemia;smoldering leukemia|C0002894;C0026986|||C0026986|NCI;SNOMEDCT|||
MDS|[M]Myelodysplastic syndrome||||C0026986|SNOMEDCT|||
MDS|[X]Myelodysplastic syndrome, unspecified||||C0026986|SNOMEDCT|||
MDS|[X]Myelodysplastic syndrome, unspecified (disorder)||||C0026986|SNOMEDCT|||
MDS|maternal deprivation syndrome||||||||1
MDS|medical data screen||||||||1
MDS|medical data system||||||||1
MDS|membrane-spanning domain||||||||1
MDS|microdebrider system||||||||1
MDS|microdialysis system||||||1|0.0096|
MDS|microdilution system||||||||1
MDS|microsurgical drill system||||||||1
MDS|milk drinker's syndrome|C0026141|||||||1
MDS|multidimensional scaling|C0681930|||||1|0.0431|1
MDS|multilineage dysplasia||1|0.002|||||
MDS|myelodysplastic||||||1|0.007|
MDS|myocardial depressant substance||||||||1
MDS|patients with myelodysplasia||||||1|0.007|
MDS|physicians|C0031831|||||1|0.005|
MFM|Millipore filter method||||||||1
MFM|magnetic force microscope||||||||1
MFM|magnetic force microscopy||||||||1
MFM|maternal fetal medicine;maternal-fetal medicine|C1555790|1|1|||1|0.4737|1
MFM|multifidus muscle|C0224319|||||||1
MFM|myofibrillar myopathy|C2678065|||||1|0.5263|
MICD|MHC class I polypeptide-related sequence D (pseudogene)||||C1417165|HUGO|||
MICD|MICD;MICD gene;PERB11.4|C1417165|||C1417165|HUGO;MTH|||
MICD|mental illness chemical dependency||1|1.000|||||
MI|AMI||||C0027051|AOD;CHV|||
MI|ATTACK CORONARY;attacks coronary;coronary attack;ATTACK HEART (NOS);Attack - heart;HEART ATTACK;Heart Attack;Heart attack;Heart attack, NOS;attack hearts;attacking heart;attacks hearts;heart attack;heart attacks;Cardiac infarction;Cardiac infarction, NOS;cardiac infarction;HEART INFARCTION;Infarction of heart;Infarction of heart, NOS;heart infarction;INFARCT MYOCARDIAL;Infarct, Myocardial;Infarcts, Myocardial;MYOCARDIAL INFARCT;Myocardial Infarct;Myocardial Infarcts;Myocardial infarct;infarcts myocardial;myocardial infarct;myocardial infarcted;myocardial infarcts;mied;mies;syndrome myocardial infarction|C0027051|||C0027051|AOD;CHV;CSP;CST;DXP;MEDLINEPLUS;MSH;NCI;NDFRT;SNOMEDCT|1|0.0353|
MI|History of Myocardial Infarction Within 6 Months;History of myocardial infarction within 6 months;history of myocardial infarction within 6 months||||C0278960|MTH;NCI;PDQ|||
MI|INFARCTION (MI), MYOCARDIAL;MI - Myocardial infarction;MI, MYOCARDIAL INFARCTION;MYOCARDIAL INFARCTION, (MI);Myocardial infarction (MI);Infarction, Myocardial;Infarctions, Myocardial;MYOCARDIAL INFARCTION;Myocardial Infarction;Myocardial Infarctions;Myocardial infarction;Myocardial infarction NOS;Myocardial infarction, NOS;infarctions myocardial;myocardial infarction;myocardial infarctions|C0027051;C2926063|1|1|C0027051|AIR;AOD;CHV;COSTAR;CSP;CST;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0371|1
MI|MALAWI;Malawi;malawi;MWI;Nyasaland;Republic of Malawi|C0024548|||C0024548|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MI|MI;Mi;MITF wt Allele;Microphthalmia-Associated Transcription Factor wt Allele|C2346914|||C0024548;C0025939;C0025953;C0027051;C0278960;C0332288;C1417172;C1553043;C2346914|CHV;CSP;HUGO;MEDLINEPLUS;MSH;MTH;NCI;OMIM;PDQ;SNOMEDCT|||
MI|MICROBIOL||||C0025953|MSH|||
MI|MICROPHTHALMIA, MOUSE, HOMOLOG OF;homolog of mouse microphthalmia;MITF;MITF Gene;MITF gene;Microphthalmia-Associated Transcription Factor Gene|C1417172|||C1417172|HUGO;MTH;NCI;OMIM|||
MI|MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR;microphthalmia-associated transcription factor|C0218694;C1417172|||C1417172|HUGO;OMIM|||
MI|MW|C0024548;C0026385;C0556966|||C0024548|NCI|||
MI|Magical Ideation||||||1|0.0067|
MI|Malawi (geographic location)||||C0024548|SNOMEDCT|||
MI|Mebi;mebi|C1553043|||C1553043|HL7V3.0;MTH;NCI|||
MI|Meiosis I;meiosis I|C1155812|||||1|0.0152|1
MI|Metabolic Intermediate||||||1|0.0079|
MI|Michigan;michigan;Michigan (geographic location)|C0025939|||C0025939|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MI|Microbiological|C0025953|||C0025953|MTH|||
MI|Minus;minus|C0332288|||C0332288|CHV;SNOMEDCT|||
MI|Myocardial Infarction [Disease/Finding]||||C0027051|NDFRT|||
MI|Myocardial infarction (disorder);disorder infarction myocardial||||C0027051|CHV;SNOMEDCT|||
MI|WS2A||||C2346914|NCI|||
MI|Without;without||||C0332288|CHV;MTH;NCI;SNOMEDCT|||
MI|Without (attribute)||||C0332288|SNOMEDCT|||
MI|after acute myocardial infarction||||||1|0.0718|
MI|bHLHe32|C0218694;C1417172;C2346914|||C1417172;C2346914|HUGO;NCI|||
MI|cardiac remodeling after myocardial infarction||||||1|0.0061|
MI|first meiotic division||||||1|0.0043|
MI|first meiotic metaphase||||||1|0.003|
MI|infection|C0021311|||||1|0.0067|
MI|intensity|C0522510|||||1|0.0073|
MI|intervention|C0886296;C1273869;C1948041|||||1|0.0073|
MI|macrophage migration inhibition||||||1|0.003|
MI|magnetic-guided intubation||||||||1
MI|massa intermedia|C0228325;C1289610|||C0228325;C1289610|FMA;SNOMEDCT|||
MI|maturation index||||||||1
MI|meconium ileus|C0270246;C0546982;C2939175|||||1|0.0134|1
MI|medical inspection|C0582103|||C0582103|NCI|||1
MI|melanophore index||||||||1
MI|membrane intact||||||||1
MI|menstruation induction||||||||1
MI|mental illness|C0004936|||C0004936|AOD;CHV;CSP;MEDLINEPLUS;NCI;SNOMEDCT|||1
MI|mental institution|C0020021|||C0020021|MSH|||1
MI|mentally impaired||||||||1
MI|mesenteric ischemia|C0920157|||||||1
MI|mesioincisal||||||||1
MI|metabolic index||||||||1
MI|metabolic inhibition|C0021469|||||1|0.0225|
MI|metaphase I||||||1|0.0517|
MI|methyl indole||||||||1
MI|microbiology|C0025952;C0025953;C0085672|||C0025953|MSH|||
MI|microphthalmic||||||1|0.0061|
MI|microsatellite instability|C0796369;C0920269|||||1|0.0883|1
MI|migration index||||||||1
MI|migration inhibition||||||||1
MI|mild irritant||||||||1
MI|mile|C0331865;C2347127;C2348616|||||||1
MI|mitotic|C1513354|||||1|0.011|
MI|mitotic index;mitotic indices|C0812425|||C0812425|CHV;LNC;MSH;NCI;SNOMEDCT|1|0.2264|1
MI|mitral incompetence;mitral insufficiency|C0026266|||C0026266|CHV;COSTAR;CST;DXP;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0207|1
MI|mononucleosis infectiosa||||||||1
MI|morphology index||||||||1
MI|motility index||||||||1
MI|motivational interviewing|C0683474|||||1|0.0256|
MI|motor imagery||||||1|0.0085|
MI|mouse microphthalmia||||||1|0.0061|
MI|multiple imputation||||||1|0.0079|
MI|mutual information||||||1|0.0225|
MI|myo-inositol;myoinositol|C0021547|||C0021547|FMA;NCI;PDQ|||1
MI|myocardial ischemia|C0010054;C0151744|||C0010054;C0151744|AOD;CHV;CSP;CST;LNC;MSH;MTH;MTHICD9;NDFRT;OMIM;SNOMEDCT|1|0.0274|1
MI|myocardial necrosis|C0027051;C1442837|||C0027051|CHV|||
MI|myometrial invasion||||||1|0.0055|
MI|nono|C0332288;C1417758|||C0332288|NCI|||
MI|patients after myocardial infarction||||||1|0.0329|
MI|patients with acute myocardial infarction||||||1|0.1223|
MI|primary motor||||||1|0.0158|
MI|primary motor area||||||1|0.0037|
MI|primary motor cortex|C0026607|||||1|0.0645|
MI|ventricular remodeling after myocardial infarction||||||1|0.0055|
MMF|DHAD/5-FU/MTX||||C0083765|NCI;PDQ|||
MMF|Fluorouracil/Methotrexate/Mitoxantrone;fluorouracil/methotrexate/mitoxantrone||||C0083765|NCI;PDQ|||
MMF|MMF|C0083765;C0209368|||C0083765;C0209368|NCI;PDQ|||
MMF|MYCOPHENOLATE MOFETIL;Mycophenolate Mofetil;Mycophenolate mofetil;mofetil mycophenolate;mycophenolate mofetil;mycophenolic acid morpholinoethyl ester|C0209368|1|1|C0209368|CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.9232|
MMF|Mycophenolate mofetil (product)||||C0209368|SNOMEDCT|||
MMF|Mycophenolate mofetil (substance)||||C0209368|SNOMEDCT|||
MMF|NMF|C0066373;C0083765;C1882111|||C0083765|NCI;PDQ|||
MMF|NMF protocol;fluorouracil/methotrexate/mitoxantrone protocol|C0083765|||C0083765|MSH;MTH|||
MMF|fraction|C1264633;C1554103|||||1|0.0093|
MMF|macrophagic myofasciitis|C2931639|||C2931639|MSH|1|0.0114|
MMF|mandibulomaxillary fixation||||||||1
MMF|maxillomandibular fixation|C0376509|||C0376509|MSH|1|0.0342|1
MMF|maximal midexpiratory flow||||||||1
MMF|maximal midexpiratory flow rate|C0024966;C1306018|||C0024966;C1306018|AOD;MSH;MTH|||
MMF|maximum mid-expiratory flow||||||1|0.0041|
MMF|mean maximal flow||||||||1
MMF|mismatch field||||||1|0.0176|
MMF|monomethylformamide|C0066373|||C0066373|MSH;NCI;PDQ|||
MMF|monomethylfumarate|C0209986|||C0209986|MSH|||
MMF|mycophenolate mofetil [Chemical/Ingredient]||||C0209368|NDFRT|||
MN|BLOOD GROUP--MN LOCUS;GYPA Gene;GYPA gene|C1367455|||C1367455|HUGO;MTH;NCI;OMIM|||
MN|CA IX;CAIX;CA9;CA9 gene;CARBONIC ANHYDRASE IX;carbonic anhydrase IX;MEMBRANE ANTIGEN MN|C1413052|||C1413052|HUGO;MTH;OMIM|||
MN|CD235a|C0017955;C1367455|||C1367455|HUGO;LNC|||
MN|Dietary Manganese|C2348271|||C2348271|MTH;NCI|||
MN|GPA||||C1367455;C1706550|HUGO;NCI|||
MN|GYPA||||C1367455;C1706550|HUGO;NCI;OMIM|||
MN|GYPA wt Allele|C1706550|||C1706550|MTH;NCI|||
MN|Glycophorin A (Includes MN Blood Group) Gene||||C1367455|NCI|||
MN|Glycophorin A (Includes MN Blood Group) wt Allele||||C1706550|NCI|||
MN|MANGANESE;Manganese;Manganese, NOS;manganese|C0024706;C2348271|||C0024706;C2348271|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.2704|1
MN|MC||||C0026405|NCI|||
MN|MCO|C0026405;C0605527;C1417073|||C0026405|NCI|||
MN|MG|C1960952;C2346927|||C0026410|NCI|||
MN|MN;MNS;Mn|C0025237;C1415376;C1706550|||C0024706;C0026183;C0026405;C0026410;C1367455;C1413052;C1706550;C2348271|AOD;HUGO;LNC;NCI;OMIM|||
MN|MNG|C0025800;C0026410|||C0026410|NCI|||
MN|MONACO;Monaco;monaco|C0026405|||C0026405|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
MN|MONGOLIA;Mongolia;mongolia|C0026410|||C0026410|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MN|Manganese (product)||||C0024706|SNOMEDCT|||
MN|Manganese (substance)||||C0024706|SNOMEDCT|||
MN|Manganese [Chemical/Ingredient]||||C0024706|NDFRT|||
MN|Mauthner neurons||||||1|0.0049|
MN|Melanocytic nevi;melanocytic nevus|C0027962;C1456781|||C0027962;C1456781|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.0103|1
MN|Membranous nephropathy;membranous nephropathy|C0017665|||C0017665|CHV;CSP;MSH;NDFRT|1|0.0955|1
MN|Minnesota;minnesota|C0026183|1|1|C0026183|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MN|Minnesota (geographic location)||||C0026183|SNOMEDCT|||
MN|Mn - Manganese;Mn element|C0024706|||C0024706|CSP;SNOMEDCT|||
MN|Monaco (geographic location)||||C0026405|SNOMEDCT|||
MN|Mongolia (geographic location)||||C0026410|SNOMEDCT|||
MN|RCC-associated protein G250||||C1413052|HUGO|||
MN|blood group in MNS blood group system||||||||1
MN|blood monocytes|C0026473|||||1|0.006|
MN|carbonic dehydratase|C1413052;C1538425|||C1413052|HUGO|||
MN|glycophorin A (MNS blood group)||||C1367455|HUGO|||
MN|malignant nephrosclerosis|C0238307|||||||1
MN|meal number||||||1|0.0049|
MN|median nerve|C0025058;C1278845|||C0025058;C1278845|CHV;FMA;LCH;MSH;NCI;SNOMEDCT;UWDA|1|0.0141|1
MN|meganewton||||||||1
MN|melena neonatorum||||||||1
MN|membranous neuropathy||||||||1
MN|mental nerve|C0228739;C1281199|||||1|0.0054|
MN|mesenteric node|C0229792|||C0229792|CHV;FMA;UWDA|||1
MN|metanephrine|C0025562|||C0025562|AOD;CHV;CSP;LNC;MSH;MTH;NDFRT;SNOMEDCT|||1
MN|methyl nicotinate|C0066412|||||1|0.0087|
MN|micrococcal nuclease|C0025965|||||1|0.006|
MN|micronucleated||||||||1
MN|micronuclei;micronucleus|C0026004|||C0026004|AOD;CHV;CSP;GO;SNOMEDCT|1|0.5043|1
MN|micronucleus assay;micronucleus test|C0026006|||||1|0.0092|
MN|midnight|C0332172|||C0332172|CHV;SNOMEDCT|||1
MN|millinormal||||||||1
MN|mononuclear|C1513475|||||||1
MN|mononuclear cells|C0806987|||||1|0.0109|
MN|motoneuron;motor neuron|C0026609|||C0026609|AOD;CHV;CSP;FMA;MSH;NCI;SNOMEDCT|1|0.0364|1
MN|mucosal neurolysis||||||||1
MN|multinodular|C0205416|||||||1
MN|myoneural||||||||1
MN|nucleus|C0007610|||||1|0.0076|
MN|number average molecular weight||||||1|0.0054|
MOM|Miokamycin;miocamycin|C0026202|||||1|0.1379|
MOM|MoM;Multiple of the median;multiple of the median;multiples of median;multiples of the median|C1442163|1|0.878|C1442163|LNC;SNOMEDCT|1|0.7143|1
MOM|Multiple of the median (qualifier value)||||C1442163|SNOMEDCT|||
MOM|metal-on-metal||||||1|0.0542|
MOM|midecamycin acetate|C1136781|||||1|0.0493|
MOM|milk of magnesia|C0591789|1|0.114|||||1
MOM|modifier of Min||||||||1
MOM|mother|C0026591|||||||1
MOM|mucoid otitis media|C0029883|||||1|0.0443|1
MP|(device) MP||1|0.010|||||
MP|(drug) MP||1|0.004|||||
MP|1,7-Dihydro-6H-purine-6-thione;6H-Purine-6-thione, 1,7-dihydro-||||C0000618|MSH;NCI;NDFRT;PDQ|||
MP|1,7-Dihydro-6H-purine-6-thione Monohydrate||||C0000618|NCI;PDQ|||
MP|3-mercaptopropionic acid|C0000424|||C0000424|MSH;NDFRT|1|0.0091|
MP|3H-Purine-6-thiol;6 MP;6-MP;6-mp;6MP;6 Mercaptopurine;6 mercaptopurine;6-Mercaptopurine;6-mercaptopurine;Mercapto-6-purine;Purine, 6-mercapto-;6 Thiohypoxanthine;6-Thiohypoxanthine;6 Thiopurine;6 thiopurine;6-Thiopurine;6-thiopurine;6-Purinethiol;6-Thioxopurine;6MP - Mercaptopurine;MERCAPTOPURINE;Mercaptopurine;mercaptopurine;Mercapurin;Mern|C0000618|1|0.214|C0000618|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0254|
MP|6-Mercaptopurine [Chemical/Ingredient]||||C0000618|NDFRT|||
MP|6H-Purine-6-thione, 1,7-dihydro- (9CI)||||C0000618|NCI;PDQ|||
MP|7-Mercapto-1,3,4,6-tetrazaindene||||C0000618|NCI;PDQ|||
MP|AP protocol 2;MPH-P protocol;melphalan/prednisone protocol|C0284383|||C0284383|MSH;MTH|||
MP|CQ|C1705968|||C0282245|NCI|||
MP|L-PAM/PRED||||C0284383|NCI;PDQ|||
MP|MAURITIUS;Mauritius;mauritius|C0024944|||C0024944|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MP|MERCAPTOPURINE A 06||||C0000618|MSH|||
MP|MNP;NORTHERN MARIANA ISLANDS;Northern Mariana Islands|C0282245|||C0282245|AOD;MSH;MTH;NCI|||
MP|MP||||C0000618;C0024944;C0282245;C0284383|NCI;PDQ|||
MP|MU;MUS|C0024944;C0026809;C0347978|||C0024944|NCI|||
MP|Matching pursuit||||||1|0.0073|
MP|Mauritius (geographic location)||||C0024944|SNOMEDCT|||
MP|Melphalan and prednisone;Melphalan/Prednisone;melphalan-prednisone;melphalan/prednisone||||C0284383|NCI;PDQ|1|0.0247|
MP|Mercaptopurine (product)||||C0000618|SNOMEDCT|||
MP|Mercaptopurine (substance)||||C0000618|SNOMEDCT|||
MP|Methyl palmoxirate|C0127952|||||1|0.0121|
MP|Mibelli porokeratosis|C0949506|||||||1
MP|Mononuclear phagocytes;mononuclear phagocyte|C2952444|||C2952444|FMA|1|0.0175|
MP|Mycoplasma pneumoniae|C0026941;C0032302|||||1|0.0284|
MP|Purine-6-thiol (8CI)||||C0000618|NCI;PDQ|||
MP|machine perfusion||||||1|0.0103|
MP|machine preservation||||||||1
MP|macrophage;macrophages|C0024432;C1546706;C1550652|||C0024432;C1546706;C1550652|AOD;CHV;CSP;FMA;HL7V2.5;HL7V3.0;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0066|1
MP|macular pigment||||||1|0.0193|
MP|magnetization prepared||||||||1
MP|main process||||||1|0.0054|
MP|malignant pyoderma|C0263211|||||||1
MP|mannoprotein||||||1|0.0097|
MP|mastoparan|C0065739|||C0065739|MSH|1|0.0139|
MP|matrix protein||||||||1
MP|maximum parsimony||||||1|0.0375|
MP|mean pressure|C0445074|||C0445074|SNOMEDCT|||1
MP|mechanical percussion||||||||1
MP|mechanical percussor||||||||1
MP|meconium peritonitis|C0270250|||||1|0.0066|
MP|medial plantar||||||||1
MP|melting point;melting points|C1881775|||C1881775|NCI|1|0.003|1
MP|membrane potential|C0025251|||C0025251|AOD;CHV;CSP;MSH;NCI|1|0.0568|1
MP|membrane protein|C0025252|||C0025252|CHV;CSP;MSH;NCI;NDFRT|||
MP|menstrual period|C0025329;C0025344|1|0.002|C0025329;C0025344|MEDLINEPLUS;NCI|||1
MP|mentum posterior||||||||1
MP|mesangial proliferative||1|0.002|||||
MP|mesenteric panniculitis|C0025470|||||||1
MP|mesial pit||||||||1
MP|mesiopulpal||||||||1
MP|metabolic panel||1|0.024|||||
MP|metacarpophalangeal||1|0.358|||1|0.0471|1
MP|metalloproteinase|C0025543|||C0025543;C1150172|CHV;CSP;NCI;SNOMEDCT|1|0.0066|
MP|metarsophalangeal||1|0.012|||||
MP|metatarsophalangeal||1|0.110|||1|0.0103|1
MP|metatarsophalangeal/metacarpophalangeal||1|0.210|||||
MP|methapyrilene|C0025625|||C0025625|CHV;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0127|
MP|methyl parathion|C0025709|||C0025709|CHV;LNC;MSH;NDFRT;SNOMEDCT|1|0.0181|
MP|methyl prednisolone;methylprednisolone|C0025815|||C0025815|CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.3305|
MP|methylphenidate|C0025810|||C0025810|AOD;CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0175|
MP|methylphosphonate|C0066424|||C0066424|LNC;MSH|1|0.0066|
MP|methylprednisolone sodium succinate|C0700546|||||1|0.0115|
MP|microfibrillar protein|C0066514|||||||1
MP|micronized progesterone|C0873071|||C0873071|CHV|1|0.0145|
MP|microparticles||||||1|0.0308|
MP|microperoxidase|C0066521|||C0066521|MSH|1|0.006|
MP|micturition pressure||||||1|0.0048|
MP|middle phalanx|C0576463|||C0576463|SNOMEDCT|||1
MP|migration percentage||||||1|0.0097|
MP|military police||1|0.008|||||
MP|millipond||||||||1
MP|minimal pigment||||||||1
MP|minipool||||||||1
MP|mitral prolapse||||||1|0.006|
MP|modulator protein||||||||1
MP|moist pack||||||||1
MP|monitor pattern||||||||1
MP|monophasic|C0205186|||||||1
MP|monophosphate||||||||1
MP|monopolar||||||1|0.006|
MP|motor potential|C0429441|||||1|0.0133|1
MP|mouth pressure||||||||1
MP|mouthpiece||||||||1
MP|movement protein||||||1|0.0912|
MP|mucopolysaccharide|C0017973;C2267150|||C0017973;C2267150|CHV;CSP;NDFRT;SNOMEDCT|||1
MP|multiparous|C0026751|||C0026751|CHV;SNOMEDCT|||1
MP|multiprogrammable pacemaker||||||||1
MP|muscle potential||||||||1
MP|muscularis propria|C0225358|||||1|0.0066|
MP|mycoplasma pneumoniae pneumonia;mycoplasmal pneumonia|C0032302|||C0032302|CHV;CSP;SNOMEDCT|1|0.003|1
MP|myelopeptides|C0067043|||C0067043|MSH|||
MP|myeloperoxidase|C0027021;C0440053;C1417245;C2698399|||C0027021;C0440053;C1417245;C2698399|CHV;CSP;HUGO;LNC;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0085|
MP|myenteric plexus|C0027028;C0038564;C1280770|||||1|0.0066|
MP|myocardial perfusion|C0428857|||||1|0.0073|1
MP|myosin phosphatase|C0067062|||||1|0.0073|
MP|peptide|C0030956|||||1|0.0054|
MP|peritoneal macrophages|C0206190|||||1|0.0073|
MP|proteins|C0033684|||||1|0.0109|
MRA|ANGIOGR MR;MR ANGIOGR||||C0243032|MSH|||
MRA|Angiographies, MRI;Angiography, MRI;MRI Angiographies;MRI Angiography;Angiographies, Magnetic Resonance;Angiography, Magnetic Resonance;Magnetic Resonance Angiographies;Magnetic Resonance Angiography;Magnetic resonance angiography;Magnetic resonance angiography, NOS;magnetic resonance angiography;Magnetic resonance imaging (MRI) of vessels;Magnetic resonance imaging of vessels;Vascular MRI;Vascular magnetic resonance imaging;magnetic resonance angiography (MRA)|C0243032|||C0243032|CHV;HL7V2.5;MSH;MTH;SNOMEDCT|1|0.6635|1
MRA|Immunoglobulin G1, Anti-(Human Interleukin 6 Receptor) (Human-Mouse Monoclonal MRA Heavy Chain), Disulfide with Human-Mouse Monoclonal MRA .Kappa.-Chain, Dimer||||C1609165|NCI|||
MRA|MR angiography||||||1|0.2323|
MRA|MR arthrography||||||1|0.0048|
MRA|MRA;mra|C0243032;C1609165|||C0243032;C1609165|CHV;NCI;SNOMEDCT|||
MRA|MRI ANGIOGR||||C0243032|MSH|||
MRA|Magnetic resonance angiography (procedure)||||C0243032|SNOMEDCT|||
MRA|Magnetic resonance imaging of vessels (procedure)||||C0243032|SNOMEDCT|||
MRA|Multiple regression analysis||||||1|0.015|
MRA|TOCILIZUMAB;Tocilizumab;tocilizumab;atlizumab;monoclonal antibody, MRA|C1609165|||C1609165|MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
MRA|Tocilizumab (product)||||C1609165|SNOMEDCT|||
MRA|Tocilizumab (substance)||||C1609165|SNOMEDCT|||
MRA|Vascular MRI (procedure)||||C0243032|SNOMEDCT|||
MRA|Vascular magnetic resonance imaging (procedure)||||C0243032|SNOMEDCT|||
MRA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0095|
MRA|magnetic resonance angiogram||||||1|0.0082|1
MRA|magnetic resonance angiograph||1|1.000|||||1
MRA|magnetic resonance angiographic||||||1|0.0068|
MRA|magnetic resonance arteriograph||||||||1
MRA|magnetic resonance arteriography||||||1|0.0061|1
MRA|magnetic resonance arteriogrem||||||||1
MRA|magnetic resonance arthrography||||||1|0.0095|
MRA|main renal artery||||||||1
MRA|malignant rheumatoid arthritis||||||1|0.0095|
MRA|marrow repopulating ability||||||1|0.0136|
MRA|marrow repopulation activity||||||||1
MRA|mesenteric resistance arteries||||||1|0.0123|
MRA|midright atrium||||||||1
MRA|multivariate regression analysis||||||||1
MRA|risk assessment|C0086930|||||1|0.0089|
MRCP|Cholangiopancreatographies, Magnetic Resonance;Cholangiopancreatography, Magnetic Resonance;Magnetic Resonance Cholangiopancreatographies;Magnetic Resonance Cholangiopancreatography;Magnetic resonance cholangiopancreatography;magnetic resonance cholangiopancreatography;MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP);MRCP - Magnetic resonance cholangiopancreatography|C0994163|||C0994163|HCPCS;MSH;SNOMEDCT|1|0.6294|1
MRCP|MR cholangiopancreatography||||||1|0.2912|
MRCP|Magnetic resonance cholangiography||||||1|0.0206|
MRCP|Magnetic resonance cholangiopancreatography (procedure)||||C0994163|SNOMEDCT|||
MRCP|magnetic resonance cholangiopancreatograph||1|1.000|||||1
MRCP|mental retardation, cerebral palsy||||||||1
MRCP|movement-related cortical potential;movement-related cortical potentials||||||1|0.0588|1
MRCP|mrcp||||C0994163|HCPCS|||
MRI|Imaging, Magnetic Resonance;Magnetic Resonance Imaging;Magnetic resonance imaging;Magnetic resonance imaging, NOS;magnetic resonance images;magnetic resonance imaging;MRI - Magnetic resonance imaging;magnetic resonance imaging (MRI)|C0024485;C1552358|1|1|C0024485;C1552358|AOD;CCS;CHV;CSP;HL7V3.0;LCH;MEDLINEPLUS;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.9931|1
MRI|Imaging, NMR;NMR Imaging;nmr imaging;MR - Magnetic resonance;MR Tomography;Tomography, MR;MRI;MRI, NOS;Magnetic Resonance Imaging Scan;Magnetic resonance imaging scan;Magnetic resonance imaging - action;Magnetic resonance study;Magnetic resonance technique;NMR - Nuclear magnetic resonance;NMR Tomography;Tomography, NMR;Nuclear Magnetic Resonance Imaging;imaging magnetic nuclear resonance;nuclear magnetic resonance imaging;Zeugmatography|C0024485|||C0024485|AOD;CHV;CSP;LNC;MSH;NCI;SNOMEDCT|1|0.0004|
MRI|MR TOMOGR;TOMOGR MR||||C0024485|MSH|||
MRI|MRI Scan;MRI Scans|C0024485;C0917711|||C0024485|MEDLINEPLUS;NCI|||
MRI|Magnetic resonance imaging (procedure)||||C0024485|SNOMEDCT|||
MRI|Magnetic resonance imaging - action (qualifier value)||||C0024485|SNOMEDCT|||
MRI|Magnetic resonance study (procedure)||||C0024485|SNOMEDCT|||
MRI|Magnetic resonance: [imaging] or [study]||||C0024485|SNOMEDCT|||
MRI|Magnetic resonance: [imaging] or [study] (procedure)||||C0024485|SNOMEDCT|||
MRI|Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance||||C0024485|NCI|||
MRI|NMR|C0024485;C0028580|||C0024485|CSP;MEDLINEPLUS;PDQ|||
MRI|NMR Scan||||C0024485|SNOMEDCT|||
MRI|NMR TOMOGR;TOMOGR NMR||||C0024485|MSH|||
MRI|NMRI|C0024485;C1513846|||C0024485|NCI|||
MRI|Nuclear magnetic resonance;Nuclear magnetic resonance NOS;nuclear magnetic resonance|C0024485;C0028580;C1547989|||C0024485|MEDLINEPLUS;PDQ;SNOMEDCT|||
MRI|Nuclear magnetic resonance NOS (procedure)||||C0024485|SNOMEDCT|||
MRI|Research Institute|C0035172|||||1|0.0005|
MRI|ZEUGMATOGR||||C0024485|MSH|||
MRI|machine-readable identifier||||||||1
MRI|magnetic resonance|C0028580;C0917874;C1551403|||||1|0.004|
MRI|magnetic resonance imagery||||||1|0.0006|
MRI|magnetic resonance tomography||||||1|0.0013|
MRI|medical records information||||||||1
MRI|moderate renal insufficiency||||||||1
MR|ALDOSTERONE RECEPTOR;Aldosterone Receptor|C0051133;C0066563|||C0066563;C1417835|NCI;OMIM|||
MR|HISTIOCYTOMA, GIANT CELL|C0035290;C0311284|||C0311284|DXP|||
MR|LIPOID DERMATOARTHRITIS;Lipoid dermatoarthritis;lipoid dermatoarthritis;MRH;Multicentric Reticulohistiocytosis;Multicentric reticulohistiocytosis;multicentric reticulohistiocytosis;Nicolau-Balus syndrome;RETICULOHISTIOCYTOMA, MULTICENTRIC|C0311284|||C0311284|CHV;DXP;MTH;MTHICD9;NCI;SNOMEDCT|1|0.0015|1
MR|Lipoid dermatoarthritis (disorder)||||C0311284|SNOMEDCT|||
MR|MAURITANIA;Mauritania;mauritania|C0024943|||C0024943|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MR|MCR;MLR|C0066563;C1417835;C1705928|||C0066563;C1417835|NCI;OMIM|||
MR|MINERALOCORTICOID RECEPT;RECEPT MINERALOCORTICOID;RECEPT MINERALOCORTICOIDS||||C0066563|MSH|||
MR|MINERALOCORTICOID RECEPTOR;Mineralocorticoid Receptor;Mineralocorticoid Receptors;Mineralocorticoids Receptors;Receptor, Mineralocorticoid;Receptors, Mineralocorticoid;Receptors, Mineralocorticoids;mineralocorticoid receptor;NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2;Nuclear Receptor Subfamily 3 Group C Member 2;nuclear receptor subfamily 3, group C, member 2|C0066563;C1417835|||C0066563;C1417835|CSP;HUGO;MSH;MTH;NCI;NDFRT;OMIM|1|0.0339|1
MR|MR|C2347167|||C0024943;C0066563;C0311284;C1417835;C1996908|DXP;HUGO;LNC;NCI;OMIM|||
MR|MR (in LOINC)||||C1996908|MTH|||
MR|MRT|C0024943;C2949870|||C0024943|NCI|||
MR|Maddox rod||||||||1
MR|Maillard reaction|C0024495|||||1|0.0007|
MR|Maudsley Reactive||||||1|0.0016|
MR|Mauritania (geographic location)||||C0024943|SNOMEDCT|||
MR|Menstrual regulation;menstrual regulation|C0025335|||||1|0.0014|1
MR|Mental Rotation||||||1|0.0008|
MR|Moro reflex|C0234173|||||||1
MR|Multicentric reticulohistiocytosis (disorder)||||C0311284|SNOMEDCT|||
MR|NR3C2||||C0066563;C1417835|HUGO;NCI;OMIM|||
MR|NR3C2 Gene;NR3C2 gene;Nuclear Receptor Subfamily 3, Group C, Member 2 Gene|C1417835|||C1417835|HUGO;MTH;NCI|||
MR|Receptors, Mineralocorticoid [Chemical/Ingredient]||||C0066563|NDFRT|||
MR|macrophage mannose receptor|C1417249|||||1|0.0008|
MR|magnetic resonance|C0028580;C0917874;C1551403|1|0.628|C0028580;C0917874;C1551403|CHV;HL7V3.0;MSH;MTH;NCI|1|0.7672|1
MR|magnetoresistance||||||1|0.0008|
MR|malar rash|C0277942|||||||1
MR|mandelate racemase|C0065635|||||1|0.0009|
MR|mandible ramus||||||||1
MR|mandibular reflex||||||||1
MR|manifest refraction|C1301318|||||||1
MR|mannose-resistant||||||1|0.0023|1
MR|maximal right||||||||1
MR|may repeat||||||||1
MR|measles-rubella||||||||1
MR|medial rectus|C0224130;C0582820|||||1|0.0022|1
MR|medial rotation|C0231459|||||||1
MR|median raphe||||||1|0.0021|1
MR|median raphe nucleus|C0228432|||||1|0.0024|
MR|medical record|C0025102|1|0.002|C0025102|CHV;CSP;MSH;NCI;SNOMEDCT|||1
MR|medical rehabilitation|C0034991|||||||1
MR|medication responder||||||||1
MR|medium range||||||||1
MR|megaroentgen||||||||1
MR|mental retardation|C0025362|1|0.006|C0025362|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICPC;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.0234|1
MR|mentally retarded|C0079822|||C0079822|AOD;CHV;MSH;MTH|1|0.0032|1
MR|mesencephalic raphe||||||||1
MR|metabolic rate|C0870882|||C0870882|CHV|1|0.0079|1
MR|metabolic ratio||||||1|0.0072|
MR|methemoglobin reductase|C0025636;C1412802|||C0025636;C1412802|MSH;MTH;OMIM|||1
MR|methicillin-resistant|C1955827|||C1955827|MSH|1|0.002|
MR|methyl red|C0066279|||C0066279|MSH;MTH;SNOMEDCT|||1
MR|milk replacer||||||1|0.0009|
MR|milk ring||||||||1
MR|milliroentgen||||||||1
MR|minor responses||||||1|0.001|
MR|mitochondria-rich||||||1|0.0039|
MR|mitotic rate||||||1|0.0017|
MR|mitral reflux||||||||1
MR|mitral regurgitation|C0026266|1|0.352|C0026266|CHV;COSTAR;CSP;DXP;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0578|1
MR|mixed respiratory||||||||1
MR|moderate resistance||||||||1
MR|modified release|C1709058|||||1|0.0022|
MR|modulation rate||||||||1
MR|mol wt||||||1|0.0039|
MR|molecular remission||||||1|0.0008|
MR|molecular replacement||||||1|0.0007|
MR|molecular size|C0596969|||||1|0.0005|
MR|molecular weight|C0026385|||||1|0.0325|
MR|morbid risk||||||1|0.0004|
MR|morphinone reductase|C0255930|||||1|0.0005|
MR|mortality rate|C0026565;C0205848|||C0026565;C0205848|AOD;CHV;NCI;SNOMEDCT|1|0.0022|1
MR|mortality ratio||||||1|0.0017|1
MR|mother-reared||||||1|0.001|
MR|motivation research||||||||1
MR|multiplication rate||||||||1
MR|multiplicity reactivation||||||||1
MR|multiresistant||||||1|0.0008|
MR|muscle receptor||||||||1
MR|muscle relaxant|C0358430;C2911818|||C0358430;C2911818|CHV;CSP;NCI;NDFRT|||1
MR|myocardial revascularization|C0027056|||C0027056|AOD;CHV;LCH;MSH;SNOMEDCT|||1
MR|myotactic reflex||||||||1
MR|relative molecular mass||||||1|0.0238|1
MR|resistance|C0237834;C1514892|||||1|0.0014|
MRSA|Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus||||C2350012|ICD9CM|||
MRSA|Encounter due to methicillin resistant Staphylococcus aureus;Personal history of Methicillin resistant Staphylococcus aureus|C2350012|||C2350012|ICD9CM;MTH|||
MRSA|Hx Methicln resist Staph||||C2350012|ICD9CM|||
MRSA|Infection due to Methicillin resistant Staphylococcus aureus;MRSA - Methicillin resistant Staphylococcus aureus infection;methicillin-resistant staphylococcus aureus (MRSA) infection;MRSA infection;mrsa infection;Methicillin resistant Staphylococcus aureus infection;Methicillin-resistant staphylococcus aureus infection|C0343401|||C0343401|CHV;MTH;SNOMEDCT|||
MRSA|METHICILLIN RESISTANT STAPH AUREUS||||C1265292|MSH|||
MRSA|MRSA|C0343401;C1265292;C2350012|||C0343401;C1265292;C2350012|CHV;CSP;MEDLINEPLUS;MSH;MTHICD9;SNOMEDCT|||
MRSA|MRSA - Methicillin-resistant staphylococcus aureus;methicillin resistant staphylococcus aureus (MRSA);Methicillin Resistant Staphylococcus Aureus;Methicillin resistant Staphylococcus aureus;Methicillin resistant staphylococcus aureus;Methicillin-Resistant Staphylococcus aureus;Methicillin-resistant Staphylococcus aureus;Methicillin-resistant staphylococcus aureus;Staphylococcus aureus.methicillin resistant;methicillin resistant Staphylococcus aureus;methicillin-resistant Staphylococcus aureus|C0343401;C1265292|1|1|C0343401;C1265292|CHV;CSP;LNC;MEDLINEPLUS;MSH;MTHICD9;SNOMEDCT|1|0.9512|1
MRSA|Meth resis Staph carrier||||C2350012|ICD9CM|||
MRSA|Methicillin resistant Staphylococcus aureus (organism)|C1265292|||C1265292|MTH;SNOMEDCT|||
MRSA|Methicillin resistant Staphylococcus aureus infection (disorder);Methicillin-resistant staphylococcus aureus infection (disorder)||||C0343401|SNOMEDCT|||
MRSA|Methicillin-resistant S aureus||||||1|0.0072|
MRSA|Methicillin-resistant Staphylococcus aureus strains||||||1|0.003|
MRSA|methicillin-resistant;resistant to methicillin|C1955827|||||1|0.0335|
MRSA|methicillin-resistant strains||||||1|0.0051|
MS|(drug) MS;medical student|C0038495|1|0.004|||||
MS|5-@METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE;5-methyltetrahydrofolate-homocysteine methyltransferase;METHIONINE SYNTHASE;methionine synthase;TETRAHYDROPTEROYLGLUTAMATE METHYLTRANSFERASE|C0039676;C1417453|||C0039676;C1417453|CHV;CSP;HUGO;MSH;NDFRT;OMIM;SNOMEDCT|1|0.005|
MS|ANAL MASS SPECTRUM;MASS SPECTRUM ANAL;SPECTRUM ANAL MASS||||C0037813|MSH|||
MS|Analyses, Mass Spectrum;Mass Spectrum Analyses;Spectrum Analyses, Mass;Analysis, Mass Spectrum;Mass Spectrum Analysis;Spectrum Analysis, Mass;mass spectrum analysis;MASS SPECTROMETRY;Mass Spectrometry;Mass spectrometry;Spectrometry, Mass;mass spectrometry;Mass Spec;Mass Spectroscopy;Spectroscopy, Mass;mass spectroscopy;Mass Spectrum;Mass spectrometry measurement;Mass spectrometry measurement, NOS;Mass spectroscopy measurement;Mass spectroscopy measurement, NOS;mass spectrography|C0037813|||C0037813|AOD;CHV;CSP;LCH;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.0967|1
MS|Chinese Meishan||||||1|0.0008|
MS|DISSEMINATED SCLEROSIS;Disseminated Sclerosis;Disseminated sclerosis;SCLEROSIS, DISSEMINATED;Sclerosis, Disseminated;disseminated sclerosis|C0026769;C1868685|||C0026769;C1868685|CHV;CSP;DXP;MSH;NDFRT;OMIM;SNOMEDCT|||
MS|DS - Disseminated sclerosis;Generalised multiple sclerosis;Generalized multiple sclerosis;SCLEROSIS, INSULAR;insular sclerosis|C0026769|||C0026769|CHV;CSP;DXP;SNOMEDCT|||
MS|Generalized multiple sclerosis (disorder)||||C0026769|SNOMEDCT|||
MS|M.S.|C0369637;C0441923;C1553034|||C1513009|NCI|||
MS|MASS SPECTROMETER, CLINICAL USE;Mass Spectrometer;mass spectrometer;Mass Spectrometers (device)|C0183396|||C0183396|CHV;MTH;NCI;SPN|1|0.0042|
MS|MH||||C0026514|NCI|||
MS|MITRAL STENOSIS;Mitral Stenosis;Mitral stenosis;STENOSIS, MITRAL;Stenosis, Mitral;mitral stenosis;MITRAL VALVE STENOSIS;MITRAL VALVE, STENOSIS;Mitral Valve Stenosis;Mitral valve stenosis;Mitral valve stenosis, NOS;Stenosis, Mitral Valve;Valve Stenosis, Mitral;mitral valve stenosis|C0026269;C0264766|1|0.002|C0026269;C0264766|CHV;COSTAR;CSP;DXP;ICD9CM;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.0243|1
MS|MONTSERRAT;Montserrat;Montserrat island|C0026514|||C0026514|AOD;MSH;MTH;NCI;SNOMEDCT|||
MS|MS;Ms;Ms.;ms|C2349943|||C0025867;C0026221;C0026269;C0026514;C0026769;C0037813;C0183396;C0439223;C1417325;C1417453;C1513009;C1552156;C1868685;C1881819;C2349943|CHV;CSP;DXP;HL7V3.0;HUGO;MEDLINEPLUS;MSH;NCI;OMIM;SNOMEDCT|||
MS|MS (Multiple Sclerosis);MS - Multiple sclerosis;MS multiple sclerosis;multiple sclerosis (MS);multiple sclerosis MS;MULTIPLE SCLEROSIS;Multiple Sclerosis;Multiple sclerosis;Multiple sclerosis NOS;Multiple sclerosis, NOS;SCLEROSIS MULTIPLE;SCLEROSIS, MULTIPLE;Sclerosis, Multiple;multiple sclerosis;multiples sclerosis|C0026769;C1417325|1|0.414|C0026769;C1417325|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;HUGO;ICD9CM;ICPC;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;QMR;SNOMEDCT|1|0.737|1
MS|MS - Mitral stenosis;Mitral Stenoses;Stenoses, Mitral;Mitral Valve Stenoses;Stenoses, Mitral Valve;Valve Stenoses, Mitral|C0026269|||C0026269|MSH;SNOMEDCT|||
MS|MS gene|C1417325|||C1417325|HUGO;MTH|||
MS|MS1|C1417325;C1868685|||C1417325;C1868685|HUGO;OMIM|||
MS|MSR|C0026514;C1417458;C1826541|||C0026514|NCI|||
MS|MTR;MTR gene;cblG|C1417453|||C1417453|HUGO;MTH;OMIM|||
MS|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO|C1868685|||C1868685|MTH;OMIM|||
MS|MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1||||C1868685|OMIM|||
MS|Manchester Scale||||||1|0.0005|
MS|Mass spectrometry (procedure)||||C0037813|SNOMEDCT|||
MS|Mass spectrometry measurement (procedure)||||C0037813|SNOMEDCT|||
MS|Master of Science;master of science|C1513009|1|0.006|C1513009|HL7V2.5;MTH;NCI|||
MS|Maternal serum||||||1|0.0042|
MS|Meal size||||||1|0.0006|
MS|Mean sensitivity||||||1|0.0027|
MS|Meckel syndrome|C0265215|||||||1
MS|Mental Stress|C0038443|||||1|0.0013|
MS|Metric System;Metric Systems;Metric system;System, Metric;Systems, Metric;metric system|C0025867|||C0025867|CHV;LCH;MSH;MTH;NCI|||
MS|Microbiology Susceptibility;Microbiology Susceptibility Domain|C1881819|||C1881819|MTH;NCI|||
MS|Millisecond;millisecond;milliseconds;Msec;msec;millisecond (ms)|C0439223|||C0439223|CHV;MTH;NCI;SNOMEDCT|1|0.0029|1
MS|Mississippi;mississippi;Mississippi (geographic location)|C0026221|||C0026221|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
MS|Mitral Valve Stenosis [Disease/Finding]||||C0026269|NDFRT|||
MS|Mitral valve stenosis (disorder)||||C0026269|SNOMEDCT|||
MS|Montserrat island (geographic location)||||C0026514|SNOMEDCT|||
MS|Ms. - Title|C2349943;C1519530;C1704446;C1705823;C1705824|||C2349943|MTH|||
MS|Multiple Sclerosis [Disease/Finding]||||C0026769|NDFRT|||
MS|Multiple sclerosis (disorder);Multiple sclerosis NOS (disorder)||||C0026769|SNOMEDCT|||
MS|Murashige and Skoog;Murashige-Skoog||||||1|0.0063|
MS|Mycoplasma synoviae|C0317810|||||1|0.0045|
MS|Photometry/Spectrum Analysis, Mass||||C0037813|NCI|||
MS|Supernumerary mandibular left primary canine|C1552156|||C1552156|MTH|||
MS|duration|C0449238;C2926735|||||1|0.0007|
MS|interval|C1272706;C1552654;C1552713|||||1|0.0008|
MS|magnetic source||||||1|0.0008|
MS|magnetic stimulation||||||1|0.0021|
MS|main scale||||||||1
MS|mainstream|C0024500|||C0024500|CHV|1|0.0025|
MS|mainstream smoke||||||1|0.0015|
MS|maladjustment score||||||||1
MS|malate synthase|C0024545|||C0024545|CSP;MSH;MTH;NDFRT;SNOMEDCT|||
MS|malignant Schwannoma;malignant schwannoma|C0751690|||C0751690|CHV;MSH;NCI;OMIM;SNOMEDCT|1|0.0006|
MS|mannose-sensitive||||||1|0.0032|1
MS|manuscript|C0600659|||C0600659|AOD;CHV;NCI|||1
MS|marbling score||||||1|0.0007|
MS|marijuana smokers||||||1|0.0005|
MS|mass screening|C0024870|||||1|0.0013|
MS|mass spectral||||||1|0.0007|
MS|mass spectrometric||||||1|0.0116|
MS|mass spectrophotometer||||||||1
MS|maternal separation||||||1|0.0017|
MS|maxillary sinus|C0024957;C1278899|||||||1
MS|mean score||||||||1
MS|mechanical stimulation|C1285354|||||||1
MS|mechanosensitive||||||1|0.0038|
MS|medial septal||||||1|0.0032|
MS|medial septal nucleus|C0175233|||||1|0.0016|
MS|medial septum||||||1|0.008|
MS|median sternotomy|C1282959|||||1|0.0008|1
MS|median survival||||||1|0.0038|
MS|medical services|C0587569|||||||1
MS|medical supply|C0740043|||||||1
MS|medical survey||||||||1
MS|medical-surgical|C1552239;C1555987|||||||1
MS|medium|C0009458;C0439536;C1705217|||||1|0.001|
MS|melanonychia striata|C1142305|||||||1
MS|menopausal syndrome|C0025319|||||||1
MS|mental status|C0278060|||||||1
MS|metabolic syndrome|C0524620;C0948265|||||1|0.0134|1
MS|methionine synthetase|C0039676|||C0039676|CHV;MSH;NDFRT|1|0.0009|
MS|methyl salicylate|C0066282|||||1|0.0008|
MS|microsatellite|C1519302|||C1519302|CHV;MSH;NCI|1|0.0038|
MS|microscope slide|C0026017|||||||1
MS|microsphere;microspheres|C0026032|||C0026032|CHV;CSP;LCH;MSH;NCI|1|0.0092|
MS|middle suprasylvian||||||1|0.0008|
MS|mild steel||||||1|0.0012|
MS|milkshake||||||||1
MS|mineralizing surface||||||1|0.0007|
MS|minimal support||||||||1
MS|mitral sound||||||||1
MS|mobile surgical||||||||1
MS|modal sensitivity||||||||1
MS|moderately susceptible|C0442815|||||||1
MS|molar solution||||||||1
MS|molar substitution||||||1|0.0005|
MS|mongolian spot|C0265985|||||||1
MS|morning stiffness|C0457086|||||||1
MS|morphine|C0026549;C2698261|||||1|0.0014|
MS|morphine sulfate|C0066814|1|0.558|C0066814|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0071|1
MS|motile sperm||||||||1
MS|motion sickness|C0026603|||C0026603|AOD;CHV;COSTAR;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0028|
MS|ms (qualifier value)||||C0439223|SNOMEDCT|||
MS|mucosal-to-serosal||||||1|0.0008|
MS|mucosubstance||||||||1
MS|multilaminated structure||||||||1
MS|multiple sclerosys||||C0026769|CHV|||
MS|multiple sderosis||||||1|0.0008|
MS|multiple-scattering||||||1|0.0008|
MS|multiples sclerosi||||C0026769|CHV|||
MS|murmurs|C0018808|||||||1
MS|muscle shortening|C0185423|||||||1
MS|muscle spasm|C0037763|||||||1
MS|muscle strength|C0517349|||||||1
MS|musculoskeletal|C0497254;C2707260|1|0.004|||||1
MS|mutans streptococci||||||1|0.0115|
MS|mutator strain||||||1|0.0006|
MS|myasthenic syndrome|C0022972;C0549225|||||||1
MS|myeloid sarcoma|C0152276|||||||1
MS|strength|C0237897;C0808080;C1705922|||||1|0.0008|
MSSA|Encounter due to Methicillin susceptible Staphylococcus aureus|C2355591|||C2355591|MTH|||
MSSA|MSSA;Methicillin susceptible Staphylococcus aureus;methicillin-susceptible Staphylococcus aureus|C1635274;C2355591|1|0.164|C1635274;C2355591|ICD9CM;MTHICD9;SNOMEDCT|1|0.3333|1
MSSA|Meth susc Staph carrier||||C2355591|ICD9CM|||
MSSA|Methicillin susceptible Staphylococcus aureus (organism)|C1635274|||C1635274|MTH;SNOMEDCT|||
MSSA|Methicillin-susceptible S aureus||||||1|0.0133|
MSSA|methicillin-sensitive||||||1|0.0733|
MSSA|methicillin-sensitive S aureus||||||1|0.04|
MSSA|methicillin-sensitive Staphylococcus aureus||||||1|0.38|
MSSA|methicillin-susceptible||||||1|0.16|
MSSA|modified selective severity assessment||1|0.836|||||
MTP|ABL||||C1826328|HUGO|||
MTP|D-Glucose, 4-O-alpha-D-glucopyranosyl-, tetrahexadecanoate;Maltose tetrapalmitate;maltose tetrapalmitate;maltose tetrapalmitate (MTP)|C0065610|||C0065610|CHV;MSH;MTH;SNOMEDCT|1|0.0443|
MTP|MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN, 88-KD;MTP, LARGE SUBUNIT;MTTP gene|C1826328|||C1826328|HUGO;MTH;OMIM|||
MTP|MTP|C0065610;C1826328|||C0065610;C1826328|OMIM;SNOMEDCT|||
MTP|MTTP|C0069187;C1538010;C1826328|||C1826328|HUGO;OMIM|||
MTP|Maltose tetrapalmitate (substance)||||C0065610|SNOMEDCT|||
MTP|Treatment Project||||||1|0.0285|
MTP|first metatarsophalangeal||||||1|0.0823|
MTP|master treatment plan||||||||1
MTP|maximal tolerated pressure||||||||1
MTP|medial tibial plateau||||||||1
MTP|median time to progression||||||1|0.0222|
MTP|median time to tumor progression||||||1|0.0222|
MTP|medical termination of pregnancy|C3146282|||||1|0.0443|1
MTP|mesencephalic tegmental paralysis|C0455715|||||||1
MTP|metatarsal periostitis||||||||1
MTP|metatarsophalangeal||1|1.000|||||1
MTP|microsomal triglyceride transfer protein|C0207079;C1826328|||C0207079;C1826328|HUGO;MSH;MTH|1|0.6203|1
MTP|microtubule protein;microtubule proteins|C0026042|||||1|0.0158|1
MTP|mitochondrial permeability transition pore|C0908146;C2000322|||C0908146|MSH;MTH|1|0.057|
MTP|mitochondrial transmembrane potential||||||1|0.0633|
MTP|multidisciplinary treatment plan||||||||1
MUGA|MUGA;MUGA - Multiple-gated acquisition;MUGA Scan;MUGA scan;muga scan;muga scans;scan muga;Multi-Gated Acquisition Scan;Multiple gated acquisition scanning;Multiple gated acquisition scanning, NOS;acquisition gated multiple scanning;multiple gated acquisition scan;Radionuclide Ventriculogram Scan|C0521317|||C0521317|CHV;NCI;SNOMEDCT|||
MUGA|MUGA - Multiple-gated acquisiton||||C0521317|SNOMEDCT|||
MUGA|Multiple gated acquisition;multiple gated acquisition||1|1|||1|0.4074|1
MUGA|Multiple gated acquisition scanning (procedure)||||C0521317|SNOMEDCT|||
MUGA|multigated angiogram||||||||1
MUGA|radionuclide angiography|C0034604|||||1|0.2222|
MUGA|radionuclide ventriculography|C0034610|||||1|0.3704|
MVA|AVM protocol;doxorubicin/mitomycin/vinblastine protocol|C0052712|||C0052712|MSH;MTH|||
MVA|DOX/MITO/VBL||||C0052712|NCI;PDQ|||
MVA|Doxorubicin/Mitomycin/Vinblastine;doxorubicin/mitomycin/vinblastine||||C0052712|NCI;PDQ|||
MVA|Instability mitotic non disjunction syndrome;MOSAIC VARIEGATED ANEUPLOIDY SYNDROME;Mosaic variegated aneuploidy syndrome;MVA SYNDROME|C1850343|||C1850343|MSH;MTH;OMIM|||
MVA|MOTOR VEHICLE ACCIDENT;Motor vehicle accident;motor vehicle accident|C0000932;C1553508;C2939181|1|0.986|C0000932;C1553508;C2939181|CHV;COSTAR;HL7V3.0;MTH;SNOMEDCT|1|0.1809|1
MVA|MOTOR VEHICLE TRAFFIC ACCIDENTS;Motor vehicle traffic accident;Motor vehicle traffic accident NOS;MVA - Motor vehicle accident;MVTA - Motor vehicle traffic accident|C2939181|||C2939181|ICD9CM;SNOMEDCT|||
MVA|MVA|C0052712;C1850343;C2939181|||C0052712;C1850343;C2939181|NCI;OMIM;PDQ;SNOMEDCT|||
MVA|Modified vaccinia Ankara||||||1|0.0589|
MVA|Modified vaccinia virus Ankara;modified vaccinia virus Ankara||||||1|0.187|1
MVA|Motor vehicle accident (event)||||C2939181|SNOMEDCT|||
MVA|Motor vehicle collision NOS|C0000932|||C2939181|SNOMEDCT|||
MVA|Motor vehicle collision NOS (event)||||C2939181|SNOMEDCT|||
MVA|Motor vehicle collision NOS (finding)||||C2939181|SNOMEDCT|||
MVA|Motor vehicle traffic accident (event);Motor vehicle traffic accident NOS (event)||||C2939181|SNOMEDCT|||
MVA|Motor vehicle traffic accident (finding);Motor vehicle traffic accident NOS (finding)||||C2939181|SNOMEDCT|||
MVA|Multivariate analysis;multivariate analysis|C0026777|||C0026777|AOD;CHV;MSH|1|0.0366|
MVA|RTA - motor vehicle||||C2939181|SNOMEDCT|||
MVA|car/truck accident||||C2939181|AOD|||
MVA|malignant ventricular arrhythmia||||||||1
MVA|manual vacuum aspiration||||||1|0.0874|1
MVA|mechanical ventricular assistance||||||||1
MVA|mevalonate|C0677647|||C0677647|CHV;CSP;LNC;MSH;SNOMEDCT|1|0.0874|
MVA|mevalonic acid|C0025879|||||1|0.1037|1
MVA|microvascular angina|C0206064|||C0206064|CHV;MSH;NDFRT|||
MVA|microvascular angiopathy||||||||1
MVA|microvillus atrophy||||||||1
MVA|mitral valve area|C0428818|||C0428818|SNOMEDCT|1|0.2581|1
MVI|malignant vascular injury||||||||1
MVI|mitral valve insufficiency|C0026266|||||||1
MVI|motor vehicle injury|C1318747|||||||1
MVI|multi vitamin||1|1.000|||||
MVI|multiple vitamin injection||||||||1
MVI|multivalvular involvement||||||||1
MVI|multivitamin infusion||||||||1
N0|Lymph Node Stage N0;N0 Lymph Node Stage;N0;N0 Cancer Stage Finding;N0 Lymph Node Finding;N0 Node Finding;N0 Node Stage;Node Stage N0;Node stage N0;N0 Regional Lymph Node Stage Finding;N0 Stage;N0 stage;N0 Stage Finding;N0 stage (finding);N0 TNM Finding;N0 category|C0441959|||C0441959|MTH;NCI;SNOMEDCT|||
N0|N0 Regional Lymph Nodes Finding||||C0441959|NCI|||
N0|N0 category (finding)||||C0441959|SNOMEDCT|||
N0|N0 stage (tumor staging)||||C0441959|SNOMEDCT|||
N0|NO|C1298908;C1549444|||C0441959|SNOMEDCT|||
N0|Node stage N0 (tumor staging)||||C0441959|SNOMEDCT|||
N0|clinically negative||||||1|0.1875|
N0|clinically negative neck||||||1|0.125|
N0|lymph node involvement|C0806692|||||1|0.1042|
N0|no lymph nodes containing cancer cells||1|1.000|||||1
N0|node-negative|C0279781;C0678034|||C0279781;C0678034|CHV;NCI|1|0.5833|
NAD|.Beta.-NAD;Adenine Dinucleotide, Dihydronicotinamide;Dihydronicotinamide Adenine Dinucleotide;Dinucleotide, Dihydronicotinamide Adenine;dihydronicotinamide adenine dinucleotide;Co-I;Codehydrogenase I;Coenzyme I;Cozymase;DPN;Dinucleotide, Nicotinamide-Adenine;Nicotinamide Adenine Dinucleotide;Nicotinamide adenine dinucleotide;Nicotinamide-Adenine Dinucleotide;nicotinamide adenine dinucleotide;nicotinamide-adenine dinucleotide;Diphosphopyridine Nucleotide;Nucleotide, Diphosphopyridine;NAD;NAD+;nad;NADIDE;Nadide;Nicotinamide adenine dinucleotide (NAD);nicotinamide adenine dinucleotide (NAD)|C0027270|||C0027270;C0205748;C1850380|AOD;CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;RXNORM;SNOMEDCT|1|0.8123|1
NAD|3-Carbamoyl-1-.Beta.-D-Ribofuranosylpyridinium Hydroxide 5'-5'-Ester with Adenosine 5'-(Trihydrogen Pyrophosphate) Inner Salt||||C0027270|NCI|||
NAD|3-Carbamoyl-1-.Beta.-D-Ribofuranosylpyridinium Hydroxide, 5'-Ester with Adenosine 5'-Pyrophosphate, Inner Salt||||C0027270|NCI|||
NAD|Adenosine 5'-(Trihydrogen Diphosphate), 5'-5'-Ester with 3-(Aminocarbonyl)-1-.Beta.-D-Ribofuranosylpyridinium, Hydroxide, Inner Salt||||C0027270|NCI|||
NAD|Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt||||C0027270|MSH;NDFRT|||
NAD|Atypical Nevus;Atypical naevus;Atypical nevus;atypical naevus;atypical nevi;atypical nevus;Atypical naevus of skin;Atypical nevus of skin;Clark Nevus;Clark's Nevus;DN - Dysplastic naevus;DN - Dysplastic nevus;Dysplastic Nevi;Dysplastic Nevus;Dysplastic naevus;Dysplastic nevus;Nevi, Dysplastic;Nevus, Dysplastic;dysplastic naevus;dysplastic nevi;dysplastic nevus;naevus dysplastic;Dysplastic naevus of skin;Dysplastic nevus of skin;Lentiginous Nevus;atypical nevis;dysplastic nevis|C0205748|||C0205748|CHV;MSH;MTH;NCI;SNOMEDCT|||
NAD|COENZYME A A 01||||C0027270|MSH|||
NAD|Dysplastic naevus (disorder)||||C0205748|SNOMEDCT|||
NAD|Dysplastic nevus (morphologic abnormality)||||C0205748|SNOMEDCT|||
NAD|Dysplastic nevus of skin (disorder)||||C0205748|SNOMEDCT|||
NAD|NAD [Chemical/Ingredient]||||C0027270|NDFRT|||
NAD|NEUTROPHIL ACTIN DYSFUNCTION|C1850380|||C1850380|MTH;OMIM|||
NAD|Neuroaxonal dystrophy;neuroaxonal dystrophy|C0338473|||C0338473|MSH;OMIM;SNOMEDCT|1|0.0686|
NAD|Nevus with Architectural Disorder and Cytologic Atypia of Melanocytes||||C0205748|NCI|||
NAD|Nicotinamide adenine dinucleotide (substance)||||C0027270|SNOMEDCT|||
NAD|[M] Dysplastic naevus;[M] Dysplastic nevus;[M]Dysplastic naevus;[M]Dysplastic nevus||||C0205748|SNOMEDCT|||
NAD|dehydrogenase|C0030016|||||1|0.0289|
NAD|nadolol|C0027302|||C0027302|AOD;CHV;CSP;LCH;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
NAD|nevus with architectural disorder||||||||1
NAD|new antigenic determinant||||||||1
NAD|nicotinic acid dehydrogenase||||||||1
NAD|no abnormal discovery||||||||1
NAD|no abnormality demonstrable||||||||1
NAD|no active disease||||||||1
NAD|no acute disease||||||||1
NAD|no acute distress||1|0.754|||||1
NAD|no apparent distress||||||||1
NAD|no appreciable disease||||||||1
NAD|noradrenaline|C0028351;C0202145|||||1|0.0903|
NAD|normal axis deviation|C1512122|||C1512122|NCI|||1
NAD|nothing abnormal detected||1|0.246|||||1
NAD|nothing abnormal discovered||||||||1
NAD|sodium dialysate||||||||1
NA|Country of Namibia;Republic of Namibia;South West Africa;Southwest Africa|C0027366|||C0027366|MSH;MTH|||
NA|Dietary Sodium;Sodium, Dietary;dietary sodium|C0037570|||C0037570|CSP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT|||
NA|Dosage Form Not Applicable||||C1705113|MTH;NCI|||
NA|N-acetyl||||||1|0.0029|
NA|N-acetyl compounds||||||1|0.0009|
NA|N/A;a n;n a;NOT APPLICABLE;Not Applicable;Not applicable;not applicable;{Not applicable}|C1272460|1|0.02|C1272460;C1546968;C1547280;C1549103;C1609491;C1610044;C1610595;C1611147;C1619691;C1705112;C1705113;C1705512|CHV;HL7V2.5;HL7V3.0;MTH;NCI;SNOMEDCT|||1
NA|NA;Na;{NA}|C0597484;C1272460|||C0027366;C0037473;C0037570;C1272460;C1417587;C1705113;C1705512;C2700321|AOD;CHV;HUGO;NCI|||
NA|NA gene;neurocanthocytosis|C1417587|||C1417587|HUGO;MTH|||
NA|NAM|C0027366;C2826269|||C0027366|NCI|||
NA|NAMIBIA;Namibia;namibia|C0027366;C1504632|||C0027366|AOD;CHV;LCH;MSH;NCI;SNOMEDCT|||
NA|Na - Sodium;na sodium;Sodium product;[TN440] SODIUM|C0037473|||C0037473|CHV;NDFRT;SNOMEDCT|||
NA|Na element|C0037473;C0597484|||C0037473|CSP|||
NA|Nadia;Nadia - zebrafish;Nadia Zebrafish|C2700321|||C2700321|MTH;NCI|||
NA|Namibia (geographic location)||||C0027366|SNOMEDCT|||
NA|Naphthalene|C0027375;C0027378|||||1|0.0022|
NA|Narcotics Anonymous||1|0.948|||||1
NA|Nephrogenic adenoma;nephrogenic adenoma|C0334039|||||1|0.0019|1
NA|No unit of measure required||||C1272460|NCI|||
NA|Nomina Anatomica||||||||1
NA|None or Not Applicable||||C1272460|NCI|||
NA|North America|C0028405|||||1|0.0019|
NA|North American|C0425358;C2700615|||||1|0.0036|
NA|Not applicable (qualifier value)||||C1272460|SNOMEDCT|||
NA|Route of Administration Not Applicable||||C1705512|MTH;NCI|||
NA|SODIUM;Sodium;Sodium (NOS);Sodium, NOS;sodium|C0037473;C0037570;C0597484|1|0.028|C0037473;C0037570|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0855|1
NA|Sodium (substance)||||C0037473|SNOMEDCT|||
NA|Sodium [Chemical/Ingredient]||||C0037473|NDFRT|||
NA|Sodium product (product)||||C0037473|SNOMEDCT|||
NA|Sodium product (substance)||||C0037473|SNOMEDCT|||
NA|Sodium, Dietary [Chemical/Ingredient]||||C0037570|NDFRT|||
NA|WA|C0043038|||C0027366|NCI|||
NA|[3H]-noradrenaline||||||1|0.0055|
NA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0036|
NA|applicable|C1272460;C1706839|||C1272460|CHV|||
NA|concentration|C0086045;C1446561|||||1|0.0015|
NA|influenza virus neuraminidase||||||1|0.0067|
NA|naked neck||||||1|0.0015|
NA|nalidixic acid|C0027353|||C0027353|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0134|1
NA|nanoampere||||||||1
NA|naphthenic acid|C0068418|||C0068418|MSH|||
NA|nasopharyngeal angiofibroma|C1367536|||||||1
NA|needle aspiration|C0181959;C2243017|||||||1
NA|negative affect||||||1|0.0077|
NA|negative affectivity||||||1|0.0062|
NA|neuraminidase|C0027803|||C0027803|CHV;CSP;LNC;MSH;MTH;NDFRT;SNOMEDCT|||1
NA|neurologic age||||||||1
NA|neuropathic arthropathy|C0003892|||||||1
NA|neutralizing antibodies;neutralizing antibody|C0475463;C1142254|||C0475463|CHV;CSP;MSH;NDFRT;SNOMEDCT|1|0.0087|1
NA|neutrophil antibody|C0807098|||C0807098|CHV;LNC|||1
NA|neutrophil antigen||||||1|0.001|
NA|new admission||||||||1
NA|nicotianamine|C0660841|||||1|0.0017|
NA|nicotinamide|C0028027;C1142101|||C0028027;C1142101|AOD;CHV;CSP;LNC;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0099|1
NA|nicotinic acid|C0027996;C0028049|||C0027996;C0028049|AOD;CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT;USPMG;VANDF|1|0.0183|1
NA|nitrosamine|C0028197|||C0028197|AOD;CHV;CSP;NCI;SNOMEDCT|||
NA|nitrous acid|C0028214|||C0028214|AOD;CSP;LCH;MSH;NDFRT;SNOMEDCT|||
NA|no abnormality||||||||1
NA|nocturnal asthma||||||1|0.0022|
NA|nodular amyloidoma||||||||1
NA|non-A||||||||1
NA|non-adherent||||||1|0.0015|
NA|nonadherent||||||1|0.0038|1
NA|nonalcoholic||||||||1
NA|nonamniotic||||||||1
NA|nonmyelinated axon|C0682683|||||||1
NA|noradrenalin;noradrenaline|C0028351;C0202145|||C0028351;C0202145|AOD;CHV;CSP;FMA;MSH;NCI;NDFRT;SNOMEDCT;UWDA|1|0.6919|
NA|noradrenaline-storing||||||1|0.0024|
NA|noradrenergic|C0599861|||||1|0.0332|
NA|norepinephrine|C0028351|||||1|0.0051|
NA|norethindrone acetate|C0068980|||C0068980|CHV;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0019|
NA|normal axis||||||||1
NA|nosocomially acquired||||||||1
NA|not admitted||||||||1
NA|not antagonized||||||||1
NA|not attempted||||||||1
NA|not available|C1548671|||C1548671|HL7V2.5|||1
NA|nuclear antibody|C0487261|||||||1
NA|nuclear antigen|C0069115|||C0069115|CHV|||1
NA|nuclear area||||||1|0.0094|
NA|nucleic acid|C0028606|||C0028606;C1325813|CHV;CSP;GO;NCI;SNOMEDCT|1|0.007|1
NA|nucleoside analog|C1579410|||C1579410|CHV;CSP;NDFRT|||
NA|nucleus accumbens|C0028633|||C0028633|AOD;CHV;CSP;FMA;MSH;SNOMEDCT|1|0.0202|1
NA|nucleus ambiguous||||||1|0.0024|
NA|nucleus ambiguus|C0152400;C1281211|||C0152400;C1281211|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0231|1
NA|nucleus angularis||||||1|0.0034|
NA|numeric aperture||||||||1
NA|numerical aperture||||||1|0.0038|
NA|nurse anesthetist|C1321571|1|0.002|||||
NA|nurse's aide;nursing assistant;nursing auxiliary|C0028663|||C0028663|AOD;CHV;HL7V3.0;MSH;NCI;SNOMEDCT|||
NA|nutrient agar||||||1|0.0019|
NA|release of [3H]noradrenaline||||||1|0.0019|
NG|1-Methyl-3-nitro-1-nitrosoguanidine;Guanidine, N-methyl-N'-nitro-N-nitroso-;MNNG;Methylnitronitrosoguanidine;Methylnitrosonitroguanidine;N Methyl N' nitro N nitrosoguanidine;N methyl N' nitro N nitrosoguanidine;N-Methyl-N'-nitro-N-nitrosoguanidine;N-Methyl-N-nitro-N-Nitrosoguanidine;N-methyl-N'-nitro-N-nitrosoguanidine;N'-nitro-N-nitroso-N-methylguanidine;Nitrosomethylnitroguanidine;Nitrosonitromethylguanidine|C0025800|||C0025800|CSP;MSH;MTH;NCI;NDFRT|1|0.0308|
NG|Did not receive therapy or drug for;did not receive therapy or drug for;untreated|C0332155|||C0332155|CHV;MTH;SNOMEDCT|||
NG|Did not receive therapy or drug for (contextual qualifier)||||C0332155|SNOMEDCT|||
NG|Did not receive therapy or drug for (contextual qualifier) (qualifier value)||||C0332155|SNOMEDCT|||
NG|Federal Republic of Nigeria;NIGERIA;Nigeria;nigeria|C0028075|||C0028075|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
NG|MNG|C0025800;C0026410|||C0025800|NCI|||
NG|Methylnitronitrosoguanidine [Chemical/Ingredient]||||C0025800|NDFRT|||
NG|NANOGRAM;Nanogram;nanogram;nanogram(s);nanograms;NGM;nanogram (ng)|C0439212|||C0439212|CHV;MTH;NCI;SNOMEDCT|||1
NG|NASOGASTRIC;Nasogastric;nasogastric;NG - Nasogastric route;NG - Nasogastric use;Nasogastric Route of Administration;Nasogastric Route of Drug Administration;Nasogastric route;Nasogastric use|C0694637|1|1|C0694637|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|1|0.1851|1
NG|NE||||C0028074|NCI|||
NG|NER|C0028074;C0524550;C1417823|||C0028074|NCI|||
NG|NG;Ng;ng||||C0025800;C0028074;C0028075;C0332155;C0439212;C0694637|CHV;LNC;NCI;SNOMEDCT|||
NG|NGA|C0028075;C1882122|||C0028075|NCI|||
NG|NI|C2348274|||C0028075|NCI|||
NG|NIGER;Niger;niger|C0028074;C0997002|||C0028074|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
NG|Nasogastric route (qualifier value)||||C0694637|SNOMEDCT|||
NG|Neisseria gonorrhoeae|C0027573|||||1|0.1028|1
NG|Niger (geographic location)||||C0028074|SNOMEDCT|||
NG|Nigeria (geographic location)||||C0028075|SNOMEDCT|||
NG|Nitroglycerine;nitroglycerin;nitroglycerine|C0017887;C0885378|||C0017887;C0885378|AOD;CHV|1|0.2313|
NG|Not treated for||||C0332155|SNOMEDCT|||
NG|Republic of Niger|C0028074|||C0028074|MSH|||
NG|group|C0441833;C0687744;C1257890;C1552516;C1705428;C1705429|||||1|0.0591|
NG|levonorgestrel|C0023566|||||1|0.0257|
NG|nanogram (qualifier value)||||C0439212|SNOMEDCT|||
NG|net grains/nucleus||||||1|0.0231|
NG|neurogranin|C0083727;C1417847|||C0083727;C1417847|MSH;MTH;NDFRT;OMIM|1|0.0386|
NG|neutrophil granulocytes||||||1|0.018|
NG|new growth|C0027651|||||||1
NG|ng (qualifier value)||||C0439212|SNOMEDCT|||
NG|night guard||||||||1
NG|nitrosoguanidine|C0028203|||C0028203|CSP|1|0.0231|
NG|no good||||||||1
NG|no growth|C0445119|||||||1
NG|nodose ganglia;nodose ganglion|C0028252|||C0028252|FMA;MSH;UWDA|1|0.1208|1
NG|nodular goiter|C0018023;C1318500|||C0018023;C1318500|CHV;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0231|
NG|nongenetic||||||||1
NG|nongroupable||||||||1
NG|norgestrel|C0028368|||C0028368|AOD;CHV;LCH;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.036|
NG|normal glucose|C0860800|||C0860800|CHV|1|0.0283|
NG|not given||||||||1
NG|nuclear grade|C1518435|||C1518435|CHV;NCI|1|0.054|
NJ|NJ;New Jersey;jersey new;new jersey|C0027971|1|0.002|C0027971|AOD;CHV;LCH;MSH;NCI;SNOMEDCT|1|0.3426|
NJ|New Jersey (geographic location)||||C0027971|SNOMEDCT|||
NJ|nanojoule||||||||1
NJ|nasojejunal||1|0.998|C0595833|SNOMEDCT|||1
NJ|neighbor-joining;neighbour-joining||||||1|0.6575|
NKDA|no known drug allergies|C0262581|1|1.000|||||1
NO|Lymph Node Stage N0;N0 Lymph Node Stage;N0;N0 Cancer Stage Finding;N0 Lymph Node Finding;N0 Node Finding;N0 Node Stage;Node Stage N0;Node stage N0;N0 Regional Lymph Node Stage Finding;N0 Stage;N0 stage;N0 Stage Finding;N0 stage (finding);N0 TNM Finding;N0 category|C0441959|||C0441959|MTH;NCI;SNOMEDCT|||
NO|N|C0369718;C0441922;C1553036|||C1298908|NCI|||
NO|N0 Regional Lymph Nodes Finding||||C0441959|NCI|||
NO|N0 category (finding)||||C0441959|SNOMEDCT|||
NO|N0 stage (tumor staging)||||C0441959|SNOMEDCT|||
NO|NO;No;no;no)|C1298908;C1549444|||C0028423;C0441959;C1298908;C1546943;C1546946;C1546967;C1548170;C1549056;C1549062;C1549442;C1549444|CHV;HL7V2.5;LNC;MTH;NCI;SNOMEDCT|||
NO|NOR||||C0028423|NCI|||
NO|NORWAY;Norway;norway|C0028423|||C0028423|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
NO|Nitric oxide;nitric oxide;nitric oxide gas;nitrogen monoxide|C0028128|1|0.002|C0028128|AOD;CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.9978|1
NO|No (qualifier value)||||C1298908|SNOMEDCT|||
NO|No - Assignment of Benefits|C1549442|||C1549442|MTH|||
NO|No - Event Expected||||C1546946|MTH|||
NO|No - Event Seriousness|C1546943|||C1546943|MTH|||
NO|No - Expanded yes/no indicator|C1549056|||C1549056|MTH|||
NO|No - Identity May Be Divulged||||C1546967|MTH|||
NO|No - Notify Clergy Code|C1549062|||C1549062|MTH|||
NO|No - Release Information|C1548170|||C1548170|MTH|||
NO|No - yes/no indicator|C1549444|||C1549444|MTH|||
NO|Node stage N0 (tumor staging)||||C0441959|SNOMEDCT|||
NO|Norway (geographic location)||||C0028423|SNOMEDCT|||
NO|concentration|C0086045;C1446561|||||1|0.0009|
NO|nasal oxygen||||||||1
NO|nitric oxide radical||||||1|0.0003|
NO|nitroso-||||||||1
NO|nitrous oxide|C0028215|||C0028215|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
NO|nobelium|C0028237|||||||1
NO|nodes|C0746922|||||1|0.0004|
NO|none obtained||||||||1
NO|nonobese||||||||1
NO|normal|C0205307;C0439166;C2347086|||C0205307;C0558145;C1550457;C1550469;C1551394;C1553386;C1553399;C1553402;C1553406;C1704701;C1873497;C2698497|CHV;HL7V2.5;HL7V3.0;LNC;MTH;NCI;OMIM;SNOMEDCT|||
NO|not operable||||||||1
NO|nucleolar organizer|C0028609|||C0028609|MSH|1|0.0003|
NO|nucleolus organizer||||||1|0.0003|
NO|number|C0237753;C0449788|1|0.004|||||1
NOS|EC 1.14.13.39||||C0132555|NCI|||
NOS|Endothelium-derived relaxation factor-forming enzyme||||C0132555|SNOMEDCT|||
NOS|Endothelium-derived relaxing factor synthase;NO Synthase;NO synthase;NO-synthase;Nitric Oxide Synthase;Nitric-Oxide Synthase;Nitric-oxide synthase;Oxide Synthase, Nitric;Synthase, Nitric Oxide;nitric oxide synthase;nitric oxide synthases;Nitric Oxide Synthetase;Nitric oxide synthetase;Nitric-Oxide Synthetase;nitric oxide synthetase;synthase|C0132555|||C0132555|CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.972|1
NOS|HEP-NOS;Macrophage Nitric Oxide Synthase;NITRIC OXIDE SYNTHASE, MACROPHAGE;NITRIC OXIDE SYNTHASE 2A;Nitric Oxide Synthase 2A;NOS2A|C0669372;C1417760|||C0669372;C1417760|HUGO;NCI;OMIM|||
NOS|HEP-NOS protein, human;Hepatocyte Nitric Oxide Synthase;NOS Type II;NOS2 protein, human;NOS2A protein, human;Nanos2 protein, human;hepatocyte NOS protein, human;iNOS protein, human;inducible nitric oxide 2A, human|C0669372|||C0669372|MSH;MTH;NCI|||
NOS|INOS;iNOS|C0669372;C1417760;C1968833|||C0669372;C1417760|HUGO;NCI;OMIM|||
NOS|Inducible Nitric Oxide Synthase;NITRIC OXIDE SYNTHASE, INDUCIBLE|C0669372;C1417760;C1533698|||C0669372;C1417760|NCI;OMIM|||
NOS|L-Arginine,NADPH:oxygen oxidoreductase (nitric-oxide-forming)||||C0132555|MSH;NDFRT|||
NOS|NADPH-Diaphorase|C0027312;C0132555|||C0132555|NCI|||
NOS|NOS;Not Otherwise Specified;Not otherwise specified;not otherwise specified;{NOS}|C1518425|1|0.986|C0132555;C0669372;C1417760;C1518425;C1705516|CSP;HUGO;LNC;MTH;NCI|1|0.0253|1
NOS|NOS1 wt Allele|C1705516|||C1705516|MTH;NCI|||
NOS|NOS2||||C0669372;C1417760|HUGO;NCI;OMIM|||
NOS|NOS2 gene;NOS2A Gene;NOS2A, INDUCIBLE, HEPATOCYTE;nitric oxide synthase 2, inducible|C1417760|||C1417760|HUGO;MTH;NCI;OMIM|||
NOS|Nitric Oxide Synthase 1 (Neuronal) wt Allele||||C1705516|NCI|||
NOS|Nitric Oxide Synthase 2A (Inducible, Hepatocytes) Gene||||C1417760|NCI|||
NOS|Nitric Oxide Synthase [Chemical/Ingredient]||||C0132555|NDFRT|||
NOS|Nitric-oxide synthase (substance)||||C0132555|SNOMEDCT|||
NOS|Not Specified||||C1518425|NCI|||
NOS|network operating system||||||||1
NOS|new-onset seizures|C0748604|||||||1
NOS|nitric oxide synthase 2A (inducible, hepatocytes), human||||C0669372|MSH|||
NOS|nitric oxide synthesis|C1157570|||C1157570|GO|1|0.0027|
NOS|nitrous oxide synthase||||||||1
NOS|no organisms seen||||||||1
NOS|nonorgan-specific||||||||1
NOS|nopaline synthase|C0068949|||C0068949|MSH|||
NOS|not on staff||||||||1
NOS|numbers|C0237753;C0449788|||||||1
NPH|Familial juvenile nephronophthisis|C0687120;C1855681|||||1|0.0395|
NPH|HYDROCEPHALUS, NORMAL-PRESSURE;Hydrocephalus, Normal Pressure;NORMAL PRESSURE HYDROCEPHALUS;Normal Pressure Hydrocephalus;Normal pressure hydrocephalus;Normal pressure hydrocephalus NOS;hydrocephalus normal pressure;hydrocephalus pressure normal;normal pressure hydrocephalus;normal-pressure hydrocephalus;Hakim Syndrome;Hakim Syndromes;Hakim's Syndrome;Hakim's Syndromes;Hakims Syndrome;Syndrome, Hakim;Syndrome, Hakim's;Syndromes, Hakim;Syndromes, Hakim's;hakim syndrome;Low pressure hydrocephalus;low pressure hydrocephalus;NPH;Nph;nph;NPH (Normal Pressure Hydrocephalus);NPH - Normal pressure hydrocephalus;hydrocephalus normal nph pressure;normal pressure hydrocephalus (nph);normal pressure hydrocephaly|C0020258|||C0020258|CHV;COSTAR;DXP;LNC;MSH;MTHICD9;NDFRT;OMIM;QMR;SNOMEDCT|1|0.6626|1
NPH|Hydrocephalus, Normal Pressure [Disease/Finding]||||C0020258|NDFRT|||
NPH|Low pressure hydrocephalus (disorder)||||C0020258|SNOMEDCT|||
NPH|NPH insulin|C0021658|||||1|0.0243|
NPH|NPHs (Normal Pressure Hydrocephalus)||||C0020258|MSH|||
NPH|Normal pressure hydrocephalus (disorder)||||C0020258|SNOMEDCT|||
NPH|hydrocephalis normal pressure||||C0020258|CHV|||
NPH|nephronophthisis|C0687120|||C0687120|CHV;MTH;OMIM;SNOMEDCT|||1
NPH|neutral protamine Hagedorn;neutral protamine hagedorn||1|1|||1|0.155|
NPH|no previous history||||||||1
NPH|nucleus prepositus hypoglossi|C0152399|||C0152399|FMA|1|0.0699|
NPH|nucleus pulposus herniation||||||||1
NPH|patients with normal-pressure hydrocephalus||||||1|0.0486|
NPO|Fasting patient;fasting patients;NBM - Nil by mouth;NPO - Nothing by mouth;Nil by mouth;nil by mouth;Nil per os;nil per os;Nothing by Mouth;Nothing by mouth;nothing by mouth;nil peros|C0419179|1|1|C0419179|CHV;MTH;NCI;SNOMEDCT|||1
NPO|NBM||||C0419179|SNOMEDCT|||
NPO|NON PROFIT ORGAN;ORGAN NON PROFIT||||C0029247|MSH|||
NPO|NONPROFIT ORGAN;ORGAN NONPROFIT||||C0029247|MSH|||
NPO|NPO|C0029247;C0419179|||C0029247;C0419179|NCI;SNOMEDCT|||
NPO|Nil by mouth (procedure)||||C0419179|SNOMEDCT|||
NPO|Nil by mouth (regime/therapy)||||C0419179|SNOMEDCT|||
NPO|Non Profit Organizations;Non-Profit Organization;Non-Profit Organizations;Organization, Non-Profit;Organizations, Non Profit;Organizations, Non-Profit;non profit organizations;non-profit organizations;Non-profit;Nonprofit;nonprofit;nonprofits;Nonprofit Group;Nonprofit Organization;Nonprofit Organizations;Organization, Nonprofit;Organizations, Nonprofit;nonprofit organization;nonprofit organizations;Not for Profit Organization|C0029247|||C0029247|AOD;CHV;MSH;MTH;NCI|||
NPO|Nothing by mouth (procedure)||||C0419179|SNOMEDCT|||
NPO|Starving the patient;patients starving||||C0419179|CHV;SNOMEDCT|||
NPO|channel activity|C1153410|||||1|0.1098|
NPO|neurogenic pulmonary edema|C0340098|||C0340098|CHV;SNOMEDCT|||
NPO|nucleus pontis oralis||||||1|0.122|
NPO|nucleus preopticus||||||1|0.3659|1
NPO|open probability||||||1|0.4024|
NP|(drug) NP||1|0.002|||||
NP|1-nitropyrene|C0044508|||C0044508|MSH;NCI|1|0.0142|
NP|4-hydroxy-3-nitrophenyl acetyl;4-hydroxy-3-nitrophenylacetyl|C0048309|||||1|0.0171|
NP|4-nonylphenol|C0097405|||||1|0.0266|
NP|CAGH1;CAGH1A;CIZ;NMP4;NUCLEAR MATRIX PROTEIN 4;ZINC FINGER PROTEIN 384;zinc finger protein 384;ZNF384;ZNF384 gene|C1420834|||C1420834|HUGO;MTH;OMIM|||
NP|CAS-INTERACTING ZINC FINGER PROTEIN||||C1420834|OMIM|||
NP|CTF2P;CTF2P gene;cardiotrophin 2, pseudogene;neuropoietin|C1824810|||C1824810|HUGO;MTH|||
NP|EC 2.4.2.1||||C0034135|NCI|||
NP|Inosine Phosphorylase;Inosine phosphorylase;Phosphorylase, Inosine;inosine phosphorylase;PNP - Purine nucleoside phosphorylase;PNP Human|C0034135|||C0034135|CSP;MSH;NCI;NDFRT;SNOMEDCT|||
NP|NEPAL;Nepal;nepal|C0027689|||C0027689|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
NP|NP;Nurse Practitioner;Nurse Practitioners;Nurse practitioner;Nurse practitioners;Practitioner, Nurse;Practitioners, Nurse;nurse practitioner;nurse practitioners|C0028657|1|0.876|C0027689;C0028657;C0034135;C0332124;C1417772;C1420834;C1549435;C1549986;C1618092;C1824810|AOD;CHV;CSP;HL7V2.5;HL7V3.0;HUGO;LCH;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.0898|
NP|NP Gene;Nucleoside Phosphorylase Gene;PNP gene;PUNP|C1417772|||C1417772|HUGO;MTH;NCI|||
NP|NPL|C0027689;C1150873;C1424540|||C0027689|NCI|||
NP|NUCLEOSIDE PHOSPHORYLASE;nucleoside phosphorylase|C0133234;C1417772|||C0133234;C1417772|CSP;MSH;MTH;OMIM|1|0.0195|1
NP|Nasal polyposis;nasal polyp;nasal polyps|C0027430|||C0027430|CHV;COSTAR;CST;MSH;NCI;SNOMEDCT|1|0.0443|1
NP|Nepal (geographic location)||||C0027689|SNOMEDCT|||
NP|Niemann-Pick||||||||1
NP|No past history;No past history of;no past history of|C0332124|||C0332124|CHV;MTH;SNOMEDCT|||
NP|No past history of (contextual qualifier)||||C0332124|SNOMEDCT|||
NP|No past history of (contextual qualifier) (qualifier value)||||C0332124|SNOMEDCT|||
NP|Nucleoside Phosphorylases, Purine;PURINE NUCLEOSIDE PHOSPHORYLASE;Phosphorylase, Purine-Nucleoside;Phosphorylases, Purine Nucleoside;Purine Nucleoside Phosphorylase;Purine Nucleoside Phosphorylases;Purine nucleoside phosphorylase;Purine-Nucleoside Phosphorylase;Purine-nucleoside phosphorylase;purine nucleoside phosphorylase;purine nucleoside phosphorylases|C0034135;C1417772|||C0034135;C1417772|AOD;CHV;CSP;HUGO;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||
NP|Nurse practitioner (occupation)||||C0028657|SNOMEDCT|||
NP|PNP||||C0034135;C1417772|HUGO;NCI;OMIM|||
NP|PURINE-NUCLEOSIDE:ORTHOPHOSPHATE RIBOSYLTRANSFERASE;Purine-nucleoside:orthophosphate ribosyltransferase||||C0034135;C1417772|MSH;NDFRT;OMIM|||
NP|Purine-Nucleoside Phosphorylase [Chemical/Ingredient]||||C0034135|NDFRT|||
NP|Purine-nucleoside phosphorylase (substance)||||C0034135|SNOMEDCT|||
NP|alcohol nonpreferring||||||1|0.0041|
NP|anti-(4-hydroxy-3-nitrophenyl)acetyl||||||1|0.0112|
NP|hapten (4-hydroxy-3-nitrophenyl)acetyl||||||1|0.0106|
NP|influenza virus nucleoprotein||||||1|0.0266|
NP|metabolite norpropoxyphene||||||1|0.003|
NP|nanoparticle;nanoparticles|C1450054|||C1450054|MSH;NCI|1|0.0337|
NP|nasal prong;nasal prongs|C0445087|||C0445087|CHV|||1
NP|nasopharyngeal|C0027442|1|0.106|C0027442|CHV;HL7V2.5;SNOMEDCT|1|0.0473|1
NP|nasopharynx|C0027442;C1268975|1|0.004|||1|0.01|1
NP|natriuretic peptide|C1144709;C2709270|1|0.002|C1144709;C2709270|CHV;LNC;MTH;NDFRT|1|0.0437|1
NP|near point|C0429572|||||||1
NP|neck pressure||||||1|0.0095|
NP|necrotizing pancreatitis|C0267941|||C0267941|CHV;CST;SNOMEDCT|1|0.0089|1
NP|negative priming||||||1|0.0136|
NP|neonatal-perinatal||||||||1
NP|neopterin|C0068527;C0202143|||C0068527;C0202143|CHV;LNC;MSH;NCI;NDFRT;SNOMEDCT|1|0.0106|
NP|nepals||||C0027689|CHV|||
NP|neper|C1553004|||||||1
NP|nephrographic phase||||||||1
NP|neptunium|C0027734|||||||1
NP|nerve palsy|C0262576|||||||1
NP|neuritic plaque|C0333463|||C0333463|CHV;CSP;MSH|1|0.0065|1
NP|neuropathic pain|C0027796|||||1|0.0065|1
NP|neuropathology|C0876934;C1540677;C1555824|||||||1
NP|neuropeptide|C0027895|||C0027895|CHV;CSP;MSH;NCI;NDFRT|||1
NP|neurophysin|C0027900|||C0027900|CSP;FMA;LNC;SNOMEDCT;UWDA|1|0.0236|1
NP|neuropsychiatric||||||1|0.0189|1
NP|neuropsychiatry|C0870956|||||||1
NP|neuropsychological||||||1|0.0573|
NP|neutrogenic precautions||||||||1
NP|new patient||||||||1
NP|newly presented||||||||1
NP|nifedipine|C0028066|||C0028066|AOD;CHV;CSP;LCH;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0059|
NP|nitrogen-phosphorus||||||||1
NP|nitrophenol|C0028187|||||||1
NP|nitroprusside|C0028193|||C0028193|AOD;CHV;CSP;LNC;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG|||
NP|nitrosopiperidine|C0068235|||C0068235|MSH|||
NP|no pain|C0234225|||||||1
NP|no phone||||||||1
NP|no progress||||||||1
NP|no progression||||||||1
NP|nodular paragranuloma||||||||1
NP|non-pregnant;nonpregnant||||||1|0.0485|
NP|nonpalpable||||||||1
NP|nonpathologic||||||||1
NP|nonpaying||||||||1
NP|nonphagocytic||||||||1
NP|nonpracticing||||||||1
NP|nonproducer||||||||1
NP|nonylphenol|C0068946|||C0068946|CHV;MSH|1|0.0797|
NP|normal|C0205307;C0439166;C2347086|||||1|0.0077|
NP|normal plasma|C0440742|||C0440742|CHV;SNOMEDCT|1|0.0047|1
NP|normal pregnancy|C0232989|||||1|0.0065|
NP|normal pregnant||||||1|0.0053|
NP|normal pregnant women||||||1|0.0035|
NP|normal pressure||||||||1
NP|normal prostate||||||1|0.0047|
NP|normal protein|C0860902|||C0860902|CHV|||
NP|normal-phase||||||1|0.0142|
NP|norpropoxyphene|C0069020|||C0069020|CHV;LNC;MSH;SNOMEDCT|||
NP|nosocomial pneumonia|C0949083|||C0949083|CHV;SNOMEDCT|1|0.0307|1
NP|not palpable||||||||1
NP|not perceptible||||||||1
NP|not performed||||||||1
NP|not practiced||||||||1
NP|not pregnant|C0232973;C2826362|||||||1
NP|not present||||||||1
NP|not protected||||||||1
NP|not provided||||||||1
NP|noun phrase||||||1|0.0077|
NP|nuclear pharmacy|C1556041|||||||1
NP|nuclear protein|C0028589;C0949374|||C0028589;C0949374|CHV;CSP;MSH;MTH;NCI|||
NP|nucleocapsid|C0178774;C1167518|||C0178774;C1167518|CSP;GO;MSH;MTH|1|0.023|
NP|nucleocapsid protein|C0524816|||C0524816|MSH;NCI;NDFRT|1|0.0478|
NP|nucleoplasmic||||||||1
NP|nucleoprotein;nucleoproteins|C0028612|||C0028612|CHV;CSP;MSH;NDFRT;SNOMEDCT|1|0.0071|1
NP|nucleotide pair||||||1|0.0112|1
NP|nucleotide position||||||1|0.0224|
NP|nucleus pulposus|C1185714|||C1185714|CHV;FMA;UWDA|1|0.0337|
NP|nursed poorly||||||||1
NP|nursing practice||||||||1
NP|nursing procedure|C0204636|||||||1
NP|p-nonylphenol||||||1|0.0171|
NP|patients|C0030705|||||1|0.0059|
NP|proper name||||||||1
NP|sodium nitroprusside|C0037533|||||1|0.0555|
NSAID|AIANS||||C0003211|MSH|||
NSAID|ANTI INFLAMM AGENTS NONSTEROIDAL;ANTIINFLAMM AGENTS NON STEROIDAL;NON STEROIDAL ANTI INFLAMM AGENTS||||C0003211|MSH|||
NSAID|ANTIINFLAMMATORY AGENTS NONSTEROIDAL;Agents, Non-Steroidal Anti-Inflammatory;Agents, Nonsteroidal Anti-Inflammatory;Agents, Nonsteroidal Antiinflammatory;Anti Inflammatory Agents, Non Steroidal;Anti Inflammatory Agents, Nonsteroidal;Anti-Inflammatory Agents, Non-Steroidal;Anti-Inflammatory Agents, Nonsteroidal;Antiinflammatory Agents, Non Steroidal;Antiinflammatory Agents, Nonsteroidal;NONSTEROIDAL ANTIINFLAMMATORY AGENTS;Non Steroidal Anti Inflammatory Agents;Non-Steroidal Anti-Inflammatory Agents;Non-steroidal Anti-inflammatory Agent;Non-steroidal Antiinflammatory Agent;Non-steroidal anti-inflammatory agent;Non-steroidal anti-inflammatory agent, NOS;Nonsteroidal Anti Inflammatory Agents;Nonsteroidal Anti-Inflammatory Agents;Nonsteroidal Anti-inflammatory Agent;Nonsteroidal Antiinflammatory Agent;Nonsteroidal Antiinflammatory Agents;non-steroidal anti-inflammatory agent;nonsteroidal antiinflammatory agent;NSAID;NSAIDS;NSAIDs;nsaid;nsaids;NSAID - Non-steroidal anti-inflammatory drug;Non-steroidal Anti-inflammatory Drug;Non-steroidal Antiinflammatory Drug;Non-steroidal anti-inflammatory drug;Nonsteroidal Anti-inflammatory Drug;Nonsteroidal Anti-inflammatory Drugs;Nonsteroidal Antiinflammatory Drug;non-steroidal anti-inflammatory drug;non-steroidal antiinflammatory drugs;nonsteroidal anti-inflammatory drug;nonsteroidal anti-inflammatory drugs;nonsteroidal antiinflammatory drug;nonsteroidal antiinflammatory drugs;Nonsteroidal Anti-inflammatory Drug [EPC];nonsteroidal anti-inflammatory drugs (NSAIDs)|C0003211|1|1|C0003211|AOD;CHV;CSP;MSH;NCI;NDFRT;SNOMEDCT;USPMG|1|0.994|1
NSAID|NSAIA||||C0003211|MSH|||
NSAID|Non-steroidal anti-inflammatory agent (product)||||C0003211|SNOMEDCT|||
NSAID|Non-steroidal anti-inflammatory agent (substance)||||C0003211|SNOMEDCT|||
NSAID|Non-steroidal anti-inflammatory drug (substance)||||C0003211|SNOMEDCT|||
NSAID|Non-steroidal anti-inflammatory product||||C0003211|SNOMEDCT|||
NSAID|Non-steroidal anti-inflammatory product (substance)||||C0003211|SNOMEDCT|||
NSAID|non-steroidal anti-inflammatory||||||1|0.0059|
NST|Nonsense Syllable Test||||||||1
NST|Nutrition Support Team||||||1|0.027|
NST|neospinothalamic||||||||1
NST|neostigmine test||||||||1
NST|nerve sheath tumor|C0206727|||C0206727|CHV;NCI;SNOMEDCT|||
NST|nerve stimulation therapy||||||||1
NST|neurostructural integration technique||||||||1
NST|no specific type||||||||1
NST|nocistatin|C0672514;C1418716|||C0672514;C1418716|HUGO;MSH;MTH|1|0.0202|
NST|non-shivering thermogenesis||||||1|0.0427|
NST|non-stress test;nonstress test;nonstress testing|C1314734|1|0.996|C1314734|CHV;SNOMEDCT|1|0.3011|1
NST|nondirective supportive therapy||||||1|0.0135|
NST|nonmyeloablative stem cell transplant||||||||1
NST|nonshivering thermogenesis||||||1|0.1596|1
NST|normal sphincter tone||||||||1
NST|not sooner than||||||||1
NST|nucleus of the solitary tract|C0175518|||C0175518|MSH;NCI|1|0.3191|
NST|nutritional status type||||||||1
NST|nutritional support technologist||1|0.002|||||
NST|stem cell transplantation|C1504389|||||1|0.1169|
NSVD|NSVD;Normal Spontaneous Vaginal Delivery;normal spontaneous vaginal delivery|C2986704|1|1|C2986704|NCI|||1
NSVD|Normal Delivery|C0269694;C1384485;C2986704|||C2986704|NCI|||
NSVD|nonstructural valve deterioration||||||||1
NTD|Defect, Neural Tube;Defects, Neural Tube;NEURAL TUBE DEFECTS;Neural Tube Defect;Neural Tube Defects;Neural tube defect;defect neural tube;defects neural tube;neural tube defect;neural tube defects;tube neural defects;Developmental Defects, Neural Tube;Developmental Neural Tube Defects;Neural Tube Developmental Defects;NTD;NTD - Neural tube defect|C0027794|1|0.002|C0027794|CHV;CSP;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8646|1
NTD|N-terminal domain||||||1|0.1069|
NTD|NTD Laboratories, Inc||1|0.988|||||
NTD|Neural Tube Defects [Disease/Finding]||||C0027794|NDFRT|||
NTD|Neural tube defect (disorder)||||C0027794|SNOMEDCT|||
NTD|Normalized Total Dose||||||1|0.0285|
NTD|Spinal Dysraphism|C0027794;C0080178|||C0027794|NCI|||
NTD|negative to date||1|0.010|||||1
NTD|nitrendipine|C0028127|||C0028127|AOD;CHV;CSP;LCH;MSH;NCI;NDFRT;RXNORM;SNOMEDCT|||
NTD|nitroblue tetrazolium dye||||||||1
NTD|noise tone difference||||||||1
OB|CAD11;CDH11;CDH11 gene;CDHOB|C1413269|||C1413269|HUGO;MTH;OMIM|||
OB|CADHERIN 11;CADHERIN, OSTEOBLAST;OB-CADHERIN;OB-Cadherin|C0297505;C1413269|||C1413269|HUGO;OMIM|||
OB|Discipline of obstetrics;Obstetrics;obstetrics;field of maternity care|C0028773|||C0028773;C0334897;C0700061;C1549402|CHV;CSP;HL7V2.5;HL7V3.0;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|||1
OB|FLJ94114;LEP wt Allele|C2986870|||C2986870|MTH;NCI|||
OB|LEP||||C1416825|HUGO;NCI;OMIM|||
OB|LEP Gene;LEP gene|C1416825|||C1416825|HUGO;MTH;NCI|||
OB|LEPTIN;leptin|C0299583;C1295176;C1416825|||C1416825|HUGO;OMIM|1|0.0332|
OB|Leptin (Murine Obesity Homolog) Gene||||C1416825|NCI|||
OB|Leptin (Murine Obesity Homolog) wt Allele||||C2986870|NCI|||
OB|Maternity care|C0028773;C0374764|||C0028773|SNOMEDCT|||
OB|OB;OBS|C0028773;C1413269;C1416825;C2986870|||C0028773;C1413269;C1416825;C2986870|HUGO;LNC;NCI;OMIM|||
OB|OBESE, MOUSE, HOMOLOG OF||||C1416825|OMIM|||
OB|OBESITY, MORBID, WITH HYPOGONADISM||||C1416825|OMIM|||
OB|OBESITY, SEVERE, DUE TO LEPTIN DEFICIENCY||||C1416825|OMIM|||
OB|Obese, Mouse, Homolog of Gene||||C2986870|NCI|||
OB|Obstetrical;obstetric|C0028773;C0205484|1|1|C0028773;C0205484|LNC;NCI|||1
OB|Obstetrics (qualifier value)||||C0028773|SNOMEDCT|||
OB|Olfactory bulbectomy||||||1|0.0123|
OB|Oligoclonal bands;oligoclonal band|C0069426|||C0069426|CHV;SNOMEDCT|1|0.0283|1
OB|Otilonium bromide;otilonium bromide|C0134250|||C0134250|CHV;MSH;NCI;RXNORM|1|0.0098|
OB|cadherin 11, type 2, OB-cadherin (osteoblast)||||C1413269|HUGO|||
OB|estradiol benzoate;oestradiol benzoate|C0167626|||C0167626|CHV;LCH;MSH;NCI;SNOMEDCT|1|0.0811|
OB|obese|C0028754|||C0028754|CHV;DXP;SNOMEDCT|||1
OB|obese gene||||||1|0.0209|
OB|obesity|C0028754;C1963185|||C0028754;C1963185|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;QMR;SNOMEDCT|||1
OB|objective benefit||||||||1
OB|obliterative bronchiolitis|C0006272|||C0006272|CHV;DXP;SNOMEDCT|1|0.1597|1
OB|obstetrician|C0334897|||C0334897|CHV;MTH;SNOMEDCT|||
OB|occlusion bodies||||||1|0.0098|
OB|occult bacteremia||||||||1
OB|occult bleeding|C0333282|||C0333282|CHV;SNOMEDCT|||1
OB|occult blood|C0028792;C2698644|||C0028792;C2698644|CHV;MSH;MTHICD9;NCI|||1
OB|olfactory bulb|C0028936;C1281094|||C0028936;C1281094|AOD;CHV;CSP;FMA;MSH;NCI;SNOMEDCT|1|0.4484|1
OB|olfactory bulbectomized||||||1|0.027|
OB|oligoclonal IgG bands||||||1|0.0111|
OB|open biopsy|C0184922|||||||1
OB|osteoblast;osteoblasts|C0029418|||C0029418|AOD;CHV;CSP;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0713|1
OB|osteoblast-enriched||||||1|0.0209|
OB|osteoblast-like||||||1|0.016|
OB|osteoblastic||||||1|0.0147|
OB|osteoblastoma|C0029417|||||||1
OB|oxidative burst|C0085416|||C0085416|CHV;GO;MSH;NCI|1|0.0246|
OB|product of the obesity||||||1|0.0111|
OCD|Anancastic neurosis;Anankastic neurosis;anancastic neurosis;Disorder, Obsessive-Compulsive;Disorders, Obsessive-Compulsive;OBSESSIVE COMPULSIVE DISORDER;OBSESSIVE-COMPULSIVE DISORDER;Obsessive Compulsive Disorder;Obsessive compulsive disorder;Obsessive compulsive disorder, NOS;Obsessive-Compulsive Disorder;Obsessive-Compulsive Disorders;Obsessive-compulsive disorder;Obsessive-compulsive disorder NOS;Obsessive-compulsive disorders;obsessive compulsive disorder;obsessive-compulsive disorder;obsessive-compulsive disorders;NEUROSIS, OBSESSIVE COMPULSIVE;Neuroses, Obsessive-Compulsive;Neurosis, Obsessive Compulsive;Neurosis, Obsessive-Compulsive;OBSESSIVE COMPULSIVE NEUROSIS;OBSESSIVE-COMPULSIVE NEUROSIS;Obsessive Compulsive Neurosis;Obsessive compulsive neurosis;Obsessive-Compulsive Neuroses;Obsessive-Compulsive Neurosis;Obsessive-compulsive neurosis;obsessive compulsive neurosis;obsessive-compulsive neurosis;OBSESSIVE-COMPULSIVE REACTION;REACTION OBSESSIVE-COMPULSIVE;OCD - Obsessive-compulsive disorder;obsessive compulsive disorder (OCD)|C0028768|1|0.952|C0028768|AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;QMR;RAM;SNOMEDCT|1|0.94|1
OCD|Anankastic Personalities;Anankastic Personality;Personalities, Anankastic;Personality, Anankastic|C0009595;C0028768|||C0028768|MSH;NDFRT|||
OCD|Dissecans, Osteochondritis;OSTEOCHONDRITIS DISSECANS;Osteochondritis Dissecans;Osteochondritis dissecans;osteochondritis dissecans;Idiopathic avascular necrosis;idiopathic avascular necrosis;OCD - Osteochondritis dissecans;OD - Osteochondritis dissecans;OSTEOCHONDRITIS DESSICANS;Osteochondrosis dessicans;Osteochondrosis dissecans;osteochondrosis dissecans|C0029421|1|0.048|C0029421|CHV;COSTAR;DXP;ICD9CM;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0352|1
OCD|OBSESSIVE COMPULSIVE DIS;Obsessive-compulsive dis||||C0028768|ICD9CM;MSH|||
OCD|OCC||||C0029421|SNOMEDCT|||
OCD|OCD|C0028768;C0029421|||C0028768;C0029421|CHV;CSP;MEDLINEPLUS;NCI;OMIM;SNOMEDCT|||
OCD|OD|C0029421;C0439164;C1512019|||C0029421|OMIM|||
OCD|OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS||||C0029421|OMIM|||
OCD|Obsessive compulsive disorder (disorder);Obsessive-compulsive disorder (disorder);Obsessive-compulsive disorder NOS (disorder)||||C0028768|SNOMEDCT|||
OCD|Obsessive-Compulsive Disorder [Disease/Finding]||||C0028768|NDFRT|||
OCD|Osteochondrit dissecans||||C0029421|ICD9CM|||
OCD|Osteochondritis Dissecans [Disease/Finding]||||C0029421|NDFRT|||
OCD|Osteochondritis dissecans (disorder)||||C0029421|SNOMEDCT|||
OCD|[X]Obsessive-compulsive disorder, unspecified||||C0028768|SNOMEDCT|||
OCD|[X]Obsessive-compulsive disorder, unspecified (disorder)||||C0028768|SNOMEDCT|||
OCD|obsessive-compulsive||||||1|0.0068|
OCD|obsessive-compulsive psychoneurosis or reaction||||C0028768|AOD|||
OCD|occupational contact dermatitis||||||1|0.0093|
OCD|organ-confined disease||||||1|0.0031|
OCD|osteochondral defect||||||||1
OCD|ovarian cholesterol depletion||||||||1
OCD|oxygen cost diagram||||||1|0.0056|
ODT|Oculodynamic Test;oculodynamic test||||||1|1|1
ODT|optical Doppler tomography||||||||1
ODT|orally disintegrating tablet||1|1.000|||||1
ODT|right occiput transverse||||||||1
OFC|CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1||||C1861537|OMIM|||
OFC|CLEFT LIP/PALATE, NONSYNDROMIC||||C1861537|OMIM|||
OFC|OFC;OROFACIAL CLEFT, NONSYNDROMIC|C1861537|||C1861537|OMIM|||
OFC|OFC1;OROFACIAL CLEFT 1|C1417940;C1861537|||C1861537|MTH;OMIM|||
OFC|head circumference;occipital-frontal circumference|C0262499|1|1|||1|0.1111|1
OFC|occipitofrontal circumference||||||1|0.127|
OFC|office|C0442603|||||||1
OFC|open food challenge||||||||1
OFC|oral food challenge||||||||1
OFC|orbitofacial cleft||||||||1
OFC|orbitofrontal cortex|C2331062|||||1|0.7619|
OFC|osteitis fibrosa cystica|C0029405|||C0029405|CHV;DXP;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
OKT3|Anti-CD3 Monoclonal Antibody OKT3;Anti-CD3 monoclonal antibody OKT3;Anti-CD3 monoclonal antibody OKT 3;MOAB OKT 3;MOAB OKT3;MoAb OKT3;MUROMONAB-CD3;Muromonab CD3;Muromonab-CD3;muromonab cd3;muromonab-CD3;muromonab-cd3;Monoclonal Antibody OKT3;monoclonal antibody OKT3;Muromonab-CD3 Monoclonal Antibody;muromonab-CD3 monoclonal antibody;OKT3;okt3;monoclonal antibody OKT 3|C0085379|||C0085379|CHV;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.3571|
OKT3|Muromonab-CD3 (product)||||C0085379|SNOMEDCT|||
OKT3|Muromonab-CD3 (substance)||||C0085379|SNOMEDCT|||
OKT3|Muromonab-CD3 [Chemical/Ingredient]||||C0085379|NDFRT|||
OKT3|anti-CD3 antibodies||||||1|0.1667|
OKT3|anti-CD3 monoclonal antibody||||||1|0.3095|
OKT3|murine monoclonal anti-CD3 antibody||||||1|0.1667|
OKT3|orthoclone OKT3/Muromonab-CD3||1|1.000|||||
OM1|obtuse marginal 1||1|1.000|||||
OM|MU|C0347978|||C0028971|NCI|||
OM|OM|C0028971;C1705272|||C0028971;C1705272|NCI|||
OM|OMAN;Oman;oman;OMN|C0028971|||C0028971|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
OM|Occupational medicine;occupational medicine|C0028802|||C0028802;C1552437;C1555855;C1555921|CHV;CSP;HL7V3.0;MSH;NCI;SNOMEDCT|1|0.0121|1
OM|Oman (geographic location)||||C0028971|SNOMEDCT|||
OM|Oncostatin M;oncostatin M|C0069535;C1149423;C1335093|||||1|0.0836|1
OM|Oral mucositis;oral mucositis|C0038362;C1568868|||C0038362;C1568868|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.0189|1
OM|Organ Measurement Domain;Organ Measurements|C1705272|||C1705272|MTH;NCI|||
OM|Osborn-Mendel||||||||1
OM|Osborne-Mendel||||||1|0.035|
OM|Ovum mutant||||||1|0.0135|
OM|every morning|C0585329|||||||1
OM|obtuse marginal||1|1.000|||||
OM|occipitomental||||||||1
OM|ocular melanoma|C0558356|||||||1
OM|ocular movement||||||||1
OM|oculomotor|C0872237|||C0872237|CHV;CSP|||1
OM|olfactory mucosa|C0028937|||C0028937|CHV;LCH;MSH;NCI|1|0.0202|
OM|omans||||C0028971|CHV|||
OM|omental|C0028977|||C0028977|CHV;SNOMEDCT|||
OM|omeprazole|C0028978|||C0028978|AOD;CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0229|
OM|oncomodulin|C0069534;C1417929|||C0069534;C1417929|HUGO;MSH;MTH;OMIM|1|0.0121|
OM|operating microscope|C0181849|||||||1
OM|operative mortality||||||1|0.0323|
OM|optical microscopy|C2984701|||C2984701|NCI|1|0.0323|
OM|oral motor||||||||1
OM|oral mucosa|C0026639|||||1|0.0121|
OM|orbitomeatal||||||||1
OM|organomegaly||||||||1
OM|osteomalacia|C0029442|||C0029442|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.035|1
OM|osteomyelitis|C0029443|||C0029443|AIR;AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.027|1
OM|osteopathic manipulation|C0949744|||C0949744|CHV;MSH;SNOMEDCT|||1
OM|osteopathic manipulative||||||||1
OM|otitis media|C0029882;C2827407|||C0029882;C2827407|CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.2709|1
OM|outer medulla||||||1|0.0337|
OM|outer membrane|C1167331|||C1167331|CHV;GO|1|0.3073|1
OM|ovomucoid|C0029960|||C0029960|CHV;CSP;LNC;MSH;NDFRT;SNOMEDCT|1|0.0162|
OM|ovulation method||||||1|0.0148|1
OM|oxygen mask|C0181744|||||||1
OM|oxymatrine|C0069821|||C0069821|CHV;MSH|||
OP|1,10-phenanthroline;o-phenanthroline|C0087870|||||1|0.0497|
OP|4-Tert-octylphenol;4-tert-octylphenol|C0537565|||C0537565|MSH|1|0.0464|
OP|Organophosphorus pesticides||||||1|0.011|
OP|mice homozygous for the osteopetrosis||||||1|0.0088|
OP|obesity-prone||||||1|0.0099|
OP|oblique presentation|C0426058|||||||1
OP|oblique presentation/occiput posterior||1|0.242|||||
OP|occipitoparietal||||||||1
OP|occiput posterior|C0856256|1|0.006|C0856256|CHV|||1
OP|occupational physician|C0401976|||C0401976|CHV;SNOMEDCT|||
OP|octylphenol|C1258354|||C1258354|MSH|||
OP|old patient||||||||1
OP|olfactory peduncle|C2335775|||C2335775|FMA|||1
OP|oligodendrocyte progenitor||||||1|0.0166|
OP|opaque|C0029053;C1261286;C1882150|||C0029053;C1261286;C1882150|CHV;MTH;NCI;SNOMEDCT|||
OP|open;opening|C0175566;C1882151|||||||1
OP|opening pressure||||||1|0.0077|1
OP|operation|C0543467|||C0543467;C1880161|CHV;MEDLINEPLUS;MTH;NCI;SNOMEDCT|||1
OP|operative|C1882154|1|0.110|||||1
OP|operative procedure|C0543467;C0677612|||C0543467;C0677612|CHV;MSH;SNOMEDCT|||1
OP|ophthalmic||1|0.010|||||
OP|ophthalmology|C0029087;C1555792|||C0029087;C1555792|CHV;HL7V3.0;LCH;LNC;MEDLINEPLUS;MSH;NCI;SNOMEDCT|||1
OP|opisthocranion|C2336409|||||||1
OP|opponens pollicis|C0224287;C1305008|||C0224287;C1305008|FMA;SNOMEDCT;UWDA|1|0.011|1
OP|oral and pharyngeal mucositis||||||||1
OP|organizing pneumonia|C0264383|||C0264383|CHV|1|0.0188|
OP|organophosphate|C0031701|||C0031701|CHV;NCI;SNOMEDCT|1|0.2829|
OP|organophosphate pesticide|C0360429|||||1|0.0122|
OP|organophosphorous||||||1|0.0254|1
OP|organophosphorus||||||1|0.2376|
OP|organophosphorus compound;organophosphorus compounds|C0029254|||C0029254|CHV;SNOMEDCT|1|0.0221|
OP|original package||||||||1
OP|oropharyngeal|C0521367|||C0521367;C0553694;C1522409|CHV;CSP;CST;MTH;NCI;SNOMEDCT|1|0.011|
OP|oropharynx|C0521367;C1280659|1|0.616|||1|0.0099|1
OP|ortho-phenanthroline|C0134184|||C0134184|MSH|||
OP|orthostatic proteinuria|C0232867|||C0232867|CHV;MTHICD9;SNOMEDCT|||1
OP|oscillatory potential;oscillatory potentials||||||1|0.053|1
OP|osmotic pressure|C0029393|||C0029393|AOD;CHV;CSP;MSH;SNOMEDCT|1|0.0088|1
OP|osteopetrosis|C0029454|||C0029454|CHV;COSTAR;CSP;DXP;ICD9CM;LCH;MSH;NCI;NDFRT;SNOMEDCT|||
OP|osteopetrotic||||||1|0.0265|
OP|osteopontin|C0069676;C1420369|||C0069676;C1420369|CHV;CSP;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||
OP|osteoporosis|C0029456|||C0029456;C1962963;C2678504;C2911643|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;ICPC;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;QMR;SNOMEDCT|1|0.1061|1
OP|osteoporotic||||||1|0.0099|
OP|other psychotic||||||||1
OP|out-patient;outpatient|C0029921;C1548439;C1549405|1|0.002|C0029921|CHV;MSH|1|0.0144|1
OP|ova and parasites||1|0.002|||||
OP|overpressure||||||||1
OP|overproof||||||||1
OP|ovine prolactin||||||||1
ORIF|Open reduction and internal fixation;open reduction and internal fixation;open reduction internal fixation;open reduction internal fixation (ORIF)|C1297885|1|1|C0747060;C1297885|CHV|1|1|1
ORIF|orif|C0747060|||C0747060|CHV|||
OR|(drug) OR||1|0.002|||||
OR|NADPH-cytochrome P450 reductase|C0027310|||||1|0.0011|
OR|OPERATING ROOM;Operating Room;Operating Rooms;Operating room;Operating rooms;Room, Operating;Rooms, Operating;operating room;operating rooms;room operating|C0029064;C1578465|1|0.932|C0029064;C1578465|CHV;CSP;HL7V2.5;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0418|1
OR|OR;Or;or||||C0029064;C0029195;C1518602;C1706533|HL7V3.0;NCI;SNOMEDCT|||
OR|OR - Operating room||||C0029064|SNOMEDCT|||
OR|OT - Operating theatre;Operating Theater;Operating Theatre;Operating theatre;operating theater;operating theaters;operating theatre;operating theatres|C0029064|||C0029064|CHV;NCI;SNOMEDCT|||
OR|Ocular retardation||||||1|0.0011|
OR|Operating theatre (environment)||||C0029064|SNOMEDCT|||
OR|Opioid receptors;opioid receptor|C0034801|||C0034801|CHV;CSP;MSH;MTH;NDFRT|1|0.0009|
OR|Or - dosing instruction fragment||||C1706533|MTH;SNOMEDCT|||
OR|Or - dosing instruction fragment (qualifier value)||||C1706533|SNOMEDCT|||
OR|Oregon;oregon;Oregon (geographic location)|C0029195|||C0029195|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
OR|P450 oxidoreductase||||||1|0.0011|
OR|objective response||||||1|0.0085|
OR|oblique ridge||||||||1
OR|odds ratio|C0028873|||C0028873|CHV;MSH;NCI|1|0.908|1
OR|odds ration||||||1|0.0018|
OR|odorant receptor|C0164313|||C0164313|MSH;NDFRT|1|0.0037|
OR|oestrogen receptor|C0034804;C1414461;C1521863|||||1|0.0028|
OR|oil retention||||||||1
OR|olfactory receptor|C1518565|||C1518565|AOD;CHV;CSP;FMA|1|0.0068|
OR|open reduction|C0185373;C2370853|||||||1
OR|open repair|C0441613|||C0441613|CHV;SNOMEDCT|1|0.002|
OR|operations research|C0029066|||C0029066|CSP;LCH;MSH|1|0.0016|1
OR|optic radiation|C0228277;C1281308|||C0228277;C1281308|FMA;SNOMEDCT|||1
OR|optical rotation|C0029141|||C0029141|CSP;LCH;MSH|1|0.0011|
OR|or - article||||C1518602|MTH|||
OR|oral rehydration|C0086904;C0309655|||C0086904;C0309655|CHV;MSH;SNOMEDCT|||1
OR|orbicularis oris|C0224147;C1304957|||||||1
OR|oregons||||C0029195|CHV|||
OR|organ recovery||||||||1
OR|orienting reaction||||||1|0.0007|
OR|orienting reflex||||||1|0.0016|1
OR|orienting response||||||1|0.0062|
OR|orthopedic|C0029355|||||||1
OR|orthopedic research||||||||1
OR|ouabain-resistant||||||1|0.0022|
OR|outflow rate||||||||1
OR|outflow resistance||||||1|0.0006|
OR|ovary reserve||||||||1
OR|overrefraction|C1688601|||||||1
OR|ovulation rate||||||1|0.0029|
OR|own recognizance||||||||1
OR|oxidized-reduced||||||||1
OR|oxidoreductase|C0030016;C1537381|||C0030016;C1537381|CHV;CSP;HUGO;MTH;NCI;SNOMEDCT|||
OR|relative risk|C0242492|||||1|0.0007|
OR|response rate|C0237629|||||1|0.0019|
OR|right operator||||||1|0.0009|
OS|BBBG1;OGS1|C2697964;C2936904|||C2697964;C2936904|NCI;OMIM|||
OS|BONE;Bone;Bone, NOS;Bones;Bones, NOS;bone;bones|C0262950;C0391978;C1266908;C1266909|||C0262950|AOD;CHV;CSP;FMA;HL7V2.5;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|||
OS|Bone (organ);Bone organ;Bone structure;bone structure;bone structures;bones structure;bones structures;structure bone;Bones set;Set of bones;Ossa;Skeletal bone;skeletal bone;Skeleton system;skeleton system;Systema skeletale|C0262950|||C0262950|AOD;CHV;FMA;MTH;SNOMEDCT;UWDA|||
OS|Bone structure (body structure)||||C0262950|SNOMEDCT|||
OS|Circumoral region of face;Mouth region;mouth region;Mouth region structure;Mouth structure;mouth structure;mouth structures;Oral part of face;Oral region of face;Perioral region of face;Regio oralis;Structure of oral region of face|C0230028|||C0230028|CHV;FMA;SNOMEDCT;UWDA|||
OS|FINGER ON X AND Y, MOUSE, HOMOLOG OF||||C1417167|OMIM|||
OS|FXY;RNF59;TRIM18|C1417167;C2697964|||C1417167;C2697964|HUGO;NCI;OMIM|||
OS|G syndrome;g syndrome;HYPERTELORISM-HYPOSPADIAS SYNDROME;Hypertelorism-hypospadias syndrome;Opitz-Frias syndrome;opitz fria syndrome;opitz-frias syndrome;TELECANTHUS-HYPOSPADIAS SYNDROME;bbb syndrome|C1801950;C2936904|||C2936904|CHV;MTH;OMIM;SNOMEDCT|||
OS|GBBB1;MID1 wt Allele;XPRF;ZNFXY|C2697964|||C2697964|MTH;NCI|||
OS|GGGB1;OPITZ BBBG SYNDROME, TYPE I;OPITZ GBBB SYNDROME, TYPE I;OPITZ GBBB SYNDROME, X-LINKED;OPITZ SYNDROME;Opitz syndrome;opitz syndrome;opitz syndromes;OPITZ SYNDROME, X-LINKED;OPITZ-G SYNDROME, TYPE I|C2936904|||C2936904|CHV;OMIM;SNOMEDCT|1|0.0032|
OS|HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS||||C2936904|OMIM|||
OS|MID1|C1417167;C2986643|||C1417167|HUGO;NCI;OMIM|||
OS|MID1 Gene;MID1 gene;MIDLINE 1 RING FINGER GENE|C1417167|||C1417167|HUGO;MTH;NCI;OMIM|||
OS|MIDIN|C1417167;C2697964;C2698218|||C1417167;C2697964|NCI;OMIM|||
OS|MIDLINE 1|C1417167;C2698218|||C1417167|OMIM|||
OS|Midline 1 (Opitz/BBB Syndrome) Gene||||C1417167|NCI|||
OS|Midline 1 (Opitz/BBB Syndrome) wt Allele||||C2697964|NCI|||
OS|Mouth|C0226896;C0230028;C1267547;C1278910|||C0230028|FMA;SNOMEDCT;UWDA|||
OS|Mouth region structure (body structure)||||C0230028|SNOMEDCT|||
OS|OPENING SNAP;Opening snap;opening snap;OS - Opening snap;opening snap (OS)|C0232275|||C0232275|CHV;DXP;MTH;SNOMEDCT|||1
OS|OS;Os;os|C0029383;C0230028;C0262950;C1561953|||C0029383;C0230028;C0232275;C0262950;C1417167;C1561953;C1709324;C2697964;C2936904|CHV;FMA;HL7V3.0;HUGO;NCI;OMIM;SNOMEDCT;UWDA|||
OS|OSMIUM;Osmium;Osmium, NOS;osmium;Os - Osmium;Os element;Osmium Metallicum|C0029383|||C0029383|AOD;CHV;CSP;LCH;LNC;MSH;NCI;NDFRT;SNOMEDCT|||1
OS|OSX|C1424900;C2697964;C2936904|||C2697964;C2936904|NCI;OMIM|||
OS|Ocimum sanctum|C1483721|||||1|0.004|
OS|Omenn syndrome|C1801959;C2700553|||||1|0.0036|
OS|One-Step|C0534010|||||1|0.0052|
OS|Opening snap (finding)||||C0232275|SNOMEDCT|||
OS|Operating System|C1709324|||C1709324|MTH;NCI|||
OS|Opitz's (J.M.) syndrome||||C2936904|SNOMEDCT|||
OS|Opitz-Frias syndrome (disorder)||||C2936904|SNOMEDCT|||
OS|Oral region|C0230028;C1995016|||C0230028|FMA;MTH|||
OS|Osmium (substance)||||C0029383|SNOMEDCT|||
OS|Osmium [Chemical/Ingredient]||||C0029383|NDFRT|||
OS|Osseous|C0262950;C0391978|||C0262950|NCI|||
OS|Structure of oral region of face (body structure)||||C0230028|SNOMEDCT|||
OS|Supernumerary mandibular left central primary incisor|C1561953|||C1561953|MTH|||
OS|core oligosaccharide||||||1|0.004|
OS|left eye|C0229090|1|0.998|||1|0.0056|1
OS|midline 1 (Opitz/BBB syndrome)||||C1417167|HUGO|||
OS|occiput-sacrum||||||||1
OS|occupational safety|C0079921|||||||1
OS|oligosaccharide;oligosaccharides|C0028959|||C0028959|CHV;CSP;FMA;NCI;SNOMEDCT|1|0.0064|
OS|oligospermic||||||||1
OS|oligosyndactylism||||||1|0.0036|
OS|open splenectomy||||||1|0.0112|1
OS|open surgery|C0348025|||C0348025|CHV;SNOMEDCT|1|0.0036|1
OS|ophthalmic solution|C0029083;C2984066|||||||1
OS|opposite-sex||||||1|0.0036|
OS|oral secretion|C1272568|||C1272568|CHV;SNOMEDCT|||
OS|oral surgery|C0038908;C0524861|||||||1
OS|orbitale superius||||||||1
OS|orthopedic surgery|C0029355;C0162439;C1136201;C1555794|||||||1
OS|osteogenic sarcoma|C0029463|||C0029463|CHV;COSTAR;CSP;DXP;MSH;NCI;OMIM;PDQ;SNOMEDCT|1|0.0072|1
OS|osteoid surface||||||||1
OS|osteosarcoma|C0029463;C0585442;C2697383|||C0029463;C0585442;C2697383|AOD;CHV;COSTAR;CSP;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.0538|1
OS|osteosclerosis|C0029464|||||||1
OS|ouabain sensitive;ouabain-sensitive||||||1|0.0076|1
OS|outer segments||||||1|0.0261|
OS|ovarian stimulation|C0949385|||C0949385|CHV;MSH|||
OS|overall survival||||||||1
OS|overall survival rate;survival rate|C0038954|||C0038954|NCI|1|0.006|
OS|overlap syndrome|C0410000|||C0410000|CHV;SNOMEDCT|||
OS|overshoot||||||1|0.0076|
OS|oxidative stress|C0242606;C0696141|||C0242606;C0696141|AOD;CHV;CSP;MSH;MTH;NCI|1|0.0433|1
OS|oxygen saturation|C0369768;C0483415|||||||1
OS|survival|C0038952;C0220921|||||1|0.7858|
OS|survival time|C2919552|||||1|0.0044|
OS|system|C0449913;C1553451;C1704459|||||1|0.004|
OTC|Drugs, Non Prescription;Drugs, Non-Prescription;Drugs, Nonprescription;NON-PRESCRIPTION DRUGS;Non Prescription Drugs;Non-Prescription Drugs;Non-prescription drug;Non-prescription drug, NOS;Non-prescription drugs;Nonprescription Drugs;non prescription drugs;non-prescription drug;non-prescription drugs;nonprescription drug;nonprescription drugs;Drugs, OTC;OTC Drugs;OTC drug;Drugs, Over-the-Counter;Over the Counter Drugs;Over-the-Counter Drugs;over the counter drugs;over-the-counter drug;over-the-counter drugs;Medicines, Over-the-Counter;Over-the-Counter Medicines;Medicines, Patent;Patent Medicines;medicines patent;medicines patents;patent medicine;patent medicines;Nonprescription;nonprescription;OTC Medicines;OTC medicines;OTC products;otc product;otc products;Over the Counter;Over-the-Counter;over the counter;over-the-counter;Over the Counter Product;Over the counter products;Over-the-Counter Product;counter over product;over the counter products;products over the counter;pharmaceutical drug|C0013231|1|0.938|C0013231|AOD;CHV;HCPCS;LCH;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.4599|1
OTC|L-2-oxothiazolidine-4-carboxylate|C0124869|||||1|0.0168|
OTC|L-2-oxothiazolidine-4-carboxylic acid||||||1|0.0168|
OTC|MED PATENT;PATENT MED||||C0013231|MSH|||
OTC|Misc/exper non-prescript dru||||C0013231|HCPCS|||
OTC|Non-prescription drug (product)||||C0013231|SNOMEDCT|||
OTC|Non-prescription drug (substance)||||C0013231|SNOMEDCT|||
OTC|ORNITHINE CARBAMOYLTRANSFERASE;ornithine carbamoyltransferase;ORNITHINE TRANSCARBAMYLASE;ornithine transcarbamylase|C0029279;C1418193|||C1418193|HUGO;OMIM|1|0.2725|
OTC|OTC|C0013231;C1418193;C2709201|||C0013231;C1418193;C2709201|HUGO;LNC;NCI;OMIM|||
OTC|OTC - Over The Counter|C2709201|||C2709201|MTH|||
OTC|OTC Gene;OTC gene;Ornithine Carbamoyltransferase Gene|C1418193|||C1418193|HUGO;LNC;MTH;NCI|||
OTC|Over the counter products (product)||||C0013231|SNOMEDCT|||
OTC|Over the counter products (substance)||||C0013231|SNOMEDCT|||
OTC|heart rate-corrected T interval||||||||1
OTC|occult tumor cell||||||||1
OTC|open-top chambers||||||1|0.0079|
OTC|organotin compound|C0029259|||C0029259|SNOMEDCT|||
OTC|ornithine transcarbamoylase|C0029279|1|0.062|C0029279|SNOMEDCT|1|0.0228|1
OTC|oval target cell||||||||1
OTC|oxytetracycline|C0030092|||C0030092|CHV;LNC;MSH;MTHFDA;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.2032|
OT|OT|C1418208;C1705587|||C1418208;C1705587|NCI;OMIM|||
OT|OXT||||C1418208;C1705587|HUGO;NCI;OMIM|||
OT|OXT Gene;OXT gene;OXYTOCIN--NEUROPHYSIN I;PREPROOXYTOCIN;oxytocin, prepropeptide|C1418208|||C1418208|HUGO;MTH;NCI;OMIM|||
OT|OXT wt Allele|C1705587|||C1705587|MTH;NCI|||
OT|OXYTOCIN;oxytocin|C0030095;C1704206|||C0030095;C0523809;C1418208;C1704206|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;PDQ;RXNORM;SNOMEDCT;USPMG;UWDA;VANDF|1|0.8489|1
OT|Ocular torsion||||||1|0.0072|
OT|Oxytocin, Prepro- (Neurophysin I) Gene||||C1418208|NCI|||
OT|Oxytocin, Prepro- (Neurophysin I) wt Allele||||C1705587|NCI|||
OT|neurophysin I|C0027897;C1418208|||C1418208|HUGO|||
OT|object test||||||||1
OT|objective test||||||||1
OT|oblique talus||||||||1
OT|occiput transverse||||||||1
OT|occlusion time||||||1|0.0072|1
OT|occupational therapist|C0028807;C1610728|||C0028807;C1610728|CHV;HL7V3.0;MTH;NCI;SNOMEDCT|||
OT|occupational therapy|C1318464|1|1.000|C1318464;C1547993|AOD;CHV;CSP;HL7V2.5;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;SNOMEDCT|||1
OT|ocular tension|C0021888|||C0021888|CHV;CSP;MSH;SNOMEDCT|||1
OT|office treatment||||||||1
OT|old terminology||||||||1
OT|old tuberculin|C0443084|||C0443084|MTH;RXNORM;SNOMEDCT|1|0.0059|
OT|olfactory threshold|C0597130|||C0597130|CSP|||1
OT|olfactory tubercle|C0162436;C0917714|||C0162436;C0917714|FMA;MSH;MTH|1|0.0379|1
OT|oligodendroglial tumor|C1335110|||C1335110|NCI|||
OT|oligosaccharyl transferase;oligosaccharyltransferase|C0283757;C1413949|||C0283757;C1413949|MSH;OMIM|1|0.0098|
OT|on treatment||||||||1
OT|operating theatre|C0029064|||C0029064|CHV;NCI;SNOMEDCT|1|0.0046|
OT|optic tectum|C0228405|||C0228405|CSP;FMA;MSH|1|0.0209|
OT|optic tract|C0152405;C1269601|||C0152405;C1269601|CHV;CSP;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0229|1
OT|oral temperature|C1532216|||||||1
OT|oral thrush|C0006849|||||||1
OT|oral tolerance|C0597140|||C0597140|CHV;CSP;GO|1|0.0078|
OT|oral transmucosal||||||||1
OT|organotin|C0029259|||C0029259|CHV;SNOMEDCT|||
OT|orientation test||||||||1
OT|original tuberculin||||||||1
OT|ornithine transcarbamylase|C0029279;C1418193|||C0029279;C1418193|CHV;CSP;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||
OT|orotracheal||||||||1
OT|orthopedic treatment||||||||1
OT|orthostatic tremor|C2315430|||C2315430|SNOMEDCT|1|0.0118|
OT|otolaryngology|C0029892;C1555801|||C0029892;C1555801|CHV;HL7V3.0;LCH;LNC;MSH;NCI;SNOMEDCT|||1
OT|otology|C0086746|||C0086746|CHV;MSH|||1
OT|outer table||||||||1
OT|outflow tract||||||1|0.015|
OT|outlier threshold||||||||1
OU|Ornstein-Uhlenbeck||||||1|0.45|
OU|both eyes||1|1.000|||||1
OU|each eye||||||||1
OU|observation unit||||||1|0.55|
OU|obstructive uropathy|C0178879|||C0178879|CHV;COSTAR;NCI;SNOMEDCT|||
P0|HMSNIB;MPZ;MPZ gene;MYELIN GLYCOPROTEIN P-ZERO|C1417248|||C1417248|HUGO;LNC;MTH;OMIM|||
P0|L10E;LP0;PRLP0;RIBOSOMAL PHOSPHOPROTEIN, ACIDIC, P0;acidic ribosomal phosphoprotein P0;RIBOSOMAL PHOSPHOPROTEIN, LARGE, P0;RPLP0;RPLP0 gene;RPP0;ribosomal protein, large, P0|C1419691|||C1419691|HUGO;MTH;OMIM|||
P0|MPP|C0000098;C1417248|||C1417248|OMIM|||
P0|MYELIN PROTEIN ZERO;myelin protein zero|C0071316;C1417248|||C1417248|HUGO;OMIM|||
P0|MYELIN PROTEIN, PERIPHERAL|C0302243;C1417248|||C1417248|OMIM|||
P0|P0|C1417248;C1419691|||C1417248;C1419691|HUGO;OMIM|||
P0|day of birth||||||1|0.176|
P0|isometric force||||||1|0.044|
P0|isometric tension||||||1|0.036|
P0|major myelin glycoprotein||||||1|0.02|
P0|newborn|C0021289;C2239178;C2939425|||||1|0.076|
P0|para 0||1|1.000|||||
P0|postnatal day 0||||||1|0.3|
P0|pressure|C0033095;C0460139;C1306345|||||1|0.056|
P0|protein zero||||||1|0.256|
P0|tetanic tension||||||1|0.036|
PAC|(drug) PAC||1|0.004|||||
PAC|APC;apc;apcs|C0033036;C1456795|||C0033036|CHV;DXP;NCI|||
PAC|ARTIFICIAL CHROMOSOMES BACTERIOPHAGE P 001;BACTERIOPHAGE P 001 ARTIFICIAL CHROMOSOMES;CHROMOSOMES ARTIFICIAL BACTERIOPHAGE P 001;CHROMOSOMES BACTERIOPHAGE ARTIFICIAL P 001||||C0949780|MSH|||
PAC|ATRIAL BEAT PREMATURE;Atrial Beat, Premature;Atrial Beats, Premature;Atrial premature beats;PREMATURE ATRIAL BEATS;Premature Atrial Beat;Premature Atrial Beats;atrial premature beat;atrial premature beats;premature atrial beat;premature atrial beats;Atrial Complex, Premature;Atrial Premature Complex;Atrial Premature Complexes;Atrial premature complex;PREMATURE ATRIAL COMPLEXES;Premature Atrial Complex;Premature Complex, Atrial;Premature Complexes, Atrial;Premature atrial complexes;atrial premature complex;atrial premature complexes;premature atrial complex;premature atrial complexes;Atrial Complices, Premature;Atrial Premature Complices;Premature Atrial Complices;Premature Complices, Atrial;Atrial Ectopic Beat;Atrial Ectopic Beats;Ectopic Beat, Atrial;Ectopic Beats, Atrial;Ectopic atrial beats;Ectopic atrial beats, NOS;atrial ectopic beat;atrial ectopic beats;ectopic atrial beats;Atrial Extrasystole;Atrial Extrasystoles;Atrial extrasystoles;EXTRASYSTOLES ATRIAL;Extrasystole, Atrial;Extrasystoles, Atrial;Atrial Premature Complex (APC);Atrial ectopic;atrial ectopic;atrial ectopics;Atrial premature depolarisation;Atrial premature depolarization;Atrial premature systoles;premature atrial systole;premature atrial systoles;EXTRASYSTOLES SUPRAVENTRICULAR;SUPRAVENTRICULAR EXTRASYSTOLES;Supraventricular extrasystoles;supraventricular extrasystole;PAC - Premature atrial contraction;Premature Supraventricular Beat;Premature Supraventricular Beats;Supraventricular Beat, Premature;Supraventricular Beats, Premature;Supraventricular premature beats;supraventricular premature beats;Supraventricular Ectopic Beats;Supraventricular ectopic beats;Supraventricular premature contraction|C0033036|||C0033036|CHV;COSTAR;CST;DXP;ICD9CM;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
PAC|Artificial Chromosome, P1-Derived;Artificial Chromosomes, P1-Derived;Chromosome, P1-Derived Artificial;Chromosomes, P1-Derived Artificial;P1 Derived Artificial Chromosomes;P1-Derived Artificial Chromosome;P1-Derived Artificial Chromosomes;P1-derived Artificial Chromosome;Artificial Chromosomes, P1 Bacteriophage;Bacteriophage P1 Artificial Chromosomes;Chromosomes, Artificial, P1 Bacteriophage;Chromosomes, P1 Bacteriophage Artificial;P1 Bacteriophage Artificial Chromosomes|C0949780|||C0949780|MSH;MTH;NCI|||
PAC|Atrial Contraction, Premature;Atrial Contractions, Premature;Atrial premature contractions;PREMATURE ATRIAL CONTRACTION;Premature Atrial Contraction;Premature Atrial Contractions;Premature atrial contraction;Premature atrial contractions;atrial premature contractions;premature atrial contraction;premature atrial contractions|C0033036;C0488348|1|0.55|C0033036|CHV;COSTAR;LNC;MSH;NDFRT;SNOMEDCT|1|0.0262|1
PAC|Atrial Premature Complexes [Disease/Finding]||||C0033036|NDFRT|||
PAC|Atrial premature complex (disorder)||||C0033036|SNOMEDCT|||
PAC|Atrial premature complex (finding)||||C0033036|SNOMEDCT|||
PAC|Atrial premature complex [Ambiguous]||||C0033036|SNOMEDCT|||
PAC|CAP|C0179586;C1657858;C1706092;C2985259|||C0280547|PDQ|||
PAC|CAP-I;CAP-II;CISCA chemotherapy protocol;CISCA-II;cisplatin/cyclophosphamide/doxorubicin protocol|C0280547|||C0280547|CHV;MTH;NCI;PDQ|||
PAC|CDDP/CTX/DOX||||C0280547|NCI;PDQ|||
PAC|Cisplatin/Cyclophosphamide/Doxorubicin;cisplatin,cyclophosphamide and doxorubicin;cisplatin/cyclophosphamide/doxorubicin||||C0280547|CHV;NCI;PDQ|||
PAC|Ectopic atrial beats (disorder)||||C0033036|SNOMEDCT|||
PAC|Endothelial permeability||||||1|0.0236|
PAC|P A 001 BACTERIOPHAGE ARTIFICIAL CHROMOSOMES||||C0949780|MSH|||
PAC|PAC||||C0033036;C0280547;C0700105;C0949780;C2709278|AOD;CHV;CST;LNC;NCI;PDQ|||
PAC|PAC (Chromosome);PACs (Chromosomes)||||C0949780|MSH|||
PAC|PAC (in LOINC)||||C2709278|MTH|||
PAC|Peritoneal adherent cells||||||1|0.0183|
PAC|Physical Assessment Center||||||||1
PAC|Plasma Arc Curing||||||1|0.0236|
PAC|Political action committee;political action committee;political action committee (PAC)|C0700105|||C0700105|AOD;CHV;MTH|||
PAC|Port-A-Cath;Port-a-Cath|C0935727|||||1|0.0262|1
PAC|Premature atrial contraction (disorder)||||C0033036|SNOMEDCT|||
PAC|Progress Assessment Chart||||||||1
PAC|Supraventriciular premature contraction||||C0033036|SNOMEDCT|||
PAC|Supraventricular ectopic beats (disorder)||||C0033036|SNOMEDCT|||
PAC|Supraventricular premature beats (disorder)||||C0033036|SNOMEDCT|||
PAC|paclitaxel|C0144576|||C0144576|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.0393|
PAC|pancreatic adenocarcinoma|C0281361|||C0281361|CHV;NCI;OMIM|||1
PAC|papular acrodermatitis of childhood|C0263372|||C0263372|MSH;SNOMEDCT|||1
PAC|para-aminoclonidine|C0048038|||C0048038|MSH;NDFRT|||1
PAC|parent-adult-child||||||||1
PAC|penicillin acylase|C0030825|||||1|0.034|
PAC|perennial allergic conjunctivitis|C0339165|||C0339165|SNOMEDCT|1|0.0288|
PAC|pericarditis, arthropathy, camptodactyly||||||||1
PAC|perturbed angular correlation||||||1|0.034|
PAC|perturbed angular correlation of gamma-rays||||||1|0.0157|
PAC|physician assistant certification||1|0.274|||||
PAC|picture archiving communication||1|0.050|||||1
PAC|plasma aldosterone||||||1|0.0445|
PAC|plasma aldosterone concentration||||||||1
PAC|polyaluminium chloride;polyaluminum chloride|C0051518|||C0051518|MSH|1|0.0209|
PAC|polycyclic aromatic compounds||||||1|0.0628|
PAC|post anesthesia care||1|0.094|||||
PAC|post-acute care||||||1|0.034|
PAC|powdered activated carbon||||||1|0.1257|
PAC|preadmission certification||||||||1
PAC|premature auricular contraction||||||||1
PAC|pressure-assist control||||||||1
PAC|primary auditory cortex|C2954070|||C2954070|FMA|1|0.0314|
PAC|prophylactic anticonvulsant||||||||1
PAC|prostatic adenocarcinoma|C0007112|||C0007112|CHV;PDQ|1|0.034|
PAC|pulmonary arterial concentration||1|0.002|||||
PAC|pulmonary artery catheter|C0179790|1|0.002|C0179790|CHV;SNOMEDCT|1|0.2592|1
PAC|pulmonary artery catheterization|C0007438;C0190658|||C0007438;C0190658|CHV;MSH;MTH;NCI|1|0.0288|1
PAC|pulmonary artery constriction||||||1|0.0209|
PAC|surface protein antigen||||||1|0.0681|
PA|2-aminopyridine|C0051326|||||1|0.0021|
PA|ACIDIC SALIVARY PROLINE-RICH PROTEIN, HaeIII TYPE, 1;PAROTID ACIDIC PROTEIN;PRH1;PRH1 gene;PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1;proline-rich protein HaeIII subfamily 1|C1418892|||C1418892|HUGO;MTH;OMIM|||
PA|Assistant, Doctor's;Assistants, Doctor's;Doctor Assistants;Doctor's Assistant;Doctor's Assistants;doctor assistants;Extender, Physicians';Extenders, Physicians';Physician Extenders;Physician's Extenders;Physicians' Extender;Physicians' Extenders;physician extender;physician extenders;PA;Pa|C0031833|||C0030266;C0030428;C0030853;C0031833;C0205469;C0439473;C0681477;C1414426;C1418225;C1418892;C1996865|CHV;HUGO;LNC;MSH;NCI;OMIM;SNOMEDCT|||
PA|Assistant, Physicians';Assistants, Physician;Assistants, Physicians';PHYSICIAN ASSISTANT;Physician Assistant;Physician Assistants;Physician's Assistants;Physicians Assistants;Physicians' Assistant;Physicians' Assistants;Physicians' assistants;physician assistant;physician assistants;physician's assistant;physician's assistants|C0031833;C3163889|1|0.122|C0031833;C1549987;C1578492;C1704470;C3163889|AOD;CHV;CSP;HL7V2.5;HL7V3.0;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0059|
PA|Children's Hospital of Philadelphia||||||1|0.0021|
PA|Children's Hospital of Pittsburgh||||||1|0.0017|
PA|D-penicillamine;penicillamine|C0030817|||C0030817|AOD;CHV;CSP;LCH;MSH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0042|
PA|EPB42;EPB42 gene;Erythrocyte surface protein band 4.2;MGC116735;MGC116737;PROTEIN 4.2, ERYTHROCYTIC;erythrocyte membrane protein band 4.2|C1414426|||C1414426|HUGO;MTH;OMIM|||
PA|N/m2;N/sq. m;Pascal;pascal;newton per square metre|C0439473|||C0439473|HL7V3.0;MTH;NCI;SNOMEDCT|||1
PA|NIH Program Announcements;Program Announcements, NIH;Program Announcement;Program Announcements;program announcement|C0681477|||C0681477|AOD;MTH;NCI|||
PA|P||||C0439473|NCI|||
PA|PALLID, MOUSE, HOMOLOG OF||||C1418225|OMIM|||
PA|PALLIDIN;PLDN;PLDN gene|C1418225|||C1418225|HUGO;MTH;OMIM|||
PA|PAN|C0085999|||C0030266|NCI|||
PA|PANAMA;Panama;panama|C0030266|||C0030266|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
PA|PARAGUAY;Paraguay;paraguay;PY|C0030428|||C0030428|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
PA|PATHOL||||C0205469|MSH|||
PA|PM||||C0030266|NCI|||
PA|PRY|C0030428;C1422358|||C0030428|NCI|||
PA|Pa (qualifier value)||||C0439473|SNOMEDCT|||
PA|Panama (geographic location)||||C0030266|SNOMEDCT|||
PA|Paraguay (geographic location)||||C0030428|SNOMEDCT|||
PA|Paranoia;paranoia|C1456784|||C1456784|AOD;COSTAR;CSP;CST;DXP;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.0019|1
PA|Pathological aspects|C0205469|||C0205469|MTH|||
PA|Pennsylvania;pennsylvania|C0030853|||C0030853|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0029|
PA|Pennsylvania (geographic location)||||C0030853|SNOMEDCT|||
PA|Picture Arrangement||||||||1
PA|Polyacrylamide;polyacrylamide|C0071499|||C0071499|CHV;CSP;MSH;SNOMEDCT|1|0.0027|1
PA|Polyacrylate;polyacrylate|C0597265|||C0597265|CSP|1|0.005|
PA|Postero-Anterior;postero-anterior|C1996865|||C1996865|MTH|1|0.0084|
PA|Pseudoaneurysm;pseudoaneurysm|C0162868;C1510412|||||1|0.0032|1
PA|Pseudomonas aeruginosa|C0033809;C1962990|||||1|0.0268|1
PA|Psoriatic arthritis;psoriatic arthropathy|C0003872|||||1|0.0129|
PA|Pyridylamino||||||1|0.0021|
PA|Pyrophosphate arthropathy;pyrophosphate arthropathy|C1306839|||||1|0.0011|1
PA|University of Pittsburgh||||||1|0.0013|
PA|abscess|C0000833;C0549483;C1550609|||||1|0.0032|
PA|acidic protein||||||1|0.0013|
PA|agreement|C0680240|||||1|0.0017|
PA|alcohol|C0001962;C0001975;C0202304|||||1|0.0023|
PA|alveolar partial pressure||||||||1
PA|alveolar pressure;pressure, alveolar|C0232010|||C0232010|CHV;SNOMEDCT|1|0.0086|1
PA|analysis|C0002778;C0936012;C1524024|||||1|0.0023|
PA|apparent permeability coefficient to albumin||||||1|0.0002|
PA|arterial blood pressure|C1272641|||||1|0.0032|
PA|arterial pressure|C0232108;C1272641|||||1|0.0187|
PA|newton/square meter;newton/square metre||||C0439473|SNOMEDCT|||
PA|nucleus|C0007610|||||1|0.0025|
PA|paleostriatum augmentatum||||||1|0.0021|
PA|pallid||||||1|0.0019|
PA|pallidin homolog (mouse)||||C1418225|HUGO|||
PA|palmitic acid|C0030234|||C0030234|AOD;CHV;FMA;LCH;MSH;NCI;NDFRT;SNOMEDCT;VANDF|||
PA|pancreatic adenocarcinoma|C0281361|||||1|0.0013|
PA|panic attack;panic attacks|C0086769|||C0086769|AOD;CHV;MSH;MTHICD9;NCI;SNOMEDCT|1|0.0025|1
PA|pantothenic acid|C0030342;C0696237;C2700255|||C0030342;C0696237;C2700255|AOD;CHV;MEDLINEPLUS;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||1
PA|paralysis agitans|C0030567|||C0030567|CHV;COSTAR;CSP;CST;DXP;ICD9CM;MEDLINEPLUS;MSH;NDFRT;SNOMEDCT|||1
PA|paranoid||||||||1
PA|parathyroid adenoma|C0262587|||C0262587|CHV;COSTAR;MSH;NCI;OMIM;SNOMEDCT|||
PA|parietal antibody||||||||1
PA|partial pressure of alveolar fluid||||||||1
PA|partial pressure of arterial fluid||||||||1
PA|particle agglutination||||||1|0.0124|
PA|particle agglutination assay||||||1|0.0015|
PA|particle agglutination test||||||1|0.001|
PA|parvalbumin|C0030616;C1419140|||C0030616;C1419140|CHV;CSP;HUGO;OMIM;SNOMEDCT|1|0.0057|
PA|passive aggressive||||||||1
PA|passive avoidance||||||1|0.0132|
PA|paternal aunt||||||||1
PA|pathologic|C1521733|||||||1
PA|pathology|C0030664;C0205469;C0677042|||C0030664;C0205469;C0334866;C0677042;C0919386|AOD;CHV;CSP;HL7V3.0;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|||1
PA|peak amplitude||||||||1
PA|peanut allergy|C0559470|||||||1
PA|penicillic acid|C0030821|||C0030821|AOD;MSH;NDFRT;SNOMEDCT|||
PA|penicillin acylase|C0030825|||C0030825|MSH;NDFRT|||
PA|pentanoic acid|C0068263|||||||1
PA|perceptual asymmetry||||||1|0.0015|
PA|performance assessment||||||1|0.0015|
PA|periapical|C0729269|||||||1
PA|periarteritis|C0264988|||C0264988|CHV;MTHICD9;SNOMEDCT|||1
PA|peridural artery||||||||1
PA|perinatal asphyxia|C0559477|||C0559477|CHV;MTH;SNOMEDCT|1|0.0055|
PA|periodic acid|C0031068|||C0031068|AOD;CHV;CSP;MSH;NDFRT|||1
PA|periodontal abscess|C0031085|||||||1
PA|permeability area||||||||1
PA|permeability-area product||||||1|0.0013|
PA|permeability-surface area product||||||1|0.0019|
PA|pernicious anaemia;pernicious anemia|C0002892|||C0002892|AOD;CHV;COSTAR;CSP;ICD9CM;MSH;NCI;OMIM;QMR;SNOMEDCT|1|0.0157|1
PA|peroxidatic activity||||||||1
PA|persistent asthma||||||||1
PA|phakic-aphakic||||||||1
PA|phase angle||||||1|0.0019|
PA|phenol alcohol||||||||1
PA|phenylacetate|C0031452;C0220893|||C0031452;C0220893|CHV;CSP;LNC;MSH;MTH;NCI;PDQ;RXNORM;SNOMEDCT|1|0.0075|1
PA|phenylacetic acid|C0070620|||C0070620|CHV;LCH;MSH;NCI;RXNORM;SNOMEDCT|||
PA|phenylalanine|C0031453|||C0031453|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
PA|phenylalkylamine|C0597214|||C0597214|CSP;SNOMEDCT|||
PA|phonological awareness||||||1|0.0011|
PA|phosphatidate|C0178797|||C0178797|CSP;LNC|1|0.008|
PA|phosphatidic acid|C0031610|||C0031610|AOD;MSH;NCI;SNOMEDCT|1|0.1592|1
PA|phosphoarginine|C0070818|||C0070818|MSH|||1
PA|phosphoric acid|C0031700;C0031702;C1161325|||C0031700;C0031702;C1161325|AOD;CHV;CSP;LCH;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
PA|photo allergy||||||||1
PA|photoacoustic||||||1|0.0057|
PA|photoallergy|C0206051|||C0206051|CHV;CSP;MSH;SNOMEDCT|||
PA|phthalic acid|C0070968|||C0070968|AOD;LCH;MSH|||
PA|phthalic anhydride|C0070969|||C0070969|LNC;MSH;SNOMEDCT|1|0.0059|1
PA|physical activity|C0026606|||C0026606|AOD;CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0512|1
PA|physical assistance||||||||1
PA|physician associates||1|0.166|||||
PA|phytic acid|C0031855|||C0031855|CHV;LCH;MSH;NCI;NDFRT;RXNORM|||
PA|picoampere||||||||1
PA|picolinic acid|C0071038|||C0071038|AOD;MSH;RXNORM|||
PA|pilocytic astrocytoma|C0334583|||C0334583|CHV;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.0031|
PA|pineapple|C0440279;C0475655;C1113644|||||||1
PA|pipecolic acid|C0031951|||C0031951|MSH;MTH;SNOMEDCT|||
PA|pituitary adenoma|C0032000|||||||1
PA|pituitary-adrenal||||||1|0.0021|1
PA|plaque area||||||1|0.0025|
PA|plasma aldosterone||||||||1
PA|plasmapheresis|C0032134|||C0032134|AOD;CHV;CSP;LCH;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.0063|
PA|plasminogen activation|C1622667|||C1622667|GO|1|0.004|
PA|plasminogen activator|C0032144|||C0032144;C0042071|AOD;CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.1578|1
PA|platelet adhesiveness|C0032175|||C0032175|MSH|||1
PA|platelet aggregation|C0032176;C0677599|||C0032176;C0677599|AOD;CHV;CSP;GO;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0153|1
PA|platelet associated||||||||1
PA|pleomorphic adenoma|C0026277|||C0026277|CHV;MSH;NCI;SNOMEDCT|1|0.0118|1
PA|polyadenylation|C0949765|||||1|0.0019|
PA|polyamide|C0028736|||C0028736|CHV;MSH;NDFRT;SNOMEDCT|1|0.0032|
PA|polyamine|C0032433|||C0032433|CHV;CSP;SNOMEDCT|1|0.0147|
PA|polyarteritis|C0264992|||C0264992|CHV;SNOMEDCT|||1
PA|polyarthritis|C0162323|||C0162323|AOD;CHV;COSTAR;CSP;CST;DXP;MSH;MTH;NCI;SNOMEDCT|||1
PA|popliteal artery|C0032649;C1278953|||C0032649;C1278953|CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|||
PA|positive affect||||||1|0.0075|
PA|positive affectivity||||||1|0.0017|
PA|postabsorptive||||||1|0.0023|
PA|postaural|C0442167|||C0442167|SNOMEDCT|||1
PA|posterior-anterior|C1999039|1|0.424|||1|0.0078|1
PA|posteroanterior||||||1|0.0273|1
PA|prealbumin|C0032923|||C0032923|AOD;CHV;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
PA|predictive accuracy||||||||1
PA|pregnancy associated;pregnancy-associated||||||1|0.0019|1
PA|preinfarction angina|C0002965;C0086666|||C0002965;C0086666|CHV;MSH;MTHICD9;SNOMEDCT|1|0.0015|
PA|premature adrenarche|C0342546|||C0342546|CHV;OMIM;SNOMEDCT|1|0.0032|1
PA|presents again||||||||1
PA|pressure augmentation||||||||1
PA|pressure, atrial|C0428877|||||||1
PA|primary aldosteronism|C1384514|||C1384514|CHV;SNOMEDCT|1|0.0225|1
PA|primary amenorrhea|C0232939|||C0232939|CHV;COSTAR;CSP;MTHICD9;OMIM;SNOMEDCT|||1
PA|primary anemia||||||||1
PA|primary angioplasty||||||1|0.0017|
PA|prior to admission||||||||1
PA|proactivator||||||||1
PA|proanthocyanidin|C0072018|||C0072018|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.0027|1
PA|procainamide|C0033216|||C0033216|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.017|
PA|professional association|C0680403|||||||1
PA|progressive aphasia|C0338457|||||1|0.001|
PA|proinsulin antibody||||||||1
PA|prolonged action||||||||1
PA|prophylactic antibiotic|C0362063|||||||1
PA|propionic acid|C0033482;C0072186|||C0033482;C0072186|AOD;CHV;LCH;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||1
PA|propionic acidaemia;propionic acidemia|C0268579|||C0268579|CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0063|
PA|prostate adenocarcinoma|C0007112|||||1|0.0013|
PA|prostate antigen|C1704988|||C1704988|NCI|||1
PA|protactinium|C0033597|||||||1
PA|protective antigen|C1443846|||C1443846|SNOMEDCT|1|0.0417|1
PA|proteolytic activity||||||||1
PA|prothrombin activity|C0200396|||||||1
PA|proton affinity||||||1|0.0021|
PA|protrusio acetabuli|C0409495|||C0409495|CHV;MTH;OMIM;SNOMEDCT|||1
PA|psychoanalysis|C0033884;C0392892|||||||1
PA|psychoanalyst|C0600090|||C0600090|CHV;SNOMEDCT|||
PA|psychogenic aspermia||||||||1
PA|psychosocial assessment|C1455743|||||||1
PA|pubic arch|C0735723|||||||1
PA|pullulan acetate||||||1|0.0011|
PA|pulmonary|C0024109;C2707265;C2709248|||||1|0.0017|
PA|pulmonary angiography|C0677490|||C0677490|CHV;SNOMEDCT|1|0.0027|1
PA|pulmonary arterial||||||1|0.0138|
PA|pulmonary arterial pressure|C1168098|||C1168098|CHV|||
PA|pulmonary artery|C0034052;C1269026|1|0.276|C0034052;C1269026|AOD;CHV;CSP;FMA;HL7V2.5;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.1368|1
PA|pulmonary atresia|C0242855|||C0242855|CHV;MSH;NDFRT;OMIM;SNOMEDCT|1|0.0042|1
PA|pulmonary auscultation||1|0.002|||||
PA|pulmonary autograft||||||||1
PA|pulmonaryarterial||||||||1
PA|pulpoaxial||||||||1
PA|pulse amplitude||||||1|0.005|
PA|pulsus alternans|C0232121|||||||1
PA|puromycin aminonucleoside|C0034146|||C0034146|MSH;NDFRT|1|0.0075|1
PA|pyloric atresia|C0266159|||||1|0.0019|
PA|pyridylaminated||||||1|0.0031|
PA|pyrrolizidine alkaloid|C0034335|||C0034335|CHV|1|0.0105|1
PA|pyruvic acid|C0072802|||C0072802|CHV;MSH;MTH;NDFRT;RXNORM;SNOMEDCT|||
PA|solitary parathyroid adenoma||||||1|0.001|
PA|yearly|C0332181|||||||1
PCA|2-Pyrrolidinone-5-Carboxylic Acid;5-Pyrrolidinone-2-Carboxylic Acid;2-Pyrrolidone-5-Carboxylate;2-Pyrrolidone-5-Carboxylic Acid;5 oxoproline;5-Oxoproline;5-oxoproline;5-Carboxy-2-Pyrrolidinone;5-Ketoproline;5-L-Oxoproline;5-Oxo-L-Proline;5-Oxo-L-proline;L-5-Oxoproline;L-Proline, 5-oxo-;5-Oxopyrrolidine-2-Carboxylic Acid;Acid, Pyroglutamic;Pyroglutamic Acid;Pyroglutamic acid;pyroglutamic acid;Acid, Pyrrolidonecarboxylic;Pyrrolidonecarboxylic Acid;L-Glutamic Acid Gamma-Lactam;L-Pyroglutamic Acid;PIDOLIC ACID;Pidolic Acid;pyrrolidone carboxylic acid|C0034330|||C0034330|CHV;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|||1
PCA|4-Chloroamphetamine;Benzeneethanamine, 4-chloro-alpha-methyl-;CHLORAMPHETAMINE P;p Chloramphetamine;p-Chloramphetamine;CHLOROAMPHETAMINE P;p Chloroamphetamine;p-Chloroamphetamine;p-chloroamphetamine;Para-chloroamphetamine;para Chloroamphetamine;para-Chloroamphetamine;Parachloroamphetamine;parachloroamphetamine;alpha-Methyl-p-chlorophenethylamine|C0030131|||C0030131|AOD;MSH;MTH;NCI;NDFRT|1|0.0574|
PCA|5-Oxoproline (substance)||||C0034330|SNOMEDCT|||
PCA|A. cerebri posterior||||C0149576|UWDA|||
PCA|AMYLOIDOSIS IX;Amyloidosis IX;AMYLOIDOSIS, FAMILIAL CUTANEOUS LICHEN;AMYLOIDOSIS, PRIMARY CUTANEOUS, 1;AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1;Dominant primary localised cutaneous amyloidosis;Dominant primary localized cutaneous amyloidosis;Familial amyloidosis cutis;Familial generalised dyschromic amyloidosis cutis;Familial generalized dyschromic amyloidosis cutis;Familial lichen amyloidosis;LICHEN AMYLOIDOSIS, FAMILIAL;PLCA1|C0268398|||C0268398|MTH;OMIM;SNOMEDCT|||
PCA|Analgesia, Patient Controlled;Analgesia, Patient-Controlled;Patient Controlled Analgesia;Patient controlled analgesia;Patient-Controlled Analgesia;analgesia controlled patient;patient controlled analgesia;patient-controlled analgesia;PCA - Patient controlled analgesia|C0078944|1|0.996|C0078944|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.1818|1
PCA|Analyses, Principal Component;Principal Component Analyses;principal component analyses|C0429865|||C0429865|MSH|1|0.0064|
PCA|Analysis, Principal Component;Principal Component Analysis;Principal Components Analysis;principal component analysis;principal components analysis;principal-components analysis|C0429865;C1704235|||C0429865;C1704235|AOD;MSH;MTH;NCI;SNOMEDCT|1|0.2491|1
PCA|Anaphylaxis, Passive Cutaneous;Cutaneous Anaphylaxis, Passive;Passive Cutaneous Anaphylaxis;passive cutaneous anaphylaxis;passive cutaneous anaphylaxis (PCA)|C0030625|||C0030625|AOD;CHV;MSH;MTH|1|0.1002|1
PCA|Arteria cerebri posterior||||C0149576|FMA|||
PCA|Arteries, Posterior Cerebral;Artery, Posterior Cerebral;Cerebral Arteries, Posterior;Cerebral Artery, Posterior;Posterior Cerebral Arteries;Posterior Cerebral Artery;Posterior cerebral artery;Posterior cerebral artery, NOS;posterior cerebral artery|C0149576;C1269013|||C0149576;C1269013|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.041|1
PCA|CHOANAL ATRESIA, POSTERIOR|C0220723|||C0220723|DXP;MTH;OMIM|||
PCA|Ca2+ concentration||||||1|0.0012|
PCA|Dominant primary localized cutaneous amyloidosis (disorder)||||C0268398|SNOMEDCT|||
PCA|FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 1;FLVCR;FLVCR1;FLVCR1 gene;MFSD7B;feline leukemia virus subgroup C cellular receptor 1|C1836722|||C1836722|HUGO;MTH;OMIM|||
PCA|Familial lichen amyloidosis (disorder)||||C0268398|SNOMEDCT|||
PCA|OXOPROLINE 05||||C0034330|MSH|||
PCA|PCA;pca|C0268398;C1552962;C1836722|||C0030131;C0030625;C0034330;C0078944;C0149576;C0220723;C0268398;C0429865;C1549860;C1836722|CHV;HL7V2.5;HUGO;MSH;NCI;OMIM|||
PCA|PCA Message Structure|C1549860|||C1549860|MTH|||
PCA|PCA1|C0268398;C1414407;C1823176|||C0268398|OMIM|||
PCA|PRINCIPAL COMPONENT ANAL||||C0429865|MSH|||
PCA|Passive cutaneous anaphylactic||||||1|0.0066|
PCA|Patient controlled analgesia (procedure)||||C0078944|SNOMEDCT|||
PCA|Porous-coated anatomic;porous-coated anatomic||||||1|0.0113|1
PCA|Posterior cortical atrophy||||||1|0.0047|
PCA|Pyroglutamic acid (substance)||||C0034330|SNOMEDCT|||
PCA|Pyrrolidonecarboxylic Acid [Chemical/Ingredient]||||C0034330|NDFRT|||
PCA|Structure of posterior cerebral artery|C0149576|||C0149576|MTH;SNOMEDCT|||
PCA|Structure of posterior cerebral artery (body structure)||||C0149576|SNOMEDCT|||
PCA|p-Chloroamphetamine [Chemical/Ingredient]||||C0030131|NDFRT|||
PCA|pancreatic cancer|C0235974;C0346647;C2984259|||||||1
PCA|pancreatic carcinoma|C0235974|||||||1
PCA|para-chloramphetamine||||||||1
PCA|parenteral controlled analgesia||||||||1
PCA|parietal cell|C0030559|||||1|0.0019|
PCA|parietal cell antibodies;parietal cell antibody|C0369797;C0863184|||C0369797;C0863184|CHV;LNC;MTH;SNOMEDCT|1|0.0075|1
PCA|patient care attendant||1|0.002|||||
PCA|patient-controlled analgesic||||||1|0.0019|1
PCA|pentachloroanisole|C0070265|||||1|0.0026|
PCA|percent cortical area||||||1|0.0009|
PCA|perchloric acid|C0030981|||C0030981|AOD;MSH;NDFRT;SNOMEDCT|1|0.0151|1
PCA|percutaneous carotid angiography||||||||1
PCA|percutaneous carotid angioplasty||||||||1
PCA|percutaneous carotid arteriogram||||||||1
PCA|phenylcarboxylic acid||||||||1
PCA|photocontact allergic||||||||1
PCA|photocontact allergic allergy||||||||1
PCA|plasma calcium|C0858090|||||1|0.0014|
PCA|plasma catecholamines||||||||1
PCA|plate count agar||||||1|0.0035|
PCA|portacaval anastomosis;portocaval anastomosis|C0032716|||||1|0.0196|1
PCA|postcardiac arrest||||||||1
PCA|postciliary artery||||||||1
PCA|postconceptional age||||||1|0.0205|1
PCA|postcoronary arrest||||||||1
PCA|posterior cerebral||||||1|0.0026|
PCA|posterior ciliary arteries;posterior ciliary artery|C0923318|||C0923318|FMA;UWDA|1|0.0028|
PCA|posterior communicating aneurysm||||||||1
PCA|posterior communicating artery|C0149559;C1269014|||||||1
PCA|posterior cricoarytenoid|C0224179;C0448337|||C0224179;C0448337|FMA;MTH;SNOMEDCT;UWDA|1|0.0297|1
PCA|posterior cricoarytenoid muscle|C0224179|||C0224179|SNOMEDCT|1|0.0075|
PCA|precoronary care area||||||||1
PCA|prehospital cardiac arrest||||||||1
PCA|probe competition assay||||||1|0.0009|
PCA|procoagulant activity||||||1|0.0717|1
PCA|prostate adenocarcinoma;prostatic adenocarcinoma|C0007112|||||1|0.0061|1
PCA|prostate cancer|C0376358;C0600139;C2984325|||C0376358;C0600139;C2984325|CHV;CSP;MEDLINEPLUS;MSH;NCI;OMIM;PDQ|1|0.1057|1
PCA|prostate carcinoma;prostatic carcinoma|C0600139|||C0600139|CHV;COSTAR;CST;MTH;NCI;SNOMEDCT|1|0.0239|1
PCA|protected catheter aspirate||||||||1
PCA|protein fragment complementation assay||||||1|0.0009|
PCA|protocatechuate||||||1|0.0047|
PCA|protocatechuic acid|C0072489|||C0072489|MSH|1|0.0064|
PCA|weeks post-conceptional age||||||1|0.0024|
PCI|ACTIVATED PROTEIN C INHIB;PROTEIN C INHIB ACTIVATED||||C0072348|MSH|||
PCI|Acrosomal Serine Protease Inhibitor;Activated Protein C Inhibitor;Activated protein C inhibitor;Protein C Inhibitor, Activated;Protein C inhibitor.activated;PAI-3;Plasma Serine Protease Inhibitor;Plasminogen Activator Inhibitor 3;Plasminogen Activator Inhibitor-3;Plasminogen activator inhibitor-3;Plasminogen Activator Inhibitor III;Plasminogen Activator Inhibitor, Type 3;Type 3 Plasminogen Activator Inhibitor;Serpin A5|C0072348|||C0072348|LNC;MSH;NCI;NDFRT;SNOMEDCT|||
PCI|Activated protein C inhibitor (substance)||||C0072348|SNOMEDCT|||
PCI|Alpha-1 Antiproteinase|C0002191;C0072348|||C0072348|NCI|||
PCI|Antitrypsin|C0072348;C1418544|||C0072348|NCI|||
PCI|Isogravimetric capillary pressure||||||1|0.0064|
PCI|PAI 03||||C0072348|MSH|||
PCI|PAI3;SERPINA5 Gene;SERPINA5 gene|C1418370|||C1418370|HUGO;MTH;NCI|||
PCI|PCI;pCi||||C0072348;C1418370;C1514496;C1705930;C2347515|NCI;OMIM|||
PCI|PLANH3|C0072348;C1705930|||C0072348;C1705930|NCI|||
PCI|PLASMINOGEN ACTIVATOR INHIB 3||||C0072348|MSH|||
PCI|PLASMINOGEN ACTIVATOR INHIB TYPE 3;TYPE 3 PLASMINOGEN ACTIVATOR INHIB||||C0072348|MSH|||
PCI|PLASMINOGEN ACTIVATOR INHIBITOR 03||||C0072348|MSH|||
PCI|PROCI|C0072348;C1418370;C1705930|||C0072348;C1418370;C1705930|HUGO;NCI|||
PCI|PROTEIN C INHIB||||C0072348|MSH|||
PCI|PROTEIN C INHIBITOR;Protein C Inhibitor;Protein C inhibitor;SERPINA5|C0072348;C1418370|||C0072348;C1418370|HUGO;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0722|
PCI|Phenomenology of Consciousness Inventory||||||1|0.0051|
PCI|Photochemical internalisation;photochemical internalization||||||1|0.0173|
PCI|Picocurie;picocurie|C2347515|||C2347515|MTH;NCI|||1
PCI|Plasminogen activator inhibitor-3 (substance)||||C0072348|SNOMEDCT|||
PCI|Pneumatosis cystoides intestinalis;pneumatosis cystoides intestinalis|C0032266|||C0032266|DXP;MSH;NDFRT;SNOMEDCT|1|0.039|1
PCI|Potato carboxypeptidase inhibitor||||||1|0.0109|
PCI|Premarital Communication Inventory||||||||1
PCI|Prophylactic Cranial Irradiation;prophylactic cranial irradiation|C1514496|||C1514496|MTH;NCI|1|0.0786|1
PCI|Protein C Inhibitor [Chemical/Ingredient]||||C0072348|NDFRT|||
PCI|SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5||||C1418370|OMIM|||
PCI|SERPINA5 wt Allele|C1705930|||C1705930|MTH;NCI|||
PCI|Serine (or Cysteine) Proteinase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 5 Gene||||C1418370|NCI|||
PCI|Serine (or Cysteine) Proteinase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 5 wt Allele||||C1705930|NCI|||
PCI|Serine or Cysteine Proteinase Inhibitor Clade A Member 5||||C0072348|NCI|||
PCI|partial coherence interferometry||||||1|0.0115|1
PCI|percutaneous coronary intervention|C1532338|1|0.998|C1532338|SNOMEDCT|1|0.7284|1
PCI|peritoneal cancer index||||||1|0.0045|
PCI|physiological cost index||||||1|0.016|
PCI|positive chemical ionization||||||1|0.007|
PCI|posterior curve intermediate||||||||1
PCI|proliferating cell index||||||1|0.0032|
PCI|prothrombin consumption index||||||||1
PCI|serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5||||C1418370|HUGO|||
PCP|1-(1-Phenylcyclohexyl)piperidine;Piperidine, 1-(1-phenylcyclohexyl)-||||C0031381|MSH;NDFRT|||
PCP|5-@OXOPROLYL PEPTIDASE;PYROGLUTAMYL PEPTIDASE I;pyroglutamyl-peptidase I;PYRROLIDONE-CARBOXYLATE PEPTIDASE|C0034307;C1422070|||C1422070|HUGO;OMIM|||
PCP|ANGIOTENSINASE C;PROLYLCARBOXYPEPTIDASE;prolylcarboxypeptidase|C0072114;C1418873|||C0072114;C1418873|MSH;OMIM|||
PCP|Angel Dust;Angel dust;Dust, Angel;angel dust;PCP - Phencyclidine;phencyclidine(PCP)|C0031381|||C0031381|CHV;MSH;NDFRT;SNOMEDCT|||
PCP|Angel dust measurement;PCP Measurement;PCP measurement;Phencyclidine Measurement;Phencyclidine measurement;Phenylcyclohexylpiperidine|C0202445|||C0202445|MTH;NCI;SNOMEDCT|||
PCP|HUMPCP;PRCP;PRCP gene|C1418873|||C1418873|HUGO;MTH;OMIM|||
PCP|Interstitial plasma cell pneumonia;PNEUMONIA, INTERSTITIAL PLASMA CELL;Pneumonia, Interstitial Plasma Cell;interstitial plasma cell pneumonia;PCP - Pneumocystis carinii pneumonia;pneumocystis carinii pneumonia (PCP);PCP - Pneumocystis pneumonia;PJP;PNEUMOCYSTIS CARINII PNEUMONIA;PNEUMONIA, PNEUMOCYSTIS CARINII;Pneumocystis Carinii Pneumonia;Pneumocystis carinii Pneumonia;Pneumocystis carinii pneumonia;Pneumonia, Pneumocystis carinii;Pneumonias, Pneumocystis carinii;pneumocystis carinii pneumonia;PNEUMOCYSTIS PNEUMONIA;PNEUMONIA, PNEUMOCYSTIS;Pneumocystis Pneumonia;Pneumocystis Pneumonias;Pneumocystis pneumonia;Pneumonia, Pneumocystis;Pneumonias, Pneumocystis;pneumocystis pneumonia;Pneumocystoses;Pneumocystosis;pneumocystosis;Pneumocystosis jiroveci pneumonia;Pneumocystosis pneumonia;Pneumonia due to Pneumocystis carinii;Pulmonary pneumocystosis|C0032305|||C0032305|CHV;COSTAR;CSP;DXP;ICD9CM;LCH;MSH;MTH;MTHICD9;NCI;NDFRT;QMR;SNOMEDCT|1|0.332|
PCP|PCP;Pcp||||C0030855;C0031381;C0032305;C0033131;C0202445;C1418873;C1422070;C1744653|AOD;CHV;CSP;GO;HUGO;LNC;NCI;OMIM;SNOMEDCT|||
PCP|PCP - Pentachlorophenol;pentachlorophenol (PCP);Pentachlorophenol;Phenol, pentachloro-;pentachlorophenol|C0030855|||C0030855|CHV;LCH;LNC;MSH;MTH;NDFRT;SNOMEDCT|1|0.1764|1
PCP|PCP - Primary care physician;Physician, Primary Care;Physicians, Primary Care;Primary Care Physician;Primary Care Physicians;Primary care physician;care physician primary;care physicians primary;primary care physician;primary care physicians;primary physician care|C0033131|1|0.222|C0033131|CHV;CSP;HL7V3.0;MSH;MTH;SNOMEDCT|1|0.0252|1
PCP|PGP|C1418520;C1422070|||C1422070|HUGO;OMIM|||
PCP|PGP I;PGP-I;PGPEP1;PGPEP1 gene;PGPI|C1422070|||C1422070|HUGO;MTH;OMIM|||
PCP|PHENCYCLIDINE;Phencyclidine;phencyclidine;phencyclidines|C0031381;C0202445;C2919094|1|0.186|C0031381;C0202445|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT;VANDF|1|0.3795|1
PCP|Pentachlorophenol (substance)||||C0030855|SNOMEDCT|||
PCP|Pentachlorophenol [Chemical/Ingredient]||||C0030855|NDFRT|||
PCP|Phencyclidine (substance)||||C0031381|SNOMEDCT|||
PCP|Phencyclidine [Chemical/Ingredient]||||C0031381|NDFRT|||
PCP|Phencyclidine measurement (procedure)||||C0202445|SNOMEDCT|||
PCP|Phencyclidine substance of abuse||||C0031381|SNOMEDCT|||
PCP|Phencyclidine substance of abuse (substance)||||C0031381|SNOMEDCT|||
PCP|Pneumocystis|C0032305;C0597258|||C0032305|NCI|||
PCP|Pneumocystis Jiroveci Pneumonia;Pneumocystis jiroveci pneumonia|C0032305;C1535939|1|0.588|C0032305|NCI|||1
PCP|Pneumocystis carinii|C0032276;C0182833;C0320385|||||1|0.0094|
PCP|Pneumocystis carinii pneumonia (disorder)||||C0032305|SNOMEDCT|||
PCP|Pneumocystis carinii pneumonitis||||||1|0.0044|
PCP|Pneumocystosis (disorder)||||C0032305|SNOMEDCT|||
PCP|Pneumocystosis jiroveci pneumonia (disorder)||||C0032305|SNOMEDCT|||
PCP|Pneumocytosis||||C0032305|SNOMEDCT|||
PCP|Pneumonia, Pneumocystis [Disease/Finding]||||C0032305|NDFRT|||
PCP|Primary care physician (occupation)||||C0033131|SNOMEDCT|||
PCP|Procollagen C-proteinase|C1412804|||||1|0.0035|
PCP|Pulmonary pneumocystosis (disorder)||||C0032305|SNOMEDCT|||
PCP|[3H]Phencyclidine||||||1|0.0038|
PCP|aminoacylproline carboxypeptidase activity||||C1744653|GO|||
PCP|lysosomal Pro-Xaa carboxypeptidase activity||||C1744653|GO|||
PCP|palliative care program||||||||1
PCP|parachlorophenate||||||||1
PCP|parachlorophenol|C0048197|||C0048197|MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
PCP|patient care plan|C0030678|||||||1
PCP|peptidyl carrier protein||||||1|0.0063|
PCP|peptidylprolylamino acid carboxypeptidase activity||||C1744653|GO|||
PCP|peripheral coronary pressure||||||||1
PCP|persistent cough and phlegm||||||||1
PCP|phencyclidine (PCP) test||||C0202445|CHV|||
PCP|phencyclidine hydrochloride|C0282301|||||1|0.0057|
PCP|phenol-chloroform-petroleum ether||||||1|0.0031|
PCP|planar cell polarity||||||1|0.0173|
PCP|pneumococcal capsular polysaccharide||||||1|0.0031|
PCP|pneumocystic pneumonia||||||||1
PCP|pollen-coat protein||||||||1
PCP|postoperative constrictive pericarditis||||||||1
PCP|primary care provider|C1547431;C2735025;C2735026|||C1547431;C2735025;C2735026|HL7V2.5;LNC;MTH|1|0.0132|1
PCP|procollagen peptide|C0443754|||||||1
PCP|proline carboxypeptidase activity||||C1744653|GO|||
PCP|prolyl carboxypeptidase activity||||C1744653|GO|||
PCP|prolylcarboxypeptidase (angiotensinase C)||||C1418873|HUGO|||
PCP|protein C activation peptide|C0072347|||||1|0.0019|
PCP|pulmonary capillary pressure||||||1|0.0123|1
PCP|pulse cytophotometry||||||||1
PCP|pyrrolidone carboxyl peptidase||||||1|0.0028|
PCP|serine-type Pro-X carboxypeptidase activity|C1744653|||C1744653|GO;MTH|||
PCR|CR||||C0677874|NCI|||
PCR|Complete Remission;In complete remission;complete remission;Pathological Complete Remission;complete response;full remission|C0677874|||C0677874|AOD;CHV;MTH;NCI;SNOMEDCT|1|0.0007|
PCR|In complete remission (qualifier value)||||C0677874|SNOMEDCT|||
PCR|PCR;pCR|C0032520;C0677874|||C0032520;C0677874|AOD;CHV;CSP;MSH;NCI;PDQ|||
PCR|PCR - Polymerase chain reaction;polymerase chain reaction (PCR);Polymerase Chain Reaction;Polymerase Chain Reactions;Polymerase chain reaction;Reaction, Polymerase Chain;Reactions, Polymerase Chain;polymerase chain reaction|C0032520|1|1|C0032520|AOD;CHV;CSP;HL7V3.0;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.983|1
PCR|Polymerase chain reaction (qualifier value)||||C0032520|SNOMEDCT|||
PCR|Principal Component Regression||||||1|0.0022|
PCR|enzymatic amplification||||||1|0.0004|
PCR|pathologic complete response||||||1|0.002|
PCR|pathologically confirmed complete remission||||||||1
PCR|patient care report||||||||1
PCR|patient contact record||||||||1
PCR|percutaneous coronary revascularization||||||||1
PCR|phosphocreatine|C0031634|||C0031634|AOD;CHV;CSP;MSH;NDFRT;SNOMEDCT|1|0.0003|1
PCR|phosphocreatinine|C0070826|||||1|0.0005|
PCR|photoconvulsive response||||||||1
PCR|plaque control record||||||1|0.0003|
PCR|plasma clearance rate||||||||1
PCR|plasma creatinine|C1278055|||||1|0.001|
PCR|plasma creatinine concentration||||||1|0.0004|
PCR|polymerase chain||||||1|0.0004|
PCR|polymerase chain reaction amplification||||||1|0.0006|
PCR|polymerase chain reaction assay||||||1|0.0009|
PCR|polymerase chain reaction method||||||1|0.0011|
PCR|polymerase chain reaction technique||||||1|0.0011|
PCR|postcompression remodeling||||||||1
PCR|probable causal relationship||||||||1
PCR|progressive condylar resorption||||||||1
PCR|protein catabolic rate||||||1|0.0046|1
PCR|psychiatric case register||||||1|0.0004|
PDA|DUCTUS ARTERIOSUS PATENT;DUCTUS ARTERIOSUS, PATENT;Ductus Arteriosus, Patent;PATENT DUCTUS ARTERIOSUS;Patent Ductus Arteriosus;Patent ductus arteriosus;arteriosus ductus patent;patent arteriosus ductus;patent ductus arteriosus;PDA - Patent ductus arteriosus;PDA1;Patency of the Ductus Arteriosus;Patent arterial duct;Patent ductus Botalli;Patent ductus arteriosus - persisting type;Persistent ductus arteriosus;ductus arteriosus persistent;persistent ductus arteriosus;arteriosis ductus patent;patent ductus arteriosis|C0013274|1|0.276|C0013274|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.7188|1
PDA|Dorsal aortic blood pressure||||||1|0.0063|
PDA|Ductus Arteriosus, Patent [Disease/Finding]||||C0013274|NDFRT|||
PDA|PDA|C0013274;C0226047|||C0013274;C0226047|FMA;OMIM;UWDA|||
PDA|Patent ductus arteriosus (disorder)||||C0013274|SNOMEDCT|||
PDA|Patent ductus arteriosus - persisting type (disorder)||||C0013274|SNOMEDCT|||
PDA|Personal Digital Assistant;personal digital assistant|C1136134|||C1136134|CHV;MSH;MTH|1|0.0875|1
PDA|Population and Community Development Association||||||1|0.0135|
PDA|Posterior descending artery;posterior descending artery;posterior descending artery (PDA)|C0226047;C0500492|1|0.722|C0226047;C0500492|CHV;FMA;SNOMEDCT;UWDA|1|0.0198|1
PDA|Posterior descending branch of right coronary artery;Posterior descending coronary artery;Posterior interventricular artery;Posterior interventricular branch of right coronary artery;Right posterior interventricular artery;Structure of posterior descending branch of right coronary artery;posterior interventricular artery (PIV)|C0226047|||C0226047|CHV;FMA;MTH;SNOMEDCT;UWDA|||
PDA|Ramus interventricularis posterior||||C0226047|UWDA|||
PDA|Ramus interventricularis posterior (Arteria coronaria dextra)||||C0226047|FMA|||
PDA|Structure of posterior descending branch of right coronary artery (body structure)||||C0226047|SNOMEDCT|||
PDA|cis-2,3-piperidine dicarboxylic acid||||||1|0.0187|
PDA|pancreatic ductal adenocarcinoma|C1335302|||C1335302|MTH;NCI|1|0.0052|
PDA|pancreaticoduodenal artery|C1709455|||||1|0.0125|
PDA|panic disorder and agoraphobia;panic disorder with agoraphobia|C0236800|||C0236800|CHV;CSP;MTHICD9;SNOMEDCT|1|0.0073|
PDA|parenteral drug abuser||||||||1
PDA|pathological demand avoidance||||||||1
PDA|patient distress alarm||||||||1
PDA|pediatric allergy||||||||1
PDA|pericardial diaphragmatic adhesion||||||||1
PDA|phenylenediamine|C0031468|||C0031468|AOD;CHV;CSP;NDFRT;VANDF|||
PDA|phorbol 12,13-diacetate||||||1|0.0333|
PDA|photodiode array||||||1|0.0292|
PDA|plantar digital artery|C0226481;C1279877|||||||1
PDA|polydiacetylene|C0218502|||C0218502|MSH|||
PDA|polymorphic delta activity||||||1|0.0042|1
PDA|poorly differentiated adenocarcinoma||||||||1
PDA|potato dextrose agar||||||1|0.0323|
PDA|predialyzed human albumin||||||||1
PDA|prolonged depolarizing afterpotential||||||1|0.0115|
PDA|property damage accident||||||||1
PDA|pulmonary disease anemia||||||||1
PD|(device) PD||1|0.012|||||
PD|(drug) PD||1|0.006|||||
PD|PALLADIUM;Palladium;Palladium, NOS;palladium;Palladium Metallicum;Pd - Palladium;Pd element|C0030230|||C0030230|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
PD|PARK|C0562547;C3160718|||C3160718|OMIM|||
PD|PARKINSON DISEASE, LATE-ONSET|C3160718|||C3160718|OMIM|||
PD|PD;Pd|C0030230;C2362652;C3160718|||C0030230;C1524059;C2362652;C3160718|MSH;NCI;OMIM;SNOMEDCT|||
PD|PHARMACOL||||C1524059|MSH|||
PD|Palladium (substance)||||C0030230|SNOMEDCT|||
PD|Palladium [Chemical/Ingredient]||||C0030230|NDFRT|||
PD|Pancreas divisum;pancreas divisum|C0266270|||C0266270|CHV;MTHMST;SNOMEDCT|1|0.0016|1
PD|Parkinson disease;Parkinson's disease|C0030567;C1521736;C2681933|1|0.002|||1|0.5496|1
PD|Parkinson's disease with dementia||||||1|0.0003|
PD|Parkinsonism|C0242422|||||1|0.0009|
PD|Perfusion defect||||||1|0.0009|
PD|Phosducin|C0084024;C1335199|||||1|0.0011|
PD|Possible|C0332149;C1705910;C2362652|||C2362652|SNOMEDCT|||
PD|Possible diagnosis;Possibly|C2362652|||C2362652|MTH;SNOMEDCT|||
PD|Possible diagnosis (contextual qualifier)||||C2362652|SNOMEDCT|||
PD|Possible diagnosis (contextual qualifier) (qualifier value)||||C2362652|SNOMEDCT|||
PD|Postnatal Day||||||1|0.0243|
PD|Prenatal diagnosis;prenatal diagnosis|C0033053|||C0033053|AOD;CHV;CSP;LCH;MSH|1|0.0023|
PD|Preterm Delivery|C0151526|||||1|0.0006|
PD|Prisoner's Dilemma;prisoner's dilemma|C0033166|||C0033166|MSH|1|0.0011|
PD|Prolidase deficiency|C0268532|||||1|0.0008|
PD|Psychopathic deviate;psychopathic deviate||||||1|0.0017|1
PD|after pancreaticoduodenectomy||||||1|0.001|
PD|after pancreatoduodenectomy||||||1|0.0014|
PD|along the proximodistal||||||1|0.0008|
PD|cell membrane potential|C0311434|||||1|0.0007|
PD|coronary artery|C0205042;C1269008|||||1|0.0006|
PD|cyclic nucleotide phosphodiesterase|C1413553|||||1|0.0006|
PD|depression|C0011570;C0011581;C0344315;C0460137|||||1|0.001|
PD|diastolic pressure|C0428883|||C0428883|CHV;MSH;NCI|1|0.0007|
PD|diffusional water permeability||||||1|0.0014|
PD|disease of bone|C0005940|||||1|0.0011|
PD|disease progression;progression disease|C0242656;C1947900|||||1|0.001|1
PD|duration|C0449238;C2926735|||||1|0.0009|
PD|interpupillary distance|C1275637|||C1275637|SNOMEDCT|||
PD|mechanism of action|C0031327;C1524059|||C1524059|MSH|||
PD|mechanism of action qualifier;mode of action|C1524059|||C1524059|MSH;MTH|||
PD|paired domain||||||1|0.0017|
PD|pancreatic duct|C0030288;C1269003|1|0.016|C0030288;C1269003|CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.0015|1
PD|pancreaticoduodenectomy;pancreatoduodenectomy|C0085162|||C0085162|CHV;CSP;MSH;NCI;SNOMEDCT|||1
PD|panic disorder|C0030319;C1868649|||C0030319;C1868649|AOD;CHV;COSTAR;CSP;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0419|1
PD|papilla diameter||||||||1
PD|paralyzing dose||||||||1
PD|parkinsonian||||||1|0.001|
PD|parkinsonian dementia||||||||1
PD|paroxysmal discharge||||||||1
PD|pars distalis||||||1|0.0066|1
PD|patent ductus||1|0.002|||||1
PD|patient day||||||||1
PD|patient demonstration||||||||1
PD|patients|C0030705|||||1|0.0017|
PD|pediatric dose||||||||1
PD|pediatrics|C0030755|||||||1
PD|percutaneous discectomy|C0206080|||||||1
PD|percutaneous drain||||||||1
PD|percutaneous drainage||||||1|0.0012|
PD|period|C0439531;C1948053|||||||1
PD|periodontal disease|C0031090|||C0031090|AOD;CHV;COSTAR;CSP;LCH;MEDLINEPLUS;MSH;NCI;OMIM;SNOMEDCT|||
PD|peripheral dose||||||1|0.0009|
PD|peritoneal dialysate|C0353714|||||1|0.0013|
PD|peritoneal dialysis|C0031139;C1555974|1|0.818|C0031139;C1706534|AOD;CCS;CHV;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;SNOMEDCT|1|0.1391|1
PD|peritoneal drainage||||||1|0.0008|
PD|persistent diarrhea;persistent diarrhoea|C0743188|||||1|0.0024|
PD|personality disorder|C0031212|1|0.002|C0031212|AOD;CHV;COSTAR;CSP;CST;DXP;ICPC;MSH;NCI;SNOMEDCT|1|0.0182|1
PD|pharmacodynamic|C0851347;C1709518|||C0851347;C1709518|CHV;NCI|||
PD|pharmacodynamics|C0243145;C0851347|||C0243145;C0851347|AOD;CHV;CSP;MSH;MTH;NCI|||1
PD|pharmacokinetic (PK)-pharmacodynamic||||||1|0.0009|
PD|pharmacology|C0031330;C1524059|||C1524059|MSH|||
PD|phenyldichloroarsine|C0070673|||||||1
PD|phosphate dehydrogenase||1|0.018|||||1
PD|phosphate depletion||||||1|0.0023|
PD|photosensitivity dermatitis|C0031762|||||||1
PD|physical diagnosis||||||||1
PD|pirfenidone|C0298067|||||1|0.0009|
PD|plasma defect||||||||1
PD|plasma desorption||||||1|0.0011|
PD|plasmodesma;plasmodesmata|C1135842|||C1135842|GO|1|0.0019|
PD|platelet deposition||||||1|0.0006|
PD|pneumatic dilatation||||||1|0.0007|
PD|pneumatic dilation||||||1|0.0009|
PD|pocket depth||||||||1
PD|police department||1|0.028|||||
PD|poorly differentiated|C0205617|||C0205617|CHV;MTH;NCI;SNOMEDCT|1|0.0019|1
PD|population doublings||||||1|0.0068|
PD|porphobilinogen deaminase|C0032706;C1415597|||||||1
PD|postdischarge||||||||1
PD|posterior descending||1|0.068|||||1
PD|posterior division||||||||1
PD|postnasal drainage||||||||1
PD|postural drainage|C0086915|||C0086915|CHV;MSH;MTHICD9;SNOMEDCT|1|0.0011|1
PD|potential difference||||||1|0.0848|1
PD|potential difference across the cell membrane||||||1|0.0009|
PD|power Doppler||||||1|0.0049|
PD|power density||||||1|0.0012|
PD|prednisolone|C0032950|||||1|0.0016|
PD|preferred direction||||||1|0.0009|
PD|present disease||||||||1
PD|pressor dose||||||||1
PD|pressure dressing|C1289828|||||||1
PD|primary dendrite||||||||1
PD|prism diopter;prism diopters;prism dioptres|C0439487|1|0.006|||1|0.0079|1
PD|probing depth|C1317646|||C1317646|CHV;LNC|1|0.0392|1
PD|probing pocket depth||||||1|0.0021|
PD|problem drinker|C0687725|||||||1
PD|process diagnostic||||||||1
PD|progressed|C1272688|||||1|0.0011|
PD|progressive disease|C0677932;C1335499|||C0677932;C1335499|MTH;NCI;OMIM|||1
PD|prostatodynia|C0240812|||||||1
PD|protein|C0033684|||||1|0.0009|
PD|protein degradation|C0597297;C0597304;C1623036|||C0597297;C0597304;C1623036|CHV;CSP;GO;MSH;NCI|1|0.0013|1
PD|protein deposition|C0333584|||||1|0.0005|
PD|protein deprived||||||||1
PD|protein diet|C0452269|||||||1
PD|proton density||||||1|0.0033|
PD|provocation dose||||||||1
PD|proximal-distal||||||1|0.0014|
PD|pseudodeficiency||||||1|0.0016|
PD|psychiatric disorder|C0004936|||C0004936|AOD;CHV;NCI;SNOMEDCT|||
PD|psychological distress|C0815107|||C0815107|AOD;CHV|||
PD|psychotic dementia||||||||1
PD|psychotic depression|C0270458|||||||1
PD|pulmonary disease|C0024115;C1555769|||||||1
PD|pulpodistal||||||||1
PD|pulse duration||||||||1
PD|pulsed Doppler|C0242846|||||1|0.0022|1
PD|pulsed diastolic||||||||1
PD|pupil diameter|C0489618|||C0489618|CHV;LNC|||1
PD|pupillary diameter||||||1|0.001|
PD|pupillary distance|C0946328|||||||1
PD|pure dysarthria||||||||1
PD|pyloric dilator||||||1|0.0047|1
PD|pyridostigmine|C0034261|||C0034261|CHV;CSP;LNC;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0046|
PEEP|End-Expiratory Pressure, Positive;End-Expiratory Pressures, Positive;Positive End Expiratory Pressure;Positive End-Expiratory Pressure;Positive End-Expiratory Pressures;Positive end expiratory pressure;Pressure, Positive End-Expiratory;Pressure.positive end expiratory;Pressures, Positive End-Expiratory;positive end expiratory pressure;positive end-expiratory pressure;PEEP;peep;peeps;PEEP - Positive end expiratory pressure;positive end expiratory pressure (PEEP);Positive Pressure Respiration;Positive-Pressure Respiration;Positive-Pressure Respirations;Respiration, Positive-Pressure;Respirations, Positive-Pressure;positive pressure respiration;positive pressure breathing|C0032740|1|1|C0032740|AOD;CHV;CSP;LNC;MSH;MTH;SNOMEDCT|1|0.9694|1
PEEP|Positive Pressure Ventilation;Positive-Pressure Ventilation;Positive-Pressure Ventilations;Ventilation, Positive-Pressure;Ventilations, Positive-Pressure|C0021778;C0032740|||C0032740|MSH|||
PEEP|Positive end expiratory pressure (observable entity)||||C0032740|SNOMEDCT|||
PEEP|peak end-expiratory pressure||||||||1
PEEP|positive and expiratory pressure||||||1|0.0161|
PEEP|positive end-expiratory pressure ventilation||||||1|0.0145|
PEG|1,2 Propanediol;1,2-Propanediol||||C0072225|MSH;NCI;NDFRT|||
PEG|1,2-Dihydroxypropane||||C0072225|NCI|||
PEG|Endoscopic gastrostomy;endoscopic gastrostomy;PEG (procedure);peg procedure;PEG - Percutaneous endoscopic gastrostomy;Percutaneous [endoscopic] gastrostomy [PEG];percutaneous endoscopic gastrostomy (PEG);Percutaneous endoscopic gastrostomy;percutaneous endoscopic gastrostomy;Percutaneous gastrostomy;percutaneous gastrostomy;Percutaneous transabdominal gastrostomy|C0176751|1|1|C0176751|CHV;ICD9CM;LNC;MTH;MTHICD9;MTHMST;SNOMEDCT|1|0.2255|1
PEG|Ethanol, 2,2'-(oxybis(2,1-ethanediyloxy)bis-||||C0032478|NCI|||
PEG|Glycol 400, Polyethylene;POLYETHYLENE GLYCOL 400;Polyethylene Glycol 400;polyethylene glycol 400;PEG-400;Peg 400;peg 400;PEO 400;PEO-400;POLYETHYLENE GLYCOL 400 [VA Product]|C0032478|||C0032478|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;VANDF|1|0.0044|
PEG|Glycol, Polyethylene;Glycol, polyethylene;Glycols, Polyethylene;POLYETHYLENE GLYCOL;Polyethylene Glycol;Polyethylene Glycols;Polyethylene glycol;Polyethylene glycol, NOS;Polyethyleneglycol;glycol polyethylene;glycol, polyethylene;polyethylene glycol;polyethylene glycols;Oxide, Polyethylene;Oxides, Polyethylene;Polyethylene Oxide;Polyethylene Oxides;polyethylene oxide;Polyethyleneoxide;Polyethyleneoxides|C0032478;C0032483|||C0032478;C0032483|AOD;CHV;CSP;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.7265|1
PEG|Glycol, Propylene;PROPYLENE GLYCOL;Propylene Glycol;Propylene glycol;propylene glycol;propyleneglycol;Propylene glycol preparation|C0072225|||C0072225|CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
PEG|Macrogol;Macrogols;macrogol;macrogols;PEG - Polyethylene glycol;POLYOXYETHYLENE;Polyoxyethylene;Polyoxyethylenes;polyoxyethylene;Polyethylene glycol product|C0032483|||C0032483|CHV;MSH;NDFRT;SNOMEDCT;VANDF|||
PEG|Macrogol (substance)||||C0032483|SNOMEDCT|||
PEG|PEG;peg||||C0032478;C0032483;C0072225;C0176751|CHV;CSP;LNC;MTHICD9;MTHMST;NCI|||
PEG|POLYETHYLENE GLYCOL 400 @ @ UNIDENTIFIED;POLYETHYLENE GLYCOL 400 UNIDENTIFIED||||C0032478|RXNORM|||
PEG|POLYETHYLENE GLYCOL 400 LIQUID|C0032478;C1178139|||C0032478|NDFRT;VANDF|||
PEG|PROPANEDIOL 01 02||||C0072225|MSH|||
PEG|Patient Evaluation Grid||||||||1
PEG|Percu endosc gastrostomy||||C0176751|ICD9CM|||
PEG|Percutaneous endoscopic gastrostomy (procedure)||||C0176751|SNOMEDCT|||
PEG|Percutaneous gastrostomy (procedure)||||C0176751|MTHMST|||
PEG|Poly(oxyethylene)||||C0032478|NCI|||
PEG|Polyethylene Glycols [Chemical/Ingredient]||||C0032483|NDFRT|||
PEG|Polyethylene glycol (substance)||||C0032483|SNOMEDCT|||
PEG|Polyethylene glycol product (product)||||C0032483|SNOMEDCT|||
PEG|Polyethylene glycol product (substance)||||C0032483|SNOMEDCT|||
PEG|Propan-1,2-Diol||||C0072225|MSH;NDFRT|||
PEG|Propylene Glycol [Chemical/Ingredient]||||C0072225|NDFRT|||
PEG|Propylene glycol (product)||||C0072225|SNOMEDCT|||
PEG|Propylene glycol (substance)||||C0072225|SNOMEDCT|||
PEG|pegylated||||||1|0.0044|1
PEG|percutaneous endoluminal gastrostomy||||||||1
PEG|pericyte edema generation||||||||1
PEG|pneumoencephalogram;pneumoencephalography|C0032279|||C0032279|AOD;CHV;CSP;LCH;MSH;SNOMEDCT|1|0.008|1
PEG|pneumonencephalograph||||||||1
PEG|pneumonencephalography||||||||1
PEG|poly(ethyleneglycol)||||||1|0.0068|
PEG|polyethylene glycol 4000|C0032479|||||1|0.0052|
PEG|polyethylene glycol 6000|C0030775|||||1|0.01|
PEG|polyethylene glycol 8000|C0030776|||||1|0.004|
PEG|polyethylene glycol solution||||||1|0.0016|
PEG|polyethylenglycol||||||1|0.0036|
PEG|propanediol|C0033437;C0072225|||C0072225|CSP|||
PE|ACE inhibitor perindopril||||||1|0.0014|
PE|ADAPTIN, BETA-3A;ADTB3A;AP3B1;AP3B1 gene;HPS2 GENE|C1412446|||C1412446|HUGO;MTH;OMIM|||
PE|ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT;adaptor-related protein complex 3, beta 1 subunit||||C1412446|HUGO;OMIM|||
PE|CDDP/VP-16||||C0078414|NCI;PDQ|||
PE|Cephalin;Cephalins;cephalin;Phosphatidyl ethanolamine;phosphatidyl ethanolamine;phosphatidyl-ethanolamine;Phosphatidylethanolamine;Phosphatidylethanolamines;phosphatidylethanolamine;phosphatidylethanolamines|C0031618;C1450468|||C0031618;C1450468|AOD;CHV;CSP;FMA;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|1|0.01|1
PE|Cisplatin/Etoposide;cisplatin and etoposide;cisplatin etoposide;cisplatin-etoposide;cisplatin/etoposide;P-VP protocol;VP-P protocol;VP-P chemotherapy protocol;VP-Plat;VPP;cisplatin/etoposide protocol|C0078414|||C0078414|CHV;MSH;MTH;NCI;PDQ|1|0.0109|
PE|EP||||C0078414|PDQ|||
PE|Ethanolamine Phosphoglycerides;Ethanolamine phosphoglyceride;Phosphoglycerides, Ethanolamine;Ethanolamineglycerophospholipids|C0031618|||C0031618|MSH;NDFRT;SNOMEDCT|||
PE|Ever told by doctor that you had pulmonary embolus||||C2926590|LNC|||
PE|Ever told by doctor that you had pulmonary embolus:Find:Pt:^Patient:Ord||||C2926590|LNC|||
PE|Ever told by doctor that you had pulmonary embolus:Finding:Point in time:^Patient:Ordinal||||C2926590|LNC;MTH|||
PE|HPS2||||C1412446|HUGO;OMIM|||
PE|PE||||C0031238;C0031618;C0078414;C1412446;C1744699;C2926590|AOD;LNC;NCI;OMIM;PDQ|||
PE|PEARL, MOUSE, HOMOLOG OF||||C1412446|OMIM|||
PE|PER||||C0031238|NCI|||
PE|PERU;Peru;peru|C0031238|||C0031238|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
PE|PVp||||C0078414|NCI;PDQ|||
PE|Pemphigus erythematosus|C0263312|||||1|0.0041|
PE|Peru (geographic location)||||C0031238|SNOMEDCT|||
PE|Phosphatidyl ethanolamine (substance)||||C0031618|SNOMEDCT|||
PE|Phosphatidylethanolamines [Chemical/Ingredient]||||C0031618|NDFRT|||
PE|Phosphoethanolamine;phosphoethanolamine|C0031618;C0070939|||C0031618;C0070939|CHV;LNC;MSH;MTH;SNOMEDCT|1|0.0127|
PE|Physical Exam|C0031809;C0804816;C1744699|||C1744699|NCI|||
PE|Physical Exam Domain|C1744699|||C1744699|MTH;NCI|||
PE|Proenkephalin;proenkephalin|C0072068;C1418457|||C0072068;C1418457|HUGO;MSH;MTH;OMIM|1|0.0141|
PE|Proestrus;proestrus|C0033274;C2960704|||C0033274;C2960704|GO;MSH;MTH;SNOMEDCT|1|0.0059|
PE|Pseudo-exfoliation||||||1|0.005|
PE|Pseudomonas exotoxin||||||1|0.0518|1
PE|Pclet number||||||||1
PE|after phacoemulsification||||||1|0.0027|
PE|agonist phenylephrine||||||1|0.0268|
PE|beta-phenylethylamine|C0070559|||C0070559|MSH;SNOMEDCT|1|0.005|
PE|cisplatin and etoposide chemotherapy protocol||||C0078414|CHV|||
PE|days postexposure||||||1|0.005|
PE|early promoter||||||1|0.0023|
PE|elastase|C0030306;C0699918|||||1|0.0086|
PE|element|C0013879;C1705248|||||1|0.005|
PE|epithelial cells|C0014597;C1273342;C2699513|||||1|0.0059|
PE|error positivity||||||1|0.0023|
PE|errors|C0743559|||||1|0.0059|
PE|esophageal pressure|C0232531|||||1|0.0027|
PE|expiratory pressure||||||||1
PE|extract|C2828366|||||1|0.0254|
PE|pancreatic extract||||||||1
PE|panendoscopy|C0679547|||||||1
PE|paper electrophoresis|C0013861|||C0013861|AOD;CSP;MSH|||1
PE|parallel elastic||||||||1
PE|parasitized erythrocytes||||||1|0.0045|
PE|parietal endoderm||||||1|0.0095|
PE|partial epilepsy|C0014547|||C0014547|CHV;MSH;NDFRT;SNOMEDCT|1|0.0032|1
PE|pectinesterase|C0070205|||C0070205|MSH;MTH;SNOMEDCT|1|0.0059|
PE|pectus excavatum|C0016842|||C0016842|CHV;COSTAR;DXP;ICD9CM;MSH;NDFRT;OMIM;SNOMEDCT|1|0.0082|
PE|pedal edema|C0574002|||||||1
PE|pelvic examination|C0200045|||C0200045|CHV;MSH;MTHICD9;NCI;SNOMEDCT|||1
PE|penile erection|C0030847|||C0030847|AOD;CHV;GO;MSH;SNOMEDCT|1|0.0109|1
PE|percutaneous endoscopic||||||||1
PE|pericardial effusion|C0031039;C1253937|||C0031039;C1253937|CHV;COSTAR;CST;DXP;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT;UWDA|1|0.0173|1
PE|perindopril|C0136123|||C0136123|CHV;MSH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
PE|peritoneal exudate|C0003962|||C0003962|CSP|1|0.0218|1
PE|periventricular hypothalamic nucleus|C1283308|||||1|0.0027|
PE|periventricular nucleus|C0003741|||C0003741|FMA|1|0.0041|
PE|permeability|C0031164|||||1|0.0045|
PE|persistent estrus||||||1|0.005|
PE|perus||||C0031238|CHV|||
PE|perylene|C0031243|||||||1
PE|petroleum ether|C0068407;C0303762|||C0068407;C0303762|AOD;CHV;CSP;MSH;SNOMEDCT|1|0.0059|
PE|phacoemulsification|C0282545|||C0282545|CHV;MSH;SNOMEDCT|||1
PE|pharyngoesophageal||||||1|0.0064|1
PE|phase encoding||||||||1
PE|phenylephrine|C0031469|||C0031469|AOD;CHV;CSP;LNC;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
PE|phenylephrine hydrochloride|C0031470|||C0031470|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
PE|phenylethylamine|C0031399|||C0031399|AOD;CHV;CSP|||
PE|phorbol esters|C0031586|||||1|0.0023|
PE|phosphorylethanolamine|C0070939|||C0070939|MSH|1|0.0082|
PE|photographic effect||||||||1
PE|phycoerythrin|C0031789|||C0031789|CSP;MSH;NDFRT;SNOMEDCT|||1
PE|physical education|C0031805|||C0031805|CHV;MSH|1|0.0223|1
PE|physical evaluation||||||||1
PE|physical examination|C0031809|||C0031809|AIR;AOD;AOT;CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0204|1
PE|physical exercise|C0015259|||C0015259|AOD;CHV;MSH;SNOMEDCT|1|0.0045|1
PE|physiologic ecology||||||||1
PE|phytoestrogens|C0071011|||||1|0.0041|
PE|pigment epithelial;pigmented epithelial||||||1|0.0168|
PE|pigment epithelium;pigmented epithelium|C1519082|||C1519082|NCI|1|0.0241|1
PE|pigmented ciliary epithelial||||||1|0.0055|
PE|placental extract|C0032048|||C0032048|CHV|||
PE|plasma epinephrine||||||1|0.0036|
PE|plasma exchange|C0032113;C0032134|||C0032113;C0032134|AOD;CHV;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.1608|1
PE|plasma extravasation||||||1|0.0068|
PE|plating efficiency||||||1|0.02|1
PE|pleiotropic functional defect||||||||1
PE|pleural effusion|C0032227;C1253943|1|0.002|C0032227;C1253943|AOD;CHV;COSTAR;CST;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;SNOMEDCT;UWDA|1|0.0232|1
PE|pneumatic equalization||||||||1
PE|point of entry||||||||1
PE|polychromatic erythrocytes||||||1|0.0036|
PE|polyelectrolyte||||||1|0.0059|
PE|polyethylene|C0032487;C0137914|||C0032487;C0137914|AOD;CHV;CSP;LCH;MSH;MTH;NDFRT;SNOMEDCT;VANDF|1|0.105|1
PE|polynuclear eosinophil||||||||1
PE|porcine pancreatic endocrine||||||1|0.0027|
PE|portal embolization||||||||1
PE|portoenterostomy|C0032722|||C0032722|CHV;MSH;SNOMEDCT|1|0.0041|
PE|post-exposure||||||1|0.0077|
PE|potential energy|C0678538|||C0678538|AOD;NCI|1|0.0059|1
PE|powdered extract||||||||1
PE|power of exclusion||||||1|0.0041|
PE|pre-eclampsia;preeclampsia|C0032914|||C0032914|CHV;MSH;MTH;NDFRT;SNOMEDCT|1|0.0691|1
PE|precedence effect|C0599694|||C0599694|CSP|1|0.0045|
PE|prediction error||||||1|0.0041|
PE|preeclamptic||||||1|0.0073|
PE|preexcitation|C0032915|||||||1
PE|pregnenolone|C0033016;C0373704|||||1|0.0045|
PE|premature ejaculation|C0033038|||C0033038|AOD;CHV;COSTAR;ICD9CM;NCI;SNOMEDCT|1|0.0182|1
PE|preoperative portal embolization||||||1|0.0018|
PE|prescription error||||||||1
PE|present examination||||||||1
PE|pressure equalization||1|0.178|||||1
PE|pressure on expiration||||||||1
PE|prior to exposure||||||||1
PE|probability of exclusion||||||1|0.005|
PE|probable error||||||||1
PE|probe excision||||||||1
PE|proliferative enteritis||||||1|0.0045|
PE|proliferative enteropathy||||||1|0.0045|
PE|prolonged exposure||||||1|0.0036|
PE|prolyl endopeptidase|C0072132;C1418885|||||1|0.0036|
PE|protective efficacy||||||1|0.005|
PE|protein excretion||||||||1
PE|pseudoephedrine|C0033798;C0524257|||C0033798;C0524257|CHV;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|||
PE|pseudoexfoliation||||||1|0.0041|
PE|psychotic event||||||||1
PE|pulmonary edema|C0034063|||C0034063|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0145|1
PE|pulmonary emboli;pulmonary embolus;pulmonary embolism|C0034065|1|0.816|C0034065|CHV;COSTAR;CSP;CST;DXP;ICPC;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0458|1
PE|pulmonary emphysema|C0034067|||C0034067|CHV;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;QMR;SNOMEDCT|1|0.0082|1
PE|pulmonary thromboembolism|C0524702;C2709204|||||1|0.0064|
PE|push enteroscopy|C0399620|||C0399620|SNOMEDCT|||
PE|pyramidal eminence|C1186249|||||||1
PE|pyroelectric||||||||1
PE|pyrogenic exotoxin||||||||1
PERRL|PERRL;Pupils Equal Round and Reactive to Light Result|C2143305|||C2143305|NCI|||
PERRL|Pupils Equal, Round and Reactive to Light||||C2143305|NCI|||
PERRL|pupils equal, round, react to light||1|1.000|||||1
PET|Animal, Companion;Animals, Companion;Companion Animal;Companion Animals;Pet Animal;pet animal;pets (animal)|C0031268|||C0031268|AOD;CHV;MSH;MTH|||
PET|FDG-PET|C0032743;C0872169|||C0032743|NCI|||
PET|Imaging, PET;PET imaging;imaging pet;pet imaging;Medical Imaging, Positron Emission Tomography;PET - Positron emission tomography;Positron emission tomography (PET);positron-emission tomography (PET);PET Scan;PET Scans;PET scan;PET scan, NOS;Scan, PET;Scans, PET;pet scan;pet scans;Positron Emission Tomography;Positron emission tomography;Positron emission tomography, NOS;Positron-Emission Tomography;Tomography, Positron Emission;Tomography, Positron-Emission;positron emission tomography;positron-emission tomography;Positron Emission Tomography Scan;positron emission tomography scan;Positron emission tomographic imaging;Positron emission tomographic imaging - action|C0032743|1|1|C0032743|AOD;CHV;CSP;HL7V2.5;HL7V3.0;LNC;MEDLINEPLUS;MSH;MTH;MTHHH;NCI;PDQ;SNOMEDCT|1|0.8997|1
PET|PET;Pet;Pets;pet;pets|C0031268;C1456682|||C0031268;C0032743|AOD;CHV;CSP;MSH;NCI|||
PET|PETT||||C0032743|CSP|||
PET|POSITRON EMISS TOMOGR;TOMOGR POSITRON EMISS||||C0032743|MSH|||
PET|Parent Effectiveness Training||||||||1
PET|Peritoneal Equilibration Test;peritoneal equilibration test|C0430949;C0878801|||C0430949;C0878801|MTH;MTHICD9;SNOMEDCT|1|0.0272|1
PET|Polyethyleneterephthalate;polyethylene terephthalate|C0032485|||C0032485|CHV;MSH;NDFRT|1|0.0166|1
PET|Positron emission tomographic imaging - action (qualifier value)||||C0032743|SNOMEDCT|||
PET|Positron emission tomography (procedure)||||C0032743|SNOMEDCT|||
PET|Professional Employment Test||||||||1
PET|functional|C0205245;C0542341;C2700217|||||1|0.0016|
PET|pancreatic endocrine tumor;pancreatic endocrine tumors|C0242363|||C0242363|CHV;SNOMEDCT|1|0.0009|
PET|paraffin-embedded tissue||||||1|0.0017|1
PET|patulous eustachian tube|C0155434|||||1|0.0008|
PET|peak ejection time||||||||1
PET|pear-shaped extension tube||||||||1
PET|petrolatum|C0031262|||||1|0.0018|
PET|phosphatidylethanol|C0070787|||||1|0.0112|
PET|photoinduced electron transfer||||||1|0.0051|
PET|polyester|C0032474|||C0032474|CHV;MSH;SNOMEDCT|1|0.0013|
PET|polyethylene terephtalate||||||1|0.0007|
PET|polyethylene tube||||||||1
PET|poor exercise tolerance|C3149603|||||||1
PET|positron emission tomograph||||||1|0.0027|
PET|positron emission tomographic||||||1|0.0262|
PET|postexposure treatment||||||||1
PET|pre-eclamptic toxaemia|C0032914|||||1|0.0014|
PET|predominantly epithelial thymoma||||||||1
PET|preeclamptic toxemia|C0032914;C2931877|||C2931877|MSH|||1
PET|pressure equalization tube||||||||1
PET|problem elicitation technique||||||||1
PET|progressive exercise test|C0430513|||||||1
PET|proton magnetic resonance spectroscopic imaging|C0032743;C1522706|||C0032743|NCI|||
PET|pulmonary endodermal tumor||||||||1
PET|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0012|
PFO|patent foramen ovale|C0016522;C2939192|1|1.000|C0016522|CHV;MSH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8947|1
PFO|perfluoro-N-octane;perfluoro-n-octane|C0166273|||||1|0.0263|1
PFO|perfluorooctanoate|C2964281|||C2964281|LNC;MSH|||
PFO|perfringolysin O|C0110119|||||1|0.0614|
PFO|persistent foramen ovale|C1397674|||C1397674|OMIM|||
PFO|plantar fasciitis orthosis||||||||1
PFO|pyruvate|C0034354;C0244104|||||1|0.0175|
PH|1 Chromosome, Ph;1 Chromosomes, Ph;Chromosome, Ph 1;Chromosomes, Ph 1;Ph 1 Chromosome;Ph 1 Chromosomes;ph 1 chromosome;Chromosome, Ph1;Chromosomes, Ph1;Ph1 Chromosome;Ph1 Chromosomes;Chromosome, Philadelphia;Philadelphia Chromosome;Philadelphia chromosome;chromosome philadelphia;chromosomes philadelphia;philadelphia chromosome|C0031526|||C0031526|CHV;CSP;MSH;MTH;NCI;NDFRT|1|0.0748|
PH|Concentration, Hydrogen-Ion;Concentrations, Hydrogen-Ion;Hydrogen Ion Concentration;Hydrogen ion concentration;Hydrogen-Ion Concentration;Hydrogen-Ion Concentrations;Hydrogen-ion concentration;hydrogen ion concentration;H+ concentration;H^+^ concentration;potential of Hydrogen|C0020283|1|1|C0020283|CSP;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0086|1
PH|Finding of pH;pH - finding;pH level|C1304686|||C1304686|CHV;MTH;SNOMEDCT|||
PH|Finding of pH (finding)||||C1304686|SNOMEDCT|||
PH|H/O: medical history NOS||||C0455458|SNOMEDCT|||
PH|H/O: medical history NOS (situation)||||C0455458|SNOMEDCT|||
PH|H<sup>+</sup> concentration||||C0020283|SNOMEDCT|||
PH|History of;history|C0019664;C0019665;C0262512;C0262926;C1705255;C2004062|||C0332119|LNC;SNOMEDCT|1|0.0045|
PH|History of (situation)||||C0332119|SNOMEDCT|||
PH|History of - medical history NOS||||C0455458|SNOMEDCT|||
PH|History of - medical history NOS (context-dependent category)||||C0455458|SNOMEDCT|||
PH|History of - medical history NOS (situation)||||C0455458|SNOMEDCT|||
PH|Hydrogen ion concentration (function)||||C0020283|SNOMEDCT|||
PH|Hydrogen ion concentration (observable entity)||||C0020283|SNOMEDCT|||
PH|Hydrogen ion concentration, function (observable entity)||||C0020283|SNOMEDCT|||
PH|Intracellular pH||||||1|0.004|
PH|PAH||||C1418251|HUGO;OMIM|||
PH|PAH gene|C1418251|||C1418251|HUGO;LNC;MTH|||
PH|PH;Ph;[pH];pH;ph|C0020283;C0450407;C0450408;C0450409;C1304686|||C0020283;C0031526;C0031529;C0031843;C0332119;C0455458;C1304686;C1418251|CHV;CSP;HL7V3.0;HUGO;LNC;MSH;MTH;NCI;SNOMEDCT|||
PH|PHAA CHROMOSOME||||C0031526|MSH|||
PH|PHENYLALANINE HYDROXYLASE;phenylalanine hydroxylase;phenylalanine 4-monooxygenase|C0031456;C1418251|||C0031456;C1418251|CHV;HUGO;LNC;MSH;MTH;NDFRT;OMIM;SNOMEDCT|1|0.0071|1
PH|PHILIPPINES;Philippines;philippines;Philipines;Phillipines;Phillippines|C0031529|||C0031529|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
PH|PHL||||C0031529|NCI|||
PH|PHYSIOL||||C0031843|MSH|||
PH|PMH - past medical history;health history|C0455458|||C0455458|CHV;MTH;SNOMEDCT|||
PH|Past history of;past history|C0332119|||C0332119;C0455458|CHV;MTH;SNOMEDCT|||1
PH|Past history of (context-dependent category)||||C0332119|SNOMEDCT|||
PH|Past history of (situation)||||C0332119|SNOMEDCT|||
PH|Past medical history;Past medical history of|C0262926;C0455458|||C0455458|LNC;SNOMEDCT|||
PH|Past medical history (situation)||||C0455458|SNOMEDCT|||
PH|Past medical history of (contextual qualifier) (context-dependent category)||||C0455458|SNOMEDCT|||
PH|Periventricular heterotopia;periventricular heterotopia|C2678104|||C2678104|OMIM|1|0.0045|
PH|Philadelphia|C0031525|||||1|0.1647|
PH|Philadelphia Chromosome [Disease/Finding]||||C0031526|NDFRT|||
PH|Philippines (geographic location)||||C0031529|SNOMEDCT|||
PH|Pleckstrin homology||||||1|0.2602|
PH|RP|C1538326|||C0031529|NCI|||
PH|acidity|C0001128;C0847097;C0920750|||||1|0.0081|
PH|function|C0031843;C0542341;C0700205;C1705273|||C0031843|MSH|||
PH|hydrochloride|C1512523|||||1|0.0066|
PH|hydrogen-Ion concentration (pH)||||C0020283|CHV|||
PH|hyperplasia|C0020507|||||1|0.0091|
PH|palmar hyperhidrosis|C1856953|||C1856953|OMIM|1|0.0086|
PH|parathyroid hormone|C0030520;C1882913|||||||1
PH|parenchymal hematoma||||||||1
PH|parenchymal hemorrhage|C0747264|||||||1
PH|partial hepatectomy|C0193398|||C0193398|ICD9CM;MTH;NCI;SNOMEDCT|||1
PH|partial hysterectomy|C1270947|||||||1
PH|partially hepatectomized||||||1|0.0045|
PH|passive hemagglutination||||||||1
PH|peak height||||||1|0.004|
PH|peliosis hepatitis|C0030781|||||||1
PH|perianal herpes||||||||1
PH|persistent hepatitis||||||||1
PH|personal history|C0262926;C0424945|||||||1
PH|pharmacopeia|C0376689|||||||1
PH|phase|C0205390|||||||1
PH|phenanthrene|C0031367|||||||1
PH|phenol|C0031428;C0070570|||C0031428;C0070570;C1556058|CHV;CSP;HL7V2.5;HL7V3.0;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0101|
PH|phenol hydroxylase|C0070571|||C0070571|MSH;SNOMEDCT|||
PH|phentolamine|C0031448|||C0031448|AOD;CHV;CSP;LCH;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0096|
PH|phenyl|C2945751|||||||1
PH|phenylephrine|C0031469|||||1|0.0061|
PH|phenylhydrazine|C0031479|||C0031479|CHV;CSP;MSH;RXNORM;SNOMEDCT|1|0.0061|
PH|phial|C0184301;C1533199;C1706497|||||||1
PH|phote||||||||1
PH|physiological aspects|C0031843|||C0031843|MTH|||
PH|physiology|C0031842;C0031843|||C0031843|MSH|||
PH|physostigmine|C0031849|||C0031849|AOD;CHV;CSP;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0056|
PH|pinhole|C0450042|||||||1
PH|polycythemia hypertonica|C0541719;C2242785|||||||1
PH|polyhomeotic|C0137798|||C0137798|NCI|1|0.0147|
PH|poor health|C0683321|||||||1
PH|porphyria hepatica||||||||1
PH|portal hypertension|C0020541|||C0020541|AOD;CHV;COSTAR;CSP;DXP;ICD9CM;MSH;NCI;OMIM;SNOMEDCT|||
PH|posterior|C0205095|||||1|0.0056|
PH|posterior hypothalamic nucleus|C0228385;C1289574|||C0228385;C1289574|FMA;SNOMEDCT|1|0.0051|
PH|posterior hypothalamus|C0020670|||C0020670|FMA;MSH|1|0.0273|1
PH|postural hypotension|C0020651|||C0020651|CHV;COSTAR;CSP;CST;ICPC;MSH;NCI;OMIM;SNOMEDCT|1|0.0101|
PH|prepositus hypoglossi||||||1|0.0131|
PH|previous history||||||||1
PH|primary hyperoxaluria|C0020501|||C0020501|CSP;DXP;MSH;MTHICD9;NDFRT;SNOMEDCT|1|0.0157|
PH|primary hyperparathyroidism|C0221002|||C0221002|CHV;ICD9CM;MSH;NCI;NDFRT;SNOMEDCT|1|0.0045|1
PH|primary hypertension|C0085580|||C0085580|AOD;CHV;CSP;NCI;SNOMEDCT|||
PH|primary hypogonadism|C0022735;C0948896;C1384582|||||||1
PH|prolyl 4-hydroxylase|C0033384;C1622631|||||1|0.0121|
PH|prolyl hydroxylase;prolylhydroxylase|C0033384|||C0033384|MSH;NDFRT|1|0.0147|1
PH|proportional hazards||||||1|0.0086|
PH|prostatic hypertrophy|C0005001;C1739363;C2937421|||||||1
PH|pseudohermaphroditism|C0033804|||||||1
PH|pubic hair|C0221988;C1305636|||||1|0.0056|1
PH|pubic hair stage|C0429608|||C0429608|SNOMEDCT|||
PH|public health|C0034019;C0699943|||C0034019;C0699943;C1552283|AOD;CHV;CSP;HL7V3.0;LCH;LNC;MSH;NCI|1|0.0035|1
PH|pulmonary arterial hypertension|C0152171;C2973725|||C0152171;C2973725|MEDLINEPLUS;MSH;MTH;OMIM|||
PH|pulmonary hemorrhage|C0151701|||C0151701|CHV;CST;MTH;NCI;OMIM;SNOMEDCT|1|0.0106|
PH|pulmonary hypertension|C0020542;C1963220|||C0020542;C1963220|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.2299|1
PH|pulmonary hypoplasia|C0265783|||C0265783|CHV;OMIM;SNOMEDCT|1|0.0121|
PH|pulp horn|C0447400|||||||1
PH|punctate hemorrhage||||||||1
PICC|Long line;PIC line;pic line;PICC line;picc line;Peripherally inserted central catheter (physical object);picc|C0179740|||C0179740|CHV;MTH;SNOMEDCT|||
PICC|Peripherally inserted central catheter;peripherally inserted central catheter||1|1|C0179740|SNOMEDCT|1|1|1
PICC|peripherally inserted central catheter (PICC)||||C0179740|CHV|||
PIC|PIC|C0014878;C0522667;C0730321|||C0730321|SNOMEDCT|||
PIC|Paediatric intensive care;pediatric intensive care|C1627360|||C1627360|SNOMEDCT|1|0.0389|
PIC|Personality Inventory for Children||||||1|0.0973|1
PIC|Punctate inner choroiditis;punctate inner choroiditis;Punctate inner choroidopathy;punctate inner choroidopathy|C0730321|||C0730321|SNOMEDCT|||1
PIC|Punctate inner choroidopathy (disorder)||||C0730321|SNOMEDCT|||
PIC|complexes|C1704241|||||1|0.0506|
PIC|intracranial pressure|C0021880|||||1|0.0272|
PIC|islet cells|C0022131|||||1|0.0195|
PIC|particle-in-cell||||||1|0.0428|
PIC|penicillin-inhibitor combinations||||||||1
PIC|peripherally inserted catheter||1|1.000|||||1
PIC|personal injury collision||||||||1
PIC|phosphate carrier||||||1|0.0506|
PIC|phosphoinositidase C|C0136864|||||1|0.1323|
PIC|phospholipase C|C0031669|||||1|0.035|
PIC|plasmin-inhibitor complex||||||||1
PIC|polymorphism information content||||||1|0.3541|
PIC|polysaccharide-iron complex|C0357080|||||||1
PIC|posterior intermediate curve||||||||1
PIC|postinflammatory corticoid||||||||1
PIC|postintercourse||||||||1
PIC|preinitiation complex||||||1|0.1518|1
PIC|preinvasive cancer||||||||1
PID|DISEASE (PID), PELVIC INFLAMMATORY;INFLAMMATORY DISEASE (PID), PELVIC;PELVIC INFLAMMATORY DISEASE, (PID);PID - pelvic inflammatory disease;PID, PELVIC INFLAMMATORY DISEASE;Pelvic inflammatory disease (PID);pelvic inflammatory disease (PID);DISEASE PELVIC INFLAMMATORY;Disease, Inflammatory Pelvic;Disease, Pelvic Inflammatory;Diseases, Inflammatory Pelvic;Diseases, Pelvic Inflammatory;Inflammatory Disease, Pelvic;Inflammatory Diseases, Pelvic;Inflammatory Pelvic Disease;Inflammatory Pelvic Diseases;PELVIC INFLAMMATORY DISEASE;Pelvic Disease, Inflammatory;Pelvic Diseases, Inflammatory;Pelvic Inflammatory Disease;Pelvic Inflammatory Diseases;Pelvic inflammatory disease;Pelvic inflammatory disease NOS;inflammatory pelvic disease;pelvic inflammatory disease;pelvic inflammatory diseases;Female pelvic inflammation;Female pelvic inflammatory disease;Female pelvic inflammatory disease NOS;Female pelvic inflammatory diseases NOS;INFLAMMATION PELVIC;PELVIC INFLAMMATION;pelvic inflammation;INFLAMMATORY DISEASE OF FEMALE PELVIC ORGANS;Inflammatory diseases of female pelvic organs|C0242172|1|1|C0242172|CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;ICPC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.7821|1
PID|DKFZp686F2281;MTA2 wt Allele|C2985251|||C2985251|MTH;NCI|||
PID|Fem pelv inflam dis NOS||||C0242172|ICD9CM|||
PID|Female pelvic infection||||C0242172|SNOMEDCT|||
PID|Female pelvic inflammatory disease (disorder);Female pelvic inflammatory disease NOS (disorder);Female pelvic inflammatory diseases NOS (disorder)||||C0242172|SNOMEDCT|||
PID|INFLAMM DIS PELVIC;INFLAMM PELVIC DIS;PELVIC DIS INFLAMM;PELVIC INFLAMM DIS||||C0242172|MSH|||
PID|Inflam. dis.- pelvic||||C0242172|SNOMEDCT|||
PID|Inflammatory disease of female pelvic organs AND/OR tissues||||C0242172|SNOMEDCT|||
PID|Inflammatory disease of female pelvic organs AND/OR tissues (disorder)||||C0242172|SNOMEDCT|||
PID|Inflammatory disease of female pelvic organs AND/OR tissues [Ambiguous]||||C0242172|SNOMEDCT|||
PID|Inflammatory disease of female pelvic organs and tissues, NOS||||C0242172|SNOMEDCT|||
PID|METASTASIS-ASSOCIATED 1-LIKE 1||||C1417406|OMIM|||
PID|METASTASIS-ASSOCIATED PROTEIN 2||||C1417406|OMIM|||
PID|MTA1-L1;MTA2;MTA2 Gene;MTA2 gene|C1417406|||C1417406|HUGO;MTH;NCI;OMIM|||
PID|MTA1L1|C1417406;C2985251|||C1417406;C2985251|NCI;OMIM|||
PID|Metastasis Associated 1 Family, Member 2 Gene||||C1417406|NCI|||
PID|Metastasis Associated 1 Family, Member 2 wt Allele||||C2985251|NCI|||
PID|PID;pid|C0242172;C1417406;C2985251|||C0242172;C1417406;C2985251|CHV;CSP;DXP;MEDLINEPLUS;MTHICD9;NCI;OMIM;SNOMEDCT|||
PID|Pain intensity difference;pain intensity difference||||||1|0.0231|1
PID|Pelvic Infection;Pelvic infection|C0030790;C0242172|||C0242172|NCI|||
PID|Pelvic Inflammatory Disease [Disease/Finding]||||C0242172|NDFRT|||
PID|Pelvic inflam. disease NOS||||C0242172|SNOMEDCT|||
PID|Unspecified inflammatory disease of female pelvic organs and tissues||||C0242172|ICD9CM|||
PID|[X]Inflammatory diseases of female pelvic organs||||C0242172|SNOMEDCT|||
PID|[X]Inflammatory diseases of female pelvic organs (disorder)||||C0242172|SNOMEDCT|||
PID|metastasis associated 1 family, member 2||||C1417406|HUGO|||
PID|phosphotyrosine interaction domain||||||1|0.006|
PID|photoionization detector||||||1|0.009|1
PID|plasma iron disappearance||||||||1
PID|position-indicating device||||||||1
PID|post-inertia dyskinesia||||||||1
PID|post-inoculation day||||||1|0.0171|
PID|postinoculation day||||||1|0.1034|
PID|preimplantation diagnosis|C0086142|||||1|0.006|1
PID|primary immunodeficiencies;primary immunodeficiency|C0398686;C2984310|||C0398686;C2984310|CHV;NCI;SNOMEDCT|1|0.011|1
PID|primary immunodeficiency diseases||||||1|0.008|
PID|prolapsed intervertebral disc|C0242362|||||||1
PID|proportional-integral-derivative||||||1|0.0341|1
PID|protruded intervertebral disc||||||||1
PIH|PIF;pif||||C0033373|CHV;OMIM;SNOMEDCT|||
PIH|PIF preparation;PROLACTIN RELEASE-INHIBITING FACTOR;Prolactin Release Inhibiting Factors;Prolactin Release-Inhibiting Factors;Prolactin Release Inhibiting Hormone;Prolactin Release-Inhibiting Hormone;prolactin-release-inhibiting hormone;Prolactin inhibiting factor;prolactin inhibiting factor;Prolactin inhibiting factor preparation;prolactin IH;prolactin inhibiting hormone;prolactin-inhibiting hormone;prolactin release- inhibiting hormone (PIH);prolactin release-inhibiting factor (PIF)|C0033373|||C0033373|AOD;CHV;CSP;MSH;MTH;NDFRT;OMIM;SNOMEDCT|||1
PIH|PIH;pih|C0033373;C1418570|||C0033373;C1418570|AOD;CHV;HUGO|||
PIH|PIH gene|C1418570|||C1418570|HUGO;MTH|||
PIH|PRIH||||C0033373|MSH|||
PIH|PROLACTIN RELEASE INHIB HORMONE||||C0033373|MSH|||
PIH|Prolactin Release Inhibitory Factor;Prolactin Release-Inhibitory Factor||||C0033373|MSH;NDFRT|||
PIH|Prolactin Release-Inhibiting Factors [Chemical/Ingredient]||||C0033373|NDFRT|||
PIH|Prolactin inhibiting factor (substance)||||C0033373|SNOMEDCT|||
PIH|Prolactin inhibiting factor preparation (product)||||C0033373|SNOMEDCT|||
PIH|Prolactin inhibiting factor preparation (substance)||||C0033373|SNOMEDCT|||
PIH|postinflammatory hyperpigmentation|C0333616|||C0333616|MTH;SNOMEDCT|||
PIH|postinjection hours||||||1|0.0163|
PIH|postinoculation hour||||||1|0.0163|
PIH|pregnancy-induced hypertension|C0340274|1|1.000|C0340274|CHV;MSH;SNOMEDCT|1|0.8442|1
PIH|pregnancy-induced hypertension (pre-eclampsia, eclampsia, toxemia of pregnancy included)||||C1418570|HUGO|||
PIH|preventricular intraventricular hemorrhage||||||||1
PIH|primary intracerebral hemorrhage||||||||1
PIH|pseudointimal hyperplasia||||||||1
PIH|pyridoxal isonicotinoyl hydrazone|C0072702|||C0072702|MSH|1|0.1233|
PIP|GCDFP-15|C1144261;C1418587;C2985149|||C1418587|HUGO;OMIM|||
PIP|GCDFP15;GPIP4|C1418587;C2985149|||C1418587|HUGO|||
PIP|GROSS CYSTIC DISEASE FLUID PROTEIN;PIP Gene;PIP gene|C1418587|||C1418587|HUGO;MTH;NCI;OMIM|||
PIP|MP/MTX/VCR||||C0279391|NCI;PDQ|||
PIP|Mercaptopurine/Methotrexate/Vincristine;mercaptopurine/methotrexate/vincristine|C0279391|||C0279391|MTH;NCI;PDQ|||
PIP|PIP|C0279391;C1418587|||C0279391;C1418587|HUGO;NCI;OMIM;PDQ|||
PIP|PROLACTIN-INDUCIBLE PROTEIN;prolactin inducible protein;prolactin-inducible protein|C1144261;C1418587|||C1144261;C1418587|HUGO;NCI;OMIM|1|0.0285|1
PIP|Piperacillin;piperacillin|C0031955|||C0031955|CHV;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0549|
PIP|Prolactin-Induced Protein Gene||||C1418587|NCI|||
PIP|Psychotic Inpatient Profile||||||||1
PIP|carboxy-terminal propeptide of procollagen type I||||||1|0.0102|
PIP|paraffin immunoperoxidase||||||||1
PIP|paralytic infantile paralysis||||||||1
PIP|peak inflation pressure;peak inflation pressures||||||1|0.0203|1
PIP|peak inspiratory pressure|C0232021|1|0.034|C0232021|SNOMEDCT|1|0.3293|1
PIP|personal injury protection||||||||1
PIP|phosphatidylinositol monophosphate||||||1|0.0224|
PIP|phosphatidylinositol phosphate|C0071655|||C0071655|AOD|1|0.061|
PIP|piperidine|C0031959|||C0031959|AOD;CHV;CSP;LCH;MSH;SNOMEDCT|||
PIP|plasma cell interstitial pneumonitis||||||||1
PIP|positive inspiratory pressure||1|0.002|||||1
PIP|posterior interphalangeal||||||||1
PIP|postictal psychosis||||||||1
PIP|postinflammatory polyposis||||||||1
PIP|postinfusion phlebitis||||||||1
PIP|postinspiratory pressure||||||||1
PIP|pressure inversion point||||||||1
PIP|prevention of immune precipitation||||||1|0.0142|
PIP|probable intrauterine pregnancy||||||||1
PIP|prolactin-induced protein||||C1418587|HUGO|||
PIP|proline iminopeptidase|C0243766|||C0243766|MSH;MTH;SNOMEDCT|||
PIP|prostatic inhibin peptide|C1457875|||C1457875|MSH|1|0.0183|
PIP|proximal interphalangeal||1|0.964|||1|0.4004|1
PIP|proximal interphalangeal joint|C0932508|||||1|0.0407|
PIP|psychosis, intermittent hyponatremia, polydipsia||||||||1
PIP|pulmonary immaturity of prematurity||||||||1
PIP|pulmonary insufficiency of the premature||||||||1
PKU|Classical Phenylketonuria;Classical Phenylketonurias;Classical phenylketonuria;Phenylketonuria, Classical;Phenylketonurias, Classical;Deficiencies, Phenylalanine Hydroxylase;Deficiency, Phenylalanine Hydroxylase;Hydroxylase Deficiencies, Phenylalanine;Hydroxylase Deficiency, Phenylalanine;PHENYLALANINE HYDROXYLASE DEFICIENCY;Phenylalanine Hydroxylase Deficiencies;Phenylalanine Hydroxylase Deficiency;Phenylalanine hydroxylase deficiency;Deficiency Disease, Phenylalanine Hydroxylase;Phenylalanine Hydroxylase Deficiency Disease;Deficiency Disease, Phenylalanine Hydroxylase, Severe;Phenylalanine Hydroxylase Deficiency Disease, Severe;Disease, Folling;Disease, Folling's;Diseases, Folling;FOLLING DISEASE;Folling Disease;Folling Diseases;Folling's Disease;FOELLING SYNDROME;Folling's syndrome;HYPERPHENYLALANINEMIA TYPE I;Hyperphenylalaninaemia, type I;Hyperphenylalaninemia, type I;Imbecilitus phenylpyruvica;OLIGOPHRENIA PHENYLPYRUVICA;Oligophrenia Phenylpyruvica;Oligophrenia Phenylpyruvicas;Oligophrenia phenylpyruvica;Phenylpyruvica, Oligophrenia;Phenylpyruvicas, Oligophrenia;OLIGOPHRENIA, PHENYLPYRUVIC;Phenylpyruvic Oligophrenia;Phenylpyruvic oligophrenia;phenylpyruvic oligophrenia;PAH - Phenylalanine hydroxylase deficiency;PAH DEFICIENCY;PAH deficiency;PKU1 - Phenylketonuria;Phenylketonuria I;Severe phenylalanine hydroxylase deficiency|C0751434|||C0751434|CSP;DXP;MSH;MTH;OMIM;SNOMEDCT|||
PKU|Classical phenylketonuria (disorder)||||C0751434|SNOMEDCT|||
PKU|DEFIC DIS PHENYLALANINE HYDROXYLASE;PHENYLALANINE HYDROXYLASE DEFIC DIS||||C0751434|MSH|||
PKU|DEFIC DIS PHENYLALANINE HYDROXYLASE SEVERE;PHENYLALANINE HYDROXYLASE DEFIC DIS SEVERE||||C0751434|MSH|||
PKU|FOLLING DIS||||C0751434|MSH|||
PKU|FOLLINGS DIS||||C0751434|MSH|||
PKU|PHENYLKETONURIA;Phenylketonuria;Phenylketonuria, NOS;Phenylketonurias;phenylketonuria;phenylketonurias;PKU - Phenylketonuria;Phenylketonuria - pku;Phenylketonuria [PKU];phenylketonuria (PKU);pku phenylketonuria|C0031485;C0751434;C2720373|1|1|C0031485;C0751434;C2720373|AOD;CHV;CSP;CST;DXP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9616|1
PKU|PHENYLKETOURIA;phenylketouria;phenylalaninemia|C0031485|||C0031485|CHV;CSP;CST|||
PKU|PKU|C0031485;C0751434|||C0031485;C0751434|CHV;CSP;DXP;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;OMIM;SNOMEDCT|||
PKU|Phenylalanine hydroxylase deficiency (disorder)||||C0751434|SNOMEDCT|||
PKU|Phenylketonuria (disorder)||||C0031485|SNOMEDCT|||
PKU|Phenylketonuria Is||||C0751434|MSH|||
PKU|Phenylketonurias [Disease/Finding]||||C0031485|NDFRT|||
PKU|phenylketonuric||||||1|0.0384|
PMD|ANOPHTHALMIA AND PULMONARY HYPOPLASIA;Anophthalmia with pulmonary hypoplasia;MATTHEW-WOOD SYNDROME;Matthew Wood syndrome;Matthew-Wood syndrome;MCOPS9;MICROPHTHALMIA, SYNDROMIC 9|C1832661|||C1832661|MSH;MTH;OMIM|||
PMD|ANOPHTHALMIA, CLINICAL, WITH MILD FACIAL DYSMORPHISM AND VARIABLE MALFORMATIONS OF THE LUNG, HEART, AND DIAPHRAGM||||C1832661|OMIM|||
PMD|ANOPHTHALMIA/MICROPHTHALMIA AND PULMONARY HYPOPLASIA||||C1832661|OMIM|||
PMD|HLD1;LEUKODYSTROPHY, HYPOMYELINATING, 1;Pelizaeus Merzbacher brain sclerosis|C0205711|||C0205711|CSP;OMIM|||
PMD|Leukodystrophy, sudanophilic;Sudanophilic leukodystrophy;sudanophilic leukodystrophy|C0007795;C0205711|||C0205711|CHV;MTHICD9;SNOMEDCT|||
PMD|MMPL;PLP1 wt Allele|C2698697|||C2698697|MTH;NCI|||
PMD|PELIZAEUS MERZBACHER DIS||||C0205711|MSH|||
PMD|PELIZAEUS-MERZBACHER DISEASE;Pelizaeus Merzbacher Disease;Pelizaeus Merzbacher disease;Pelizaeus-Merzbacher Disease;Pelizaeus-Merzbacher disease;pelizaeus merzbacher disease;pelizaeus-merzbacher disease|C0205711;C1418654|||C0205711|CHV;CSP;MSH;MTH;MTHICD9;NDFRT;OMIM;SNOMEDCT|1|0.4417|
PMD|PLP||||C2698697|NCI|||
PMD|PLP/DM20||||C2698697|NCI|||
PMD|PMD|C0205711;C1832661;C2698697|||C0205711;C1832661;C2698697|NCI;OMIM|||
PMD|PULMONARY AGENESIS, MICROPHTHALMIA, AND DIAPHRAGMATIC DEFECT;Pulmonary agenesis, Microphthalmia, and Diaphragmatic defect||||C1832661|MSH;OMIM|||
PMD|Pelizaeus-Merzbacher Disease [Disease/Finding]||||C0205711|NDFRT|||
PMD|Pelizaeus-Merzbacher disease (disorder)||||C0205711|SNOMEDCT|||
PMD|Proteolipid Protein 1 (Pelizaeus-Merzbacher Disease, Spastic Paraplegia 2, Uncomplicated) wt Allele||||C2698697|NCI|||
PMD|SPEAR SYNDROME||||C1832661|OMIM|||
PMD|SPG2|C1839264;C2698697|||C2698697|NCI|||
PMD|dorsal premotor||||||1|0.0485|
PMD|dorsal premotor area||||||1|0.0437|
PMD|dorsal premotor cortex||||||1|0.1602|
PMD|papillary muscle dysfunction|C0149957|||||||1
PMD|pellucid marginal degeneration||||||1|0.0388|
PMD|perceptual motor development|C0679018|||||||1
PMD|piecemeal degranulation||||||1|0.0825|1
PMD|polarization mode dispersion||||||1|0.0631|
PMD|posterior mandibular depth||||||||1
PMD|primary medical doctor||1|1.000|||||
PMD|primary myocardial disease|C0033141|||C0033141|MSH|||1
PMD|private medical doctor||||||||1
PMD|programmed multiple development||||||||1
PMD|progressive muscular dystrophy|C0026850|||C0026850|CHV;SNOMEDCT|1|0.1214|1
PMI|MANNOSEPHOSPHATE ISOMERASE;mannose phosphate isomerase;mannose-6-phosphate isomerase|C0024744;C1417244|||C1417244|HUGO;OMIM|||
PMI|MPI|C0663932;C1417244|||C1417244|HUGO;OMIM|||
PMI|MPI gene;PHOSPHOMANNOSE ISOMERASE 1;PMI1|C1417244|||C1417244|HUGO;MTH;OMIM|||
PMI|PM1|C0456957;C1823304|||C1823304|HUGO|||
PMI|PMI|C1417244;C1823304|||C1417244;C1823304|HUGO;OMIM|||
PMI|Pain Management Index||||||1|0.0678|1
PMI|TMEM11;TMEM11 gene;transmembrane protein 11|C1823304|||C1823304|HUGO;MTH|||
PMI|past medical illness||||||||1
PMI|patient medical instruction||||||||1
PMI|patient medication instruction||||||||1
PMI|patient medicine instruction||||||||1
PMI|perioperative myocardial infarct||||||||1
PMI|perioperative myocardial infarction||||||1|0.3107|1
PMI|petition of mental illness||||||||1
PMI|phosphomannose isomerase|C0024744|||||1|0.2316|1
PMI|plea of mental incompetence||||||||1
PMI|point of maximal impulse||1|1.000|||||1
PMI|posterior myocardial infarct||||||||1
PMI|posterior myocardial infarction|C0340319|||C0340319|CHV;NCI|||1
PMI|postmortem interval||||||1|0.3898|1
PMI|postmyocardial infarct||||||||1
PMI|postmyocardial infarction||||||||1
PMI|present medical illness||||||||1
PMI|previous medical illness||||||||1
PM|(11beta-21-[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11,17-dihydroxypregna-1,4-diene-3,20-dione||||C0032949|NCI|||
PM|11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-[4-[p-[bis(3-chloroethyl)amino]phenyl]butyrate]||||C0032949|NCI|||
PM|Attomole per Microliter;Femtomole per Milliliter;Femtomole per milliliter;Femtomole per millilitre;Nanomole per Cubic Meter;Picomole per Liter;picomole per liter;Yoctomole per Picoliter;Zeptomole per Nanoliter;picomolar|C0439284|||C0439284|MTH;NCI;SNOMEDCT|||1
PM|BASIC SALIVARY PROLINE-RICH PROTEIN, BstNI TYPE, 1;CON2;PRB1 gene;PRB1L;PRB1M;PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1;proline-rich protein BstNI subfamily 1|C1418866|||C1418866|HUGO;MTH;OMIM|||
PM|Chlorambucil Prednisolone Ester;PREDNIMUSTINE;Prednimustine;prednimustine|C0032949|||C0032949|MSH;MTH;NCI;NDFRT;PDQ;RXNORM|||
PM|Every afternoon at institution specified times||||C1550750|MTH|||
PM|Miquelon and Saint Pierre;SAINT PIERRE AND MIQUELON;Saint Pierre and Miquelon||||C0038111|MSH;MTH;NCI|||
PM|Miquelon and St. Pierre;St. Pierre and Miquelon||||C0038111|MSH|||
PM|PA|C0031833|||C0030266|NCI|||
PM|PAN|C0085999|||C0030266|NCI|||
PM|PANAMA;Panama;panama|C0030266|||C0030266|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
PM|PAROTID MIDDLE BAND PROTEIN|C1867051|||C1867051|MTH;OMIM|||
PM|PM;PMS;Pm;PmS;pM;pm|C0033046;C1418866;C1868117|||C0030266;C0032949;C0038111;C0439284;C1418866;C1550750;C1867051;C2347516|HL7V3.0;HUGO;NCI;OMIM;PDQ;SNOMEDCT|||
PM|PMF;PmF|C1418866;C1868201|||C1418866|HUGO;OMIM|||
PM|PRB1|C0599575;C1418866;C1419295;C2984536|||C1418866|HUGO;OMIM|||
PM|Palatal myoclonus|C0030214|||||1|0.0044|
PM|Panama (geographic location)||||C0030266|SNOMEDCT|||
PM|Pasteurella multocida|C0030637|||||1|0.0073|
PM|Periodontal mechanosensitive||||||1|0.0044|
PM|Picometer;picometer|C2347516|||C2347516|MTH;NCI|||1
PM|Picomole/Liter;picomole/liter;picomole/litre||||C0439284|NCI;SNOMEDCT|||
PM|Plasmodium malariae|C0032153|||||||1
PM|Prednimustine [Chemical/Ingredient]||||C0032949|NDFRT|||
PM|Pregna-1,4-diene-3,20-dione, 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-||||C0032949|MSH;NDFRT|||
PM|Psychological Mindedness||||||1|0.0049|
PM|SB||||C0038111|NCI|||
PM|SPM|C2986827|||C0038111|NCI|||
PM|after death||||||||1
PM|afternoon|C0439550|1|0.846|||||1
PM|amol/mcL||||C0439284|NCI|||
PM|amol/uL||||C0439284|NCI|||
PM|evening|C0587117|||||||1
PM|fmol/mL||||C0439284|NCI;SNOMEDCT|||
PM|intrapulmonary metastasis||||||1|0.0029|
PM|medial pulvinar||||||1|0.0053|
PM|method|C0025663;C0449851;C0871511|||||1|0.0044|
PM|monocytes|C0026473;C0200637|||||1|0.0044|
PM|mouth pressure||||||1|0.015|
PM|nmol/m3||||C0439284|NCI|||
PM|pacemaker|C0030163;C1546728|||C0030163;C1546728|CHV;COSTAR;CSP;HL7V2.5;NCI|1|0.0471|1
PM|pagetoid melanocytosis||||||||1
PM|papillae mammae||||||||1
PM|papillary muscle|C0030352;C1281066|||C0030352;C1281066|CHV;CSP;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0291|1
PM|papular mucinosis|C0263390|||||||1
PM|paraspinal mapping||||||||1
PM|partial mastectomy|C0024885;C0851238|||C0024885;C0851238|CHV;COSTAR;MSH;NCI;SNOMEDCT|||
PM|partial meniscectomy||||||||1
PM|partial mole|C0334529|||C0334529|NCI;SNOMEDCT|1|0.0044|
PM|partially muscular||||||||1
PM|particulate matter|C1720884|||C1720884|MSH|1|0.2028|1
PM|pathologic myopia|C1417579|||C1417579|HUGO|||
PM|patients with polymyositis||||||1|0.0199|
PM|pectinate muscle|C0225854|||C0225854|CHV;FMA|||
PM|pectoralis major|C0224340;C0585574|||C0224340;C0585574|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0223|1
PM|perfect match||||||1|0.0039|
PM|perinatal morbidity|C0848215|||||||1
PM|perinatal mortality|C0031062;C0701826|||C0031062;C0701826|AOD;CHV;ICPC;MSH;SNOMEDCT|1|0.0044|1
PM|periodontal membrane|C0031093|||||||1
PM|peritoneal macrophage;peritoneal macrophages|C0206190|||C0206190|CHV;FMA;MSH;NCI|1|0.0791|1
PM|peritoneal mesothelioma|C1377610|||C1377610|MTH;NCI|1|0.0024|
PM|peritrophic matrix||||||1|0.0097|
PM|permethrin|C0070455;C1446695|||C0070455;C1446695|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|||
PM|petit mal|C0014553|||||||1
PM|phosphoramide mustard|C0070913|||C0070913|MSH;NCI|1|0.018|
PM|photomultiplier|C0597229|||||||1
PM|physical medicine|C0031813|||||||1
PM|picomole/liter (pmol/l)||||C0439284|CHV|||
PM|placental malaria||||||1|0.0039|
PM|plasma|C0032105;C1546740;C1609077|||||1|0.0044|
PM|plasma membrane|C0007603|||C0007603|AOD;CHV;CSP;FMA;GO;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.262|1
PM|platelet membrane||||||||1
PM|platelet microsome||||||||1
PM|pleural mesothelioma|C0812413;C1377913|||||1|0.0034|
PM|pmol/L||||C0439284|NCI;SNOMEDCT|||
PM|pmol/L (qualifier value)||||C0439284|SNOMEDCT|||
PM|pneumomediastinum|C0025062|||||||1
PM|poliomyelitis|C0032371|||||||1
PM|polymorphic|C1882417|||||||1
PM|polymorphism|C0032529;C1882417|||C0032529;C1882417|CHV;MSH;MTH;NCI|||
PM|polymorphonuclear||||||||1
PM|polymyositis|C0085655|||C0085655|AIR;AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
PM|pons-medulla||||||1|0.0053|
PM|poor metabolisers;poor metabolizer;poor metabolizers||||||1|0.0907|1
PM|porokeratosis of Mibelli|C0949506|||||||1
PM|post meridiem|C1509133|||||||1
PM|post mortem;post-mortem;postmortem|C0004398;C0580205;C0848632|||C0848632|CHV|1|0.0223|1
PM|posterior mitral||||||||1
PM|postmenopausal|C0232970|||C0232970|CHV;NCI;PDQ|1|0.0082|1
PM|prediction model||||||1|0.0034|
PM|premamillary nucleus||||||||1
PM|premenopausal|C0279752|||C0279752|CHV;NCI;PDQ|||
PM|premolar|C1704302|||||||1
PM|premotor||||||1|0.0087|
PM|premotor area|C0458359|||C0458359|SNOMEDCT|1|0.0029|
PM|premotor cortex|C0228202|||C0228202|CHV;FMA;SNOMEDCT|1|0.0126|
PM|presents mainly||||||||1
PM|presystolic murmur|C0232265|||||||1
PM|pretibial myxedema|C0033103|||||||1
PM|preventive medicine|C0033110;C1555852|||||||1
PM|primary motivation||||||||1
PM|promethazine|C0033405|||||1|0.0044|
PM|promethium|C0033406|||||||1
PM|prophylactic mastectomy|C2191320|||C2191320|NCI;SNOMEDCT|1|0.0082|
PM|prospective memory|C0589154|||C0589154|CHV;MSH;SNOMEDCT|1|0.0087|
PM|prostatic massage|C0194852|||||||1
PM|protein methylesterase|C0072376|||||||1
PM|psammomatous meningioma|C0334607|||||||1
PM|psoas major|C0224419;C1305045|||C0224419;C1305045|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0092|
PM|pterygoid muscle|C0034001;C1280264|||||||1
PM|puberal macromastia||||||||1
PM|pulmonary macrophage;pulmonary macrophages|C0085236|||C0085236|MSH|1|0.0121|1
PM|pulmonary metastases;pulmonary metastasis|C0153676|||C0153676|CHV;SNOMEDCT|1|0.0068|
PM|pulpomesial||||||||1
PM|puromycin|C0034145|||C0034145|CSP;LCH;MSH;NCI;NDFRT|1|0.0058|
PM|purple membrane|C0034149|||C0034149|MSH|||
PM|pyogenic meningitis|C0302869|||||1|0.0024|
PM|pyridoxamine|C0034268|||C0034268|AOD;CSP;MSH;NDFRT;SNOMEDCT|1|0.0184|
PM|ymol/pL||||C0439284|NCI|||
PM|zmol/nL||||C0439284|NCI|||
PND|ANF||||C1417807|OMIM|||
PND|ANP||||C1417807|OMIM|||
PND|ATRIAL NATRIURETIC FACTOR|C0027481;C1417807|||C1417807|OMIM|||
PND|ATRIAL NATRIURETIC POLYPEPTIDES;ATRIONATRIURETIC FACTOR;CARDIONATRIN;NPPA gene|C1417807|||C1417807|HUGO;MTH;OMIM|||
PND|ATRIOPEPTIN|C0027481;C0201900|||C1417807|OMIM|||
PND|DYSPNEA, NOCTURNAL PAROXYSMAL;Dyspnea Paroxysmal Nocturnal;Dyspnea, Paroxysmal Nocturnal;PAROXYSMAL NOCTURNAL DYSPNEA;Paroxysmal nocturnal dyspnea;Paroxysmal nocturnal dyspnoea;dyspnea nocturnal paroxysmal;dyspnea paroxysmal nocturnal;dyspnoea paroxysmal nocturnal;paroxysmal nocturnal dyspnea;paroxysmal nocturnal dyspnoea|C0013405;C1956415|1|0.998|C0013405;C1956415|CHV;COSTAR;DXP;MSH;MTH;NCI;QMR;SNOMEDCT|||1
PND|Dyspnea, Paroxysmal;Dyspneas, Paroxysmal;Paroxysmal Dyspnea;Paroxysmal Dyspneas;Paroxysmal dyspnea;Paroxysmal dyspnoea;dyspnea paroxysmal;paroxysmal dyspnea;PND - Paroxysmal nocturnal dyspnea;PND - Paroxysmal nocturnal dyspnoea;paroxysmal nocturnal dyspnea pnd|C0013405|||C0013405;C1956415|CHV;MSH;MTH;NDFRT;SNOMEDCT|||
PND|Dyspnea, Paroxysmal [Disease/Finding]||||C0013405|NDFRT|||
PND|NATRIURETIC PEPTIDE PRECURSOR A||||C1417807|OMIM|||
PND|NPPA|C0068273;C1417807|||C1417807|HUGO;OMIM|||
PND|PND;pnd;pnds|C0013405;C1417807;C1956415|||C0013405;C1417807;C1956415|CHV;DXP;OMIM|||
PND|PRONATRIODILATIN|C0052649;C1417807|||C1417807|OMIM|||
PND|Paroxysmal dyspnea (finding)||||C0013405|SNOMEDCT|||
PND|Paroxysmal nocturnal dyspnea (finding);Paroxysmal nocturnal dyspnoea (finding)||||C1956415|SNOMEDCT|||
PND|Postnatal depression;postnatal depression|C0221074|||C0221074|CHV;CSP;MSH;NDFRT;SNOMEDCT|1|0.0346|1
PND|cardiac asthma|C0013405;C1956414|||C0013405|CHV|||
PND|natriuretic peptide A||||C1417807|HUGO|||
PND|nipple discharge|C0149741|||||1|0.0062|
PND|partial neck dissection||||||||1
PND|pelvic node dissection||||||||1
PND|phrenic nerve discharge||||||1|0.0087|
PND|postnasal drainage||1|0.002|||||1
PND|postnasal drip|C0032781|||C0032781|CHV;COSTAR;CST;ICD9CM;NCI;SNOMEDCT|||
PND|postnatal day||||||1|0.8121|
PND|postneonatal death|C1272076|||||||1
PND|pregnancy, not delivered|C0549206|||||||1
PND|prenatal diagnosis|C0033053|||||1|0.068|
PND|principal neutralizing determinant||||||1|0.0457|
PND|principal neutralizing domain||||||1|0.0247|
PND|purulent nasal drainage||||||||1
PND|pyronaridine|C0072768|||C0072768|MSH;NCI|||
PNT|PNT|C1518963;C2347617|||C1518963|NCI|||
PNT|Percutaneous Neuromodulation Therapy|C1518963|||C1518963|NCI|||
PNT|paroxysmal nodal tachycardia|C0546960|||||||1
PNT|partial nodular transformation||||||||1
PNT|percutaneous nephrostomy tube|C1979960|1|1.000|||||1
PNT|percutaneous neuromodulatory therapy||||||||1
PNT|pneumotachograph|C0182334|||||1|1|
PO|Activity intolerance risk;At risk for activity intolerance;Potential activity intolerance|C0150009|||C0150009|LNC;MTH;SNOMEDCT|||
PO|At risk for activity intolerance (finding)||||C0150009|SNOMEDCT|||
PO|At risk for cognitive impairment;Potential cognitive impairment;Potential for cognitive impairment|C0231393|||C0231393|MTH;SNOMEDCT|||
PO|At risk for cognitive impairment (finding)||||C0231393|SNOMEDCT|||
PO|At risk for deficient fluid volume;Fluid volume deficit risk;Potential fluid volume deficit|C0150032|||C0150032|LNC;MTH;SNOMEDCT|||
PO|At risk for deficient fluid volume (finding)||||C0150032|SNOMEDCT|||
PO|At risk for deficient parenting;At risk for impaired parenting;Potential alteration in parenting|C0231416|||C0231416|MTH;SNOMEDCT|||
PO|At risk for deficient parenting (finding)||||C0231416|SNOMEDCT|||
PO|At risk for imbalanced body temperature;Potential alteration in body temperature;Risk for altered body temperature|C0231359|||C0231359|MTH;SNOMEDCT|||
PO|At risk for imbalanced body temperature (finding)||||C0231359|SNOMEDCT|||
PO|At risk for impaired skin integrity;At risk for skin ulceration;At risk to skin ulceration;Potential for skin breakdown;Potential skin breakdown;Potential impairment of skin integrity;Skin integrity impairment risk;Vulnerable to skin tissue breakdown|C0231357|||C0231357|LNC;MTH;SNOMEDCT|||
PO|At risk for impaired skin integrity (finding)||||C0231357|SNOMEDCT|||
PO|At risk for infection;At risk of infection;Infection risk;infection risk;infection risks;infections risk;risk for infection;Potential for infection|C0582147|||C0582147|CHV;LNC;MTH;SNOMEDCT|||
PO|At risk for infection (finding);At risk of infection (finding)||||C0582147|SNOMEDCT|||
PO|At risk for injury;At risk of injury;at risk of injury;At risk for trauma;Injury risk;injuries risk;injury risk;injury risks;risk injury;risk injury for;Trauma risk|C0582456|||C0582456|CHV;LNC;MTH;SNOMEDCT|||
PO|At risk for injury (finding);At risk of injury (finding)||||C0582456|SNOMEDCT|||
PO|At risk for joint contractures;Potential for joint contractures;Potential joint contractures|C0231379|||C0231379|MTH;SNOMEDCT|||
PO|At risk for joint contractures (finding)||||C0231379|SNOMEDCT|||
PO|At risk for poisoning injury;Poisoning risk;Potential for poisoning|C0150061|||C0150061|LNC;MTH;SNOMEDCT|||
PO|At risk for poisoning injury (finding)||||C0150061|SNOMEDCT|||
PO|At risk for suffocation;Potential for suffocation;Suffocation risk|C0150082|||C0150082|LNC;MTH;SNOMEDCT|||
PO|At risk for suffocation (finding)||||C0150082|SNOMEDCT|||
PO|At risk for suffocation [dup] (finding)||||C0150082|SNOMEDCT|||
PO|At risk for violence;Potential for violence;Violence risk|C0231418|||C0231418|LNC;MTH;SNOMEDCT|||
PO|At risk for violence (finding)||||C0231418|SNOMEDCT|||
PO|By mouth;by mouth;Oral Route of Administration;Oral Route of Drug administration;Oral use;oral use;use oral;PO - Per os;Per Os;Per os;per os;Per oral route;Peroral route;per oral|C1527415|1|0.998|C1527415|CHV;MTH;NCI;SNOMEDCT|1|0.0576|1
PO|Maximum isometric tetanic force||||||1|0.0064|
PO|ORAL;Oral;oral;Orally;orally;PO;Po|C0442027|||C0032344;C0032729;C0150009;C0150032;C0150061;C0150082;C0231357;C0231359;C0231379;C0231393;C0231416;C0231418;C0442027;C0582147;C0582456;C1446409;C1527415|AOD;CHV;HL7V2.5;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.1295|
PO|Oral (qualifier value)||||C0442027|SNOMEDCT|||
PO|Oral route;OralRoute;oral route|C0205531;C1527415|||C1527415|CHV;HL7V3.0;SNOMEDCT|||
PO|Oral route (qualifier value)||||C1527415|SNOMEDCT|||
PO|PO - Oral||||C0442027|SNOMEDCT|||
PO|POIS||||C0032344|MSH|||
PO|PORTUGAL;Portugal;portugal|C0032729|||C0032729|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
PO|PRT|C0020687;C0032729;C1152182|||C0032729|NCI|||
PO|PT||||C0032729|NCI|||
PO|Perceptual Organization;perceptual organization||||||1|0.0056|1
PO|Personality Organization||||||1|0.0048|
PO|Phenol oxidase;phenoloxidase|C0041484|||C0041484|CHV;MSH;NDFRT|1|0.0624|
PO|Plasmodium ovale|C0320744|||||||1
PO|Poisoning aspects|C0032344|||C0032344|MTH|||
PO|Portugal (geographic location)||||C0032729|SNOMEDCT|||
PO|Positive;Positive for;positive;positive for|C0439178;C1446409;C1514241;C2825490|||C1446409|CHV;MTH;NCI;SNOMEDCT|||
PO|Positive (qualifier value)||||C1446409|SNOMEDCT|||
PO|Posterior group of thalamic nuclei||||||1|0.008|
PO|Potential for injury (trauma)||||C0582456|SNOMEDCT|||
PO|Pulse oximetry;pulse oximetry|C0034108|||C0034108|CHV;LNC;MSH;NCI;SNOMEDCT|1|0.0088|1
PO|Ruled in;rule;ruled;ruling|C0805874;C0870077;C1446409|||C1446409|CHV;SNOMEDCT|||
PO|Skin at risk of breakdown||||C0231357|SNOMEDCT|||
PO|Skin at risk of breakdown (finding)||||C0231357|SNOMEDCT|||
PO|Skin integrity at risk||||C0231357|SNOMEDCT|||
PO|administered|C1521801|||||1|0.0072|
PO|day of birth||||||1|0.0096|
PO|granulosa cells of preovulatory||||||1|0.0032|
PO|maximum isometric force||||||1|0.0072|
PO|maximum isometric tension||||||1|0.008|
PO|open probability;probability of opening||||||1|0.2206|
PO|opening pressure||||||||1
PO|oral administration|C0001563|||||1|0.0128|
PO|oral gavage||||||1|0.0112|
PO|palm oil|C0069962|||||1|0.02|
PO|paraoxon|C0030480|||C0030480|LNC;MSH;NDFRT;SNOMEDCT|1|0.012|
PO|parapineal organ||||||||1
PO|parietal operculum|C0228265|||C0228265|FMA;MTH;SNOMEDCT|||1
PO|parieto-occipital;parietooccipital||||||1|0.0072|1
PO|peanut oil|C0052300|||C0052300|CHV;MSH;NCI;NDFRT;SNOMEDCT;VANDF|1|0.0088|
PO|period of onset|C0458004|||C0458004|SNOMEDCT|||1
PO|perioperative|C1518988;C1552246|||C1518988;C1552246|HL7V3.0;MTH;NCI|||1
PO|periosteum|C0031110|||||||1
PO|peroral||||||1|0.024|
PO|perorally||||||1|0.012|
PO|peroxidase|C0027021;C0031179;C1318719|||C0027021;C0031179;C1318719|CHV;CSP;LCH;LNC;MSH;MTH;NDFRT;SNOMEDCT|1|0.0488|
PO|phone order||||||||1
PO|phosphodiester|C0599124|||C0599124|CSP|1|0.0336|
PO|physician only||||||||1
PO|poise|C1551084;C2937256|||||||1
PO|poisoning|C0032343;C0032344|||C0032344|MSH|||
PO|polonium|C0032390|||||||1
PO|polyolefin|C0950546|||C0950546|MSH;SNOMEDCT|1|0.0072|
PO|porion|C2346418|||||||1
PO|post box|C1550717;C2698859|1|0.002|||||
PO|posterior|C0205095|||C0205095;C0751438|CHV;CST;FMA;HL7V2.5;NCI;SNOMEDCT;UWDA|1|0.0184|1
PO|posterior complex||||||1|0.0048|
PO|posterior nuclear group||||||1|0.0096|
PO|posterior nucleus||||||1|0.0064|
PO|postoperative|C0032790|||C0032790|CHV;NCI;SNOMEDCT|1|0.0344|1
PO|postoperatively||||||1|0.0112|1
PO|power output|C0445194|||C0445194|CHV;SNOMEDCT|1|0.0528|
PO|predominating organism||||||||1
PO|preoptic area|C0033063|||C0033063|AOD;CSP;FMA;MSH;SNOMEDCT|1|0.0088|
PO|pressure|C0033095;C0460139;C1306345|||||1|0.0248|
PO|principal olive||||||1|0.0128|
PO|probability of being open||||||1|0.0056|
PO|probability of channel opening||||||1|0.008|
PO|probability of the channel being open||||||1|0.004|
PO|progesterone|C0033308;C2757070|||||1|0.0128|
PO|prophylactic oophorectomy|C2945703|||C2945703|CHV;NCI|||1
PO|propylene oxide|C0072229|||C0072229|MSH;NCI;SNOMEDCT|||
PO|prostate only||||||1|0.004|
PO|protein oxidation|C1159301|||C1159301|GO|1|0.0096|
PO|pulse oximeter|C0182109|||||||1
PO|punctal occlusion|C0395275|||||||1
PO|rulings|C1446409|||C1446409|CHV|||
PO|tetanic tension||||||1|0.036|
PPD|ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD;Arthropathy, progressive pseudorheumatoid, of childhood;PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD;Progressive pseudorheumatoid arthropathy of childhood;PPAC;PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA;Progressive pseudorheumatoid dysplasia;progressive pseudorheumatoid dysplasia;SEDT-PA;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY;Spondyloepiphyseal dysplasia tarda with progressive arthropathy|C0432215|||C0432215|MSH;MTH;OMIM;SNOMEDCT|||
PPD|Argonaute2;eIF2C2|C1414333;C2827477|||C2827477|NCI|||
PPD|Eukaryotic Translation Initiation Factor 2C 2;Eukaryotic Translation Initiation Factor 2C2;PAZ Piwi Domain Protein;Protein Argonaute-2;Protein Slicer;eIF-2C 2;eIF2C 2;hAgo2|C2827477|||C2827477|MTH;NCI|||
PPD|PPD;ppd's;ppds;PPD - Purified protein derivative - S;PPD-S;Purified Protein Derivative;Purified protein derivative;derivative protein purified;purified protein derivative;Purified Protein Derivative of Tuberculin;TUBERCULIN,PURIFIED PROTEIN DERIVATIVE;Tuberculin purified protein derivative;tuberculin purified protein derivative;Purified protein derivative - S;Tuberculin PPD|C0034131|1|1|C0034131;C0432215;C1421473;C1552732;C2827477|CHV;HUGO;MSH;MTH;MTHSPL;NCI;NDFRT;OMIM;RXNORM;SNOMEDCT;VANDF|1|0.6694|1
PPD|Paired-pulse depression||||||1|0.0424|
PPD|Parametric Probability Distribution|C1552662;C1552732|||C1552732|HL7V3.0;NCI|||
PPD|Parametric Probability Distribution - DataType|C1552732|||C1552732|MTH|||
PPD|Progressive pseudorheumatoid dysplasia (disorder)||||C0432215|SNOMEDCT|||
PPD|Purified Protein Derivative of Tuberculin [Chemical/Ingredient]||||C0034131|NDFRT|||
PPD|Purified protein derivative (product)||||C0034131|SNOMEDCT|||
PPD|Purified protein derivative (substance)||||C0034131|SNOMEDCT|||
PPD|Purified protein derivative - S (substance)||||C0034131|SNOMEDCT|||
PPD|RETINAL INNER NUCLEAR LAYER HOMEOBOX;RINX;VSX1;VSX1 gene;visual system homeobox 1|C1421473|||C1421473|HUGO;MTH;OMIM|||
PPD|Tuberculin|C0034131;C0041289;C1532464|||C0034131|SNOMEDCT|||
PPD|Tuberculin purified protein derivative (product)||||C0034131|SNOMEDCT|||
PPD|Tuberculin purified protein derivative (substance)||||C0034131|SNOMEDCT|||
PPD|VISUAL SYSTEM HOMEOBOX GENE 1, ZEBRAFISH, HOMOLOG OF||||C1421473|OMIM|||
PPD|p-phenylenediamine;para-phenylenediamine;paraphenylenediamine|C0048678|||C0048678|CHV;MSH;NDFRT;SNOMEDCT;VANDF|1|0.064|1
PPD|packs per day||||||||1
PPD|percussion and postural drainage||||||||1
PPD|permanent partial disability||||||||1
PPD|photodynamic diagnosis||||||||1
PPD|pinch-point density||||||||1
PPD|pocket probing depth;probing pocket depth||||||1|0.0976|1
PPD|posterior polymorphous dystrophy||||||1|0.006|1
PPD|postpartum day||||||1|0.0045|1
PPD|postpartum depression|C0221074|||C0221074|CHV;CSP;MEDLINEPLUS;MSH;NCI;NDFRT;SNOMEDCT|1|0.0343|1
PPD|postprandial|C0376674|||||||1
PPD|preaxial polydactyly|C0345354|||C0345354|OMIM;SNOMEDCT|||
PPD|prepared||||||||1
PPD|preprodynorphin|C0071827|||C0071827|MSH;SNOMEDCT|1|0.0335|
PPD|primary peritoneal drainage||||||||1
PPD|primary physical dependence||||||||1
PPD|progressive perceptive deafness||||||||1
PPD|progressive pulmonary dystrophy||||||||1
PPD|proximal pars distalis||||||1|0.029|
PPD|purified protein derivative from tuberculin||||||1|0.0022|
PPD|purified protein derivative of Mycobacterium tuberculosis||||||1|0.0104|
PPD|pylorus-sparing pancreaticoduodenectomy|C1293563|||||||1
PPD|tuberculin skin test|C0041290|||||1|0.0067|
PPI|Inhibitors, Proton Pump;Proton Pump Inhibitor;Proton Pump Inhibitors;Proton pump inhibitor;Proton pump inhibitors;inhibitor proton pump;inhibitors proton pump;proton pump inhibitor;proton pump inhibitors|C0358591;C1384478|1|0.998|C0358591|CHV;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT;USPMG|1|0.289|1
PPI|PPI|C0358591;C0871125|||C0358591;C0871125|GO;NCI|||
PPI|Patient Package Insert;patient package insert||||||1|0.0073|1
PPI|Plan-Position-Indication||||||||1
PPI|Proton Pump Inhibitor [EPC]|C0358591|||C0358591|NDFRT|||
PPI|Proton pump inhibitor (product)||||C0358591|SNOMEDCT|||
PPI|Proton pump inhibitor (substance)||||C0358591|SNOMEDCT|||
PPI|Psychopathic Personality Inventory||||||1|0.0073|1
PPI|inorganic pyrophosphate||||||1|0.1057|1
PPI|paired-pulse index||||||1|0.0082|
PPI|partial permanent impairment||||||||1
PPI|peptidyl prolyl cis-trans isomerase|C0136073;C1414624|||||1|0.0046|
PPI|permanent pacemaker insertion|C2924511;C2926072|||||||1
PPI|phosphoinositide|C0031621|||||1|0.0237|
PPI|polyphosphoinositide|C0071655|||C0071655|AOD;MSH;NDFRT|1|0.0629|
PPI|polypropyleneimine|C1100475|||C1100475|MSH|||
PPI|post pacing interval||||||||1
PPI|postpartum interval||||||1|0.0055|
PPI|pre-pulse inhibition;prepulse inhibition;prepulse inhibition activity|C0871125|||C0871125|GO;MTH|1|0.4111|1
PPI|preceding preparatory interval||||||||1
PPI|preproinsulin|C0071928|||C0071928|MSH|1|0.01|
PPI|prepulse inhibition of acoustic startle||||||1|0.01|
PPI|present pain intensity||||||1|0.0301|1
PPI|protein-protein interaction|C0872079|||C0872079|NCI|1|0.0064|
PPI|psychophysiological insomnia|C0751250|||C0751250|MSH;MTHICD9|||
PPI|pulse polio immunization||||||1|0.0064|
PPI|purified pork insulin||||||1|0.0119|
PPT|CLN1|C1418854;C1850451|||C1418854|HUGO|||
PPT|INCL|C0268281;C1418854|||C1418854|HUGO|||
PPT|PALMITOYL-PROTEIN THIOESTERASE;palmitoyl-protein thioesterase|C0380804;C1418854|||C0380804;C1418854|MSH;OMIM;SNOMEDCT|1|0.0866|
PPT|PALMITOYL-PROTEIN THIOESTERASE 1;palmitoyl-protein thioesterase 1|C0917464;C1418854|||C1418854|HUGO;OMIM|||
PPT|PAP|C0523444|||C2266415|GO|||
PPT|PPT;ppt|C1153596;C1418854;C1551050;C2266415|||C1153596;C1418854;C1551050;C2266415|GO;NCI;OMIM|||
PPT|PPT1;PPT1 gene|C1418854|||C1418854|HUGO;LNC;MTH;OMIM|||
PPT|Part per Thousand;parts per thousand;ppth|C1551050|||C1551050|HL7V3.0;MTH;NCI|||
PPT|Physical Performance Test;physical performance test|C0679543|||C0679543|AOD;CHV|1|0.0628|1
PPT|Platelet production time||||||1|0.013|
PPT|ceroid-lipofuscinosis, neuronal 1, infantile|C1418854;C2931673|||C1418854|HUGO|||
PPT|parietal pleural tissue||||||||1
PPT|part per trillion;parts per trillion|C1551051|||||1|0.0844|1
PPT|partial prothrombin time|C0853653|1|1.000|C0853653|CHV|||1
PPT|paw pressure threshold||||||1|0.013|
PPT|peak-to-peak threshold||||||||1
PPT|pedunculopontine tegmental||||||1|0.0325|
PPT|pedunculopontine tegmental nucleus|C0262306|||C0262306|FMA;MSH|1|0.0671|
PPT|pedunculopontine tegmentum|C0872242|||C0872242|CSP|1|0.0281|
PPT|person, place, and time||||||||1
PPT|phosphinothricin|C0070815|||C0070815|MSH|1|0.039|
PPT|phosphoenolpyruvate transmembrane transporter activity||||C1153596|GO|||
PPT|phosphoenolpyruvate/phosphate translocator||||C1153596|GO|||
PPT|phosphoenolpyruvate:phosphate antiporter activity|C1153596|||C1153596|GO;MTH|||
PPT|pineal parenchymal tumor|C0031941|||C0031941|MSH;NCI|||
PPT|plant protease test||||||||1
PPT|pneumonia prevention therapy||||||||1
PPT|polyp prevention trial|C1514210|||C1514210|NCI|||
PPT|polyphosphate:AMP phosphotransferase activity|C2266415|||C2266415|GO;MTH|||
PPT|polypurine tract||||||1|0.1494|
PPT|post-partum thyroiditis;postpartum thyroiditis|C0271815|||C0271815|CHV;MSH;NDFRT;SNOMEDCT|1|0.0887|1
PPT|posterior pelvic tilt||||||||1
PPT|potassium phosphotungstate||||||||1
PPT|precipitate;precipitated|C1882443|||||||1
PPT|precipitation|C0032931;C0032932;C1642401;C2584299|||||||1
PPT|preprotachykinin|C0071942|||C0071942|MSH|1|0.1905|
PPT|pressure pain threshold||||||1|0.1277|1
PPT|professional protective technology||||||||1
PPT|propyl pyrazole triol|C1172032;C1527986|||C1172032|MSH|1|0.0173|
PPT|pulmonary physical therapy||||||||1
PPT|pulmonary platelet trapping||||||||1
PRN|As Necessary;PRN (schedule frequency)|C1879745|||C1879745|MTH;NCI|||
PRN|As Needed;as needed;as-needed|C1883728|1|1|C1879745;C1883728|MTH;NCI|1|0.1262|1
PRN|As Required;As required;as required;given as needed|C0558288|||C0558288|CHV;HL7V2.5;MTH;NCI;SNOMEDCT|||
PRN|As Situation Arises||||C1883728|NCI|||
PRN|As required (qualifier value)||||C0558288|SNOMEDCT|||
PRN|FLJ21988;HPRN;IOP1;IRON-ONLY HYDROGENASE-LIKE PROTEIN 1;iron-only hydrogenase-like protein 1;NARFL;NARFL gene|C1422467|||C1422467|HUGO;MTH;OMIM|||
PRN|NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE;nuclear prelamin A recognition factor-like||||C1422467|HUGO;OMIM|||
PRN|PRN;Prn;prn||||C0558288;C1422467;C1879745;C1883728|CHV;HUGO;LNC;NCI;SNOMEDCT|||
PRN|Pro Re Nata;pro re nata|C1879745;C1883728|||C1879745;C1883728|NCI|1|0.1456|
PRN|When required;when required||||C0558288|CHV;SNOMEDCT|||
PRN|paramedian reticular nucleus|C0682738|||||1|0.2816|
PRN|plaque reduction neutralization||||||1|0.2621|
PRN|polyradiculoneuropathy|C0032587|||C0032587|CHV;MSH;NDFRT;SNOMEDCT|||
PRN|post-rotatory nystagmus;postrotatory nystagmus|C0524671|||C0524671|MSH|1|0.1748|
PRN|practice and research network||||||1|0.0097|
PRN|prn - When required||||C0558288|SNOMEDCT|||
PR|(drug) PR||1|0.004|||||
PR|ACIDIC SALIVARY PROLINE-RICH PROTEIN, HaeIII TYPE, 2;acidic salivary proline-rich protein, HaeIII type, 2;PAROTID PROLINE-RICH PROTEIN;parotid proline-rich protein;PRH2;PRH2 gene;PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2;proline-rich protein HaeIII subfamily 2|C1418893|||C1418893|HUGO;MTH;OMIM|||
PR|Diagnosis.primary;The primary diagnosis;primary diagnosis|C0332137;C0801658|||C0332137|CHV;HL7V2.5;LNC|||
PR|In partial remission;Partial Remission;partial remission;Partial Response;partial response|C1521726|||C1521726|AOD;MTH;NCI;SNOMEDCT|1|0.6902|1
PR|In partial remission (qualifier value)||||C1521726|SNOMEDCT|||
PR|Incomplete remission -RETIRED-||||C1521726|SNOMEDCT|||
PR|Main diagnosis|C0332137|||C0332137|SNOMEDCT|||
PR|NR3C3|C1366500;C1705324|||C1366500;C1705324|HUGO;NCI|||
PR|PGR;PgR||||C0034833;C1366500;C1705324|HUGO;NCI;OMIM;PDQ|||
PR|PGR Gene;PGR gene;Progesterone Receptor Gene|C1366500|||C1366500|HUGO;MTH;NCI|||
PR|PGR wt Allele;Progesterone Receptor wt Allele|C1705324|||C1705324|MTH;NCI|||
PR|PR;Pr;pr|C0279759;C0279766;C1418864|||C0034044;C0034833;C0332137;C1366500;C1418893;C1521726;C1540007;C1705324|CHV;HUGO;NCI;OMIM;SNOMEDCT|||
PR|PR - Progesterone receptor;progesterone receptor (PR);PROGESTERONE RECEPTOR;Progesterone Receptor;Progesterone Receptors;Progesterone receptor;Receptor, Progesterone;Receptors, Progesterone;progesterone receptor;progesterone receptors|C0034833;C1366500|1|0.176|C0034833;C1366500|CHV;CSP;HUGO;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
PR|PR1;TMEM37;TMEM37 gene;transmembrane protein 37|C1540007|||C1540007|HUGO;MTH|||
PR|PRI;PUERTO RICO;Puerto Rico;puerto rico;puerto ricos|C0034044|||C0034044|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0045|
PR|PROGESTERONE RECEPT;RECEPT PROGESTERONE||||C0034833|MSH|||
PR|PROGESTIN RECEPT;RECEPT PROGESTIN||||C0034833|MSH|||
PR|Paeoniae radix|C0949958|||||1|0.0029|
PR|Panama red||||||||1
PR|Photoreactivation;photoreactivation||||||1|0.0064|1
PR|Plain radiography|C1306645|||||1|0.0029|
PR|Preyer reflex||||||||1
PR|Principal Diagnosis;Principal diagnosis;principal diagnosis|C0332137;C2598194|||C0332137|CHV;LNC;MTH;SNOMEDCT|||
PR|Principal diagnosis (contextual qualifier)||||C0332137|SNOMEDCT|||
PR|Principal diagnosis (contextual qualifier) (qualifier value)||||C0332137|SNOMEDCT|||
PR|Progesterone receptor (substance)||||C0034833|SNOMEDCT|||
PR|Progesterone receptor site;Progestin Receptors;Receptors, Progestin|C0034833|||C0034833|MSH;NDFRT;SNOMEDCT|||
PR|Projection reconstruction||||||1|0.0106|
PR|Puerto Rico (geographic location)||||C0034044|SNOMEDCT|||
PR|RQ||||C0034044|NCI|||
PR|Receptors, Progesterone [Chemical/Ingredient]||||C0034833|NDFRT|||
PR|Release|C0030685;C0391871;C0439180;C0680255;C1283071;C1963578|||||1|0.0051|
PR|expression of pathogenesis-related||||||1|0.0071|
PR|form of phytochrome||||||1|0.0019|
PR|onset of ventricular depolarization||||||||1
PR|pack removal||||||||1
PR|pain relief|C0451615|||||1|0.0029|
PR|palindromic rheumatism|C0085574|||||||1
PR|panic reaction|C0030318|||||||1
PR|panoramic radiography|C0034579|||||1|0.0023|
PR|parallax refraction||||||||1
PR|pars recta||||||1|0.0029|1
PR|partial regression||||||1|0.0029|
PR|partial reinforcement||||||||1
PR|partial responders||||||1|0.0084|
PR|particulate respirator||||||||1
PR|passive recovery||||||1|0.0026|
PR|patient relations||||||||1
PR|pattern recognition|C1518918|||||1|0.0029|
PR|pattern reversal|C0439717|||||1|0.0035|
PR|peer review|C0030768|||||||1
PR|pelvic rock||||||||1
PR|pentoxyresorufin|C0070318|||C0070318|MSH|||
PR|per rectum|C1527425|1|0.282|||||1
PR|percentile rank||||||||1
PR|perennial rhinitis|C0848309|||||||1
PR|perfusion rate||||||||1
PR|peripheral resistance|C1258192|||C1258192|CHV;MSH|1|0.0071|1
PR|perirenal||||||1|0.0029|
PR|perirhinal cortex||||||1|0.0029|
PR|phenol red|C0031430|||C0031430|CHV;MSH;NCI;NDFRT|1|0.0055|1
PR|photoreaction||||||||1
PR|photoreceptor|C0031760|||C0031760|AOD;CHV;FMA|||
PR|physical rehabilitation|C0849487|||||||1
PR|physician reviewer||||||||1
PR|pityriasis rosea|C0032026|||C0032026|CHV;COSTAR;CST;DXP;ICD9CM;ICPC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.008|1
PR|placental restriction||||||1|0.0016|
PR|plaque reduction||||||1|0.0032|
PR|pneumatic retinopexy|C0395578|||||1|0.0029|
PR|polymorphic reticulosis|C0019623;C2350168|||C0019623;C2350168|CHV;MSH;MTH;SNOMEDCT|1|0.0048|
PR|polymyalgia rheumatica|C0032533;C0039483|||||||1
PR|posterior root|C2332346|||||||1
PR|postural reflex|C0234154|||||||1
PR|potency ratio||||||||1
PR|potential relation||||||||1
PR|pr interval|C0429087;C0488345;C0520877|1|0.504|||||
PR|praseodymium|C0032904|||||||1
PR|prealbumin|C0032923|||||1|0.0032|
PR|prednisolone|C0032950|||C0032950|AOD;CHV;CSP;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0055|
PR|preference record||||||||1
PR|pregnancy|C0032961|||||||1
PR|pregnancy rate|C0032975|||C0032975|CHV;MSH|1|0.0621|1
PR|pregnant|C0549206;C0553641;C0600457|||||1|0.0029|
PR|premature|C0205252|||||||1
PR|presbyopia|C0033075|||||||1
PR|pressoreceptor|C0033093|||||||1
PR|pressure|C0033095;C0460139;C1306345|||||||1
PR|prevalence ratio||||||1|0.0183|
PR|prevention|C0199176;C1706420;C2700409|||||||1
PR|proctology|C0033248|||||||1
PR|production rate||||||||1
PR|professional relations||||||||1
PR|profile|C1979963;C2003903|||||||1
PR|progestin|C0033306|||C0033306|AOD;CHV;CSP;NCI;NDFRT;PDQ;SNOMEDCT|||
PR|progressive ratio||||||1|0.0302|
PR|progressive relaxation||||||||1
PR|progressive resistive exercise||||||||1
PR|prolactin|C0033371;C1744644|||||||1
PR|proliferative retinopathy|C0339467|||C0339467|CHV|1|0.0035|
PR|proline-rich||||||1|0.0029|
PR|prolonged remission||||||||1
PR|prone|C0033422|||||||1
PR|propranolol|C0033497|||C0033497|AOD;CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0129|
PR|prorenin;prorennin|C0072249;C0072250|||C0072250|MSH;MTH;SNOMEDCT|1|0.0035|
PR|prosthion|C2339454|||||||1
PR|protease|C0030946;C1947941|||C0030946;C1947941|CHV;CSP;LNC;NCI;NDFRT;SNOMEDCT;VANDF|||1
PR|protein|C0033684|||||1|0.0061|1
PR|protein restriction||||||1|0.0019|
PR|proteinase|C0030946;C1622131;C1947941|||C0030946;C1622131;C1947941|CHV;CSP;GO;LCH;NCI;SNOMEDCT|||
PR|pseudorabies|C0033839|||||1|0.0039|
PR|psychotherapy responder||||||||1
PR|public relations|C0034034|||||||1
PR|pulmonary regurgitation;pulmonic regurgitation|C0034088|1|0.024|C0034088|CHV;DXP;MSH;NCI;NDFRT;SNOMEDCT|1|0.0161|1
PR|pulmonary rehabilitation|C0199529;C1552326;C1552340|||C0199529;C1552326;C1552340|CHV;HL7V3.0;SNOMEDCT|1|0.0087|1
PR|pulse rate|C0232117;C0391850|1|0.002|||||1
PR|pulse repetition||||||||1
PR|punctum remotum||||||||1
PR|pyramidal response||||||||1
PR|reaction|C0443286;C1114821|||||1|0.0039|
PR|region|C0017446;C0205147|||||1|0.0035|
PR|release probability||||||1|0.0023|
PR|retention|C0035280;C0333117;C1753315|||||1|0.0029|
PR|under a progressive-ratio||||||1|0.0035|
PR|viral proteinase||||||1|0.0032|
PSA|AMINOPEPTIDASE, PUROMYCIN-SENSITIVE;aminopeptidase puromycin sensitive;puromycin-sensitive aminopeptidase|C0139360;C1417779|||C0139360;C1417779|HUGO;MSH;MTH;OMIM|1|0.0024|
PSA|ANTIGEN, PROSTATE-SPECIFIC;Antigen, Prostate-Specific;PROSTATE-SPECIFIC ANTIGEN;Prostate Specific Antigen;Prostate specific Antigen;Prostate specific antigen;Prostate-Specific Antigen;prostate specific antigen;prostate-specific antigen;PSA - Prostate specific antigen;prostate specific antigen (PSA)|C0138741;C0201544;C1366489|1|1|C0138741;C0201544;C1366489|CHV;CSP;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.8806|1
PSA|APS||||C1366489;C1705954|NCI;OMIM|||
PSA|Antigens|C0003320|||||1|0.002|
PSA|Benign Mixed Salivary Gland Neoplasm;Benign Mixed Salivary Gland Tumor;Benign Mixed Salivary Neoplasm;Benign Mixed Salivary Tumor;Pleomorphic adenoma of salivary gland;SALIVARY GLAND ADENOMA, PLEOMORPHIC;Salivary Gland Pleomorphic Adenoma|C1519176|||C1519176|MTH;NCI;OMIM;SNOMEDCT|||
PSA|EC 3.4.21.77||||C0138741|NCI|||
PSA|ENDOMETRIAL PROGESTERONE-INDUCED PROTEIN||||C1426033|OMIM|||
PSA|EPIP;PHOSPHOSERINE AMINOTRANSFERASE 1;phosphoserine aminotransferase 1;PSAT;PSAT1;PSAT1 gene|C1426033|||C1426033|HUGO;MTH;OMIM|||
PSA|Gamma-Seminoprotein;gamma Seminoprotein;gamma seminoprotein;gamma-Seminoprotein;Kallikrein hK3;Kallikrein, hK3;hK3 Kallikrein;P-30 Antigen;P-30 antigen;Prostate Specific Antigen Preproprotein;Prostate specific Ag;prostate specific ag;Semenogelase;Seminin;psa antigen|C0138741|||C0138741|CHV;CSP;LNC;MSH;NCI;NDFRT;SNOMEDCT|||
PSA|HK 003 KALLIKREIN;KALLIKREIN HK 003||||C0138741|MSH|||
PSA|KALLIKREIN 3;Kallikrein-3|C0138741;C1366489|||C0138741;C1366489|NCI;OMIM|||
PSA|KALLIKREIN-RELATED PEPTIDASE 3;kallikrein-related peptidase 3||||C1366489|HUGO;OMIM|||
PSA|KLK2A1;KLK3 wt Allele|C1705954|||C1705954|MTH;NCI|||
PSA|KLK3|C0138741;C1366489;C2987230|||C0138741;C1366489|HUGO;NCI;OMIM|||
PSA|KLK3 Gene;KLK3 gene|C1366489|||C1366489|HUGO;MTH;NCI|||
PSA|Kallikrein 3, (Prostate Specific Antigen) Gene||||C1366489|NCI|||
PSA|Kallikrein 3, (Prostate Specific Antigen) wt Allele||||C1705954|NCI|||
PSA|METALLOPROTEASE MP100;MP100;NPEPPS;NPEPPS gene;metalloproteinase MP100|C1417779|||C1417779|HUGO;MTH;OMIM|||
PSA|PLAG1 wt Allele;Pleiomorphic Adenoma Gene 1 wt Allele|C2347427|||C2347427|MTH;NCI|||
PSA|PROS1;PROS1 gene;PROTEIN S, ALPHA;protein S (alpha)|C1418948|||C1418948|HUGO;LNC;MTH;OMIM|||
PSA|PROTEIN S|C0072393;C1418948|||C1418948|OMIM|||
PSA|PSA||||C0138741;C0201544;C0687688;C1366489;C1417779;C1418948;C1426033;C1519176;C1705954;C2347427|AOD;CHV;CSP;HUGO;NCI;OMIM|||
PSA|PSA - Prostate-specific antigen level;PSA - Serum prostate specific antigen level;PSA Assay;PSA measurement;PSA test;Prostate Specific Antigen Assay;Prostate Specific Antigen Measurement;Prostate specific antigen measurement;Prostatic Specific Antigen Measurement;antigen prostate specific test;antigen prostate specific testing;prostate specific antigen test;prostate-specific antigen test|C0201544|||C0201544|CHV;MTH;NCI;SNOMEDCT|||
PSA|Pisum sativum|C1262903|||||1|0.0034|
PSA|Pisum sativum agglutinin||||||1|0.0055|1
PSA|Pleomorphic adenoma of salivary gland (disorder)||||C1519176|SNOMEDCT|||
PSA|Power spectral analysis;power spectral analysis||||||1|0.0086|1
PSA|Prostate specific antigen (& serum level)||||C0201544|SNOMEDCT|||
PSA|Prostate specific antigen (& serum level) (procedure)||||C0201544|SNOMEDCT|||
PSA|Prostate specific antigen (procedure)||||C0138741|SNOMEDCT|||
PSA|Prostate specific antigen (substance)||||C0138741|SNOMEDCT|||
PSA|Prostate specific antigen measurement (procedure)||||C0201544|SNOMEDCT|||
PSA|Prostate-Specific Antigen [Chemical/Ingredient]||||C0138741|NDFRT|||
PSA|Prostate-specific antigen level||||C0201544|SNOMEDCT|||
PSA|Prostate-specific antigen level (procedure)||||C0201544|SNOMEDCT|||
PSA|SGPA|C0258101;C1519176;C2347427|||C1519176;C2347427|NCI;OMIM|||
PSA|Semenogelase (substance)||||C0138741|SNOMEDCT|||
PSA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0028|
PSA|biochemical|C0205474|||||1|0.0026|
PSA|hK3|C1150530;C1415556;C1428139;C1705954|||C1705954|NCI|||
PSA|pacemaker system analysis||||||||1
PSA|pathologic spontaneous activity||||||||1
PSA|persistent sciatic artery||||||1|0.0024|1
PSA|picryl sulfonic acid||||||||1
PSA|polar surface area||||||1|0.0024|
PSA|polyethylene sulfonic acid||||||||1
PSA|polysialic acid|C0071677|||C0071677|MSH;NCI;PDQ|1|0.0225|
PSA|polysubstance abuse|C0747752|||||||1
PSA|population spike amplitude||||||1|0.0028|
PSA|porcine serum albumin||||||1|0.0016|
PSA|posterior spinal artery|C0226233;C1278947|||||||1
PSA|potentiometric stripping analysis||||||1|0.002|
PSA|pressure sensitive adhesive||||||1|0.0018|
PSA|procedural sedation and analgesia||||||||1
PSA|product selection allowed||||||||1
PSA|progressive spinal ataxia|C1827682|||||||1
PSA|prolonged sleep apnea||||||||1
PSA|proportion of survivors affected||||||||1
PSA|prostate specific antigen (PSA) level test||||C0201544|CHV|||
PSA|pseudoaneurysm|C0162868;C1510412|||C0162868;C1510412|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
PSA|psoriatic arthritis|C0003872|||C0003872|AIR;CHV;COSTAR;CSP;MEDLINEPLUS;MSH;NCI;QMR;SNOMEDCT|1|0.0528|1
PSA|public service announcement|C0687688|||C0687688|AOD;CHV;MTH|||1
PSA|systemic arterial pressure|C1272641|||||1|0.0037|1
PSVT|PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA;Paroxysmal Supraventricular Tachycardia;Paroxysmal supraventricular tachycardia;Paroxysmal supraventricular tachycardia NOS;TACHYCARDIA, PAROXYSMAL SUPRAVENTRICULAR;paroxysmal supraventricular tachycardia;PSVT;psvt;paroxysmal supraventricular tachycardia (PSVT)|C0030590|1|1|C0030590|CCS;CHV;DXP;ICD9CM;MTH;NCI;SNOMEDCT|1|1|1
PSVT|Parox atrial tachycardia||||C0030590|ICD9CM|||
PSVT|Paroxysmal sup. tachy.||||C0030590|SNOMEDCT|||
PSVT|Paroxysmal supraventricular tachycardia (disorder);Paroxysmal supraventricular tachycardia NOS (disorder)||||C0030590|SNOMEDCT|||
PSVT|Supravent. tach. parox.||||C0030590|SNOMEDCT|||
PSVT|Tachycardia - parox.sup||||C0030590|SNOMEDCT|||
PTCA|Angioplasties, Coronary Balloon;Angioplasty, Balloon, Coronary;Angioplasty, Coronary Balloon;Balloon Angioplasties, Coronary;Balloon Angioplasty, Coronary;Coronary Balloon Angioplasties;Coronary Balloon Angioplasty;coronary balloon angioplasty;Balloon Dilation, Coronary Artery;coronary artery balloon dilation;Coronary Angioplasty, Transluminal Balloon;Transluminal Coronary Balloon Dilation|C0002997|||C0002997|CHV;MSH;MTH|||
PTCA|Angioplasty, Transluminal, Percutaneous Coronary;Percutaneous Transluminal Coronary Angioplasty;Percutaneous transluminal coronary angioplasty;percutaneous transluminal coronary angioplasty;PTCA (percutaneous transluminal coronary angioplasty);PTCA - Percutaneous transluminal coronary angioplasty;Percutaneous transluminal coronary angioplasty (PTCA);Percutaneous transluminal coronary angioplasty [PTCA];percutaneous transluminal coronary angioplasty (PTCA);Percutaneous angioplasty of coronary artery;Percutaneous transluminal coronary balloon angioplasty|C2936173|1|1|C0002997;C2936173|CCS;CHV;CSP;ICD9CM;MSH;MTH;NCI;SNOMEDCT|1|0.99|1
PTCA|Balloon angioplasty of coronary artery;PTCA;PTCA NOS;ptca|C0002997;C2936173|||C0002997;C2936173|CHV;CSP;ICD9CM;MTHICD9;SNOMEDCT|||
PTCA|Percutaneous balloon angioplasty of coronary artery||||C2936173|SNOMEDCT|||
PTCA|Percutaneous transluminal coronary angioplasty (procedure)||||C2936173|SNOMEDCT|||
PTCA|balloon angioplasty|C0002996;C0002997|||C0002997|CHV|||
PTCA|coronary angioplasty|C0002997;C0190211|||C0002997|CHV|||
PTCA|parent to child aggression||||||||1
PTCA|percutaneous transhepatic cholangiogram|C0203085;C1548898|||||||1
PTCA|percutaneous transhepatic cholangiograph||||||||1
PTCA|percutaneous transhepatic cholangiography|C0203085|||||||1
PTCA|percutaneous transluminal coronary angiography||||||1|0.0036|
PTCA|percutaneous transluminal coronary arteriography||||||||1
PTCA|pyrrole-2,3,5-tricarboxylic acid||||||1|0.0064|
PTFE|Ethene, tetrafluoro-, homopolymer;PTFE;PTFE (polytetrafluoroethylene);PTFE - Polytetrafluoroethylene;polytetrafluoroethylene (PTFE);Paratetrafluoroethylene;Politef;Polytef;Polytetrafluoroethylene;poly(tetrafluoroethylene);polytetrafluoroethylene|C0032611|1|1|C0032611|CHV;CSP;MSH;MTH;NDFRT;SNOMEDCT|1|0.9388|1
PTFE|FEP|C0032611;C0281678|||C0032611|MSH;NDFRT|||
PTFE|Paratetrafluoroethylene (substance)||||C0032611|SNOMEDCT|||
PTFE|Polytetrafluorethylene||||||1|0.0531|
PTFE|Polytetrafluoroethylene (substance)||||C0032611|SNOMEDCT|||
PTFE|Polytetrafluoroethylene [Chemical/Ingredient]||||C0032611|NDFRT|||
PTFE|TFE|C0032611;C0076258|||C0032611|MSH;NDFRT|||
PTFE|Teflon|C0032611;C0699518|||C0032611|SNOMEDCT|||
PTFE|polytetraflouroethylene||||||1|0.0081|
PTH|Hormone, Parathyroid;PARATHYROID HORMONE;Parathyroid Hormone;Parathyroid hormone;Parathyroid hormone, NOS;Parathyroid hormones;parathyroid hormone;parathyroid hormones|C0030520;C1882913|1|1|C0020063;C0030520;C1419072;C1882913|AOD;CHV;CSP;FMA;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.9204|1
PTH|Intact parathyroid hormone (substance)||||C0030520|SNOMEDCT|||
PTH|PARATHORMONE;Parathormone;Parathormone, NOS;parathormone;PARATHYRIN;Parathyrin;parathyrin;PTH - Parathyroid hormone;Parathormone preparation;Parathormone preparation, NOS;Parathyroid Hormone [EPC];Parathyroid extract;Parathyroid extract, NOS;Parathyroid hormone agent;Parathyroid hormone preparation;Parathyroid hormone preparation, NOS;Parathyroid-class Hormone;[HS600] PARATHYROID|C0030520|||C0020063;C0030520;C0202159;C1419072|AOD;CHV;CSP;HUGO;LNC;MSH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.0432|
PTH|PARATHYROID;Parathyroid;parathyroid|C0030518;C0030520|||C0030520|NDFRT;USPMG;VANDF|1|0.0037|
PTH|PTH||||C0020063;C0030520;C1419072;C1705340|CHV;CSP;HUGO;NCI;OMIM;PDQ|||
PTH|PTH (1-84)||||C0030520|MSH;NDFRT|||
PTH|PTH Gene;PTH gene;Parathyroid Hormone Gene;parathyroid hormone gene;parathyroid hormone 1|C1419072|||C1419072|HUGO;MTH;NCI|1|0.0015|
PTH|PTH protein, human;parathyroid hormone, human|C0020063|||C0020063|MSH;MTH|||
PTH|PTH wt Allele;Parathyroid Hormone wt Allele|C1705340|||C1705340|MTH;NCI|||
PTH|PTH1|C1419072;C1826737|||C1419072|HUGO|||
PTH|Parathormone (substance)||||C0030520|SNOMEDCT|||
PTH|Parathyroid Hormone (1-84)||||C0030520|MSH;NDFRT|||
PTH|Parathyroid Hormone [Chemical/Ingredient]||||C0030520|NDFRT|||
PTH|Parathyroid hormone (substance)||||C0030520|SNOMEDCT|||
PTH|Parathyroid hormone agent (substance)||||C0030520|SNOMEDCT|||
PTH|Parathyroid hormone preparation (product)||||C0030520|SNOMEDCT|||
PTH|Parathyroid hormone preparation (substance)||||C0030520|SNOMEDCT|||
PTH|Posttetanic hyperpolarization;post-tetanic hyperpolarization||||||1|0.0024|
PTH|chest wall elastic recoil pressure||||||||1
PTH|hPTH(1-84)||||C0020063|MSH|||
PTH|parathyroid hormone 1-34||||||1|0.0007|
PTH|parathyroid hormone levels||||||1|0.002|
PTH|pathologic|C1521733|||||||1
PTH|pathology|C0030664;C0205469;C0677042|||||||1
PTH|peptidyl-tRNA hydrolase|C0051616|||||1|0.0035|
PTH|phenylthiohydantoin|C0031504|||C0031504|AOD;MSH;NDFRT|1|0.007|
PTH|plasma parathyroid hormone||||||||1
PTH|plasma thromboplastin||||||||1
PTH|post-transfusion hepatitis;posttransfusion hepatitis|C0520788|||C0520788|CSP;SNOMEDCT|1|0.0111|1
PTH|posttraumatic headache|C0032816|||C0032816|CHV;MSH;SNOMEDCT|||
PTH|pressure threshold;threshold pressure||||||1|0.0046|
PTH|primary thrombocythemia|C0040028|||||||1
PTH|prior to hospitalization||||||||1
PT|*^patient;PATIENT;Patient;Patients;^Patient;patient;patients|C0030705|||C0030705;C1550655;C1578478;C1578479;C1578480;C1578481;C1578483;C1578484;C1578485;C1578486;C1705908|AOD;CHV;HL7V2.5;HL7V3.0;LCH;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0126|1
PT|Coagulation Factor II (Thrombin) wt Allele||||C2826539|NCI|||
PT|F2 wt Allele|C2826539|||C2826539|MTH;NCI|||
PT|LAY USER/PATIENT||||C0030705|NCI|||
PT|Modalities, Physical Therapy;Modality, Physical Therapy;Physical Therapy Modalities;Physical Therapy Modality;PT - Physiotherapy;Physiatric Procedure;Physiatric procedure;Physiatric procedure, NOS;Physical Medicine Procedure;Physical medicine procedure;Physical medicine procedure, NOS;Physical Therapeutics;Physical Therapy Procedure;Physical therapy procedure;Physical therapy procedure, NOS;physical procedures therapy;procedure physical therapy;Physical Therapy Technique;Physical Therapy Techniques;Techniques, Physical Therapy;physical technique therapy;physical therapy techniques;Physical therapy treatment;physical therapy treatment;physical therapy treatments;treatment physical therapy;Physiotherapies (Techniques);Physiotherapy (Techniques);physiotherapy techniques;Physiotherapy;Physiotherapy, NOS;Therapy - physio.;physiotherapies;physiotherapy;Physiotherapy Procedure;Physiotherapy procedure;Physiotherapy procedure, NOS|C0949766|||C0949766|AOD;CHV;LNC;MSH;NCI;PDQ;SNOMEDCT|1|0.007|
PT|Nuclei parataeniales thalami;Nucleus parataenialis;Nucleus parataenialis thalami;Nucleus paratenialis thalami;Nucleus, Paratenial Thalamic;Paratenial Thalamic Nucleus;Paratenial thalamic nucleus;Thalamic Nucleus, Paratenial;Structure of paratenial nucleus of thalamus|C0175252|||C0175252|FMA;MSH;SNOMEDCT|||
PT|Nucleus parataenialis (Hassler)||||C0175252|FMA|||
PT|Nucleus, Paratenial;Parataenial nucleus;Paratenial Nucleus;Paratenial nucleus;paratenial nucleus;Parataenial nucleus of thalamus;Paratenial nucleus of thalamus|C0175252;C1828005|||C0175252|CHV;FMA;MSH;MTH;SNOMEDCT|||
PT|One stage prothrombin time||||C0033707|SNOMEDCT|||
PT|One stage prothrombin time (procedure)||||C0033707|SNOMEDCT|||
PT|PHYSICAL THER TECHNIQUES||||C0949766|MSH|||
PT|PHYSIOTHER PRACTICE||||C0949766|MSH|||
PT|PINT;Pint;pint|C0560012|||C0560012|CHV;HL7V3.0;MTH;NCI;SNOMEDCT|||1
PT|PLATINUM;Platinum;Platinum, NOS;platinum;Pt - Platinum;platinum (Pt)|C0032207;C1171558;C1553253|||C0032207|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0644|1
PT|PO|C0442027|||C0032729|NCI|||
PT|PORTUGAL;Portugal;portugal|C0032729|||C0032729|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
PT|PRT|C0020687;C0032729;C1152182|||C0032729|NCI|||
PT|PT;Pt;pT;pt||||C0030705;C0032207;C0032729;C0033707;C0175252;C0560012;C0949766;C1270004;C1442880;C1705337;C2347664;C2826539|CHV;FMA;LNC;MTH;NCI;SNOMEDCT|||
PT|PT - Prothrombin time;PT assay;Prothrombin Time;Prothrombin Times;Prothrombin time;Time, Prothrombin;Times, Prothrombin;prothrombin time;prothrombin times;Prothrombin time assay;Protime;Quick one stage prothrombin time;prothrombin test|C0033707|1|0.044|C0033707|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.3054|1
PT|PT Term Type|C1705337|||C1705337|MTH;NCI|||
PT|PTT - Prothrombin time||||C0033707|SNOMEDCT|||
PT|Pain threshold;pain threshold|C0162703|||C0162703|CHV;CSP;MSH;NCI;SNOMEDCT|1|0.0097|
PT|Parataenial nucleus of thalamus (body structure)||||C0175252|SNOMEDCT|||
PT|Pathologic T category;TNM category pT;pT category;pT stage|C1270004|||C1270004|MTH;SNOMEDCT|||
PT|Patient (person)||||C0030705|SNOMEDCT|||
PT|Physical Medicine and Rehabilitation Procedures||||C0949766|MTHCH|||
PT|Physical Therapy;Physical therapy;physical therapies;physical therapy;therapy physical|C0699718;C0949766|1|0.91|C0699718;C0949766;C1547999;C1552441|AOD;CCS;CHV;CSP;HL7V2.5;HL7V3.0;LCH;LNC;MEDLINEPLUS;MTH;NCI|1|0.0281|1
PT|Physical medicine procedure (procedure)||||C0949766|SNOMEDCT|||
PT|Physical medicine procedure (regime/therapy)||||C0949766|SNOMEDCT|||
PT|Physical therapy procedure (procedure)||||C0949766|SNOMEDCT|||
PT|Physical therapy procedure (regime/therapy)||||C0949766|SNOMEDCT|||
PT|Planum Temporale||||||1|0.0164|
PT|Platinum (substance)||||C0032207|SNOMEDCT|||
PT|Platinum Black;Pt element|C0032207|||C0032207|CSP;MSH;NDFRT|||
PT|Platinum [Chemical/Ingredient]||||C0032207|NDFRT|||
PT|Point in time|C1442880;C1552684;C2348792|||C1442880|MTH|||
PT|Portugal (geographic location)||||C0032729|SNOMEDCT|||
PT|Preferred Term|C1709637;C2347664|||C2347664|MTH;NCI|||
PT|Prothrombin Time Test;prothrombin time test;prothrombin time (PT) test|C0033707;C0491338|||C0033707|CHV;NCI|||
PT|Prothrombin time (procedure)||||C0033707|SNOMEDCT|||
PT|Structure of paratenial nucleus of thalamus (body structure)||||C0175252|SNOMEDCT|||
PT|Twitch tension||||||1|0.0097|
PT|[pt_us]||||C0560012|NCI|||
PT|depth of tumor invasion||||||1|0.0015|
PT|isometric twitch||||||1|0.0018|
PT|pT category (observable entity)||||C1270004|SNOMEDCT|||
PT|pT category (tumor staging)||||C1270004|SNOMEDCT|||
PT|pT stage (tumor staging)||||C1270004|SNOMEDCT|||
PT|palatal tremor|C1837546|||C1837546|OMIM|||
PT|palatine tonsil|C0040421;C1280736|||C0040421;C1280736|CHV;FMA;MSH;MTH;NCI;SNOMEDCT;UWDA|||
PT|pancreas transplantation|C0030275|||C0030275|CHV;CSP;MEDLINEPLUS;MSH;MTH;MTHCH;NCI|1|0.0029|
PT|paralytic tremor||||||1|0.0044|
PT|parathyroid|C0030518;C0030520|||C0030517;C0030518;C0030520|AOD;CHV;CST;LNC;NCI;NDFRT;SNOMEDCT;USPMG;VANDF|1|0.01|
PT|parathyroid hormone|C0030520;C1882913|||||||1
PT|paroxysmal tachycardia|C0039236|||||||1
PT|pars tensa|C0229372|||C0229372|SNOMEDCT|||
PT|pars tuberalis||||||1|0.0284|
PT|part|C0449719;C1709471|||||||1
PT|patch test|C0030646|||C0030646|AOD;CHV;MSH;SNOMEDCT|||
PT|patellar tendon|C0206332;C1827621|||C0206332;C1827621|CHV;MSH;SNOMEDCT|1|0.0132|
PT|peak torque||||||1|0.0261|
PT|percutaneous tracheostomy|C0584877|||C0584877|CHV;SNOMEDCT|1|0.0035|
PT|pericardial tamponade|C0007177|||||||1
PT|perinuclear theca|C2246398|||C2246398|GO|1|0.0038|
PT|permanent and total||||||||1
PT|permeability transition||||||1|0.024|
PT|permissive temperature||||||1|0.0015|
PT|pertussis|C0043167|||C0031237;C0043167|AOD;CHV;COSTAR;CSP;DXP;HL7V2.5;HL7V3.0;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|||
PT|pertussis toxin|C0020731|||C0020731|CHV;CSP;LCH;MSH;NCI;NDFRT;SNOMEDCT|1|0.1669|1
PT|pertussis toxoid|C0070476|||C0070476|MSH|1|0.0041|1
PT|phacotrabeculectomy||||||||1
PT|phage type|C0441761|||C0441761|SNOMEDCT|1|0.0231|1
PT|pharmacy and therapeutics||||||||1
PT|phenytoin|C0031507|||C0031507|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0044|
PT|phonation time||||||||1
PT|phosphotransferase|C0031727|||||||1
PT|phosphotyrosine|C0070948|||C0070948|MSH;NDFRT|||
PT|photophobia|C0085636|||||||1
PT|phototherapy|C0031765|||C0031765|AOD;CHV;CSP;LCH;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.0035|
PT|photothermal||||||1|0.0026|
PT|phototoxicity|C0162830;C1527358|||||||1
PT|phyllodes tumor|C0010701|||C0010701|CHV;MSH;MTH;NCI;NDFRT;OMIM;PDQ;SNOMEDCT|1|0.0047|
PT|physical therapis||||C0949766|CHV|||
PT|physical therapist;physiotherapist|C2362565|||C2362565|CHV;HL7V3.0;MSH;MTH;NCI;SNOMEDCT|||
PT|physical training||||||1|0.0061|1
PT|physiotherapi;physiotherapis||||C0949766|CHV|||
PT|picrotoxin|C0031890|||C0031890|AOD;CHV;CSP;LCH;MSH;MTH;NDFRT;SNOMEDCT|1|0.0026|
PT|pine tar|C0031938|||||||1
PT|pint (qualifier value)||||C0560012|SNOMEDCT|||
PT|pituitary tumor|C0032019|||C0032019|CHV;DXP;MSH;NCI;PDQ;SNOMEDCT|||
PT|plasma thromboplastin||||||||1
PT|plastid|C0206524|||||1|0.0026|
PT|platelet|C0005821|||C0005821|CHV;CSP;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|||
PT|pluridirectional tomography||||||||1
PT|pneumotachograph|C0182334|||C0182334|SNOMEDCT|1|0.0026|
PT|pneumothorax|C0032326;C1963215|||||||1
PT|point|C1552961;C2347617|||||||1
PT|polyvalent tolerance||||||||1
PT|post-treatment|C2709088|||||1|0.0073|
PT|posterior tibial||1|0.042|||1|0.0029|1
PT|posttransplant||||||||1
PT|pregnanetriol|C0033007|||C0033007|LNC;MSH;MTH;NDFRT;SNOMEDCT|||
PT|premature thelarche|C0425772|||C0425772|CHV;OMIM;SNOMEDCT|||
PT|presynaptic terminal|C0206181;C1514404|||C0206181;C1514404|CHV;MSH;NCI|||
PT|pretectum|C0175354|||C0175354|FMA|1|0.0047|
PT|preterm||||||1|0.0108|1
PT|prick test|C0430561|||C0430561|CHV;SNOMEDCT|||
PT|primary thrombocythaemia;primary thrombocythemia|C0040028|||C0040028|CHV;CSP;MSH;NCI|1|0.0079|1
PT|primary tumor;primary tumour|C0677930|||C0677930|CHV;NCI|1|0.0015|
PT|process tomography||||||||1
PT|proficiency testing||||||1|0.0158|
PT|pronator teres|C0224249|||C0224249|CHV;FMA;NCI;SNOMEDCT;UWDA|||1
PT|protein|C0033684|||C0033684;C0555903;C1325816;C1521746|CHV;CSP;FMA;GO;LNC;NCI;NDFRT;SNOMEDCT;UWDA;VANDF|||
PT|prothrombin|C0033706;C2828369|1|0.002|C0033706;C1414504;C2828369|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0193|
PT|proton transfer||||||1|0.0044|
PT|proximal|C0205107|||||1|0.0035|
PT|proximal tubular||||||1|0.0161|
PT|proximal tubule|C0022677|||C0022677|AOD;CHV|1|0.0428|1
PT|pseudotumor|C0033844|||||||1
PT|psychasthenia|C0338900|||||||1
PT|ptaquiloside|C0072576|||C0072576|MSH|1|0.0029|
PT|pulmonary thrombosis|C0151946|||||||1
PT|pulmonary toilet||||||||1
PT|pulmonary trunk|C0034052|||C0034052|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0041|1
PT|pulmonary tuberculosis|C0041327|||C0041327|AOD;CHV;ICD9CM;MSH;NCI;NDFRT;SNOMEDCT|1|0.0076|1
PT|pure tone||||||||1
PT|putamen|C0034169;C1281335|||C0034169;C1281335|AOD;CHV;CSP;FMA;MSH;NCI;SNOMEDCT|||
PT|pyramidal tract|C0034229|||C0034229|CHV;CSP;FMA;LCH;MSH;SNOMEDCT|1|0.0246|1
PT|pyrithiamine|C0034294|||C0034294|AOD;MSH;NDFRT|||
PT|temporal plane|C1184151|||||||1
PT|tests|C0022885;C0392366|||||1|0.0035|
PT|tissue|C0040300;C1547928|||||1|0.0029|
PT|tracheal pressure||||||1|0.0059|
PT|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0044|
PT|tumor stage|C1300072|||||1|0.002|
PT|tumors|C0027651|||||1|0.005|
PT|twitch force||||||1|0.0023|
PTSD|Combat fatigue;combat fatigue;Neuroses, Post Traumatic;Neuroses, Post-Traumatic;Neuroses, Posttraumatic;Post-Traumatic Neuroses;Posttraumatic Neuroses;POST TRAUMATIC STRESS DISORDER;Post Traumatic Stress Disorders;Post-Traumatic Stress Disorder;Post-Traumatic Stress Disorders;Post-traumatic stress disorder;Stress Disorder, Post Traumatic;Stress Disorder, Post-Traumatic;Stress Disorders, Post Traumatic;Stress Disorders, Post-Traumatic;disorder, post-traumatic stress;post traumatic stress disorder;post traumatic stress disorders;post-traumatic stress disorder;post-traumatic stress disorders;POSTTRAUMATIC STRESS DISORDERS;Posttraumatic Stress Disorder;Posttraumatic Stress Disorders;Posttraumatic stress disorder;Posttraumatic stress disorder NOS;Posttraumatic stress disorder, NOS;Stress Disorder, Posttraumatic;Stress Disorders, Posttraumatic;posttraumatic stress disorder;posttraumatic stress disorders;PTSD;PTSD - Post-traumatic stress disorder;Post-Traumatic Stress Disorder (PTSD);post-traumatic stress disorder (PTSD);Post-traumatic stress syndrome;post traumatic stress syndrome;post-traumatic stress syndrome;Traumatic neuroses;Traumatic neurosis;traumatic neurosis;battle fatigue|C0038436|1|1|C0038436|AOD;CHV;COSTAR;CSP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;PDQ;SNOMEDCT|1|1|1
PTSD|Combat fatigue (disorder)||||C0038436|SNOMEDCT|||
PTSD|POST TRAUMATIC STRESS DIS;STRESS DIS POST TRAUMATIC||||C0038436|MSH|||
PTSD|POSTTRAUMATIC STRESS DIS;Posttraumatic stress dis;STRESS DIS POSTTRAUMATIC||||C0038436|ICD9CM;MSH|||
PTSD|Post-traumatic stress disorder (disorder)||||C0038436|SNOMEDCT|||
PTSD|Posttraumatic stress disorder (disorder)||||C0038436|SNOMEDCT|||
PTSD|Stress Disorders, Post-Traumatic [Disease/Finding]||||C0038436|NDFRT|||
PTSD|[X]Combat fatigue||||C0038436|SNOMEDCT|||
PTT|2beta-propanoyl-3beta-(4-tolyl)-tropane||||||1|0.0662|
PTT|APTT;aPTT;aptt;APTT - Activated partial thromboplastin time;Activated Partial Thromboplastin Time;Activated partial thromboplastin time;Partial thromboplastin time activated;Partial thromboplastin time, activated;Activated Partial Thromboplastin Time measurement;PTT;PTT - Partial thromboplastin time;partial thromboplastin time: PTT;PTT, activated;activated ptt;Partial Thromboplastin Time;Thromboplastin Time, Partial;partial thromboplastin time|C0030605|1|1|C0030605|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||1
PTT|Activated Partial Thromboplastin Time (APTT) test||||C0030605|CHV|||
PTT|Activated partial thromboplastin time (procedure);Partial thromboplastin time activated (procedure);Partial thromboplastin time, activated (procedure)||||C0030605|SNOMEDCT|||
PTT|PTT assay||||C0030605|SNOMEDCT|||
PTT|partial thromboplastin||||||1|0.0464|
PTT|particle transport time||||||||1
PTT|patellar tendon transfer||||||||1
PTT|pharyngeal transit time||||||||1
PTT|platelet transfusion therapy||||||||1
PTT|poly(trimethylene terephthalate)|C1567176|||C1567176|MSH|||
PTT|posterior tibial tendinitis|C0554595|||||||1
PTT|posterior tibial tendon||||||1|0.106|1
PTT|posterior tibial transfer||||||||1
PTT|protein truncation test;protein truncation testing|C2737268|||C2737268|LNC|1|0.7219|1
PTT|pulmonary transit time||||||||1
PTT|pulse transit time||||||||1
PTT|pure tone threshold||||||||1
PTT|threshold|C0449864|||||1|0.0596|
PVC|CDDP/CTX/VP-16||||C0280556|NCI;PDQ|||
PVC|CEP||||C0280556|PDQ|||
PVC|CVP|C0056633;C0280556|||C0280556|NCI;PDQ|||
PVC|Chlorethylene polymer;Chloride, Polyvinyl;POLYVINYL CHLORIDE;Polyvinyl Chloride;Polyvinyl chloride;polyvinyl chloride;Chloroethylene Homopolymer;Homopolymer, Chloroethylene;Chloroethylene Polymer;Chloroethylene polymer;Polymer, Chloroethylene;Ethene, chloro-, homopolymer;PVC - Polyvinyl chloride;Polychloroethylene;Polymer, Vinyl Chloride;Vinyl Chloride Polymer;vinylchloride polymer;Vinyl;vinyl;polyvinylchloride|C0032624|||C0032624|CHV;CSP;LCH;MSH;MTH;NDFRT;SNOMEDCT;VANDF|1|0.7951|1
PVC|Cisplatin/Cyclophosphamide/Etoposide;cisplatin/cyclophosphamide/etoposide||||C0280556|NCI;PDQ|||
PVC|ECTOPIC BEATS (VENTRICULAR);Ectopic Beat, Ventricular;Ectopic Beats, Ventricular;Ventricular Ectopic Beat;Ventricular Ectopic Beats;Ventricular ectopic beats;ventricular ectopic beat;EXTRASYSTOLES VENTRICULAR;Extrasystole, Ventricular;VENTRICULAR EXTRASYSTOLES;Ventricular Extrasystole;Ventricular Extrasystoles;Ventricular extrasystoles;ventricular extrasystole;ventricular extrasystoles;PREMATURE VENTRICULAR BEATS;Premature Ventricular Beat;Premature Ventricular Beats;VENTRICULAR BEAT PREMATURE;Ventricular Beat, Premature;Ventricular Beats, Premature;Ventricular premature beats;premature ventricular beat;premature ventricular beats;ventricular premature beat;ventricular premature beats;PREMATURE VENTRICULAR COMPLEX;Premature Ventricular Complex;Premature ventricular complex;Ventricular Complex, Premature;Ventricular Premature Complex;Ventricular Premature Complexes;Ventricular premature complex;premature ventricular complex;premature ventricular complexes;ventricular premature complexes;VPC;VPC'S;Ventricular ectopic complex;Ventricular premature depolarisation;Ventricular premature depolarization;Ventricular premature systoles;ventricular ectopic activity;ventricular ectopy|C0151636|||C0151636|CHV;COSTAR;CST;DXP;MSH;NCI;NDFRT;SNOMEDCT|1|0.0461|1
PVC|Late Endosome;Late endosome;late endosome;prevacuolar compartment|C1166848|||C1166848|FMA;GO;MTH;NCI;UWDA|1|0.0109|
PVC|PCE|C0246101;C0280556;C1588205|||C0280556|NCI;PDQ|||
PVC|PREMATURE VENTRICULAR CONTRACTION;PREMATURE VENTRICULAR CONTRACTIONS;Premature Ventricular Contraction;Premature Ventricular Contractions;Premature ventricular contractions;VENTRICULAR CONTRACTIONS PREMATURE;Ventricular Contraction, Premature;Ventricular Contractions, Premature;Ventricular premature contractions;premature ventricular contraction;premature ventricular contractions|C0151636;C0488307|1|0.998|C0151636|COSTAR;CSP;CST;DXP;LNC;MSH;MTH;NDFRT;SNOMEDCT|1|0.1194|1
PVC|PVC;PVC'S;pvcs|C0151636;C1883717|||C0032624;C0151636;C0280556;C1166848|CHV;CSP;CST;DXP;GO;MSH;NCI;NDFRT;PDQ;SNOMEDCT|||
PVC|PVC (polyvinylchloride)||||C0032624|CSP|||
PVC|Polyvinyl Chloride [Chemical/Ingredient]||||C0032624|NDFRT|||
PVC|Polyvinyl chloride (substance)||||C0032624|SNOMEDCT|||
PVC|VCP-1;cisplatin/cyclophosphamide/etoposide protocol|C0280556|||C0280556|MTH;NCI;PDQ|||
PVC|VPB|C0151636;C0279462|||C0151636|DXP|||
PVC|Ventricular Premature Complexes [Disease/Finding]||||C0151636|NDFRT|||
PVC|Ventricular ectopic beats (disorder)||||C0151636|SNOMEDCT|||
PVC|Ventricular ectopic beats (finding)||||C0151636|SNOMEDCT|||
PVC|Ventricular ectopics;ventricular ectopic;ventricular ectopics|C0151636;C0488470|||C0151636|CHV;LNC|||
PVC|Ventricular premature beats (disorder)||||C0151636|SNOMEDCT|||
PVC|Ventricular premature complex (disorder)||||C0151636|SNOMEDCT|||
PVC|paravestibular canaliculus||||||1|0.0122|
PVC|peripheral venous catheterization|C0031127|||||||1
PVC|persistent vaginal cornification||||||||1
PVC|polyethylene vacuum cup||||||||1
PVC|porcelain veneer crown||||||||1
PVC|postvoiding cystogram||||||||1
PVC|predicted vital capacity||||||||1
PVC|primary visual cortex|C0038446;C2336068|||C0038446;C2336068|FMA;SNOMEDCT|||1
PVC|pulmonary venous capillary||||||||1
PVC|pulmonary venous congestion|C0582411|1|0.002|||||1
PVC|vaginal cornification||||||1|0.0163|
PVC|ventricular ectopic complex (PVC)||||C0151636|CHV|||
PVC|ventricular ectopic complex (PVC) [heart disease]||||C0151636|CHV|||
QD|Daily;daily;Each day;each day;Every day;every day;QD;everyday|C0332173|1|1|C0332173|CHV;MTH;NCI;SNOMEDCT|||1
QD|Daily (qualifier value)||||C0332173|SNOMEDCT|||
QD|Daily -RETIRED-||||C0332173|SNOMEDCT|||
QD|dialysate flow||||||1|0.0609|1
QD|once a day||||||1|0.0783|
QD|once daily|C0556983|||||1|0.5217|
QD|quantum dot|C1258084|||C1258084|MSH;NCI|1|0.1478|
QD|quaque die||||C0332173|NCI|||
QD|quinidine|C0034414|||C0034414|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.1913|
QHS|HS;Once a day, at bedtime|C1275563|||C1275563|HL7V3.0;MTH;SNOMEDCT|||
QHS|Once a day, at bedtime (qualifier value)||||C1275563|SNOMEDCT|||
QHS|at bedtime||1|1.000|||||1
QHS|qHS;qh;qhs|C0558292;C1275563|||C1275563|CHV;SNOMEDCT|||
QHS|qinghaosu|C0052430|||||1|1|
QHS|quantitative hepatobiliary scintigraphy||||||||1
QTC|Bazett's formula||||||1|0.0306|
QTC|QT corrected for heart rate||||||||1
QTC|QT interval corrected for heart rate||||||1|0.104|
QTC|corrected|C0205202|||||1|0.0367|
QTC|corrected QT||||||1|0.3914|
QTC|corrected QT interval||||||1|0.4373|
QTC|electrocardiograph waves||1|1.000|||||
QTC|quantitative tip culture||||||||1
RAP|A2RAP;LRPAP1;LRPAP1 gene;RAP|C1416920|||C1416920|HUGO;MTH;OMIM|||
RAP|ALPHA-2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN;HBP44|C0173695;C1416920|||C1416920|HUGO;OMIM|||
RAP|LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1;low density lipoprotein receptor-related protein associated protein 1||||C1416920|HUGO;OMIM|||
RAP|MRAP|C1416920;C1537935|||C1416920|OMIM|||
RAP|RNAIII activating protein||||||||1
RAP|Rehabilitation Activities Profile||||||1|0.012|
RAP|Relative Aspects of Potential||||||||1
RAP|atrial pacing||||||1|0.0285|
RAP|rapamycin|C0072980|||C0072980|CHV;CSP;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.072|
RAP|receptor-associated protein||||||1|0.2909|1
RAP|recurrent abdominal pain|C2585575|||C2585575|OMIM;SNOMEDCT|1|0.1424|1
RAP|recurrent acute pancreatitis|C0267937|||C0267937|SNOMEDCT|||
RAP|regional acceleratory phenomenon||||||1|0.0165|
RAP|regression-associated protein||||||||1
RAP|relative average perturbation||||||||1
RAP|remote access perfusion||||||||1
RAP|renal arterial pressure||||||1|0.069|
RAP|renal artery pressure||||||||1
RAP|renal artery pseudoaneurysm||||||||1
RAP|resistance-area product||||||1|0.0075|
RAP|retinal angiomatous proliferation||||||1|0.015|
RAP|rheumatoid arthritis precipitin||||||||1
RAP|right abdominal pain||||||||1
RAP|right atrial||||||1|0.0225|
RAP|right atrial pressure|C0456165|1|1.000|C0456165|CHV;SNOMEDCT|1|0.3238|1
RAP|robot-assisted laparoscopy||||||||1
RA|ANEMIA REFRACTORY;ANEMIA, REFRACTORY;Anemia, Refractory;Anemias, Refractory;REFRACTORY ANEMIA;Refractory Anemia;Refractory Anemias;Refractory anaemia;Refractory anemia;Refractory anemia, NOS;Refractory anemias;anemia refractory;refractory anaemia;refractory anemia;refractory anemias;Refractory anemia (RA)|C0002893;C2981142|||C0002893;C2981142|CHV;CST;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;PDQ;SNOMEDCT|1|0.0193|1
RA|ARTHRITIS RHEUMATOID;ARTHRITIS, RHEUMATOID;Arthritis, Rheumatoid;RHEUMATOID ARTHRITIS;Rheumatoid Arthritis;Rheumatoid arthritis;Rheumatoid arthritis NOS;rheumatoid arthritis|C0003873;C2697391|1|0.132|C0003873;C2697391|AIR;AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.6896|1
RA|ARTHRITIS, RHEUMATIC;rheumatic arthritis|C0003873;C0035436|||C0003873;C0035436|DXP;MSH;NDFRT|||
RA|Anemia, Refractory [Disease/Finding]||||C0002893|NDFRT|||
RA|Aregenerative Anemia|C0002893;C0553669|||C0002893|NCI|||
RA|Arthritis or polyarthritis, atrophic||||C0003873|MTHICD9|||
RA|Arthritis or polyarthritis, rheumatic||||C0003873|MTHICD9|||
RA|Arthritis, Rheumatoid [Disease/Finding]||||C0003873|NDFRT|||
RA|Atrophic Arthritis;Atrophic arthritis;atrophic arthritis;Chronic rheumatic arthritis;RA - Rheumatoid arthritis;RhA - Rheumatoid arthritis;Rheumatic gout;gout rheumatic;Rheumatoid disease|C0003873|||C0003873|CHV;NCI;SNOMEDCT|||
RA|IL-1 receptor antagonist||||||1|0.0028|
RA|RA;Ra||||C0002893;C0003873;C0034571;C0034625|MEDLINEPLUS;MSH;NCI;OMIM|||
RA|RADIOGR||||C0034571|MSH|||
RA|RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO||||C0003873|OMIM|||
RA|Radionuclide angiography;radionuclide angiography|C0034604|||C0034604|CHV;MSH|1|0.0005|1
RA|Radium;Radium, NOS;radium|C0034625|||C0034625|AOD;CHV;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
RA|Radium (substance)||||C0034625|SNOMEDCT|||
RA|Radium [Chemical/Ingredient]||||C0034625|NDFRT|||
RA|Rayleigh number||||||||1
RA|Refractory anaemia (disorder);Refractory anemia (disorder)||||C0002893|SNOMEDCT|||
RA|Refractory anaemia -RETIRED-;Refractory anemia -RETIRED-||||C0002893|SNOMEDCT|||
RA|Refractory anemia (morphologic abnormality)||||C0002893|SNOMEDCT|||
RA|Renin activity;renin activity|C1150120|||C1150120|CHV;GO;MTH|1|0.001|1
RA|Renin-angiotensin;renin-angiotensin||||||1|0.002|1
RA|Repeated acquisition||||||1|0.0004|
RA|Retinol acetate;retinyl acetate|C0073109|||||1|0.002|
RA|Rheumatoid arthritis (disorder);Rheumatoid arthritis NOS (disorder)||||C0003873|SNOMEDCT|||
RA|Risk assessment|C0086930|||||1|0.0007|
RA|Rokitansky-Aschoff||||||||1
RA|X-ray|C0034571;C0043299;C0043309;C1306645;C1962945|||C0034571|MSH|||
RA|X-ray diagnosis|C0034571;C1578656|||C0034571|MSH|||
RA|X-ray image;roentgenographic|C0034571|||C0034571|MSH;MTH|||
RA|afferent|C0205115|||||1|0.0008|
RA|afferent arteriolar resistance||||||1|0.0008|
RA|airway resistance|C0001884|||C0001884|AOD;CHV;MSH;SNOMEDCT|||
RA|amplitude|C2346753|||||1|0.0005|
RA|analysis|C0002778;C0936012;C1524024|||||1|0.0005|
RA|appearance rate;rate of appearance||||||1|0.0098|
RA|arterial|C0003842;C0221464|||||1|0.0009|
RA|arterial resistance|C0429119|||||1|0.0007|
RA|glucose production||||||1|0.0051|
RA|nucleus robustus archistriatalis||||||1|0.0019|
RA|proliferative arthritis|C0003873;C1306838|||C0003873|CHV|||
RA|radial artery|C0162857;C1278948|||||1|0.0071|1
RA|radioactive|C0034553;C1514697;C1548770;C1550589|||C0034553;C1514697;C1548770;C1550589|HL7V2.5;HL7V3.0;MTH;NCI|||1
RA|radioactivity|C0034553|||C0034553|AOD;CHV;LCH;LNC;MSH;NCI;SNOMEDCT|||
RA|radiographic absorptiometry||||||1|0.0013|1
RA|radiography|C0034571;C0043299;C1962945|||C0034571|MSH|||
RA|radionuclide angiogram||||||||1
RA|radionuclide angiograph||||||||1
RA|ragged||||||1|0.0006|
RA|ragocyte|C0333833|||||||1
RA|ragweed antigen||||||||1
RA|rales|C0034642;C0240859|||||||1
RA|rapidly adapting||||||1|0.0045|
RA|rat aorta|C1882561|||||1|0.0005|
RA|rates||||||1|0.0006|
RA|rates of glucose appearance||||||1|0.0018|
RA|reactive arthritis|C0085435|||||||1
RA|reading age||||||||1
RA|readmission|C1548168|||||||1
RA|reciprocal asymmetrical||||||||1
RA|rectus abdominis|C0206066;C1305918|||||1|0.0029|
RA|refractory ascites||||||||1
RA|regional anaesthesia;regional anesthesia|C0002911|||||1|0.0012|1
RA|relative anisotropy||||||1|0.001|
RA|remittance advice||||||||1
RA|renal artery|C0035065;C1278951|||C0035065;C1278951|AOD;CHV;CSP;FMA;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.0027|1
RA|repeat action||||||||1
RA|residual air||||||||1
RA|resistance to reabsorption of CSF||||||1|0.0006|
RA|retinoic acid|C0040845|1|0.002|C0040845|AOD;CHV;MSH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.1878|1
RA|retrograde amnesia|C0002624|||||1|0.0011|
RA|rheumatoid||||||1|0.0023|
RA|rheumatoid agglutinin||||||||1
RA|rheumatoid arthritic||||||1|0.0013|
RA|rheumatoid arthritis patients||||||1|0.0006|
RA|rheumatoid arthritis systemic||||C0003873|CHV|||
RA|rhinocerebral aspergillosis||||||||1
RA|rhodotorulic acid|C0073212|||C0073212|MSH|||
RA|riboadenylate||||||||1
RA|ricin A chain|C0035570|||||1|0.0005|
RA|right|C0205090|||||1|0.0007|
RA|right angle||||||||1
RA|right arm|C0230346;C1268255|||C0230346;C1268255|CHV;FMA;HL7V2.5;SNOMEDCT;UWDA|||1
RA|right atria;right atrium|C0225844;C1269890|1|0.788|C0225844;C1269890|AOD;CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0137|1
RA|right atrial||||||1|0.0118|1
RA|right atrial pressure|C0456165|||||1|0.0006|
RA|right auricle|C0225845|||C0225845|FMA;UWDA|||1
RA|risk area||||||1|0.0006|
RA|robust nucleus of the archistriatum||||||1|0.0057|
RA|roentgenography|C0034571;C0043299;C1306645;C1962945|||C0034571|MSH|||
RA|room air||1|0.072|||1|0.0034|1
RA|rotational angiography||||||||1
RA|rotational atherectomy|C0162655|||||1|0.0017|1
RA|rounded atelectasis|C2062952|||||1|0.0007|
RA|surface roughness||||||1|0.0033|
RBC|Anucleate erythrocyte;Blood Corpuscle, Red;Blood Corpuscles, Red;Corpuscle, Red Blood;Corpuscles, Red Blood;Red Blood Corpuscle;Red Blood Corpuscles;Red blood corpuscle;Red blood corpuscule;blood corpuscles red;red blood corpuscle;RBC - Red blood cell;blood cells rbc red;Red Cell;Red cells;Reticuloendothelial System, Erythrocytes;blood erythrocytes;erythrocytic|C0014792|||C0014792|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|||
RBC|Blood Cell Count, Red;Red Blood Cell Count;Red blood cell count;Red blood cell count NOS;blood cell count red;blood cell counts red;blood cells count red;cell red blood count;red blood cell count;red cell blood count|C0014772;C1287262|||C0014772|AOD;CHV;MSH;NCI;SNOMEDCT|1|0.0214|
RBC|Blood Cell, Red;Blood Cells, Red;Red Blood Cell;Red Blood Cells;Red blood cell;Red blood cells;bloods cells red;cells red blood;red blood cell;red blood cells|C0014772;C0014792;C0439179;C1277078|1|1|C0014772;C0014792|AOD;CHV;CSP;FMA;HL7V2.5;MSH;NCI;SNOMEDCT;UWDA|1|0.9306|1
RBC|Count, Erythrocyte;Counts, Erythrocyte;Erythrocyte Count;Erythrocyte Counts;erythrocyte count;Erythrocyte Number;Erythrocyte Numbers;RBC - Red blood cell count;RBC count;RBC count NOS;count rbc;count rbcs;counting rbc;counts rbc;rbc count;Red Blood Cell Count measurement;Red Cell Count|C0014772|||C0014772|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|1|0.0051|
RBC|Erythrocyte;Erythrocyte, NOS;Erythrocytes;erythrocyte;erythrocytes;RBC;rbcs|C0014772;C0014792|||C0014772;C0014792|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|||
RBC|Erythrocyte (cell)||||C0014792|SNOMEDCT|||
RBC|RBC count NOS (procedure)||||C0014772|SNOMEDCT|||
RBC|Ranitidine bismuth citrate|C0139919|||||1|0.0153|
RBC|Red blood cell (cell)||||C0014792|SNOMEDCT|||
RBC|Red blood cell count (procedure);Red blood cell count NOS (procedure)||||C0014772|SNOMEDCT|||
RBC|Rotating Biological Contactor||||||1|0.0058|
RBC|blood corpuscle|C0005773;C0014792|||C0014792|CHV|||
RBC|human erythrocytes||||||1|0.0127|
RBC|resin-based composite||||||1|0.0092|
RCA|Raji cell assay|C0201454|||||||1
RCA|Ricinus Communis Agglutinin I||||||1|0.0165|
RCA|Ricinus communis|C0007341|||||1|0.0189|
RCA|Ricinus communis agglutinin|C0140570|||||1|0.0979|
RCA|RubisCO activase||||||1|0.0106|
RCA|complement activation|C0009528;C2984768|||||1|0.0601|
RCA|radiographic contrast agent|C2917425|||||||1
RCA|radionuclide cerebral angiogram||||||||1
RCA|reactive cutaneous angioendotheliomatosis||||||||1
RCA|red cell adherence||||||||1
RCA|red cell agglutination||||||||1
RCA|red cell aggregation||||||1|0.0165|
RCA|red cell aplasia|C0281963|||||||1
RCA|relative chemotactic activity||||||||1
RCA|renal cell carcinoma|C0007134;C2984311|||C0007134;C2984311|CHV;CSP;DXP;MSH;MTH;NCI;NDFRT;PDQ;QMR;SNOMEDCT|||1
RCA|replication-competent adenovirus||||||1|0.0142|
RCA|retained cortical activity||||||||1
RCA|retrochiasmatic area|C0262326|||||1|0.0106|
RCA|right carotid artery||||||||1
RCA|right coronary||||||1|0.0165|
RCA|right coronary angiography||||||||1
RCA|right coronary artery|C1261316|1|1.000|C1261316|CHV;FMA;HCPCS;NCI;SNOMEDCT;UWDA|1|0.6969|1
RCA|rolling circle amplification||||||1|0.0318|1
RCA|root cause analysis|C3179036|||C3179036|MSH|1|0.0094|1
RCA|rotational coronary atherectomy|C3161299|||||||1
RDW|Erythrocyte Distribution Width Measurement;Erythrocyte distribution width;Erythrocytes Distribution Width;RDW;RDW - Red blood cell distribution width;RDW determination;Red cell distribution width determination;cell distribution red width;cells distribution red width;red cell distribution width;red cell width distribution|C0427460|||C0427460|CHV;LNC;MTH;NCI;SNOMEDCT|1|1|
RDW|Red blood cell distribution width||||C0427460|SNOMEDCT|||
RDW|Red blood cell distribution width (& level)||||C0427460|SNOMEDCT|||
RDW|Red blood cell distribution width (& level) (procedure)||||C0427460|SNOMEDCT|||
RDW|Red blood cell distribution width (observable entity)||||C0427460|SNOMEDCT|||
RDW|Red cell distribution width determination (procedure)||||C0427460|SNOMEDCT|||
RDW|red distribution width||1|1.000|||||1
ROS|2,4-Thiazolidinedione, 5-004-02-((((methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-||||C0289313|MSH;NDFRT|||
ROS|5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate||||C0289313|MSH;NDFRT|||
ROS|Active Oxygen;Active oxygen;Oxygen, Active;active oxygen;Oxygen Radical;Oxygen Radicals;oxygen radical;oxygen radicals;Oxygen Species, Reactive;Reactive Oxygen Species;oxygen reactive species;reactive oxygen species;Pro Oxidants;Pro-Oxidants;Pro-oxidant;pro oxidant;pro-oxidant|C0162772|||C0162772|AOD;CHV;CSP;LCH;MSH;MTH;NCI;NDFRT|1|0.9195|1
ROS|Avian UR2 Sarcoma Virus Oncogene Homolog 1;ONCOGENE ROS;Oncogene ROS;ROS1 Gene;ROS1 gene;c-ros oncogene 1, receptor tyrosine kinase;c-ros-1|C0812281|||C0812281|HUGO;MTH;NCI;OMIM|||
ROS|MCF3;V-ROS AVIAN UR2 SARCOMA VIRUS ONCOGENE HOMOLOG 1|C0812281;C1709820|||C0812281|HUGO;OMIM|||
ROS|ROS|C0162772;C0289313;C0489633;C0812281|||C0162772;C0289313;C0489633;C0812281|HUGO;NCI;OMIM;PDQ|||
ROS|ROS1|C0216760;C0812281|||C0812281|HUGO;NCI;OMIM|||
ROS|ROSIGLITAZONE;Rosiglitazone;rosiglitazone|C0289313|||C0289313|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
ROS|Rat osteosarcoma|C1882806|||||1|0.0032|
ROS|Reactive Oxygen Species [Chemical/Ingredient]||||C0162772|NDFRT|||
ROS|Review of Systems;Review of systems;review of systems;review system;review systems;system review;systems of review|C0488564;C0488565;C0489633|1|1|C0489633|CHV;LNC;NCI;SNOMEDCT|||1
ROS|Review of systems (procedure)|C0489633|||C0489633|MTH;SNOMEDCT|||
ROS|Rosiglitazone (product)||||C0289313|SNOMEDCT|||
ROS|Rosiglitazone (substance)||||C0289313|SNOMEDCT|||
ROS|V-ROS UR2 Sarcoma Virus Oncogene Homolog 1 (Avian) Gene||||C0812281|NCI|||
ROS|oscillatory resistance||||||1|0.001|
ROS|reactive oxygen||||||1|0.0039|
ROS|reactive oxygen substances||||||1|0.0008|
ROS|respiratory resistance||||||1|0.0012|
ROS|rod outer segment;rod outer segments|C0035798|||||1|0.0705|1
ROS|rosiglitazone [Chemical/Ingredient]||||C0289313|NDFRT|||
ROS|rosiglitazones||||C0289313|CHV|||
ROS|rostral sulcus||||||||1
RPR|EXTL3 wt Allele;KIAA0519;RPR|C1705631|||C0201405;C1705631|LNC;MTH;NCI|||
RPR|EXTR1|C1367595;C1705631|||C1705631|NCI|||
RPR|Exostoses (Multiple)-Like 3 wt Allele||||C1705631|NCI|||
RPR|REG|C1419333;C1705631|||C1705631|NCI|||
RPR|RPR test;Rapid Plasma Reagin;rapid plasma reagin;Rapid Plasma Reagin Measurement;Rapid plasma reagin test;rapid plasma reagin test;rapid plasma reagin (rpr) test|C0201405|1|1|C0201405|CHV;MTH;NCI;SNOMEDCT|1|1|1
RPR|Rapid plasma reagin test (procedure)||||C0201405|SNOMEDCT|||
RPR|Reiter protein reagin||||||||1
RPR|rotational panoramic radiography||||||||1
RR|R-R interval|C0488420;C2041217|||||1|0.0036|
RR|Relative risk of death||||||1|0.0009|
RR|Resonance Raman||||||1|0.0377|
RR|Respiratory rates;respiratory rate|C0231832;C0489258|1|1|C0231832;C0489258|CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.0023|1
RR|Riva-Rocci||||||||1
RR|Ross River||||||1|0.0047|
RR|Roundup Ready||||||1|0.0016|
RR|blood pressure|C0005823;C1271104;C1272641|||||1|0.0016|
RR|cycle length||||||1|0.0018|
RR|heart period||||||1|0.0014|
RR|intervals|C1272706|||||1|0.0025|
RR|patients with relapsing-remitting||||||1|0.005|
RR|radial rate||||||||1
RR|radiation reaction||||||||1
RR|radiation response||||||||1
RR|rapid radiometric||||||||1
RR|rate ratio||||||1|0.0542|1
RR|reactive|C0205332|||||1|0.0018|
RR|reading retarded||||||||1
RR|recovery room|C0034871|||C0034871|CHV;MSH;SNOMEDCT|1|0.0036|1
RR|recurrence|C0034897;C1458156;C2825055|||||1|0.0016|
RR|red reflex|C0278244|||||||1
RR|reference range|C0034926|||C0034926|CHV;HL7V2.5;MSH;NCI|||
RR|region|C0017446;C0205147|||||1|0.0016|
RR|regular rate||||||||1
RR|regular respiration||||||||1
RR|relapsing remitting||||||1|0.0057|
RR|relative recovery||||||1|0.0013|
RR|relative response||||||1|0.0038|1
RR|relative risk|C0242492|||C0242492|AOD;CHV;MSH;NCI|1|0.7104|1
RR|renin release||||||1|0.0031|1
RR|resistant relapse||||||||1
RR|respiration rate|C0231832|||C0231832|CHV;LNC;MSH|||
RR|respiratory reserve||||||||1
RR|response rate|C0237629|||C0237629|CHV;NCI|1|0.0298|1
RR|response regulator||||||1|0.0018|
RR|retinal reflex||||||||1
RR|reversal reaction||||||1|0.0027|
RR|reverse redistribution||||||1|0.0038|
RR|rheumatoid rosette||||||||1
RR|ribonucleotide reductase|C0035547|||C0035547|CHV;CSP;MSH;MTH;NCI;NDFRT|1|0.025|
RR|right rotation;rotation right||||||||1
RR|righting reflex|C0234156|||C0234156|AOD;GO;MSH;SNOMEDCT|1|0.0025|
RR|risk ratio|C0028873;C0242492|||C0028873;C0242492|CHV;MSH;NCI|1|0.0519|1
RR|road rash||||||||1
RR|roentgenographic pelvimetry||||||||1
RR|ruthenium red|C0035975|||C0035975|MSH;NDFRT|1|0.0323|1
RSV|Human Respiratory Syncytial Virus|C0035236;C0206545|||C0035236|NCI|||
RSV|RSV||||C0035236;C0086943|CHV;CSP;MEDLINEPLUS;NCI;SNOMEDCT|||
RSV|Respiratory Syncytial Virus;Respiratory Syncytial Viruses;Respiratory syncytial virus;Syncytial Virus, Respiratory;Syncytial Viruses, Respiratory;Virus, Respiratory Syncytial;Viruses, Respiratory Syncytial;respiratory syncytial virus;syncytial respiratory virus;respiratory syncytial virus (RSV);respiratory syncytial virus RSV;respiratory syncytial virus RS;respiratory syncytial virus RS virus|C0035236|1|1|C0035236|CHV;CSP;LNC;MSH;MTH;NCBI;NCI;SNOMEDCT|1|0.7779|1
RSV|Respiratory syncytial viral||||||1|0.0034|
RSV|Respiratory syncytial virus (organism)||||C0035236|SNOMEDCT|||
RSV|Rous Sarcoma Virus;Rous sarcoma virus;rous sarcoma virus;sarcoma virus, Rous;virus, Rous sarcoma;Rous sarcoma virus RSV|C0086943|||C0086943|AOD;CHV;CSP;MSH;MTH;NCBI;NCI;SNOMEDCT|1|0.2092|1
RSV|Rous sarcoma virus (organism)||||C0086943|SNOMEDCT|||
RSV|regurgitant stroke volume||||||1|0.003|1
RSV|respiratory syncytial||||||1|0.0034|
RSV|right subclavian vein|C0489887|||||||1
RSV|saphenous vein|C0036186;C0392907|||||1|0.003|
RT|(drug) RT||1|0.002|||||
RT|Cancer Radiotherapy;RT - Radiotherapy;Radiotherapeutics;Therapeutic radiology for cancer treatment;Therapeutic radiology procedure|C1522449|||C1522449|CCS;MTH;NCI;SNOMEDCT|||
RT|Irradiate;Irradiated;irradiated|C1517600;C1522449;C1548980|||C1522449|NCI|||
RT|Irradiation;irradiation|C1282930;C1522449|||C1522449|CHV;NCI;PDQ|1|0.0237|
RT|LGMD2K|C1418752;C1836373|||C1418752|HUGO|||
RT|POMT1;POMT1 gene;PROTEIN O-MANNOSYLTRANSFERASE 1;protein-O-mannosyltransferase 1|C1418752|||C1418752|HUGO;LNC;MTH;OMIM|||
RT|RADIATION THERAPY;Radiation Therapy;Radiation therapy;Radiation therapy, NOS;Therapy, Radiation;radiation therapies;radiation therapy;radiations therapy;therapy radiation;therapy, radiation|C0034619;C1522449|1|0.672|C0034619;C1522449|AOD;CHV;CSP;DXP;MEDLINEPLUS;MSH;NCI;PDQ;SNOMEDCT|1|0.1781|1
RT|RADIOTHER||||C0034619;C1522449|MSH|||
RT|RNA-directed DNA polymerase activity|C1152411|||C1152411|GO;MTH|||
RT|ROTATED ABDOMEN, DROSOPHILA, HOMOLOG OF||||C1418752|OMIM|||
RT|RT||||C0034619;C1152411;C1418752;C1522449;C2826321;C2953923|FMA;GO;MSH;NCI;OMIM|||
RT|Radiation;radiation|C0034519;C0560559;C0851346;C1522449;C1524020;C1524021|||C1522449|NCI|1|0.0168|
RT|Radiation oncology AND/OR radiotherapy||||C1522449|SNOMEDCT|||
RT|Radiation oncology AND/OR radiotherapy (procedure)||||C1522449|SNOMEDCT|||
RT|Radiation therapy (procedure)||||C1522449|SNOMEDCT|||
RT|Radiotherapies;Radiotherapy;Radiotherapy, NOS;radiotherapy|C0034619;C0243005;C1522449|||C0034619;C1522449|AOD;CCS;CHV;CSP;LCH;MEDLINEPLUS;MSH;NCI;PDQ;SNOMEDCT|1|0.3211|
RT|Radiotherapy (regime/therapy)||||C1522449|SNOMEDCT|||
RT|Refractory Thrombocytopenia|C2826321|||C2826321|MTH;NCI|||
RT|Reporter's Test||||||||1
RT|Rostrotemporal auditory area|C2953923|||C2953923|FMA;MTH|||
RT|Therapeutic radiology|C0243004;C0243005;C1522449|||C1522449|CCS|||
RT|nucleus rotundus||||||1|0.0022|
RT|rabbit trachea||||||||1
RT|radiation treatment||||||1|0.0016|
RT|radiologic technology|C0039431|||||||1
RT|radiotelemetry|C0260285|||||||1
RT|radiotherapeutic|C0034619|||C0034619|MTH|||
RT|radiotherapy alone||||||1|0.0058|
RT|radium therapy|C0454073|||||||1
RT|rainbow trout|C0036108|||||1|0.0026|
RT|random transfusion||||||||1
RT|raphe transection||||||||1
RT|rational therapy||||||||1
RT|reaction|C0443286;C1114821|||||1|0.002|
RT|reaction time|C0034746|||||1|0.2407|1
RT|reactive thrombocytosis|C0457506|||||1|0.0068|
RT|reading task||||||||1
RT|reading test||||||||1
RT|reading time||||||||1
RT|real-time|C1550177|||||1|0.0024|
RT|receptor transforming||||||||1
RT|reciprocal translocations||||||1|0.0022|
RT|reciprocating tachycardia|C0242514|||||1|0.0014|1
RT|recovery time||||||||1
RT|recreational therapy|C0034873|||||||1
RT|rectal temperature|C0489749|||||1|0.0148|1
RT|recurrent tonsillitis||||||1|0.0036|
RT|red tetrazolium||||||||1
RT|reduction time||||||||1
RT|related to||||||||1
RT|relaxation time||||||||1
RT|relaxation training|C0282333|||||1|0.0024|
RT|renal transplant;renal transplantation|C0022671|||||1|0.029|1
RT|repetition time|C2826099|||||||1
RT|reptilase time|C0677634|||||||1
RT|resistance training|C0814409;C0872279|||||1|0.007|1
RT|resistance transfer||||||||1
RT|respiratory technology||||||||1
RT|respiratory therapist|C1709924|1|0.004|||||
RT|respiratory therapy|C0035239|1|0.298|||||1
RT|respiratory tract|C0035237;C0282335;C1283798|||||1|0.0034|
RT|response times||||||1|0.0028|
RT|rest tremor|C0234379|||||||1
RT|resting tension||||||1|0.0046|
RT|reticular|C0439739|||||1|0.0018|
RT|reticular thalamic nucleus;thalamic reticular nucleus|C0228357;C1744590|||||1|0.0078|
RT|retransformation||||||||1
RT|retrograde tachycardia||1|0.014|||||
RT|reverse transcribed||||||1|0.0028|
RT|reverse transcriptase;reverse-transcriptase|C0035379|||||1|0.0106|1
RT|reverse transcription|C0035380|||||1|0.0501|
RT|ribothymidine|C0073347|||||||1
RT|right|C0205090|1|0.002|||||1
RT|right thigh|C0230425;C1279548|||||||1
RT|right triceps||||||||1
RT|room temperature|C2348236|||||1|0.0275|1
RT|running total||||||||1
RT|total pulmonary vascular resistance||||||1|0.0016|
RT|total vascular resistance||||||1|0.0014|
RT|transepithelial electrical resistance||||||1|0.0036|
RT|transepithelial resistance||||||1|0.0164|
RT|tumor|C0027651;C1578706|||||1|0.0018|
RV|Lung residual volume;lung residual volume;lungs residual volume;residual lung volume;residual volume lung;RV;rv;rvs;RV - Residual respiratory volume;Residual respiratory volume|C0035190|||C0035190|CHV;SNOMEDCT|||
RV|Rappaport-Vassiliadis||||||1|0.0085|
RV|Rauscher virus|C0034725|||||||1
RV|Renal venous;renal venous||||||1|0.0021|1
RV|Residual Volume;Residual Volumes;Residual volume;Volume, Residual;Volume.residual;Volumes, Residual;residual volume|C0035190;C0429713;C0802961|||C0035190;C0429713;C0802961|AOD;CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.1275|1
RV|Residual respiratory volume (observable entity)||||C0035190|SNOMEDCT|||
RV|Rhinovirus;rhinovirus|C0035473|||||1|0.0259|1
RV|Russell viper|C0206318|||||||1
RV|Venous resistance||||||1|0.0035|
RV|rabies virus|C0034497|||||1|0.0329|
RV|random variable||||||||1
RV|rat virus|C0023104|||||1|0.0092|1
RV|rectal vault||||||||1
RV|rectovaginal|C0450213;C0545864|||||||1
RV|reference value|C0034926|||||||1
RV|regurgitant volume|C0946338|||||||1
RV|reinforcement value||||||||1
RV|renal vein|C0035092;C1278961|||||1|0.0039|1
RV|reovirus|C0206596;C0999948;C1963012|||||||1
RV|reserve volume||||||||1
RV|respiratory volume|C0024129|||||||1
RV|retinal vasculitis|C0152026|||||1|0.0043|1
RV|retrovaginal||||||||1
RV|retroversion|C0333055|||||||1
RV|retrovesical||||||||1
RV|retroviral vector|C1514926|||||1|0.0043|
RV|return visit||||||||1
RV|rhabdovirus|C0035414;C1540830|||||||1
RV|rheumatoid vasculitis|C0240903|||||1|0.0074|1
RV|right ventricle|C0225883;C1269891|1|1.000|||1|0.1863|1
RV|right ventricular||||||1|0.5002|1
RV|right ventricular free wall||||||1|0.0021|
RV|rotavirus|C0035870;C0724688|||||1|0.0375|1
RV|rubella vaccine|C0035923|||||||1
RV|rubella virus|C0035924|||||1|0.0443|1
RVR|BD73;EAR-1r;Hs.37288;NR1D2;NR1D2 gene;NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2;nuclear receptor subfamily 1, group D, member 2;RVR|C1417822|||C1417822|HUGO;MTH;OMIM|||
RVR|HZF2|C1417822;C1421754|||C1417822|HUGO|||
RVR|REV-ERBA-ALPHA-RELATED RECEPTOR||||C1417822|OMIM|||
RVR|rapid ventricular response|C0748243|1|1.000|||||1
RVR|reduced vascular response||||||||1
RVR|reduced vestibular response||||||||1
RVR|relative vascular resistance||||||||1
RVR|renal vascular resistance||||||1|0.9306|1
RVR|renal vein renin||||||1|0.0174|1
RVR|renovascular resistance||||||||1
RVR|repetitive ventricular response||||||1|0.0304|1
RVR|resistance to venous return||||||1|0.0217|1
RVR|right ventricular rhythm||||||||1
RVSP|RVSP;RVSP (Right Ventricular Systolic Pressure)|C1979972|||C1979972|LNC;MTH|||
RVSP|right ventricular systolic pressure|C0456181|1|1.000|||1|1|1
SAB|Anesthesia, Spinal;Anesthesias, Spinal;Spinal Anesthesia;Spinal Anesthesias;Spinal anaesthesia;Spinal anesthesia;spinal anaesthesia;spinal anesthesia;Intradural block;Intrathecal block;Local anaesthetic intrathecal block;Local anesthetic intrathecal block;Spinal Block;Spinal block;spinal block;Spinal anaesthetic;Spinal anaesthetic NOS;Spinal anesthetic;Spinal anesthetic NOS;spinal anesthetic;Subarachnoid block;subarachnoid block|C0002928|||C0002928|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0946|1
SAB|Local anaesthetic intrathecal block (procedure);Local anesthetic intrathecal block (procedure)||||C0002928|SNOMEDCT|||
SAB|SAB;Sab|C0002928;C1420024|||C0002928;C1420024|HUGO;LNC;NCI;OMIM|||
SAB|SH3 DOMAIN-BINDING PROTEIN 5;SH3 binding protein;SH3BP5;SH3BP5 gene|C1420024|||C1420024|HUGO;MTH;OMIM|||
SAB|SH3-domain binding protein 5 (BTK-associated)||||C1420024|HUGO|||
SAB|Spinal anesthesia (procedure)||||C0002928|SNOMEDCT|||
SAB|Spinal anesthetic NOS (procedure)||||C0002928|SNOMEDCT|||
SAB|Staphylococcus aureus bacteremia|C1142423|||||1|0.2838|1
SAB|sequential androgen blockade||||||||1
SAB|serum albumin|C0036773;C0728877|||||||1
SAB|short-acting block||||||||1
SAB|side air bags||||||||1
SAB|significant asymptomatic bacteriuria||||||||1
SAB|sinuatrial block||||||||1
SAB|solid-adherent bacteria||||||1|0.0676|
SAB|spontaneous abortion|C0000786|1|1.000|C0000786|AOD;CCS;CHV;COSTAR;CSP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.4189|1
SAB|spontaneous alternation behavior||||||1|0.1351|
SAB|streptavidin-biotin||||||||1
SAB|subacromial bursa|C0224792;C1269087|||C0224792;C1269087|CHV;FMA;SNOMEDCT;UWDA|||
SAB|subarachnoid bleed||||||||1
SA|37LRP||||C1539696|HUGO|||
SA|67LR||||C1539696|OMIM|||
SA|ACSM3;ACSM3 gene;ACYL-CoA SYNTHETASE MEDIUM-CHAIN FAMILY MEMBER 3;acyl-CoA synthetase medium-chain family member 3;SAH|C1825840|||C1825840|HUGO;MTH;OMIM|||
SA|LAMBR|C1539696;C1705231|||C1539696|OMIM|||
SA|LAMININ RECEPTOR 1;LAMININ RECEPTOR, 67-KD;RIBOSOMAL PROTEIN SA;ribosomal protein SA|C1367780;C1539696|||C1539696|HUGO;OMIM|||
SA|LAMR1|C1367780;C1539696;C1705231|||C1539696|OMIM|||
SA|LRP|C2987171|||C1539696|HUGO|||
SA|NATO code for arsine||||||||1
SA|RPSA;RPSA Gene;RPSA gene;Ribosomal Protein SA Gene|C1539696|||C1539696|HUGO;MTH;NCI;OMIM|||
SA|SA|C0036243;C1539696;C1825840|||C0036243;C1539696;C1825840|HUGO;NCI;OMIM|||
SA|SA, RAT, HOMOLOG OF||||C1825840|OMIM|||
SA|SAU;SAUDI ARABIA;Saudi Arabia;arabia saudi;saudi arabia|C0036243|||C0036243|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
SA|Saudi Arabia (geographic location)||||C0036243|SNOMEDCT|||
SA|Schizophrenics Anonymous||||||||1
SA|Sexaholics Anonymous||||||||1
SA|Situation Awareness||||||1|0.0024|
SA|Skeletal age;skeletal age||||||1|0.0049|1
SA|Sleep apnoea;sleep apnea|C0037315|||||1|0.0225|1
SA|Sodium salicylate|C0037549|||||1|0.0103|
SA|South Africa|C0037712|||||1|0.0064|
SA|South African|C0238605|||||1|0.0078|
SA|South Australia|C0037715|||||1|0.0093|
SA|Spinal anesthesia;spinal anaesthesia;spinal anesthesia|C0002928|||||1|0.0166|1
SA|Spontaneous abortion|C0000786|||||1|0.0122|
SA|Staphylococcus aureus|C0038172;C1318973|||||1|0.0548|1
SA|Staphylococcus aureus Cowan I||||||1|0.0054|
SA|Status asthmaticus;status asthmaticus|C0038218|||||1|0.0064|1
SA|Stokes-Adams||||||||1
SA|according to art||||||||1
SA|antigens|C0003320|||||1|0.0049|
SA|cocaine self-administration||||||1|0.0049|
SA|heroin self-administration||||||1|0.0039|
SA|isolated rabbit sino-atrial||||||1|0.002|
SA|isolated rabbit sinoatrial||||||1|0.0039|
SA|p40||||C1539696|HUGO|||
SA|sacroanterior||||||||1
SA|salicylic acid|C0036079|||C0036079|AOD;CHV;LCH;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.2851|
SA|saline|C0036082|||||1|0.0073|1
SA|salt added||||||||1
SA|salvage angioplasty||||||||1
SA|sarcoidosis|C0036202;C2697310|||||1|0.0093|
SA|sarcoma|C1261473|||||||1
SA|satellite association||||||1|0.0034|
SA|saturation|C0522534|1|0.008|||||
SA|second antibody||||||||1
SA|secondary amenorrhea|C0232940|||||||1
SA|secondary anemia|C0340952|||||||1
SA|secondary arrest||||||||1
SA|self-agglutinating||||||||1
SA|self-analysis|C0683472|||||||1
SA|semen analysis|C0202533|||||||1
SA|sensitizing antibody||||||||1
SA|sensory awareness||||||||1
SA|separation anxiety|C0003477;C1527281;C1879354|||||1|0.0044|
SA|septal apical||||||||1
SA|septic arthritis|C0003874;C1692886|||||1|0.0078|
SA|serrated adenoma|C1266025|||||1|0.0044|
SA|serratus anterior||||||1|0.0059|1
SA|serum albumin|C0036773;C0728877|||||1|0.0328|1
SA|serum aldolase||||||||1
SA|serum aldosterone|C0428395|||||1|0.0039|
SA|severe asthma|C0581126|||||||1
SA|short acting||||||||1
SA|short-axis|C0522488|||||1|0.0059|
SA|sialic acid|C0037024;C0067762|||C0037024;C0067762|AOD;CHV;MSH;NCI;NDFRT;SNOMEDCT|1|0.0553|1
SA|sialoadenectomy|C0193311|||||||1
SA|siblings apart||||||||1
SA|sideroblastic anaemia|C0002896|||||1|0.0034|
SA|simian adenovirus|C0001491|||||||1
SA|simulated annealing||||||1|0.0244|
SA|sinuatrial||1|0.176|||||1
SA|sinus arrest|C0178428|1|0.004|||||1
SA|sinus arrhythmia|C0003813;C1959628|||||1|0.0034|1
SA|slide agglutination||||||1|0.0039|
SA|slightly active||||||||1
SA|slow acetylator|C1827377|||||||1
SA|slow acting/sustained action||1|0.746|||||
SA|slowly adapting||||||1|0.0372|
SA|social acquiescence||||||||1
SA|social age||||||||1
SA|sodium L-ascorbate||||||1|0.0068|
SA|sodium alginate|C0142791|||||1|0.0044|
SA|sodium arsenite|C0074719|||||1|0.0068|
SA|soluble in alkaline||||||||1
SA|spatial average||||||||1
SA|specific activity||||||1|0.0455|1
SA|spectral analysis||||||1|0.0073|
SA|spectrum analysis|C0037812|||||||1
SA|sperm abnormality||||||||1
SA|sperm agglutinin||||||||1
SA|spherical aberration||||||1|0.0039|
SA|sphinganine|C0074987|||||1|0.0112|
SA|spiking activity||||||||1
SA|splenic artery|C0037996;C1280127|||||1|0.0064|1
SA|spontaneous activity||||||1|0.0093|
SA|spontaneous alternation||||||1|0.0054|
SA|stable angina|C0340288;C0699826|||||1|0.0259|
SA|standard accuracy||||||||1
SA|state anxiety|C0700613;C1279420|||||1|0.0049|
SA|stearylamine|C0075209|||C0075209|MSH|1|0.0171|
SA|stimulus artifact||||||||1
SA|streptavidin|C0075278|||||1|0.0298|
SA|streptococcal antigen||||||1|0.0103|
SA|stretch-activated||||||1|0.0176|
SA|subarachnoid|C1515008|||||||1
SA|subcarinal angle||||||||1
SA|subclavian artery|C0038530;C1280737|||||1|0.0078|
SA|substance abuse|C0740858|||||1|0.0117|1
SA|succinic anhydride|C0075430|||||1|0.0049|
SA|succinylacetone|C0075455|||||1|0.0196|
SA|suicide alert||||||||1
SA|suicide attempt|C0038663;C1547270|||||||1
SA|sulcus angle||||||1|0.0044|
SA|sulfanilamide|C0038702;C1161332|||||1|0.0044|
SA|sulfonamide|C0038760|||||1|0.0098|
SA|surface antigen|C0003339|||||||1
SA|surface area||||||1|0.0333|1
SA|surgery alone||||||1|0.0049|
SA|sustained action||||||||1
SA|sympathetic activity||||||||1
SA|sympathoadrenal||||||1|0.0103|
SA|systemic artery|C0933549|||||||1
SA|systemic aspergillosis|C0343856|||||||1
SBE|BACT ENDOCARDITIDES SUBACUTE;BACT ENDOCARDITIS SUBACUTE;ENDOCARDITIDES SUBACUTE BACT;ENDOCARDITIS SUBACUTE BACT;SUBACUTE BACT ENDOCARDITIDES;SUBACUTE BACT ENDOCARDITIS||||C0014122|MSH|||
SBE|BACTERIAL ENDOCARDITIS (SUBACUTE);Bacterial Endocarditides, Subacute;Bacterial Endocarditis, Subacute;ENDOCARDITIS, BACTERIAL, SUBACUTE;Endocarditides, Subacute Bacterial;Endocarditis, Subacute Bacterial;Subacute Bacterial Endocarditides;Subacute Bacterial Endocarditis;Subacute bacterial endocarditis;Subacute endocarditis, bacterial;bacterial endocarditis subacute;subacute bacterial endocarditis;Endocarditis Lenta;Endocarditis lenta;Endocarditis, lenta;endocarditis lenta;SBE;sbe;SBE - Subacute bacterial endocarditis;Subacute endocarditis, lenta;endocarditis infectious;infectious endocarditis|C0014122|1|1|C0014122|CHV;COSTAR;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.4048|1
SBE|Endocarditis, Subacute Bacterial [Disease/Finding]||||C0014122|NDFRT|||
SBE|SMAD-binding element||||||1|0.1905|
SBE|Subacute bacterial endocarditis (disorder)||||C0014122|SNOMEDCT|||
SBE|ie|C0014122;C0022067;C1881173|||C0014122|CHV|||
SBE|saturated base excess||||||||1
SBE|self-breast examination|C0085105|||||||1
SBE|short below-elbow||||||||1
SBE|short-segment Barrett esophagus||||||||1
SBE|shortness of breath on exertion||||C0231807|CHV|||1
SBE|single base extension||||||1|0.2857|
SBE|small-bowel enteroscopy||||||||1
SBE|sporadic bovine encephalitis;sporadic bovine encephalomyelitis|C0276112|||C0276112|SNOMEDCT|||
SBE|starch branching enzyme|C0000052;C1152072|||||1|0.119|
SBP|ABP|C1412100|||C1705296|NCI|||
SBP|SBP;sbp|C1306620;C1705296|||C1306620;C1705296|CHV;NCI|||
SBP|SHBG||||C1705296|NCI|||
SBP|SHBG wt Allele;Sex Hormone-Binding Globulin wt Allele|C1705296|||C1705296|MTH;NCI|||
SBP|Systolic blood pressure measurement|C1306620|||C1306620|MTH|||
SBP|blood pressure systolic;systolic blood pressure|C0488055;C0871470;C1306620|1|0.166|C0488055;C0871470;C1306620|CHV;LNC;NCI;SNOMEDCT|1|0.6653|1
SBP|school breakfast program||||||||1
SBP|scleral buckling procedure|C0036411|||||||1
SBP|selenium-binding protein|C1527491|||||||1
SBP|serotonin binding proteins;serotonin-binding protein|C0074385|||||1|0.0014|1
SBP|sex steroid-binding protein|C0036883|||||1|0.0237|
SBP|small-bowel phytobezoar||||||||1
SBP|solitary bone plasmacytoma||||||||1
SBP|soybean peroxidase||||||1|0.0028|
SBP|spontaneous bacterial peritonitis|C0275551|1|0.834|C0275551|ICD9CM;SNOMEDCT|1|0.0515|1
SBP|spontaneous biliary perforation||||||||1
SBP|steroid-binding plasma protein||||||||1
SBP|sulfobromophthalein|C0038753|||C0038753|CHV;CSP;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|||1
SBP|systemic blood pressure|C1272641|||C1272641|CHV;SNOMEDCT|||1
SBP|systolic|C0039155|||||1|0.1471|
SBP|systolic BP|C0871470|||||1|0.1083|
SIADH|ADH INAPPROPRIATE;INAPPROPRIATE ADH;Inappropriate ADH;inappropriate adh;ADH INAPPROPRIATE SECRETION;adh inappropriate secretion;inappropriate ADH secretion;inappropriate adh secretion;ADH Syndrome, Inappropriate;Inappropriate ADH Syndrome;SYNDROME INAPPROPRIATE ADH;Syndrome, Inappropriate ADH;adh inappropriate syndrome;adh inappropriate syndromes;ANTIDIURETIC HORMONE INAPPROPRIATE SECRETION SYNDROME <SIADH>;ANTIDIURETIC HORMONE INAPPROPRIATE SECRETION SYNDROME SIADH;SIADH - Syndrome of inappropriate secretion of antidiuretic hormone;Antidiuretic Hormone, Inappropriate Secretion;INAPPROPRIATE SECRETION OF ANTIDIURETIC HORMONE;Inappropriate Antidiuretic Hormone Secretion Syndrome;Syndrome of Inappropriate Antidiuretic Hormone Secretion;Syndrome of inappropriate secretion of antidiuretic hormone;syndrome of inappropriate antidiuretic hormone secretion;syndrome of inappropriate secretion of antidiuretic hormone;Inappropriate Vasopressin Secretion Syndrome;Syndrome of inappropriate vasopressin secretion;SCHWARTZ-BARTTER SYNDROME;Schwartz Bartter Syndrome;Schwartz-Bartter Syndrome;Schwartz-Bartter syndrome;Syndrome, Schwartz-Bartter;SIAD - Syndrome of inappropriate antidiuresis;SIADH;siadh;siadhs;SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE;syndrome of inappropriate antidiuretic hormone;Syndrome of inappropriate ADH production;Syndrome of inappropriate antidiuresis;Syndrome of inappropriate antidiuretic hormone (SIADH);Syndrome of inappropriate secretion of ADH;syndrome of inappropriate secretion of ADH|C0021141|||C0021141|AOD;CHV;COSTAR;CST;DXP;MSH;MTHICD9;NCI;NDFRT;OMIM;QMR;RAM;SNOMEDCT|1|1|1
SIADH|ANTIDIURETIC HORMONE INAPPROPRIATE SECRET||||C0021141|MSH|||
SIADH|INAPPROPRIATE VASOPRESSIN SECRET SYNDROME||||C0021141|MSH|||
SIADH|Inappropriate ADH Syndrome [Disease/Finding]||||C0021141|NDFRT|||
SIADH|SYNDROME INAPPROPRIATE ADH SIADH SECRET||||C0021141|MSH|||
SIADH|Schwarz-Bartter syndrome||||C0021141|SNOMEDCT|||
SIADH|Syndrome of Inappropriate ADH (SIADH) Secretion||||C0021141|MSH;NDFRT|||
SIADH|Syndrome of inappropriate secretion of antidiuretic hormone (disorder)||||C0021141|SNOMEDCT|||
SIADH|Syndrome of inappropriate vasopressin secretion (disorder)||||C0021141|SNOMEDCT|||
SIADH|syndrome of inappropriate diuretic hormone secretion||1|1.000|||||
SI|(drug) SI||1|0.002|||||
SI|95 kDa Melanocyte-Specific Secreted Glycoprotein;ME20 antigen, human;ME20 protein, human;ME20-M;ME20-M/ME20-S;ME20M;Melanocyte Protein MEL17;Melanocyte Protein PMEL17;Melanocyte protein mel 17, human;PMEL17 protein, human;Pmel 17 protein, human;SILV protein, human;Silver Homolog|C0257766|||C0257766|MSH;MTH;NCI|||
SI|D12S53E|C1420066;C1705301|||C1420066;C1705301|HUGO;NCI|||
SI|GP100;gp100||||C0257766;C1420066;C1705301|HUGO;NCI;OMIM|||
SI|International System of Units;international system of units;Modern Metric System;Systeme International d'Unites|C0021791|||C0021791|CHV;MSH;MTH;NCI|||1
SI|ME20;PMEL17;Pmel17|C0257766;C1420066;C1705301|||C0257766;C1420066;C1705301|HUGO;NCI;OMIM|||
SI|ME20M/ME20S||||C0257766|NCI|||
SI|MELANOCYTE PROTEIN 17;PMEL;PMEL gene;PREMELANOSOMAL PROTEIN;SILV Gene;premelanosome protein|C1420066|||C1420066|HUGO;MTH;NCI;OMIM|||
SI|Melanocyte Lineage-Specific Antigen gp100;Melanocyte Protein Pmel 17;Silver Locus Protein Homolog|C0257766;C1608320|||C0257766|NCI|||
SI|Melanoma-Associated ME20 Antigen||||C0257766|NCI|||
SI|Oligosaccharide alpha-1,6-glucosidase||||C1420044|HUGO|||
SI|SI;Si||||C0021791;C0037107;C0037334;C0257766;C1420044;C1420066;C1705301|HUGO;LNC;NCI;OMIM|||
SI|SI Unit;SI Units;Unit, SI;Units, SI;si unit;si units;units si|C0021791;C1705302|||C0021791|CHV;MSH|||
SI|SI gene|C1420044|||C1420044|HUGO;MTH|||
SI|SIL||||C0257766;C1705301|NCI|||
SI|SILICON;Silicon;Silicon, NOS;silicon;Si - Silicon;Si element|C0037107|||C0037107|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT|1|0.0392|1
SI|SILV|C0257766;C1420066|||C0257766;C1420066|NCI;OMIM|||
SI|SILV wt Allele|C1705301|||C1705301|MTH;NCI|||
SI|SILVER, MOUSE, HOMOLOG OF||||C1420066|OMIM|||
SI|SLOVENIA;Slovenia;slovenia;SVN|C0037334|||C0037334|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|||
SI|SUCRASE-ISOMALTASE;sucrase-isomaltase|C0028941;C1420044|||C0028941;C1420044|CHV;OMIM;SNOMEDCT|1|0.049|1
SI|Salience Inventory||||||||1
SI|Serum iron;serum iron|C1318312|||C1318312|CHV|1|0.0187|1
SI|Silicon (substance)||||C0037107|SNOMEDCT|||
SI|Silicon [Chemical/Ingredient]||||C0037107|NDFRT|||
SI|Silver Homolog (Mouse) Gene||||C1420066|NCI|||
SI|Silver Homolog (Mouse) wt Allele||||C1705301|NCI|||
SI|Silver Like||||C0257766|NCI|||
SI|Simulated ischemia||||||1|0.0089|
SI|Singh Index||||||||1
SI|Slovenia (geographic location)||||C0037334|SNOMEDCT|||
SI|Sputum induction||||||1|0.0047|
SI|Structured Interview;structured interview|C0681913|||C0681913|AOD|1|0.0221|
SI|Systematic Inquiry||||||||1
SI|first|C0205435;C1279901|||||1|0.006|
SI|first somatic sensory area||||||1|0.0047|
SI|first somatosensory area||||||1|0.0034|
SI|infection|C0021311|||||1|0.0043|
SI|injury|C0175677|||||1|0.0038|
SI|insulin sensitivity|C0920563|||C0920563|CHV;CSP;MSH|1|0.0826|
SI|interval|C1272706;C1552654;C1552713|||||1|0.0038|
SI|most anterior point on lower contour of sella turcica||||||||1
SI|primary|C0205225;C0439631|||||1|0.02|
SI|primary somatosensory||||||1|0.0379|
SI|primary somatosensory area||||||1|0.0038|
SI|primary somatosensory cortex||||||1|0.1069|
SI|sacroiliac|C0555898|1|0.980|C0555898|CHV;HL7V2.5;LNC;SNOMEDCT|1|0.0387|1
SI|sacroiliitis|C0574960|||C0574960|AIR;AOD;CHV;COSTAR;MSH;NDFRT;OMIM;SNOMEDCT|1|0.006|
SI|sagittal index||||||||1
SI|saline infusion||||||||1
SI|saline injection||||||||1
SI|saturation index||||||||1
SI|sector iridotomy||||||||1
SI|self-incompatibility|C1654759|||||1|0.0353|
SI|self-incompatible||||||1|0.0055|
SI|self-inflicted||||||||1
SI|sensitive index||||||||1
SI|sensory integration|C0679019;C0695560|||C0679019;C0695560|AOD;CHV;MTH|1|0.0034|1
SI|sequential injection||||||1|0.0038|
SI|serious illness||||||||1
SI|serum insulin|C0428357;C1261415|||||||1
SI|service index||||||||1
SI|severity index||||||||1
SI|sex inventory||||||||1
SI|sexual intercourse|C0009253|||||||1
SI|short interfering||||||1|0.0043|
SI|signal intensity|C0871362|||C0871362|CHV|1|0.1294|1
SI|silent ischemia||||||1|0.0038|
SI|silent myocardial ischemia|C0340291|||C0340291|SNOMEDCT|1|0.0043|
SI|silica|C0037098|||C0037098|CHV;LCH;LNC;MSH;NCI;NDFRT;SNOMEDCT|1|0.0077|
SI|silicone|C0037114|||C0037114|CHV;LNC;MSH;NCI;NDFRT;SNOMEDCT;VANDF|||
SI|silver homolog (mouse) protein, human||||C0257766|MSH|||
SI|single injection||||||||1
SI|sinus|C0016169;C0030471;C1305231|||||||1
SI|sinus irregularity||||||||1
SI|situs inversus|C0037221|||C0037221|CHV;COSTAR;ICD9CM;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0047|
SI|small interfering||||||1|0.0051|
SI|small intestinal|C0021852|||C0021852|SNOMEDCT|1|0.0081|
SI|small intestine|C0021852;C1268998|||C0021852;C0341268;C1268998|AOD;CHV;CSP;CST;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.0226|1
SI|small-intestine channel||||||||1
SI|smoke inhalation|C0037367|||C0037367|CHV;COSTAR;CSP;SNOMEDCT|||
SI|social interaction|C0037420|||C0037420|AOD;CHV;MSH;MTH;SNOMEDCT|1|0.0149|
SI|social introversion||||||||1
SI|social isolation|C0037421|||||1|0.003|
SI|soluble insulin|C0021641|||||||1
SI|somatosensory area I||||||1|0.0021|
SI|special intervention||||||1|0.0132|1
SI|specific insulin||||||1|0.0026|
SI|spectroscopic imaging||||||1|0.017|
SI|spinal cord isolation||||||1|0.0047|
SI|splenic irradiation||||||1|0.0064|
SI|stimulation index;stimulation indices||||||1|0.1123|1
SI|stoichiometry of inhibition||||||1|0.0034|
SI|stress incontinence|C0042025;C2712321|||C0042025;C2712321|CHV;COSTAR;MEDLINEPLUS;SNOMEDCT|1|0.006|1
SI|strict isolation||||||||1
SI|stroke index|C0456712|||C0456712|SNOMEDCT|||1
SI|structure of intellect||||||||1
SI|substantia innominata|C0038589|||C0038589|AOD;CSP;FMA;MSH;MTH|1|0.0247|
SI|sucrase-isomaltase (alpha-glucosidase)||||C1420044|HUGO|||
SI|suicidal ideation|C0424000|1|0.016|||1|0.0047|1
SI|sulfated insulin||||||||1
SI|superior-inferior||||||||1
SI|suppression index||||||||1
SI|syncytia-inducing;syncytium-inducing||||||1|0.0826|1
SI|syncytium-inhibiting||||||||1
SI|systolic index||||||||1
SLE|DISSEMINATED LUPUS ERYTHEMATOSUS;Disseminated lupus erythematosus;LUPUS ERYTHEMATOSUS, DISSEMINATED;disseminated lupus erythematosus;LE SYNDROME;le syndrome;les syndrome;LUPUS ERYTHEMATOSIS (NOS);lupus erythematosis;LUPUS SYNDROME;SYNDROME LUPUS;lupus syndrome;lupus syndromes;syndrome lupus;Lupus Erythematosus Disseminatus;lupus erythematosus disseminatus;SLE;SYSTEMIC LUPUS ERYTHEMATOSIS;erythematosis lupus systemic;systemic lupus erythematosis;sles|C0024141|||C0014060;C0024141;C0037063|AOD;CHV;COSTAR;CSP;CST;DXP;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0071|
SLE|ENCEPH SAINT LOUIS;SAINT LOUIS ENCEPH||||C0014060|MSH|||
SLE|ENCEPH ST LOUIS;ST LOUIS ENCEPH||||C0014060|MSH|||
SLE|ENCEPH VIRAL ST LOUIS;ST LOUIS VIRAL ENCEPH||||C0014060|MSH|||
SLE|ENCEPHALITIS C;ENCEPHALITIS, SAINT LOUIS;Encephalitis, Saint Louis;Saint Louis Encephalitis;Saint Louis encephalitis;saint louis encephalitis;Encephalitis, St. Louis;St Louis encephalitis;St. Louis Encephalitis;St. Louis encephalitis;st louis encephalitis;st. louis encephalitis;Lethargic Encephalitis, Type C;Type C Lethargic Encephalitis;Type C lethargic encephalitis;Neuroinvasive Saint Louis encephalitis virus infection;SLE - Saint Louis encephalitis;St-Louis viral disease;St. Louis viral disease|C0014060|||C0014060|CHV;CSP;DXP;ICD9CM;LCH;MSH;MTH;NDFRT;SNOMEDCT|||1
SLE|Encephalitis, St. Louis [Disease/Finding]||||C0014060|NDFRT|||
SLE|Encephalitis, Viral, St. Louis;St. Louis Viral Encephalitis||||C0014060|MSH;NDFRT|||
SLE|LETHARGIC ENCEPH TYPE C;TYPE C LETHARGIC ENCEPH||||C0014060|MSH|||
SLE|LUPUS ERYTHEMATOSIS DISSEMINATED||||C0024141|CST|||
SLE|LUPUS ERYTHEMATOSUS SYSTEMIC;LUPUS ERYTHEMATOSUS, SYSTEMIC;LUPUS, ERYTHEMATOSUS, SYSTEMIC;Lupus Erythematosus, Systemic;Lupus erythematosus, Systemic;SYSTEMIC LUPUS ERYTHEMATOSUS;Systemic Lupus Erythematosus;Systemic lupus erythematosus;Systemic lupus erythematosus NOS;erythematosu lupus systemic;systemic lupus erythematosus;SLE - Lupus Erythematosus, Systemic;SLE - Systemic lupus erythematosus;systemic lupus erythematosus (SLE)|C0024141;C2984317|1|1|C0024141;C2984317|AIR;AOD;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.9618|1
SLE|Louis encephalitis||||||1|0.0165|
SLE|Louis encephalitis virus||||||1|0.0017|
SLE|Lupus;lupus|C0024131;C0024138;C0024141;C0409974|||C0024141|CHV;CSP;MEDLINEPLUS|||
SLE|Lupus Erythematosus, Systemic [Disease/Finding]||||C0024141|NDFRT|||
SLE|Neuroinvasive Saint Louis encephalitis virus infection (disorder)||||C0014060|SNOMEDCT|||
SLE|Neuroinvasive St. Louis encephalitis virus infection||||C0014060|SNOMEDCT|||
SLE|Neuroinvasive St. Louis encephalitis virus infection (disorder)||||C0014060|SNOMEDCT|||
SLE|Republic of Sierra Leone;SIERRA LEONE;Sierra Leone;leone sierra;sierra leone|C0037063|||C0037063|AOD;CHV;DXP;LCH;MSH;MTH;NCI;SNOMEDCT|||
SLE|SL||||C0037063|NCI|||
SLE|SYNDROME DISSEMINATED LUPUS ERYTHEMATOSIS||||C0024141|CST|||
SLE|Sierra Leone (geographic location)||||C0037063|SNOMEDCT|||
SLE|Slit lamp examination;slit-lamp examination|C0419360|||||1|0.0017|1
SLE|St. Louis encephalitis (disorder)||||C0014060|SNOMEDCT|||
SLE|St. Louis encephalitis virus infection||||C0014060|SNOMEDCT|||
SLE|St. Louis encephalitis virus infection (disorder)||||C0014060|SNOMEDCT|||
SLE|St. Louis encephalitis virus neuroinvasive disease||||C0014060|SNOMEDCT|||
SLE|Syst lupus erythematosus||||C0024141|ICD9CM|||
SLE|Systemic lupus erythematosus (disorder);Systemic lupus erythematosus NOS (disorder)||||C0024141|SNOMEDCT|||
SLE|stressful life events||||||1|0.0008|
SLE|systemic LE||||||1|0.0023|
SLE|systemic lupus||||||1|0.0014|
SLE|systemic lupus erythematodes||||||1|0.0029|
SLE|systemic lupus erythematous||||||1|0.0029|
SLE|systemic lupus erythmatosus||||||1|0.0009|
SL|ADMIN SUBLINGUAL;SUBLINGUAL ADMIN||||C0001565|MSH|||
SL|Administration, Sublingual;Administrations, Sublingual;Sublingual Administration;Sublingual Administrations;sublingual administration;Administration, Sublingual Drug;Administrations, Sublingual Drug;Drug Administration, Sublingual;Drug Administrations, Sublingual;Sublingual Drug Administration;Sublingual Drug Administrations;Sublingual Route of Administration;Sublingual Route of Drug Administration;Sublingual use;SublingualRoute|C0001565|||C0001565|AOD;HL7V3.0;MSH;MTH;NCI;SNOMEDCT|||
SL|Borrelia burgdorferi sensu lato||||||1|0.0263|
SL|DRUG ADMIN SUBLINGUAL;SUBLINGUAL DRUG ADMIN||||C0001565|MSH|||
SL|Republic of Sierra Leone;SIERRA LEONE;Sierra Leone;leone sierra;sierra leone|C0037063|||C0037063|AOD;CHV;DXP;LCH;MSH;MTH;NCI;SNOMEDCT|||
SL|SL||||C0001565;C0037063;C1704626|NCI|||
SL|SLE|C0024141|||C0037063|NCI|||
SL|SUBLINGUAL;Sublingual;sublingual|C0001565;C0558302|1|1|C0001565;C0558302|CHV;HL7V2.5;NCI;SNOMEDCT|1|0.0409|1
SL|Schwalbe line|C0929602|||||||1
SL|Sentinel lymphadenectomy;sentinel lymphadenectomy||||||1|0.0073|1
SL|Short latency||||||1|0.0117|
SL|Sibley-Lehninger||||||||1
SL|Sierra Leone (geographic location)||||C0037063|SNOMEDCT|||
SL|Sleep Polysomnography Data;Sleep Polysomnography Domain|C1704626|||C1704626|MTH;NCI|||
SL|Smyth line||||||1|0.0234|
SL|Spin lock;spin-lock||||||1|0.0088|1
SL|Steel|C0038239|||||||1
SL|Sublingual route|C0001565;C0521136|||C0001565|SNOMEDCT|||
SL|Sublingual route (qualifier value)||||C0001565|SNOMEDCT|||
SL|Sublingually;sublingually||||C0001565|SNOMEDCT|||1
SL|Suspensory Ligament||||||1|0.0161|
SL|cardiac sarcolemma||||||1|0.019|
SL|cardiac sarcolemmal||||||1|0.0277|
SL|db sensation level||||||1|0.0131|
SL|layer|C0934502;C1522408;C1561599|||||1|0.0204|
SL|lymphocytes|C0024264;C0200635|||||1|0.0161|
SL|saline lock|C0179694|||C0179694|CHV|||1
SL|salt loser||||||||1
SL|sarcolemma|C0036208|||C0036208|AOD;CSP;FMA;GO;LCH;MSH;MTH;NCI;SNOMEDCT;UWDA|||1
SL|sarcomere length||||||1|0.1153|
SL|satellite-like||||||||1
SL|scapholunate||||||1|0.0292|1
SL|sclerosing leukoencephalopathy||||||||1
SL|sea level||||||1|0.2|
SL|secondary leukemia|C0856053|||C0856053|CHV|||1
SL|segment length||||||||1
SL|sensation level||||||||1
SL|sensory latency||||||||1
SL|septal leaflet||||||||1
SL|serious list||||||||1
SL|serotonin level||||||||1
SL|serum lipid|C0428462|||||||1
SL|sesquiterpene lactone|C2985517|||C2985517|NCI|1|0.0292|
SL|sham laparotomy||||||1|0.0088|
SL|short leg|C0426901|||C0426901|CHV;SNOMEDCT|||1
SL|sidelying|C0444379|||||||1
SL|signal level||||||||1
SL|sleep latency||||||1|0.0161|
SL|sleeve lobectomy|C2986519|||C2986519|NCI|||
SL|slice|C1519355|||||||1
SL|slight|C2937276;C2945599|||||||1
SL|slit lamp;slit-lamp|C0183355;C0419360|||C0183355;C0419360|CHV;NCI;SNOMEDCT|||1
SL|slow|C0439834|||||||1
SL|slyke||||||||1
SL|small leukocyte||||||||1
SL|small lymphocyte|C0229616|||||||1
SL|small lymphocytic lymphoma|C0023434;C0855095|||C0023434;C0855095|CHV;MSH;MTH;NCI;PDQ|||
SL|smear layer|C0085070|||C0085070|CHV;MSH;NDFRT|||
SL|soda lime|C0074716|||||||1
SL|sodium lactate|C0142874;C1176295|||C0142874;C1176295|CHV;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0088|1
SL|soleus|C0242694;C1305356|||C0242694;C1305356|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0146|
SL|solidified liquid||||||||1
SL|sonoluminescence||||||1|0.019|
SL|sound level|C0428754|||C0428754|CHV;SNOMEDCT|||1
SL|soybean lecithin|C1617265|||C1617265|NCI;RXNORM|||
SL|sphingolipid|C0037900|||C0037900|CHV;CSP;NCI;SNOMEDCT|||
SL|spinal length||||||||1
SL|spiral ligament|C0229477|||C0229477|MSH|1|0.019|
SL|spironolactone|C0037982|||C0037982|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.0234|
SL|spleen|C0037993;C1278932|||C0037993;C1278932|AOD;CHV;CSP;FMA;HL7V2.5;LCH;LNC;MSH;MTH;NCI;OMIM;SNOMEDCT;UWDA|||
SL|spliced leader|C0600446|||C0600446|MSH|1|0.1533|
SL|spotting lethal||||||1|0.0131|
SL|staging laparoscopy|C0460043|||C0460043|SNOMEDCT|||1
SL|staging laparotomy|C0843591|||C0843591|CHV|||
SL|standard laparoscopy||||||||1
SL|stem-loop||||||1|0.0234|
SL|step length|C0427126|||C0427126|SNOMEDCT|||
SL|stereolithographic||||||1|0.0131|
SL|stereolithography||||||||1
SL|sterically stabilized liposomes||||||1|0.0088|
SL|stratum lucidum|C0221922|||C0221922|AOD;NCI;SNOMEDCT|||
SL|streptolysin|C0038419|||C0038419|CHV;CSP;LCH;LNC;MSH;NDFRT|||
SL|stride length||||||1|0.035|
SL|stromelysin|C0164371|||C0164371;C1150206|CHV;CSP;GO;MSH;NDFRT|||
SL|structured lipids||||||1|0.0146|
SL|supraglottic laryngectomy|C0189240|||C0189240|CHV;NCI;SNOMEDCT|||
SL|surface Laplacian||||||1|0.0131|
SL|surrogate light||||||1|0.0117|
SL|surrogate light chain|C0253781|||C0253781|MSH;NDFRT|||
SMA|Atrophy, Spinal Muscular;MUSCULAR ATROPHY, SPINAL;Muscular Atrophy, Spinal;Spinal Muscular Atrophy;Spinal muscular atrophy;Spinal muscular atrophy NOS;Spinal muscular atrophy, NOS;atrophies muscular spinal;atrophy muscular spinal;atrophy spinal muscular;muscular atrophy spinal;muscular spinal atrophy;spinal muscular atrophy;SMA - Spinal muscular atrophy;atrophy muscular sma spinal;SPINAL MUSCLE ATROPHY;muscle spinal atrophy;spinal muscle atrophy;Spinal muscular atrophy, unspecified;Unspecified spinal muscular atrophy;spinal amyotrophy|C0026847|1|0.112|C0026847|CHV;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.2825|1
SMA|Muscular Atrophy, Spinal [Disease/Finding]||||C0026847|NDFRT|||
SMA|SMA;Sma|C0026847;C1367790|||C0026847;C1367790|MEDLINEPLUS;NCI|||
SMA|SNRPF;Sm-F;Small Nuclear Ribonucleoprotein Polypeptide F|C1367790;C1420293|||C1367790|MSH;MTH;NCI|||
SMA|Sm Protein F;snRNP-F|C1367790|||C1367790|NCI|||
SMA|SmF||||C1367790|NCI|||
SMA|Small Nuclear Ribonucleoprotein Associated Protein F;Small Nuclear Ribonucleoprotein-Associated Protein F||||C1367790|MSH|||
SMA|Smooth muscle alpha-actin||||||1|0.0085|
SMA|Snow Mountain agent||||||1|0.008|
SMA|Spinal muscl atrophy NOS||||C0026847|ICD9CM|||
SMA|Spinal muscular atrophy (disorder);Spinal muscular atrophy NOS (disorder)||||C0026847|SNOMEDCT|||
SMA|Unspecified spinal muscular atrophy (disorder)||||C0026847|SNOMEDCT|||
SMA|muscle actin||||||1|0.0873|
SMA|schedule of maximal allowance||||||||1
SMA|sequential multiple autoanalysis||||||||1
SMA|sequential multiple autoanalyzer||1|0.168|||||1
SMA|serum muramidase activity||||||||1
SMA|shape memory alloy;shape-memory alloy||||||1|0.0038|1
SMA|simultaneous multiple autoanalysis||||||||1
SMA|simultaneous multiple autoanalyzer||||||||1
SMA|small mesenteric arteries||||||1|0.0042|
SMA|small muscle atrophy||||||||1
SMA|smallpox vaccine, not otherwise specified|C0037355|||||||1
SMA|smooth muscle|C1267092|||||1|0.009|
SMA|smooth muscle actin|C1825843|1|0.004|C1825843|OMIM|||1
SMA|smooth muscle antibodies;smooth muscle antibody|C0369998|1|0.006|C0369998|CHV;LNC;MTH;SNOMEDCT|1|0.0382|1
SMA|smooth muscle autoantibody||||||||1
SMA|sorbitol MacConkey agar||||||1|0.0033|
SMA|specific methanogenic activity||||||1|0.0061|
SMA|spiral modiolar artery|C0226244;C1278423|||C0226244;C1278423|FMA;SNOMEDCT;UWDA|||
SMA|spontaneous mechanical activities||||||1|0.0024|
SMA|spontaneous motor activity||||||1|0.0274|1
SMA|standard method agar||||||||1
SMA|styrene Maleic anhydride||||||1|0.0104|
SMA|superior mesenteric|C1979979|||||1|0.0099|
SMA|superior mesenteric arterial||||||1|0.0047|
SMA|superior mesenteric artery|C0162861|1|0.706|C0162861|CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.2665|1
SMA|supplemental motor area||||||||1
SMA|supplementary motor||||||1|0.0042|
SMA|supplementary motor area||||||1|0.2193|
SMA|supplementary motor cortex||||||1|0.0042|
SPEP|Serum protein electrophoresis;electrophoresis protein serum;electrophoresis proteins serum;serum electrophoresis protein;serum protein electrophoresis;spep|C0201720|1|1|C0201720|CHV;SNOMEDCT|||1
SPEP|Serum protein electrophoresis (procedure)||||C0201720|SNOMEDCT|||
SR|BCSG1;SNCG Gene;SNCG gene|C1335851|||C1335851|HUGO;MTH;NCI;OMIM|||
SR|BREAST CANCER-SPECIFIC GENE 1|C1335851;C1709991|||C1335851|OMIM|||
SR|Dutch Guiana;Netherlands Guiana;SURINAME;Suriname;suriname;Surinam|C0038944|||C0038944|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|||
SR|NS||||C0038944|NCI|||
SR|PERSYN;persyn;SNCG;SYNUCLEIN, GAMMA;synoretin|C0753208;C1335851|||C1335851|HUGO;NCI;OMIM|||
SR|Racer|C0327335|||||1|0.0031|
SR|SCTR wt Allele;Secretin Receptor wt Allele|C1705646|||C1705646|MTH;NCI|||
SR|SR;Sr||||C0038467;C0038944;C1335851;C1705646;C1705825;C1710261|HUGO;NCI|||
SR|STRONTIUM;Strontium;Strontium, NOS;strontium;Sr - Strontium;Strontium preparation|C0038467|||C0038467|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT|1|0.0171|1
SR|SUR|C0038880;C0038944;C1412082|||C0038944|NCI|||
SR|Saccharopolyspora rectivirgula|C0317734|||||1|0.0021|
SR|Senior;senior;Senior - Suffix|C1705825|||C1705825|MTH;NCI|||1
SR|Spontaneous Regression;spontaneous regression|C1710162|||C1710162|NCI|1|0.0019|
SR|Stereotactic radiosurgery;stereotactic radiosurgery|C0085203|||C0085203|CHV;ICD9CM;MSH;MTHHH;NCI;PDQ;SNOMEDCT|1|0.0031|
SR|Stochastic resonance||||||1|0.0099|
SR|Strontium (substance)||||C0038467|SNOMEDCT|||
SR|Strontium [Chemical/Ingredient]||||C0038467|NDFRT|||
SR|Strontium preparation (product)||||C0038467|SNOMEDCT|||
SR|Suriname (geographic location)||||C0038944|SNOMEDCT|||
SR|Sustained Release;sustained release;sustained-release;Sustained Release Dosage Form;Sustained Release Dose Form|C1710261|1|1|C1710261|MTH;NCI|1|0.0505|1
SR|Sweat rate;Sweating rate||||||1|0.0105|
SR|Synuclein, Gamma (Breast Cancer-Specific Protein 1) Gene||||C1335851|NCI|||
SR|Systematic review|C1955832|||||1|0.0027|
SR|region|C0017446;C0205147|||||1|0.0029|
SR|resection|C0015252;C0728940|||||1|0.0021|
SR|salt resistant||||||1|0.0023|
SR|sarcoplasmic reticular||||||1|0.0097|
SR|sarcoplasmic reticulum|C0036226|||C0036226|CHV;CSP;FMA;GO;LCH;MSH;NCI;SNOMEDCT;UWDA|1|0.6843|1
SR|sarcoplasmic reticulum membranes||||||1|0.0012|
SR|sarcoplasmic reticulum vesicles||||||1|0.0019|
SR|saturation recovery||||||1|0.0029|1
SR|scanning radiometer||||||||1
SR|scavenger receptor;scavenger receptors|C0074129|||C0074129|CHV;CSP;MSH;MTH;NDFRT|1|0.0101|
SR|schizophrenic reaction|C0151898|||||||1
SR|screen|C0220908;C0430054;C1305399;C1705053|||||||1
SR|secretin receptor|C0074254;C1335806|||C0074254;C1335806|HUGO;MSH;MTH;NCI;OMIM|||
SR|secretion rate||||||||1
SR|sedimentation rate|C0200704;C1176468|||C0200704;C1176468|CHV;NCI;SNOMEDCT|||1
SR|see report||||||||1
SR|seizure resistant;seizure-resistant||||||1|0.0066|1
SR|self-recording||||||||1
SR|self-reinforced||||||1|0.0025|
SR|sensitivity response||||||||1
SR|sensitization response||||||||1
SR|sensory rhodopsin||||||1|0.0017|
SR|sentence repetition||||||||1
SR|sepiapterin reductase|C0074350;C1420371|||C0074350;C1420371|MSH;MTH;OMIM;SNOMEDCT|1|0.0027|
SR|serine-arginine||||||1|0.0054|
SR|serine/arginine-rich||||||1|0.0076|
SR|seroreversion||||||||1
SR|service record||||||||1
SR|sex ratio|C0036893|||C0036893|CHV;LCH;MSH|1|0.0025|1
SR|shift reagent||||||1|0.0014|
SR|short hair|C2750590|||||||1
SR|side rails||||||||1
SR|sigma reaction||||||||1
SR|silicone rubber|C0037110|||C0037110|CHV;CSP;LCH;MSH;NDFRT|1|0.0041|1
SR|sinus rhythm|C0232201|||C0232201|CHV;MTH;SNOMEDCT|1|0.0532|1
SR|skin resistance|C0871375|||C0871375|CHV|1|0.0017|1
SR|sleep and rest||||||||1
SR|slew rate||||||||1
SR|slow release;slow-release||||||1|0.0206|1
SR|smooth-rough||||||||1
SR|social recreation||||||||1
SR|soluble repository||||||||1
SR|somatostatin receptor|C0074830|||C0074830|CHV;MSH;MTH;NCI;NDFRT|||
SR|spatial resolution||||||||1
SR|specific release||||||||1
SR|specific resistance||||||||1
SR|specific response||||||||1
SR|speech reception||||||||1
SR|spontaneous rate||||||1|0.0074|
SR|spontaneous remission|C0035053|||||1|0.0012|1
SR|spontaneous respiration|C0412771|||||1|0.0014|
SR|stabilizing reversal||||||||1
SR|stage of resistance||||||||1
SR|standard risk||||||1|0.0066|
SR|stapedial reflex;stapedius reflex|C0034934|||C0034934|CHV|1|0.0033|
SR|steradian|C1705832|||||||1
SR|steroid receptor|C0034840|||C0034840|CHV;MSH;NDFRT;SNOMEDCT|||
SR|steroid resistance||||||||1
SR|steroid-resistant||||||1|0.006|
SR|stimulation ratio||||||||1
SR|stimulus response|C0542478|||||||1
SR|storage phosphor radiography||||||1|0.001|
SR|strain rate||||||1|0.0068|
SR|stratum radiatum||||||1|0.0058|
SR|stress related||||||||1
SR|stress relaxation||||||||1
SR|stretch receptor|C0034841|||C0034841|CSP;MSH;SNOMEDCT|||
SR|stretch reflex|C0034942|||||1|0.0014|1
SR|structured reporting||||||||1
SR|sulfonamide-resistant||||||||1
SR|superior rectus|C0224128;C0582818|||C0224128;C0582818|CHV;FMA;SNOMEDCT;UWDA|1|0.0039|1
SR|survival rate|C0038954|||C0038954|CHV;MSH;NCI|||
SR|sustained responders||||||1|0.0031|
SR|sustained response||||||1|0.0089|1
SR|suture removal|C0184936|||||||1
SR|synaptic ribbon;synaptic ribbons|C1179874|||C1179874|FMA;GO;UWDA|1|0.0039|
SR|synchronization ratio||||||||1
SR|synchrotron radiation|C0599746|||C0599746|CSP|1|0.0066|
SR|synuclein, gamma (breast cancer-specific protein 1)||||C1335851|HUGO|||
SR|systemic reaction|C1710276|||C1710276|NCI|1|0.0043|1
SR|systemic resistance||||||||1
SR|systems research||||||||1
SR|systems review||||||||1
SS|5' splice site|C0887917|||||1|0.0032|
SS|AFND|C0085077;C1863616|||C0085077|OMIM|||
SS|Acute Febrile Neutrophilic Dermatosis;Acute febrile neutrophilic dermatosis;Dermatosis, Neutrophilic, Febrile, Acute;NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE;Neutrophilic Dermatosis, Acute Febrile;Febrile neutrophilic dermatosis;febrile neutrophilic dermatosis;SWEET SYNDROME;SWEET'S SYNDROME;Sweet Syndrome;Sweet's Syndrome;Sweet's syndrome;Sweets Syndrome;Syndrome, Sweet;Syndrome, Sweet's;sweet syndrome;sweet's syndrome;sweets syndrome;Sweet's disease;sweet's disease|C0085077|||C0085077|CHV;COSTAR;DXP;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||
SS|Acute febrile neutrophilic dermatosis (disorder)||||C0085077|SNOMEDCT|||
SS|BLOOD GROUP--Ss LOCUS;CD235b;GYPB;GYPB gene|C1415374|||C1415374|HUGO;MTH;OMIM|||
SS|Dahl salt-sensitive||||||1|0.0088|
SS|GCFX;PHOG;SHORT STATURE HOMEOBOX;short stature homeobox;SHOX;SHOX Gene;SHOX gene;SHOXY;Short Stature Homeobox Gene|C1420041|||C1420041|HUGO;LNC;MTH;NCI;OMIM|||
SS|GLYCOPHORIN B|C0017957;C1415374|||C1415374|OMIM|||
SS|GOMM-BUTTON DISEASE|C0085077;C2931897|||C0085077|OMIM|||
SS|GPB|C1415192;C1415374|||C1415374|HUGO;OMIM|||
SS|Malignant synovioma;Synovioma, malignant;SARCOMA, SYNOVIAL;Sarcoma, Synovial;Sarcomas, Synovial;Synovial Sarcoma;Synovial Sarcomas;Synovial sarcoma;Synovial sarcoma, NOS;sarcoma synovial;synovial sarcoma;Synovioma;Synovioma, NOS;Synoviomas;synovioma|C0039101|||C0039101|CHV;LCH;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0277|1
SS|PSEUDOAUTOSOMAL HOMEOBOX-CONTAINING OSTEOGENIC GENE||||C1420041|OMIM|||
SS|SHORT STATURE HOMEOBOX, Y-LINKED||||C1420041|OMIM|||
SS|SICCA;SICCA SYNDROME;SYNDROME SICCA;Sicca Syndrome;Sicca syndrome;Syndrome, Sicca;sicca syndrome;xerodermosteosis|C0086981|||C0086981|CHV;CSP;CST;DXP;ICD9CM;MSH;MTH;NCI;OMIM;SNOMEDCT|||
SS|SS;Ss;ss||||C0039101;C0085077;C0086981;C1415374;C1420041;C1552161|CHV;DXP;HL7V3.0;HUGO;NCI;OMIM|||
SS|Salmonella-Shigella||||||1|0.004|1
SS|Sarcoma, Synovial [Disease/Finding]||||C0039101|NDFRT|||
SS|Schizophrenia Subscale||||||||1
SS|Seizure-sensitive;seizure sensitive||||||1|0.0128|1
SS|Septic shock;septic shock|C0036983|||C0036983|CHV;COSTAR;CSP;DXP;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0072|1
SS|Sicca syndrome (disorder)||||C0086981|SNOMEDCT|||
SS|Social Security|C0037435|||||||1
SS|Supernumerary mandibular right first primary molar|C1552161|||C1552161|MTH|||
SS|Sweet Syndrome [Disease/Finding]||||C0085077|NDFRT|||
SS|Synovial sarcoma (disorder)||||C0039101|SNOMEDCT|||
SS|Synovial sarcoma (morphologic abnormality)||||C0039101|SNOMEDCT|||
SS|Systolic shortening||||||1|0.004|
SS|[M]Synovial sarcoma NOS||||C0039101|SNOMEDCT|||
SS|[M]Synovioma NOS||||C0039101|SNOMEDCT|||
SS|glands from patients with Sjogren's syndrome||||||1|0.002|
SS|glycophorin B (MNS blood group)||||C1415374|HUGO|||
SS|half|C2825407|||||||1
SS|homozygous|C0019904|||||1|0.0072|
SS|homozygous sickle cell||||||1|0.0494|
SS|sacral sulcus|C1562319|||||||1
SS|sacrosciatic||||||||1
SS|sagittal sinus|C0447120|||C0447120|CHV;NCI;SNOMEDCT|||
SS|saikosaponin|C0073959|||C0073959|MSH|||
SS|salbutamol sulfate|C0543495|||C0543495|CHV;PDQ;SNOMEDCT|1|0.0024|
SS|saline;saline solution|C0036082|||C0036082|CHV;MSH;MTH;MTHFDA;RXNORM|1|0.0112|1
SS|saline soak||||||||1
SS|saliva sample||||||||1
SS|saliva substitute|C0036088|||||||1
SS|salt sensitive||||||1|0.0056|
SS|salt sensitivity||||||||1
SS|salt substitute|C0784217|||||||1
SS|saturated solution||||||||1
SS|schizophrenia spectrum||||||||1
SS|scleral spur|C0229116;C1281274|||||||1
SS|scleroderma systematica||||||1|0.0052|
SS|segmental shortening||||||1|0.0032|
SS|self-stimulation|C0036602|||||1|0.0309|
SS|sensation seeking|C0871336|||C0871336|CHV|||
SS|sensitivity|C0036667;C0312418;C0427965;C1511883;C1522640;C2346484;C2349185|||||1|0.004|
SS|sensu stricto||||||1|0.0068|
SS|sepsis syndrome|C0242966|||C0242966|CHV;MSH;NDFRT;SNOMEDCT|||
SS|serotonin syndrome|C0024586;C0699828|||C0024586;C0699828|CHV;MSH;MTH;NDFRT;SNOMEDCT|||1
SS|serum|C0229671;C1546774;C1550100|||||1|0.0036|
SS|serum sickness|C0036830;C1963234|||||||1
SS|serum soluble||||||||1
SS|severity score|C0457451|||C0457451|CHV;SNOMEDCT|||
SS|sewage sludge||||||1|0.0032|
SS|shear stress|C1171318|||C1171318|CHV;CSP|1|0.012|
SS|short stature|C0013336;C0349588|||C0013336;C0349588;C2919142|CHV;CST;ICD9CM;MTH;NCI;OMIM;SNOMEDCT|1|0.0048|1
SS|short stay|C1698490|||||||1
SS|siblings|C0037047|||||||1
SS|sickle cell|C0221283|||C0221283|CHV;NCI;SNOMEDCT|||1
SS|sickle cell anaemia;sickle cell anemia|C0002895;C2700574|||C0002895;C2700574|AOD;CCS;CHV;COSTAR;CSP;DXP;LNC;MEDLINEPLUS;MSH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.0474|
SS|sickle cell disease|C0002895|||||1|0.0072|
SS|sickle cell genotype SS||1|0.008|||||
SS|side-to-side|C0516750|||||||1
SS|sidestream smoke||||||1|0.0064|
SS|sigmoid sinus|C0226865;C1281038|||C0226865;C1281038|CHV;FMA;SNOMEDCT;UWDA|||
SS|signs and symptoms|C0037088|||||||1
SS|simple spike||||||1|0.008|
SS|single session||||||||1
SS|single stranded;single-strand;single-stranded|C1979975|||||1|0.2124|1
SS|single strength||1|0.878|||||1
SS|skull series||||||||1
SS|slice select||||||||1
SS|sliding scale|C2937251|||||||1
SS|slip sent||||||||1
SS|slow sleep;slow wave sleep;slow-wave sleep;synchronized sleep|C0234451|||C0234451|AOD;CHV;CSP;SNOMEDCT|1|0.0052|1
SS|small|C0700321|||||1|0.004|
SS|small subunit||||||1|0.006|
SS|smoking status|C1519386|||||||1
SS|soapsuds||||||||1
SS|social services|C0037440;C0037441|||||||1
SS|social support|C0037438;C0748877;C1540833|||C0037438;C0748877;C1540833|AOD;CHV;MSH;MTH;NCI;SNOMEDCT|1|0.0048|
SS|sodium saccharin|C0917900|||C0917900|CHV|||
SS|sodium salicylate|C0037549|||C0037549|AOD;CHV;LNC;MSH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.0108|
SS|sodium selenite|C0142923|||C0142923|CHV;MSH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;VANDF|1|0.0076|
SS|somatostatin|C0037659;C1881011|||C0037659;C0373723;C1335871;C1881011;C2697526|AOD;CHV;CSP;FMA;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;RXNORM;SNOMEDCT|1|0.23|
SS|sorbitan sesquioleate|C0074916|||||||1
SS|sparingly soluble||||||||1
SS|special service||||||||1
SS|spermatocytic seminoma|C0334517|||C0334517|NCI;SNOMEDCT|1|0.0036|
SS|sport sheath||||||||1
SS|squalene synthase|C0597790;C1414563|||C0597790;C1414563|HUGO;MSH;NDFRT;OMIM|1|0.0044|
SS|stable sarcoidosis||||||||1
SS|staccato syndrome||||||||1
SS|stainless steel|C0038126|||C0038126|CHV;MSH;NDFRT;SNOMEDCT|1|0.0349|1
SS|standard score|C0871421|||||||1
SS|starch synthase|C0038180|||||1|0.0044|
SS|statistically significant|C0237881|||||||1
SS|steady state;steady-state|C0678587|||C0678587|AOD;CHV|1|0.0261|1
SS|stenosis|C0009814;C0678234;C0947637;C1261287;C2632116|||||1|0.0044|
SS|sterile solution||||||||1
SS|steroid sensitivity||||||||1
SS|steroid sulfurylation||||||||1
SS|steroid-sensitive||||||1|0.0064|
SS|straight sinus|C0226862;C1281036|||C0226862;C1281036|FMA;SNOMEDCT;UWDA|1|0.0032|
SS|stress-susceptible||||||1|0.0036|
SS|stromal sarcoma|C0206630;C1370723|||||||1
SS|subaortic stenosis|C0340375|||||||1
SS|subjects||||||1|0.0422|1
SS|subsarcolemmal||||||1|0.0096|
SS|subscapularis|C0224233;C0584884|||||||1
SS|subsegmental||||||||1
SS|subsequent sibling||||||||1
SS|subspinale||||||||1
SS|substernal||||||||1
SS|sucrose synthase|C0075485|||C0075485|MSH;MTH;SNOMEDCT|1|0.0072|
SS|suction socket||||||||1
SS|sulindac sulfide|C0075615|||C0075615|MSH;NCI|||
SS|sum squares||||||||1
SS|supersaturated||||||||1
SS|supersaturation||||||1|0.004|
SS|support and stimulation||||||||1
SS|supraspinatus|C0224229;C0584869|||C0224229;C0584869|CHV;FMA;NCI;SNOMEDCT;UWDA|1|0.0044|
SS|susceptible|C0231204;C2827758|||||||1
SS|suspended solids||||||1|0.0225|
SS|suture system||||||||1
SS|symmetrical strength||||||||1
SS|sympathetic stimulation||||||1|0.004|
SS|syringosubarachnoid shunting||||||||1
SS|system|C0449913;C1553451;C1704459|||||1|0.0076|
SS|systemic scleroderma;systemic sclerosis|C0036421|||C0036421|CHV;CSP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.0357|1
SS|systolic segment shortening||||||1|0.002|
SSRI|SSRI;SSRIs;Selective Serotonin Reuptake Inhibitor;Selective Serotonin Reuptake Inhibitors;Selective serotonin reuptake inhibitors;selective serotonin reuptake inhibitor;Selective Serotonin Reuptake Inhibitor (SSRI);Selective Serotonin Reuptake Inhibitors (SSRIs)|C0360105;C2911696|1|1|C0360105;C2911696|MEDLINEPLUS;MSH;NCI;NDFRT;USPMG|1|1|1
SSRI|SSRI - Selective serotonin re-uptake inhibitor;Selective serotonin re-uptake inhibitor|C0360105|||C0360105|MTH;SNOMEDCT|||
SSRI|Selective serotonin re-uptake inhibitor (product)||||C0360105|SNOMEDCT|||
SSRI|Selective serotonin re-uptake inhibitor (substance)||||C0360105|SNOMEDCT|||
SSRI|Serotonin Reuptake Inhibitor;Serotonin Reuptake Inhibitor (SSRI)|C0162758;C2911696|||C2911696|NDFRT|||
SSRI|Serotonin Reuptake Inhibitor [EPC]|C2911696|||C2911696|MTH;NDFRT|||
STD|DEHYDROEPIANDROSTERONE SULFOTRANSFERASE;DHEA SULFOTRANSFERASE|C0057278;C1420519|||C1420519|OMIM|||
STD|DHEA-ST;DHEAST;SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1;SULFOTRANSFERASE, DEHYDROEPIANDROSTERONE-PREFERRING;SULT2A1;SULT2A1 gene|C1420519|||C1420519|HUGO;MTH;OMIM|||
STD|DISEASE (VD), VENEREAL;VD - Venereal disease;VD, VENEREAL DISEASE;VENEREAL DISEASE (VD);Disease with a predominantly sexual mode of transmission;Disease, Sexually Transmitted;Diseases, Sexually Transmitted;SEXUALLY TRANSMITTED DISEASE NOS;Sexually Transmitted Disease;Sexually Transmitted Diseases;Sexually transmitted disease;Sexually transmitted disease, NOS;Sexually transmitted diseases;disease sexually transmit;disease sexually transmitted;diseases sexually transmitted;sexually transmitted disease;sexually transmitted diseases;Disease, Venereal;Diseases, Venereal;VENEREAL DISEASE;Venereal Disease;Venereal Diseases;Venereal disease;Venereal disease NOS;Venereal disease, NOS;Venereal diseases;disease venereal;diseases venereal;venereal disease;venereal diseases;STD;STDs;STD - Sexually transmitted disease;sexually transmitted disease (STD);sexually transmitted diseases (STDs);Sexually Transmitted Disorder;Sexually Transmitted Infection;Sexually transmitted infections;Sexually transmissible disease;Statutory venereal disease;Venereal disease, unspecified|C0036916|1|1|C0036916;C1420519;C1421567;C1705831;C1867549|AOD;CHV;COSTAR;CSP;DXP;HUGO;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9483|1
STD|PROTEIN TYROSINE KINASE ZAP70;ZETA-CHAIN-ASSOCIATED PROTEIN KINASE|C1421567;C1527940|||C1421567|OMIM|||
STD|SELECTIVE T-CELL DEFECT;selective T-cell defect;SELECTIVE T-CELL DEFECT GENE|C1867549|||C1867549|MTH;OMIM|||1
STD|SEX TRANSM DIS||||C0036916|MSH|||
STD|SRK||||C1421567;C1705831|NCI;OMIM|||
STD|ST-segment depression|C0520887|||||1|0.01|1
STD|SYK-RELATED TYROSINE KINASE|C0246976;C1421567;C1527940|||C1421567|OMIM|||
STD|Saturation transfer difference||||||1|0.0111|
STD|Sexually Transmitted Diseases [Disease/Finding]||||C0036916|NDFRT|||
STD|Sexually transmitted infectious disease;Sexually transmitted infectious disease, NOS||||C0036916|SNOMEDCT|||
STD|Sexually transmitted infectious disease (disorder)||||C0036916|SNOMEDCT|||
STD|VD;vds|C0036916;C0042682|||C0036916|CHV;NCI|||
STD|VENEREAL DIS||||C0036916|MSH|||
STD|Venereal disease (disorder);Venereal disease NOS (disorder)||||C0036916|SNOMEDCT|||
STD|ZAP-70;ZAP70|C1421567;C1527940;C1705831|||C1421567;C1705831|HUGO;LNC;NCI;OMIM|||
STD|ZAP-70 Gene;ZAP70 wt Allele|C1705831|||C1705831|MTH;NCI|||
STD|ZAP70 Gene;ZAP70 gene|C1421567;C1705831|||C1421567|HUGO;MTH;NCI|||
STD|ZETA-ASSOCIATED PROTEIN, 70-KD||||C1421567|OMIM|||
STD|Zeta-Chain (TCR) Associated Protein Kinase 70kDa Gene||||C1421567|NCI|||
STD|Zeta-Chain (TCR) Associated Protein Kinase 70kDa wt Allele||||C1705831|NCI|||
STD|[X]Infections with a predominantly sexual mode of transmission||||C0036916|SNOMEDCT|||
STD|[X]Infections with a predominantly sexual mode of transmission (disorder)||||C0036916|SNOMEDCT|||
STD|[X]Unspecified sexually transmitted disease||||C0036916|SNOMEDCT|||
STD|[X]Unspecified sexually transmitted disease (disorder)||||C0036916|SNOMEDCT|||
STD|disease sexualli transmit||||C0036916|CHV|||
STD|disease sexually transmited;diseases sexually transmited||||C0036916|CHV|||
STD|saturated|C0522534;C1705188|||||||1
STD|seminiferous tubular diameter||||||1|0.0037|
STD|short-term depression||||||1|0.0074|
STD|short-term disability||||||||1
STD|skin test done||||||||1
STD|skin test dose||||||||1
STD|skin-to-tumor distance||||||||1
STD|sodium tetradecyl sulfate|C0037556|||||||1
STD|source-to-tray distance||||||||1
STD|standard|C1442989;C1548173;C2828392|||||1|0.0195|1
STD|standard density||||||||1
STD|standard test dose||||||||1
STD|standardized||||||||1
STD|sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1||||C1420519|HUGO|||
STD|zeta-chain (TCR) associated protein kinase 70kDa||||C1421567|HUGO|||
STT|ST-T wave||1|1.000|||||
STT|Schirmer tear test|C0200152;C0493032|||||1|0.0929|
STT|scaphoid, trapezium, trapezoid||||||||1
STT|scaphotrapeziotrapezoid||||||||1
STT|scaphotrapezoid-trapezial||||||||1
STT|sensitization test||||||||1
STT|serial thrombin time||||||||1
STT|short-term tests||||||1|0.0328|
STT|skin temperature test||||||||1
STT|soft tissue tumor;soft tissue tumors|C0037579|||||1|0.082|1
STT|spinothalamic||||||1|0.1038|
STT|spinothalamic tract|C0037953;C1283383|||||1|0.6885|1
STT|standard triple therapy||||||||1
STT|subtotal thyroidectomy|C0193790|||||||1
STT|superficial tibiotalar||||||||1
SVC|SVC;svc;SVC - Slow vital capacity;slow vital capacity (SVC);Slow vital capacity;slow vital capacity|C0231957|1|0.016|C0231957|CHV;SNOMEDCT|1|0.0364|1
SVC|Slow vital capacity (observable entity)||||C0231957|SNOMEDCT|||
SVC|saphenous vein cutdown||||||||1
SVC|segmental venous capacitance||||||||1
SVC|selective vascular clamping||||||||1
SVC|selective venous catheterization||||||||1
SVC|spring viremia of carp|C0276361|||C0276361|SNOMEDCT|||
SVC|subclavian vein catheter||||||||1
SVC|subclavian vein catheterization|C1319106|||C1319106|CHV|||1
SVC|subclavian vein compression||||||||1
SVC|superior|C1282910|||||1|0.0192|
SVC|superior vena cava|C0042459;C1269023|1|0.982|C0042459;C1269023|CHV;FMA;MSH;NCI;SNOMEDCT;UWDA|1|0.8927|1
SVC|superior vena caval|C0521359|||||1|0.0517|
SVC|suprahepatic vena cava||||||||1
SVC|supraventricular crest|C0225884;C1305151|||||||1
SVG|SVG;Scalable Vector Graphics|C2827658|||C2827658|NCI|||
SVG|saphenous vein graft|C0729538|1|1.000|||1|0.9167|1
SVG|sauvagine|C0074087|||||1|0.0833|
SVG|scatter and veiling glare||||||||1
SVG|seminal vesiculography|C0203133|||||||1
SVT|STYCAR Vision Test|C0430941|||||||1
SVT|SUPRAVENTRICULAR TACHYCARDIA;Supraventricular Tachycardia;Supraventricular Tachycardias;Supraventricular tachycardia;Supraventricular tachycardia NOS;Supraventricular tachycardia, NOS;TACHYCARDIA SUPRAVENTRICULAR;TACHYCARDIA, SUPRAVENTRICULAR;Tachycardia, Supraventricular;Tachycardias, Supraventricular;supraventricular tachycardia;supraventricular tachycardias;tachycardia supraventricular|C0039240;C1963244|||C0039240|CHV;COSTAR;CST;DXP;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.8574|
SVT|SVT;SVT - Supraventricular tachycardia|C0039240|||C0039240|DXP;SNOMEDCT|||
SVT|Supraventricular tachycardia (disorder);Supraventricular tachycardia NOS (disorder)||||C0039240|SNOMEDCT|||
SVT|Tachycardia, Supraventricular [Disease/Finding]||||C0039240|NDFRT|||
SVT|sinoventricular tachyarrhythmia||||||||1
SVT|sinus venous thrombosis|C0740384|||||1|0.0106|
SVT|sinus-vein thrombosis||||||||1
SVT|subclavian vein thrombosis|C0749087|||C0749087|CHV|||1
SVT|superficial vein thrombosis;superficial venous thrombosis|C0235511|||||1|0.0404|1
SVT|supraventricular||||||1|0.0191|
SVT|supraventricular tachyarrhythmia;supraventricular tachyarrhythmias||1|1|||1|0.0723|1
SVT|sustained ventricular tachycardia|C0750197|||C0750197|CHV;NCI;SNOMEDCT|||1
SVT|symptom validity test|C0589097|||||||1
T&A|tonsillectomy and adenoidectomy|C0193959|1|1.000|C0193959|SNOMEDCT|1|1|1
T&A|tonsils and adenoids||||C0580788;C1284098;C2362558|MEDLINEPLUS;SNOMEDCT|||1
T1|1 month|C1442451|||||1|0.017|
T1|1/R1||||C2697938|NCI|||
T1|AAC1|C1335833;C1417602|||C1335833|OMIM|||
T1|ADENINE NUCLEOTIDE TRANSLOCATOR 1;Adenine Nucleotide Translocator-1|C0600149;C1335833;C1442881|||C1335833;C1442881|NCI;OMIM|||
T1|ADP-ATP Translocase-1;ADP/ATP TRANSLOCASE 1;Heart-Skeletal Muscle ADP-ATP Carrier Protein-T1;Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-4;SLC25A4 protein, human;Skeletal Muscle Adenine Nucleotide Translocator-1|C1442881|||C1335833;C1442881|MTH;NCI;OMIM|||
T1|ADP/ATP CARRIER 1;SLC25A4;SLC25A4 Gene;SLC25A4 gene|C1335833|||C1335833|HUGO;LNC;MTH;NCI;OMIM|||
T1|ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE||||C1335833|OMIM|||
T1|ANT|C0003455|||C1335833;C1442881;C1705600|NCI;OMIM|||
T1|ANT1|C1826706|||C1335833;C1442881;C1705600|NCI;OMIM|||
T1|CD5||||C1413227|HUGO;NCI;OMIM|||
T1|CD5 Gene;CD5 gene;CD5 Molecule Gene|C1413227|||C1413227|HUGO;MTH;NCI|||
T1|CD5 Molecule wt Allele;CD5 wt Allele|C2347263|||C2347263|MTH;NCI|||
T1|CD5 molecule;LYMPHOCYTE ANTIGEN CD5|C0054964;C1413227|||C1413227|HUGO;OMIM|||
T1|DER4;FIT-1;IL1RL1;IL1RL1 gene;IL33R;INTERLEUKIN 1 RECEPTOR-LIKE 1;interleukin 1 receptor-like 1;INTERLEUKIN 33 RECEPTOR;ST2V|C1416400|||C1416400|HUGO;MTH;OMIM|||
T1|GROWTH STIMULATION-EXPRESSED GENE, MOUSE, HOMOLOG OF||||C1416400|OMIM|||
T1|IKBKBBP;KIAA1882;NIBP;TRAPP 120 kDa subunit;TRAPPC9;TRAPPC9 gene;TRS120;tularik gene 1|C2677743|||C2677743|HUGO;MTH;OMIM|||
T1|LEU1||||C1413227;C2347263|NCI;OMIM|||
T1|Longitudinal Relaxation Time;longitudinal relaxation time;Spin-Lattice Relaxation Time;spin-lattice relaxation time|C2697938|||C2697938|MTH;NCI|1|0.2512|
T1|Ly1, MOUSE, HOMOLOG OF||||C1413227|OMIM|||
T1|MRT13|C2677743;C2750791|||C2677743|HUGO|||
T1|NIK- AND IKBKB-BINDING PROTEIN||||C2677743|OMIM|||
T1|PEO2|C1705600;C2711773|||C1705600|NCI|||
T1|PEO3;SLC25A4 wt Allele|C1705600|||C1705600|MTH;NCI|||
T1|SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4;solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4||||C1335833|HUGO;OMIM|||
T1|ST2|C0450499;C1416400;C1420442|||C1416400|HUGO;OMIM|||
T1|ST2, MOUSE, HOMOLOG OF||||C1416400|OMIM|||
T1|ST2L|C1416400;C1539983|||C1416400|HUGO|||
T1|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 4 Gene||||C1335833|NCI|||
T1|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 4 wt Allele||||C1705600|NCI|||
T1|Spin-lattice||||||1|0.1396|
T1|Spin-lattice relaxation||||||1|0.0146|
T1|T1;t1||||C0475372;C1179687;C1335833;C1413227;C1416400;C1442881;C1705600;C2347263;C2677743;C2697938|CHV;FMA;HUGO;NCI;OMIM;SNOMEDCT;UWDA|||
T1|T1 (MRI)||1|0.206|||||
T1|T1 Cancer Stage Finding;T1 Primary Tumor Finding;T1 Primary Tumor Stage Finding;T1 Stage;T1 stage;T1 Stage Finding;T1 stage (finding);T1 TNM Finding;T1 Tumor Finding;T1 Tumor Stage;Tumor Stage T1;Tumor stage T1;Tumour stage T1;T1 category|C0475372|||C0475372|MTH;NCI;SNOMEDCT|||
T1|T1 category (finding)||||C0475372|SNOMEDCT|||
T1|T1 innervation|C1179687|||C1179687|MTH|||
T1|T1 stage (tumor staging)||||C0475372|SNOMEDCT|||
T1|TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9||||C2677743|OMIM|||
T1|Time 1||||||1|0.034|
T1|admission|C0184666;C0809949|||||1|0.0146|
T1|baseline|C0168634;C1442488|||||1|0.0583|
T1|beginning|C0439659|||||1|0.0182|
T1|control group|C0009932|||||1|0.0061|
T1|degrees C|C0439237|||||1|0.0121|
T1|early|C1279919|||||1|0.0182|
T1|first|C0205435;C1279901|||||1|0.0316|
T1|first response||||||1|0.0243|
T1|first thoracic||||||1|0.0109|
T1|first thoracic (t1) nerve||||C1179687|CHV|||
T1|first thoracic vertebra|C0459933|||C0459933|FMA;SNOMEDCT;UWDA|||
T1|first twitch||||||1|0.0607|
T1|first twitch of the TOF||||||1|0.0036|
T1|first twitch of the train-of-four||||||1|0.0085|
T1|homolog of mouse growth stimulation-expressed||||C1416400|HUGO|||
T1|hours|C0439227|||||1|0.0109|
T1|induction of anesthesia|C0853212|||||1|0.0085|
T1|later||||||1|0.0218|
T1|longitudinal|C0205127|||||1|0.0655|
T1|longitudinal relaxation||||||1|0.017|
T1|lowest excited triplet||||||1|0.0049|
T1|months|C0439231|||||1|0.0316|
T1|period|C0439531;C1948053|||||1|0.0158|
T1|phase|C0205390|||||1|0.0121|
T1|stage|C0205390;C1300072;C1306673|||||1|0.0109|
T1|term 1||1|0.002|||||
T1|therapy|C0039798;C0087111;C1363945|||||1|0.0146|
T1|thoracic (level) 1||1|0.388|||||
T1|trafficking protein particle complex 9||||C2677743|HUGO|||
T1|tumor stage 1||1|0.396|||||
T1|twitch height||||||1|0.0291|
T1|type 1|C0441729|||C0441729|CHV;SNOMEDCT|1|0.034|
T1|type 1 (diabetes mellitus)|C0011854;C2984334|1|0.002|||||
T2|1/R2||||C2700066|NCI|||
T2|2F1||||C1335834;C1442882;C1705601|HUGO;NCI|||
T2|6 months later||||||1|0.018|
T2|AAC2||||C1335834|OMIM|||
T2|ACAT||||C1412111|OMIM|||
T2|ACAT1|C1412111;C1420304|||C1412111|HUGO;OMIM|||
T2|ACAT1 gene;ACETOACETYL-CoA THIOLASE, MITOCHONDRIAL;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE;mitochondrial acetoacetyl-CoA thiolase;ACETYL-CoA ACETYLTRANSFERASE 1;acetyl-CoA acetyltransferase 1;THIL|C1412111|||C1412111|HUGO;MTH;OMIM|1|0.0341|
T2|ADENINE NUCLEOTIDE TRANSLOCATOR 2;Adenine Nucleotide Translocator-2|C0600150;C1335834;C1442882|||C1335834;C1442882|NCI;OMIM|||
T2|ADP-ATP Translocase-2;ADP/ATP TRANSLOCASE 2;Fibroblast ADP-ATP Carrier Protein;Fibroblast Adenine Nucleotide Translocator-2;Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-5;SLC25A5 protein, human;Solute Carrier Family 25 Member-5|C1442882|||C1335834;C1442882|MTH;NCI;OMIM|||
T2|ADP/ATP CARRIER 2;SLC25A5;SLC25A5 Gene;SLC25A5 gene|C1335834|||C1335834|HUGO;MTH;NCI;OMIM|||
T2|ADP/ATP TRANSLOCATOR OF FIBROBLASTS||||C1335834|OMIM|||
T2|ANT2|C1335834;C1705601|||C1335834;C1705601|NCI;OMIM|||
T2|MAT|C0175648|||C1412111|OMIM|||
T2|SLC25A5 wt Allele|C1705601|||C1705601|MTH;NCI|||
T2|SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5||||C1335834|OMIM|||
T2|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 5 Gene||||C1335834|NCI|||
T2|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 5 wt Allele||||C1705601|NCI|||
T2|Spin-Spin Relaxation Time;Transverse Relaxation Time;Transverse Spin Relaxation Time|C2700066|||C2700066|MTH;NCI|||
T2|T2||||C0475373;C1179688;C1335834;C1412111;C1442882;C1705601;C2700066|FMA;HUGO;NCI;OMIM;SNOMEDCT;UWDA|||
T2|T2 (MRI)||1|0.454|||||
T2|T2 Cancer Stage Finding;T2 Primary Tumor Finding;T2 Primary Tumor Stage Finding;T2 Stage;T2 stage;T2 Stage Finding;T2 stage (finding);T2 TNM Finding;T2 Tumor Finding;T2 Tumor Stage;Tumor Stage T2;Tumor stage T2;Tumour stage T2;T2 category|C0475373|||C0475373|MTH;NCI;SNOMEDCT|||
T2|T2 Nodes||1|0.002|||||
T2|T2 category (finding)||||C0475373|SNOMEDCT|||
T2|T2 innervation|C1179688|||C1179688|MTH|||
T2|T2 stage (tumor staging)||||C0475373|SNOMEDCT|||
T2|T3||||C1335834;C1442882;C1705601|HUGO;NCI|||
T2|Time 2;time 2|C0808270|||C0808270|LNC|1|0.0461|
T2|acetoacetyl Coenzyme A thiolase|C1412111;C1412112|||C1412111|HUGO|||
T2|after treatment|C0001758|||||1|0.018|
T2|degrees C|C0439237|||||1|0.016|
T2|diiodothyronine||||||1|0.018|
T2|discharge|C0012621;C0030685;C2926602|||||1|0.0261|
T2|follow-up|C0589120;C1522577;C1704685|||||1|0.0401|
T2|hours|C0439227|||||1|0.0281|
T2|minutes|C0439232;C0700321;C1282918|||||1|0.018|
T2|months|C0439231|||||1|0.1022|
T2|period|C0439531;C1948053|||||1|0.022|
T2|postoperatively||||||1|0.018|
T2|relaxation time||||||1|0.3908|
T2|second target||||||1|0.014|
T2|second thoracic||||||1|0.014|
T2|second thoracic (t2) nerve||||C1179688|CHV|||
T2|second thoracic vertebra|C0459936|||C0459936|FMA;SNOMEDCT;UWDA|||
T2|solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5||||C1335834|HUGO|||
T2|spin-spin relaxation||||||1|0.012|
T2|stage B|C0441781|||||1|0.012|
T2|term 2||1|0.002|||||
T2|therapy|C0039798;C0087111;C1363945|||||1|0.024|
T2|thoracic (level) 2||1|0.194|||||
T2|transverse relaxation||||||1|0.02|
T2|tumor stage 2||1|0.332|||||
T2|weeks|C0439230|||||1|0.0521|
T2|years|C0439234|||||1|0.022|
T2|years later||||||1|0.0341|
T3|2F1||||C1335834;C1442882;C1705601|HUGO;NCI|||
T3|3 months|C1442461|||||1|0.0183|
T3|3,3',5'-triiodothyronine;3,5,3' Triiodothyronine||||C0041014|SNOMEDCT|1|0.0155|
T3|3,3',5-tri-iodothyronine||||||1|0.0127|
T3|3,3',5-triiodo-L-thyronine||||C0041014|NCI|||
T3|AAC2||||C1335834|OMIM|||
T3|ADENINE NUCLEOTIDE TRANSLOCATOR 2;Adenine Nucleotide Translocator-2|C0600150;C1335834;C1442882|||C1335834;C1442882|NCI;OMIM|||
T3|ADP-ATP Translocase-2;ADP/ATP TRANSLOCASE 2;Fibroblast ADP-ATP Carrier Protein;Fibroblast Adenine Nucleotide Translocator-2;Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-5;SLC25A5 protein, human;Solute Carrier Family 25 Member-5|C1442882|||C1335834;C1442882|MTH;NCI;OMIM|||
T3|ADP/ATP CARRIER 2;SLC25A5;SLC25A5 Gene;SLC25A5 gene|C1335834|||C1335834|HUGO;MTH;NCI;OMIM|||
T3|ADP/ATP TRANSLOCATOR OF FIBROBLASTS||||C1335834|OMIM|||
T3|ANT2|C1335834;C1705601|||C1335834;C1705601|NCI;OMIM|||
T3|L-3,3',5-triiodothyronine;L-3,5,3'-triiodothyronine||||||1|0.0535|
T3|L-Triiodothyronine;L-triiodothyronine;l-Triiodothyronine|C0041014;C2936843|||C0041014;C2936843|NCI;NDFRT;PDQ|1|0.1786|
T3|L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-||||C0041014|MSH;NDFRT|||
T3|L-triiodothyronine preparation;LIOTHYRONINE;Liothyronine;liothyronine;T-3;T>3<;T3 - Liothyronine;T3 - Triiodothyronine;T3 Thyroid Hormone;Thyroid Hormone, T3;t3 thyroid hormone;T3 preparation;Therapeutic T3;Tri-iodothyronine product;Triiodothyronine preparation;therapeutic triiodothyronine|C0041014|||C0041014|CHV;MSH;MTHSPL;NCI;NDFRT;PDQ;SNOMEDCT;USPMG;VANDF|||
T3|Liothyronine (product)||||C0041014|SNOMEDCT|||
T3|Liothyronine (substance)||||C0041014|SNOMEDCT|||
T3|SLC25A5 wt Allele|C1705601|||C1705601|MTH;NCI|||
T3|SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5||||C1335834|OMIM|||
T3|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 5 Gene||||C1335834|NCI|||
T3|Solute Carrier Family 25 (Mitochondrial Carrier; Adenine Nucleotide Translocator), Member 5 wt Allele||||C1705601|NCI|||
T3|T AAA THYROID HORMONE 003||||C0041014|MSH|||
T3|T2||||C1335834;C1442882;C1705601|HUGO;NCI|||
T3|T3;t3||||C0041014;C0428419;C0475374;C1235740;C1335834;C1442882;C1705601;C2936843|CHV;CSP;FMA;HUGO;NCI;NDFRT;SNOMEDCT;UWDA|||
T3|T3 (ECG pattern)||1|0.008|||||
T3|T3 - Triiodothyronine level;Total T3;total T3;Triiodothyronine Measurement;Triiodothyronine measurement;Triiodothyronine level|C0428419|||C0428419|MTH;NCI;SNOMEDCT|1|0.0084|
T3|T3 Cancer Stage Finding;T3 Primary Tumor Finding;T3 Primary Tumor Stage Finding;T3 Stage;T3 stage;stage t3;t3 stage;T3 Stage Finding;T3 stage (finding);T3 TNM Finding;T3 Tumor Finding;T3 Tumor Stage;Tumor Stage T3;Tumor stage T3;Tumour stage T3;T3 category|C0475374|||C0475374|CHV;MTH;NCI;SNOMEDCT|||
T3|T3 category (finding)||||C0475374|SNOMEDCT|||
T3|T3 stage (tumor staging)||||C0475374|SNOMEDCT|||
T3|T3 thoracic segmental innervation;third thoracic vertebra nerves|C1235740|||C1235740|CHV;MTH|||
T3|T<sub>3</sub>||||C0041014|SNOMEDCT|||
T3|T<sub>3</sub> preparation||||C0041014|SNOMEDCT|||
T3|T>3< preparation||||C0041014|SNOMEDCT|||
T3|Thyroid hormone|C0040135|||||1|0.4543|
T3|Total Triiodothyronine;Total triiodothyronine;Triiodothyronine;triiodothyronin;triiodothyronine|C0041014;C0428419|1|0.536|C0041014;C0428419|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT|1|0.0183|
T3|Triiodothyronine (substance)||||C0041014|SNOMEDCT|||
T3|Triiodothyronine [Chemical/Ingredient]||||C0041014|NDFRT|||
T3|Triiodothyronine measurement (procedure)||||C0428419|SNOMEDCT|||
T3|Triiodothyronine preparation (product)||||C0041014|SNOMEDCT|||
T3|Triiodothyronine preparation (substance)||||C0041014|SNOMEDCT|||
T3|Tylenol with codeine|C0724034|||||||1
T3|Type 3;type 3|C0441731|||C0441731|CHV;SNOMEDCT|1|0.0155|
T3|[125I]triiodothyronine||||||1|0.0155|
T3|advanced|C0205179|||||1|0.0127|
T3|after|C0231290;C0687676|||||1|0.0253|
T3|hours|C0439227|||||1|0.0169|
T3|l-Triiodothyronine (T3)||||C2936843|NDFRT|||
T3|l-Triiodothyronine [EPC];l-Triiodothyronine-containing Agent|C2936843|||C2936843|MTH;NDFRT|||
T3|later||||||1|0.0155|
T3|period|C0439531;C1948053|||||1|0.0155|
T3|solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5||||C1335834|HUGO|||
T3|term 3||1|0.004|||||
T3|third thoracic vertebra|C0459952|||C0459952|FMA;SNOMEDCT;UWDA|||
T3|thoracic (level) 3||1|0.130|||||
T3|thyroid hormone 3,3',5-triiodo-L-thyronine||||||1|0.0098|
T3|transurethral thermoablation therapy||||||||1
T3|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||1|0.0183|
T3|triidothyronine||||||1|0.0267|
T3|triiodothyroxine||||||1|0.0197|
T3|triodothyronine||||||1|0.0183|
T3|tumor stage 3||1|0.312|||||
T3|weeks|C0439230|||||1|0.0155|
T3|years|C0439234|||||1|0.0155|
T4|3,5,3',5'-Tetraiodothyronine;3,5,3'5' Tetraiodothyronine||||C0040165|MSH;NDFRT;SNOMEDCT|||
T4|L Thyroxine;L-Thyroxine;l thyroxine;l-Thyroxine;l-thyroxine|C0040165;C1881373;C2936885|||C0040165;C2936885|CHV;MSH;NDFRT|||
T4|L-3,5,3',5'-Tetraiodothyronine||||C0040165|MSH;NDFRT|||
T4|L-3,5,5'-tetraiodothyronine||||C0040165|NCI|||
T4|LEVOTHYROXINE;Levothyroxine;levothyroxine|C0040165;C1881373|||C0040165|CHV;MSH;MTHSPL;NDFRT;PDQ;USPMG;VANDF|1|0.0259|
T4|O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine||||C0040165|MSH;NDFRT|||
T4|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine||||C0040165|MSH;NDFRT|||
T4|T AAB THYROID HORMONE 004||||C0040165|MSH|||
T4|T helper||||||1|0.0155|
T4|T helper cells|C0018894|||||1|0.0086|
T4|T4||||C0040165;C0475751;C1235738;C1281902;C2936885|CHV;CSP;FMA;NCI;NDFRT;PDQ;SNOMEDCT;UWDA|||
T4|T4 - Thyroxine;thyroxine (T4);T4 Thyroid Hormone;Thyroid Hormone, T4;T4 preparation;TT4 - Total thyroxine;Tetraiodothyronine preparation;Thyroxine preparation;Thyroxine product;Total thyroxine|C0040165|||C0040165|CHV;MSH;NDFRT;SNOMEDCT|||
T4|T4 Cancer Stage Finding;T4 Primary Tumor Finding;T4 Primary Tumor Stage Finding;T4 Stage;T4 stage;T4 Stage Finding;T4 stage (finding);T4 TNM Finding;T4 Tumor Finding;T4 Tumor Stage;Tumor Stage T4;Tumor stage T4;Tumour stage T4;T4 category|C0475751|||C0475751|MTH;NCI;SNOMEDCT|||
T4|T4 category (finding)||||C0475751|SNOMEDCT|||
T4|T4 stage (tumor staging)||||C0475751|SNOMEDCT|||
T4|T4 thoracic segmental innervation;fourth thoracic vertebra nerves|C1235738|||C1235738|CHV;MTH|||
T4|T<sub>4</sub>||||C0040165|SNOMEDCT|||
T4|T<sub>4</sub> preparation||||C0040165|SNOMEDCT|||
T4|T>4<||||C0040165|SNOMEDCT|||
T4|T>4< preparation||||C0040165|SNOMEDCT|||
T4|THROXINE L||||C0040165|MSH|||
T4|Tetraiodothyronine preparation (product)||||C0040165|SNOMEDCT|||
T4|Tetraiodothyronine preparation (substance)||||C0040165|SNOMEDCT|||
T4|Thyroxin;Thyroxine;thyroxin;thyroxine|C0040165;C1281902|1|0.848|C0040165;C1281902|AOD;CHV;CSP;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT|||
T4|Thyroxine (substance)||||C0040165|SNOMEDCT|||
T4|Thyroxine [Chemical/Ingredient]||||C0040165|NDFRT|||
T4|Total T4;Total Thyroxine Measurement;Total thyroxine measurement;Total thyroxine level|C1281902|||C1281902|MTH;NCI;SNOMEDCT|||
T4|Total thyroxine measurement (procedure)||||C1281902|SNOMEDCT|||
T4|Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-||||C0040165|MSH;NDFRT|||
T4|fourth thoracic vertebra|C0459951|||C0459951|FMA;SNOMEDCT;UWDA|||
T4|helper/inducer||||||1|0.0276|
T4|invasion|C1269955;C2699153|||||1|0.0172|
T4|l-Thyroxine (T4)||||C2936885|NDFRT|||
T4|l-Thyroxine [EPC];l-Thyroxine-containing Agent|C2936885|||C2936885|MTH;NDFRT|||
T4|later||||||1|0.0155|
T4|locally advanced||||||1|0.0241|
T4|months|C0439231|||||1|0.019|
T4|serum thyroxine|C0036833|||||1|0.7879|
T4|thoracic (level) 4||1|0.082|||||
T4|thyroid hormone|C0040135|||||1|0.0259|
T4|thyroxine level|C0202231;C0428416|||||1|0.0103|
T4|tripchlorolide|C0146876|||||1|0.0224|
T4|tumor stage 4||1|0.070|||||
T8|T8;T8 innervation|C1179692|||C1179692|FMA;MTH;UWDA|||
T8|eighth thoracic (t8) nerve||||C1179692|CHV|||
T8|eighth thoracic vertebra|C0459953|||C0459953|FMA;SNOMEDCT;UWDA|||
T8|thoracic (level) 8||1|1.000|||||
T9|CD71||||C1619635|LNC;NCI|||
T9|CD71 Antigen;CD71 antigen;Lymphocyte antigen CD71;Transferrin Receptor Protein 1|C1619635|||C1619635|MSH;MTH;NCI;SNOMEDCT|||
T9|Lymphocyte antigen CD71 (substance)||||C1619635|SNOMEDCT|||
T9|MESOTRYPSIN;mesotrypsin;MESOTRYPSINOGEN;PROTEASE, SERINE, 3;protease, serine, 3;PRSS3;PRSS3 gene;TRY3;TRYPSINOGEN 3|C1418972|||C1418972|HUGO;MTH;OMIM|||
T9|T9|C1179693;C1418972;C1619635|||C1179693;C1418972;C1619635|FMA;NCI;OMIM;UWDA|||
T9|T9 innervation|C1179693|||C1179693|MTH|||
T9|TFR||||C1619635|NCI|||
T9|TFR1;Transferrin Receptor 1|C1420708;C1619635|||C1619635|NCI|||
T9|TFRC;TRFR|C1420708;C1619635;C1705610|||C1619635|NCI|||
T9|TR||||C1619635|NCI|||
T9|TRY4|C1418972;C3150814|||C1418972|HUGO|||
T9|Transferrin Receptor|C0034845;C1420708;C1619635|||C1619635|NCI|||
T9|ninth thoracic (t9) nerve||||C1179693|CHV|||
T9|ninth thoracic vertebra|C0459954|||C0459954|FMA;SNOMEDCT;UWDA|||
T9|p90|C1413107;C1537472;C1619635|||C1619635|NCI|||
T9|thoracic||||||1|1|
T9|thoracic (level) 9||1|1.000|||||
T10|ADP-Ribosyl Cyclase 1|C1413221;C2827388|||C2827388|MTH;NCI|||
T10|CD38||||C2827388|NCI|||
T10|CD38 Antigen|C0075742;C1413221;C2827388|||C2827388|NCI|||
T10|CD38 Antigen (p45) Gene||||C2827387|NCI|||
T10|CD38 Molecule wt Allele;CD38 wt Allele|C2827387|||C2827387|MTH;NCI|||
T10|Cyclic ADP-Ribose Hydrolase 1;EC3.2.2.5;cADPr Hydrolase 1|C2827388|||C2827388|NCI|||
T10|T10;t10|C1179694;C2827387;C2827388|||C1179694;C2827387;C2827388|CHV;FMA;NCI;UWDA|||
T10|T10 - Thoracic segmental innervation|C1179694|||C1179694|MTH|||
T10|tenth thoracic (T10) nerve||||C1179694|CHV|||
T10|tenth thoracic vertebra|C0459955|||C0459955|FMA;SNOMEDCT;UWDA|||
T10|thoracic (level) 10||1|1.000|||||
T11|CD2|C1367475;C2347546|||C1367475|HUGO;NCI;OMIM|||
T11|CD2 Antigen (p50), Sheep Red Blood Cell Receptor Gene||||C1367475|NCI|||
T11|CD2 Antigen (p50), Sheep Red Blood Cell Receptor wt Allele||||C1705087|NCI|||
T11|CD2 Gene;CD2 gene;SHEEP ERYTHROCYTE RECEPTOR;T-LYMPHOCYTE SURFACE CD2 ANTIGEN|C1367475|||C1367475|HUGO;MTH;NCI;OMIM|||
T11|CD2 molecule|C0108773;C1367475|||C1367475|HUGO|||
T11|CD2 wt Allele|C1705087|||C1705087|MTH;NCI|||
T11|SRBC|C1367475;C1418917;C1705087|||C1367475;C1705087|NCI;OMIM|||
T11|T11|C1179695;C1367475;C1705087|||C1179695;C1367475;C1705087|FMA;NCI;OMIM;UWDA|||
T11|T11 innervation|C1179695|||C1179695|MTH|||
T11|eleventh thoracic (T11) nerve||||C1179695|CHV|||
T11|eleventh thoracic vertebra|C0459956|||C0459956|FMA;SNOMEDCT;UWDA|||
T11|thoracic (level) 11||1|1.000|||||
T12|12 months||||||1|1|
T12|CD 6 antigen;CD6 - Cluster of differentiation antigen 6;Cluster of differentiation antigen 6;Lymphocyte antigen CD6;T-cell lineage 12;T12 - T-cell lineage 12|C0054967|||C0054967|MSH;SNOMEDCT|||
T12|CD6||||C0054967|CSP;LNC|||
T12|CD6 Antigen;CD6 antigen;T-Cell Differentiation Antigen CD6|C0054967;C1413232|||C0054967|MSH;MTH;NCI|||
T12|Lymphocyte antigen CD6 (substance)||||C0054967|SNOMEDCT|||
T12|Message structure -T12|C1549876|||C1549876|MTH|||
T12|T12|C0054967;C1179696;C1549876|||C0054967;C1179696;C1549876|FMA;HL7V2.5;NCI;UWDA|||
T12|T12 Thoracic segmental innervation|C1179696|||C1179696|MTH|||
T12|TP120|C0054967;C1413232;C2347264|||C0054967|NCI|||
T12|thoracic (level) 12||1|1.000|||||
T12|transkarbam 12|C1505043|||C1505043|MSH|||
T12|twelfth thoracic (T12) nerve||||C1179696|CHV|||
T12|twelfth thoracic vertebra|C0459957|||C0459957|FMA;SNOMEDCT;UWDA|||
TAH|Abdominal panhysterectomy;Bonney operation hysterectomy;Richardson operation hysterectomy;TAH - Total abdominal hysterectomy;Total Abdominal Hysterectomy;Total abdominal hysterectomy;Total abdominal hysterectomy, NOS;abdominal hysterectomy total;total abdominal hysterectomy;tah|C0404079|1|1|C0404079|CCS;CHV;ICD9CM;MTH;NCI;SNOMEDCT|1|0.2578|1
TAH|Total abdominal hysterectomy (procedure)||||C0404079|SNOMEDCT|||
TAH|Total hysterectomy without removal of tube or ovary||||C0404079|SNOMEDCT|||
TAH|abdominal hysterectomys total||||C0404079|CHV|||
TAH|total artificial heart|C0182433|||C0182433|CHV;CSP|1|0.7422|1
TBI|BRAIN INJ TRAUMATIC;INJ BRAIN TRAUMATIC;TRAUMATIC BRAIN INJ||||C0876926|MSH|||
TBI|Brain Injuries, Traumatic;Brain Injury, Traumatic;Injuries, Traumatic Brain;Injury, Brain, Traumatic;Injury, Traumatic Brain;Traumatic Brain Injuries;Traumatic Brain Injury;Traumatic brain injury;brain injuries traumatic;brain injury traumatic;traumatic brain injuries;traumatic brain injury;Brain Trauma;Brain Traumas;Trauma, Brain;Traumas, Brain;brain trauma;brain traumas;Brain damage - traumatic;traumatic brain damage;TBI|C0876926|1|0.042|C0876926|CHV;CSP;LNC;MEDLINEPLUS;MSH;MTH;SNOMEDCT|1|0.6371|1
TBI|Brain damage - traumatic (disorder)||||C0876926|SNOMEDCT|||
TBI|ENCEPH TRAUMATIC;TRAUMATIC ENCEPH||||C0876926|MSH|||
TBI|Encephalopathies, Traumatic;Encephalopathy, Traumatic;Traumatic Encephalopathies;Traumatic Encephalopathy;Traumatic encephalopathy;traumatic encephalopathy|C0236959;C0876926|||C0876926|CHV;MSH;NCI;SNOMEDCT|||
TBI|TBI (Traumatic Brain Injury);TBI (traumatic brain injury);TBIs (Traumatic Brain Injury)||||C0876926|CSP;MSH|||
TBI|TSH binding inhibition||||||1|0.002|
TBI|Traumatic brain injury (disorder)||||C0876926|SNOMEDCT|||
TBI|Traumatic encephalopathy (disorder)||||C0876926|SNOMEDCT|||
TBI|Traumatic encephalopathy (disorder) [Ambiguous]||||C0876926|SNOMEDCT|||
TBI|brain injured||||||1|0.0068|
TBI|thrombotic brain infarction||||||||1
TBI|thyroxine-binding index|C1441288|||||||1
TBI|tick-borne illness||||||||1
TBI|toe-brachial index|C2116889|||C2116889|MSH|||
TBI|tooth-brushing instruction||||||||1
TBI|total body irradiation|C0043162|1|0.958|C0043162|CHV;MSH;NCI;SNOMEDCT|1|0.3469|1
TBI|tracheobronchial injury||||||||1
TBI|traumatic brain-injured||||||1|0.0034|
TBI|traumatically brain-injured||||||1|0.0037|
TBI|tumor burden index||||||||1
TB|1,2,3-Propanetriyl Butanoate||||C0077025|NCI;PDQ|||
TB|1,2,3-Tributyrylglycerol||||C0077025|NCI;PDQ|||
TB|Butanoic Acid 1,2,3-Propanetriyl Ester;Butanoic Acid, 1,2,3-Propanetriyl Ester;butanoic acid, 1,2,3- propanetriyl ester||||C0077025|MSH;NCI;PDQ|||
TB|Butyryl Triglyceride;Glyceryl Tributyrate;Glyceryl tributyrate;glyceryl tributyrate;TRIBUTYRIN;Tributyrin;tributyrin;tributyrylglycerol|C0077025|||C0077025|MSH;MTH;NCI;PDQ|1|0.0022|
TB|Disease, Koch's;Koch Disease;Koch's Disease;Disease, Kochs;Kochs Disease;INFECTION TBC;INFECTION TUBERCULOSIS;infection tuberculosis;tuberculosis infection;Infection due to Mycobacterium tuberculosis;TB - Tuberculosis;tuberculosis (TB);TUBERCULOSIS;Tuberculoses;Tuberculosis;Tuberculosis NOS;Tuberculosis, NOS;tuberculosis;Tuberculous;tuberculous|C0041296|1|1|C0041296|AOD;CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;LNC;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.803|1
TB|Infection due to Mycobacterium tuberculosis (disorder)||||C0041296|SNOMEDCT|||
TB|MTB - Mycobacterium tuberculosis infection||||C0041296|SNOMEDCT|||
TB|Mycobacterium tuberculosis infection||||C0041296|SNOMEDCT|||
TB|TB||||C0041296;C0077025;C0332289;C1704474|CHV;MEDLINEPLUS;NCI;PDQ;SNOMEDCT|||
TB|TBC||||C0041296|CHV|||
TB|TUBE;Tube;Tubes|C0175730;C1547937;C1561954;C1704474;C1704730;C1704731|||C1704474|NCI;SNOMEDCT|||
TB|Tapes for the Blind||||||||1
TB|Thoroughbred||||||1|0.0041|
TB|Transmitted by;transmit;transmits;transmitted;transmitted by;transmitting|C0242781;C0332289;C1521797|||C0332289|CHV;MTH;SNOMEDCT|||
TB|Transmitted by (attribute)||||C0332289|SNOMEDCT|||
TB|Tris-borate||||||1|0.0024|
TB|Trypanosoma brucei|C0041217|||||1|0.0022|
TB|Tube (qualifier value)||||C1704474|SNOMEDCT|||
TB|Tube - unit dose;Tube Dosing Unit;Tube - unit of product usage|C1704474|||C1704474|MTH;NCI;SNOMEDCT|||
TB|Tube - unit of product usage (qualifier value)||||C1704474|SNOMEDCT|||
TB|Tuberculosis (disorder);Tuberculosis NOS (disorder)||||C0041296|SNOMEDCT|||
TB|Tuberculosis [Disease/Finding]||||C0041296|NDFRT|||
TB|Tuberculous (disorder)||||C0041296|SNOMEDCT|||
TB|Tuberculous (qualifier value)||||C0041296|SNOMEDCT|||
TB|anti-tuberculosis||||||1|0.0032|
TB|biologic half-life||||||||1
TB|body temperature|C0005903|||||1|0.0829|
TB|terbium|C0039541|||||1|0.0034|
TB|term birth|C0233324|||||||1
TB|terminal bronchiole|C0225666;C1269572;C1280599|||||||1
TB|terrible burning||||||||1
TB|testosterone buciclate|C0164583|||||1|0.0022|
TB|theobromine|C0039763|||||1|0.0071|
TB|thiabendazole|C0039832|||||1|0.0022|
TB|thiobenzamide|C0076443|||||1|0.0029|
TB|thought broadcasting|C0233688|||||||1
TB|thromboxane B||||||||1
TB|thymol blue|C0076605|||||||1
TB|tissue basophils|C0024880|||||1|0.0022|
TB|tolbutamide|C0040374|||||1|0.0029|
TB|toluidine blue|C0040380|||||1|0.009|1
TB|toothbrush|C0040461;C0183975|||||||1
TB|total base||||||||1
TB|total bilirubin|C0005437;C0201913;C0368753|||||1|0.008|
TB|total body|C0229960|||||1|0.0115|1
TB|total bound||||||||1
TB|tracheal bronchial||||||||1
TB|tracheobronchial|C0450123|||||1|0.0056|
TB|tracheobronchitis|C0040586|||||||1
TB|trapezoid body|C0152379;C1289448|||||1|0.0032|1
TB|triceps brachii|C0559502;C1279040|||||1|0.0102|
TB|trypan blue|C0041213|||||1|0.0112|
TB|tub bath||||||||1
TB|tubercle bacillus||||||||1
TB|tuberculin|C0034131;C0041289;C1532464|||C0034131;C0041289;C1532464|CHV;LCH;LNC;MSH;MTH;NCI;NDFRT;RXNORM;SNOMEDCT|||1
TB|tumor bearing;tumor-bearing||||||1|0.0183|1
TEDS|thromboembolic disease stockings||1|1.000|||||1
TEDS|transesophageal echo-Doppler system||||||||1
TEDS|treatment episode data set||||||||1
TEE|ECHOCARDIOGR TRANSESOPHAGEAL||||C0206054|MSH|||
TEE|Echocardiography, Transesophageal;Transesophageal Echocardiography;Transesophageal echocardiography;Transoesophageal echocardiography;transesophageal echocardiography;TEE procedure;TOE - Transesophageal echocardiography;TOE - Transoesophageal echocardiography;Transesophageal echocardiogram;Transoesophageal echocardiogram;echocardiograms transesophageal;transesophageal echocardiogram|C0206054|||C0206054|CHV;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.8121|1
TEE|TEE;Tee Device Component;Transesophogeal Echocardiogram Device|C1710361|||C0206054;C1710361|MSH;MTH;NCI|||
TEE|Transesophageal echocardiography (procedure);Transoesophageal echocardiography (procedure)||||C0206054|SNOMEDCT|||
TEE|thermal effect of exercise||||||||1
TEE|total energy expended||||||||1
TEE|total energy expenditure|C0429629|||||1|0.142|
TEE|transesophageal echocardiograph||1|1.000|||||1
TEE|transesophageal echocardiographic||||||1|0.0377|
TEE|transesophageal echography||||||1|0.0082|
TEE|transnasal endoscopic ethmoidectomy||||||||1
TEE|tyrosine ethyl ester||||||||1
TENS|Antibiotic necrolysis||||C0014518|SNOMEDCT|||
TENS|EPIDERMAL NECROLYSIS TOX;TOX EPIDERMAL NECROLYSIS||||C0014518|MSH|||
TENS|EPIDERMOLYSIS, ACUTE TOXIC;Epidermal Necrolyses, Toxic;Epidermal Necrolysis, Toxic;NECROLYSIS, TOXIC EPIDERMAL;Necrolyses, Toxic Epidermal;Necrolysis, Toxic Epidermal;Toxic Epidermal Necrolyses;Toxic Epidermal Necrolysis;Toxic epidermal necrolysis;toxic epidermal necrolyses;toxic epidermal necrolysis;LYELL SYNDROME;LYELL'S SYNDROME;Lyell Syndrome;Lyell's Syndrome;Lyell's syndrome;Lyells Syndrome;SYNDROME LYELL'S;Syndrome, Lyell's;lyell syndrome;lyell's syndrome;lyells syndrome;Lyell toxic epidermal necrolysis, subepidermal type;Lyell's toxic epidermal necrolysis, subepidermal type;Nonstaphylococcal Scalded Skin Syndrome;Scalded Skin Syndrome, Nonstaphylococcal;TEN - Toxic epidermal necrolysis;TOXIC EPIDEONEAL NECROLYSIS;lyell;lyells|C0014518|||C0014518|CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|||
TENS|Electric Stimulation, Transcutaneous;Stimulation, Transcutaneous Electric;Transcutaneous Electric Stimulation;Electrical Stimulation, Transcutaneous;Stimulation, Transcutaneous Electrical;Transcutaneous Electrical Stimulation;Electrostimulation, Transdermal;Transdermal Electrostimulation;transdermal electrostimulation;Nerve Stimulation, Transcutaneous;Stimulation, Transcutaneous Nerve;Transcutaneous Nerve Stimulation;transcutaneous nerve stimulation;Percutaneous Electric Nerve Stimulation;Percutaneous Electrical Nerve Stimulation;TCNS - Transcutaneous nerve stimulation;TENS - Transcutaneous electrical nerve stimulation;Transcutaneous Electrical Nerve Stimulation (TENS);transcutaneous electrical nerve stimulation (TENS);TNS - Transcutaneous nerve stimulation;Transcutaneous Electric Nerve Stimulation;transcutaneous electric nerve stimulation;Transcutaneous Electrical Nerve Stimulation;Transcutaneous electrical nerve stimulation;transcutaneous electrical nerve stimulation;Transcutaneous electrical neural stimulation;Transcutaneous nerve stimulation therapy|C0040654|||C0040654|CHV;LNC;MSH;MTH;NCI;SNOMEDCT|1|1|
TENS|Epidermal Necrolysis, Toxic [Disease/Finding]||||C0014518|NDFRT|||
TENS|Leyell's syndrome||||C0014518|SNOMEDCT|||
TENS|Lyell's toxic epidermal necrolysis, subepidermal type (disorder)||||C0014518|SNOMEDCT|||
TENS|NONSTAPH SCALDED SKIN SYNDROME;SCALDED SKIN SYNDROME NONSTAPH||||C0014518|MSH|||
TENS|Necrolysis - toxic;Toxic necrolysis||||C0014518|SNOMEDCT|||
TENS|TEN|C0014518;C0205456|||C0014518|NCI|||
TENS|TENS;tens||||C0014518;C0040654|CHV;DXP;MSH;NCI|||
TENS|Toxic epidrml necrolysis||||C0014518|ICD9CM|||
TENS|Transcutaneous electrical nerve stimulation (procedure)||||C0040654|SNOMEDCT|||
TENS|Transcutaneous electrical nerve stimulation (regime/therapy)||||C0040654|SNOMEDCT|||
TENS|transcutaneous electrical nerve stimulator|C0491576|||C0491576|SNOMEDCT|||
TENS|transcutaneous electrical neuromuscular stimulation||||||||1
TENS|transcutaneous electrical neuromuscular stimulator||1|1.000|||||1
THC|(-)-.DELTA.9-Tetrahydrocannabinol;Delta 9-Tetrahydrocannabinol;delta 9-tetrahydrocannabinol;delta(9)-Tetrahydrocannabinol;delta-9-Tetrahydrocannabinol;delta-9-tetrahydrocannabinol;9 ene Tetrahydrocannabinol;9-ene-Tetrahydrocannabinol;DRONABINOL;Dronabinol;dronabinol;Synthetic delta-9-Tetrahydrocannabinol;Tetrahydrocannabinol;tetrahydrocannabinol;tetrahydrocannabinol (THC)|C0039663|1|1|C0039663|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|1|0.7902|1
THC|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-||||C0039663|MSH;NDFRT|||
THC|DELTA THC 09||||C0039663|MSH|||
THC|Dronabinol (product)||||C0039663|SNOMEDCT|||
THC|Dronabinol (substance)||||C0039663|SNOMEDCT|||
THC|IMD2|C0043194;C0258432;C1705616|||C1705616|NCI|||
THC|THC|C0039663;C1705616;C1839163|||C0039663;C1705616;C1839163|AOD;CHV;CSP;MSH;NCI;NDFRT;OMIM;PDQ|||
THC|THC1;THROMBOCYTOPENIA 1;THROMBOCYTOPENIA 1 (disorder);THROMBOCYTOPENIA, X-LINKED;XLT|C1839163|||C1839163|MTH;OMIM|||
THC|THROMBOCYTOPENIA, X-LINKED, 1|C1839163;C2678137|||C1839163|OMIM|||
THC|Tetrahydrocannabinol (substance)||||C0039663|SNOMEDCT|||
THC|Tetrahydrocannabinol [Chemical/Ingredient]||||C0039663|NDFRT|||
THC|WAS wt Allele;Wiskott-Aldrich syndrome Gene|C1705616|||C1705616|MTH;NCI|||
THC|WASP|C0043041|||C1705616|NCI|||
THC|Wiskott-Aldrich Syndrome (Eczema-Thrombocytopenia) wt Allele||||C1705616|NCI|||
THC|delta 1-tetrahydrocannabinol;delta(1)-Tetrahydrocannabinol||||C0039663|MSH;NDFRT|1|0.0102|
THC|delta(1)-THC||||C0039663|MSH;NDFRT|||
THC|delta(9)-THC||||C0039663|MSH;NDFRT|||
THC|delta-9-Tetrahydrocannabinol (substance)||||C0039663|SNOMEDCT|||
THC|delta9-tetrahydrocannabinol||||||1|0.1576|
THC|tetrahydrocortisol|C0039664|||||||1
THC|tetrahydrocortisone|C0039665|||||||1
THC|tetrahydrocurcumin|C0382876|||C0382876|MSH|1|0.0113|
THC|thigh circumference||||||||1
THC|thiocarbanidin|C2699929|||||||1
THC|total haemocyte count||||||1|0.0204|
THC|total hydrocarbon||||||1|0.0102|
THC|transhepatic cholangiogram||||||||1
THC|transhepatic cholangiograph||||||||1
THC|transhepatic cholangiography||||||||1
THC|transplantable hepatocellular carcinoma||||||||1
TIA|ATTACK, TRANSIENT ISCHEMIC;Attack, Transient Ischemic;Attacks, Transient Ischemic;ISCHEMIC ATTACK, TRANSIENT;Ischemic Attack, Transient;Ischemic Attacks, Transient;TRANSIENT ISCHEMIC ATTACK;TRANSIENT ISCHEMIC ATTACKS;Transient Ischemic Attack;Transient Ischemic Attacks;Transient ischaemic attack;Transient ischaemic attacks;Transient ischemic attack;Transient ischemic attacks;attack ischemic transient;attacks ischemic transient;ischemic attack transient;transient ischaemic attack;transient ischaemic attacks;transient ischemic attack;transient ischemic attacks;Brain TIA;TIA, Brain;brain tia;tia brain;STROKE, TEMPORARY;TIA (Transient Ischemic Attack);TIA - Transient ischaemic attack;TIAs (Transient Ischemic Attack);transient ischemic attack (TIA);Temporary cerebral vascular dysfunction;transient cerebral ischemic attack|C0007787|1|1|C0007787|AOD;CHV;COSTAR;CSP;CST;DXP;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9153|1
TIA|CEREBRAL ISCHEMIA, TRANSIENT;Cerebral Ischemia, Transient;Cerebral Ischemias, Transient;Ischemia, Transient Cerebral;Ischemias, Transient Cerebral;Transient Cerebral Ischemia;Transient Cerebral Ischemias;Transient cerebral ischaemia;Transient cerebral ischaemia NOS;Transient cerebral ischaemia, NOS;Transient cerebral ischemia;Transient cerebral ischemia NOS;Transient cerebral ischemia, NOS;transient cerebral ischemia|C0007787;C0917805|||C0007787;C0917805|CCS;CHV;COSTAR;DXP;ICD9CM;ICPC;MSH;MTH;SNOMEDCT|||
TIA|CEREBRAL ISCHEMIA, TRANSITORY;Unspecified transient cerebral ischemia|C0917805|||C0917805|DXP;ICD9CM|||
TIA|Ischemic Attack, Transient [Disease/Finding]||||C0007787|NDFRT|||
TIA|Polynesian arrowroot;Tacca leontopetaloides;Tacca leontopetaloides (L.) Kuntze;Tacca pinnatifida|C1054154|||C1054154|MTH;NCBI|||
TIA|T-cell-restricted intracellular antigen||||||||1
TIA|TIA;tia|C0007787;C0917805;C1054154|||C0007787;C0917805;C1054154|AOD;CHV;CSP;CST;DXP;MEDLINEPLUS;MTHICD9;NCBI;NCI;SNOMEDCT|||
TIA|Tacca pinnatifida J.R.Forst. & G.Forst.||||C1054154|NCBI|||
TIA|Test Anxiety Inventory||||||||1
TIA|Thrombosis-inducing activity||||||1|0.0131|
TIA|Trans cereb ischemia NOS||||C0917805|ICD9CM|||
TIA|Transient cer. ischaem.||||C0917805|SNOMEDCT|||
TIA|Transient cer. ischem.||||C0917805|SNOMEDCT|||
TIA|Transient cerebral ischaemia NOS (disorder);Transient cerebral ischemia (disorder);Transient cerebral ischemia NOS (disorder)||||C0007787;C0917805|SNOMEDCT|||
TIA|Transient cerebral ischemia (disorder) [Ambiguous]||||C0007787|SNOMEDCT|||
TIA|Transient ischemic attack (disorder);Transient ischemic attacks (disorder)||||C0007787|SNOMEDCT|||
TIA|intermittent cerebral ischemia|C0917805;C1521728|||C0917805|CHV|||
TIA|thin layer immunoassay||||||1|0.0179|
TIA|thymidine incorporation assay||||||1|0.0119|
TIA|trabecular-iris angle||||||1|0.006|
TIA|trypsin inhibitor activity|C1152594|||||1|0.0179|
TIA|tumor-induced angiogenesis||||||||1
TIA|turbidimetric immunoassay||||||1|0.0179|
TIBC|Serum Total Iron-Binding Capacity result;tibc|C0036835|||C0036835|CHV;MTH|||
TIBC|Serum iron and total iron binding capacity||||||1|0.0753|
TIBC|total iron binding capacity;total iron-binding capacity|C0700379;C1283048|1|1|C0700379;C1283048|CHV;NCI;SNOMEDCT|1|0.9247|1
TIBC|total iron binding capacity (TIBC) test||||C0036835|CHV|||
TIMI|Thrombolysis in Myocardial Infarction trial||||||1|0.0327|
TIMI|Thrombolysis in Myocardial Ischemia||||||1|0.0184|
TIMI|thrombolysis in myocardial infarction||1|1.000|||1|0.949|
TIPS|Portasystemic Shunt, Transjugular Intrahepatic;Portosystemic Shunt, Transjugular Intrahepatic;Shunt, Transjugular Intrahepatic Portasystemic;Shunt, Transjugular Intrahepatic Portosystemic;Transjugular Intrahepatic Portasystemic Shunt;Transjugular intrahepatic portosystemic shunt;transjugular intrahepatic portosystemic shunt;transjugular intrahepatic portosystemic shunting|C0339897;C1301416|1|1|C0339897;C1301416|LNC;MSH;MTHICD9;SNOMEDCT|1|0.9549|1
TIPS|TIPS;TIPSS;Transjugular intrahepatic portosystemic shunt (procedure);Transjugular intrahepatic portosystemic shunt procedure|C0339897|||C0339897|MSH;MTH;MTHICD9;SNOMEDCT|||
TIPS|TIPS - Transjugular intrahepatic portosystemic shunt||||C0339897|SNOMEDCT|||
TIPS|Tonoplast intrinsic proteins||||||1|0.0109|
TIPS|transjugular intrahepatic portosystemic stent-shunt||||||1|0.0342|
TIPS|transvenous intrahepatic portosystemic shunt||||||||1
TKA|total knee arthroplasty|C0086511|1|1.000|C0086511|CHV;COSTAR|1|0.9871|1
TKA|total knee arthroscopy||||||||1
TKA|transketolase activity|C1152029|||||||1
TKA|trochanter-knee-ankle||||||||1
TKA|tyrosine kinase activity||||||1|0.0129|1
TLSO|thoracolumbar spinal orthosis||||||||1
TLSO|thoracolumbosacral orthosis||1|1.000|||||1
TMJ|Articulatio temporomandibularis;JAW JOINT;Jaw Joint;jaw joint;Temporomandibular joint structure|C0039493|||C0039493|CHV;FMA;NCI;SNOMEDCT;UWDA|||
TMJ|Costen Syndrome;Costen's Syndrome;Costen's syndrome;Costens Syndrome;Syndrome, Costen's;costen syndrome;costen's syndrome;costens syndrome;Jaw snapping;Snapping jaw;jaw snap;jaw snapping;jaw snaps;Joint Syndrome, Temporomandibular;Syndrome, Temporomandibular Joint;TEMPOROMANDIBULAR JOINT SYNDROME;Temporomandibular Joint Syndrome;Temporomandibular joint syndrome;Temporomandibular joint syndrome, NOS;temporomandibular joint syndrome;Mandibular dysfunction;mandibular dysfunction;Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint;Myofascial pain - dysfunction syndrome of TMJ;PAIN-DYSFUNCTION SYNDROME;pain-dysfunction syndrome;Syndrome, TMJ;TMJ SYNDROME;TMJ Syndrome;TMJ syndrome;syndrome tmj;tmj syndrome;TEMPOROMANDIBULAR JOINT PAIN-DYSFUNCTION SYNDROME;TEMPOROMANDIBULAR JOINT-PAIN-DYSFUNCTION SYNDROME;Temporomandibular joint pain dysfunction syndrome;Temporomandibular joint-pain-dysfunction syndrome;TMJ-pain-dysfunction syndrome;TMJPDS - Temporomandibular joint pain dysfunction syndrome;Temporomandibular Joint Dysfunction;Temporomandibular Joint Dysfunction Syndrome;dysfunction tmj;tmj dysfunction;temporomandibular dysfunction syndrome|C0039496|||C0039496|CHV;COSTAR;CSP;DXP;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;NDFRT;SNOMEDCT|||
TMJ|Costen's complex||||C0039496|SNOMEDCT|||
TMJ|Costen's syndrome (disorder)||||C0039496|SNOMEDCT|||
TMJ|Joint, Temporomandibular;Joints, Temporomandibular;Temporomandibular Joint;Temporomandibular Joints;Temporomandibular joint;Temporomandibular joint, NOS;Temporomandibular joints;temporomandibular joint;temporomandibular joint (TMJ);tmj temporomandibular joint|C0039493;C1269048|1|1|C0039493;C1269048|CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;SNOMEDCT;UWDA|1|0.9947|1
TMJ|TMD||||C0039496|MEDLINEPLUS|||
TMJ|TMJ||||C0039493;C0039496|CHV;DXP;MEDLINEPLUS;MSH;MTH;NCI|||
TMJ|Temporomandibular Joint Dysfunction Syndrome [Disease/Finding]||||C0039496|NDFRT|||
TMJ|Temporomandibular joint dis.||||C0039496|SNOMEDCT|||
TMJ|Temporomandibular joint dysf.||||C0039496|SNOMEDCT|||
TMJ|Temporomandibular joint structure (body structure)||||C0039493|SNOMEDCT|||
TMJ|Temporomandibular joint-pain-dysfunction syndrome (disorder)||||C0039496|SNOMEDCT|||
TMJ|Temporomandibular synd.||||C0039496|SNOMEDCT|||
TMJ|Temporomandibular syndrome||||C0039496|SNOMEDCT|||
TMJ|temporomandibular||||||1|0.0053|
TM|Ear Drum;Ear drum;Ear drum, NOS;ear drum;Eardrum;Eardrums;eardrum;eardrums;Lateral wall of tympanic cavity;Membrana Tympanica;Membrana tympanica;Membranous wall of tympanic cavity;Paries membranaceus cavi tympani;Rivinus' membrane;Tympanic membrane structure|C0041445|||C0041445|AOD;CHV;CSP;FMA;MSH;MTH;NCI;SNOMEDCT;UWDA|||
TM|Landsat Thematic Mapper||||||1|0.005|
TM|Meditation, Transcendental;Transcendental Meditation;Transcendental meditation;transcendental Meditation;transcendental meditation|C0150814|||C0150814|AOD;MSH;MTH;NCI;SNOMEDCT|1|0.021|1
TM|Membrane, Tympanic;Membranes, Tympanic;TYMPANIC MEMBRANE;Tympanic Membrane;Tympanic Membranes;Tympanic membrane;Tympanic membrane, NOS;tympanic membrane;tympanic membranes|C0041445;C1268971|1|1|C0041445|CHV;CSP;FMA;LCH;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.0605|1
TM|Molybdate(2-), tetrathioxo-, (T-4)-||||C0076339|MSH|||
TM|TKM;TURKMENISTAN;Turkmenistan;turkmenistan;Turkmen S.S.R.|C0041403|||C0041403|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
TM|TM||||C0040722;C0041403;C0041445;C0076339;C0150814|MSH;NCI;PDQ|||
TM|TRANSM||||C0040722|MSH|||
TM|TTM cpd;Tetrathiomolybdate;tetrathiomolybdate;Tetrathiomolybdic acid|C0076339|||C0076339|CHV;MSH;MTH;PDQ;SNOMEDCT|1|0.0073|
TM|TX||||C0041403|NCI|||
TM|Tamoxifen|C0039286|||||1|0.0037|
TM|Tetrathiomolybdate (substance)||||C0076339|SNOMEDCT|||
TM|Thayer-Martin||||||||1
TM|Thrombotic microangiopathy|C2717961|||||1|0.0067|
TM|Tibetan medicine||||||||1
TM|Transcendental Meditation Therapy|C0150814;C0204530|||C0150814|NCI|||
TM|Transcendental meditation (religion/philosophy)||||C0150814|SNOMEDCT|||
TM|Tunicamycin;tunicamycin|C0041385|||C0041385|CHV;CSP;LCH;MSH;NDFRT|1|0.0383|
TM|Turkmen SSR||||C0041403|MSH|||
TM|Turkmenistan (geographic location)||||C0041403|SNOMEDCT|||
TM|Tympanic membrane structure (body structure)||||C0041445|SNOMEDCT|||
TM|alpha-tropomyosin|C0002317|||||1|0.006|
TM|capacity|C1516240|||||1|0.0037|
TM|disease transmission qualifier|C0040722|||C0040722|MTH|||
TM|melting point|C1881775|||||1|0.0033|
TM|melting temperature||||||1|0.0659|1
TM|method|C0025663;C0449851;C0871511|||||1|0.003|
TM|midpoint||||||1|0.003|
TM|muscle|C0026845|||||1|0.0037|
TM|neurons of the tuberomammillary||||||1|0.0007|
TM|phase transition|C1257888|||||1|0.0023|
TM|phase transition temperature||||||1|0.023|
TM|seven-transmembrane||||||1|0.0037|
TM|tail moment||||||1|0.0043|
TM|tectorial membrane|C0039432;C1289393|||||1|0.0163|1
TM|telangiectatic matting||||||||1
TM|temperature by mouth||||||||1
TM|temperature, muscle||||||||1
TM|temporalis muscle|C0039487;C1275494|||||||1
TM|temporomandibular||||||1|0.01|1
TM|teres major||||||||1
TM|term milk||||||||1
TM|testicular microlithiasis|C1864873|||||1|0.009|
TM|thalassaemia major;thalassemia major|C0002875|||||1|0.017|1
TM|thrombomodulin|C0145779;C0373785;C1420720|||||1|0.2079|1
TM|thulium|C0040066|||||||1
TM|time and modifying||||||||1
TM|time motion||||||||1
TM|time required to complete M phase of cell cycle||||||||1
TM|timolol maleate|C0087093|||||1|0.0033|
TM|tooth mobility|C0040445|||||1|0.0037|
TM|trabecular meshwork|C0040573;C1281294|||||1|0.0619|1
TM|trademark|C0282291|||||||1
TM|transformed migraine|C1960870|||||1|0.0057|
TM|transgenic mice|C0025936|||||1|0.0037|
TM|transitional mucosa||||||1|0.004|1
TM|transmediastinal||||||||1
TM|transmembrane|C1167322;C2752508|||||1|0.2176|
TM|transmembrane domain;transmembrane region|C1519623|||||1|0.0386|
TM|transmembrane glycoprotein|C1415205|||||1|0.0043|
TM|transmembrane protein|C0021699|||||1|0.009|
TM|transmembrane segment||||||1|0.0126|
TM|transmembrane subunit||||||1|0.003|
TM|transmetatarsal||||||||1
TM|transmission|C0040722;C0242781;C1521797|||C0040722|MSH|||
TM|transport maximum||||||1|0.0113|1
TM|transport mechanism||||||||1
TM|transport medium||||||||1
TM|transverse myelitis|C0026976|||||1|0.008|1
TM|treadmill|C0184069;C2712999|||||1|0.0143|1
TM|trimester|C0032982|||||||1
TM|tropical medicine|C0041186|||||||1
TM|tropomyosin|C0041197|||||1|0.0549|
TM|tuberculosis meningitis;tuberculous meningitis|C0041318|||||1|0.004|1
TM|tuberomamillary nucleus||||||1|0.0027|
TM|tuberomammillary nucleus|C0228377;C1289549|||||1|0.0077|
TM|tubular maximal||||||||1
TM|tubular maximum||||||||1
TM|tubular myelin|C0077483|||||1|0.0033|1
TM|tumor|C0027651;C1578706|||||||1
TM|tumor-bearing mice||||||||1
TM|tumour markers|C0041365;C1139415|||||1|0.0017|
TM|tympanometric||||||||1
TOBI|Tobi;tobi;tobi [brand name]|C0723764|||C0723764|CHV;RXNORM|||
TOBI|tobramycin|C0040341|1|1.000|||||
TOBI|tobramycin solution for inhalation||||||||1
TOBI|toxin binding inhibition||||||1|1|
TPA|12 Myristoyl 13 acetylphorbol;12-Myristoyl-13-acetylphorbol;12 O Tetradecanoyl Phorbol 13 Acetate;12-O-Tetradecanoyl Phorbol 13-Acetate;13-Acetate, 12-O-Tetradecanoyl Phorbol;Phorbol 13-Acetate, 12-O-Tetradecanoyl;12-O-tetradecanoylphorbol 13-acetate;12-O-tetradecanoylphorbol-13-acetate;Acetate, Phorbol Myristate;Myristate Acetate, Phorbol;Phorbol Myristate Acetate;Acetate, Tetradecanoylphorbol;Tetradecanoylphorbol Acetate;tetradecanoylphorbol acetate;PMAS;tetradecanoyl phorbol acetate|C0039654|||C0039654|CSP;MSH;MTH;NCI;NDFRT;PDQ|1|0.124|1
TPA|12-O-Tetra-decanoylphorbol-13-acetate||||||1|0.0106|
TPA|12-O-tetra-decanoyl-phorbol-13-acetate||||||1|0.0053|
TPA|12-O-tetradecanoyl-13-acetate||||||1|0.0095|
TPA|12-tetradecanoyl-phorbol-13-acetate||||||1|0.0071|
TPA|12-tetradecanoylphorbol-13-acetate||||||1|0.0065|
TPA|ALTEPLASE;Alteplase;alteplase;Plasminogen Activator, Tissue Type;Plasminogen Activator, Tissue-Type;Plasminogen activator tissue type;Tissue Type Plasminogen Activator;Tissue-Type Plasminogen Activator;Tissue-type plasminogen activator;Recombinant Tissue Plasminogen Activator;recombinant tissue plasminogen activator;T Plasminogen Activator;T-Plasminogen Activator;T-plasminogen activator;t-plasminogen activator;T-PA;t-PA;t-pa;T-PA - tissue-type plasminogen activator;TPA;Tpa;tPA;tpa;Tisokinase;Tissue Activator D 44;Tissue Activator D-44;Tissue plasminogen activator preparation;Tissue-type plasminogen activator preparation;r-tPA;rt-PA;rt-PA preparation;t-PA preparation|C0032143|||C0032143;C0039654;C1367601;C1623117;C1706149|CHV;CSP;GO;LNC;MSH;MTH;NCI;NDFRT;OMIM;PDQ;RXNORM;SNOMEDCT;VANDF|1|0.01|
TPA|ALTEPLASE,RECOMBINANT||||C0032143|NDFRT;VANDF|||
TPA|Activase|C0032143;C0701942|||C0032143|NCI|||
TPA|Alteplase (product)||||C0032143|SNOMEDCT|||
TPA|Alteplase (substance)||||C0032143|SNOMEDCT|||
TPA|Alteplase - chemical||||C0032143|SNOMEDCT|||
TPA|Alteplase - chemical (substance)||||C0032143|SNOMEDCT|||
TPA|PLASMINOGEN ACTIVATOR, TISSUE;Plasminogen Activator, Tissue;Tissue Plasminogen Activator;Tissue plasminogen activator;plasminogen activator, tissue;tissue plasminogen activator|C0032143;C1367601|1|0.998|C0032143;C1367601|CHV;CSP;HUGO;MSH;NCI;NDFRT;OMIM;SNOMEDCT|||1
TPA|PLAT||||C0032143;C1367601|HUGO;NCI;OMIM|||
TPA|PLAT Gene;PLAT gene;Plasminogen Activator, Tissue Gene|C1367601|||C1367601|HUGO;MTH;NCI|||
TPA|PLAT wt Allele;Plasminogen Activator, Tissue wt Allele|C1706149|||C1706149|MTH;NCI|||
TPA|PMA|C0039654;C0048451;C2825188|||C0039654|NCI;PDQ|||
TPA|PMA (phorbol myristate acetate)||||C0039654|CSP|||
TPA|Plasminogen Activator (Human Tissue-Type Protein Moiety)||||C0032143|NCI|||
TPA|T-plasminogen activator (substance)||||C0032143|SNOMEDCT|||
TPA|TPA (tetradecanoylphorbol acetate)||||C0039654|CSP|||
TPA|TPA (tissue plasminogen activator)||||C0032143|CSP|||
TPA|TTPA|C0032143;C1421223|||C0032143|MSH;NDFRT|||
TPA|Terephthalic acid|C0076117|||||1|0.0089|
TPA|Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-||||C0039654|MSH;NDFRT|||
TPA|Tetradecanoylphorbol Acetate [Chemical/Ingredient]||||C0039654|NDFRT|||
TPA|Tissue Plasminogen Activator [Chemical/Ingredient]||||C0032143|NDFRT|||
TPA|Tissue plasminogen activator (substance)||||C0032143|SNOMEDCT|||
TPA|Tissue plasminogen activator preparation (product)||||C0032143|SNOMEDCT|||
TPA|Tissue plasminogen activator preparation (substance)||||C0032143|SNOMEDCT|||
TPA|Treponema pallidum agglutination||||||||1
TPA|phorbol 12-myristate 13-acetate||||||1|0.0727|
TPA|phorbol diester||||||1|0.0041|
TPA|phorbol ester|C0031586|||||1|0.1229|
TPA|phorbol ester 12-0-tetradecanoylphorbol-13-acetate||||||1|0.01|
TPA|phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate||||||1|0.0644|
TPA|phorbol ester 12-O-tetradecanoylphorbol-13-acetate||||||1|0.2014|
TPA|tannic acid, polyphosphomolybdic acid, and amido acid||||||||1
TPA|taurine-pyruvate aminotransferase activity;taurine:pyruvate aminotransferase activity|C1623117|||C1623117|GO;MTH|||
TPA|temporary portacaval anastomosis||||||||1
TPA|temporopolar artery||||||||1
TPA|tetradecanoylphorbol-13-acetate||||||1|0.0112|
TPA|texture profile analysis||||||1|0.0071|
TPA|third-party administrator||||||||1
TPA|thrombotic pulmonary artery||||||||1
TPA|time-resolved phosphorescence anisotropy||||||1|0.0083|
TPA|tissue polypeptide antigen|C0076729|||C0076729|LNC;MSH;MTH;NDFRT;SNOMEDCT|||1
TPA|tissue type|C0019633;C2713035|||||1|0.0177|
TPA|tissue-type PA||||||1|0.0892|
TPA|total parenteral alimentation||||||||1
TPA|total phobic anxiety||||||||1
TPA|tripropylamine|C0382766|||||1|0.0059|
TPA|tumor polypeptide antigen||||||||1
TPA|tumor promoter|C0041370|||||1|0.0059|
TPA|tumor promoter 12-0-tetradecanoyl-phorbol-13-acetate||||||1|0.01|
TPA|tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate||||||1|0.0313|
TPA|tumor promoter 12-O-tetradecanoylphorbol-13-acetate||||||1|0.1483|
TPA|two-photon absorption||||||1|0.0077|
TPN|Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt||||C0027303|MSH;NDFRT|||
TPN|COENZYME A A 02||||C0027303|MSH|||
TPN|Central hyperalimentation;Hyperalimentation, Parenteral;Parenteral Hyperalimentation;Parenteral hyperalimentation;Nutrition, Total Parenteral;Parenteral Nutrition, Total;Total Parenteral Nutrition;Total parenteral nutrition;total parenteral nutrition;Parenteral infusion of concentrated nutritional substances;Superalimentation;Suralimentation;TPN (total parenteral nutrition);TPN - Total parenteral nutrition;total parenteral nutrition (TPN);TPN procedure;Total parenteral nutrition administration|C0030548|1|1|C0030548|CHV;CSP;ICD9CM;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.9815|1
TPN|Coenzyme II;Dinucleotide Phosphate, Nicotinamide-Adenine;Nicotinamide Adenine Dinucleotide Phosphate;Nicotinamide adenine dinucleotide phosphate;Nicotinamide-Adenine Dinucleotide Phosphate;Phosphate, Nicotinamide-Adenine Dinucleotide;nicotinamide adenine dinucleotide phosphate;nicotinamide-adenine dinucleotide phosphate;NAD phosphate;NAD(H) phosphate;NADH phosphate;NADP;nadp;NADPH;nadph;Nucleotide, Triphosphopyridine;Triphosphopyridine Nucleotide;triphosphopyridine nucleotide;nicotinamide adenine dinucleotide phosphate (NADP)|C0027303|||C0027303|AOD;CHV;CSP;MSH;MTH;NCI;NDFRT;SNOMEDCT|||1
TPN|Hyperalimentation;hyperalimentation|C0020505;C0030548;C1368829|||C0030548|CHV;MEDLINEPLUS;MTHICD9;NCI;SNOMEDCT|||
TPN|NADP [Chemical/Ingredient]||||C0027303|NDFRT|||
TPN|Nicotinamide adenine dinucleotide phosphate (substance)||||C0027303|SNOMEDCT|||
TPN|Parent infus nutrit sub||||C0030548|ICD9CM|||
TPN|TAP binding protein (tapasin)||||C1420583|HUGO|||
TPN|TAP-BINDING PROTEIN||||C1420583|OMIM|||
TPN|TAPA|C0617168;C1420583|||C1420583|HUGO|||
TPN|TAPASIN|C0664943;C1420583|||C1420583|OMIM|||
TPN|TAPBP;TAPBP gene;TPN;TPSN|C1420583|||C0027303;C0030548;C1420583|CHV;DXP;HUGO;LNC;MEDLINEPLUS;MSH;MTH;MTHICD9;NCI;OMIM;SNOMEDCT|||
TPN|Total parenteral nutrition (procedure)||||C0030548|SNOMEDCT|||
TPN|Total parenteral nutrition (regime/therapy)||||C0030548|SNOMEDCT|||
TPN|hyperalimentation therapy|C0030548;C0204706|||C0030548|CHV;CSP|||
TPN|parenteral alimentation|C0030547;C0030548;C0204706|||C0030548|CHV|||
TPN|parenteral nutrition|C0030547;C0030548|||C0030548|NCI|||
TPN|thalamic projection neuron||||||||1
TPN|total parenteral||||||1|0.0025|
TPN|total parenteral nutrient||||||1|0.016|
TR|CD71||||C1619635|LNC;NCI|||
TR|CD71 Antigen;CD71 antigen;Lymphocyte antigen CD71;Transferrin Receptor Protein 1|C1619635|||C1619635|MSH;MTH;NCI;SNOMEDCT|||
TR|CF2R|C1366449;C1705939|||C1366449;C1705939|HUGO;NCI;OMIM|||
TR|COAGULATION FACTOR II RECEPTOR;F2R;PROTEASE-ACTIVATED RECEPTOR 1|C0668084;C1366449|||C1366449|HUGO;NCI;OMIM|||
TR|CT120.2;HPP1;HYPERPLASTIC POLYPOSIS GENE 1;TENB2;TMEFF2;TMEFF2 gene;TOMOREGULIN;tomoregulin;TPEF;cancer/testis antigen family 120, member 2;transmembrane protein TENB2|C1420775|||C1420775|HUGO;MTH;OMIM|||
TR|Coagulation Factor II (Thrombin) Receptor Gene||||C1366449|NCI|||
TR|Coagulation Factor II (Thrombin) Receptor wt Allele||||C1705939|NCI|||
TR|Country of Turkey;Turkey (country);Turkey - country|C0041400|||C0041400|CSP;MTH;SNOMEDCT|||
TR|F2R Gene;F2R gene|C1366449|||C1366449|HUGO;MTH;NCI|||
TR|F2R wt Allele|C1705939|||C1705939|MTH;NCI|||
TR|Lymphocyte antigen CD71 (substance)||||C1619635|SNOMEDCT|||
TR|PAR-1;PAR1|C1366449;C1414387|||C1366449;C1705939|HUGO;NCI;OMIM|||
TR|Repetition Time;repetition time;time to repetition|C2826099|||C2826099|MTH;NCI|1|0.1558|1
TR|SCARNA19;TELOMERASE RNA CANDIDATE 3;TERC Gene;TERC gene;Telomerase RNA Component Gene;small Cajal body-specific RNA 19|C1366448|||C1366448|HUGO;MTH;NCI;OMIM|||
TR|SELENOPROTEIN Z;selenoprotein Z;SELZ;THIOREDOXIN REDUCTASE, MITOCHONDRIAL;TRXR2;TXNRD2;TXNRD2 gene;thioredoxin reductase beta|C1425351|||C1425351|HUGO;MTH;OMIM|||
TR|T regulatory;regulatory T||||||1|0.0369|
TR|T9|C1179693;C1418972;C1619635|||C1619635|NCI|||
TR|TELOMERASE RNA COMPONENT;telomerase RNA component;hTR|C0935992;C1366448|||C1366448|HUGO;OMIM|||
TR|TERC|C0935992;C1366448;C1705312|||C1366448;C1705312|HUGO;NCI;OMIM|||
TR|TERC wt Allele;Telomerase RNA Component wt Allele|C1705312|||C1705312|MTH;NCI|||
TR|TFR||||C1619635|NCI|||
TR|TFR1;Transferrin Receptor 1|C1420708;C1619635|||C1619635|NCI|||
TR|TFRC;TRFR|C1420708;C1619635;C1705610|||C1619635|NCI|||
TR|THIOREDOXIN REDUCTASE 2;thioredoxin reductase 2|C1258336;C1425351|||C1425351|HUGO;OMIM|||
TR|THROMBIN RECEPTOR;thrombin receptor|C0076552;C0668084;C1366449|||C0076552;C0668084;C1366449|CSP;MSH;MTH;NCI;NDFRT;OMIM|||
TR|TR||||C0040733;C0041400;C0332121;C1366448;C1366449;C1420775;C1425351;C1619635;C1705312;C1705939;C2826099|HUGO;MSH;NCI;OMIM;SNOMEDCT|||
TR|TR-BETA|C0242469;C1425351|||C1425351|OMIM|||
TR|TR3||||C1425351|HUGO;OMIM|||
TR|TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2||||C1420775|OMIM|||
TR|TRANSPL||||C0040733|MSH|||
TR|TRC3|C1366448;C1705312|||C1366448;C1705312|HUGO;NCI;OMIM|||
TR|TU|C1532464;C2700314|||C0041400|NCI|||
TR|TUR||||C0041400|NCI|||
TR|TURKEY;Turkey;turkey|C0041400;C0325628;C2348826|||C0041400|AOD;CHV;LCH;MSH;NCI|||
TR|Texas red|C0076359|||||1|0.0072|
TR|Thiazin red|C0963609|||||1|0.0043|
TR|Thioredoxin reductase;thioredoxin reductase|C0039941|||C0039941|CSP;MSH;NDFRT|1|0.058|1
TR|Tiazofurin;tiazofurin|C0076656|||C0076656|MSH;NCI;PDQ|1|0.013|
TR|Transferrin Receptor;transferrin receptor|C0034845;C1420708;C1619635|||C0034845;C1420708;C1619635|CHV;CSP;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||
TR|Treatment required for||||C0332121|MTH;SNOMEDCT|||
TR|Treatment required for (contextual qualifier)||||C0332121|SNOMEDCT|||
TR|Treatment required for (contextual qualifier) (qualifier value)||||C0332121|SNOMEDCT|||
TR|Turkey - country (geographic location)||||C0041400|SNOMEDCT|||
TR|Turnover rates;turnover rate||||||1|0.0043|1
TR|coagulation factor II (thrombin) receptor||||C1366449|HUGO|||
TR|human transferrin receptor||||||1|0.008|
TR|p90|C1413107;C1537472;C1619635|||C1619635|NCI|||
TR|ratio|C0456603;C1547037|||||1|0.0145|
TR|recovery time||||||||1
TR|rectal temperature|C0489749|||C0489749|CHV;SNOMEDCT|1|0.0486|1
TR|recurrence|C0034897;C1458156;C2825055|||||1|0.0065|
TR|repetition|C0205341|||||1|0.0101|
TR|residual tuberculin||||||||1
TR|resistance|C0237834;C1514892|||||1|0.0109|
TR|resistant|C0332325;C2827757|||||1|0.0065|
TR|response|C0871261;C1704632;C1706817;C2911692|||||1|0.0101|
TR|retention times||||||1|0.0058|
TR|tandem repeat|C0039290|||C0039290|CHV;MSH|1|0.0116|
TR|taste reactivity||||||1|0.013|
TR|temperature-resistant||||||1|0.0065|
TR|terminal repeat|C0039551|||C0039551|MSH|1|0.0268|1
TR|tetrazolium reduction||||||||1
TR|therapeutic radiology|C0243004;C0243005;C1522449|||C0243004;C0243005;C1522449;C1555882|CCS;HL7V3.0;MSH;NCI;SNOMEDCT|||1
TR|therapeutic reaction||||||||1
TR|therapeutic recreation|C0034873|||||||1
TR|thyroid hormone|C0040135|||||1|0.0101|
TR|thyroid hormone receptor|C0034843|||C0034843|CHV;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.2333|1
TR|time to repeat||||||||1
TR|time-resolved||||||1|0.0065|
TR|timed release||||||||1
TR|tincture|C0991583|||||||1
TR|to return||||||||1
TR|total repair||||||||1
TR|total resistance||||||||1
TR|total response||||||||1
TR|trace|C0442822;C1883002|||||||1
TR|trachea|C0040578;C1278905;C3146235|||C0040578;C0040580;C1278905;C3146235|AOD;CHV;CSP;CST;FMA;LCH;LNC;MSH;MTH;NCBI;NCI;SNOMEDCT;UWDA|1|0.0065|1
TR|trained;training|C0040607;C0220931;C2673163|||C0040607;C0220931;C1554161;C2673163|CSP;HL7V2.5;HL7V3.0;MSH;MTH;NCI;SNOMEDCT|1|0.0312|
TR|transferrin|C0040679;C1442762|||C0040679;C0202105;C1442762|AOD;CHV;CSP;HUGO;LCH;LNC;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0116|
TR|transfusion reaction|C0274435|||||||1
TR|transitional region|C1704529|||||1|0.0051|
TR|transmembrane protein with EGF-like and two follistatin-like domains 2||||C1420775|HUGO|||
TR|transplant recipient|C0376387|||||||1
TR|transplantation|C0029216;C0040732;C0040733|||C0040733|MSH|||
TR|transplantation aspects|C0040733|||C0040733|MTH|||
TR|transport rate||||||1|0.0116|
TR|transrectal|C0205518|||||||1
TR|transverse relaxation||||||||1
TR|trapezius|C0224361;C1305027|||||1|0.0072|
TR|treadmill running||||||1|0.0109|
TR|treatment|C0039798;C0087111;C1522326;C1533734;C1705169;C3161471|||||||1
TR|trembler||||||1|0.0116|
TR|tremor|C0040822;C1963252|||C0040822;C1963252|AOD;CHV;COSTAR;CSP;CST;DXP;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|||1
TR|trenimon|C0917860|||C0917860|MSH|||
TR|triamcinolone|C0040864|||C0040864|CHV;CSP;LCH;LNC;MSH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;USPMG;VANDF|||
TR|tricuspid regurgitation|C0040961|1|1.000|||1|0.1543|1
TR|triiodothyronine receptor||||||||1
TR|triradial||||||||1
TR|trp repressor|C0077443|||||1|0.0043|
TR|true reading||||||||1
TR|trypanothione reductase|C0077419|||||1|0.0304|
TR|trypsin|C0041236|||C0041236|AOD;CHV;CSP;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;RXNORM;SNOMEDCT;SPN;VANDF|1|0.0065|
TR|tuberculin Ruckland||||||||1
TR|tuberculin residue||||||||1
TR|tubular resorption||||||||1
TR|tumor registry|C1976635|||||||1
TR|turbidity reducing||||||||1
TSH|Hormone, Thyroid-Stimulating;Thyroid Stimulating Hormone;Thyroid stimulating hormone;Thyroid-Stimulating Hormone;thyroid stimulating hormone;thyroid-stimulating hormone;TSH (Thyroid Stimulating Hormone);TSH - Thyroid stimulating hormone;thyroid stimulating hormone (TSH)|C0040160;C0696098;C1535531|1|1|C0040160;C0202230|CHV;CSP;MSH;MTH;NCI;NDFRT;PDQ;SNOMEDCT|1|0.5193|1
TSH|TSH||||C0040160;C0202230|CHV;CSP;NCI;SNOMEDCT|||
TSH|TSH - Thyroid stimulating hormone level;TSH - thyroid stimulating hormone (& level);TSH level;TSH measurement;Thyroid Stimulating Hormone Measurement;Thyroid stimulating hormone measurement;Thyrotropin Measurement;Thyrotropin measurement;Thyrotropin stimulating hormone measurement|C0202230|||C0202230|MTH;NCI;SNOMEDCT|||
TSH|TSH - thyroid stim. hormone||||C0202230|SNOMEDCT|||
TSH|TSH - thyroid stimulating hormone (& level) (procedure)||||C0202230|SNOMEDCT|||
TSH|TSH preparation;Thyreotropin;Thyrotrophin product;Thyrotropic hormone preparation;thyrotropic hormone|C0040160|||C0040160|CHV;MSH;NCI;NDFRT;SNOMEDCT|||
TSH|Thyroid Stimulating Hormone [EPC]|C0040160;C2825077|||C0040160|NDFRT|||
TSH|Thyroid stimulating hormone (& level);Thyroid stimulating hormone level|C0202230;C0428414|||C0202230|SNOMEDCT|||
TSH|Thyroid stimulating hormone (& level) (procedure)||||C0202230|SNOMEDCT|||
TSH|Thyroid stimulating hormone (substance)||||C0040160|SNOMEDCT|||
TSH|Thyroid stimulating hormone measurement (procedure)||||C0202230|SNOMEDCT|||
TSH|Thyrotrophic hormone product||||C0040160|SNOMEDCT|||
TSH|Thyrotrophin;Thyrotropin;thyrotrophin;thyrotropin|C0040160;C1535531|||C0040160;C0202230|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;NCI;NDFRT;PDQ;RXNORM;SNOMEDCT;UWDA|1|0.4623|
TSH|Thyrotrophin product (product)||||C0040160|SNOMEDCT|||
TSH|Thyrotrophin product (substance)||||C0040160|SNOMEDCT|||
TSH|Thyrotropic hormone preparation (product)||||C0040160|SNOMEDCT|||
TSH|Thyrotropic hormone preparation (substance)||||C0040160|SNOMEDCT|||
TSH|Thyrotropin [Chemical/Ingredient]||||C0040160|NDFRT|||
TSH|anti-thyrotropin||||||1|0.0025|
TSH|gene teashirt||||||1|0.0015|
TSH|serum thyrotrophin||||||1|0.0081|
TSH|temperature-sensitive hemagglutinin||||||1|0.0019|
TSH|thyroid stimulating hormone (TSH) test||||C0202230|CHV|||
TSH|thyrotropic||||||1|0.0023|
TSH|thyrotropine||||||1|0.0021|
TTP|2'-deoxythymidine-5'-triphosphate;Deoxythymidine triphosphate;deoxythymidine triphosphate;Thymidine triphosphate;thymidine triphosphate;dTTP;thymidine 5'-triphosphate|C0076582|||C0076582|CSP;MSH;MTH;SNOMEDCT|1|0.0099|1
TTP|A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13||||C1413036|OMIM|||
TTP|ADAM metallopeptidase with thrombospondin type 1 motif, 13||||C1413036|HUGO|||
TTP|ADAMTS13;ADAMTS13 gene;DKFZp434C2322;FLJ42993;MGC118899;MGC118900;VWFCP;vWF-CP|C1413036|||C1413036|HUGO;MTH;OMIM|||
TTP|Congenital Thrombotic Thrombocytopenic Purpura;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL;Thrombotic Thrombocytopenic Purpura, Congenital;Familial Thrombotic Microangiopathies;Familial Thrombotic Microangiopathy;Microangiopathies, Familial Thrombotic;Microangiopathy, Familial Thrombotic;THROMBOTIC MICROANGIOPATHY, FAMILIAL;Thrombotic Microangiopathies, Familial;Thrombotic Microangiopathy, Familial;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;SCHULMAN-UPSHAW SYNDROME;Schulman Upshaw Syndrome;Schulman-Upshaw Syndrome;Syndrome, Schulman-Upshaw;Syndrome, Upshaw-Schulman;UPSHAW-SCHULMAN SYNDROME;Upshaw Schulman Syndrome;Upshaw-Schulman Syndrome;Upshaw-Schulman syndrome;USS|C1268935|||C1268935|MSH;MTH;OMIM;SNOMEDCT|||
TTP|Deoxythymidine triphosphate (substance)||||C0076582|SNOMEDCT|||
TTP|Disease, Moschcowitz;Moschcowitz Disease;Disease, Moschkowitz;Moschkowitz Disease;MOSCHCOWITZ SYNDROME;Moschcowitz syndrome;Moschcowitz's syndrome;moschcowitz's syndrome;Moschowitz Disease;PURPURA THROMBOPENIC THROMBOTIC;Purpura, Thrombotic Thrombopenic;Purpuras, Thrombotic Thrombopenic;Thrombopenic Purpura, Thrombotic;Thrombopenic Purpuras, Thrombotic;Thrombotic Thrombopenic Purpura;Thrombotic Thrombopenic Purpuras;thrombotic thrombopenic purpura;PURPURA, THROMBOCYTOPENIC, THROMBOTIC;Purpura, Thrombotic Thrombocytopenic;Purpuras, Thrombotic Thrombocytopenic;THROMBOTIC THROMBOCYTOPENIC PURPURA;Thrombocytopenic Purpura, Thrombotic;Thrombocytopenic Purpuras, Thrombotic;Thrombotic Thrombocytopenic Purpura;Thrombotic Thrombocytopenic Purpuras;Thrombotic thrombocytopenic purpura;thrombotic thrombocytopenic purpura;PURPURA, THROMBOHEMOLYTIC;TTP - Thrombotic thrombocytopenic purpura;thrombotic thrombocytopenic purpura (TTP)|C0034155|1|1|C0034155|CHV;COSTAR;CST;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;QMR;SNOMEDCT|1|0.6341|1
TTP|Familial TTP/HUS||||C1268935|SNOMEDCT|||
TTP|Familial thrombotic thrombocytopenic purpura / haemolytic uraemic syndrome;Familial thrombotic thrombocytopenic purpura / hemolytic uremic syndrome||||C1268935|SNOMEDCT|||
TTP|G0S24;NUP475;RNF162A;TIS11;ZFP36;ZFP36 gene|C1421571|||C1421571|HUGO;MTH;OMIM|||
TTP|MICROANGIOPATHIC HEMOLYTIC ANEMIA|C0221021;C1268935|||C1268935|OMIM|||
TTP|MOSCHKOWITZ DIS||||C0034155|MSH|||
TTP|Moschowitz's syndrome|C0034155;C2584778|||C0034155|SNOMEDCT|||
TTP|Purpura, Thrombotic Thrombocytopenic [Disease/Finding]||||C0034155|NDFRT|||
TTP|TRISTETRAPROLIN|C0084795;C1421571|||C1421571|OMIM|||
TTP|TTP;ttp;Time to Progression;Time to progression;time to progression|C2985467|||C0034155;C0076582;C1268935;C1413036;C1421571;C2985467|CHV;DXP;HUGO;MSH;MTH;NCI;OMIM;SNOMEDCT|1|0.1821|1
TTP|Testicular Tumor Panel||||||||1
TTP|Thrombotic thrombocytopenic purpura (disorder)||||C0034155|SNOMEDCT|||
TTP|Thrombotic thrombocytopenic purpura [Ambiguous]||||C0034155|SNOMEDCT|||
TTP|Tolpa Torf Preparation|C0248452|||||1|0.0066|
TTP|UPSHAW FACTOR, DEFICIENCY OF;Upshaw Factor, Deficiency of||||C1268935|MSH;OMIM|||
TTP|Upshaw-Schulman syndrome (disorder)||||C1268935|SNOMEDCT|||
TTP|VON WILLEBRAND FACTOR-CLEAVING PROTEASE|C0389918;C1413036|||C1413036|OMIM|||
TTP|ZINC FINGER PROTEIN 36, MOUSE, HOMOLOG OF||||C1421571|OMIM|||
TTP|protein tristetraprolin||||||1|0.0083|
TTP|temporary transvenous pacemaker||||||||1
TTP|tender to palpation||||||||1
TTP|tender to pressure||||||||1
TTP|thiamin triphosphate;thiamine triphosphate|C0039853|||||1|0.0183|
TTP|thymidine 5'-(tetrahydrogen triphosphate)||||C0076582|MSH|||
TTP|thymidine 5'-triphosphate (TTP)||||C0076582|CHV|||
TTP|thyrotoxic paralysis||||||||1
TTP|time to peak|C2923471|||C2923471|LNC|1|0.053|1
TTP|time to peak contraction||||||1|0.0066|
TTP|time to peak tension||||||1|0.0124|
TTP|time to pregnancy||||||1|0.0248|1
TTP|time to tumor progression||||||1|0.0439|1
TTP|transtrabecular plane||||||||1
TTP|transtubercular plane|C0458356|||||||1
TTP|zinc finger protein 36, C3H type, homolog (mouse)||||C1421571|HUGO|||
TURP|Endoscopic prostatectomy;Endoscopic resection of prostate;Loop prostatectomy;Prostate Resection, Transurethral;Prostate Resections, Transurethral;Prostate Transurethral Resection;Prostate Transurethral Resections;Resection, Transurethral Prostate;Resections, Transurethral Prostate;Transurethral Prostate Resection;Transurethral Prostate Resections;Transurethral Resection of Prostate;Transurethral Resection of the Prostate;Transurethral resection of prostate;transurethral prostate resection;transurethral resection of prostate;transurethral resection of the prostate;Prostatectomies, Transurethral;Prostatectomy, Transurethral;TRANSURETHRAL PROSTATECTOMY;Transurethral Prostatectomies;Transurethral Prostatectomy;Transurethral prostatectomy;Transurethral prostatectomy NOS;Transurethral prostatectomy, NOS;transurethral prostatectomy;TUR of prostate;TUR of prostate, NOS;TURP;TURPs;turp;TURP - Transurethral resection of prostate;Transurethral resection of prostate (TURP);transurethral resection of prostate (TURP);Transurethral Prostatic Resection;transurethral prostatic resection|C0040771|1|1|C0040771|CCS;CHV;COSTAR;ICD9CM;LCH;MSH;MTH;MTHICD9;NCI;SNOMEDCT|1|0.9516|1
TURP|TURP (transurethral resection of prostate gland)||||C0040771|CSP|||
TURP|Transurethral prostatectomy (procedure)||||C0040771|SNOMEDCT|||
TURP|transurethral resection|C1519630|||||1|0.0483|
TV|Ellice Islands;TUV;TUVALU;Tuvalu;Tuvala|C0041413|||C0041413|AOD;MSH;MTH;NCI;SNOMEDCT|||
TV|TV;t.v.;tv|C0039461;C0040210|||C0039461;C0041413;C1704705|AOD;CHV;NCI|||
TV|Tacaribe virus|C1304600|||||1|0.0235|
TV|Television;Televisions;television;televisions|C0039461|||C0039461|AOD;CHV;CSP;LCH;MSH;MTH;SNOMEDCT|1|0.2549|1
TV|Television (physical object)||||C0039461|SNOMEDCT|||
TV|Tellina virus|C1653138|||||||1
TV|Thermoactinomyces vulgaris|C0318210|||||||1
TV|Trial Visits;trial visit||||C1704705|NCI|||1
TV|Trial Visits Domain||||C1704705|MTH;NCI|||
TV|Trichomonas vaginalis|C0040922|||||1|0.1373|1
TV|Tuvala (geographic location)||||C0041413|SNOMEDCT|||
TV|talipes varus|C0158722|||||||1
TV|target volume||||||||1
TV|temporary visit||||||||1
TV|tetrazolium violet|C2603970|||||||1
TV|thoracic vertebra|C0039987;C1269050|||||||1
TV|thyroid volume||||||||1
TV|tick-borne virus|C0206549|||||||1
TV|tidal volume|C0040210|1|0.014|||1|0.251|1
TV|tonic vergence||||||||1
TV|total volume||||||||1
TV|toxic vertigo||||||||1
TV|transfer vesicle||||||||1
TV|transvaginal|C0175672|||||1|0.051|1
TV|transvenous|C0522521|||||||1
TV|transverse|C0205106;C0446380|||||||1
TV|tricuspid valve|C0040960;C1269006|||||1|0.1843|1
TV|trivalent||||||||1
TV|true vertebra||||||||1
TV|truncal vagotomy|C0042275|||||1|0.098|1
TV|tuberculin volutin||||||||1
TV|tubulovesicular||||||||1
TV|tumor virus|C0029017|||||||1
TV|typhoid vaccine|C0041469|||||||1
UA|Laboratory: urine examination||||C0042014|AIR|||
UA|UA|C0041580;C0042014|||C0041580;C0042014|LNC;NCI|||
UA|UKR;UKRAINE;Ukraine;ukraine|C0041580|||C0041580|AOD;CHV;CSP;LCH;MSH;MTH;NCI;SNOMEDCT|||
UA|UP||||C0041580|NCI|||
UA|Ukraine (geographic location)||||C0041580|SNOMEDCT|||
UA|Ulex agglutinin||||||||1
UA|Urinalyses;Urinalysis;Urinalysis, NOS;urinalyses;urinalysis;Urinalysis (procedure);Urinalysis Procedures;Urinalysis procedure;Urinalysis procedure, NOS;Urine examination;examination urine;urine examination;Urine test NOS (procedure);procedures test urine;urine test procedure;analysis urine;urine analysis;testings urine|C0042014|1|1|C0042014|AOD;CHV;CSP;LNC;MSH;MTH;MTHCH;NCI;SNOMEDCT|1|0.0174|1
UA|Urinalysis - general||||C0042014|SNOMEDCT|||
UA|Urinalysis studies||||C0042014|LNC|||
UA|Urine exam. - general;Urine exam. - general NOS;general urine exam|C0042014;C0205246;C1553889|||C0042014|CHV;SNOMEDCT|||
UA|Urine exam. - general NOS (procedure)||||C0042014|SNOMEDCT|||
UA|Urine examination (procedure)||||C0042014|SNOMEDCT|||
UA|Urine examination - general;Urine examination - general NOS||||C0042014|SNOMEDCT|||
UA|Urine examination - general (procedure);Urine examination - general NOS (procedure)||||C0042014|SNOMEDCT|||
UA|Urine test;Urine test NOS;test urine;tested urine;testing urine;tests urine;urine test|C0042014;C1263430|||C0042014|CHV;SNOMEDCT|||
UA|activity|C0026606;C0205177;C0439167;C0441655;C1561536|||||1|0.0105|
UA|aldosterone|C0002006|||||1|0.0105|
UA|ultraaudible||||||||1
UA|ultrasonic arteriogram||||||||1
UA|ultrasonic arteriograph||||||||1
UA|ultrasonic arteriography||||||||1
UA|umbilical arterial||||||1|0.0233|
UA|umbilical artery|C0041632;C1280618|||C0041632;C1280618|CHV;FMA;LNC;MSH;NCI;SNOMEDCT;UWDA|1|0.1826|1
UA|unaggregated||||||||1
UA|unauthorized absence||||||||1
UA|uncertain about||||||||1
UA|undifferentiated arthritis||||||1|0.0198|
UA|unicystic ameloblastoma|C0457521|||||||1
UA|unit of analysis||||||||1
UA|unrelated apart||||||||1
UA|unstable angina;unstable angina pectoris|C0002965|||C0002965|CHV;MSH;MTHICD9;NCI;NDFRT;SNOMEDCT|1|0.2919|1
UA|upper airway;upper airways||||||1|0.1163|1
UA|upper arm|C0446516;C1269612|||C0446516;C1269612|AOD;CHV;LNC;MTH;SNOMEDCT|||1
UA|uranyl acetate|C0077854|||C0077854|MSH|1|0.0174|
UA|urethra|C0041967;C1281574;C1550675|||||||1
UA|uric acid|C0041980;C0202239|||C0041980;C0202239|AOD;CHV;LCH;MSH;MTH;NCI;NDFRT;SNOMEDCT|1|0.286|1
UA|uridylic acid|C0042002|||C0042002|CHV;MSH;NDFRT;SNOMEDCT|||
UA|urinalysys||||C0042014|CHV|||
UA|urinary aldosterone|C0852887|||C0852887|CHV|||1
UA|urinary amylase||||||1|0.0128|
UA|urine aliquot||||||||1
UA|urine analysi||||C0042014|CHV|||
UA|urocanic acid|C0042054|||||||1
UA|uronic acid|C0042081|||C0042081|SNOMEDCT|||
UA|ursolic acid|C0077938|||C0077938|CHV;MSH|||
UA|uterine arteries;uterine artery|C0226378;C1280153|||C0226378;C1280153|CHV;FMA;LNC;MSH;SNOMEDCT;UWDA|1|0.0116|1
UA|uterine aspiration||||||||1
UC|Uldall catheter||||||||1
UC|University of California||||||1|0.0607|
UC|controls||||||1|0.0364|
UC|ulcerative colitis|C0009324|1|0.016|C0009324|AIR;AOD;CHV;COSTAR;CSP;CST;ICD9CM;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;QMR;SNOMEDCT|1|0.0364|1
UC|ultracentrifugal||||||||1
UC|ultracentrifugation|C0041609|||C0041609|AOD;CSP;MSH;SNOMEDCT|1|0.0526|
UC|umbilical cholesterol||||||||1
UC|umbilical cord|C0041633;C1281286|||C0041633;C1281286|AOD;CHV;CSP;FMA;LCH;LNC;MSH;NCI;SNOMEDCT|1|0.1377|1
UC|unchanged|C0442739;C2346711|||||||1
UC|unclassifiable||||||||1
UC|unconscious|C0041657|||||||1
UC|undifferentiated carcinoma|C0205698|||C0205698|CHV;MSH;MTH;NCI;SNOMEDCT|1|0.0486|1
UC|undifferentiated cells||||||||1
UC|unesterified cholesterol|C0368909|||C0368909|SNOMEDCT|1|0.17|
UC|unfixed cryostat||||||||1
UC|universal coverage|C0376640|||C0376640|MSH|||
UC|unsatisfactory condition||||||||1
UC|untreated cell||||||||1
UC|urea clearance|C0428604;C1318428|||||||1
UC|urethral catheter|C0179800|||||||1
UC|urethral catheterization|C0042019;C1455681|||||||1
UC|urgent care|C1552460;C2362545|1|0.002|||||
UC|urinary catheter|C0179802|||||||1
UC|urinary catheterization|C0042019|||||||1
UC|urine concentrate||||||||1
UC|urine culture|C0430404|1|0.974|||||1
UC|urothelial carcinoma|C0007138|||C0007138|CHV;NCI;SNOMEDCT|1|0.0526|
UC|usual care||||||1|0.3563|1
UC|uterine contraction;uterine contractions|C0042130|||C0042130|CHV;DXP;MSH;NCI;SNOMEDCT|1|0.0486|1
URI|C19orf2;C19orf2 gene;FLJ10575;NNX3 PROTEIN;UNCONVENTIONAL PREFOLDIN RPB5 INTERACTOR;unconventional prefoldin RPB5 interactor;chromosome 19 open reading frame 2|C1421895|||C1421895|HUGO;MTH;OMIM|||
URI|INFECT UPPER RESPIRATORY;UPPER RESPIRATORY INFECT||||C0041912|MSH|||
URI|INFECTION UPPER RESPIRATORY;Infections, Upper Respiratory;Respiratory Infection, Upper;UPPER RESPIRATORY INFECTION;Upper Respiratory Infections;Upper respiratory infection;Upper respiratory infection NOS;Upper respiratory infection, NOS;upper respiratory infection;upper respiratory infections;INFECTION, UPPER RESPIRATORY TRACT;Infection of the upper respiratory tract;Infections, Upper Respiratory Tract;Upper Respiratory Tract Infection;Upper Respiratory Tract Infections;Upper respiratory tract infection;Upper respiratory tract infection NOS;Upper respiratory tract infections;upper respiratory tract infection;UPPER RESP TRACT INFECTION;URI - Upper respiratory infection;upper respiratory infection (URI);URTI - Infection of the upper respiratory tract;upper respiratory tract infection (URTI)|C0041912|1|1|C0041912|CHV;COSTAR;CST;DXP;MSH;MTH;MTHICD9;NCI;OMIM;SNOMEDCT|1|0.9143|1
URI|Infection of the upper respiratory tract (disorder)||||C0041912|SNOMEDCT|||
URI|NNX3|C1421895;C1708129|||C1421895|HUGO;OMIM|||
URI|RMP|C1412063;C1421895;C1708129|||C1421895|HUGO;OMIM|||
URI|RNA POLYMERASE II, SUBUNIT 5-MEDIATING PROTEIN||||C1421895|OMIM|||
URI|RPB5-MEDIATING PROTEIN||||C1421895|OMIM|||
URI|URI|C0041912;C1421895;C1548524|||C0041912;C1421895;C1548524|DXP;HUGO;NCI;OMIM|||
URI|Uniform Resource Identifier|C1548524|||C1548524|HL7V2.5;MTH;NCI|||
URI|Upper respiratory infection (disorder);Upper respiratory infection NOS (disorder)||||C0041912|SNOMEDCT|||
URI|common cold|C0009443;C0041912|||C0041912|CHV|||
URI|upper respiratory illness||||||1|0.0857|
US|California|C0006754;C0324542;C3146274|||||1|0.0015|
US|Diagnosis (US)||||C0041618|NCI|||
US|Diagnosis, Ultrasound;General ultrasound;Imaging, Ultrasonic;Ultrasonic Imaging;ultrasonic imaging;Imagings, Ultrasonic;Ultrasonic Imagings;Medical Imaging, Ultrasound;Medical Sonography;Sonography, Medical;Sonogram;sonogram;sonograms;US - Ultrasound;USS - Ultrasound scan;Ultrasonogram;ultrasonogram;Ultrasound Test;testing ultrasound;tests ultrasound;ultrasound test;Ultrasound procedure;Ultrasound procedure, NOS;procedure ultrasound;ultrasound procedure;Ultrasound scan;Ultrasound scan, NOS;scan ultrasound;scans ultrasound;ultrasound scan;ultrasound scanning;Ultrasound, Medical;diagnostics ultrasound;sonography;sound measurement|C0041618|||C0041618|AOD;CHV;CSP;LNC;MEDLINEPLUS;MSH;NCI;SNOMEDCT|1|0.0215|
US|Diagnostic Ultrasound;Diagnostic ultrasound;diagnostic ultrasound;ultrasound diagnostic||||C0041618|CCS;CHV;CSP;ICD9CM;NCI|||
US|Diagnostic Ultrasound Procedures;Ultrasound diagnostic procedure;ultrasound diagnostic procedure||||C0041618|CHV;MTHCH;SNOMEDCT|||
US|Diagnostic sonar||||C0041618|SNOMEDCT|||
US|Diagnostic ultrasonography;Diagnostic ultrasonography, NOS||||C0041618|SNOMEDCT|||
US|Diagnostic ultrasonography (procedure)||||C0041618|SNOMEDCT|||
US|ECHOGR||||C0041618|MSH|||
US|ECHOTOMOGR||||C0041618|MSH|||
US|Echography;Echography, NOS;echographies;echography;Echotomographies;Echotomography;echotomography|C0041618;C0175676|||C0041618;C0175676|AOD;CHV;MSH;SNOMEDCT|||
US|Echography (procedure)||||C0041618|SNOMEDCT|||
US|GEN.US||||C0041618|LNC|||
US|Microsecond;microsecond|C0439224|||C0439224|MTH;NCI;SNOMEDCT|||
US|U S;U.S.;UNITED STATES;United States;USA;USA - United States of America;United States of America|C0041703|1|0.804|C0041703|AOD;CHV;CSP;HL7V3.0;LCH;MSH;MTH;NCI;SNOMEDCT|1|0.0538|
US|U.S.A.;u s a;u.s.a.||||C0041703|AOD;CHV|||
US|ULTRASONOGR||||C0041618;C0175676|MSH|||
US|ULTRASOUND;Ultrasound;ultrasound;ultrasounds|C0041618;C0041621;C0220934;C1456803;C1875843|1|0.188|C0041618;C0041621;C0220934;C1456803;C1875843|AOD;CHV;CSP;HL7V2.5;HL7V3.0;MEDLINEPLUS;MSH;NCI;NDFRT;SNOMEDCT;VANDF|1|0.4581|1
US|US;us||||C0041618;C0041703;C0175676;C0439224|AOD;LNC;MSH;NCI;SNOMEDCT|||
US|Ultrasonography;Ultrasonography, NOS;ultrasonography|C0041618;C0162481;C0175676|||C0041618;C0162481;C0175676|AOD;CHV;CSP;MSH;MTH;NCI;PDQ;SNOMEDCT|1|0.3175|1
US|Ultrasonography (procedure)||||C0041618|SNOMEDCT|||
US|Ultrasound Imaging;imaging ultrasound;ultrasound imaging|C0041618;C0701813|||C0041618|CHV;CSP;NCI|1|0.0013|
US|Ultrasound diagnostic procedure (procedure)||||C0041618|SNOMEDCT|||
US|Ultrasound procedure (procedure)||||C0041618|SNOMEDCT|||
US|Ultrasound scan (procedure)||||C0041618|SNOMEDCT|||
US|United States of America (geographic location)||||C0041703|SNOMEDCT|||
US|Usher syndrome|C0271097|||||1|0.0011|
US|short unique;unique short||||||1|0.0078|
US|sonographic||||||1|0.0055|
US|ultrasonic|C0220934;C1456803|||C0220934;C1456803|MSH;MTH|1|0.0062|1
US|ultrasonic diagnosis|C0080351;C0175676|||C0175676|MSH;MTH|||
US|ultrasonograph||||||||1
US|ultrasonographic||||||1|0.0502|
US|ultrasonographically||||||1|0.0032|
US|ultrasound examination|C0948501|||||1|0.0021|
US|ultrasound imaging/scanning||||C0041618|CSP|||
US|ultrasounded;ultrasounding||||C0041618|CHV|||
US|unconditioned stimulus|C0234403|||C0234403|AOD;CHV;MTH;SNOMEDCT|1|0.0703|1
US|undetermined significance|C1272585|||C1272585|CHV|||
US|upper segment|C0442063|||||||1
US|urinary sugar|C0017979|||||||1
US|urine specimen|C0444180|||||||1
US|us (qualifier value)||||C0439224|SNOMEDCT|||
US|use of ultrasonography|C0175676|||C0175676|MTH|||
UTI|A1M;AMBP;AMBP gene;EDC1;HI30;ITILC;inter-alpha-trypsin inhibitor light chain;trypstatin;uristatin;uronic-acid-rich protein|C1412376|||C1412376|HUGO;MTH;OMIM|||
UTI|ALPHA-1 MICROGLOBULIN;BIKUNIN;bikunin;PROTEIN HC;protein HC|C0051266;C1412376|||C1412376|HUGO;OMIM|||
UTI|ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR;alpha-1-microglobulin/bikunin precursor||||C1412376|HUGO;OMIM|||
UTI|COMPLEX-FORMING GLYCOPROTEIN HETEROGENEOUS IN CHARGE;complex-forming glycoprotein heterogeneous in charge||||C1412376|HUGO;OMIM|||
UTI|HCP|C2985545|||C1412376|HUGO;OMIM|||
UTI|IATIL|C1412376;C1867668|||C1412376|HUGO|||
UTI|INFECTION URINARY TRACT;INFECTION, URINARY TRACT;Infection of urinary tract;Infection, Urinary Tract;Infections, Urinary Tract;TRACT, INFECTION OF URINARY;Tract Infection, Urinary;Tract Infections, Urinary;URINARY TRACT INFECTION;Urinary Tract Infection;Urinary Tract Infections;Urinary tract infection;Urinary tract infection (& [NOS]);Urinary tract infection NOS;Urinary tract infection, NOS;Urinary tract infections;urinary tract infection;urinary tract infections;Infection - urinary NOS;Urinary infection NOS;urinary infection;UTI - Urinary tract infection;urinary tract infection (UTI);Urinary tract infection, site not specified;Urinary tract infection, site not specified NOS;Urinary tract infection; site not specified;Urinary tract infectious disease;Urinary tract infectious disease, NOS|C0042029|1|1|C0042029|CCS;CHV;COSTAR;CSP;CST;DXP;ICD9CM;LCH;MEDLINEPLUS;MSH;MTH;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9204|1
UTI|URINARY TRACT INFECT||||C0042029|MSH|||
UTI|UTI;uti;utis|C0042029;C1412376|||C0042029;C1412376|CHV;DXP;HUGO;MEDLINEPLUS;RAM|||
UTI|Urin tract infection NOS||||C0042029|ICD9CM|||
UTI|Urinary Tract Infections [Disease/Finding]||||C0042029|NDFRT|||
UTI|Urinary infection NOS (disorder)||||C0042029|SNOMEDCT|||
UTI|Urinary tract infection (& [NOS]) (disorder)||||C0042029|SNOMEDCT|||
UTI|Urinary tract infection, site not specified NOS (disorder)||||C0042029|SNOMEDCT|||
UTI|Urinary tract infectious disease (disorder)||||C0042029|SNOMEDCT|||
UTI|growth-inhibiting protein 19||||C1412376|HUGO|||
UTI|ulinastatin;urinary trypsin inhibitor|C0077906|||C0077906|MSH|1|0.0733|1
UTI|urinary tract|C0042027;C1508753|||||1|0.0063|
VAC|ACO||||C0054889|NCI;PDQ|||
VAC|CAV||||C0054889|PDQ|||
VAC|CAV chemotherapy protocol;CAV protocol;VADRC;cyclophosphamide/doxorubicin/vincristine protocol|C0054889|||C0054889|CHV;MSH;MTH;NCI;PDQ|||
VAC|CDV||||C0054889|NCI;PDQ|||
VAC|CHO||||C0054889|NCI;PDQ|||
VAC|CTX/DACT/VBL||||C0280063|NCI;PDQ|||
VAC|CTX/DACT/VCR||||C0077964|NCI;PDQ|||
VAC|CTX/DOX/VBL||||C0280062|NCI;PDQ|||
VAC|CTX/DOX/VCR||||C0054889|NCI;PDQ|||
VAC|CVA;VA-C|C0038454;C0054889|||C0054889|NCI;PDQ|||
VAC|Cyclophosphamide/Dactinomycin/Vinblastine;cyclophosphamide/dactinomycin/vinblastine||||C0280063|NCI;PDQ|||
VAC|Cyclophosphamide/Dactinomycin/Vincristine;cyclophosphamide/dactinomycin/vincristine||||C0077964|NCI;PDQ|||
VAC|Cyclophosphamide/Doxorubicin/Vinblastine;cyclophosphamide/doxorubicin/vinblastine||||C0280062|NCI;PDQ|||
VAC|Cyclophosphamide/Doxorubicin/Vincristine;cyclophosphamide/doxorubicin/vincristine||||C0054889|NCI;PDQ|||
VAC|OCA|C1015366|||C0054889|NCI;PDQ|||
VAC|VAC||||C0054889;C0077964;C0280062;C0280063|NCI;PDQ|||
VAC|VAC (CTX/DACT/VCR)||||C0077964|NCI;PDQ|||
VAC|VAC protocol;cyclophosphamide/dactinomycin/vincristine protocol|C0077964|||C0077964|MSH;MTH|||
VAC|cyclophosphamide/dactinomycin/vinblastine protocol||||C0280063|MTH|||
VAC|cyclophosphamide/doxorubicin/vinblastine protocol||||C0280062|MTH|||
VAC|vaccine|C0042210;C1552558|||||||1
VAC|vaccinia virus|C0042216|||||1|0.3559|
VAC|vacuum|C0042221|||||||1
VAC|vacuum-assisted closure|C1956080|1|1.000|||1|0.5593|1
VAC|ventriculoarterial connection||||||||1
VAC|ventriculoatrial condition||||||||1
VAC|ventriculoatrial conduction||||||1|0.0847|1
VAD|DM/DOX/VCR||||C0077973|NCI;PDQ|||
VAD|Dexamethasone/Doxorubicin/Vincristine;dexamethasone/doxorubicin/vincristine||||C0077973|NCI;PDQ|||
VAD|VAD;VAD I protocol|C0077973|||C0077973|MSH;NCI;PDQ|||
VAD|Vibroacoustic disease||||||1|0.049|
VAD|vascular access device|C0184269|1|0.026|C0184269|CHV|||1
VAD|vascular access dressing||||||||1
VAD|vascular atherosclerotic disease||||||1|0.0232|
VAD|vascular dementia|C0011269|||C0011269|CHV;ICD9CM;MSH;NCI;NDFRT;SNOMEDCT|||1
VAD|venous access device||||||||1
VAD|ventricular assist device|C0179926|1|0.174|C0179926|CHV;SNOMEDCT|1|0.5747|1
VAD|vertebral artery dissection|C0338586|||C0338586|CHV;MSH;NDFRT;SNOMEDCT|1|0.0361|1
VAD|vincristine adriamycin and dexamethasone;vincristine-Adriamycin-dexamethasone||1|0.792|||1|0.0284|
VAD|virus-adjusting diluent||||||||1
VAD|vitamin A deficiency|C0042842|||||1|0.1624|1
VAD|vitamin A-deficient||||||1|0.1263|
VATS|Surgeries, Video-Assisted Thoracic;Surgery, Thoracic, Video-Assisted;Surgery, Video-Assisted Thoracic;Thoracic Surgeries, Video-Assisted;Thoracic Surgery, Video Assisted;Thoracic Surgery, Video-Assisted;Video Assisted Thoracic Surgery;Video-Assisted Thoracic Surgeries;Video-Assisted Thoracic Surgery;Video-assisted Thoracic Surgery;Video-assisted thoracic surgery;video assisted thoracic surgery;video-assisted thoracic surgery;VATS;vats;VATSs;video-assisted thoracic surgery (VATS)|C0752151|1|1|C0752151|CHV;MSH;NCI|1|0.4494|1
VATS|Surgeries, Video-Assisted Thoracoscopic;Surgery, Video-Assisted Thoracoscopic;Thoracoscopic Surgeries, Video-Assisted;Thoracoscopic Surgery, Video-Assisted;Video Assisted Thoracoscopic Surgery;Video-Assisted Thoracoscopic Surgeries;Video-Assisted Thoracoscopic Surgery;video-assisted thoracoscopic surgery||||C0752151|MSH|1|0.4189|1
VATS|variable antigen types||||||1|0.0417|
VATS|variable antigen, surface||||||||1
VATS|video-assisted thoracic surgical||||||1|0.0241|
VATS|video-assisted thoracoscopic||||||1|0.0225|
VATS|video-assisted thoracoscopic surgical||||||1|0.0128|
VATS|video-assisted thoracoscopy||||||1|0.0305|1
VATS|video-assisted transthoracic surgery||||||||1
VBAC|VBAC;Vaginal Birth After Cesarean;Vaginal Birth after Cesarean;Vaginal Birth after Cesareans;Vaginal Births after Cesarean;Vaginal birth after cesarean;vaginal birth after Caesarean;vaginal birth after caesarean;vaginal birth after cesarean;vaginal births after cesarean|C0080301|1|1|C0080301|CHV;COSTAR;MSH;NCI|1|0.6154|1
VBAC|vaginal birth after cesarean delivery||||||1|0.1319|
VBAC|vaginal birth after cesarean section||||||1|0.2527|
VBG|Veronal-buffered gelatin||||||||1
VBG|Vertical banded gastroplasty;vertical banded gastroplasty|C0729258|1|0.598|||1|1|1
VBG|vagotomy and Billroth gastroenterostomy||||||||1
VBG|vascularized bone graft||||||||1
VBG|venoaortocoronary artery bypass graft||||||||1
VBG|venous blood gas||1|0.402|||||1
VBG|venous bypass graft||||||||1
VCUG|voiding cysto-urethrography;voiding cystourethrography||||||1|0.7867|
VCUG|voiding cystourethrogram|C0203123|1|1.000|||1|0.2133|
VDRL|VDRL;VDRL - Venereal diseases research laboratory test;Venereal Disease Research Laboratory (VDRL) test;venereal disease research laboratory (VDRL) test;VDRL test;VDRL test, NOS;vdrl test|C0201406|||C0201406|CHV;LNC;MTH;SNOMEDCT|||
VDRL|VDRL test (procedure)||||C0201406|SNOMEDCT|||
VDRL|Venereal Disease Research Laboratory;venereal disease research laboratory|C0042430|1|1|C0042430|MTH|1|0.9355|1
VDRL|Venereal Disease Research Laboratory (VDRL) test (procedure)||||C0201406|SNOMEDCT|||
VDRL|Venereal Disease Research Laboratory test;Venereal diseases research laboratory test||||C0201406|SNOMEDCT|1|0.0645|
VDRL|Venereal diseases research laboratory test (procedure)||||C0201406|SNOMEDCT|||
VK|V potassium||1|1.000|||||
VK|vervet kidney||||||||1
VK|vitamin K|C0042878;C2936884|||||1|1|
VLDL|Lipoprotein.pre-beta;Pre beta Lipoproteins;Pre-beta lipoprotein;Pre-beta-Lipoproteins;pre-beta Lipoprotein;Lipoproteins, VLDL;VLDL Lipoproteins;Lipoproteins, Very-Low-Density;Very Low Density Lipoproteins;Very low density lipoprotein;Very-Low-Density Lipoproteins;very low density lipoprotein;very low density lipoproteins;very-low-density lipoprotein;very-low-density lipoproteins;Prebeta Lipoproteins;Prebeta-Lipoproteins;VLDL - Very low density lipoprotein;very low density lipoprotein (VLDL)|C0023825|1|1|C0023825;C1325416|AOD;CHV;CSP;GO;LNC;MSH;MTH;NDFRT;SNOMEDCT|1|0.0693|1
VLDL|Lipoproteins, VLDL [Chemical/Ingredient]||||C0023825|NDFRT|||
VLDL|Serum VLDL Cholesterol Measurement;Serum VLDL cholesterol measurement;Serum VLDL cholesterol level;VLDL;vldl|C0428461|||C0023825;C0428461;C1325416|AOD;CHV;CSP;GO;MTH;NCI;SNOMEDCT|||
VLDL|Serum VLDL cholesterol measurement (procedure)||||C0428461|SNOMEDCT|||
VLDL|VLDL Cholesterol|C0023826;C0428461|||C0428461|NCI|||
VLDL|Very low density lipoprotein (substance)||||C0023825|SNOMEDCT|||
VLDL|lipoprotein cholesterol|C0065055|||||1|0.0037|
VLDL|low density||||||1|0.0436|
VLDL|low density lipoprotein|C0023823|||||1|0.8731|
VLDL|very-low-density||||||1|0.0104|
VLDL|very-low-density lipoprotein activity|C1325416|||C1325416|MTH|||
VP|ADH||||C0138318;C1706109|NCI|||
VP|ARVP||||C0138318;C1706109|NCI|||
VP|AVP||||C0138318;C1706109|NCI|||
VP|AVP wt Allele|C1706109|||C1706109|MTH;NCI|||
VP|AVP-NPII;AVRP|C0138318;C1706109|||C0138318;C1706109|NCI|||
VP|Arginine Vasopressin (Neurophysin II, Antidiuretic Hormone, Diabetes Insipidus, Neurohypophyseal) wt Allele||||C1706109|NCI|||
VP|Arginine Vasopressin-Neurophysin II Preproprotein;Prepro-Arginine-Vasopressin-Neurophysin II;Vasopressin-Neurophysin II-Copeptin|C0138318|||C0138318|MTH;NCI|||
VP|Arginine-vasopressin|C0003779;C1527128|||||1|0.006|
VP|CBDCA/VCR||||C0280102|NCI;PDQ|||
VP|CDDP and VBL chemotherapy protocol||||C0280544|CHV|||
VP|CDDP/DAVA||||C0280545|NCI;PDQ|||
VP|CDDP/VBL||||C0280544|NCI;PDQ|||
VP|Carboplatin/Vincristine;carboplatin/vincristine||||C0280102|NCI;PDQ|||
VP|Cisplatin/Vinblastine;cisplatin/vinblastine||||C0280544|NCI;PDQ|||
VP|Cisplatin/Vindesine;cisplatin/vindesine||||C0280545|NCI;PDQ|||
VP|Dean-Barnes syndrome;Deficiencies, Protoporphyrinogen Oxidase;PROTOPORPHYRINOGEN OXIDASE DEFICIENCY;Protoporphyrinogen Oxidase Deficiency;Protoporphyrinogen oxidase deficiency;Mixed porphyria;PORPHYRIA CUTANEA TARDA HEREDITARIA;PORPHYRIA VARIEGATA;Porphyria variegata;porphyria variegata;PORPHYRIA, MIXED HEPATIC;PORPHYRIA, SOUTH AFRICAN GENETIC;South African genetic porphyria;PORPHYRIA, VARIEGATE;Porphyria Variegate;Porphyria Variegates;Porphyria, Variegate;VARIEGATE PORPHYRIA;Variegate Porphyria;Variegate porphyria;Variegate, Porphyria;Variegates, Porphyria;porphyria variegate;porphyria variegated;variegate porphyria;PPOX DEFICIENCY;Protocoproporphyria;South African porphyria;VP - Variegate porphyria|C0162532|||C0162532|AOD;CHV;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.0312|1
VP|Nuclei ventrales posteriores;Nucleus, Ventral Posterior;Posterior Nucleus, Ventral;Ventral Posterior Nucleus;Ventral posterior nucleus;ventral posterior nucleus;Structure of ventral posterior nucleus of thalamus;Ventral Posterior Thalamic Nucleus;Ventral posterior thalamic nucleus;Ventrobasal complex;ventrobasal complex;Ventrobasal nucleus|C0228336|||C0228336|CHV;FMA;MSH;MTH;SNOMEDCT|||
VP|Nucleus ventralis posterior||||C0228336|FMA;SNOMEDCT|||
VP|Nucleus ventralis posterior (body structure)||||C0228336|SNOMEDCT|||
VP|PRDL/VCR||||C0078413|NCI;PDQ|||
VP|PROTOPORPHYRINOGEN OXIDASE DEFIC||||C0162532|MSH|||
VP|PVe;V-DDP;cisplatin/vinblastine protocol|C0280544|||C0280544|MTH;NCI;PDQ|||
VP|Porphyria, Variegate [Disease/Finding]||||C0162532|NDFRT|||
VP|Prednisolone/Vincristine;prednisolone/vincristine||||C0078413|NCI;PDQ|||
VP|Protoporphyrinogen oxidase deficiency (disorder)||||C0162532|SNOMEDCT|||
VP|Structure of ventral posterior nucleus of thalamus (body structure)||||C0228336|SNOMEDCT|||
VP|VP;{VP};Viral Particle Unit|C1883540|||C0078413;C0138318;C0162532;C0228336;C0280102;C0280544;C0280545;C1706109;C1883540;C2247213|FMA;GO;MTH;NCI;OMIM;PDQ|||
VP|VP protocol;prednisolone/vincristine protocol|C0078413|||C0078413|MSH;MTH|||
VP|Variegate porphyria (disorder)||||C0162532|SNOMEDCT|||
VP|VeP||||C0280544|PDQ|||
VP|Ventral posterior nucleus of thalamus|C0228336;C1284633|||C0228336|SNOMEDCT|||
VP|Vind-Plat;cisplatin/vindesine protocol (CDDP/DAVA)|C0280545|||C0280545|MTH;NCI;PDQ|||
VP|Viral Particle;Viral Particles;viral particles|C0042760;C1883540|||C1883540|NCI|1|0.0042|
VP|Voges-Proskauer||||||||1
VP|carboplatin/vincristine protocol||||C0280102|MTH|||
VP|cisplatin and vincristine chemotherapy protocol||||C0280544|CHV|||
VP|correction for the residual plasma volume||||||1|0.003|
VP|etoposide|C0015133|||||1|0.006|
VP|flow propagation velocity||||||1|0.0126|
VP|hybrid peroxidase activity;polyvalent peroxidase activity;versatile peroxidase activity|C2247213|||C2247213|GO;MTH|||
VP|plasma volume|C0032127|||||||1
VP|potential|C0035647|||||1|0.0072|
VP|principal sensory trigeminal nucleus|C0228701|||||1|0.0042|
VP|proteins|C0033684|||||1|0.0054|
VP|reactive-black-5:hydrogen-peroxide oxidoreductase activity||||C2247213|GO|||
VP|vagal paraganglioma|C0474819|||||||1
VP|vapor pressure|C0563290|||C0563290|AOD;MSH;SNOMEDCT|||1
VP|variably positive||||||||1
VP|vascular parkinsonism|C0393568|||||1|0.0162|
VP|vascular permeability|C0162337|||C0162337|CHV;MSH;SNOMEDCT|1|0.0192|1
VP|vasopressin|C0003779;C0042413;C1705480|||C0003779;C0042413;C0201849;C1705480|AOD;CHV;CSP;FMA;LCH;LNC;MSH;MTH;MTHSPL;NCI;NDFRT;PDQ;SNOMEDCT;USPMG;UWDA;VANDF|1|0.5357|1
VP|velopharyngeal||||||1|0.0144|1
VP|venipuncture|C0190979;C0600406;C1548758|||||||1
VP|venous plethysmograph||||||||1
VP|venous pressure|C0042486|||C0042486|CHV;LCH;MSH;SNOMEDCT|1|0.0132|1
VP|ventral|C1704448|||||1|0.0066|
VP|ventral pallidum|C2328531|||||1|0.0414|
VP|ventral posterior||||||1|0.0036|
VP|ventral prostate||||||1|0.0498|
VP|ventralis posterior||||||1|0.003|
VP|ventricle to peritoneal cavity||||||||1
VP|ventricular pacing||||||1|0.0156|1
VP|ventricular pericardium||||||||1
VP|ventricular peritoneal||1|1.000|||||1
VP|ventricular premature||||||||1
VP|ventriculo-peritoneal;ventriculoperitoneal||||||1|0.1434|
VP|ventroposterior||||||1|0.009|1
VP|ventroposterior nucleus||||||1|0.006|
VP|verapamil|C0042523|||||1|0.033|
VP|vertex potential||||||||1
VP|viral protein;virus protein|C0042736|||C0042736|NCI|1|0.0042|1
VP|visual perception|C0042789;C0042830|||||||1
VP|voiding pressure||||||||1
VP|volume plethysmograph|C0492284|||||||1
VP|volume-pressure||||||||1
VP|volumetric lung depth||||||||1
VP|vulnerable period||||||1|0.006|1
VQ|US Virgin Islands;US Virgin island;US Virgin islands||||C0042752|AOD;SNOMEDCT|||
VQ|US Virgin island (geographic location)||||C0042752|SNOMEDCT|||
VQ|United States Virgin Islands;United States Virgin island;Virgin Islands of the United States;VIR;VIRGIN ISLANDS;Virgin Islands;VIRGIN ISLANDS, U.S.;Virgin Islands, U.S.|C0042752|||C0042752|AOD;LCH;MSH;MTH;NCI;SNOMEDCT|||
VQ|VI|C0445379;C1706398|||C0042752|NCI|||
VQ|VQ||||C0042752|NCI|||
VQ|vector quantization||||||1|0.4545|
VQ|ventilation perfusion;ventilation-perfusion||1|1|||1|0.5455|
VQ|voice quality|C0042943|||C0042943|CHV;MSH;MTH|||1
VRE|VRE;vre;Vancomycin Resistant Enterococcus;Vancomycin resistant enterococcus;vancomycin-resistant Enterococcus;vancomycin-resistant enterococci;vancomycin-resistant enterococcus;vancomycin resistant enterococcus (VRE)|C1265175|1|1|C1265175|CHV;NCI;SNOMEDCT|1|0.9155|1
VRE|Vancomycin Resistant Enterococcus (organism);Vancomycin resistant enterococcus (organism)||||C1265175|SNOMEDCT|||
VRE|vancomycin-resistant Enterococcus faecium||||||1|0.0533|
VRE|vancomycin-resistant enterococcal||||||1|0.0313|
VRE|vision right eye||||||||1
VSD|DEFECT INTERVENTRICULAR SEPTUM;Defect, Intraventricular Septal;Defects, Intraventricular Septal;Intraventricular Septal Defect;Intraventricular Septal Defects;Septal Defect, Intraventricular;Septal Defects, Intraventricular;Defect, Ventricular Septal;Septal Defect, Ventricular;Septal Defects, Ventricular;VENTRICULAR SEPTAL DEFECT;Ventricular Septal Defect;Ventricular Septal Defects;Ventricular septal defect;Ventricular septal defect NOS;Ventricular septal defects;ventricular septal defect;ventricular septal defects;Heart Septal Defects, Ventricular;Interventricular septal defect;interventricular septal defect;SEPTUM INTERVENTRICULAR PATENT;VSD;vsd;VSD - Ventricular septal defect;Ventricular Septal Defect (VSD);Ventricular septal defect (VSD);Ventricular septal abnormality|C0018818|1|1|C0018818|AOD;CCS;CHV;COSTAR;CST;DXP;ICD9CM;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.9446|1
VSD|Heart Septal Defects, Ventricular [Disease/Finding]||||C0018818|NDFRT|||
VSD|Interventricular septal defect (disorder)||||C0018818|SNOMEDCT|||
VSD|Septal def.-ventricular;Ventricular septal def.||||C0018818|SNOMEDCT|||
VSD|Vaccine Safety Datalink||||||1|0.0123|1
VSD|Ventricular sept defect||||C0018818|ICD9CM|||
VSD|Ventricular septal abnormality (disorder)||||C0018818|SNOMEDCT|||
VSD|Ventricular septal defect (disorder);Ventricular septal defect NOS (disorder)||||C0018818|SNOMEDCT|||
VSD|Ventricular septal defect, unspecified||||C0018818|SNOMEDCT|||
VSD|Ventricular septal defect, unspecified (disorder)||||C0018818|SNOMEDCT|||
VSD|vascular surface density||||||1|0.0164|
VSD|vesical external sphincter dyssynergia||||||||1
VSD|vesicular stomatitis virus|C0042587;C0206548;C1623048|||||||1
VSD|virtually safe dose||||||1|0.0175|1
VSD|voltage-sensitive dye||||||1|0.0092|
VT|Holy See||||C0042427|NCI|||
VT|Holy See (Vatican City State)||||C0042427|NCI|||
VT|Lung tidal volume;lungs tidal volume;TV - Tidal volume;Tidal Volume;Tidal Volumes;Tidal volume;Volume, Tidal;Volumes, Tidal;tidal volume;tidal volumes;VT;vt;vts;VT - Tidal volume;tidal volume (vt);respiratory airway volume|C0040210|1|0.002|C0040210;C0042427;C0042514;C0042537|AOD;CHV;CSP;DXP;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.3243|1
VT|TACHYCARDIA VENTRICULAR;TACHYCARDIA, VENTRICULAR;Tachycardia, Ventricular;Tachycardia, ventricular;Tachycardias, Ventricular;VENTRICULAR TACHYCARDIA;Ventricular Tachycardia;Ventricular Tachycardias;Ventricular tachycardia;Ventricular tachycardia, NOS;ventricular tachycardia;ventricular tachycardia (V-tach)|C0042514;C1963247|1|0.98|C0042514;C1963247|CHV;COSTAR;CST;DXP;MSH;MTH;MTHICD9;NCI;NDFRT;OMIM;SNOMEDCT|1|0.5322|1
VT|Tachycardia - ventric.||||C0042514|SNOMEDCT|||
VT|Tachycardia, Ventricular [Disease/Finding]||||C0042514|NDFRT|||
VT|Tidal volume (observable entity)||||C0040210|SNOMEDCT|||
VT|V T;V>T<;t v;v t|C0039461;C0040210|||C0040210|CHV;SNOMEDCT|||
VT|V<sub>T</sub>||||C0040210|SNOMEDCT|||
VT|VA||||C0042427|NCI|||
VT|VAT;VATICAN CITY STATE;Vatican City|C0042427|||C0042427|AOD;LCH;MSH;MTH;NCI;SNOMEDCT|||
VT|VENTRICULAR TACHYARRHYTHMIA;Ventricular tachyarrhythmia;ventricular tachyarrhythmia;ventricular tachyarrhythmias;VT - Ventricular tachycardia;v tach|C0042514|||C0042514|CHV;COSTAR;SNOMEDCT|1|0.0135|1
VT|Vatican City (geographic location)||||C0042427|SNOMEDCT|||
VT|Ventilation tube;ventilation tube|C0850121;C1317862|||C0850121;C1317862|CHV;LNC;MTH;SNOMEDCT|1|0.0029|
VT|Ventricular tachyarrhythmia (disorder)||||C0042514|SNOMEDCT|||
VT|Ventricular tachycardia (disorder)||||C0042514|SNOMEDCT|||
VT|Ventricular techycardia||||C0042514|SNOMEDCT|||
VT|Vermont;vermont|C0042537|1|0.002|C0042537|AOD;CHV;LCH;MSH;MTH;NCI;SNOMEDCT|||
VT|Vermont (geographic location)||||C0042537|SNOMEDCT|||
VT|exposure to the trichothecene vomitoxin||||||1|0.001|
VT|insertion of ventilation tubes||||||1|0.0012|
VT|tetrazolium violet|C2603970|||||||1
VT|total ventilation||||||||1
VT|transepithelial potential||||||1|0.0053|
VT|transepithelial potential difference||||||1|0.0043|
VT|transepithelial voltage||||||1|0.0176|
VT|unsustained ventricular tachycardia||||||||1
VT|vacuum tube||||||||1
VT|vacuum tuberculin||||||||1
VT|validation therapy|C0556529|||||||1
VT|variable temperature||||||||1
VT|vasotocin|C0042418|||||1|0.0111|1
VT|venous thromboembolism|C1861172|||||1|0.0027|
VT|venous thrombosis|C0042487;C0517555|1|0.002|||1|0.0092|1
VT|venous tone||||||1|0.0012|
VT|ventilating tubes||||||1|0.0014|
VT|ventilatory threshold||||||1|0.035|
VT|ventral tegmentum||||||1|0.0019|
VT|vero cytotoxin;verocytotoxin;verotoxin|C0148323|||||1|0.0282|1
VT|video telemetry||||||||1
VT|vitellin|C0042892|||||1|0.0046|
VT|vocational training|C0204116|||||1|0.0012|
VT|volume transmission||||||1|0.0012|
WBC|Blood Cell Count, White;White Blood Cell Count;White blood cell count;white blood cell count|C0023508;C0427512|||C0023508;C0427512|AOD;CHV;MSH;MTH;SNOMEDCT|1|0.1588|
WBC|Blood Cell, White;Blood Cells, White;White Blood Cell;White Blood Cells;White blood cell;White blood cell, NOS;White blood cells;blood white cell;blood white cells;bloods cells white;white blood cell;white blood cells|C0023508;C0023516|1|1|C0023508;C0023516|AOD;CHV;FMA;MSH;NCI;SNOMEDCT|1|0.7498|1
WBC|Blood Corpuscle, White;Blood Corpuscles, White;Corpuscle, White Blood;Corpuscles, White Blood;White Blood Corpuscle;White Blood Corpuscles;blood corpuscles white;white blood corpuscle;Leucocyte;Leukocyte;Leukocyte, NOS;Leukocytes;leucocyte;leucocytes;leukocyte;leukocytes;Leukocyte (cell);cell leukocyte;Reticuloendothelial System, Leukocytes;WBC (white blood cell);WBC - White blood cell;white blood cell (WBC);White Cell;blood leukocytes;leukocytic|C0023516|||C0023508;C0023516|AOD;CHV;CSP;FMA;HL7V2.5;LNC;MSH;MTH;NCI;SNOMEDCT|1|0.054|
WBC|Count, Leukocyte;Counts, Leukocyte;Leukocyte Count;Leukocyte Counts;leukocyte count;Leukocyte Number;Number, Leukocyte;Leukocyte Numbers;Numbers, Leukocyte;WBC - White blood cell count;WBC count;WCC - White blood cell count;White Blood Cell Count procedure;White blood cell count (procedure);white blood cell count procedure;White blood cell count - observation;White blood cell test|C0023508|||C0023508|AOD;CHV;CSP;MSH;MTH;NCI;SNOMEDCT|||
WBC|WBC|C0023508;C0023516;C1882326|||C0023508;C0023516|CHV;LNC;MTH;NCI|||
WBC|White blood cell (cell)||||C0023516|SNOMEDCT|||
WBC|White blood cell test (procedure)||||C0023508|SNOMEDCT|||
WBC|weightbearing with crutches||||||||1
WBC|well-baby clinic||||||||1
WBC|white blood count||||||1|0.0332|
WBC|whole-body counter|C0043160|||||1|0.0043|
XRT|external beam radiation therapy|C1517033|||C1517033|MTH;NCI|||
XRT|external radiation therapy|C1517033;C1880643|||||||1
XRT|irradiation|C1282930;C1522449|||||1|0.1185|
XRT|radiation|C0034519;C0560559;C0851346;C1522449;C1524020;C1524021|||||1|0.1533|
XRT|radiation therapy|C0034619;C1522449|1|1.000|||1|0.3589|
